data_2km1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2km1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.6 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 12.8 t80 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -117.47 141.63 48.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.772 1.273 . . . . 0.0 111.347 -170.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.26 120.89 42.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.359 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.27 -161.13 9.69 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 123.59 1.661 . . . . 0.0 117.086 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.5 tp -127.95 139.9 52.31 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 111.795 -2.203 . . . . 0.0 107.196 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -124.37 129.28 50.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 162.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.455 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -123.34 120.07 31.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -176.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.0 pt -131.21 139.99 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.492 -0.755 . . . . 0.0 111.218 -167.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.4 129.69 36.09 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 166.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.31 -13.9 18.08 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 N-CA-C 120.205 3.117 . . . . 0.0 120.205 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.52 -50.2 66.13 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -163.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.28 -34.02 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.166 170.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.5 p -83.49 0.4 46.53 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 t -76.58 -6.01 50.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.687 1.585 . . . . 0.0 114.573 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.312 62.8 m -98.94 168.11 10.24 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 169.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.59 -6.72 16.41 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 N-CA-C 116.915 1.852 . . . . 0.0 116.915 -170.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.12 -50.19 20.55 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.721 1.146 . . . . 0.0 113.833 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.99 -31.44 70.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.656 0.662 . . . . 0.0 112.123 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.77 -47.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 122.232 -0.292 . . . . 0.0 111.044 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.35 -32.69 72.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.49 -49.09 52.05 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.4 t -61.83 -40.08 94.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.176 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.33 -34.2 77.6 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.3 70.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.287 1.403 . . . . 0.0 113.246 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.297 1.5 tm0? -54.85 -53.7 51.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.11 82.93 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.58 -50.03 14.88 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -25.54 61.14 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -85.8 -114.83 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.628 -0.67 . . . . 0.0 109.659 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -154.1 11.79 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.1 149.88 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.817 0.818 . . . . 0.0 111.778 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.6 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 88.6 tttt -128.44 137.88 52.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 162.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -88.75 139.45 30.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.3 t -117.21 -35.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.542 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -122.05 120.15 33.5 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -157.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -114.88 114.17 25.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -162.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.455 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 18.5 m-30 -119.05 120.57 37.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.56 HD21 ' H ' ' A' ' 43' ' ' ASN . 7.6 tt -91.47 149.37 21.73 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.49 -40.05 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.56 ' H ' HD21 ' A' ' 41' ' ' LEU . 21.2 m120 -80.51 -30.35 37.28 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.55 -31.44 42.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.33 -0.856 . . . . 0.0 112.823 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.42 -40.36 70.51 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.866 0.757 . . . . 0.0 112.107 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.46 -24.56 63.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.26 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.09 -35.26 37.2 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.71 -0.619 . . . . 0.0 111.42 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.41 15.15 6.07 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.937 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.6 m -75.07 -36.1 61.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.68 1.24 . . . . 0.0 113.834 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.71 111.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 122.766 1.269 . . . . 0.0 108.815 -165.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.2 m -133.28 115.15 14.59 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.259 18.1 tp -124.63 -52.94 1.69 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.293 -0.963 . . . . 0.0 113.308 -159.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -149.36 169.47 20.75 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -120.6 49.05 1.5 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 170.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.14 -86.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -100.22 62.29 1.1 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -160.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.473 ' C ' ' H ' ' A' ' 59' ' ' THR . 2.2 m-85 -112.15 22.06 15.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.827 166.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.48 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -161.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.473 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.03 115.53 6.7 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 168.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.487 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 14.0 t -119.59 134.51 62.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.601 -164.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.475 ' HE2' HG22 ' A' ' 92' ' ' ILE . 10.8 m80 -122.46 134.67 54.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.47 110.21 16.65 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.42 102.03 13.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.886 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -120.09 154.59 55.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 CA--C 1.537 0.639 0 C-N-CA 122.114 1.876 . . . . 0.0 115.148 170.45 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.7 t80 . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -82.16 149.71 15.43 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.773 0.954 . . . . 0.0 111.171 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.58 -39.77 94.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.68 -31.43 69.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.5 mt -76.67 -30.29 56.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.445 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.01 -37.59 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.045 1.293 . . . . 0.0 111.226 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.4 p -68.47 -39.15 81.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.112 1.324 . . . . 0.0 112.672 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.19 -39.77 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.912 -0.493 . . . . 0.0 112.201 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -39.34 93.37 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.62 -0.675 . . . . 0.0 112.683 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.95 -29.8 70.76 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.11 -10.02 55.6 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -99.82 16.51 23.46 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.3 mt -131.18 -174.11 3.29 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.526 1.155 . . . . 0.0 110.289 -168.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -140.04 174.93 3.53 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -170.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.4 -16.3 46.41 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 N-CA-C 118.341 2.401 . . . . 0.0 118.341 -170.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -102.27 45.06 0.98 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.467 1.03 . . . . 0.0 110.544 168.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.15 144.22 34.38 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 78.7 p -146.99 109.84 4.68 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.249 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.285 0.6 OUTLIER -93.29 129.96 39.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.805 -173.363 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.729 HD12 ' CB ' ' A' ' 116' ' ' CYS . 27.6 mm -113.34 84.56 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.471 1.032 . . . . 0.0 108.894 170.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -83.23 0.06 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 121.361 3.304 . . . . 0.0 121.361 -166.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.36 146.89 42.12 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.636 1.208 . . . . 0.0 110.308 -135.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.2 p -94.61 -129.4 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.535 -156.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.5 -48.51 15.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -158.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.69 -29.52 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 124.555 2.122 . . . . 0.0 111.339 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.532 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 87.0 m-85 -76.73 -14.4 59.95 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.834 -172.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.31 -55.24 37.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.824 -1.173 . . . . 0.0 112.571 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.86 -34.35 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.812 -0.555 . . . . 0.0 111.295 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.35 -42.0 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 173.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.49 -48.66 80.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.882 0.849 . . . . 0.0 112.334 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.15 -35.45 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.212 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -71.57 -18.81 62.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 33.92 3.94 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.673 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 72.6 m-85 -106.7 159.64 16.06 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.29 104.39 9.1 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.013 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.569 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.8 tt -83.7 110.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.787 1.28 . . . . 0.0 114.377 -167.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.6 tt -111.64 131.41 63.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 113.183 -1.826 . . . . 0.0 108.928 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -109.42 86.93 2.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 124.059 1.885 . . . . 0.0 112.181 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 114' ' ' ASP . 55.1 mt-10 -134.41 100.49 12.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -54.77 28.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 1 N-CA-C 124.663 4.832 . . . . 0.0 124.663 -144.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.8 p-10 -99.58 100.29 11.28 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 131.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -80.05 115.28 19.53 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.907 -0.496 . . . . 0.0 110.763 -164.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.249 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.4 p -147.24 -161.16 1.27 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 124.621 2.153 . . . . 0.0 115.177 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.569 ' CD1' HG13 ' A' ' 109' ' ' ILE . 19.0 m0 -137.4 126.28 24.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 109.71 -3.405 . . . . 0.0 106.462 -167.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.303 0.1 OUTLIER -112.65 111.22 35.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 O-C-N 121.365 -0.834 . . . . 0.0 109.483 177.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -79.1 134.28 36.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.2 ttt . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.539 170.599 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.602 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 6.6 t80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -117.7 141.83 47.95 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.98 141.86 32.23 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 162.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.7 -159.47 9.0 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 122.98 1.322 . . . . 0.0 116.243 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.01 139.51 46.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 113.172 -1.514 . . . . 0.0 107.379 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.7 tp -124.6 131.4 53.48 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.292 1.044 . . . . 0.0 108.506 170.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 120.18 38.82 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.133 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.0 pt -123.54 139.81 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -90.32 130.01 43.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.13 -18.23 9.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 121.603 3.655 . . . . 0.0 121.603 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.19 71.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 -158.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.16 -27.28 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.26 168.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.6 p -71.52 -14.29 62.07 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.7 m -76.62 -4.03 40.86 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 120.795 1.634 . . . . 0.0 111.933 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.326 96.3 m -98.55 168.18 10.25 Favored Pre-proline 0 CA--C 1.558 1.264 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.42 -0.69 10.87 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 N-CA-C 117.768 2.18 . . . . 0.0 117.768 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.05 -50.54 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.351 1.432 . . . . 0.0 113.952 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.18 -31.51 70.18 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.741 0.7 . . . . 0.0 112.422 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.4 -48.41 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 122.121 -0.362 . . . . 0.0 110.768 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -61.84 -33.25 73.82 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -47.45 60.51 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.405 ' HA ' HE21 ' A' ' 28' ' ' GLN . 6.8 t -63.26 -39.99 96.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.432 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -62.72 -34.75 77.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.684 -0.674 . . . . 0.0 112.776 169.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -44.34 72.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.167 1.349 . . . . 0.0 113.674 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.405 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.3 mt-30 -59.9 -53.16 61.09 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.766 0.317 . . . . 0.0 111.704 173.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.6 -37.73 76.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.32 -42.94 19.82 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -170.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.9 p -57.8 -20.14 33.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 170.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.77 -100.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -158.14 19.21 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -170.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.93 110.73 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -167.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.602 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 81.6 tttt -99.09 134.94 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -88.97 139.68 30.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.113 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.83 -31.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.34 -168.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -121.74 120.36 34.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -161.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -114.64 124.59 52.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -165.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -127.47 120.2 27.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.17 149.73 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 tp -63.21 -39.53 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -77.65 -30.31 52.05 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -80.48 -32.82 37.01 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.392 -0.818 . . . . 0.0 113.043 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -73.89 -40.59 63.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.294 0.952 . . . . 0.0 112.393 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -74.24 -20.43 60.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.768 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.5 -37.37 25.37 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.61 -0.681 . . . . 0.0 111.593 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.75 15.21 6.4 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 120.613 -0.803 . . . . 0.0 114.966 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -76.27 -31.63 58.39 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.813 1.307 . . . . 0.0 114.199 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.73 120.26 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -167.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.5 m -122.59 120.05 32.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.046 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -122.35 -161.65 0.95 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.84 170.02 9.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.82 1.295 . . . . 0.0 111.202 -169.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -115.26 71.6 0.77 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.336 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.94 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -97.13 43.66 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -157.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 59' ' ' THR . 2.6 m-85 -112.21 21.68 15.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 117.545 -1.217 . . . . 0.0 110.685 -170.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.65 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -158.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 57' ' ' TYR . 7.0 t -134.37 115.31 13.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 164.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 65.9 t -119.43 110.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -163.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.49 ' HE2' HG22 ' A' ' 92' ' ' ILE . 13.7 m80 -107.63 134.29 50.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.36 110.52 15.26 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.122 -0.986 . . . . 0.0 110.165 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.94 100.32 8.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.1 m -119.96 88.63 40.89 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 CA--C 1.536 0.621 0 C-N-CA 122.185 1.923 . . . . 0.0 111.749 170.231 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.1 t80 . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -82.33 149.91 15.16 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 120.659 0.906 . . . . 0.0 112.088 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -62.45 -35.42 79.23 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -60.34 -34.34 73.7 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.55 -30.4 57.07 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.655 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.9 -38.52 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 120.357 1.435 . . . . 0.0 111.298 171.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 95.2 p -69.18 -40.74 77.94 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.79 1.177 . . . . 0.0 113.11 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.1 -38.64 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.799 -0.563 . . . . 0.0 112.262 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -33.84 71.62 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.82 -29.77 69.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -69.16 -9.83 54.78 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.4 m -97.99 29.83 3.3 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.15 171.02 14.82 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.359 1.076 . . . . 0.0 112.989 -162.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 49.7 mttm -122.39 -158.02 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 170.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 10.7 Cg_endo -67.65 -43.72 5.2 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 119.834 2.974 . . . . 0.0 119.834 -163.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -90.51 63.29 5.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 122.386 2.357 . . . . 0.0 111.495 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.31 133.99 13.61 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 170.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.6 p -139.16 159.27 42.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.16 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.251 1.1 tt -127.94 129.62 47.12 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.819 HD13 ' CB ' ' A' ' 116' ' ' CYS . 24.8 mm -112.3 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.914 0.864 . . . . 0.0 109.41 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.419 ' HA3' HD11 ' A' ' 94' ' ' LEU . . . -143.72 -79.27 0.04 OUTLIER Glycine 0 C--N 1.318 -0.445 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 -161.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.421 HD11 HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.65 171.15 7.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.962 1.363 . . . . 0.0 111.121 -139.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 m -92.97 -162.74 0.96 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.178 -1.373 . . . . 0.0 113.318 -164.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.17 -36.49 84.38 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.25 -32.63 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 124.817 2.246 . . . . 0.0 111.283 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 93.8 m-85 -76.81 -12.23 59.94 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.501 -172.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HZ1' ' HB2' ' A' ' 99' ' ' LYS . 4.5 ttmp? -58.94 -53.63 56.24 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.815 -1.178 . . . . 0.0 112.367 169.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.04 -37.1 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.802 -0.561 . . . . 0.0 111.068 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.57 -45.57 93.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.92 172.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.02 74.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.871 -0.518 . . . . 0.0 111.72 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.58 -50.1 70.98 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.655 0.74 . . . . 0.0 112.748 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.35 -34.22 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -71.79 -17.8 62.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.69 29.94 5.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 92.2 m-85 -106.46 159.66 15.99 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -127.55 107.6 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.642 HD13 ' HH ' ' A' ' 115' ' ' TYR . 16.9 tt -76.18 149.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.484 1.135 . . . . 0.0 111.914 -167.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.08 125.13 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.47 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -106.48 100.0 9.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.483 1.611 . . . . 0.0 111.302 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -134.06 175.2 3.85 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 112.449 -2.16 . . . . 0.0 107.252 -170.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -54.97 -19.97 21.5 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.82 109.97 19.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 156.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.642 ' HH ' HD13 ' A' ' 109' ' ' ILE . 5.9 t80 -87.11 111.11 20.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.637 -0.664 . . . . 0.0 109.258 -170.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.16 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 17.6 p -147.26 -157.18 0.79 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 124.251 1.977 . . . . 0.0 112.694 174.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.61 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.4 m0 -137.25 149.93 47.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 110.305 -3.134 . . . . 0.0 104.421 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.74 144.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.363 161.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 10.0 tmtt? -91.64 134.47 34.66 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 108.765 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.665 0.745 . . . . 0.0 110.563 -170.016 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 122.22 1.009 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.3 147.23 24.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.813 1.292 . . . . 0.0 112.419 -165.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.21 120.88 42.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.653 170.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.32 -160.98 10.41 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 118.446 -1.835 . . . . 0.0 115.418 170.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 139.85 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -164.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.371 0.2 OUTLIER -124.8 129.29 50.15 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.143 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.416 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 8.0 mp -116.04 120.36 38.84 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.489 HG13 ' HG1' ' A' ' 16' ' ' THR . 6.7 tt -130.29 139.48 51.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.902 0.858 . . . . 0.0 109.681 -167.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -103.19 129.67 25.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -9.32 17.5 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 N-CA-C 122.032 3.82 . . . . 0.0 122.032 -170.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.36 70.04 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.546 2.424 . . . . 0.0 117.546 -158.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.2 t -93.06 -30.69 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.23 0.923 . . . . 0.0 108.809 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.489 ' HG1' HG13 ' A' ' 11' ' ' ILE . 67.4 p -80.21 0.26 33.22 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -170.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -76.41 9.3 2.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.42 1.463 . . . . 0.0 113.134 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.332 64.2 m -99.03 168.34 9.85 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 164.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -77.45 -3.99 14.21 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 117.734 2.167 . . . . 0.0 117.734 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -50.4 19.23 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -164.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -29.89 67.9 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.886 0.766 . . . . 0.0 112.752 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.7 t -70.4 -44.29 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.498 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.63 -34.1 72.36 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.052 -1.03 . . . . 0.0 113.634 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.44 72.68 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -58.88 -47.85 83.48 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -29.82 70.18 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -47.54 64.6 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.386 0.994 . . . . 0.0 112.815 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.304 1.4 tm0? -54.98 -52.49 62.92 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -33.5 69.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.31 -50.16 19.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.1 m -60.72 -34.67 74.74 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 170.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.94 -131.02 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -145.1 5.71 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.418 HG21 HG22 ' A' ' 59' ' ' THR . 4.1 p -98.93 154.1 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.681 0.753 . . . . 0.0 111.742 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -128.03 142.43 51.23 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 166.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.73 100.65 12.83 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.637 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.18 -30.79 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.749 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.83 169.64 10.57 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.615 1.198 . . . . 0.0 109.769 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -142.68 116.46 9.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.416 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 14.3 m-30 -118.73 115.34 24.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.74 149.51 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 tp -63.63 -40.26 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.08 -30.25 31.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.77 -29.09 18.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.087 0.858 . . . . 0.0 112.785 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.84 -40.45 79.42 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.015 1.279 . . . . 0.0 111.471 170.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.17 -27.91 66.83 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.97 19.54 19.89 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.54 11.22 45.11 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 117.459 1.743 . . . . 0.0 117.459 152.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -82.8 -23.6 33.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -167.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.8 mt -114.63 167.82 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.464 1.029 . . . . 0.0 110.364 -161.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 m -99.73 117.42 34.05 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.718 1.247 . . . . 0.0 110.488 -173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -96.83 120.35 37.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.242 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -107.58 120.27 41.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 166.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -84.83 67.8 10.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.461 -170.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -74.32 0.07 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -100.27 45.78 0.97 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -160.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.27 21.48 15.74 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.701 165.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.598 ' HG3' ' H ' ' A' ' 86' ' ' LYS . 8.9 mm-40 -61.67 58.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 171.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.418 HG22 HG21 ' A' ' 34' ' ' VAL . 10.7 t -146.69 113.12 5.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 144.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.448 HG13 ' H ' ' A' ' 92' ' ' ILE . 0.6 OUTLIER -99.91 134.15 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 -170.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.506 ' HE2' HG22 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -122.58 134.56 54.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 167.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.79 110.74 16.72 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.965 0.888 . . . . 0.0 109.314 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.45 100.39 11.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.575 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -125.67 107.39 26.19 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.537 0.644 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 -162.226 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.1 t80 . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.92 149.7 50.39 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.714 1.609 . . . . 0.0 112.243 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.42 -31.91 72.68 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.69 -33.95 70.73 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.4 mt -76.79 -30.23 56.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.017 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -37.22 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 119.325 0.966 . . . . 0.0 111.382 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 97.1 p -70.52 -39.71 73.91 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.812 1.187 . . . . 0.0 112.717 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.03 -46.26 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.562 0.619 . . . . 0.0 111.448 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.05 -30.54 65.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.59 70.72 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -80.77 -9.94 59.77 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -171.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 p -97.74 50.95 1.05 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.1 159.93 28.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -156.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.598 ' H ' ' HG3' ' A' ' 58' ' ' GLU . 69.4 mmtt -100.5 174.9 2.65 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 110.67 -2.968 . . . . 0.0 106.417 163.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -53.21 -28.53 42.53 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 118.629 2.511 . . . . 0.0 118.629 170.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -102.07 70.93 1.23 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.266 . . . . 0.0 110.968 170.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.43 131.74 24.64 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 163.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -147.44 120.21 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.607 1.194 . . . . 0.0 108.241 -170.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.171 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.254 0.5 OUTLIER -106.36 129.96 54.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.195 -166.908 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.659 HD12 ' CB ' ' A' ' 116' ' ' CYS . 26.3 mm -111.21 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.963 1.256 . . . . 0.0 108.269 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' HD12 ' A' ' 94' ' ' LEU . . . -143.92 -94.46 0.19 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 121.579 3.392 . . . . 0.0 121.579 -166.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.45 ' HB2' ' CB ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -115.48 146.83 41.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.867 -137.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.3 m -107.21 -130.14 0.29 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.078 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.95 128.48 33.73 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.68 -13.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 2 O-C-N 114.952 -4.842 . . . . 0.0 117.848 11.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.3 m-85 -76.26 -0.79 23.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.591 -2.095 . . . . 0.0 113.155 -152.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.66 -55.74 10.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.74 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.58 -33.75 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.984 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.587 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.26 -41.42 96.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.311 -0.956 . . . . 0.0 113.123 172.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.89 94.07 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.929 -0.482 . . . . 0.0 111.246 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 tp -55.86 -50.06 71.63 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.619 0.723 . . . . 0.0 112.419 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.1 tt -80.04 -34.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.567 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.63 -16.21 62.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.29 4.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.076 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 76.7 m-85 -106.47 159.7 15.96 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.11 154.17 32.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.629 HG12 ' CD1' ' A' ' 117' ' ' TRP . 17.0 mt -104.32 153.25 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.98 1.371 . . . . 0.0 109.899 -171.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.7 tp -151.16 135.0 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.779 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -115.99 88.36 2.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.006 1.86 . . . . 0.0 112.295 -171.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -134.34 100.38 12.74 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -170.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -54.95 29.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.102 1 N-CA-C 124.372 4.72 . . . . 0.0 124.372 -141.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.86 105.63 17.39 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 132.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.498 ' HH ' HG23 ' A' ' 109' ' ' ILE . 22.8 t80 -79.86 115.36 19.4 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.816 -0.552 . . . . 0.0 110.052 -166.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.171 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.79 -161.31 1.3 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 124.143 1.925 . . . . 0.0 115.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.629 ' CD1' HG12 ' A' ' 109' ' ' ILE . 24.5 m0 -137.05 149.71 47.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 110.384 -3.098 . . . . 0.0 103.905 -165.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.4 mm -110.97 144.72 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 162.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 9.2 tmtt? -93.72 110.01 21.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 18.6 mmt . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 122.017 0.913 . . . . 0.0 112.2 -168.451 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.587 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 6.4 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.76 141.84 48.25 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.122 -0.986 . . . . 0.0 111.134 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.95 141.42 30.15 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.15 -161.74 9.71 Favored Glycine 0 N--CA 1.466 0.696 0 CA-C-O 124.196 1.998 . . . . 0.0 116.319 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.22 143.77 48.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 110.922 -2.639 . . . . 0.0 107.437 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 136.11 54.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.394 1.092 . . . . 0.0 109.106 170.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mt -113.67 120.2 40.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.104 -1.407 . . . . 0.0 107.657 164.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.731 HG22 ' HG1' ' A' ' 16' ' ' THR . 3.3 mp -113.62 139.8 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -95.48 129.47 34.78 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 165.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.44 -9.53 18.26 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 N-CA-C 120.872 3.374 . . . . 0.0 120.872 -170.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 -50.31 64.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -161.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -87.33 -29.05 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.119 170.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.731 ' HG1' HG22 ' A' ' 11' ' ' ILE . 76.1 p -80.78 0.48 34.56 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -170.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.2 m -76.2 0.09 20.32 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 120.197 1.362 . . . . 0.0 111.599 166.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 m -114.26 71.36 2.17 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 161.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.72 52.85 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.038 3.158 . . . . 0.0 116.808 -154.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.96 -39.85 79.24 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.671 -1.268 . . . . 0.0 112.233 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.43 -29.96 68.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.77 -46.5 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 122.227 -0.296 . . . . 0.0 110.939 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.76 -38.48 78.57 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -66.89 -49.97 63.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.481 ' HA ' HE21 ' A' ' 28' ' ' GLN . 7.9 t -61.82 -38.63 88.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.376 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -63.71 -34.45 77.89 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.15 -40.54 78.13 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.481 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.1 mt-30 -64.25 -51.9 61.32 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.04 -0.412 . . . . 0.0 111.631 173.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.6 75.13 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.49 73.53 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -75.04 -22.6 58.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.092 0.86 . . . . 0.0 112.223 -170.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.87 -103.77 0.06 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.306 0.574 . . . . 0.0 109.809 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -161.81 10.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -166.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.67 149.71 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.877 0.846 . . . . 0.0 112.196 170.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 87.5 tttt -128.58 136.12 50.29 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -88.91 139.58 30.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.849 0.833 . . . . 0.0 108.758 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.05 -41.12 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.536 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -121.94 169.83 10.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.579 1.18 . . . . 0.0 111.176 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -137.28 125.12 22.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.282 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -121.59 149.12 43.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 117.301 -1.759 . . . . 0.0 109.189 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -123.47 111.27 16.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.6 tp -49.8 -35.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.23 -30.37 43.19 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.802 1.183 . . . . 0.0 113.737 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -81.76 -28.94 33.02 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.227 -0.92 . . . . 0.0 113.139 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.45 -40.6 85.42 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.3 0.955 . . . . 0.0 112.057 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -70.32 -23.34 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.97 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.02 -37.66 33.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.49 -0.756 . . . . 0.0 111.493 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.22 15.27 5.16 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -72.32 -28.27 62.96 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -114.81 120.46 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.737 0.78 . . . . 0.0 109.254 -165.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -108.02 120.37 42.12 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.505 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.579 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 15.2 tp -120.52 -165.95 1.26 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.933 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.579 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 48.1 mt-10 -98.62 -176.02 3.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.611 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -120.15 65.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.11 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HE2' ' HZ1' ' A' ' 86' ' ' LYS . 78.4 mttt -100.04 53.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -159.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.48 ' C ' ' H ' ' A' ' 59' ' ' THR . 7.2 m-85 -112.63 21.74 15.29 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 116.903 -1.522 . . . . 0.0 112.079 166.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -61.81 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -162.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.11 115.47 6.65 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 164.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 93.4 t -111.2 134.66 52.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -165.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.501 ' HE2' HG22 ' A' ' 92' ' ' ILE . 4.2 m80 -122.53 134.86 54.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 141.34 52.07 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.03 1.741 . . . . 0.0 109.286 164.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.0 tp -124.56 90.44 3.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.724 -170.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.5 m -138.01 114.46 9.21 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo . . . . . 0 CA--C 1.533 0.468 0 C-N-CA 122.509 2.14 . . . . 0.0 115.941 -170.095 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 5.5 t80 . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 111.571 0.211 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 17.4 Cg_exo -82.14 149.93 15.55 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.206 1.271 . . . . 0.0 111.207 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -62.35 -37.16 84.59 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.59 -30.88 70.1 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -76.81 -30.09 56.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.4 mt -64.4 -35.03 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 119.915 1.234 . . . . 0.0 111.63 168.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.5 p -69.56 -36.57 76.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.505 1.502 . . . . 0.0 112.688 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.34 -39.62 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.751 -0.593 . . . . 0.0 111.728 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -40.87 97.05 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.698 -0.626 . . . . 0.0 112.655 174.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.85 70.76 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.12 -10.09 59.17 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.1 m -100.32 28.52 4.92 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mp -134.26 160.03 39.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 122.59 1.186 . . . . 0.0 111.238 -164.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HZ1' ' HE2' ' A' ' 56' ' ' LYS . 87.9 mttt -105.18 174.92 2.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.37 166.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.54 -25.33 32.21 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 118.581 2.493 . . . . 0.0 118.581 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.65 57.38 1.15 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.774 1.17 . . . . 0.0 110.208 168.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.9 145.98 36.01 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 167.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.6 p -141.62 159.27 42.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.234 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.343 1.7 tm? -128.19 129.48 46.54 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -170.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.794 HD13 ' HB3' ' A' ' 116' ' ' CYS . 44.2 mm -121.03 79.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.632 1.56 . . . . 0.0 110.019 170.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.25 -83.24 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 120.518 2.967 . . . . 0.0 120.518 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.452 HD12 HD13 ' A' ' 91' ' ' LEU . 1.1 mt -116.54 146.93 42.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.486 -1.357 . . . . 0.0 111.024 -132.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -102.41 -109.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.068 -156.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.26 -60.19 2.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -157.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 mt -61.13 -26.63 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 124.253 1.978 . . . . 0.0 111.605 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.445 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 10.5 m-85 -76.56 -19.77 57.55 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.987 -171.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.37 -56.18 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.965 -1.085 . . . . 0.0 113.013 168.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.07 -35.23 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.824 -0.548 . . . . 0.0 111.324 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -58.63 -45.34 89.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 171.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.52 -43.78 84.58 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.569 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -54.96 -49.88 70.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 112.72 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.3 tt -80.24 -34.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.72 30.51 5.19 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.076 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 47.7 m-85 -106.62 159.5 16.15 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 168.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.26 110.22 15.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.669 HD12 ' HH ' ' A' ' 115' ' ' TYR . 15.2 tt -74.92 148.55 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 122.487 1.137 . . . . 0.0 111.873 -171.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -149.65 126.98 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.97 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -109.65 98.81 8.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 123.418 1.58 . . . . 0.0 111.582 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -134.31 178.45 1.76 Allowed Pre-proline 0 N--CA 1.472 0.652 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.148 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.55 -7.99 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 N-CA-C 118.732 2.551 . . . . 0.0 118.732 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -128.4 115.23 17.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 157.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.669 ' HH ' HD12 ' A' ' 109' ' ' ILE . 10.7 t80 -85.44 111.29 19.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.227 -169.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.234 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 19.9 p -147.24 -158.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 124.424 2.059 . . . . 0.0 113.672 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.605 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.0 m0 -137.15 149.89 47.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 110.096 -3.229 . . . . 0.0 104.213 -169.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.43 144.59 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 164.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 16.1 ttpt -94.5 110.37 22.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.975 -1.078 . . . . 0.0 109.873 167.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 109.501 -170.341 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.623 ' HH ' ' HG3' ' A' ' 35' ' ' LYS . 7.5 t80 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -96.61 141.95 29.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.744 1.259 . . . . 0.0 112.929 -160.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.415 ' HG1' ' CG2' ' A' ' 37' ' ' VAL . 0.7 OUTLIER -98.38 120.45 38.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.525 169.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.416 ' HA3' ' CG2' ' A' ' 59' ' ' THR . . . -133.0 -164.92 11.02 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.889 175.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.42 141.65 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -164.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -124.13 134.79 53.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.945 1.355 . . . . 0.0 107.855 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -122.7 120.07 32.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.761 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mt -118.14 139.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.21 129.71 24.65 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 165.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -59.85 -13.61 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 N-CA-C 121.48 3.608 . . . . 0.0 121.48 -170.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.54 60.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -161.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.1 m -88.92 -27.78 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.914 0.779 . . . . 0.0 110.715 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -76.36 -14.46 60.09 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -170.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.87 2.23 15.2 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.264 1.393 . . . . 0.0 112.067 -170.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.304 86.1 m -98.85 168.62 9.44 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 166.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -77.18 -9.24 17.76 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 118.298 2.384 . . . . 0.0 118.298 -170.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.43 -50.47 18.31 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -165.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.16 -29.81 67.91 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.744 0.702 . . . . 0.0 112.417 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.15 -50.01 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.852 -0.53 . . . . 0.0 110.453 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.45 -36.99 79.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -60.07 -50.03 75.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.421 ' HA ' HE21 ' A' ' 28' ' ' GLN . 13.8 t -66.4 -39.8 89.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.786 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -61.8 -33.3 73.88 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -36.33 77.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.421 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.5 mt-30 -60.17 -56.9 15.93 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.991 -0.443 . . . . 0.0 111.172 172.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.2 77.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.97 63.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 95.7 p -59.85 -28.6 67.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 170.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -85.92 -124.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.616 -0.678 . . . . 0.0 110.017 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -136.27 9.95 3.23 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -170.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.63 150.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.596 0.712 . . . . 0.0 109.884 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.623 ' HG3' ' HH ' ' A' ' 4' ' ' TYR . 61.8 mttm -128.24 136.55 51.2 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 163.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.91 100.87 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.211 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.415 ' CG2' ' HG1' ' A' ' 6' ' ' THR . 27.8 m -81.47 -24.52 10.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.429 -1.714 . . . . 0.0 114.409 -164.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -121.71 169.75 10.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.279 1.038 . . . . 0.0 111.299 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -146.89 125.23 12.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.818 -169.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.433 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 31.0 m-85 -130.99 149.94 52.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.42 156.67 20.49 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.03 -40.08 87.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.147 -0.971 . . . . 0.0 113.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -82.02 -30.34 31.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -82.83 -30.48 28.69 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.403 1.001 . . . . 0.0 112.967 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.92 -40.56 68.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.207 0.912 . . . . 0.0 112.364 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -74.99 -19.47 60.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.767 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.28 -37.33 21.82 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.798 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.54 15.09 8.37 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -79.6 -17.63 53.44 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.4 mt -114.93 120.38 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.0 m -110.82 107.94 17.6 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.29 1.043 . . . . 0.0 110.929 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -131.15 172.99 11.48 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.435 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.16 177.69 5.32 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.833 -1.167 . . . . 0.0 110.477 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -120.03 70.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.037 -158.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.02 -83.37 0.06 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -99.91 45.15 0.99 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -156.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -112.24 21.77 15.45 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 116.325 -1.798 . . . . 0.0 112.041 -170.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.38 42.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -155.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.416 ' CG2' ' HA3' ' A' ' 7' ' ' GLY . 10.3 t -141.64 115.11 8.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 159.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 92' ' ' ILE . 0.9 OUTLIER -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 100.679 -3.823 . . . . 0.0 100.679 -170.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.475 ' HE2' HG22 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -122.24 134.53 54.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 167.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.48 110.7 16.79 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.267 18.5 tp -97.61 114.05 25.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.186 0.993 . . . . 0.0 111.507 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.409 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 27.7 m -149.28 154.88 39.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 79.7 Cg_exo . . . . . 0 CA--C 1.536 0.575 0 C-N-CA 122.215 1.943 . . . . 0.0 114.013 170.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.1 t80 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -82.12 149.53 15.46 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 CA-C-N 121.071 1.418 . . . . 0.0 110.158 -173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.65 -36.14 81.89 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -35.69 74.9 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.82 -30.19 56.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.099 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.08 -38.2 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 119.777 1.171 . . . . 0.0 111.133 168.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.7 m -68.02 -37.24 81.18 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.347 0.976 . . . . 0.0 112.634 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.28 -41.52 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.263 0.483 . . . . 0.0 111.808 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.84 -41.22 97.88 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.44 1.018 . . . . 0.0 112.362 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.93 -29.82 70.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.79 -9.94 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.7 m -84.96 -18.11 35.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.68 170.6 9.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 120.06 1.3 . . . . 0.0 111.914 -164.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.506 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 75.5 mttt -108.61 -164.9 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -170.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 12.9 Cg_endo -62.94 -29.73 76.22 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 123.159 2.164 . . . . 0.0 113.715 -170.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -102.07 41.27 1.23 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.46 145.68 29.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -147.13 117.52 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.363 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.278 0.6 OUTLIER -89.53 143.86 26.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.826 -1.988 . . . . 0.0 107.334 -173.279 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.985 HD12 ' CB ' ' A' ' 116' ' ' CYS . 46.4 mm -128.07 88.84 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.858 1.208 . . . . 0.0 108.868 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.15 -76.56 0.03 OUTLIER Glycine 0 C--N 1.316 -0.539 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.276 4.2 mp -115.56 169.89 8.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 122.688 1.233 . . . . 0.0 109.336 -129.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.81 -120.71 0.29 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.932 -157.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.1 -53.66 6.49 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 121.216 1.825 . . . . 0.0 115.792 -158.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.83 -29.9 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 124.86 2.267 . . . . 0.0 111.903 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.8 m-85 -76.97 -20.44 56.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.29 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -53.89 -55.36 27.58 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.797 -1.189 . . . . 0.0 112.427 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.12 -32.73 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.885 -0.51 . . . . 0.0 111.667 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.548 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.74 -43.79 97.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 173.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.4 88.94 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.05 -48.96 78.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.789 0.804 . . . . 0.0 112.526 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.17 -35.36 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.115 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -71.81 -17.59 62.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.7 31.6 4.78 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 119.285 -1.436 . . . . 0.0 112.523 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 50.6 m-85 -106.6 159.52 16.13 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -124.61 103.69 8.28 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.622 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.5 tt -78.67 142.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 122.707 1.242 . . . . 0.0 111.62 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.07 127.85 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.401 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -109.78 100.07 9.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.529 -1.668 . . . . 0.0 110.509 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.6 -174.86 0.29 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.353 170.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -56.37 -10.54 4.95 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 N-CA-C 118.935 2.629 . . . . 0.0 118.935 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -119.39 149.56 41.63 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 154.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -113.68 114.73 26.79 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 -170.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.363 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 28.1 p -147.73 -156.31 0.71 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.973 1.368 . . . . 0.0 114.651 170.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.622 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.9 m0 -137.21 127.7 26.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.919 -1.946 . . . . 0.0 108.28 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -108.78 110.83 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.56 -1.338 . . . . 0.0 110.183 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -79.58 110.07 14.55 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.104 0.954 . . . . 0.0 111.167 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.728 -170.296 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -106.53 142.03 36.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 122.375 1.083 . . . . 0.0 111.834 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.1 t -103.02 120.74 41.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 168.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.403 ' HA3' ' CG2' ' A' ' 59' ' ' THR . . . -128.34 -159.6 10.07 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 118.405 -1.855 . . . . 0.0 113.32 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.25 144.46 48.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -170.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.26 0.1 OUTLIER -124.51 129.41 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 172.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -111.53 120.15 41.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.074 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 pt -124.52 139.63 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.428 ' CD2' HG23 ' A' ' 64' ' ' THR . 6.3 t60 -97.24 130.34 29.88 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -54.5 -20.73 21.67 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 N-CA-C 120.931 3.396 . . . . 0.0 120.931 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.73 72.68 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.977 1.717 . . . . 0.0 112.669 -164.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -96.07 -29.53 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -171.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.5 p -85.99 0.02 54.35 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -170.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.2 m -76.46 -5.06 45.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.431 1.469 . . . . 0.0 112.816 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.315 79.7 m -98.7 168.08 10.37 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 167.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.63 -9.45 17.19 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 N-CA-C 117.598 2.115 . . . . 0.0 117.598 -170.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.06 -50.19 20.74 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -163.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.08 -31.83 70.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.784 0.72 . . . . 0.0 112.057 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.45 -47.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.637 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.13 -33.89 74.12 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.93 -47.91 60.57 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -62.62 -39.71 94.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.54 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.01 -31.89 73.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.01 -45.97 69.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.11 1.323 . . . . 0.0 112.332 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.03 -51.25 66.87 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.93 82.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.19 -50.08 13.74 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 t -57.94 -28.18 64.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 170.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.99 -127.87 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.495 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -130.05 6.78 5.03 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -104.45 150.82 7.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.863 0.84 . . . . 0.0 109.98 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -127.99 141.11 51.62 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 164.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -100.32 100.51 11.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.006 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.78 -28.89 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.995 -163.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -121.91 169.63 10.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.329 1.062 . . . . 0.0 110.395 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -147.7 111.6 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -160.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 13.7 m-30 -119.01 120.47 37.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.5 mt -86.31 149.65 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.15 -39.73 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -78.03 -30.42 49.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.39 -25.48 29.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.492 1.042 . . . . 0.0 113.225 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -40.19 74.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.842 1.201 . . . . 0.0 111.924 173.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -74.0 -21.07 60.13 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -88.3 -45.94 9.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.415 -0.803 . . . . 0.0 111.992 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.87 15.19 2.16 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 171.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -76.86 -13.55 59.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 120.213 2.006 . . . . 0.0 115.608 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.67 121.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.0 t -98.83 159.35 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 124.245 1.974 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.2 tp -130.44 120.54 24.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.217 -2.72 . . . . 0.0 111.309 -151.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.57 116.07 30.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.564 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -91.44 80.23 5.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.067 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.98 -78.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.16 14.2 20.81 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -155.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.553 ' C ' ' H ' ' A' ' 59' ' ' THR . 10.6 m-85 -83.43 21.49 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.966 -170.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.65 27.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.553 ' H ' ' C ' ' A' ' 57' ' ' TYR . 10.1 t -126.51 113.08 16.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.226 1.013 . . . . 0.0 108.938 160.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.2 t -107.65 110.33 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -97.77 134.25 41.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.61 141.37 46.47 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 168.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.7 mt -123.83 91.27 3.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.175 170.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 12' ' ' HIS . 86.1 m -129.5 88.33 50.46 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.768 1.167 . . . . 0.0 110.015 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 CA--C 1.537 0.646 0 C-N-CA 121.911 1.741 . . . . 0.0 110.333 169.916 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.3 t80 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 26.8 Cg_exo -82.27 149.54 15.18 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 CA-C-N 120.626 1.259 . . . . 0.0 111.153 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ptmm? -62.48 -35.78 80.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.69 -28.36 69.01 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.69 -30.35 56.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.789 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.4 -38.17 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 120.391 1.451 . . . . 0.0 110.977 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.1 t -66.86 -43.28 83.98 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.504 1.047 . . . . 0.0 112.716 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.15 -39.9 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.42 -37.85 83.7 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.245 0.929 . . . . 0.0 112.42 174.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.47 -29.85 68.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.284 0.947 . . . . 0.0 113.456 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.77 -10.06 59.36 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.9 m -99.46 14.93 28.1 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.7 mt -134.14 -175.95 4.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.165 0.983 . . . . 0.0 111.556 -159.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -117.75 174.88 2.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.73 -28.62 30.67 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 119.525 2.856 . . . . 0.0 119.525 170.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.43 54.45 0.79 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.191 1.359 . . . . 0.0 108.356 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.17 138.58 21.47 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.3 p -142.91 104.36 4.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.274 3.9 tt -89.86 129.46 36.23 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 4.6 mp -114.24 85.4 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 -170.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.39 -80.97 0.05 OUTLIER Glycine 0 N--CA 1.464 0.505 0 N-CA-C 121.769 3.468 . . . . 0.0 121.769 -155.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.259 0.8 OUTLIER -115.5 169.96 8.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.567 1.175 . . . . 0.0 110.058 -139.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.7 t -102.36 -148.84 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.113 -157.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.77 -42.59 24.19 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.08 -32.79 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 125.126 2.394 . . . . 0.0 112.96 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 75.7 m-85 -76.28 -10.27 59.28 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 112.941 -1.936 . . . . 0.0 110.093 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.32 -50.24 74.75 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.675 -1.266 . . . . 0.0 112.388 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -35.55 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.064 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.545 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.34 -47.83 84.36 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 171.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.98 -42.81 80.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.191 0.52 . . . . 0.0 111.949 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.4 tp -60.73 -44.83 96.17 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.0 mt -79.71 -35.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.922 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -71.7 -18.46 62.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 30.04 5.32 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.648 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.3 m-85 -106.66 159.78 15.95 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.122 0.963 . . . . 0.0 108.663 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.42 105.26 9.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.569 HG13 ' CD1' ' A' ' 117' ' ' TRP . 17.3 tt -75.49 146.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.058 -168.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.984 HG13 ' HB2' ' A' ' 116' ' ' CYS . 26.8 pt -143.16 134.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.582 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -112.2 100.13 8.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.04 1.4 . . . . 0.0 110.268 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.62 172.92 5.79 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 113.408 -1.724 . . . . 0.0 108.099 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.46 -8.86 2.06 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.12 115.38 22.34 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 158.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -79.87 142.42 35.24 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.816 -166.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.984 ' HB2' HG13 ' A' ' 110' ' ' ILE 1.064 0.5 OUTLIER -126.39 173.63 9.2 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 113.919 -2.943 . . . . 0.0 111.655 -175.114 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.569 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.0 m0 -137.4 130.23 30.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.993 2.117 . . . . 0.0 105.79 139.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.329 0.2 OUTLIER -110.14 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.207 -0.933 . . . . 0.0 111.265 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -78.19 134.86 37.56 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 123.37 1.557 . . . . 0.0 108.536 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 111.883 -2.417 . . . . 0.0 114.407 -157.792 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.475 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 7.0 t80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.144 0.973 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.95 103.85 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.927 -166.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.7 t -76.39 141.31 41.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 118.756 -1.177 . . . . 0.0 107.99 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.62 -161.92 9.89 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.49 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.435 HD21 ' CD1' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -134.23 141.21 46.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.283 -1.458 . . . . 0.0 107.53 -171.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.9 tp -124.17 130.56 52.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.615 1.198 . . . . 0.0 109.236 173.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.12 120.52 42.09 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.153 173.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.6 mt -125.13 111.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -167.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.24 129.46 51.55 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -62.98 -10.08 19.15 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 N-CA-C 121.69 3.688 . . . . 0.0 121.69 -169.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.16 -50.36 55.01 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -161.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -86.08 -31.78 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.963 170.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 18' ' ' THR . 60.9 p -81.79 0.39 39.46 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -170.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -76.53 20.05 0.24 Allowed 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 120.437 1.471 . . . . 0.0 112.296 166.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 16' ' ' THR . 40.8 m -133.2 71.48 76.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 170.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.08 50.56 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.194 3.263 . . . . 0.0 116.845 -155.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -72.97 -45.62 56.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.039 -1.038 . . . . 0.0 111.585 162.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.4 mt -57.98 -34.91 70.48 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.0 t -64.39 -49.25 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.24 175.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.74 -36.45 81.03 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -63.89 -49.45 72.62 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.439 ' HA ' HE21 ' A' ' 28' ' ' GLN . 12.7 t -63.84 -40.35 96.38 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.014 0.824 . . . . 0.0 111.316 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -65.03 -30.91 71.92 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -44.78 71.15 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.71 1.141 . . . . 0.0 113.653 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.439 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.8 mt-30 -58.36 -53.14 61.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.565 173.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.85 68.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.36 18.28 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.0 p -57.94 -27.38 63.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 170.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.87 -125.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -146.46 14.6 1.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.981 0.896 . . . . 0.0 113.223 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.4 t -98.83 149.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.011 170.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 88.1 tttt -128.39 134.76 48.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 161.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -91.21 100.61 13.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.16 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.63 -17.09 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.589 -1.642 . . . . 0.0 113.928 -162.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.56 169.7 10.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.239 1.019 . . . . 0.0 109.644 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -143.39 125.22 15.11 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.372 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.435 ' CD1' HD21 ' A' ' 8' ' ' LEU . 2.9 m-85 -129.59 120.4 25.23 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.89 149.68 22.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp -63.3 -40.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -81.95 -30.47 31.72 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -82.12 -29.49 31.64 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.305 -0.872 . . . . 0.0 112.652 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.83 -40.66 68.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.367 0.985 . . . . 0.0 112.739 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -76.78 -16.9 59.33 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.668 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.05 -37.45 29.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.545 -0.722 . . . . 0.0 111.43 166.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.67 15.4 5.84 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -78.54 -24.92 45.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mt -114.81 120.3 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -120.08 120.2 35.55 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.786 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 11.8 tp -130.99 174.44 10.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.132 0.968 . . . . 0.0 109.575 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.426 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 46.5 mt-10 -98.94 175.05 6.07 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.692 1.234 . . . . 0.0 111.724 -170.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.1 m-20 -91.41 94.06 9.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.981 -170.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.69 -147.2 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -165.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -100.08 35.0 2.16 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.64 -163.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.555 ' C ' ' H ' ' A' ' 59' ' ' THR . 7.8 m-85 -81.94 21.66 0.85 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.081 -170.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.52 27.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 57' ' ' TYR . 9.8 t -129.32 115.06 17.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 162.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 69.0 t -119.26 94.04 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -162.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.402 ' HE2' HG21 ' A' ' 92' ' ' ILE . 6.4 m80 -97.85 134.37 41.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.36 142.43 38.7 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 170.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.6 tp -122.99 108.98 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.872 0.844 . . . . 0.0 109.603 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.411 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 25.5 m -143.97 154.93 59.01 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -170.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 82.9 Cg_exo . . . . . 0 CA--C 1.536 0.577 0 C-N-CA 122.291 1.994 . . . . 0.0 114.702 170.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -82.34 149.71 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 CA-C-N 119.701 0.929 . . . . 0.0 110.587 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.48 -36.59 82.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.738 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.49 -30.1 71.02 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.6 mt -76.68 -30.14 56.61 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.268 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.26 -36.66 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 119.845 1.202 . . . . 0.0 111.061 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.8 m -66.93 -40.57 87.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.694 1.134 . . . . 0.0 112.717 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.81 -35.76 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 122.025 -0.422 . . . . 0.0 111.991 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -59.87 -47.73 84.57 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.698 -0.626 . . . . 0.0 111.498 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.3 -30.87 71.37 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.33 -10.55 59.84 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -166.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 72.1 p -74.53 -33.13 62.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 165.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 mt -88.66 -170.66 3.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 122.283 1.039 . . . . 0.0 112.079 -159.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -134.26 174.92 4.1 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -52.39 -22.39 15.98 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 N-CA-C 120.292 3.151 . . . . 0.0 120.292 -170.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -102.12 46.57 0.92 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.26 1.391 . . . . 0.0 111.096 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.44 140.67 28.64 Favored Glycine 0 N--CA 1.467 0.737 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -147.04 120.17 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.214 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.433 1.9 tm? -98.4 129.55 45.04 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 111.641 -2.527 . . . . 0.0 104.705 -167.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 1.064 HD11 ' CB ' ' A' ' 116' ' ' CYS . 44.2 mm -119.38 85.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.584 1.538 . . . . 0.0 109.804 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.04 -79.11 0.04 OUTLIER Glycine 0 N--CA 1.464 0.528 0 N-CA-C 120.878 3.111 . . . . 0.0 120.878 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.435 HD13 HD11 ' A' ' 91' ' ' LEU . 1.5 mp -115.88 169.99 8.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.669 -133.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.2 p -114.93 -123.4 0.29 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.355 -0.84 . . . . 0.0 113.185 -156.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.51 -51.02 11.4 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -157.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -60.35 -30.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.877 1.798 . . . . 0.0 111.266 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.553 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 77.7 m-85 -76.82 -16.63 59.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.581 -172.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -57.12 -55.13 38.76 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.373 -0.829 . . . . 0.0 112.277 169.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.93 -33.47 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.987 -0.446 . . . . 0.0 111.376 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.553 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.41 -45.28 95.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.02 84.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.34 -48.66 79.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.728 0.775 . . . . 0.0 112.554 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.6 tt -80.22 -35.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.309 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.63 -16.14 62.27 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.49 5.58 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 119.373 -1.394 . . . . 0.0 112.805 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.491 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 96.6 m-85 -106.63 159.58 16.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.79 108.79 11.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.631 HG13 ' CD1' ' A' ' 117' ' ' TRP . 18.1 tt -84.88 142.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.49 1.138 . . . . 0.0 112.569 -165.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.3 pt -147.13 135.07 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.579 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -126.61 100.14 6.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.002 1.858 . . . . 0.0 112.965 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.44 87.97 30.95 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.8 61.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 122.151 3.866 . . . . 0.0 122.151 -123.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -123.4 104.85 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.255 -2.869 . . . . 0.0 103.255 142.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -82.91 111.33 18.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -159.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.214 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.3 p -147.39 -156.75 0.74 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 125.061 2.362 . . . . 0.0 113.754 171.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.631 ' CD1' HG13 ' A' ' 109' ' ' ILE . 24.9 m0 -137.08 149.79 47.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 109.16 -3.654 . . . . 0.0 102.901 -167.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 144.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HB3' ' HZ3' ' A' ' 119' ' ' LYS . 6.2 ttpm? -88.44 134.92 33.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.532 0.682 . . . . 0.0 111.715 -171.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 -170.223 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.469 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 2.8 t80 . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.616 0.246 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.82 155.12 38.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.96 0.886 . . . . 0.0 110.582 -166.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -77.56 141.62 39.46 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.7 -162.97 10.24 Favored Glycine 0 N--CA 1.466 0.678 0 C-N-CA 119.421 -1.371 . . . . 0.0 114.759 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.28 139.85 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.117 -1.542 . . . . 0.0 107.925 -171.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -124.33 132.88 53.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.162 0.982 . . . . 0.0 108.843 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.65 149.65 27.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.253 165.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.656 HG23 ' HG1' ' A' ' 16' ' ' THR . 19.6 mt -132.48 143.2 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -111.22 129.59 23.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -60.16 -17.41 45.69 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 N-CA-C 120.261 3.139 . . . . 0.0 120.261 -170.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.25 67.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -161.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.97 -28.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.357 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.656 ' HG1' HG23 ' A' ' 11' ' ' ILE . 63.8 p -77.14 -11.92 59.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -170.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.6 m -76.63 -1.5 27.96 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.697 1.59 . . . . 0.0 111.718 -170.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.336 91.3 m -98.78 168.73 9.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 167.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -75.82 -8.69 19.29 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 N-CA-C 118.019 2.277 . . . . 0.0 118.019 -170.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.15 -50.1 20.86 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -163.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.99 -32.94 72.87 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.74 0.7 . . . . 0.0 112.16 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.93 -46.6 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.686 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -62.61 -34.01 76.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.65 -49.07 57.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.492 ' HA ' HE21 ' A' ' 28' ' ' GLN . 8.5 t -61.52 -41.49 97.39 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.191 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.13 -33.76 76.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.735 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.75 73.18 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.196 1.362 . . . . 0.0 113.598 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.492 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.5 mt-30 -56.93 -54.91 41.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.75 0.309 . . . . 0.0 111.586 173.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.24 -43.35 78.56 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.35 47.25 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.9 p -57.89 -36.47 72.45 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.86 -94.64 0.1 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.958 0.885 . . . . 0.0 110.351 -170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 4' ' ' TYR . 44.4 mmtm -129.88 -42.09 1.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.285 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.251 59.5 t -97.64 149.96 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 123.256 1.503 . . . . 0.0 112.594 -160.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -121.35 134.96 55.14 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.222 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -95.38 139.75 31.23 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.72 -24.7 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -170.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.436 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -121.52 169.73 10.38 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.63 1.205 . . . . 0.0 110.286 -174.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -147.34 125.57 12.22 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 114.249 -1.342 . . . . 0.0 108.85 -168.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -133.04 120.28 21.13 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.657 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.574 HD21 ' H ' ' A' ' 43' ' ' ASN . 7.8 tt -92.58 149.45 21.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.16 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.574 ' H ' HD21 ' A' ' 41' ' ' LEU . 22.0 t-20 -79.4 -30.2 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.315 -0.866 . . . . 0.0 113.021 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.19 -37.55 45.4 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.153 -0.967 . . . . 0.0 112.662 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.2 tp -68.57 -40.62 80.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.549 0.69 . . . . 0.0 112.8 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -73.5 -21.2 60.48 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.835 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -83.75 -36.1 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.541 -0.725 . . . . 0.0 112.047 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.56 15.33 6.44 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.329 0.892 . . . . 0.0 115.329 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -76.09 -35.66 59.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.849 1.324 . . . . 0.0 113.689 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.9 mt -114.69 120.35 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -168.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.7 m -129.8 120.21 24.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.596 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 38' ' ' ASP . 93.3 mt -119.6 179.9 4.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.849 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.79 175.32 6.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.608 1.194 . . . . 0.0 111.763 -168.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.8 m-20 -89.32 93.34 9.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.553 -170.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.82 -147.42 0.25 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -165.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -100.1 37.57 1.63 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.168 0.985 . . . . 0.0 113.243 -162.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.565 ' C ' ' H ' ' A' ' 59' ' ' THR . 10.6 m-85 -82.28 21.74 0.9 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 117.191 -1.385 . . . . 0.0 112.259 -170.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.23 27.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -157.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 57' ' ' TYR . 7.8 t -128.45 115.12 17.7 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 162.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 36.5 t -113.74 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -167.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.483 ' HE2' HG23 ' A' ' 92' ' ' ILE . 1.1 m80 -111.05 134.67 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.06 141.86 50.94 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.0 tp -123.78 94.28 4.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -170.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -140.47 154.72 69.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -170.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 CA--C 1.535 0.535 0 C-N-CA 122.824 2.35 . . . . 0.0 114.676 170.252 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.935 -0.024 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -82.7 151.86 14.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 121.757 1.638 . . . . 0.0 112.246 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -62.46 -34.26 76.45 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 166.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.13 -34.5 76.48 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.7 -30.07 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.683 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.34 -41.05 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 119.608 1.095 . . . . 0.0 111.155 167.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -64.76 -40.34 95.12 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.963 -1.086 . . . . 0.0 112.823 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -64.17 -37.18 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.91 -42.56 94.14 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.446 -0.784 . . . . 0.0 112.384 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.47 -29.8 70.84 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -75.79 -9.98 59.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 71.9 m -74.8 -40.05 61.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 169.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.2 mt -91.17 164.33 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.923 1.344 . . . . 0.0 113.593 -154.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.72 101.69 0.54 Allowed Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 112.206 -2.27 . . . . 0.0 105.402 163.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -51.06 6.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 N-CA-C 122.183 3.878 . . . . 0.0 122.183 -154.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -94.7 57.77 2.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 123.039 1.4 . . . . 0.0 108.571 163.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.88 167.51 38.34 Favored Glycine 0 N--CA 1.466 0.691 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.159 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -146.14 120.07 9.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.183 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.307 0.6 OUTLIER -92.7 129.85 38.5 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 112.618 -2.083 . . . . 0.0 107.905 -173.727 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.643 HD11 ' CB ' ' A' ' 116' ' ' CYS . 23.3 mm -113.75 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.85 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.462 0.42 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 mt -115.93 146.56 41.98 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.859 1.314 . . . . 0.0 110.646 -131.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.3 t -90.79 179.45 5.79 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.348 -165.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.9 44.06 0.73 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 120.25 3.426 . . . . 0.0 120.25 -161.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mt -96.16 -26.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 126.716 3.15 . . . . 0.0 109.959 137.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 92.2 m-85 -76.68 2.95 12.74 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.347 -168.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HA ' HD12 ' A' ' 109' ' ' ILE . 30.6 mtpp -71.83 -52.17 18.83 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.583 -1.323 . . . . 0.0 111.509 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.85 -33.36 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.081 -0.387 . . . . 0.0 110.732 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.94 -46.61 89.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.197 171.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.78 79.08 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.99 -0.444 . . . . 0.0 111.817 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -58.48 -50.01 75.29 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.706 0.765 . . . . 0.0 112.394 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.31 -34.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.438 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -71.79 -16.59 62.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 173.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.07 5.74 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.703 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 94.1 m-85 -106.54 159.56 16.08 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -117.46 154.09 32.0 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 161.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.596 HG12 ' CD1' ' A' ' 117' ' ' TRP . 19.1 mt -103.99 148.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.061 1.41 . . . . 0.0 109.812 -174.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 pt -140.29 125.57 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 113.246 -1.797 . . . . 0.0 106.628 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -121.99 87.41 2.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 124.072 1.892 . . . . 0.0 113.476 -168.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -134.21 100.29 12.96 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -54.82 31.42 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.167 1 N-CA-C 124.342 4.709 . . . . 0.0 124.342 -139.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -100.01 115.17 29.1 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 130.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -90.35 115.27 27.41 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.674 -164.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.183 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.86 -164.6 2.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.956 1.836 . . . . 0.0 115.452 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.596 ' CD1' HG12 ' A' ' 109' ' ' ILE . 22.7 m0 -137.55 130.04 29.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 110.804 -2.907 . . . . 0.0 105.625 -167.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.18 144.41 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -79.52 134.84 36.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.118 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 122.14 0.972 . . . . 0.0 111.138 170.334 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.79 141.74 35.96 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 123.086 1.422 . . . . 0.0 112.414 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.83 120.61 41.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.9 -1.954 . . . . 0.0 106.049 164.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 59' ' ' THR . . . -129.4 -163.62 11.23 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.906 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.37 145.02 48.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -167.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.34 135.72 53.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.583 1.182 . . . . 0.0 109.518 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -119.44 120.14 35.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.76 -1.563 . . . . 0.0 106.955 177.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -117.97 139.9 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -99.17 129.55 29.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -62.87 -11.46 24.45 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 N-CA-C 120.502 3.231 . . . . 0.0 120.502 -170.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.34 63.35 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -162.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.76 -30.16 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.574 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -81.04 0.32 36.38 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -76.23 -0.92 24.02 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 120.456 1.48 . . . . 0.0 112.018 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 m -114.82 71.48 2.58 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.99 55.88 3.5 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.717 2.945 . . . . 0.0 116.758 -154.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -71.91 -44.99 62.77 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.869 -1.144 . . . . 0.0 112.096 166.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.09 -29.93 68.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -65.2 -50.07 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.641 -0.662 . . . . 0.0 110.795 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.88 -38.18 81.49 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -60.81 -50.09 74.87 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -65.18 -38.49 90.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.534 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.61 -33.57 76.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.49 73.47 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -56.11 -56.17 24.07 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.99 96.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.3 -50.44 67.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -75.37 -11.49 60.06 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.544 -0.722 . . . . 0.0 112.704 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.85 -109.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.318 0.58 . . . . 0.0 111.467 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -139.68 20.27 2.52 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.88 110.55 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.245 -168.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.84 135.02 40.89 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -88.78 139.57 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.5 -32.63 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.014 -165.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.77 169.92 10.27 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.985 1.374 . . . . 0.0 110.904 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -142.41 125.32 16.12 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.018 -172.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 16.2 m-85 -119.61 149.64 41.62 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.009 166.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.37 149.72 26.71 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 164.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 tp -63.33 -39.41 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -78.85 -30.28 45.06 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.444 -0.785 . . . . 0.0 113.098 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.14 -30.46 38.99 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.283 -0.886 . . . . 0.0 112.933 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.63 -40.61 66.3 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 112.525 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.29 -27.64 66.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.632 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -83.16 -39.3 21.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.929 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.19 15.38 2.29 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.84 1.496 . . . . 0.0 116.84 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.4 m -78.88 -14.32 59.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 -168.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.73 161.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.542 1.064 . . . . 0.0 110.318 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -99.84 120.4 39.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.988 -172.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.69 120.0 36.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.475 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.51 120.1 39.09 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -92.46 65.6 4.49 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -167.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.17 -77.16 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 170.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -100.04 57.41 0.97 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.389 1.09 . . . . 0.0 113.629 -161.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.5 ' C ' ' H ' ' A' ' 59' ' ' THR . 11.8 m-85 -112.34 21.52 15.66 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.984 163.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.73 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 -157.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 57' ' ' TYR . 8.7 t -131.14 116.39 17.65 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 162.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG12 HD21 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -98.64 134.79 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 171.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.512 ' HE2' HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -117.52 134.55 54.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.22 110.45 15.25 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.255 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.04 89.74 3.09 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -170.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.5 m -131.08 154.45 82.02 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -170.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 CA--C 1.532 0.407 0 C-N-CA 121.974 1.782 . . . . 0.0 112.984 170.202 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 15.8 t80 . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -82.16 149.39 15.34 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 121.195 1.463 . . . . 0.0 110.25 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.73 -39.65 94.74 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -63.17 -27.64 69.51 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.83 -30.31 56.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.626 173.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.16 -35.08 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 119.729 1.15 . . . . 0.0 111.063 171.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.5 p -71.96 -36.79 69.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.789 1.177 . . . . 0.0 113.081 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.83 -38.43 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.696 -0.628 . . . . 0.0 111.816 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -40.53 95.57 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.457 -0.777 . . . . 0.0 112.168 174.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.95 -29.86 70.33 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -79.11 -29.42 43.23 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -76.52 -17.98 58.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 mp -124.32 100.82 6.87 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.541 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.266 80.4 mttt -74.77 -155.06 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.674 -166.145 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 6.1 Cg_endo -59.21 -31.38 95.17 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 N-CA-C 120.656 3.291 . . . . 0.0 120.656 -160.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -90.48 49.04 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.351 1.887 . . . . 0.0 110.659 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.43 144.07 26.55 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 173.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.7 p -146.71 117.07 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 123.445 1.593 . . . . 0.0 107.147 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.266 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.379 0.7 OUTLIER -97.42 133.95 41.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.39 -167.265 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.906 HD12 ' CB ' ' A' ' 116' ' ' CYS . 33.0 mm -121.53 87.39 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.576 1.535 . . . . 0.0 108.747 170.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.26 -78.58 0.04 OUTLIER Glycine 0 C--N 1.316 -0.546 0 N-CA-C 121.375 3.31 . . . . 0.0 121.375 -173.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.271 5.5 mp -115.67 172.01 7.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.611 1.196 . . . . 0.0 109.868 -124.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -109.13 -141.71 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.486 -156.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.96 -45.79 39.88 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -163.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mt -57.21 -32.84 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 124.397 2.046 . . . . 0.0 111.31 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 90.7 m-85 -76.89 -16.0 59.52 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.347 -1.751 . . . . 0.0 112.296 -170.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.71 -55.08 39.53 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.94 -1.1 . . . . 0.0 111.979 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.16 -35.27 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.755 -0.59 . . . . 0.0 111.795 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.75 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 173.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.99 79.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.122 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.86 -46.67 74.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.607 0.718 . . . . 0.0 112.843 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.5 tt -80.2 -34.56 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.74 -17.89 62.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.78 21.52 9.63 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.618 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 119' ' ' LYS 0.271 94.7 m-85 -106.85 112.33 25.24 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -98.48 153.48 18.58 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.96 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.627 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -109.13 145.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 111.689 -2.505 . . . . 0.0 110.867 -155.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 pt -137.94 123.01 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -112.17 99.95 8.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.205 1.479 . . . . 0.0 110.723 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.0 -175.61 0.5 Allowed Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.085 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -55.52 -11.61 4.94 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 N-CA-C 118.733 2.551 . . . . 0.0 118.733 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -124.78 149.48 47.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 152.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.434 ' HH ' HD13 ' A' ' 109' ' ' ILE . 13.5 t80 -113.03 112.52 24.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -170.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.266 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 25.2 p -147.73 -153.36 0.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.148 1.451 . . . . 0.0 112.527 169.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.627 ' CD1' HG13 ' A' ' 109' ' ' ILE . 4.4 m0 -136.85 153.52 50.75 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.559 -2.11 . . . . 0.0 105.483 -172.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.27 144.4 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 162.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 61.7 tttm -79.88 134.99 36.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.894 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.645 0.735 . . . . 0.0 110.283 170.326 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.53 103.65 10.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.567 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.77 120.44 21.94 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.38 -154.82 7.54 Favored Glycine 0 N--CA 1.464 0.505 0 CA-C-O 123.187 1.437 . . . . 0.0 115.893 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.4 tp -134.1 149.84 51.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 112.245 -1.978 . . . . 0.0 109.233 -168.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 tp -124.61 133.75 53.16 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.629 1.204 . . . . 0.0 107.782 157.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -114.46 120.36 40.0 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.262 173.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.5 mt -118.04 139.76 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -172.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -103.02 129.6 25.29 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -59.08 -16.95 35.66 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 N-CA-C 121.261 3.524 . . . . 0.0 121.261 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -50.31 58.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -160.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.78 -35.2 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.843 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -71.19 -12.14 61.32 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 t -76.7 1.14 17.94 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.984 1.265 . . . . 0.0 112.147 -170.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.352 53.9 m -98.86 168.12 10.24 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.5 -2.83 13.0 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 N-CA-C 117.873 2.22 . . . . 0.0 117.873 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -74.15 -50.45 19.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.957 1.253 . . . . 0.0 114.21 -166.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.06 -30.15 68.42 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.778 0.717 . . . . 0.0 112.368 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.43 -46.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.102 -0.374 . . . . 0.0 111.146 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -62.2 -36.33 81.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.039 0.836 . . . . 0.0 113.223 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -46.75 75.23 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.48 ' HA ' HE21 ' A' ' 28' ' ' GLN . 90.0 m -58.93 -45.68 89.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.826 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -63.97 -29.82 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.98 74.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.893 1.224 . . . . 0.0 113.38 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.48 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.1 mt-30 -57.63 -52.98 63.19 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.154 -0.341 . . . . 0.0 111.858 171.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.86 -45.71 60.01 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.883 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.83 -50.53 28.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.49 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.5 t -75.54 -29.52 59.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -170.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.86 -127.84 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.006 -0.434 . . . . 0.0 111.94 170.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -139.39 1.48 1.97 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -165.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -99.47 149.81 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.817 0.818 . . . . 0.0 112.28 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -122.65 143.78 49.55 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -104.24 100.37 10.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.279 1.037 . . . . 0.0 109.425 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.74 -40.59 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.84 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.09 169.77 10.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.246 1.022 . . . . 0.0 110.538 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -144.86 113.02 6.48 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -164.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.412 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 17.4 m-30 -118.83 120.19 36.6 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.36 150.09 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.16 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -76.74 -30.05 56.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.8 -35.73 32.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 113.137 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.12 -40.52 78.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.814 0.733 . . . . 0.0 112.724 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -66.1 -27.91 68.42 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.076 173.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -79.9 -39.12 31.08 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.3 10.69 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -78.34 -11.18 59.92 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.1 mt -114.9 121.77 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -98.6 120.84 39.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 124.014 1.864 . . . . 0.0 110.227 -164.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.0 mt -96.52 149.81 21.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 111.199 -2.728 . . . . 0.0 111.565 -163.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.76 169.75 9.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.255 -1.793 . . . . 0.0 107.498 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -116.34 35.95 4.31 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.28 -74.66 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -168.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -78.24 32.92 0.19 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -162.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -112.11 21.87 15.41 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 116.93 -1.51 . . . . 0.0 112.995 170.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.63 38.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -165.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.02 115.32 6.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 166.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.2 t -101.33 139.04 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.539 ' HE2' HG23 ' A' ' 92' ' ' ILE . 1.3 m80 -122.3 134.57 54.66 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 161.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -114.73 141.75 47.42 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.77 112.81 17.77 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 170.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.1 m -150.3 154.4 36.05 Favored Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 C-N-CA 122.902 2.401 . . . . 0.0 115.499 170.517 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.7 t80 . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -82.09 149.8 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 CA-C-N 120.01 1.039 . . . . 0.0 111.365 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.52 -36.86 83.94 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -58.54 -34.22 70.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.67 -30.18 56.66 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.919 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.84 -38.97 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 120.043 1.292 . . . . 0.0 111.236 167.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.6 m -65.68 -39.08 90.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.691 1.132 . . . . 0.0 112.908 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.55 -41.73 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.04 -41.5 92.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.652 -0.655 . . . . 0.0 112.58 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.57 -29.76 70.97 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.88 -10.12 59.33 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -105.46 33.56 3.66 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.5 mt -134.05 159.98 39.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.233 1.016 . . . . 0.0 111.053 -165.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.559 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 82.2 mttt -112.8 -156.4 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 165.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 14.8 Cg_endo -62.82 -33.81 74.63 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 CA-C-N 124.041 2.479 . . . . 0.0 113.855 -170.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.418 ' HA ' HD13 ' A' ' 118' ' ' ILE . 23.3 m120 -92.52 45.88 1.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 118.513 0.597 . . . . 0.0 109.912 -170.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.74 116.71 4.34 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.4 t -139.32 107.04 5.62 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -166.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.198 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.279 1.3 tt -91.52 129.89 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -170.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.616 HD13 ' CB ' ' A' ' 116' ' ' CYS . 20.3 mm -105.89 86.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.977 0.894 . . . . 0.0 109.746 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.432 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.74 -83.49 0.06 OUTLIER Glycine 0 C--N 1.317 -0.488 0 N-CA-C 121.509 3.364 . . . . 0.0 121.509 -166.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.432 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -115.49 171.38 7.76 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.33 -1.348 . . . . 0.0 110.196 -138.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 85.0 p -110.28 -129.34 0.29 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.942 -163.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -79.3 -47.81 15.21 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -157.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.64 -29.78 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 124.607 2.146 . . . . 0.0 111.317 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 76.0 m-85 -76.66 -11.0 59.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.354 -1.748 . . . . 0.0 111.149 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -49.36 70.73 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.789 -1.194 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.09 -36.89 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.802 -0.561 . . . . 0.0 111.141 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -60.4 -43.0 97.1 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.929 171.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.28 -43.33 83.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 111.242 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.06 -48.26 76.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.4 tt -80.13 -35.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.811 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -71.96 0.47 9.24 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.38 41.79 97.96 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 119.807 1.185 . . . . 0.0 113.935 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.416 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.0 m-85 -106.91 111.76 24.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 165.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -98.88 117.93 34.49 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 123.474 1.607 . . . . 0.0 106.746 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.625 HG12 ' CD1' ' A' ' 117' ' ' TRP . 15.8 mt -74.74 152.52 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.811 -162.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.4 pt -139.58 128.93 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.159 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -106.86 78.82 1.27 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.302 2.001 . . . . 0.0 111.112 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.27 36.7 tt0 -93.13 162.49 28.25 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 111.341 -2.663 . . . . 0.0 107.14 166.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.56 -6.13 0.92 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 N-CA-C 118.934 2.628 . . . . 0.0 118.934 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -112.43 110.29 20.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 155.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -80.75 115.13 20.09 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.878 -0.514 . . . . 0.0 110.562 -168.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.198 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 15.0 p -147.04 -164.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 123.746 1.736 . . . . 0.0 114.102 172.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.625 ' CD1' HG12 ' A' ' 109' ' ' ILE . 3.1 m0 -137.79 130.19 29.38 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 111.459 -2.61 . . . . 0.0 106.073 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER -111.88 144.22 20.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 123.001 1.381 . . . . 0.0 107.478 169.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.87 134.84 36.33 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.467 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.47 0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.432 170.355 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 122.194 0.997 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -92.32 142.06 27.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.602 1.192 . . . . 0.0 111.148 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 t -105.08 120.66 42.05 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.465 174.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.6 -161.12 10.05 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 118.814 -1.66 . . . . 0.0 113.811 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.5 tp -133.94 139.28 46.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.09 -1.055 . . . . 0.0 108.686 -167.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.7 tp -124.87 110.96 14.91 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 0.0 110.443 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.91 120.23 39.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.996 170.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -123.15 139.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.962 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.76 129.83 43.1 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.48 -11.02 10.05 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 N-CA-C 120.562 3.254 . . . . 0.0 120.562 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.71 -50.14 65.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -88.95 -30.29 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.873 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.5 p -78.74 -2.7 40.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -76.62 -9.8 58.93 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.933 1.242 . . . . 0.0 111.476 163.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.4 m -108.51 71.68 0.41 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 165.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.29 46.68 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.363 3.375 . . . . 0.0 116.235 -154.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.86 -49.98 66.18 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.396 -0.815 . . . . 0.0 112.772 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.97 -29.82 70.77 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 122.05 -0.406 . . . . 0.0 112.03 173.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -63.59 -50.0 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.735 -0.603 . . . . 0.0 111.322 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.63 -36.45 76.38 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.223 -0.923 . . . . 0.0 113.301 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.09 -49.88 72.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -64.9 -35.85 82.48 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.786 0.721 . . . . 0.0 111.562 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -64.99 -35.13 80.21 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.12 -45.28 70.56 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.536 1.062 . . . . 0.0 113.11 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.334 2.3 tm0? -54.99 -52.11 64.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.15 86.46 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.587 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.28 -50.46 65.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.419 -170.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 m -75.25 -13.95 60.48 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.835 -0.541 . . . . 0.0 112.021 -170.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.79 -113.94 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.838 -0.539 . . . . 0.0 110.393 170.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -150.72 35.22 0.61 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 t -112.65 149.85 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.443 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.23 134.91 49.07 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 162.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -98.78 100.73 11.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.21 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.84 -14.6 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -164.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.73 120.4 34.55 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -114.92 114.34 25.34 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.551 -167.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -123.68 120.21 32.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.839 0.828 . . . . 0.0 109.428 -174.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp -87.65 149.8 24.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 tp -63.29 -38.3 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -78.54 -30.29 46.86 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -77.69 -41.09 39.21 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.305 -0.872 . . . . 0.0 112.494 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -67.03 -40.38 87.21 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.644 0.735 . . . . 0.0 112.947 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -73.84 -21.37 60.14 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.761 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.92 -35.01 38.48 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.595 -0.69 . . . . 0.0 111.421 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.12 15.27 5.66 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.811 0.684 . . . . 0.0 114.811 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -78.46 -40.29 36.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.6 mt -114.93 118.74 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 122.481 1.134 . . . . 0.0 109.5 -167.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -133.31 159.23 40.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 157.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.294 1.8 pt? -131.34 -70.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.329 164.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -141.46 169.8 16.92 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.892 0.853 . . . . 0.0 109.81 172.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.54 63.14 0.85 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.55 -92.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -100.29 64.55 1.18 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -161.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -112.1 21.77 15.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 116.367 -1.778 . . . . 0.0 113.346 170.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.54 41.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -157.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.15 115.68 6.71 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 165.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 91' ' ' LEU 0.25 40.9 t -118.4 134.62 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.403 -164.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.59 134.74 54.51 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.79 110.41 17.77 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 168.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.23 104.97 17.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.031 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.8 m -119.84 120.08 30.7 Favored Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 167.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 121.875 1.717 . . . . 0.0 114.546 -164.487 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 14.7 t80 . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 27.4 Cg_exo -82.38 149.49 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 120.395 1.177 . . . . 0.0 110.161 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.6 -37.49 86.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.641 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.61 -29.55 70.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.2 mt -76.75 -30.16 56.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.322 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.31 -35.03 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-N 119.886 1.221 . . . . 0.0 111.033 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.2 t -68.5 -39.39 81.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.661 1.119 . . . . 0.0 112.657 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.916 -0.49 . . . . 0.0 111.755 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.98 -46.11 90.5 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.696 -0.628 . . . . 0.0 111.967 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.04 71.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.2 -13.01 56.29 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.3 m -71.26 -45.19 63.75 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 122.06 -0.4 . . . . 0.0 110.747 162.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.9 mt -97.67 161.47 13.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.926 1.346 . . . . 0.0 112.461 -163.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 63.9 mttp -108.43 -178.25 0.55 Allowed Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.287 -170.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 25.5 Cg_exo -56.15 -12.73 8.08 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 N-CA-C 119.96 3.023 . . . . 0.0 119.96 -170.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -102.37 33.32 3.17 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.14 1.336 . . . . 0.0 111.853 169.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.55 141.89 41.35 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 170.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 81.9 p -145.24 107.19 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.97 1.366 . . . . 0.0 108.325 -171.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -89.9 143.01 27.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.611 -1.632 . . . . 0.0 108.59 -172.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.38 88.41 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 167.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.22 -86.6 0.08 OUTLIER Glycine 0 CA--C 1.53 0.977 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 -159.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.54 169.82 8.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.052 1.926 . . . . 0.0 110.828 -147.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.4 m -104.89 -149.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -160.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.51 -43.06 86.31 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -163.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.01 -34.43 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 124.836 2.255 . . . . 0.0 110.526 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 65.7 m-85 -76.68 -10.49 59.42 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.142 -1.844 . . . . 0.0 111.073 -175.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.93 -52.83 58.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.829 -1.169 . . . . 0.0 112.188 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.76 -33.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.275 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.48 -46.01 91.85 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.531 -0.731 . . . . 0.0 112.847 172.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.6 -42.57 78.98 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.886 -0.509 . . . . 0.0 111.827 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.05 -49.35 76.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.67 0.747 . . . . 0.0 112.502 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 tt -80.08 -34.62 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -170.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -71.61 -17.41 62.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.61 29.61 5.55 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 119.296 -1.43 . . . . 0.0 112.317 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.1 m-85 -106.71 159.84 15.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -126.88 108.1 10.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.548 1.166 . . . . 0.0 108.711 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.572 HG12 ' CD1' ' A' ' 117' ' ' TRP . 25.5 mt -84.5 111.24 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.962 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.665 HG13 ' SG ' ' A' ' 116' ' ' CYS . 44.9 pt -108.55 135.05 48.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.247 169.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -105.85 100.31 9.87 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.725 1.726 . . . . 0.0 110.668 -171.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -117.31 171.37 4.99 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 111.957 -2.383 . . . . 0.0 107.698 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -56.22 -8.5 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 N-CA-C 119.117 2.699 . . . . 0.0 119.117 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -119.47 115.26 23.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -79.57 139.09 37.63 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -165.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.665 ' SG ' HG13 ' A' ' 110' ' ' ILE 0.266 5.1 p -145.72 120.88 10.14 Favored 'General case' 0 CA--C 1.54 0.586 1 N-CA-C 123.375 4.583 . . . . 0.0 123.375 -164.141 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.572 ' CD1' HG12 ' A' ' 109' ' ' ILE . 4.0 m0 -109.64 111.06 22.32 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 143.98 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.682 1.23 . . . . 0.0 108.832 170.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 77.8 tttt -91.74 110.22 21.55 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.631 -174.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.832 0.825 . . . . 0.0 110.424 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -92.64 141.77 28.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.527 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 t -89.88 141.48 28.6 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 158.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.48 -167.09 11.55 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 123.762 1.757 . . . . 0.0 115.258 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 tp -131.3 139.83 49.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 111.569 -2.315 . . . . 0.0 107.983 -173.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.285 0.2 OUTLIER -124.49 129.39 50.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 168.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -121.86 120.33 34.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -175.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.3 tt -129.1 139.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 -163.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -106.6 129.62 24.16 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -62.0 -11.67 22.58 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 N-CA-C 120.683 3.301 . . . . 0.0 120.683 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.21 -50.34 61.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -161.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.8 t -89.91 -30.35 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.689 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -84.17 0.24 49.42 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 5.72 7.01 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.364 1.438 . . . . 0.0 113.671 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.333 95.5 m -98.98 167.99 10.42 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 164.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.65 -13.23 16.4 Favored 'Trans proline' 0 N--CA 1.482 0.824 0 N-CA-C 117.133 1.936 . . . . 0.0 117.133 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.13 -50.34 19.86 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -161.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.32 -30.04 68.01 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.156 0.889 . . . . 0.0 112.189 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.59 -50.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.758 -0.589 . . . . 0.0 111.036 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.61 -36.78 76.99 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.304 -0.873 . . . . 0.0 113.335 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -61.86 -50.12 73.51 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.48 ' HA ' HE21 ' A' ' 28' ' ' GLN . 12.3 t -66.53 -37.57 85.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.691 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.413 ' HZ2' ' HB2' ' A' ' 36' ' ' PHE . 75.8 mmtt -64.89 -31.21 72.34 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 170.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.15 67.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.607 1.094 . . . . 0.0 113.195 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.48 HE21 ' HA ' ' A' ' 25' ' ' THR . 35.0 mt-30 -56.39 -54.57 44.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.341 0.591 . . . . 0.0 111.185 171.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.48 -40.33 59.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.67 -50.02 9.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.2 p -60.77 -24.54 65.84 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -126.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.655 -0.653 . . . . 0.0 110.429 170.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -144.72 -9.15 0.63 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -168.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.61 110.46 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -98.78 146.7 25.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.632 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.413 ' HB2' ' HZ2' ' A' ' 26' ' ' LYS . 62.1 m-85 -88.7 100.36 13.06 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 123.374 1.559 . . . . 0.0 110.465 -173.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -36.5 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 112.375 -2.193 . . . . 0.0 113.268 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -121.89 169.58 10.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.226 1.012 . . . . 0.0 111.377 -170.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -150.13 125.58 10.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.556 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.424 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 30.4 m-85 -133.03 120.67 21.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.62 149.45 24.29 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 tp -63.63 -40.16 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -79.17 -30.28 43.43 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.746 . . . . 0.0 112.843 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -82.24 -24.92 34.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -40.41 71.4 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.434 1.015 . . . . 0.0 111.901 174.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -78.19 -27.66 47.98 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.96 -37.56 34.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.842 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.3 15.38 2.78 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 116.904 1.522 . . . . 0.0 116.904 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -75.62 -29.44 59.21 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.457 1.629 . . . . 0.0 114.612 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.58 120.16 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.8 m -124.45 120.2 31.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.762 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.5 mt -123.79 -163.44 1.14 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.87 171.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -98.79 169.84 9.18 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.923 1.344 . . . . 0.0 111.797 -166.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 71.2 m-20 -90.21 94.62 9.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.426 170.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.65 -162.05 1.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -168.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -95.49 58.0 1.99 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.872 -170.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 59' ' ' THR . 3.9 m-85 -81.4 22.45 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 117.012 -1.47 . . . . 0.0 112.568 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.76 38.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -164.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.73 115.46 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 164.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 97.5 t -127.56 110.54 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.324 -157.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.37 106.55 16.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.982 -174.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.77 141.52 28.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 171.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.289 22.3 tp -123.53 115.11 20.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.867 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -149.27 154.35 38.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo . . . . . 0 CA--C 1.537 0.633 0 C-N-CA 122.559 2.172 . . . . 0.0 116.288 170.398 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 39.1 Cg_exo -82.12 149.67 15.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 CA-C-N 120.626 1.259 . . . . 0.0 110.332 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.62 -36.67 83.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -66.44 -26.08 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.87 -30.2 56.14 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.743 1.156 . . . . 0.0 111.106 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -39.14 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.935 1.243 . . . . 0.0 110.928 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.2 m -67.44 -40.99 85.47 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.321 -0.862 . . . . 0.0 112.586 176.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.91 -38.9 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.272 0.487 . . . . 0.0 112.266 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.86 -39.08 87.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.543 1.065 . . . . 0.0 112.381 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -29.65 70.67 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.23 -9.85 59.02 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 73.7 m -70.83 -36.43 72.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 165.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.83 159.77 18.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 123.02 1.391 . . . . 0.0 113.293 -153.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.02 101.76 0.68 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 112.02 -2.355 . . . . 0.0 105.329 162.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.17 11.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 N-CA-C 122.055 3.829 . . . . 0.0 122.055 -154.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -102.41 53.48 0.79 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.549 1.166 . . . . 0.0 108.165 162.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.54 163.41 49.4 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 168.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 30.8 t -147.02 120.13 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -99.38 139.82 34.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.505 -168.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.63 90.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 167.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.55 -94.31 0.19 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 -160.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.44 169.9 8.96 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.919 -146.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -123.38 -115.74 0.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -156.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.26 -63.01 1.15 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -157.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -59.66 -27.95 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 124.373 2.035 . . . . 0.0 111.537 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.558 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 67.8 m-85 -76.82 -19.27 57.74 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.026 -170.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.23 -52.06 62.51 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.776 -1.202 . . . . 0.0 112.345 169.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.92 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.842 -0.536 . . . . 0.0 111.819 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.558 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.56 -43.22 97.52 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.34 -42.2 98.3 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.17 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.6 tp -55.88 -46.76 78.23 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 tt -79.95 -38.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.254 -171.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -71.98 1.93 6.45 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.66 43.63 96.11 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.774 -1.203 . . . . 0.0 114.048 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.52 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.5 m-85 -109.45 111.83 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 167.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -98.92 112.23 24.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 123.61 1.671 . . . . 0.0 108.107 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.597 HG13 ' CD1' ' A' ' 117' ' ' TRP 0.257 16.3 tt -83.59 156.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 112.057 -2.338 . . . . 0.0 112.619 -164.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.63 HG23 ' SG ' ' A' ' 116' ' ' CYS . 14.6 tt -147.21 128.32 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.843 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -102.66 98.32 8.38 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 123.282 1.515 . . . . 0.0 112.386 -167.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.16 171.61 8.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.056 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.47 -10.29 4.78 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 N-CA-C 119.295 2.767 . . . . 0.0 119.295 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -125.17 115.02 19.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 160.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.432 ' HE2' ' HE1' ' A' ' 117' ' ' TRP . 38.1 t80 -79.64 138.78 37.51 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.38 -163.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.63 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.289 5.4 p -146.26 120.89 9.79 Favored 'General case' 0 CA--C 1.55 0.955 1 N-CA-C 127.042 5.941 . . . . 0.0 127.042 -164.924 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.597 ' CD1' HG13 ' A' ' 109' ' ' ILE . 7.4 m0 -109.63 114.91 28.91 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.49 1.496 . . . . 0.0 109.229 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.3 OUTLIER -99.62 143.92 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 62.9 tttp -79.91 134.9 36.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.911 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 121.699 0.762 . . . . 0.0 109.846 170.455 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.671 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 5.4 t80 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -84.34 141.79 30.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.687 0.756 . . . . 0.0 111.187 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.0 m -104.63 140.82 37.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.22 -156.69 7.95 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-O 123.86 1.811 . . . . 0.0 117.011 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.484 HD21 ' CD2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -134.54 142.37 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 111.472 -2.364 . . . . 0.0 109.704 -174.107 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 tp -124.21 133.23 53.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 162.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -120.14 120.29 35.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.442 174.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 tt -132.15 139.91 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -164.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -105.71 129.92 23.88 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -59.96 -12.37 18.62 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 N-CA-C 121.381 3.57 . . . . 0.0 121.381 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.33 -50.36 71.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -160.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.3 t -88.86 -28.92 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.491 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.7 p -79.05 0.3 28.39 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -170.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.1 m -76.62 0.74 19.09 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 119.575 1.079 . . . . 0.0 111.993 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 m -98.55 169.09 8.79 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 162.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -77.18 2.48 7.61 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 N-CA-C 120.676 3.299 . . . . 0.0 120.676 171.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.31 -50.93 16.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 121.212 1.824 . . . . 0.0 115.312 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.43 -31.6 70.03 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.558 -0.714 . . . . 0.0 112.56 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.88 -47.67 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.644 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.93 -33.27 75.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -64.74 -49.89 69.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.44 ' HA ' HE21 ' A' ' 28' ' ' GLN . 10.1 t -64.05 -41.75 97.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.321 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.7 -30.23 71.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.575 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -45.64 69.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.179 1.354 . . . . 0.0 113.511 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.44 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.4 mt-30 -56.52 -53.81 53.14 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.689 173.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.9 79.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.741 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.26 43.36 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.998 -0.439 . . . . 0.0 111.23 -170.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.2 p -73.32 -21.8 60.47 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.606 0.639 . . . . 0.0 111.568 -170.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.73 -113.44 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -157.41 17.36 0.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -168.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.87 152.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.3 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.671 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 87.1 tttt -128.39 135.02 48.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 165.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.75 100.56 13.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.816 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -21.22 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -167.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.98 121.47 37.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -167.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -114.2 124.28 51.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.089 0.947 . . . . 0.0 109.635 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.484 ' CD2' HD21 ' A' ' 8' ' ' LEU . 22.2 m-30 -127.32 103.25 7.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.528 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.533 HD21 ' H ' ' A' ' 43' ' ' ASN . 8.0 tt -84.97 149.79 25.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.03 -39.94 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -172.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.533 ' H ' HD21 ' A' ' 41' ' ' LEU . 36.8 t30 -78.57 -30.13 46.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.64 -29.59 33.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.25 0.932 . . . . 0.0 113.19 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -40.51 54.71 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.38 0.991 . . . . 0.0 112.084 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -69.56 -28.23 65.81 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.34 -41.84 24.05 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.6 15.27 8.9 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.301 1.28 . . . . 0.0 116.301 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 m -73.38 -8.27 55.15 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 119.499 1.649 . . . . 0.0 115.45 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.9 mt -114.72 121.82 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.976 -0.452 . . . . 0.0 109.99 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.7 m -98.48 120.66 39.28 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.199 1.952 . . . . 0.0 108.978 -172.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.267 63.4 tp -96.73 149.54 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 110.752 -2.931 . . . . 0.0 111.591 -161.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.42 169.79 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.667 166.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -120.1 44.42 2.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -166.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -73.1 0.07 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 119.446 3.128 . . . . 0.0 119.446 -166.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -81.71 30.53 0.37 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -157.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 59' ' ' THR . 0.6 OUTLIER -112.22 21.27 15.99 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 117.659 -1.162 . . . . 0.0 112.621 -170.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.82 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 -166.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.09 115.5 6.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 169.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 24.4 t -119.33 134.34 63.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.706 -165.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.506 ' HE2' HG23 ' A' ' 92' ' ' ILE . 5.4 m80 -122.58 134.6 54.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.44 142.45 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.77 102.37 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -137.23 113.86 9.68 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 CA--C 1.534 0.516 0 C-N-CA 122.733 2.289 . . . . 0.0 114.974 170.335 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 8.2 t80 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.551 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -55.77 149.66 49.14 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.806 1.671 . . . . 0.0 112.887 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.52 -34.74 77.5 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -31.45 67.88 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.81 -30.06 56.23 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.113 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.62 -35.45 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 119.769 1.168 . . . . 0.0 111.614 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.3 p -69.12 -36.83 77.94 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.21 1.368 . . . . 0.0 112.967 173.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.08 -37.42 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.815 -0.553 . . . . 0.0 111.902 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -59.96 -46.07 90.62 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.819 -0.551 . . . . 0.0 112.042 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.0 70.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -73.62 -9.99 59.24 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 m -106.87 30.22 6.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -134.07 162.52 31.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.044 0.926 . . . . 0.0 109.846 -169.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 174.97 2.31 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -58.52 -12.4 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 118.455 2.444 . . . . 0.0 118.455 -170.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -102.0 46.76 0.92 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.943 0.792 . . . . 0.0 110.676 170.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.31 140.58 24.75 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.5 t -146.3 106.27 4.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.184 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.259 3.1 tt -89.91 129.92 36.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -175.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 1.019 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 27.2 mm -104.42 91.11 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 122.337 1.065 . . . . 0.0 108.31 170.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.76 -95.13 0.2 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 120.745 3.058 . . . . 0.0 120.745 -162.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.5 169.62 9.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.017 -1.473 . . . . 0.0 109.464 -142.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -118.26 -118.07 0.32 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -158.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.09 -54.24 8.23 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -156.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -61.0 -29.33 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 124.548 2.118 . . . . 0.0 111.294 170.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.1 m-85 -76.78 -9.41 58.65 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.291 -1.777 . . . . 0.0 112.03 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -63.95 -56.05 17.99 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.295 -0.878 . . . . 0.0 111.468 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.84 -31.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 122.188 -0.32 . . . . 0.0 111.513 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.585 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.89 -46.5 87.56 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.539 -0.725 . . . . 0.0 112.451 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.9 -41.8 71.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.088 0.404 . . . . 0.0 111.777 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.6 tp -63.19 -45.14 93.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.6 mt -80.08 -34.95 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -71.75 -15.5 62.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 27.88 6.12 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.589 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 97.4 m-85 -106.52 159.6 16.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 172.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -118.71 154.13 33.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 161.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.646 HG12 ' CD1' ' A' ' 117' ' ' TRP . 22.5 mt -103.89 148.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 122.994 1.378 . . . . 0.0 109.282 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.82 123.11 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.891 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -115.48 100.18 7.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.942 1.829 . . . . 0.0 110.913 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -134.22 -178.54 0.88 Allowed Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 111.215 -2.72 . . . . 0.0 106.194 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.52 -7.14 1.2 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -135.07 115.27 13.28 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 161.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -86.77 115.02 23.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.296 -167.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.184 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 27.9 p -147.6 -158.62 0.93 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 122.674 1.226 . . . . 0.0 114.099 167.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.646 ' CD1' HG12 ' A' ' 109' ' ' ILE . 5.9 m0 -137.31 130.36 30.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.452 -1.703 . . . . 0.0 106.438 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.89 144.0 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 122.708 1.242 . . . . 0.0 108.276 167.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 76.4 tttt -87.16 110.39 20.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.797 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.499 0.666 . . . . 0.0 112.14 170.384 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.515 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 12.0 t80 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.1 141.94 28.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.218 1.008 . . . . 0.0 111.831 -165.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.44 141.77 28.21 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 166.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.53 -158.32 8.64 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 119.369 -1.396 . . . . 0.0 114.625 169.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.48 139.95 45.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.307 0.0 OUTLIER -124.38 129.35 50.54 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 174.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.44 120.23 40.95 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.614 HG23 ' HG1' ' A' ' 16' ' ' THR . 6.4 mt -124.81 139.98 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.636 -171.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -98.69 129.77 29.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 160.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -60.96 -11.99 20.59 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 N-CA-C 121.75 3.711 . . . . 0.0 121.75 -170.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.29 74.52 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -159.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.32 -29.83 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 119.29 0.95 . . . . 0.0 111.81 170.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.614 ' HG1' HG23 ' A' ' 11' ' ' ILE . 49.1 p -65.21 0.03 1.54 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 170.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -76.3 -10.32 59.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.118 1.781 . . . . 0.0 112.077 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.317 92.5 m -98.8 167.98 10.49 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 163.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.87 -3.17 13.27 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 N-CA-C 117.674 2.144 . . . . 0.0 117.674 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.96 -50.42 20.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.428 1.467 . . . . 0.0 114.521 -161.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.2 -32.46 71.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.429 -0.794 . . . . 0.0 112.585 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.49 -47.79 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.504 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.45 -47.3 70.57 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.778 ' HG1' HD12 ' A' ' 63' ' ' LEU . 98.3 m -58.89 -46.23 88.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.938 174.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.1 mmmt -60.92 -29.94 69.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.33 74.36 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.203 1.365 . . . . 0.0 113.488 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -60.0 -54.05 50.67 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.039 0.447 . . . . 0.0 111.401 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.06 45.77 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.94 -45.67 11.27 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.8 p -58.02 -34.19 69.78 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.92 -113.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -170.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 38.0 tptt -137.88 -13.1 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.532 -170.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.421 HG23 HG21 ' A' ' 59' ' ' THR . 3.3 p -117.26 110.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -170.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 81.6 tttt -98.65 139.58 34.15 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.218 1.009 . . . . 0.0 108.887 170.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.58 139.75 30.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.34 -30.05 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -160.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -121.61 169.88 10.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.782 1.277 . . . . 0.0 109.015 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -143.82 125.1 14.63 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.24 -1.346 . . . . 0.0 108.846 -169.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -125.87 113.84 17.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.873 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -86.8 149.93 24.5 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -40.03 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -79.93 -30.25 39.92 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -79.75 -32.54 41.06 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.356 -0.84 . . . . 0.0 113.009 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -73.61 -40.62 63.69 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.969 0.804 . . . . 0.0 112.844 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -70.55 -26.12 63.4 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.799 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.26 -42.28 16.03 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 119.106 -0.473 . . . . 0.0 112.149 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.76 15.44 2.63 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 169.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -76.21 -19.45 58.38 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.086 1.943 . . . . 0.0 115.103 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.62 121.85 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.0 t -98.96 159.38 15.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 125.249 2.452 . . . . 0.0 111.403 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.32 120.98 43.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.588 -3.46 . . . . 0.0 111.142 -158.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -98.16 169.17 9.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.552 162.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -120.55 52.67 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -159.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -86.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -100.04 57.45 0.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.017 0.913 . . . . 0.0 113.39 -158.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' THR . 4.4 m-85 -112.1 21.14 16.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.323 169.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.91 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -161.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.489 ' H ' ' C ' ' A' ' 57' ' ' TYR . 14.6 t -137.41 115.43 11.57 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 161.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 39.9 t -117.42 101.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 -164.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.495 ' HE2' HG22 ' A' ' 92' ' ' ILE . 4.7 m80 -97.83 134.4 41.03 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.66 110.31 18.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.377 1.084 . . . . 0.0 109.193 174.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.778 HD12 ' HG1' ' A' ' 25' ' ' THR . 84.7 mt -98.73 102.06 13.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.412 170.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.0 m -122.36 94.77 47.6 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.538 0.681 0 C-N-CA 122.216 1.944 . . . . 0.0 112.853 170.423 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 32.3 Cg_exo -81.88 149.44 15.9 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 CA-C-N 120.894 1.355 . . . . 0.0 110.741 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -62.6 -40.35 96.67 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.5 -32.27 68.66 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -76.7 -30.26 56.62 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.742 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.42 -35.09 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 119.817 1.189 . . . . 0.0 111.554 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -70.25 -36.79 74.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.288 1.403 . . . . 0.0 112.884 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.56 -39.22 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 121.668 -0.645 . . . . 0.0 111.597 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -60.04 -46.2 90.29 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.814 -0.554 . . . . 0.0 112.073 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.92 70.35 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.85 -32.0 72.21 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -167.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.5 p -92.68 33.27 1.14 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.6 mt -134.16 175.49 9.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.619 1.199 . . . . 0.0 111.818 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -116.32 175.06 2.09 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.66 -25.98 21.73 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 N-CA-C 119.103 2.694 . . . . 0.0 119.103 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -102.27 51.15 0.82 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.68 1.582 . . . . 0.0 110.454 169.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.23 142.92 30.01 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.2 p -144.16 105.88 4.3 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.179 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.366 0.3 OUTLIER -89.68 129.65 36.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.084 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 1.075 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 39.9 mm -112.44 91.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.11 0.957 . . . . 0.0 109.699 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.09 -86.41 0.08 OUTLIER Glycine 0 C--N 1.315 -0.607 0 N-CA-C 120.902 3.121 . . . . 0.0 120.902 -171.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.453 HD13 HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -116.18 169.77 9.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 -137.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.498 ' HG ' ' H ' ' A' ' 96' ' ' ASP . 7.9 t -108.66 -131.79 0.31 Allowed 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.87 -1.144 . . . . 0.0 112.819 -156.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.498 ' H ' ' HG ' ' A' ' 95' ' ' SER . 25.7 m-20 -80.0 -49.42 11.85 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -158.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -58.69 -30.23 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 124.33 2.014 . . . . 0.0 112.984 168.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.4 m-85 -76.46 -14.99 60.02 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 113.167 -1.833 . . . . 0.0 110.453 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.5 -50.67 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.194 -0.941 . . . . 0.0 112.316 165.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.83 -36.82 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.786 -0.571 . . . . 0.0 111.202 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.505 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.97 -43.89 94.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.83 97.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.458 0.647 . . . . 0.0 111.796 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.73 -47.82 83.3 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.467 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.5 mt -76.35 -35.18 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.055 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -71.85 -19.97 61.89 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 33.31 4.09 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.884 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 98.0 m-85 -106.67 159.83 15.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.28 1.038 . . . . 0.0 108.28 168.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.56 106.39 10.55 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.637 HD13 ' HH ' ' A' ' 115' ' ' TYR . 16.8 tt -75.32 144.97 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 122.371 1.081 . . . . 0.0 112.05 -169.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.18 129.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.669 1.223 . . . . 0.0 108.635 -173.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -96.83 99.98 11.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.328 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.86 173.92 2.71 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.139 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -54.9 -14.28 7.76 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 118.966 2.641 . . . . 0.0 118.966 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -130.0 115.22 16.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 153.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.637 ' HH ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -84.46 139.01 32.49 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.604 -164.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.179 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 12.0 p -147.77 -155.02 0.59 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 123.209 1.481 . . . . 0.0 111.731 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.636 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.7 m0 -137.13 130.11 30.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.69 144.22 19.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.529 1.157 . . . . 0.0 108.299 171.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.31 134.63 36.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.169 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.469 0.521 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.594 170.362 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.746 ' HH ' ' HG3' ' A' ' 35' ' ' LYS . 1.5 t80 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -111.59 141.82 44.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.216 1.484 . . . . 0.0 112.155 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.06 120.87 42.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 112.466 -2.152 . . . . 0.0 105.79 165.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.91 -161.95 10.27 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 119.465 -1.35 . . . . 0.0 116.255 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.421 HD23 ' CE2' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -134.24 139.27 45.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.182 -1.009 . . . . 0.0 108.69 -165.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.99 134.65 52.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.341 1.067 . . . . 0.0 108.558 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -113.02 120.55 41.75 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.512 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.35 140.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -97.77 129.73 30.65 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 163.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -63.17 -10.59 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 N-CA-C 120.441 3.208 . . . . 0.0 120.441 -170.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.92 -50.26 62.95 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 -162.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.5 t -84.88 -30.14 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.553 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -81.91 0.21 40.79 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -170.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 93.6 m -76.32 -6.24 50.63 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 120.056 1.298 . . . . 0.0 111.537 164.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 m -113.19 71.48 1.46 Allowed Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.69 58.74 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.964 3.109 . . . . 0.0 115.971 -155.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.36 -50.15 23.5 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.59 -1.319 . . . . 0.0 111.751 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 -29.89 70.93 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.69 0.677 . . . . 0.0 112.348 176.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.95 -49.98 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.857 -0.527 . . . . 0.0 111.403 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.89 -36.58 77.25 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.294 -0.879 . . . . 0.0 113.298 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -63.1 -49.45 74.39 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.502 ' HA ' HE21 ' A' ' 28' ' ' GLN . 8.7 t -64.82 -38.01 89.56 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.198 0.908 . . . . 0.0 111.597 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HZ3' ' HB2' ' A' ' 36' ' ' PHE . 74.1 mmtt -62.39 -35.22 78.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 169.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.45 72.08 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.441 1.019 . . . . 0.0 113.489 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.502 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.5 mt-30 -59.49 -53.84 53.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.867 0.365 . . . . 0.0 111.6 174.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.87 76.09 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.83 -46.99 15.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -170.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 98.1 p -57.96 -20.55 38.68 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.74 -105.08 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.737 -0.602 . . . . 0.0 109.521 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -150.39 15.53 0.8 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -170.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.8 t -126.65 110.63 23.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.509 -168.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.746 ' HG3' ' HH ' ' A' ' 4' ' ' TYR . 68.6 mttm -99.33 134.94 41.46 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 165.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.508 ' HB2' ' HZ3' ' A' ' 26' ' ' LYS . 25.7 m-85 -89.06 139.72 30.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.26 -26.05 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -163.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.69 121.36 37.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -113.98 118.24 33.58 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.812 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.421 ' CE2' HD23 ' A' ' 8' ' ' LEU . 13.0 m-30 -121.97 106.14 10.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.812 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.73 149.76 25.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -63.25 -40.07 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -76.65 -30.24 56.74 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.96 -31.8 34.71 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.69 -40.39 69.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.551 1.069 . . . . 0.0 112.346 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.79 -18.55 61.47 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.14 -38.8 16.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.496 -0.752 . . . . 0.0 111.882 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.32 15.24 7.78 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.4 m -79.11 -3.3 44.75 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -171.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -114.72 169.55 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.588 -0.695 . . . . 0.0 109.369 -163.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -99.91 158.54 15.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.629 1.681 . . . . 0.0 109.515 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.4 150.08 52.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.312 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.3 169.52 16.35 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 160.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -120.59 46.33 2.02 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -82.25 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -100.2 63.46 1.15 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.888 0.851 . . . . 0.0 111.94 -161.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.469 ' C ' ' H ' ' A' ' 59' ' ' THR . 17.9 m-85 -112.25 21.59 15.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 117.138 -1.411 . . . . 0.0 112.666 167.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -61.74 31.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -158.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 57' ' ' TYR . 8.4 t -135.85 115.36 12.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 162.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.462 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 83.6 t -115.81 110.33 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -164.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.86 134.56 49.82 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 142.04 46.32 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 162.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.94 104.53 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 170.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.7 m -143.7 120.16 6.52 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.536 0.61 0 C-N-CA 122.413 2.076 . . . . 0.0 113.507 170.095 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.4 ' CE2' HG13 ' A' ' 78' ' ' ILE . 30.9 t80 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -82.24 149.98 15.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 121.087 1.191 . . . . 0.0 111.581 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -62.33 -33.91 75.61 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.71 -30.37 71.04 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -76.62 -30.18 56.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.177 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.4 HG13 ' CE2' ' A' ' 73' ' ' PHE . 97.1 mt -61.39 -36.99 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 119.741 1.155 . . . . 0.0 111.242 166.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.4 m -64.17 -40.95 97.2 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.07 1.304 . . . . 0.0 112.448 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.08 -43.49 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.15 -37.81 88.69 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.363 -0.836 . . . . 0.0 112.914 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.86 -29.7 70.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.91 -10.4 59.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 77.3 p -104.27 11.35 34.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.21 101.49 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -165.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.517 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.257 54.1 mttp -74.19 -160.35 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.482 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.523 170.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 8.2 Cg_endo -54.21 -42.26 68.85 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 N-CA-C 120.611 3.273 . . . . 0.0 120.611 -155.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -102.11 43.31 1.08 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 121.348 1.886 . . . . 0.0 110.93 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.84 140.09 37.71 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 167.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 42.5 t -138.8 158.28 44.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 116.994 -1.882 . . . . 0.0 106.925 166.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 2.0 tt -129.01 105.26 8.08 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.038 -162.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -106.37 81.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.65 -82.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 120.627 3.011 . . . . 0.0 120.627 -155.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mt -116.22 170.6 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -147.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -110.12 -136.05 0.36 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -157.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.31 -47.82 19.0 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -161.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.62 -29.57 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 124.371 2.034 . . . . 0.0 111.236 171.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.429 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 13.7 m-85 -76.58 -16.41 59.6 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.359 -172.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.95 -52.4 65.36 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.282 -0.886 . . . . 0.0 112.871 168.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.63 -36.14 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.858 -0.526 . . . . 0.0 111.09 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.29 -44.11 97.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.06 81.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.211 0.529 . . . . 0.0 112.408 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.28 -44.76 95.79 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 99.0 mt -80.05 -33.71 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.256 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -71.94 -18.47 62.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.77 31.13 4.94 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.668 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.509 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 85.9 m-85 -106.9 159.97 15.86 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -131.01 111.46 12.04 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.604 HG13 ' CD1' ' A' ' 117' ' ' TRP . 14.1 tt -90.71 153.25 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 122.739 1.257 . . . . 0.0 112.578 -166.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.568 HG23 ' SG ' ' A' ' 116' ' ' CYS . 17.0 tt -154.04 130.38 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.193 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -93.45 98.86 11.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 123.243 1.497 . . . . 0.0 110.698 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -109.58 177.84 1.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.785 -2.007 . . . . 0.0 108.469 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -55.61 -14.28 9.8 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 119.041 2.67 . . . . 0.0 119.041 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -118.1 149.56 40.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 154.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.461 ' HE2' ' HE1' ' A' ' 117' ' ' TRP . 22.5 t80 -86.45 139.23 31.11 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 120.774 -1.204 . . . . 0.0 108.997 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.568 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.356 28.1 p -146.11 120.59 9.7 Favored 'General case' 0 CA--C 1.553 1.093 1 N-CA-C 129.216 6.747 . . . . 0.0 129.216 -173.684 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.604 ' CD1' HG13 ' A' ' 109' ' ' ILE . 8.2 m0 -109.75 117.51 34.07 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.422 1.464 . . . . 0.0 109.178 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -107.68 144.38 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.855 -1.153 . . . . 0.0 109.443 172.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -79.7 110.49 15.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.612 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.641 0.734 . . . . 0.0 109.173 -170.343 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.2 t80 . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.98 141.65 51.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.58 1.181 . . . . 0.0 110.945 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.673 ' HG1' ' CG2' ' A' ' 37' ' ' VAL . 7.8 t -94.34 120.78 35.09 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 163.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.09 -161.69 11.46 Favored Glycine 0 N--CA 1.466 0.666 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.586 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -134.04 139.77 46.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.672 -1.764 . . . . 0.0 107.4 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.6 tp -124.29 129.83 51.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.647 1.213 . . . . 0.0 108.805 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 8.6 mp -115.1 120.37 39.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.59 -1.641 . . . . 0.0 107.051 171.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 tt -128.72 140.0 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.28 0.562 . . . . 0.0 109.737 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -102.7 129.75 25.24 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.14 -13.46 31.98 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 N-CA-C 120.462 3.216 . . . . 0.0 120.462 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.13 -50.21 56.11 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -161.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.07 -30.12 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.273 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.4 p -80.77 0.14 36.06 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -76.35 3.72 10.42 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.034 1.288 . . . . 0.0 112.49 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 m -113.48 71.64 1.69 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 43.51 0.78 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.768 2.978 . . . . 0.0 116.255 -153.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.22 -40.34 90.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.418 -0.801 . . . . 0.0 112.226 163.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mp -62.26 -29.89 70.73 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.03 -50.06 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.115 -0.366 . . . . 0.0 110.779 173.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -47.43 56.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -61.75 -40.61 95.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.081 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -62.29 -38.59 89.95 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 169.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.31 78.08 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.942 1.246 . . . . 0.0 113.807 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -56.9 -56.38 22.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.71 91.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.84 -37.63 34.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -170.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -57.8 -27.7 63.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.806 1.185 . . . . 0.0 113.778 170.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.93 -119.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -153.28 40.5 0.53 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 124.317 2.008 . . . . 0.0 111.946 -170.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.04 110.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 111.183 -2.735 . . . . 0.0 108.7 170.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.09 141.87 35.88 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 167.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -88.7 139.64 30.26 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.673 ' CG2' ' HG1' ' A' ' 6' ' ' THR . 92.6 t -108.91 -36.64 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.468 -166.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -121.85 169.93 10.28 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.881 1.324 . . . . 0.0 111.309 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -135.8 125.16 24.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.635 -1.621 . . . . 0.0 108.248 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 15.6 m-30 -124.15 120.26 31.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.973 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.31 149.38 21.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 tp -63.5 -40.19 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -78.88 -30.33 44.89 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.5 -0.75 . . . . 0.0 112.92 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -80.3 -32.42 38.04 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.547 -0.721 . . . . 0.0 112.721 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.65 -40.43 80.23 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.457 -0.777 . . . . 0.0 111.89 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -78.06 -30.9 50.01 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.89 -36.75 36.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.848 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.89 15.31 2.9 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 170.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -78.06 -26.44 48.27 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.24 1.52 . . . . 0.0 114.456 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.61 120.24 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.8 m -126.87 120.12 28.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.633 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.08 -166.88 1.35 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.57 170.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -98.84 169.91 9.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.586 1.184 . . . . 0.0 110.056 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 76.9 m-20 -77.13 97.56 4.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.587 170.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.33 -151.18 0.43 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -166.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -100.08 31.73 3.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -162.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.542 ' C ' ' H ' ' A' ' 59' ' ' THR . 2.5 m-85 -81.86 21.51 0.85 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.373 -170.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HB2' ' HA2' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -61.38 35.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -166.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.542 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.62 115.45 8.25 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 163.706 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 68.4 t -118.62 134.48 62.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.237 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.508 ' HE2' HG22 ' A' ' 92' ' ' ILE . 3.6 m80 -122.61 134.77 54.5 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.72 110.89 19.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 169.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.35 102.02 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.63 1.205 . . . . 0.0 111.466 170.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -132.82 154.95 81.63 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo . . . . . 0 CA--C 1.534 0.496 0 C-N-CA 122.344 2.03 . . . . 0.0 115.816 170.749 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 11.6 t80 . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 30.7 Cg_exo -82.02 149.54 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 CA-C-N 120.505 1.216 . . . . 0.0 110.456 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.68 -36.59 83.41 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.09 -32.9 72.55 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.61 -30.32 56.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.833 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.98 -34.9 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 119.954 1.252 . . . . 0.0 111.459 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.2 m -68.34 -39.16 82.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.893 1.224 . . . . 0.0 112.62 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.91 -37.54 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.947 -0.47 . . . . 0.0 111.774 174.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.04 -47.8 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.81 -0.556 . . . . 0.0 111.956 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.33 -30.06 70.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.21 -9.86 59.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 29.7 p -71.12 -35.25 71.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.05 167.05 14.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 123.16 1.457 . . . . 0.0 114.2 -150.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.73 101.89 0.57 Allowed Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.483 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -50.93 -6.98 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 N-CA-C 120.707 3.311 . . . . 0.0 120.707 -153.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -88.96 55.03 3.19 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.769 1.622 . . . . 0.0 108.809 160.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 58' ' ' GLU . . . -88.23 157.89 28.48 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.1 p -128.05 159.17 35.9 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.274 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -127.56 142.7 51.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.542 -2.117 . . . . 0.0 106.141 -173.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 1.057 HD13 ' SG ' ' A' ' 116' ' ' CYS . 46.7 mm -129.04 89.1 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 170.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.97 -88.43 0.09 OUTLIER Glycine 0 C--N 1.318 -0.472 0 N-CA-C 121.587 3.395 . . . . 0.0 121.587 -166.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mt -116.37 146.85 42.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.617 1.199 . . . . 0.0 109.513 -130.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.7 p -86.36 -136.68 0.08 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.526 -158.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.69 -50.5 13.51 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -156.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.22 -32.5 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 124.789 2.233 . . . . 0.0 113.015 170.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.0 m-85 -76.63 -14.89 59.95 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.737 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -59.08 -55.82 30.2 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.079 -1.013 . . . . 0.0 111.951 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.07 -34.85 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.897 -0.502 . . . . 0.0 111.49 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.01 -40.93 90.96 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 171.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.59 90.98 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.912 -0.492 . . . . 0.0 111.741 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.98 -49.45 71.39 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.702 0.763 . . . . 0.0 112.543 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.3 tt -80.24 -33.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.594 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -71.72 -19.71 62.01 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.96 33.28 4.09 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 119.607 -1.282 . . . . 0.0 112.597 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.476 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 95.8 m-85 -106.48 159.65 16.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 168.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -126.13 103.88 7.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.592 HG13 ' CD1' ' A' ' 117' ' ' TRP . 18.0 tt -76.15 140.69 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 122.882 1.325 . . . . 0.0 111.316 -168.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.45 119.02 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -106.56 94.55 5.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.598 1.666 . . . . 0.0 110.642 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -134.1 179.17 1.45 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 112.496 -2.138 . . . . 0.0 106.737 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.83 -11.53 3.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 118.654 2.521 . . . . 0.0 118.654 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -122.83 111.51 16.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 157.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.09 110.26 21.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.393 -0.813 . . . . 0.0 109.23 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.274 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 26.3 p -147.75 -157.03 0.77 Allowed 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 122.808 1.29 . . . . 0.0 113.65 170.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.592 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.5 m0 -137.33 130.42 30.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.618 -170.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -112.86 144.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.276 -1.515 . . . . 0.0 110.294 166.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.77 110.49 15.17 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.375 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.47 0.552 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.344 -170.321 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.725 ' HH ' ' HG3' ' A' ' 35' ' ' LYS . 4.3 t80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.37 141.96 27.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.65 0.738 . . . . 0.0 110.839 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -95.74 141.42 29.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 162.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.76 -160.12 9.22 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-O 124.132 1.962 . . . . 0.0 115.205 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.41 HD22 ' CE2' ' A' ' 40' ' ' PHE . 3.8 mt -134.2 139.67 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.4 -2.4 . . . . 0.0 107.751 -174.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.41 130.01 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.817 1.294 . . . . 0.0 107.839 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.409 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 8.7 mp -113.85 120.34 40.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.719 175.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.2 mt -121.3 139.9 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -171.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -94.11 129.77 36.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 165.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -60.68 -16.43 43.35 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 N-CA-C 121.056 3.444 . . . . 0.0 121.056 -170.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.78 72.49 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.317 1.417 . . . . 0.0 113.111 -162.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.02 -29.93 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.6 p -86.12 0.47 53.46 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -170.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -76.29 0.35 19.63 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 120.674 1.579 . . . . 0.0 112.601 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.322 90.8 m -98.87 168.09 10.29 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 162.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.74 -7.26 16.54 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 N-CA-C 117.837 2.206 . . . . 0.0 117.837 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.17 -50.48 19.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -159.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.29 -29.83 67.78 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.468 1.031 . . . . 0.0 112.579 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 t -66.26 -49.99 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.982 -0.449 . . . . 0.0 110.513 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.4 -39.73 88.4 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.982 -1.074 . . . . 0.0 113.29 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -59.87 -50.32 74.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 t -68.47 -34.51 76.07 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.615 -0.678 . . . . 0.0 111.698 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.27 -29.96 69.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 170.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.03 -47.09 66.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.482 1.037 . . . . 0.0 112.288 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.75 -48.72 77.19 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.97 60.64 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.549 169.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.29 70.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.2 -170.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -75.34 -19.53 59.56 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.1 -111.0 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.771 -0.581 . . . . 0.0 111.255 170.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -149.48 -10.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -166.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -98.98 149.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 121.592 -0.692 . . . . 0.0 112.402 170.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.725 ' HG3' ' HH ' ' A' ' 4' ' ' TYR . 89.9 mttt -128.29 143.9 51.07 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 164.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -92.54 139.84 30.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.754 0.788 . . . . 0.0 109.453 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.36 -32.69 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -121.62 169.98 10.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.292 1.52 . . . . 0.0 109.961 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -139.8 125.18 19.02 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.687 -172.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.41 ' CE2' HD22 ' A' ' 8' ' ' LEU . 21.4 m-30 -129.49 106.42 8.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -84.92 149.57 25.56 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.45 -0.781 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 tp -63.33 -40.11 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.12 -30.35 34.57 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.576 -0.702 . . . . 0.0 112.823 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -79.03 -31.59 44.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.122 -0.987 . . . . 0.0 112.789 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -72.6 -40.59 66.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.604 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.14 -15.29 58.98 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.978 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.34 -43.41 11.54 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.26 -0.9 . . . . 0.0 111.989 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.99 15.3 2.35 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -76.05 -25.58 55.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.638 1.719 . . . . 0.0 114.575 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.7 121.7 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -169.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -98.76 159.28 15.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 124.344 2.021 . . . . 0.0 109.349 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -130.91 120.74 24.03 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.028 -153.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.79 169.67 9.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.043 168.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 66.5 m-20 -111.13 88.55 2.81 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -170.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.5 -158.81 0.9 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -164.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -90.99 35.07 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.779 -1.555 . . . . 0.0 115.052 -163.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.542 ' C ' ' H ' ' A' ' 59' ' ' THR . 10.3 m-85 -82.03 21.84 0.85 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.374 -170.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.55 37.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -163.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.542 ' H ' ' C ' ' A' ' 57' ' ' TYR . 1.0 OUTLIER -141.22 115.4 9.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 163.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 18.7 t -118.61 134.51 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.633 -1.622 . . . . 0.0 106.743 -164.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.487 ' HE2' HG21 ' A' ' 92' ' ' ILE . 2.2 m80 -122.84 134.71 54.39 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.76 110.52 16.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.4 mt -98.05 100.7 12.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.451 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -126.2 92.45 45.66 Favored Pre-proline 0 N--CA 1.474 0.752 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 167.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.536 0.622 0 C-N-CA 122.077 1.851 . . . . 0.0 111.994 170.382 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.4 t80 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -82.14 149.47 15.41 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 120.617 1.256 . . . . 0.0 110.242 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.54 -38.01 88.33 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.89 -35.15 70.6 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 mt -76.62 -30.26 56.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.51 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.05 -36.17 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 119.899 1.227 . . . . 0.0 111.429 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.8 m -68.62 -39.17 80.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.544 1.066 . . . . 0.0 112.814 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -36.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.992 -0.443 . . . . 0.0 111.855 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.7 -46.44 90.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.743 -0.598 . . . . 0.0 111.849 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.86 70.21 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.33 -10.15 59.55 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -169.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 67.0 m -76.17 -34.64 59.35 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 168.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.83 176.5 6.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 123.998 1.856 . . . . 0.0 114.885 -148.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -105.06 101.57 30.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 -170.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -51.34 16.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.384 1 N-CA-C 122.903 4.155 . . . . 0.0 122.903 -153.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -102.05 61.37 0.87 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 156.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.47 137.39 13.23 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.1 p -134.08 109.45 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.644 1.212 . . . . 0.0 107.884 -169.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.222 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.28 6.2 tt -93.38 132.25 37.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.813 -174.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 1.065 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 37.0 mm -115.68 84.94 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -170.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.88 -87.2 0.09 OUTLIER Glycine 0 C--N 1.315 -0.593 0 N-CA-C 121.168 3.227 . . . . 0.0 121.168 -163.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.88 169.85 8.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.169 -139.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.0 m -105.35 -155.32 0.54 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.282 -0.886 . . . . 0.0 112.37 -157.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.95 -42.98 84.32 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -163.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -59.8 -33.15 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 124.3 2.0 . . . . 0.0 112.545 169.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 32.0 m-85 -76.54 -12.85 60.09 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.785 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.81 -48.29 79.73 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.065 -1.022 . . . . 0.0 112.404 165.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.69 -38.33 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.489 -0.757 . . . . 0.0 110.714 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.34 -48.45 81.7 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 170.366 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.99 -41.58 71.4 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.56 -47.48 83.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.8 mt -77.16 -35.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.038 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -71.97 -16.74 62.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.84 29.93 5.36 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.947 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.3 m-85 -106.92 159.7 16.07 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.768 1.27 . . . . 0.0 108.809 173.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.59 109.52 11.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.36 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.608 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -85.63 111.15 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.905 1.336 . . . . 0.0 114.082 -164.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 19.0 tt -119.51 135.07 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.231 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -119.64 97.28 5.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.911 -168.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -117.31 -177.42 0.45 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 112.606 -2.088 . . . . 0.0 107.582 164.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.4 -11.11 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 N-CA-C 118.948 2.634 . . . . 0.0 118.948 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -103.95 113.31 26.75 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 154.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -80.12 115.16 19.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.612 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.222 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 24.4 p -147.35 -156.86 0.75 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.168 1.461 . . . . 0.0 112.343 166.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.608 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.4 m0 -132.58 149.66 52.28 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -174.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.58 144.18 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 122.983 1.373 . . . . 0.0 108.586 165.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.69 110.19 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.928 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.156 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.666 ' HH ' ' HG3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -88.89 141.8 28.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.016 0.912 . . . . 0.0 110.706 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.46 141.64 30.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 160.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.79 -168.25 11.78 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-O 123.964 1.869 . . . . 0.0 117.052 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.432 HD11 ' CE2' ' A' ' 40' ' ' PHE . 30.1 tp -134.39 115.14 13.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 111.215 -2.493 . . . . 0.0 106.213 -165.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 129.19 54.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.35 148.88 32.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.908 1.337 . . . . 0.0 108.646 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.77 HG22 ' HG1' ' A' ' 16' ' ' THR . 5.8 mt -133.7 111.63 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.651 -169.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -87.07 129.52 51.64 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -59.97 -19.74 56.89 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 N-CA-C 121.008 3.426 . . . . 0.0 121.008 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.44 74.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.685 1.13 . . . . 0.0 113.197 -162.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.59 -27.6 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -171.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.77 ' HG1' HG22 ' A' ' 11' ' ' ILE . 69.7 p -86.1 0.39 53.63 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -170.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.3 m -76.4 -0.26 22.13 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 120.681 1.582 . . . . 0.0 111.738 168.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 m -108.96 71.6 0.44 Allowed Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 43.86 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.088 3.192 . . . . 0.0 116.421 -153.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.39 -39.6 92.41 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.579 -0.701 . . . . 0.0 112.138 162.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.31 -30.72 68.56 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.11 -48.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 122.341 -0.224 . . . . 0.0 110.907 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.47 -33.07 74.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.9 -48.39 37.62 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -61.45 -42.58 98.98 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.523 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -65.52 -32.92 74.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.145 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.59 78.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.069 1.304 . . . . 0.0 113.177 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.0 -55.49 30.29 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.67 87.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.64 70.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -170.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.8 m -58.09 -28.67 64.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 170.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -85.84 -101.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.85 -0.531 . . . . 0.0 109.967 -170.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -147.26 27.72 1.02 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -131.05 110.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.978 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.666 ' HG3' ' HH ' ' A' ' 4' ' ' TYR . 99.7 mttt -101.4 139.46 37.03 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.072 -1.017 . . . . 0.0 108.989 168.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -88.99 139.84 30.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.83 -33.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.876 -166.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -121.82 169.58 10.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.684 1.23 . . . . 0.0 108.906 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -126.64 154.64 43.74 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.432 ' CE2' HD11 ' A' ' 8' ' ' LEU . 14.3 m-30 -136.12 112.93 10.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.7 149.24 25.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -63.47 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.79 -30.31 40.58 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.49 -29.68 30.39 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.099 -1.001 . . . . 0.0 113.113 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.89 -40.35 72.27 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.892 . . . . 0.0 111.874 174.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -73.37 -18.82 61.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.09 -46.41 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.291 -0.881 . . . . 0.0 112.1 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.74 15.15 1.41 Allowed Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -77.53 -10.55 59.55 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.024 1.912 . . . . 0.0 115.645 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.78 121.36 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.692 -0.63 . . . . 0.0 109.671 -169.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -98.97 120.29 39.17 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 123.814 1.769 . . . . 0.0 109.776 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -119.1 120.84 38.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.76 -158.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.5 169.57 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.472 1.129 . . . . 0.0 109.39 167.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -110.14 88.35 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.85 -119.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -100.09 56.89 0.95 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -156.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.5 ' C ' ' H ' ' A' ' 59' ' ' THR . 1.1 m-85 -112.05 10.73 20.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 170.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.253 19.3 mt-10 -78.75 46.55 0.67 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.944 2.611 . . . . 0.0 112.542 -170.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -112.99 108.85 17.92 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 150.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 59.5 t -118.61 110.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.54 -2.118 . . . . 0.0 107.894 -155.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.465 ' HE2' HG22 ' A' ' 92' ' ' ILE . 2.8 m80 -115.05 105.33 12.83 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 -174.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.83 141.97 28.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 119.819 -1.801 . . . . 0.0 109.498 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -124.06 80.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.481 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -134.06 81.9 49.94 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.94 1.7 . . . . 0.0 111.367 -170.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 CA--C 1.538 0.677 0 C-N-CA 121.993 1.795 . . . . 0.0 110.267 169.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.8 t80 . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -82.27 149.63 15.19 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 120.046 1.052 . . . . 0.0 110.402 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.49 -34.59 77.17 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -59.29 -36.53 75.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.56 -30.15 56.95 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.985 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.89 -40.18 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 O-C-N 121.281 -0.887 . . . . 0.0 110.937 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.6 m -71.23 -30.92 66.94 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.996 -1.065 . . . . 0.0 113.853 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.96 -46.01 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.858 -0.526 . . . . 0.0 110.799 171.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -37.38 75.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.4 70.48 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.02 -9.79 58.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -68.41 -50.48 52.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.938 -0.476 . . . . 0.0 112.104 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.593 ' CD1' ' H ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -98.82 -141.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -174.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.594 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.262 74.9 mmtt -129.84 -139.51 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -170.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.594 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 49.6 Cg_endo -68.97 -50.25 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 CA-C-N 124.385 2.602 . . . . 0.0 114.129 170.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -79.33 53.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.217 1.371 . . . . 0.0 114.318 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.39 164.72 28.35 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 161.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.5 t -147.02 159.23 43.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.163 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.376 1.2 tm? -128.44 129.55 46.3 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 112.222 -2.263 . . . . 0.0 104.91 -162.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.799 HD12 ' CB ' ' A' ' 116' ' ' CYS . 40.3 mm -118.49 84.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.016 1.734 . . . . 0.0 108.256 170.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.82 -88.18 0.09 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 -161.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.61 169.77 8.94 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.798 -143.038 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.4 m -108.69 -148.47 0.42 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -158.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.54 -45.05 88.81 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -163.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.89 -31.19 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 124.762 2.22 . . . . 0.0 110.84 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 79.1 m-85 -76.75 -2.97 35.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.523 -174.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 87.3 tttt -67.2 -49.18 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.213 -0.929 . . . . 0.0 111.892 170.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.4 -34.41 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.02 169.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.593 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.19 -47.94 83.84 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 172.445 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.32 80.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 tp -58.94 -49.94 75.95 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.613 0.72 . . . . 0.0 112.55 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.19 -34.38 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.4 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -71.69 -16.68 62.25 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.67 29.04 5.74 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.496 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 82.7 m-85 -106.67 159.72 15.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -120.83 153.94 36.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.522 ' CG1' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -112.07 152.45 13.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.566 -167.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 tp -154.01 120.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.66 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -107.6 100.23 9.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 123.735 1.731 . . . . 0.0 110.196 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.73 -178.24 0.64 Allowed Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 111.72 -2.491 . . . . 0.0 106.698 169.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.06 -10.73 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 119.314 2.774 . . . . 0.0 119.314 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -119.71 111.53 18.14 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 158.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.44 115.33 27.49 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.941 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.163 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 11.7 p -147.12 -163.44 1.76 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 124.321 2.01 . . . . 0.0 114.334 172.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.522 ' CD1' ' CG1' ' A' ' 109' ' ' ILE . 13.2 m0 -137.65 130.35 29.91 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 110.559 -3.019 . . . . 0.0 106.412 -165.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 144.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.585 -1.322 . . . . 0.0 108.88 165.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -79.59 110.58 15.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.753 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.391 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.405 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 22.9 t80 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.63 141.81 28.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.97 0.89 . . . . 0.0 111.319 -165.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 m -96.96 141.17 30.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 172.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.2 -158.7 8.62 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 118.787 -1.673 . . . . 0.0 115.76 172.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.31 139.67 45.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 113.252 -1.474 . . . . 0.0 108.636 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.59 138.7 54.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.997 1.379 . . . . 0.0 107.815 165.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -125.91 120.46 30.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.264 -1.789 . . . . 0.0 108.983 178.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 tt -129.02 139.84 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.05 0.929 . . . . 0.0 111.316 -160.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -106.94 129.8 23.83 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 166.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -60.0 -15.82 35.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 N-CA-C 119.984 3.032 . . . . 0.0 119.984 -170.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -50.19 74.21 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.294 0.952 . . . . 0.0 112.206 -167.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -34.26 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -85.41 -0.01 53.56 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -76.48 -8.18 56.64 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 120.064 1.302 . . . . 0.0 111.59 164.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.5 m -111.62 71.46 0.93 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 164.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.84 53.3 0.77 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.3 3.334 . . . . 0.0 116.779 -154.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.12 -48.73 27.55 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.753 -1.217 . . . . 0.0 112.67 165.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.53 -30.34 71.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.27 -45.64 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.147 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.76 -34.94 78.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.57 -48.21 49.82 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 t -60.72 -40.96 94.26 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.81 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.91 -32.99 73.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.172 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.14 74.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.942 1.246 . . . . 0.0 113.823 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -55.05 -55.26 33.01 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.66 -46.31 84.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.037 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.24 -50.01 71.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -170.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -69.85 -20.55 63.41 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 112.574 -170.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.73 -103.13 0.06 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.314 0.578 . . . . 0.0 109.443 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -157.4 4.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.86 150.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.643 0.735 . . . . 0.0 111.451 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 88.4 tttt -128.42 135.03 48.95 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 161.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -88.93 139.56 30.33 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.83 -14.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -163.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.61 120.32 34.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -114.77 125.1 53.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -163.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 60.2 m-85 -130.17 102.35 6.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.689 -175.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.7 tt -85.24 149.34 25.56 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.061 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -63.42 -40.17 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.517 ' H ' HD23 ' A' ' 41' ' ' LEU . 22.1 t-20 -81.64 -30.34 32.83 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.197 -0.939 . . . . 0.0 112.762 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.91 -30.75 56.28 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.433 -0.792 . . . . 0.0 112.577 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -40.43 70.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.882 0.765 . . . . 0.0 112.306 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.17 -20.64 47.93 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.74 -30.55 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 111.623 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.53 15.14 11.57 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 t -78.4 -34.34 48.14 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 mt -114.98 120.3 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.753 0.787 . . . . 0.0 108.983 -167.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.0 m -133.05 158.71 42.07 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.5 mt -131.71 -138.5 0.2 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.93 178.77 4.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.013 0.911 . . . . 0.0 109.937 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -120.1 67.38 0.83 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.187 -169.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.19 -77.92 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 -170.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -82.9 7.74 14.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 -157.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.571 ' C ' ' H ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -90.13 21.25 3.83 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.16 -167.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.93 26.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -167.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.571 ' H ' ' C ' ' A' ' 57' ' ' TYR . 6.4 t -133.12 115.1 14.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 162.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 18.0 t -116.56 134.32 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -167.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.455 ' HE2' HG23 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -122.71 134.75 54.45 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.28 142.23 42.18 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.36 102.66 8.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.604 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.8 m -139.43 154.75 71.94 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 170.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo . . . . . 0 CA--C 1.532 0.388 0 C-N-CA 122.849 2.366 . . . . 0.0 116.366 170.579 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.2 t80 . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -82.0 149.34 15.63 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 CA-C-N 121.233 1.476 . . . . 0.0 110.109 -175.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -37.9 88.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.11 -33.61 73.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -76.72 -30.15 56.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.34 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -36.72 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.75 1.159 . . . . 0.0 111.442 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -68.27 -36.24 79.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.84 1.2 . . . . 0.0 112.82 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.74 -41.14 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.941 -0.474 . . . . 0.0 111.533 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -60.06 -46.35 89.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.648 0.658 . . . . 0.0 112.364 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.88 70.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.7 -10.02 59.12 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -170.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -104.44 23.32 13.41 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.3 mt -134.12 -166.64 1.83 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.165 0.983 . . . . 0.0 110.829 -163.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.96 174.88 3.95 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -170.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.8 -22.72 14.25 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 170.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -102.51 45.83 0.95 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.741 1.61 . . . . 0.0 110.4 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.45 138.4 20.34 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -143.4 109.08 5.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.43 1.586 . . . . 0.0 107.041 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.151 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.368 0.2 OUTLIER -89.82 129.72 36.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -176.075 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 1.303 HD13 ' SG ' ' A' ' 116' ' ' CYS . 42.7 mm -111.44 95.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.243 1.021 . . . . 0.0 109.097 170.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.93 -83.68 0.06 OUTLIER Glycine 0 C--N 1.315 -0.625 0 N-CA-C 120.851 3.1 . . . . 0.0 120.851 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.435 HD12 HD12 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -116.09 169.94 8.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 118.764 -1.174 . . . . 0.0 108.476 -133.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -103.02 -140.94 0.36 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.07 -1.019 . . . . 0.0 112.63 -155.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.22 -44.79 24.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -162.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tp -56.63 -33.05 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 124.505 2.097 . . . . 0.0 112.569 167.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 71.8 m-85 -76.66 -10.88 59.7 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.203 -176.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.45 -51.52 69.51 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 112.256 167.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.44 -35.28 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.896 -0.503 . . . . 0.0 111.236 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -57.89 -42.96 85.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 170.126 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.35 94.57 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.164 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -54.92 -48.0 73.65 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.24 -35.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.076 -169.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.68 -18.74 62.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.95 4.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.004 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -106.71 159.69 16.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.5 154.27 35.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.539 1.162 . . . . 0.0 107.933 158.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.626 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.2 tt -107.48 149.26 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.745 -163.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.72 126.18 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 122.553 1.168 . . . . 0.0 107.953 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -106.05 100.21 9.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.593 1.663 . . . . 0.0 109.826 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -127.93 177.59 2.01 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 111.935 -2.393 . . . . 0.0 107.446 170.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.99 -11.82 4.16 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 N-CA-C 119.269 2.757 . . . . 0.0 119.269 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -115.94 108.12 15.86 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 157.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.48 ' HH ' HD12 ' A' ' 109' ' ' ILE . 9.9 t80 -86.8 113.06 22.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.668 -170.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.303 ' SG ' HD13 ' A' ' 92' ' ' ILE . 25.1 p -147.54 -153.95 0.52 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 123.072 1.415 . . . . 0.0 112.258 172.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.626 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.0 m0 -134.77 149.73 50.46 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.66 144.09 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 166.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -83.31 134.83 34.9 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.742 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 110.616 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 12.5 t80 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.764 0.316 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -105.06 160.58 14.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 123.367 1.556 . . . . 0.0 113.403 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.077 170.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.69 -156.39 9.5 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.849 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 tp -134.03 142.72 47.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -166.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.05 129.83 51.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 40' ' ' PHE . 1.3 mt -109.36 120.08 41.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 171.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.518 HG12 ' HG1' ' A' ' 16' ' ' THR . 21.3 tt -132.14 139.93 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.539 0.685 . . . . 0.0 109.324 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -101.08 129.75 26.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.39 -12.02 25.53 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.968 3.026 . . . . 0.0 119.968 -170.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.26 52.44 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -161.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -85.2 -29.81 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.175 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.518 ' HG1' HG12 ' A' ' 11' ' ' ILE . 66.2 p -81.08 0.24 36.91 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -76.33 -0.87 24.1 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.859 1.209 . . . . 0.0 112.247 165.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 m -112.47 71.5 1.18 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 163.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.17 46.1 1.08 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.986 3.124 . . . . 0.0 116.219 -152.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.24 -43.5 91.21 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.599 -0.688 . . . . 0.0 112.608 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.49 -29.94 70.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.25 -46.88 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.934 -0.479 . . . . 0.0 110.887 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.25 -33.92 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.89 -48.79 57.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.426 ' HA ' HE21 ' A' ' 28' ' ' GLN . 9.7 t -61.73 -39.21 90.74 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.477 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -66.3 -29.9 70.21 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.34 76.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.236 1.38 . . . . 0.0 113.428 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.426 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.7 mt-30 -59.69 -50.83 72.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.966 -0.459 . . . . 0.0 111.611 170.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.91 -42.66 59.58 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.69 -49.92 12.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -59.35 -37.39 77.74 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 170.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.9 -106.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.717 -0.615 . . . . 0.0 110.389 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.432 ' HB3' ' CD1' ' A' ' 4' ' ' TYR . 43.1 mmtm -129.76 -44.86 1.19 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -169.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.98 149.58 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.728 1.251 . . . . 0.0 111.335 -165.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -114.88 136.0 53.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.63 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -90.46 139.47 30.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.7 t -118.74 -32.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.63 -162.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -121.86 169.99 10.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.273 1.511 . . . . 0.0 110.859 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -134.49 125.4 27.31 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.757 -174.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.413 ' O ' HD23 ' A' ' 10' ' ' LEU . 18.4 m-30 -118.68 120.21 36.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 168.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.64 149.43 22.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.53 -40.09 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.97 -30.45 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -85.53 -31.5 22.68 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -0.918 . . . . 0.0 112.944 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -66.21 -40.56 90.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.26 0.937 . . . . 0.0 112.054 171.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -69.67 -24.98 63.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.992 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.13 -39.86 16.27 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.67 -0.644 . . . . 0.0 111.78 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.34 15.36 1.14 Allowed Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -79.74 -30.09 40.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -171.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.8 mt -114.75 120.28 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.867 0.841 . . . . 0.0 109.854 -164.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -128.26 120.45 27.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.239 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.5 -167.43 1.36 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.897 1.332 . . . . 0.0 110.537 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -98.58 120.5 39.12 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.203 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -81.17 46.67 0.94 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -161.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.03 4.42 0.63 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 119.594 3.183 . . . . 0.0 119.594 170.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -100.4 -34.59 9.89 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 122.089 2.222 . . . . 0.0 115.801 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 59' ' ' THR . 8.2 m-85 -81.87 22.04 0.8 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -157.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.3 37.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -167.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 57' ' ' TYR . 8.8 t -138.57 115.32 10.69 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 160.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 45.7 t -124.87 110.34 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.504 -160.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.488 ' HE2' HG23 ' A' ' 92' ' ' ILE . 3.6 m80 -105.88 134.6 48.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.408 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -118.06 110.42 17.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.25 -0.906 . . . . 0.0 109.017 176.357 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.51 89.5 3.23 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.468 -170.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -136.76 86.71 21.36 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 CA--C 1.54 0.786 0 C-N-CA 122.127 1.884 . . . . 0.0 112.84 170.343 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.1 t80 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -82.2 149.44 15.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 CA-C-N 120.962 1.379 . . . . 0.0 110.344 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -38.38 90.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.14 -31.76 70.39 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.68 -30.3 56.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.992 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.38 -35.28 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 120.203 1.365 . . . . 0.0 111.227 170.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.9 m -68.94 -39.93 79.26 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.597 1.09 . . . . 0.0 112.503 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.19 -38.09 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.942 -0.474 . . . . 0.0 111.84 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -40.48 91.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.709 -0.619 . . . . 0.0 112.571 176.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.0 70.72 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.86 -19.16 61.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.4 m -72.06 -17.02 62.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -111.15 159.93 17.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.123 0.963 . . . . 0.0 110.387 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -91.38 174.96 3.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.341 169.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -60.43 -10.61 13.93 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 117.508 2.08 . . . . 0.0 117.508 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -102.07 50.06 0.84 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 168.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.14 141.4 25.03 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.9 p -139.66 103.79 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.167 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.274 2.6 tt -89.96 129.78 36.25 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -178.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 1.145 HD11 ' SG ' ' A' ' 116' ' ' CYS . 32.3 mm -110.18 91.14 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -80.71 0.05 OUTLIER Glycine 0 C--N 1.315 -0.596 0 N-CA-C 121.22 3.248 . . . . 0.0 121.22 -163.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 mt -115.97 169.78 8.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.227 -141.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.839 ' HG ' ' H ' ' A' ' 96' ' ' ASP . 6.0 p -123.55 -117.31 0.29 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 119.636 -0.826 . . . . 0.0 113.009 -158.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.839 ' H ' ' HG ' ' A' ' 95' ' ' SER . 20.6 t70 -73.36 -59.39 2.73 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -155.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mt -59.7 -26.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 124.248 1.975 . . . . 0.0 111.593 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.583 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 62.4 m-85 -76.9 -18.73 58.12 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.283 -169.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -54.44 -53.96 47.22 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.988 -1.07 . . . . 0.0 112.436 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.06 -33.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.837 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.583 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.84 -43.34 94.65 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 172.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.61 97.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.86 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.03 -44.52 95.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -80.01 -35.63 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.038 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -71.78 -18.74 62.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 32.11 4.52 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.79 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.487 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.6 m-85 -106.77 159.96 15.84 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -128.51 109.09 11.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.621 HD11 ' HH ' ' A' ' 115' ' ' TYR . 20.2 tt -87.6 111.22 21.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 122.751 1.263 . . . . 0.0 114.393 -162.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.5 tt -105.12 125.25 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.756 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -115.41 81.53 1.6 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 124.285 1.993 . . . . 0.0 111.299 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -134.34 100.47 12.69 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 -170.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.63 29.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.971 1 N-CA-C 124.8 4.885 . . . . 0.0 124.8 -140.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -99.68 99.82 10.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 132.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.621 ' HH ' HD11 ' A' ' 109' ' ' ILE . 10.4 t80 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.572 -163.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 1.167 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 23.8 p -147.3 -156.49 0.72 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 123.104 1.43 . . . . 0.0 111.77 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.569 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.7 m0 -134.24 149.6 50.98 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 -174.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 143.91 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.351 1.072 . . . . 0.0 108.25 164.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 68.4 tttt -90.2 64.82 6.2 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.437 -178.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.379 170.13 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.6 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 12.8 t80 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -117.47 141.63 48.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.772 1.273 . . . . 0.0 111.347 -170.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.26 120.89 42.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.359 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.27 -161.13 9.69 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 123.59 1.661 . . . . 0.0 117.086 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.5 tp -127.95 139.9 52.31 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 111.795 -2.203 . . . . 0.0 107.196 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -124.37 129.28 50.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 162.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -123.34 120.07 31.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -176.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.0 pt -131.21 139.99 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.492 -0.755 . . . . 0.0 111.218 -167.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.4 129.69 36.09 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 166.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.31 -13.9 18.08 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 N-CA-C 120.205 3.117 . . . . 0.0 120.205 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.52 -50.2 66.13 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -163.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.28 -34.02 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.166 170.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.5 p -83.49 0.4 46.53 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 t -76.58 -6.01 50.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.687 1.585 . . . . 0.0 114.573 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.312 62.8 m -98.94 168.11 10.24 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 169.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.59 -6.72 16.41 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 N-CA-C 116.915 1.852 . . . . 0.0 116.915 -170.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.12 -50.19 20.55 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.721 1.146 . . . . 0.0 113.833 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.99 -31.44 70.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.656 0.662 . . . . 0.0 112.123 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.77 -47.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 122.232 -0.292 . . . . 0.0 111.044 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.35 -32.69 72.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.49 -49.09 52.05 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.4 t -61.83 -40.08 94.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.176 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.33 -34.2 77.6 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.3 70.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.287 1.403 . . . . 0.0 113.246 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.297 1.5 tm0? -54.85 -53.7 51.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.11 82.93 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.58 -50.03 14.88 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -25.54 61.14 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -85.8 -114.83 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.628 -0.67 . . . . 0.0 109.659 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -154.1 11.79 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.1 149.88 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.817 0.818 . . . . 0.0 111.778 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.6 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 88.6 tttt -128.44 137.88 52.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 162.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -88.75 139.45 30.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.3 t -117.21 -35.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.542 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -122.05 120.15 33.5 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -157.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -114.88 114.17 25.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -162.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.455 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 18.5 m-30 -119.05 120.57 37.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.56 HD21 ' H ' ' A' ' 43' ' ' ASN . 7.6 tt -91.47 149.37 21.73 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.49 -40.05 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.56 ' H ' HD21 ' A' ' 41' ' ' LEU . 21.2 m120 -80.51 -30.35 37.28 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.55 -31.44 42.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.33 -0.856 . . . . 0.0 112.823 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.42 -40.36 70.51 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.866 0.757 . . . . 0.0 112.107 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.46 -24.56 63.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.26 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.09 -35.26 37.2 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.71 -0.619 . . . . 0.0 111.42 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.41 15.15 6.07 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.937 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.6 m -75.07 -36.1 61.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.68 1.24 . . . . 0.0 113.834 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.71 111.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 122.766 1.269 . . . . 0.0 108.815 -165.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.2 m -133.28 115.15 14.59 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.259 18.1 tp -124.63 -52.94 1.69 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.293 -0.963 . . . . 0.0 113.308 -159.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -149.36 169.47 20.75 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -120.6 49.05 1.5 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 170.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.14 -86.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -100.22 62.29 1.1 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -160.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.473 ' C ' ' H ' ' A' ' 59' ' ' THR . 2.2 m-85 -112.15 22.06 15.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.827 166.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.48 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -161.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.473 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.03 115.53 6.7 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 168.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.487 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 14.0 t -119.59 134.51 62.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.601 -164.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.475 ' HE2' HG22 ' A' ' 92' ' ' ILE . 10.8 m80 -122.46 134.67 54.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.47 110.21 16.65 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.42 102.03 13.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.886 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -120.09 154.59 55.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.49 134.51 38.76 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.114 1.876 . . . . 0.0 115.148 170.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -120.08 30.04 7.2 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.195 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.83 -23.56 14.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 170.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -74.93 149.8 39.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.103 0.865 . . . . 0.0 110.595 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.5 m -106.45 74.22 1.01 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.997 0.903 . . . . 0.0 109.038 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -135.04 178.72 6.8 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 170.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 pt -90.74 149.26 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.571 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.43 -63.35 1.13 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 118.525 2.787 . . . . 0.0 118.525 -170.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -130.42 149.39 73.27 Favored Pre-proline 0 N--CA 1.474 0.749 0 O-C-N 120.861 -1.15 . . . . 0.0 110.331 -156.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -82.16 149.71 15.43 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.773 0.954 . . . . 0.0 111.171 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.58 -39.77 94.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.68 -31.43 69.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.5 mt -76.67 -30.29 56.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.445 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.01 -37.59 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.045 1.293 . . . . 0.0 111.226 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.4 p -68.47 -39.15 81.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.112 1.324 . . . . 0.0 112.672 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.19 -39.77 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.912 -0.493 . . . . 0.0 112.201 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -39.34 93.37 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.62 -0.675 . . . . 0.0 112.683 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.95 -29.8 70.76 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.11 -10.02 55.6 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -99.82 16.51 23.46 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.3 mt -131.18 -174.11 3.29 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.526 1.155 . . . . 0.0 110.289 -168.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -140.04 174.93 3.53 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -170.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.4 -16.3 46.41 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 N-CA-C 118.341 2.401 . . . . 0.0 118.341 -170.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -102.27 45.06 0.98 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.467 1.03 . . . . 0.0 110.544 168.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.15 144.22 34.38 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 78.7 p -146.99 109.84 4.68 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.249 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.285 0.6 OUTLIER -93.29 129.96 39.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.805 -173.363 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.729 HD12 ' CB ' ' A' ' 116' ' ' CYS . 27.6 mm -113.34 84.56 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.471 1.032 . . . . 0.0 108.894 170.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -83.23 0.06 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 121.361 3.304 . . . . 0.0 121.361 -166.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.36 146.89 42.12 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.636 1.208 . . . . 0.0 110.308 -135.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.2 p -94.61 -129.4 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.535 -156.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.5 -48.51 15.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -158.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.69 -29.52 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 124.555 2.122 . . . . 0.0 111.339 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.532 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 87.0 m-85 -76.73 -14.4 59.95 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.834 -172.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.31 -55.24 37.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.824 -1.173 . . . . 0.0 112.571 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.86 -34.35 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.812 -0.555 . . . . 0.0 111.295 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.35 -42.0 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 173.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.49 -48.66 80.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.882 0.849 . . . . 0.0 112.334 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.15 -35.45 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.212 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -71.57 -18.81 62.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 33.92 3.94 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.673 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 72.6 m-85 -106.7 159.64 16.06 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.29 104.39 9.1 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.013 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.569 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.8 tt -83.7 110.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.787 1.28 . . . . 0.0 114.377 -167.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.6 tt -111.64 131.41 63.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 113.183 -1.826 . . . . 0.0 108.928 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -109.42 86.93 2.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 124.059 1.885 . . . . 0.0 112.181 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 114' ' ' ASP . 55.1 mt-10 -134.41 100.49 12.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -54.77 28.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 1 N-CA-C 124.663 4.832 . . . . 0.0 124.663 -144.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.8 p-10 -99.58 100.29 11.28 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 131.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -80.05 115.28 19.53 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.907 -0.496 . . . . 0.0 110.763 -164.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.249 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.4 p -147.24 -161.16 1.27 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 124.621 2.153 . . . . 0.0 115.177 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.569 ' CD1' HG13 ' A' ' 109' ' ' ILE . 19.0 m0 -137.4 126.28 24.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 109.71 -3.405 . . . . 0.0 106.462 -167.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.303 0.1 OUTLIER -112.65 111.22 35.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 O-C-N 121.365 -0.834 . . . . 0.0 109.483 177.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -79.1 134.28 36.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.2 ttt . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.539 170.599 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.602 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 6.6 t80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -117.7 141.83 47.95 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.98 141.86 32.23 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 162.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.7 -159.47 9.0 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 122.98 1.322 . . . . 0.0 116.243 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.01 139.51 46.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 113.172 -1.514 . . . . 0.0 107.379 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.7 tp -124.6 131.4 53.48 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.292 1.044 . . . . 0.0 108.506 170.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 120.18 38.82 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.133 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.0 pt -123.54 139.81 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -90.32 130.01 43.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.13 -18.23 9.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 121.603 3.655 . . . . 0.0 121.603 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.19 71.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 -158.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.16 -27.28 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.26 168.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.6 p -71.52 -14.29 62.07 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.7 m -76.62 -4.03 40.86 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 120.795 1.634 . . . . 0.0 111.933 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.326 96.3 m -98.55 168.18 10.25 Favored Pre-proline 0 CA--C 1.558 1.264 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.42 -0.69 10.87 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 N-CA-C 117.768 2.18 . . . . 0.0 117.768 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.05 -50.54 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.351 1.432 . . . . 0.0 113.952 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.18 -31.51 70.18 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.741 0.7 . . . . 0.0 112.422 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.4 -48.41 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 122.121 -0.362 . . . . 0.0 110.768 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -61.84 -33.25 73.82 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -47.45 60.51 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.405 ' HA ' HE21 ' A' ' 28' ' ' GLN . 6.8 t -63.26 -39.99 96.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.432 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -62.72 -34.75 77.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.684 -0.674 . . . . 0.0 112.776 169.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -44.34 72.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.167 1.349 . . . . 0.0 113.674 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.405 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.3 mt-30 -59.9 -53.16 61.09 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.766 0.317 . . . . 0.0 111.704 173.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.6 -37.73 76.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.32 -42.94 19.82 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -170.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.9 p -57.8 -20.14 33.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 170.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.77 -100.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -158.14 19.21 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -170.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.93 110.73 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -167.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.602 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 81.6 tttt -99.09 134.94 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -88.97 139.68 30.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.113 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.83 -31.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.34 -168.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -121.74 120.36 34.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -161.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -114.64 124.59 52.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -165.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -127.47 120.2 27.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.17 149.73 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 tp -63.21 -39.53 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -77.65 -30.31 52.05 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -80.48 -32.82 37.01 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.392 -0.818 . . . . 0.0 113.043 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -73.89 -40.59 63.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.294 0.952 . . . . 0.0 112.393 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -74.24 -20.43 60.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.768 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.5 -37.37 25.37 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.61 -0.681 . . . . 0.0 111.593 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.75 15.21 6.4 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 120.613 -0.803 . . . . 0.0 114.966 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -76.27 -31.63 58.39 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.813 1.307 . . . . 0.0 114.199 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.73 120.26 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -167.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.5 m -122.59 120.05 32.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.046 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -122.35 -161.65 0.95 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.84 170.02 9.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.82 1.295 . . . . 0.0 111.202 -169.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -115.26 71.6 0.77 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.336 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.94 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -97.13 43.66 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -157.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 59' ' ' THR . 2.6 m-85 -112.21 21.68 15.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 117.545 -1.217 . . . . 0.0 110.685 -170.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.65 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -158.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 57' ' ' TYR . 7.0 t -134.37 115.31 13.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 164.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 65.9 t -119.43 110.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -163.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.49 ' HE2' HG22 ' A' ' 92' ' ' ILE . 13.7 m80 -107.63 134.29 50.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.36 110.52 15.26 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.122 -0.986 . . . . 0.0 110.165 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.94 100.32 8.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.1 m -119.96 88.63 40.89 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.24 89.54 1.31 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.185 1.923 . . . . 0.0 111.749 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -120.12 -30.28 4.69 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 170.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.34 -174.12 2.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.713 0.768 . . . . 0.0 109.859 -170.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -75.43 -70.12 0.44 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.763 -0.586 . . . . 0.0 110.127 170.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.4 t -125.12 49.93 1.82 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -170.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -135.02 80.98 1.87 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -170.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.5 tt -108.13 100.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -170.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.63 100.33 11.73 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.305 170.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -127.71 148.65 67.79 Favored Pre-proline 0 N--CA 1.473 0.723 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 168.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -82.33 149.91 15.16 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 120.659 0.906 . . . . 0.0 112.088 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -62.45 -35.42 79.23 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -60.34 -34.34 73.7 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.55 -30.4 57.07 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.655 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.9 -38.52 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 120.357 1.435 . . . . 0.0 111.298 171.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 95.2 p -69.18 -40.74 77.94 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.79 1.177 . . . . 0.0 113.11 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.1 -38.64 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.799 -0.563 . . . . 0.0 112.262 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -33.84 71.62 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.82 -29.77 69.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -69.16 -9.83 54.78 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.4 m -97.99 29.83 3.3 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.15 171.02 14.82 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.359 1.076 . . . . 0.0 112.989 -162.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 49.7 mttm -122.39 -158.02 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 170.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 10.7 Cg_endo -67.65 -43.72 5.2 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 119.834 2.974 . . . . 0.0 119.834 -163.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -90.51 63.29 5.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 122.386 2.357 . . . . 0.0 111.495 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.31 133.99 13.61 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 170.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.6 p -139.16 159.27 42.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.16 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.251 1.1 tt -127.94 129.62 47.12 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.819 HD13 ' CB ' ' A' ' 116' ' ' CYS . 24.8 mm -112.3 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.914 0.864 . . . . 0.0 109.41 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' HA3' HD11 ' A' ' 94' ' ' LEU . . . -143.72 -79.27 0.04 OUTLIER Glycine 0 C--N 1.318 -0.445 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 -161.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.421 HD11 HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.65 171.15 7.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.962 1.363 . . . . 0.0 111.121 -139.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 m -92.97 -162.74 0.96 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.178 -1.373 . . . . 0.0 113.318 -164.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.17 -36.49 84.38 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.25 -32.63 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 124.817 2.246 . . . . 0.0 111.283 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 93.8 m-85 -76.81 -12.23 59.94 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.501 -172.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HZ1' ' HB2' ' A' ' 99' ' ' LYS . 4.5 ttmp? -58.94 -53.63 56.24 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.815 -1.178 . . . . 0.0 112.367 169.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.04 -37.1 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.802 -0.561 . . . . 0.0 111.068 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.57 -45.57 93.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.92 172.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.02 74.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.871 -0.518 . . . . 0.0 111.72 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.58 -50.1 70.98 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.655 0.74 . . . . 0.0 112.748 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.35 -34.22 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -71.79 -17.8 62.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.69 29.94 5.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 92.2 m-85 -106.46 159.66 15.99 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -127.55 107.6 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.642 HD13 ' HH ' ' A' ' 115' ' ' TYR . 16.9 tt -76.18 149.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.484 1.135 . . . . 0.0 111.914 -167.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.08 125.13 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.47 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -106.48 100.0 9.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.483 1.611 . . . . 0.0 111.302 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -134.06 175.2 3.85 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 112.449 -2.16 . . . . 0.0 107.252 -170.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -54.97 -19.97 21.5 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.82 109.97 19.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 156.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.642 ' HH ' HD13 ' A' ' 109' ' ' ILE . 5.9 t80 -87.11 111.11 20.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.637 -0.664 . . . . 0.0 109.258 -170.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.16 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 17.6 p -147.26 -157.18 0.79 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 124.251 1.977 . . . . 0.0 112.694 174.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.61 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.4 m0 -137.25 149.93 47.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 110.305 -3.134 . . . . 0.0 104.421 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.74 144.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.363 161.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 10.0 tmtt? -91.64 134.47 34.66 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 108.765 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.665 0.745 . . . . 0.0 110.563 -170.016 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 122.22 1.009 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.3 147.23 24.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.813 1.292 . . . . 0.0 112.419 -165.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.21 120.88 42.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.653 170.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.32 -160.98 10.41 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 118.446 -1.835 . . . . 0.0 115.418 170.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 139.85 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -164.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.371 0.2 OUTLIER -124.8 129.29 50.15 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.143 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.416 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 8.0 mp -116.04 120.36 38.84 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.489 HG13 ' HG1' ' A' ' 16' ' ' THR . 6.7 tt -130.29 139.48 51.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.902 0.858 . . . . 0.0 109.681 -167.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -103.19 129.67 25.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -9.32 17.5 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 N-CA-C 122.032 3.82 . . . . 0.0 122.032 -170.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.36 70.04 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.546 2.424 . . . . 0.0 117.546 -158.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.2 t -93.06 -30.69 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.23 0.923 . . . . 0.0 108.809 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.489 ' HG1' HG13 ' A' ' 11' ' ' ILE . 67.4 p -80.21 0.26 33.22 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -170.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -76.41 9.3 2.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.42 1.463 . . . . 0.0 113.134 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.332 64.2 m -99.03 168.34 9.85 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 164.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -77.45 -3.99 14.21 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 117.734 2.167 . . . . 0.0 117.734 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -50.4 19.23 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -164.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -29.89 67.9 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.886 0.766 . . . . 0.0 112.752 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.7 t -70.4 -44.29 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.498 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.63 -34.1 72.36 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.052 -1.03 . . . . 0.0 113.634 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.44 72.68 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -58.88 -47.85 83.48 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -29.82 70.18 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -47.54 64.6 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.386 0.994 . . . . 0.0 112.815 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.304 1.4 tm0? -54.98 -52.49 62.92 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -33.5 69.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.31 -50.16 19.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.1 m -60.72 -34.67 74.74 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 170.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.94 -131.02 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -145.1 5.71 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.418 HG21 HG22 ' A' ' 59' ' ' THR . 4.1 p -98.93 154.1 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.681 0.753 . . . . 0.0 111.742 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -128.03 142.43 51.23 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 166.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.73 100.65 12.83 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.637 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.18 -30.79 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.749 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.83 169.64 10.57 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.615 1.198 . . . . 0.0 109.769 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -142.68 116.46 9.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.416 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 14.3 m-30 -118.73 115.34 24.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.74 149.51 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 tp -63.63 -40.26 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.08 -30.25 31.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.77 -29.09 18.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.087 0.858 . . . . 0.0 112.785 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.84 -40.45 79.42 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.015 1.279 . . . . 0.0 111.471 170.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.17 -27.91 66.83 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.97 19.54 19.89 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.54 11.22 45.11 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 117.459 1.743 . . . . 0.0 117.459 152.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -82.8 -23.6 33.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -167.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.8 mt -114.63 167.82 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.464 1.029 . . . . 0.0 110.364 -161.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 m -99.73 117.42 34.05 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.718 1.247 . . . . 0.0 110.488 -173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -96.83 120.35 37.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.242 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -107.58 120.27 41.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 166.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -84.83 67.8 10.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.461 -170.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -74.32 0.07 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -100.27 45.78 0.97 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -160.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.27 21.48 15.74 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.701 165.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.598 ' HG3' ' H ' ' A' ' 86' ' ' LYS . 8.9 mm-40 -61.67 58.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 171.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.418 HG22 HG21 ' A' ' 34' ' ' VAL . 10.7 t -146.69 113.12 5.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 144.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.448 HG13 ' H ' ' A' ' 92' ' ' ILE . 0.6 OUTLIER -99.91 134.15 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 -170.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.506 ' HE2' HG22 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -122.58 134.56 54.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 167.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.79 110.74 16.72 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.965 0.888 . . . . 0.0 109.314 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.45 100.39 11.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.575 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -125.67 107.39 26.19 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.25 -53.07 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.644 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 -162.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.93 30.04 1.12 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -161.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.46 178.49 4.72 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.675 -1.266 . . . . 0.0 110.668 -170.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -112.3 -78.64 0.58 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -125.11 -56.4 1.55 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -170.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -109.47 100.07 9.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -170.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.86 167.66 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.808 0.813 . . . . 0.0 110.189 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -85.98 94.79 9.3 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 168.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -124.05 90.96 50.2 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.64 170.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.92 149.7 50.39 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.714 1.609 . . . . 0.0 112.243 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.42 -31.91 72.68 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.69 -33.95 70.73 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.4 mt -76.79 -30.23 56.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.017 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -37.22 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 119.325 0.966 . . . . 0.0 111.382 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 97.1 p -70.52 -39.71 73.91 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.812 1.187 . . . . 0.0 112.717 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.03 -46.26 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.562 0.619 . . . . 0.0 111.448 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.05 -30.54 65.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.59 70.72 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -80.77 -9.94 59.77 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -171.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 p -97.74 50.95 1.05 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.1 159.93 28.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -156.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.598 ' H ' ' HG3' ' A' ' 58' ' ' GLU . 69.4 mmtt -100.5 174.9 2.65 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 110.67 -2.968 . . . . 0.0 106.417 163.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -53.21 -28.53 42.53 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 118.629 2.511 . . . . 0.0 118.629 170.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -102.07 70.93 1.23 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.266 . . . . 0.0 110.968 170.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.43 131.74 24.64 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 163.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -147.44 120.21 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.607 1.194 . . . . 0.0 108.241 -170.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.171 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.254 0.5 OUTLIER -106.36 129.96 54.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.195 -166.908 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.659 HD12 ' CB ' ' A' ' 116' ' ' CYS . 26.3 mm -111.21 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.963 1.256 . . . . 0.0 108.269 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' HD12 ' A' ' 94' ' ' LEU . . . -143.92 -94.46 0.19 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 121.579 3.392 . . . . 0.0 121.579 -166.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.45 ' HB2' ' CB ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -115.48 146.83 41.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.867 -137.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.3 m -107.21 -130.14 0.29 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.078 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.95 128.48 33.73 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.68 -13.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 2 O-C-N 114.952 -4.842 . . . . 0.0 117.848 11.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.3 m-85 -76.26 -0.79 23.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.591 -2.095 . . . . 0.0 113.155 -152.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.66 -55.74 10.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.74 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.58 -33.75 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.984 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.587 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.26 -41.42 96.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.311 -0.956 . . . . 0.0 113.123 172.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.89 94.07 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.929 -0.482 . . . . 0.0 111.246 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 tp -55.86 -50.06 71.63 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.619 0.723 . . . . 0.0 112.419 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.1 tt -80.04 -34.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.567 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.63 -16.21 62.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.29 4.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.076 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 76.7 m-85 -106.47 159.7 15.96 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.11 154.17 32.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.629 HG12 ' CD1' ' A' ' 117' ' ' TRP . 17.0 mt -104.32 153.25 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.98 1.371 . . . . 0.0 109.899 -171.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.7 tp -151.16 135.0 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.779 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -115.99 88.36 2.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.006 1.86 . . . . 0.0 112.295 -171.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -134.34 100.38 12.74 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -170.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -54.95 29.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.102 1 N-CA-C 124.372 4.72 . . . . 0.0 124.372 -141.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.86 105.63 17.39 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 132.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.498 ' HH ' HG23 ' A' ' 109' ' ' ILE . 22.8 t80 -79.86 115.36 19.4 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.816 -0.552 . . . . 0.0 110.052 -166.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.171 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.79 -161.31 1.3 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 124.143 1.925 . . . . 0.0 115.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.629 ' CD1' HG12 ' A' ' 109' ' ' ILE . 24.5 m0 -137.05 149.71 47.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 110.384 -3.098 . . . . 0.0 103.905 -165.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.4 mm -110.97 144.72 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 162.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 9.2 tmtt? -93.72 110.01 21.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 18.6 mmt . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 122.017 0.913 . . . . 0.0 112.2 -168.451 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.587 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 6.4 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.76 141.84 48.25 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.122 -0.986 . . . . 0.0 111.134 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.95 141.42 30.15 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.15 -161.74 9.71 Favored Glycine 0 N--CA 1.466 0.696 0 CA-C-O 124.196 1.998 . . . . 0.0 116.319 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.22 143.77 48.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 110.922 -2.639 . . . . 0.0 107.437 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 136.11 54.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.394 1.092 . . . . 0.0 109.106 170.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mt -113.67 120.2 40.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.104 -1.407 . . . . 0.0 107.657 164.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.731 HG22 ' HG1' ' A' ' 16' ' ' THR . 3.3 mp -113.62 139.8 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -95.48 129.47 34.78 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 165.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.44 -9.53 18.26 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 N-CA-C 120.872 3.374 . . . . 0.0 120.872 -170.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 -50.31 64.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -161.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -87.33 -29.05 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.119 170.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.731 ' HG1' HG22 ' A' ' 11' ' ' ILE . 76.1 p -80.78 0.48 34.56 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -170.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.2 m -76.2 0.09 20.32 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 120.197 1.362 . . . . 0.0 111.599 166.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 m -114.26 71.36 2.17 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 161.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.72 52.85 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.038 3.158 . . . . 0.0 116.808 -154.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.96 -39.85 79.24 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.671 -1.268 . . . . 0.0 112.233 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.43 -29.96 68.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.77 -46.5 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 122.227 -0.296 . . . . 0.0 110.939 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.76 -38.48 78.57 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -66.89 -49.97 63.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.481 ' HA ' HE21 ' A' ' 28' ' ' GLN . 7.9 t -61.82 -38.63 88.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.376 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -63.71 -34.45 77.89 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.15 -40.54 78.13 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.481 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.1 mt-30 -64.25 -51.9 61.32 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.04 -0.412 . . . . 0.0 111.631 173.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.6 75.13 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.49 73.53 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -75.04 -22.6 58.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.092 0.86 . . . . 0.0 112.223 -170.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.87 -103.77 0.06 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.306 0.574 . . . . 0.0 109.809 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -161.81 10.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -166.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.67 149.71 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.877 0.846 . . . . 0.0 112.196 170.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 87.5 tttt -128.58 136.12 50.29 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -88.91 139.58 30.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.849 0.833 . . . . 0.0 108.758 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.05 -41.12 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.536 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -121.94 169.83 10.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.579 1.18 . . . . 0.0 111.176 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -137.28 125.12 22.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.282 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -121.59 149.12 43.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 117.301 -1.759 . . . . 0.0 109.189 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -123.47 111.27 16.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.6 tp -49.8 -35.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.23 -30.37 43.19 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.802 1.183 . . . . 0.0 113.737 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -81.76 -28.94 33.02 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.227 -0.92 . . . . 0.0 113.139 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.45 -40.6 85.42 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.3 0.955 . . . . 0.0 112.057 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -70.32 -23.34 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.97 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.02 -37.66 33.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.49 -0.756 . . . . 0.0 111.493 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.22 15.27 5.16 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -72.32 -28.27 62.96 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -114.81 120.46 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.737 0.78 . . . . 0.0 109.254 -165.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -108.02 120.37 42.12 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.505 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.579 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 15.2 tp -120.52 -165.95 1.26 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.933 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.579 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 48.1 mt-10 -98.62 -176.02 3.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.611 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -120.15 65.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.11 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HE2' ' HZ1' ' A' ' 86' ' ' LYS . 78.4 mttt -100.04 53.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -159.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.48 ' C ' ' H ' ' A' ' 59' ' ' THR . 7.2 m-85 -112.63 21.74 15.29 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 116.903 -1.522 . . . . 0.0 112.079 166.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -61.81 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -162.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.11 115.47 6.65 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 164.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 93.4 t -111.2 134.66 52.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -165.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.501 ' HE2' HG22 ' A' ' 92' ' ' ILE . 4.2 m80 -122.53 134.86 54.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 141.34 52.07 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.03 1.741 . . . . 0.0 109.286 164.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.0 tp -124.56 90.44 3.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.724 -170.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.5 m -138.01 114.46 9.21 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.21 151.87 33.66 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.509 2.14 . . . . 0.0 115.941 -170.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -106.19 30.22 6.1 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.442 -170.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.8 -58.33 1.94 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.046 -1.034 . . . . 0.0 109.748 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -82.31 115.31 21.31 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -170.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -78.88 76.34 5.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -165.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -135.17 178.86 6.7 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -170.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -90.46 149.41 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 120.847 -1.158 . . . . 0.0 109.331 -170.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mtpt -94.08 -71.0 0.68 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 5.5 t80 -130.34 149.24 72.81 Favored Pre-proline 0 N--CA 1.475 0.791 0 O-C-N 120.796 -1.19 . . . . 0.0 111.571 -155.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 17.4 Cg_exo -82.14 149.93 15.55 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.206 1.271 . . . . 0.0 111.207 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -62.35 -37.16 84.59 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.59 -30.88 70.1 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -76.81 -30.09 56.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.4 mt -64.4 -35.03 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 119.915 1.234 . . . . 0.0 111.63 168.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.5 p -69.56 -36.57 76.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.505 1.502 . . . . 0.0 112.688 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.34 -39.62 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.751 -0.593 . . . . 0.0 111.728 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -40.87 97.05 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.698 -0.626 . . . . 0.0 112.655 174.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.85 70.76 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.12 -10.09 59.17 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.1 m -100.32 28.52 4.92 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mp -134.26 160.03 39.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 122.59 1.186 . . . . 0.0 111.238 -164.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HZ1' ' HE2' ' A' ' 56' ' ' LYS . 87.9 mttt -105.18 174.92 2.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.37 166.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.54 -25.33 32.21 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 118.581 2.493 . . . . 0.0 118.581 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.65 57.38 1.15 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.774 1.17 . . . . 0.0 110.208 168.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.9 145.98 36.01 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 167.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.6 p -141.62 159.27 42.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.234 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.343 1.7 tm? -128.19 129.48 46.54 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -170.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.794 HD13 ' HB3' ' A' ' 116' ' ' CYS . 44.2 mm -121.03 79.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.632 1.56 . . . . 0.0 110.019 170.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.25 -83.24 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 120.518 2.967 . . . . 0.0 120.518 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.452 HD12 HD13 ' A' ' 91' ' ' LEU . 1.1 mt -116.54 146.93 42.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.486 -1.357 . . . . 0.0 111.024 -132.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -102.41 -109.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.068 -156.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.26 -60.19 2.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -157.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 mt -61.13 -26.63 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 124.253 1.978 . . . . 0.0 111.605 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.445 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 10.5 m-85 -76.56 -19.77 57.55 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.987 -171.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.37 -56.18 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.965 -1.085 . . . . 0.0 113.013 168.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.07 -35.23 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.824 -0.548 . . . . 0.0 111.324 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -58.63 -45.34 89.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 171.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.52 -43.78 84.58 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.569 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -54.96 -49.88 70.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 112.72 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.3 tt -80.24 -34.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.72 30.51 5.19 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.076 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 47.7 m-85 -106.62 159.5 16.15 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 168.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.26 110.22 15.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.669 HD12 ' HH ' ' A' ' 115' ' ' TYR . 15.2 tt -74.92 148.55 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 122.487 1.137 . . . . 0.0 111.873 -171.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -149.65 126.98 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.97 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -109.65 98.81 8.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 123.418 1.58 . . . . 0.0 111.582 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -134.31 178.45 1.76 Allowed Pre-proline 0 N--CA 1.472 0.652 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.148 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.55 -7.99 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 N-CA-C 118.732 2.551 . . . . 0.0 118.732 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -128.4 115.23 17.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 157.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.669 ' HH ' HD12 ' A' ' 109' ' ' ILE . 10.7 t80 -85.44 111.29 19.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.227 -169.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.234 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 19.9 p -147.24 -158.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 124.424 2.059 . . . . 0.0 113.672 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.605 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.0 m0 -137.15 149.89 47.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 110.096 -3.229 . . . . 0.0 104.213 -169.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.43 144.59 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 164.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 16.1 ttpt -94.5 110.37 22.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.975 -1.078 . . . . 0.0 109.873 167.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 109.501 -170.341 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.623 ' HH ' ' HG3' ' A' ' 35' ' ' LYS . 7.5 t80 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -96.61 141.95 29.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.744 1.259 . . . . 0.0 112.929 -160.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.415 ' HG1' ' CG2' ' A' ' 37' ' ' VAL . 0.7 OUTLIER -98.38 120.45 38.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.525 169.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' HA3' ' CG2' ' A' ' 59' ' ' THR . . . -133.0 -164.92 11.02 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.889 175.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.42 141.65 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -164.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -124.13 134.79 53.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.945 1.355 . . . . 0.0 107.855 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -122.7 120.07 32.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.761 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mt -118.14 139.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.21 129.71 24.65 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 165.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -59.85 -13.61 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 N-CA-C 121.48 3.608 . . . . 0.0 121.48 -170.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.54 60.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -161.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.1 m -88.92 -27.78 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.914 0.779 . . . . 0.0 110.715 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -76.36 -14.46 60.09 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -170.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.87 2.23 15.2 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.264 1.393 . . . . 0.0 112.067 -170.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.304 86.1 m -98.85 168.62 9.44 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 166.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -77.18 -9.24 17.76 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 118.298 2.384 . . . . 0.0 118.298 -170.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.43 -50.47 18.31 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -165.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.16 -29.81 67.91 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.744 0.702 . . . . 0.0 112.417 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.15 -50.01 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.852 -0.53 . . . . 0.0 110.453 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.45 -36.99 79.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -60.07 -50.03 75.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.421 ' HA ' HE21 ' A' ' 28' ' ' GLN . 13.8 t -66.4 -39.8 89.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.786 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -61.8 -33.3 73.88 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -36.33 77.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.421 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.5 mt-30 -60.17 -56.9 15.93 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.991 -0.443 . . . . 0.0 111.172 172.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.2 77.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.97 63.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 95.7 p -59.85 -28.6 67.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 170.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -85.92 -124.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.616 -0.678 . . . . 0.0 110.017 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -136.27 9.95 3.23 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -170.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.63 150.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.596 0.712 . . . . 0.0 109.884 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.623 ' HG3' ' HH ' ' A' ' 4' ' ' TYR . 61.8 mttm -128.24 136.55 51.2 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 163.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.91 100.87 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.211 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.415 ' CG2' ' HG1' ' A' ' 6' ' ' THR . 27.8 m -81.47 -24.52 10.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.429 -1.714 . . . . 0.0 114.409 -164.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -121.71 169.75 10.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.279 1.038 . . . . 0.0 111.299 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -146.89 125.23 12.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.818 -169.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.433 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 31.0 m-85 -130.99 149.94 52.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.42 156.67 20.49 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.03 -40.08 87.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.147 -0.971 . . . . 0.0 113.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -82.02 -30.34 31.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -82.83 -30.48 28.69 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.403 1.001 . . . . 0.0 112.967 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.92 -40.56 68.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.207 0.912 . . . . 0.0 112.364 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -74.99 -19.47 60.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.767 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.28 -37.33 21.82 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.798 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.54 15.09 8.37 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -79.6 -17.63 53.44 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.4 mt -114.93 120.38 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.0 m -110.82 107.94 17.6 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.29 1.043 . . . . 0.0 110.929 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -131.15 172.99 11.48 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.435 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.16 177.69 5.32 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.833 -1.167 . . . . 0.0 110.477 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -120.03 70.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.037 -158.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.02 -83.37 0.06 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -99.91 45.15 0.99 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -156.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -112.24 21.77 15.45 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 116.325 -1.798 . . . . 0.0 112.041 -170.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.38 42.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -155.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.416 ' CG2' ' HA3' ' A' ' 7' ' ' GLY . 10.3 t -141.64 115.11 8.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 159.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 92' ' ' ILE . 0.9 OUTLIER -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 100.679 -3.823 . . . . 0.0 100.679 -170.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.475 ' HE2' HG22 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -122.24 134.53 54.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 167.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.48 110.7 16.79 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.267 18.5 tp -97.61 114.05 25.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.186 0.993 . . . . 0.0 111.507 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.409 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 27.7 m -149.28 154.88 39.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 79.7 Cg_exo -49.75 128.59 21.75 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.215 1.943 . . . . 0.0 114.013 170.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.85 -19.67 24.36 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.64 71.92 1.74 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.04 0.924 . . . . 0.0 109.751 170.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -112.05 115.25 28.6 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.739 -170.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -78.71 9.87 3.76 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -135.21 90.72 2.65 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.6 tt -99.94 71.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -170.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -125.11 139.88 53.38 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.928 0.87 . . . . 0.0 111.047 170.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -130.08 148.94 71.72 Favored Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 163.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -82.12 149.53 15.46 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 CA-C-N 121.071 1.418 . . . . 0.0 110.158 -173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.65 -36.14 81.89 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -35.69 74.9 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.82 -30.19 56.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.099 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.08 -38.2 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 119.777 1.171 . . . . 0.0 111.133 168.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.7 m -68.02 -37.24 81.18 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.347 0.976 . . . . 0.0 112.634 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.28 -41.52 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.263 0.483 . . . . 0.0 111.808 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.84 -41.22 97.88 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.44 1.018 . . . . 0.0 112.362 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.93 -29.82 70.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.79 -9.94 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.7 m -84.96 -18.11 35.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.68 170.6 9.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 120.06 1.3 . . . . 0.0 111.914 -164.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.506 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 75.5 mttt -108.61 -164.9 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -170.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 12.9 Cg_endo -62.94 -29.73 76.22 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 123.159 2.164 . . . . 0.0 113.715 -170.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -102.07 41.27 1.23 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.46 145.68 29.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -147.13 117.52 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.363 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.278 0.6 OUTLIER -89.53 143.86 26.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.826 -1.988 . . . . 0.0 107.334 -173.279 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.985 HD12 ' CB ' ' A' ' 116' ' ' CYS . 46.4 mm -128.07 88.84 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.858 1.208 . . . . 0.0 108.868 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.15 -76.56 0.03 OUTLIER Glycine 0 C--N 1.316 -0.539 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.276 4.2 mp -115.56 169.89 8.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 122.688 1.233 . . . . 0.0 109.336 -129.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.81 -120.71 0.29 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.932 -157.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.1 -53.66 6.49 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 121.216 1.825 . . . . 0.0 115.792 -158.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.83 -29.9 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 124.86 2.267 . . . . 0.0 111.903 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.8 m-85 -76.97 -20.44 56.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.29 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -53.89 -55.36 27.58 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.797 -1.189 . . . . 0.0 112.427 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.12 -32.73 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.885 -0.51 . . . . 0.0 111.667 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.548 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.74 -43.79 97.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 173.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.4 88.94 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.05 -48.96 78.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.789 0.804 . . . . 0.0 112.526 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.17 -35.36 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.115 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -71.81 -17.59 62.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.7 31.6 4.78 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 119.285 -1.436 . . . . 0.0 112.523 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 50.6 m-85 -106.6 159.52 16.13 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -124.61 103.69 8.28 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.622 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.5 tt -78.67 142.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 122.707 1.242 . . . . 0.0 111.62 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.07 127.85 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.401 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -109.78 100.07 9.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.529 -1.668 . . . . 0.0 110.509 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.6 -174.86 0.29 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.353 170.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -56.37 -10.54 4.95 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 N-CA-C 118.935 2.629 . . . . 0.0 118.935 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -119.39 149.56 41.63 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 154.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -113.68 114.73 26.79 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 -170.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.363 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 28.1 p -147.73 -156.31 0.71 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.973 1.368 . . . . 0.0 114.651 170.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.622 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.9 m0 -137.21 127.7 26.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.919 -1.946 . . . . 0.0 108.28 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -108.78 110.83 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.56 -1.338 . . . . 0.0 110.183 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -79.58 110.07 14.55 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.104 0.954 . . . . 0.0 111.167 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.728 -170.296 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -106.53 142.03 36.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 122.375 1.083 . . . . 0.0 111.834 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.1 t -103.02 120.74 41.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 168.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' HA3' ' CG2' ' A' ' 59' ' ' THR . . . -128.34 -159.6 10.07 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 118.405 -1.855 . . . . 0.0 113.32 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.25 144.46 48.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -170.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.26 0.1 OUTLIER -124.51 129.41 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 172.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -111.53 120.15 41.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.074 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 pt -124.52 139.63 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.428 ' CD2' HG23 ' A' ' 64' ' ' THR . 6.3 t60 -97.24 130.34 29.88 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -54.5 -20.73 21.67 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 N-CA-C 120.931 3.396 . . . . 0.0 120.931 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.73 72.68 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.977 1.717 . . . . 0.0 112.669 -164.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -96.07 -29.53 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -171.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.5 p -85.99 0.02 54.35 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -170.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.2 m -76.46 -5.06 45.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.431 1.469 . . . . 0.0 112.816 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.315 79.7 m -98.7 168.08 10.37 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 167.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.63 -9.45 17.19 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 N-CA-C 117.598 2.115 . . . . 0.0 117.598 -170.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.06 -50.19 20.74 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -163.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.08 -31.83 70.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.784 0.72 . . . . 0.0 112.057 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.45 -47.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.637 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.13 -33.89 74.12 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.93 -47.91 60.57 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -62.62 -39.71 94.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.54 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.01 -31.89 73.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.01 -45.97 69.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.11 1.323 . . . . 0.0 112.332 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.03 -51.25 66.87 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.93 82.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.19 -50.08 13.74 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 t -57.94 -28.18 64.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 170.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.99 -127.87 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.495 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -130.05 6.78 5.03 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -104.45 150.82 7.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.863 0.84 . . . . 0.0 109.98 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -127.99 141.11 51.62 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 164.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -100.32 100.51 11.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.006 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.78 -28.89 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.995 -163.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -121.91 169.63 10.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.329 1.062 . . . . 0.0 110.395 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -147.7 111.6 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -160.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 13.7 m-30 -119.01 120.47 37.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.5 mt -86.31 149.65 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.15 -39.73 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -78.03 -30.42 49.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.39 -25.48 29.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.492 1.042 . . . . 0.0 113.225 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -40.19 74.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.842 1.201 . . . . 0.0 111.924 173.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -74.0 -21.07 60.13 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -88.3 -45.94 9.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.415 -0.803 . . . . 0.0 111.992 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.87 15.19 2.16 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 171.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -76.86 -13.55 59.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 120.213 2.006 . . . . 0.0 115.608 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.67 121.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.0 t -98.83 159.35 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 124.245 1.974 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.2 tp -130.44 120.54 24.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.217 -2.72 . . . . 0.0 111.309 -151.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.57 116.07 30.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.564 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -91.44 80.23 5.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.067 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.98 -78.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.16 14.2 20.81 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -155.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.553 ' C ' ' H ' ' A' ' 59' ' ' THR . 10.6 m-85 -83.43 21.49 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.966 -170.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.65 27.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.553 ' H ' ' C ' ' A' ' 57' ' ' TYR . 10.1 t -126.51 113.08 16.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.226 1.013 . . . . 0.0 108.938 160.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.2 t -107.65 110.33 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -97.77 134.25 41.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.61 141.37 46.47 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 168.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.7 mt -123.83 91.27 3.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.175 170.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 12' ' ' HIS . 86.1 m -129.5 88.33 50.46 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.768 1.167 . . . . 0.0 110.015 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.22 76.45 4.52 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.911 1.741 . . . . 0.0 110.333 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -120.09 -30.32 4.7 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.67 178.45 5.96 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.157 0.98 . . . . 0.0 110.787 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -112.33 -56.64 2.37 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.991 -170.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 m -83.17 -49.7 9.2 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -170.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.88 178.78 0.43 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.728 0.775 . . . . 0.0 112.706 -169.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 pt -103.87 73.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.068 0.461 . . . . 0.0 111.204 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.05 26.71 0.34 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 118.351 -1.339 . . . . 0.0 114.506 170.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.3 t80 -130.49 148.86 71.65 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 167.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 26.8 Cg_exo -82.27 149.54 15.18 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 CA-C-N 120.626 1.259 . . . . 0.0 111.153 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ptmm? -62.48 -35.78 80.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.69 -28.36 69.01 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.69 -30.35 56.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.789 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.4 -38.17 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 120.391 1.451 . . . . 0.0 110.977 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.1 t -66.86 -43.28 83.98 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.504 1.047 . . . . 0.0 112.716 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.15 -39.9 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.42 -37.85 83.7 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.245 0.929 . . . . 0.0 112.42 174.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.47 -29.85 68.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.284 0.947 . . . . 0.0 113.456 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.77 -10.06 59.36 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.9 m -99.46 14.93 28.1 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.7 mt -134.14 -175.95 4.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.165 0.983 . . . . 0.0 111.556 -159.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -117.75 174.88 2.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.73 -28.62 30.67 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 119.525 2.856 . . . . 0.0 119.525 170.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.43 54.45 0.79 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.191 1.359 . . . . 0.0 108.356 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.17 138.58 21.47 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.3 p -142.91 104.36 4.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.274 3.9 tt -89.86 129.46 36.23 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 4.6 mp -114.24 85.4 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 -170.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.39 -80.97 0.05 OUTLIER Glycine 0 N--CA 1.464 0.505 0 N-CA-C 121.769 3.468 . . . . 0.0 121.769 -155.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.259 0.8 OUTLIER -115.5 169.96 8.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.567 1.175 . . . . 0.0 110.058 -139.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.7 t -102.36 -148.84 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.113 -157.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.77 -42.59 24.19 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.08 -32.79 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 125.126 2.394 . . . . 0.0 112.96 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 75.7 m-85 -76.28 -10.27 59.28 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 112.941 -1.936 . . . . 0.0 110.093 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.32 -50.24 74.75 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.675 -1.266 . . . . 0.0 112.388 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -35.55 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.064 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.545 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.34 -47.83 84.36 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 171.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.98 -42.81 80.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.191 0.52 . . . . 0.0 111.949 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.4 tp -60.73 -44.83 96.17 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.0 mt -79.71 -35.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.922 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -71.7 -18.46 62.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 30.04 5.32 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.648 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.3 m-85 -106.66 159.78 15.95 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.122 0.963 . . . . 0.0 108.663 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.42 105.26 9.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.569 HG13 ' CD1' ' A' ' 117' ' ' TRP . 17.3 tt -75.49 146.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.058 -168.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.984 HG13 ' HB2' ' A' ' 116' ' ' CYS . 26.8 pt -143.16 134.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.582 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -112.2 100.13 8.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.04 1.4 . . . . 0.0 110.268 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.62 172.92 5.79 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 113.408 -1.724 . . . . 0.0 108.099 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.46 -8.86 2.06 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.12 115.38 22.34 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 158.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -79.87 142.42 35.24 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.816 -166.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.984 ' HB2' HG13 ' A' ' 110' ' ' ILE 1.064 0.5 OUTLIER -126.39 173.63 9.2 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 113.919 -2.943 . . . . 0.0 111.655 -175.114 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.569 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.0 m0 -137.4 130.23 30.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.993 2.117 . . . . 0.0 105.79 139.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.329 0.2 OUTLIER -110.14 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.207 -0.933 . . . . 0.0 111.265 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -78.19 134.86 37.56 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 123.37 1.557 . . . . 0.0 108.536 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 111.883 -2.417 . . . . 0.0 114.407 -157.792 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.475 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 7.0 t80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.144 0.973 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.95 103.85 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.927 -166.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.7 t -76.39 141.31 41.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 118.756 -1.177 . . . . 0.0 107.99 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.62 -161.92 9.89 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.49 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD21 ' CD1' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -134.23 141.21 46.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.283 -1.458 . . . . 0.0 107.53 -171.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.9 tp -124.17 130.56 52.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.615 1.198 . . . . 0.0 109.236 173.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.12 120.52 42.09 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.153 173.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.6 mt -125.13 111.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -167.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.24 129.46 51.55 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -62.98 -10.08 19.15 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 N-CA-C 121.69 3.688 . . . . 0.0 121.69 -169.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.16 -50.36 55.01 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -161.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -86.08 -31.78 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.963 170.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 18' ' ' THR . 60.9 p -81.79 0.39 39.46 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -170.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -76.53 20.05 0.24 Allowed 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 120.437 1.471 . . . . 0.0 112.296 166.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 16' ' ' THR . 40.8 m -133.2 71.48 76.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 170.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.08 50.56 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.194 3.263 . . . . 0.0 116.845 -155.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -72.97 -45.62 56.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.039 -1.038 . . . . 0.0 111.585 162.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.4 mt -57.98 -34.91 70.48 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.0 t -64.39 -49.25 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.24 175.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.74 -36.45 81.03 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -63.89 -49.45 72.62 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.439 ' HA ' HE21 ' A' ' 28' ' ' GLN . 12.7 t -63.84 -40.35 96.38 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.014 0.824 . . . . 0.0 111.316 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -65.03 -30.91 71.92 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -44.78 71.15 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.71 1.141 . . . . 0.0 113.653 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.439 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.8 mt-30 -58.36 -53.14 61.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.565 173.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.85 68.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.36 18.28 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.0 p -57.94 -27.38 63.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 170.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.87 -125.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -146.46 14.6 1.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.981 0.896 . . . . 0.0 113.223 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.4 t -98.83 149.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.011 170.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 88.1 tttt -128.39 134.76 48.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 161.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -91.21 100.61 13.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.16 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.63 -17.09 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.589 -1.642 . . . . 0.0 113.928 -162.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.56 169.7 10.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.239 1.019 . . . . 0.0 109.644 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -143.39 125.22 15.11 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.372 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.435 ' CD1' HD21 ' A' ' 8' ' ' LEU . 2.9 m-85 -129.59 120.4 25.23 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.89 149.68 22.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp -63.3 -40.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -81.95 -30.47 31.72 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -82.12 -29.49 31.64 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.305 -0.872 . . . . 0.0 112.652 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.83 -40.66 68.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.367 0.985 . . . . 0.0 112.739 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -76.78 -16.9 59.33 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.668 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.05 -37.45 29.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.545 -0.722 . . . . 0.0 111.43 166.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.67 15.4 5.84 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -78.54 -24.92 45.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mt -114.81 120.3 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -120.08 120.2 35.55 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.786 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 11.8 tp -130.99 174.44 10.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.132 0.968 . . . . 0.0 109.575 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.426 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 46.5 mt-10 -98.94 175.05 6.07 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.692 1.234 . . . . 0.0 111.724 -170.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.1 m-20 -91.41 94.06 9.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.981 -170.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.69 -147.2 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -165.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -100.08 35.0 2.16 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.64 -163.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.555 ' C ' ' H ' ' A' ' 59' ' ' THR . 7.8 m-85 -81.94 21.66 0.85 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.081 -170.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.52 27.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 57' ' ' TYR . 9.8 t -129.32 115.06 17.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 162.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 69.0 t -119.26 94.04 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -162.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.402 ' HE2' HG21 ' A' ' 92' ' ' ILE . 6.4 m80 -97.85 134.37 41.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.36 142.43 38.7 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 170.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.6 tp -122.99 108.98 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.872 0.844 . . . . 0.0 109.603 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.411 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 25.5 m -143.97 154.93 59.01 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -170.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 82.9 Cg_exo -49.78 129.54 24.35 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.291 1.994 . . . . 0.0 114.702 170.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -89.89 -8.93 50.73 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -170.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.89 178.9 4.68 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.133 170.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -85.07 97.88 10.11 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.666 0.746 . . . . 0.0 110.103 -170.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.2 p -115.83 -63.05 1.51 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -135.27 88.36 2.41 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -170.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.9 pt -97.6 45.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.399 0.618 . . . . 0.0 111.292 -170.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.13 99.99 6.35 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -170.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -115.08 148.92 41.65 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 170.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -82.34 149.71 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 CA-C-N 119.701 0.929 . . . . 0.0 110.587 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.48 -36.59 82.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.738 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.49 -30.1 71.02 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.6 mt -76.68 -30.14 56.61 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.268 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.26 -36.66 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 119.845 1.202 . . . . 0.0 111.061 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.8 m -66.93 -40.57 87.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.694 1.134 . . . . 0.0 112.717 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.81 -35.76 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 122.025 -0.422 . . . . 0.0 111.991 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -59.87 -47.73 84.57 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.698 -0.626 . . . . 0.0 111.498 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.3 -30.87 71.37 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.33 -10.55 59.84 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -166.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 72.1 p -74.53 -33.13 62.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 165.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 mt -88.66 -170.66 3.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 122.283 1.039 . . . . 0.0 112.079 -159.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -134.26 174.92 4.1 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -52.39 -22.39 15.98 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 N-CA-C 120.292 3.151 . . . . 0.0 120.292 -170.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -102.12 46.57 0.92 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.26 1.391 . . . . 0.0 111.096 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.44 140.67 28.64 Favored Glycine 0 N--CA 1.467 0.737 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -147.04 120.17 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.214 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.433 1.9 tm? -98.4 129.55 45.04 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 111.641 -2.527 . . . . 0.0 104.705 -167.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 1.064 HD11 ' CB ' ' A' ' 116' ' ' CYS . 44.2 mm -119.38 85.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.584 1.538 . . . . 0.0 109.804 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.04 -79.11 0.04 OUTLIER Glycine 0 N--CA 1.464 0.528 0 N-CA-C 120.878 3.111 . . . . 0.0 120.878 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.435 HD13 HD11 ' A' ' 91' ' ' LEU . 1.5 mp -115.88 169.99 8.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.669 -133.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.2 p -114.93 -123.4 0.29 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.355 -0.84 . . . . 0.0 113.185 -156.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.51 -51.02 11.4 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -157.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -60.35 -30.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.877 1.798 . . . . 0.0 111.266 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.553 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 77.7 m-85 -76.82 -16.63 59.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.581 -172.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -57.12 -55.13 38.76 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.373 -0.829 . . . . 0.0 112.277 169.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.93 -33.47 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.987 -0.446 . . . . 0.0 111.376 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.553 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.41 -45.28 95.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.02 84.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.34 -48.66 79.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.728 0.775 . . . . 0.0 112.554 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.6 tt -80.22 -35.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.309 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.63 -16.14 62.27 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.49 5.58 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 119.373 -1.394 . . . . 0.0 112.805 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.491 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 96.6 m-85 -106.63 159.58 16.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.79 108.79 11.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.631 HG13 ' CD1' ' A' ' 117' ' ' TRP . 18.1 tt -84.88 142.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.49 1.138 . . . . 0.0 112.569 -165.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.3 pt -147.13 135.07 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.579 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -126.61 100.14 6.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.002 1.858 . . . . 0.0 112.965 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.44 87.97 30.95 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.8 61.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 122.151 3.866 . . . . 0.0 122.151 -123.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -123.4 104.85 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.255 -2.869 . . . . 0.0 103.255 142.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -82.91 111.33 18.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -159.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.214 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.3 p -147.39 -156.75 0.74 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 125.061 2.362 . . . . 0.0 113.754 171.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.631 ' CD1' HG13 ' A' ' 109' ' ' ILE . 24.9 m0 -137.08 149.79 47.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 109.16 -3.654 . . . . 0.0 102.901 -167.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 144.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HB3' ' HZ3' ' A' ' 119' ' ' LYS . 6.2 ttpm? -88.44 134.92 33.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.532 0.682 . . . . 0.0 111.715 -171.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 -170.223 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.469 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 2.8 t80 . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.616 0.246 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.82 155.12 38.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.96 0.886 . . . . 0.0 110.582 -166.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -77.56 141.62 39.46 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.7 -162.97 10.24 Favored Glycine 0 N--CA 1.466 0.678 0 C-N-CA 119.421 -1.371 . . . . 0.0 114.759 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.28 139.85 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.117 -1.542 . . . . 0.0 107.925 -171.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -124.33 132.88 53.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.162 0.982 . . . . 0.0 108.843 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.65 149.65 27.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.253 165.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.656 HG23 ' HG1' ' A' ' 16' ' ' THR . 19.6 mt -132.48 143.2 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -111.22 129.59 23.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -60.16 -17.41 45.69 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 N-CA-C 120.261 3.139 . . . . 0.0 120.261 -170.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.25 67.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -161.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.97 -28.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.357 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.656 ' HG1' HG23 ' A' ' 11' ' ' ILE . 63.8 p -77.14 -11.92 59.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -170.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.6 m -76.63 -1.5 27.96 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.697 1.59 . . . . 0.0 111.718 -170.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.336 91.3 m -98.78 168.73 9.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 167.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -75.82 -8.69 19.29 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 N-CA-C 118.019 2.277 . . . . 0.0 118.019 -170.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.15 -50.1 20.86 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -163.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.99 -32.94 72.87 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.74 0.7 . . . . 0.0 112.16 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.93 -46.6 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.686 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -62.61 -34.01 76.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.65 -49.07 57.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.492 ' HA ' HE21 ' A' ' 28' ' ' GLN . 8.5 t -61.52 -41.49 97.39 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.191 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.13 -33.76 76.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.735 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.75 73.18 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.196 1.362 . . . . 0.0 113.598 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.492 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.5 mt-30 -56.93 -54.91 41.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.75 0.309 . . . . 0.0 111.586 173.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.24 -43.35 78.56 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.35 47.25 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.9 p -57.89 -36.47 72.45 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.86 -94.64 0.1 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.958 0.885 . . . . 0.0 110.351 -170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 4' ' ' TYR . 44.4 mmtm -129.88 -42.09 1.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.285 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.251 59.5 t -97.64 149.96 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 123.256 1.503 . . . . 0.0 112.594 -160.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -121.35 134.96 55.14 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.222 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -95.38 139.75 31.23 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.72 -24.7 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -170.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.436 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -121.52 169.73 10.38 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.63 1.205 . . . . 0.0 110.286 -174.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -147.34 125.57 12.22 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 114.249 -1.342 . . . . 0.0 108.85 -168.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -133.04 120.28 21.13 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.657 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.574 HD21 ' H ' ' A' ' 43' ' ' ASN . 7.8 tt -92.58 149.45 21.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.16 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.574 ' H ' HD21 ' A' ' 41' ' ' LEU . 22.0 t-20 -79.4 -30.2 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.315 -0.866 . . . . 0.0 113.021 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.19 -37.55 45.4 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.153 -0.967 . . . . 0.0 112.662 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.2 tp -68.57 -40.62 80.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.549 0.69 . . . . 0.0 112.8 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -73.5 -21.2 60.48 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.835 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -83.75 -36.1 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.541 -0.725 . . . . 0.0 112.047 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.56 15.33 6.44 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.329 0.892 . . . . 0.0 115.329 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -76.09 -35.66 59.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.849 1.324 . . . . 0.0 113.689 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.9 mt -114.69 120.35 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -168.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.7 m -129.8 120.21 24.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.596 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 38' ' ' ASP . 93.3 mt -119.6 179.9 4.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.849 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.79 175.32 6.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.608 1.194 . . . . 0.0 111.763 -168.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.8 m-20 -89.32 93.34 9.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.553 -170.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.82 -147.42 0.25 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -165.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -100.1 37.57 1.63 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.168 0.985 . . . . 0.0 113.243 -162.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.565 ' C ' ' H ' ' A' ' 59' ' ' THR . 10.6 m-85 -82.28 21.74 0.9 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 117.191 -1.385 . . . . 0.0 112.259 -170.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.23 27.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -157.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 57' ' ' TYR . 7.8 t -128.45 115.12 17.7 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 162.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 36.5 t -113.74 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -167.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.483 ' HE2' HG23 ' A' ' 92' ' ' ILE . 1.1 m80 -111.05 134.67 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.06 141.86 50.94 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.0 tp -123.78 94.28 4.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -170.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -140.47 154.72 69.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -170.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.97 145.37 19.3 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.824 2.35 . . . . 0.0 114.676 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.95 -16.94 28.87 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -166.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.85 178.52 4.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.806 1.184 . . . . 0.0 111.514 170.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -112.37 149.91 31.82 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.877 0.846 . . . . 0.0 111.227 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.429 ' HG1' ' H ' ' A' ' 70' ' ' ASP . 39.6 p -125.03 -64.89 1.06 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 164.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.429 ' H ' ' HG1' ' A' ' 69' ' ' THR . 23.3 m-20 -135.14 178.92 6.66 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -170.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.4 pt -88.95 90.64 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 122.439 1.114 . . . . 0.0 108.201 -170.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -79.8 -66.47 0.87 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 117.437 -1.268 . . . . 0.0 114.266 -167.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -77.05 148.47 78.52 Favored Pre-proline 0 N--CA 1.482 1.132 0 CA-C-N 122.837 2.562 . . . . 0.0 110.935 -170.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -82.7 151.86 14.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 121.757 1.638 . . . . 0.0 112.246 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -62.46 -34.26 76.45 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 166.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.13 -34.5 76.48 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.7 -30.07 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.683 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.34 -41.05 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 119.608 1.095 . . . . 0.0 111.155 167.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -64.76 -40.34 95.12 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.963 -1.086 . . . . 0.0 112.823 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -64.17 -37.18 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.91 -42.56 94.14 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.446 -0.784 . . . . 0.0 112.384 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.47 -29.8 70.84 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -75.79 -9.98 59.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 71.9 m -74.8 -40.05 61.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 169.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.2 mt -91.17 164.33 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.923 1.344 . . . . 0.0 113.593 -154.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.72 101.69 0.54 Allowed Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 112.206 -2.27 . . . . 0.0 105.402 163.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -51.06 6.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 N-CA-C 122.183 3.878 . . . . 0.0 122.183 -154.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -94.7 57.77 2.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 123.039 1.4 . . . . 0.0 108.571 163.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.88 167.51 38.34 Favored Glycine 0 N--CA 1.466 0.691 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.159 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -146.14 120.07 9.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.183 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.307 0.6 OUTLIER -92.7 129.85 38.5 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 112.618 -2.083 . . . . 0.0 107.905 -173.727 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.643 HD11 ' CB ' ' A' ' 116' ' ' CYS . 23.3 mm -113.75 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.85 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.462 0.42 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 mt -115.93 146.56 41.98 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.859 1.314 . . . . 0.0 110.646 -131.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.3 t -90.79 179.45 5.79 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.348 -165.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.9 44.06 0.73 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 120.25 3.426 . . . . 0.0 120.25 -161.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mt -96.16 -26.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 126.716 3.15 . . . . 0.0 109.959 137.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 92.2 m-85 -76.68 2.95 12.74 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.347 -168.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HA ' HD12 ' A' ' 109' ' ' ILE . 30.6 mtpp -71.83 -52.17 18.83 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.583 -1.323 . . . . 0.0 111.509 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.85 -33.36 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.081 -0.387 . . . . 0.0 110.732 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.94 -46.61 89.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.197 171.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.78 79.08 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.99 -0.444 . . . . 0.0 111.817 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -58.48 -50.01 75.29 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.706 0.765 . . . . 0.0 112.394 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.31 -34.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.438 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -71.79 -16.59 62.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 173.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.07 5.74 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.703 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 94.1 m-85 -106.54 159.56 16.08 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -117.46 154.09 32.0 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 161.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.596 HG12 ' CD1' ' A' ' 117' ' ' TRP . 19.1 mt -103.99 148.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.061 1.41 . . . . 0.0 109.812 -174.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 pt -140.29 125.57 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 113.246 -1.797 . . . . 0.0 106.628 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -121.99 87.41 2.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 124.072 1.892 . . . . 0.0 113.476 -168.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -134.21 100.29 12.96 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -54.82 31.42 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.167 1 N-CA-C 124.342 4.709 . . . . 0.0 124.342 -139.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -100.01 115.17 29.1 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 130.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -90.35 115.27 27.41 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.674 -164.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.183 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.86 -164.6 2.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.956 1.836 . . . . 0.0 115.452 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.596 ' CD1' HG12 ' A' ' 109' ' ' ILE . 22.7 m0 -137.55 130.04 29.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 110.804 -2.907 . . . . 0.0 105.625 -167.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.18 144.41 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -79.52 134.84 36.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.118 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 122.14 0.972 . . . . 0.0 111.138 170.334 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.79 141.74 35.96 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 123.086 1.422 . . . . 0.0 112.414 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.83 120.61 41.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.9 -1.954 . . . . 0.0 106.049 164.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 59' ' ' THR . . . -129.4 -163.62 11.23 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.906 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.37 145.02 48.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -167.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.34 135.72 53.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.583 1.182 . . . . 0.0 109.518 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -119.44 120.14 35.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.76 -1.563 . . . . 0.0 106.955 177.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -117.97 139.9 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -99.17 129.55 29.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -62.87 -11.46 24.45 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 N-CA-C 120.502 3.231 . . . . 0.0 120.502 -170.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.34 63.35 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -162.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.76 -30.16 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.574 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -81.04 0.32 36.38 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -76.23 -0.92 24.02 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 120.456 1.48 . . . . 0.0 112.018 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 m -114.82 71.48 2.58 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.99 55.88 3.5 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.717 2.945 . . . . 0.0 116.758 -154.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -71.91 -44.99 62.77 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.869 -1.144 . . . . 0.0 112.096 166.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.09 -29.93 68.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -65.2 -50.07 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.641 -0.662 . . . . 0.0 110.795 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.88 -38.18 81.49 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -60.81 -50.09 74.87 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -65.18 -38.49 90.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.534 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.61 -33.57 76.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.49 73.47 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -56.11 -56.17 24.07 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.99 96.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.3 -50.44 67.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -75.37 -11.49 60.06 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.544 -0.722 . . . . 0.0 112.704 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.85 -109.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.318 0.58 . . . . 0.0 111.467 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -139.68 20.27 2.52 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.88 110.55 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.245 -168.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.84 135.02 40.89 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -88.78 139.57 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.5 -32.63 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.014 -165.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.77 169.92 10.27 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.985 1.374 . . . . 0.0 110.904 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -142.41 125.32 16.12 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.018 -172.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 16.2 m-85 -119.61 149.64 41.62 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.009 166.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.37 149.72 26.71 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 164.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 tp -63.33 -39.41 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -78.85 -30.28 45.06 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.444 -0.785 . . . . 0.0 113.098 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.14 -30.46 38.99 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.283 -0.886 . . . . 0.0 112.933 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.63 -40.61 66.3 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 112.525 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.29 -27.64 66.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.632 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -83.16 -39.3 21.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.929 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.19 15.38 2.29 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.84 1.496 . . . . 0.0 116.84 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.4 m -78.88 -14.32 59.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 -168.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.73 161.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.542 1.064 . . . . 0.0 110.318 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -99.84 120.4 39.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.988 -172.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.69 120.0 36.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.475 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.51 120.1 39.09 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -92.46 65.6 4.49 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -167.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.17 -77.16 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 170.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -100.04 57.41 0.97 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.389 1.09 . . . . 0.0 113.629 -161.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.5 ' C ' ' H ' ' A' ' 59' ' ' THR . 11.8 m-85 -112.34 21.52 15.66 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.984 163.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.73 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 -157.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 57' ' ' TYR . 8.7 t -131.14 116.39 17.65 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 162.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG12 HD21 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -98.64 134.79 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 171.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.512 ' HE2' HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -117.52 134.55 54.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.22 110.45 15.25 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.255 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.04 89.74 3.09 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -170.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.5 m -131.08 154.45 82.02 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -170.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -73.93 141.19 29.71 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 121.974 1.782 . . . . 0.0 112.984 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -89.91 -30.14 18.06 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.262 -170.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.44 73.33 1.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.873 0.844 . . . . 0.0 109.452 -170.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -112.18 160.22 17.8 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.163 170.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.4 p -89.77 9.7 26.32 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.693 -0.803 . . . . 0.0 112.968 170.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -135.34 90.8 2.66 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.9 pt -98.72 69.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.687 0.756 . . . . 0.0 109.53 -170.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.01 139.75 53.53 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.197 0.999 . . . . 0.0 110.532 -170.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -130.24 149.02 72.13 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 166.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -82.16 149.39 15.34 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 121.195 1.463 . . . . 0.0 110.25 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.73 -39.65 94.74 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -63.17 -27.64 69.51 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.83 -30.31 56.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.626 173.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.16 -35.08 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 119.729 1.15 . . . . 0.0 111.063 171.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.5 p -71.96 -36.79 69.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.789 1.177 . . . . 0.0 113.081 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.83 -38.43 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.696 -0.628 . . . . 0.0 111.816 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -40.53 95.57 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.457 -0.777 . . . . 0.0 112.168 174.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.95 -29.86 70.33 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -79.11 -29.42 43.23 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -76.52 -17.98 58.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 mp -124.32 100.82 6.87 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.541 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.266 80.4 mttt -74.77 -155.06 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.674 -166.145 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 6.1 Cg_endo -59.21 -31.38 95.17 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 N-CA-C 120.656 3.291 . . . . 0.0 120.656 -160.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -90.48 49.04 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.351 1.887 . . . . 0.0 110.659 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.43 144.07 26.55 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 173.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.7 p -146.71 117.07 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 123.445 1.593 . . . . 0.0 107.147 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.266 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.379 0.7 OUTLIER -97.42 133.95 41.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.39 -167.265 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.906 HD12 ' CB ' ' A' ' 116' ' ' CYS . 33.0 mm -121.53 87.39 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.576 1.535 . . . . 0.0 108.747 170.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.26 -78.58 0.04 OUTLIER Glycine 0 C--N 1.316 -0.546 0 N-CA-C 121.375 3.31 . . . . 0.0 121.375 -173.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.271 5.5 mp -115.67 172.01 7.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.611 1.196 . . . . 0.0 109.868 -124.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -109.13 -141.71 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.486 -156.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.96 -45.79 39.88 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -163.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mt -57.21 -32.84 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 124.397 2.046 . . . . 0.0 111.31 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 90.7 m-85 -76.89 -16.0 59.52 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.347 -1.751 . . . . 0.0 112.296 -170.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.71 -55.08 39.53 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.94 -1.1 . . . . 0.0 111.979 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.16 -35.27 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.755 -0.59 . . . . 0.0 111.795 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.75 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 173.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.99 79.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.122 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.86 -46.67 74.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.607 0.718 . . . . 0.0 112.843 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.5 tt -80.2 -34.56 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.74 -17.89 62.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.78 21.52 9.63 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.618 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 119' ' ' LYS 0.271 94.7 m-85 -106.85 112.33 25.24 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -98.48 153.48 18.58 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.96 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.627 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -109.13 145.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 111.689 -2.505 . . . . 0.0 110.867 -155.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 pt -137.94 123.01 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -112.17 99.95 8.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.205 1.479 . . . . 0.0 110.723 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.0 -175.61 0.5 Allowed Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.085 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -55.52 -11.61 4.94 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 N-CA-C 118.733 2.551 . . . . 0.0 118.733 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -124.78 149.48 47.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 152.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.434 ' HH ' HD13 ' A' ' 109' ' ' ILE . 13.5 t80 -113.03 112.52 24.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -170.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.266 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 25.2 p -147.73 -153.36 0.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.148 1.451 . . . . 0.0 112.527 169.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.627 ' CD1' HG13 ' A' ' 109' ' ' ILE . 4.4 m0 -136.85 153.52 50.75 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.559 -2.11 . . . . 0.0 105.483 -172.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.27 144.4 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 162.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 61.7 tttm -79.88 134.99 36.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.894 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.645 0.735 . . . . 0.0 110.283 170.326 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.53 103.65 10.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.567 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.77 120.44 21.94 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.38 -154.82 7.54 Favored Glycine 0 N--CA 1.464 0.505 0 CA-C-O 123.187 1.437 . . . . 0.0 115.893 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.4 tp -134.1 149.84 51.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 112.245 -1.978 . . . . 0.0 109.233 -168.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 tp -124.61 133.75 53.16 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.629 1.204 . . . . 0.0 107.782 157.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -114.46 120.36 40.0 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.262 173.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.5 mt -118.04 139.76 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -172.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -103.02 129.6 25.29 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -59.08 -16.95 35.66 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 N-CA-C 121.261 3.524 . . . . 0.0 121.261 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -50.31 58.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -160.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.78 -35.2 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.843 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -71.19 -12.14 61.32 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 t -76.7 1.14 17.94 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.984 1.265 . . . . 0.0 112.147 -170.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.352 53.9 m -98.86 168.12 10.24 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.5 -2.83 13.0 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 N-CA-C 117.873 2.22 . . . . 0.0 117.873 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -74.15 -50.45 19.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.957 1.253 . . . . 0.0 114.21 -166.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.06 -30.15 68.42 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.778 0.717 . . . . 0.0 112.368 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.43 -46.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.102 -0.374 . . . . 0.0 111.146 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -62.2 -36.33 81.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.039 0.836 . . . . 0.0 113.223 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -46.75 75.23 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.48 ' HA ' HE21 ' A' ' 28' ' ' GLN . 90.0 m -58.93 -45.68 89.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.826 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -63.97 -29.82 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.98 74.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.893 1.224 . . . . 0.0 113.38 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.48 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.1 mt-30 -57.63 -52.98 63.19 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.154 -0.341 . . . . 0.0 111.858 171.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.86 -45.71 60.01 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.883 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.83 -50.53 28.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.49 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.5 t -75.54 -29.52 59.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -170.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.86 -127.84 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.006 -0.434 . . . . 0.0 111.94 170.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -139.39 1.48 1.97 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -165.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -99.47 149.81 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.817 0.818 . . . . 0.0 112.28 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -122.65 143.78 49.55 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -104.24 100.37 10.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.279 1.037 . . . . 0.0 109.425 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.74 -40.59 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.84 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.09 169.77 10.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.246 1.022 . . . . 0.0 110.538 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -144.86 113.02 6.48 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -164.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.412 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 17.4 m-30 -118.83 120.19 36.6 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.36 150.09 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.16 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -76.74 -30.05 56.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.8 -35.73 32.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 113.137 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.12 -40.52 78.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.814 0.733 . . . . 0.0 112.724 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -66.1 -27.91 68.42 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.076 173.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -79.9 -39.12 31.08 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.3 10.69 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -78.34 -11.18 59.92 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.1 mt -114.9 121.77 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -98.6 120.84 39.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 124.014 1.864 . . . . 0.0 110.227 -164.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.0 mt -96.52 149.81 21.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 111.199 -2.728 . . . . 0.0 111.565 -163.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.76 169.75 9.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.255 -1.793 . . . . 0.0 107.498 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -116.34 35.95 4.31 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.28 -74.66 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -168.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -78.24 32.92 0.19 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -162.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -112.11 21.87 15.41 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 116.93 -1.51 . . . . 0.0 112.995 170.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.63 38.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -165.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.02 115.32 6.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 166.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.2 t -101.33 139.04 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.539 ' HE2' HG23 ' A' ' 92' ' ' ILE . 1.3 m80 -122.3 134.57 54.66 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 161.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -114.73 141.75 47.42 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.77 112.81 17.77 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 170.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.1 m -150.3 154.4 36.05 Favored Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -57.67 147.43 79.86 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.902 2.401 . . . . 0.0 115.499 170.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -120.09 30.01 7.22 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.654 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.37 -59.59 1.8 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.205 -0.934 . . . . 0.0 110.428 -170.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -81.64 115.31 20.85 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -170.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.2 p -73.71 89.75 1.8 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.335 1.064 . . . . 0.0 112.165 -170.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.05 178.89 6.67 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 170.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.13 149.31 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.577 170.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -106.07 -52.06 2.87 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 118.592 2.812 . . . . 0.0 118.592 -169.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -130.54 149.14 72.65 Favored Pre-proline 0 N--CA 1.473 0.704 0 O-C-N 120.837 -1.164 . . . . 0.0 108.76 -158.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -82.09 149.8 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 CA-C-N 120.01 1.039 . . . . 0.0 111.365 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.52 -36.86 83.94 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -58.54 -34.22 70.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.67 -30.18 56.66 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.919 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.84 -38.97 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 120.043 1.292 . . . . 0.0 111.236 167.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.6 m -65.68 -39.08 90.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.691 1.132 . . . . 0.0 112.908 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.55 -41.73 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.04 -41.5 92.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.652 -0.655 . . . . 0.0 112.58 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.57 -29.76 70.97 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.88 -10.12 59.33 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -105.46 33.56 3.66 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.5 mt -134.05 159.98 39.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.233 1.016 . . . . 0.0 111.053 -165.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.559 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 82.2 mttt -112.8 -156.4 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 165.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 14.8 Cg_endo -62.82 -33.81 74.63 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 CA-C-N 124.041 2.479 . . . . 0.0 113.855 -170.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.418 ' HA ' HD13 ' A' ' 118' ' ' ILE . 23.3 m120 -92.52 45.88 1.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 118.513 0.597 . . . . 0.0 109.912 -170.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.74 116.71 4.34 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.4 t -139.32 107.04 5.62 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -166.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.198 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.279 1.3 tt -91.52 129.89 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -170.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.616 HD13 ' CB ' ' A' ' 116' ' ' CYS . 20.3 mm -105.89 86.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.977 0.894 . . . . 0.0 109.746 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.432 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.74 -83.49 0.06 OUTLIER Glycine 0 C--N 1.317 -0.488 0 N-CA-C 121.509 3.364 . . . . 0.0 121.509 -166.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.432 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -115.49 171.38 7.76 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.33 -1.348 . . . . 0.0 110.196 -138.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 85.0 p -110.28 -129.34 0.29 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.942 -163.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -79.3 -47.81 15.21 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -157.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.64 -29.78 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 124.607 2.146 . . . . 0.0 111.317 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 76.0 m-85 -76.66 -11.0 59.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.354 -1.748 . . . . 0.0 111.149 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -49.36 70.73 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.789 -1.194 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.09 -36.89 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.802 -0.561 . . . . 0.0 111.141 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -60.4 -43.0 97.1 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.929 171.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.28 -43.33 83.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 111.242 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.06 -48.26 76.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.4 tt -80.13 -35.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.811 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -71.96 0.47 9.24 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.38 41.79 97.96 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 119.807 1.185 . . . . 0.0 113.935 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.416 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.0 m-85 -106.91 111.76 24.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 165.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -98.88 117.93 34.49 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 123.474 1.607 . . . . 0.0 106.746 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.625 HG12 ' CD1' ' A' ' 117' ' ' TRP . 15.8 mt -74.74 152.52 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.811 -162.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.4 pt -139.58 128.93 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.159 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -106.86 78.82 1.27 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.302 2.001 . . . . 0.0 111.112 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.27 36.7 tt0 -93.13 162.49 28.25 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 111.341 -2.663 . . . . 0.0 107.14 166.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.56 -6.13 0.92 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 N-CA-C 118.934 2.628 . . . . 0.0 118.934 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -112.43 110.29 20.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 155.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -80.75 115.13 20.09 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.878 -0.514 . . . . 0.0 110.562 -168.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.198 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 15.0 p -147.04 -164.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 123.746 1.736 . . . . 0.0 114.102 172.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.625 ' CD1' HG12 ' A' ' 109' ' ' ILE . 3.1 m0 -137.79 130.19 29.38 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 111.459 -2.61 . . . . 0.0 106.073 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER -111.88 144.22 20.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 123.001 1.381 . . . . 0.0 107.478 169.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.87 134.84 36.33 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.467 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.47 0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.432 170.355 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 122.194 0.997 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -92.32 142.06 27.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.602 1.192 . . . . 0.0 111.148 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 t -105.08 120.66 42.05 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.465 174.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.6 -161.12 10.05 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 118.814 -1.66 . . . . 0.0 113.811 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.5 tp -133.94 139.28 46.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.09 -1.055 . . . . 0.0 108.686 -167.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.7 tp -124.87 110.96 14.91 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 0.0 110.443 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.91 120.23 39.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.996 170.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -123.15 139.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.962 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.76 129.83 43.1 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.48 -11.02 10.05 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 N-CA-C 120.562 3.254 . . . . 0.0 120.562 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.71 -50.14 65.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -88.95 -30.29 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.873 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.5 p -78.74 -2.7 40.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -76.62 -9.8 58.93 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.933 1.242 . . . . 0.0 111.476 163.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.4 m -108.51 71.68 0.41 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 165.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.29 46.68 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.363 3.375 . . . . 0.0 116.235 -154.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.86 -49.98 66.18 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.396 -0.815 . . . . 0.0 112.772 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.97 -29.82 70.77 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 122.05 -0.406 . . . . 0.0 112.03 173.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -63.59 -50.0 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.735 -0.603 . . . . 0.0 111.322 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.63 -36.45 76.38 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.223 -0.923 . . . . 0.0 113.301 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.09 -49.88 72.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -64.9 -35.85 82.48 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.786 0.721 . . . . 0.0 111.562 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -64.99 -35.13 80.21 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.12 -45.28 70.56 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.536 1.062 . . . . 0.0 113.11 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.334 2.3 tm0? -54.99 -52.11 64.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.15 86.46 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.587 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.28 -50.46 65.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.419 -170.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 m -75.25 -13.95 60.48 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.835 -0.541 . . . . 0.0 112.021 -170.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.79 -113.94 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.838 -0.539 . . . . 0.0 110.393 170.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -150.72 35.22 0.61 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 t -112.65 149.85 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.443 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.23 134.91 49.07 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 162.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -98.78 100.73 11.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.21 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.84 -14.6 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -164.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.73 120.4 34.55 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -114.92 114.34 25.34 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.551 -167.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -123.68 120.21 32.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.839 0.828 . . . . 0.0 109.428 -174.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp -87.65 149.8 24.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 tp -63.29 -38.3 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -78.54 -30.29 46.86 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -77.69 -41.09 39.21 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.305 -0.872 . . . . 0.0 112.494 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -67.03 -40.38 87.21 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.644 0.735 . . . . 0.0 112.947 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -73.84 -21.37 60.14 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.761 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.92 -35.01 38.48 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.595 -0.69 . . . . 0.0 111.421 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.12 15.27 5.66 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.811 0.684 . . . . 0.0 114.811 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -78.46 -40.29 36.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.6 mt -114.93 118.74 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 122.481 1.134 . . . . 0.0 109.5 -167.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -133.31 159.23 40.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 157.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.294 1.8 pt? -131.34 -70.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.329 164.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -141.46 169.8 16.92 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.892 0.853 . . . . 0.0 109.81 172.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.54 63.14 0.85 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.55 -92.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -100.29 64.55 1.18 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -161.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -112.1 21.77 15.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 116.367 -1.778 . . . . 0.0 113.346 170.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.54 41.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -157.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.15 115.68 6.71 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 165.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 91' ' ' LEU 0.25 40.9 t -118.4 134.62 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.403 -164.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.59 134.74 54.51 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.79 110.41 17.77 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 168.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.23 104.97 17.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.031 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.8 m -119.84 120.08 30.7 Favored Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 167.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.01 -91.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 121.875 1.717 . . . . 0.0 114.546 -164.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -96.84 -24.09 16.06 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -165.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.87 62.73 1.17 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.321 0.964 . . . . 0.0 111.829 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -112.1 97.21 6.5 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.9 p -125.02 -58.53 1.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -91.09 -167.53 1.83 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.488 0.661 . . . . 0.0 109.629 -170.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tp -82.66 71.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -88.75 35.01 0.77 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 14.7 t80 -130.5 148.81 71.45 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 164.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 27.4 Cg_exo -82.38 149.49 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 120.395 1.177 . . . . 0.0 110.161 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.6 -37.49 86.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.641 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.61 -29.55 70.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.2 mt -76.75 -30.16 56.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.322 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.31 -35.03 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-N 119.886 1.221 . . . . 0.0 111.033 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.2 t -68.5 -39.39 81.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.661 1.119 . . . . 0.0 112.657 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.916 -0.49 . . . . 0.0 111.755 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.98 -46.11 90.5 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.696 -0.628 . . . . 0.0 111.967 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.04 71.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.2 -13.01 56.29 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.3 m -71.26 -45.19 63.75 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 122.06 -0.4 . . . . 0.0 110.747 162.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.9 mt -97.67 161.47 13.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.926 1.346 . . . . 0.0 112.461 -163.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 63.9 mttp -108.43 -178.25 0.55 Allowed Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.287 -170.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 25.5 Cg_exo -56.15 -12.73 8.08 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 N-CA-C 119.96 3.023 . . . . 0.0 119.96 -170.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -102.37 33.32 3.17 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.14 1.336 . . . . 0.0 111.853 169.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.55 141.89 41.35 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 170.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 81.9 p -145.24 107.19 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.97 1.366 . . . . 0.0 108.325 -171.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -89.9 143.01 27.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.611 -1.632 . . . . 0.0 108.59 -172.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.38 88.41 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 167.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.22 -86.6 0.08 OUTLIER Glycine 0 CA--C 1.53 0.977 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 -159.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.54 169.82 8.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.052 1.926 . . . . 0.0 110.828 -147.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.4 m -104.89 -149.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -160.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.51 -43.06 86.31 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -163.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.01 -34.43 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 124.836 2.255 . . . . 0.0 110.526 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 65.7 m-85 -76.68 -10.49 59.42 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.142 -1.844 . . . . 0.0 111.073 -175.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.93 -52.83 58.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.829 -1.169 . . . . 0.0 112.188 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.76 -33.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.275 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.48 -46.01 91.85 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.531 -0.731 . . . . 0.0 112.847 172.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.6 -42.57 78.98 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.886 -0.509 . . . . 0.0 111.827 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.05 -49.35 76.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.67 0.747 . . . . 0.0 112.502 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 tt -80.08 -34.62 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -170.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -71.61 -17.41 62.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.61 29.61 5.55 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 119.296 -1.43 . . . . 0.0 112.317 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.1 m-85 -106.71 159.84 15.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -126.88 108.1 10.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.548 1.166 . . . . 0.0 108.711 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.572 HG12 ' CD1' ' A' ' 117' ' ' TRP . 25.5 mt -84.5 111.24 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.962 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.665 HG13 ' SG ' ' A' ' 116' ' ' CYS . 44.9 pt -108.55 135.05 48.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.247 169.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -105.85 100.31 9.87 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.725 1.726 . . . . 0.0 110.668 -171.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -117.31 171.37 4.99 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 111.957 -2.383 . . . . 0.0 107.698 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -56.22 -8.5 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 N-CA-C 119.117 2.699 . . . . 0.0 119.117 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -119.47 115.26 23.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -79.57 139.09 37.63 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -165.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.665 ' SG ' HG13 ' A' ' 110' ' ' ILE 0.266 5.1 p -145.72 120.88 10.14 Favored 'General case' 0 CA--C 1.54 0.586 1 N-CA-C 123.375 4.583 . . . . 0.0 123.375 -164.141 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.572 ' CD1' HG12 ' A' ' 109' ' ' ILE . 4.0 m0 -109.64 111.06 22.32 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 143.98 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.682 1.23 . . . . 0.0 108.832 170.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 77.8 tttt -91.74 110.22 21.55 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.631 -174.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.832 0.825 . . . . 0.0 110.424 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -92.64 141.77 28.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.527 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 t -89.88 141.48 28.6 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 158.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.48 -167.09 11.55 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 123.762 1.757 . . . . 0.0 115.258 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 tp -131.3 139.83 49.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 111.569 -2.315 . . . . 0.0 107.983 -173.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.285 0.2 OUTLIER -124.49 129.39 50.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 168.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -121.86 120.33 34.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -175.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.3 tt -129.1 139.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 -163.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -106.6 129.62 24.16 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -62.0 -11.67 22.58 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 N-CA-C 120.683 3.301 . . . . 0.0 120.683 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.21 -50.34 61.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -161.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.8 t -89.91 -30.35 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.689 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -84.17 0.24 49.42 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 5.72 7.01 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.364 1.438 . . . . 0.0 113.671 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.333 95.5 m -98.98 167.99 10.42 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 164.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.65 -13.23 16.4 Favored 'Trans proline' 0 N--CA 1.482 0.824 0 N-CA-C 117.133 1.936 . . . . 0.0 117.133 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.13 -50.34 19.86 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -161.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.32 -30.04 68.01 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.156 0.889 . . . . 0.0 112.189 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.59 -50.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.758 -0.589 . . . . 0.0 111.036 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.61 -36.78 76.99 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.304 -0.873 . . . . 0.0 113.335 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -61.86 -50.12 73.51 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.48 ' HA ' HE21 ' A' ' 28' ' ' GLN . 12.3 t -66.53 -37.57 85.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.691 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.413 ' HZ2' ' HB2' ' A' ' 36' ' ' PHE . 75.8 mmtt -64.89 -31.21 72.34 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 170.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.15 67.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.607 1.094 . . . . 0.0 113.195 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.48 HE21 ' HA ' ' A' ' 25' ' ' THR . 35.0 mt-30 -56.39 -54.57 44.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.341 0.591 . . . . 0.0 111.185 171.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.48 -40.33 59.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.67 -50.02 9.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.2 p -60.77 -24.54 65.84 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -126.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.655 -0.653 . . . . 0.0 110.429 170.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -144.72 -9.15 0.63 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -168.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.61 110.46 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -98.78 146.7 25.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.632 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.413 ' HB2' ' HZ2' ' A' ' 26' ' ' LYS . 62.1 m-85 -88.7 100.36 13.06 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 123.374 1.559 . . . . 0.0 110.465 -173.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -36.5 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 112.375 -2.193 . . . . 0.0 113.268 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -121.89 169.58 10.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.226 1.012 . . . . 0.0 111.377 -170.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -150.13 125.58 10.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.556 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.424 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 30.4 m-85 -133.03 120.67 21.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.62 149.45 24.29 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 tp -63.63 -40.16 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -79.17 -30.28 43.43 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.746 . . . . 0.0 112.843 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -82.24 -24.92 34.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -40.41 71.4 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.434 1.015 . . . . 0.0 111.901 174.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -78.19 -27.66 47.98 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.96 -37.56 34.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.842 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.3 15.38 2.78 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 116.904 1.522 . . . . 0.0 116.904 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -75.62 -29.44 59.21 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.457 1.629 . . . . 0.0 114.612 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.58 120.16 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.8 m -124.45 120.2 31.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.762 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.5 mt -123.79 -163.44 1.14 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.87 171.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -98.79 169.84 9.18 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.923 1.344 . . . . 0.0 111.797 -166.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 71.2 m-20 -90.21 94.62 9.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.426 170.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.65 -162.05 1.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -168.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -95.49 58.0 1.99 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.872 -170.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 59' ' ' THR . 3.9 m-85 -81.4 22.45 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 117.012 -1.47 . . . . 0.0 112.568 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.76 38.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -164.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.73 115.46 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 164.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 97.5 t -127.56 110.54 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.324 -157.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.37 106.55 16.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.982 -174.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.77 141.52 28.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 171.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.289 22.3 tp -123.53 115.11 20.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.867 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -149.27 154.35 38.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.34 128.86 31.78 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.559 2.172 . . . . 0.0 116.288 170.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.01 28.68 7.94 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.592 -170.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.93 -68.42 0.81 Allowed 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.13 -0.981 . . . . 0.0 109.029 -170.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.28 115.15 21.85 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -82.01 78.74 8.67 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.879 0.847 . . . . 0.0 110.265 170.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -135.14 47.7 2.32 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.027 168.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.6 pt -108.11 149.86 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -170.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -124.98 140.1 53.22 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.051 0.929 . . . . 0.0 110.757 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 -127.03 149.03 68.21 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 167.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 39.1 Cg_exo -82.12 149.67 15.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 CA-C-N 120.626 1.259 . . . . 0.0 110.332 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.62 -36.67 83.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -66.44 -26.08 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.87 -30.2 56.14 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.743 1.156 . . . . 0.0 111.106 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -39.14 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.935 1.243 . . . . 0.0 110.928 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.2 m -67.44 -40.99 85.47 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.321 -0.862 . . . . 0.0 112.586 176.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.91 -38.9 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.272 0.487 . . . . 0.0 112.266 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.86 -39.08 87.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.543 1.065 . . . . 0.0 112.381 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -29.65 70.67 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.23 -9.85 59.02 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 73.7 m -70.83 -36.43 72.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 165.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.83 159.77 18.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 123.02 1.391 . . . . 0.0 113.293 -153.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.02 101.76 0.68 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 112.02 -2.355 . . . . 0.0 105.329 162.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.17 11.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 N-CA-C 122.055 3.829 . . . . 0.0 122.055 -154.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -102.41 53.48 0.79 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.549 1.166 . . . . 0.0 108.165 162.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.54 163.41 49.4 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 168.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 30.8 t -147.02 120.13 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -99.38 139.82 34.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.505 -168.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.63 90.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 167.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.55 -94.31 0.19 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 -160.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.44 169.9 8.96 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.919 -146.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -123.38 -115.74 0.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -156.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.26 -63.01 1.15 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -157.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -59.66 -27.95 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 124.373 2.035 . . . . 0.0 111.537 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.558 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 67.8 m-85 -76.82 -19.27 57.74 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.026 -170.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.23 -52.06 62.51 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.776 -1.202 . . . . 0.0 112.345 169.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.92 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.842 -0.536 . . . . 0.0 111.819 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.558 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.56 -43.22 97.52 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.34 -42.2 98.3 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.17 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.6 tp -55.88 -46.76 78.23 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 tt -79.95 -38.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.254 -171.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -71.98 1.93 6.45 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.66 43.63 96.11 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.774 -1.203 . . . . 0.0 114.048 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.52 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.5 m-85 -109.45 111.83 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 167.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -98.92 112.23 24.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 123.61 1.671 . . . . 0.0 108.107 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.597 HG13 ' CD1' ' A' ' 117' ' ' TRP 0.257 16.3 tt -83.59 156.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 112.057 -2.338 . . . . 0.0 112.619 -164.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.63 HG23 ' SG ' ' A' ' 116' ' ' CYS . 14.6 tt -147.21 128.32 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.843 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -102.66 98.32 8.38 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 123.282 1.515 . . . . 0.0 112.386 -167.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.16 171.61 8.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.056 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.47 -10.29 4.78 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 N-CA-C 119.295 2.767 . . . . 0.0 119.295 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -125.17 115.02 19.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 160.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.432 ' HE2' ' HE1' ' A' ' 117' ' ' TRP . 38.1 t80 -79.64 138.78 37.51 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.38 -163.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.63 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.289 5.4 p -146.26 120.89 9.79 Favored 'General case' 0 CA--C 1.55 0.955 1 N-CA-C 127.042 5.941 . . . . 0.0 127.042 -164.924 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.597 ' CD1' HG13 ' A' ' 109' ' ' ILE . 7.4 m0 -109.63 114.91 28.91 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.49 1.496 . . . . 0.0 109.229 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.3 OUTLIER -99.62 143.92 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 62.9 tttp -79.91 134.9 36.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.911 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 121.699 0.762 . . . . 0.0 109.846 170.455 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.671 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 5.4 t80 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -84.34 141.79 30.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.687 0.756 . . . . 0.0 111.187 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.0 m -104.63 140.82 37.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.22 -156.69 7.95 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-O 123.86 1.811 . . . . 0.0 117.011 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.484 HD21 ' CD2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -134.54 142.37 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 111.472 -2.364 . . . . 0.0 109.704 -174.107 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 tp -124.21 133.23 53.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 162.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -120.14 120.29 35.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.442 174.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 tt -132.15 139.91 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -164.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -105.71 129.92 23.88 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -59.96 -12.37 18.62 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 N-CA-C 121.381 3.57 . . . . 0.0 121.381 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.33 -50.36 71.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -160.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.3 t -88.86 -28.92 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.491 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.7 p -79.05 0.3 28.39 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -170.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.1 m -76.62 0.74 19.09 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 119.575 1.079 . . . . 0.0 111.993 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 m -98.55 169.09 8.79 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 162.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -77.18 2.48 7.61 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 N-CA-C 120.676 3.299 . . . . 0.0 120.676 171.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.31 -50.93 16.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 121.212 1.824 . . . . 0.0 115.312 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.43 -31.6 70.03 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.558 -0.714 . . . . 0.0 112.56 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.88 -47.67 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.644 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.93 -33.27 75.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -64.74 -49.89 69.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.44 ' HA ' HE21 ' A' ' 28' ' ' GLN . 10.1 t -64.05 -41.75 97.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.321 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.7 -30.23 71.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.575 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -45.64 69.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.179 1.354 . . . . 0.0 113.511 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.44 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.4 mt-30 -56.52 -53.81 53.14 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.689 173.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.9 79.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.741 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.26 43.36 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.998 -0.439 . . . . 0.0 111.23 -170.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.2 p -73.32 -21.8 60.47 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.606 0.639 . . . . 0.0 111.568 -170.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.73 -113.44 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -157.41 17.36 0.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -168.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.87 152.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.3 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.671 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 87.1 tttt -128.39 135.02 48.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 165.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.75 100.56 13.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.816 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -21.22 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -167.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.98 121.47 37.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -167.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -114.2 124.28 51.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.089 0.947 . . . . 0.0 109.635 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.484 ' CD2' HD21 ' A' ' 8' ' ' LEU . 22.2 m-30 -127.32 103.25 7.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.528 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.533 HD21 ' H ' ' A' ' 43' ' ' ASN . 8.0 tt -84.97 149.79 25.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.03 -39.94 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -172.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.533 ' H ' HD21 ' A' ' 41' ' ' LEU . 36.8 t30 -78.57 -30.13 46.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.64 -29.59 33.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.25 0.932 . . . . 0.0 113.19 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -40.51 54.71 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.38 0.991 . . . . 0.0 112.084 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -69.56 -28.23 65.81 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.34 -41.84 24.05 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.6 15.27 8.9 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.301 1.28 . . . . 0.0 116.301 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 m -73.38 -8.27 55.15 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 119.499 1.649 . . . . 0.0 115.45 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.9 mt -114.72 121.82 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.976 -0.452 . . . . 0.0 109.99 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.7 m -98.48 120.66 39.28 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.199 1.952 . . . . 0.0 108.978 -172.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.267 63.4 tp -96.73 149.54 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 110.752 -2.931 . . . . 0.0 111.591 -161.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.42 169.79 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.667 166.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -120.1 44.42 2.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -166.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -73.1 0.07 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 119.446 3.128 . . . . 0.0 119.446 -166.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -81.71 30.53 0.37 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -157.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 59' ' ' THR . 0.6 OUTLIER -112.22 21.27 15.99 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 117.659 -1.162 . . . . 0.0 112.621 -170.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.82 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 -166.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.09 115.5 6.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 169.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 24.4 t -119.33 134.34 63.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.706 -165.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.506 ' HE2' HG23 ' A' ' 92' ' ' ILE . 5.4 m80 -122.58 134.6 54.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.44 142.45 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.77 102.37 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -137.23 113.86 9.68 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.3 133.76 36.91 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.733 2.289 . . . . 0.0 114.974 170.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -120.04 30.18 7.14 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.884 -170.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.84 -66.0 0.93 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.516 -0.74 . . . . 0.0 110.256 -170.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -80.65 -63.59 1.38 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -170.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.1 p -90.84 158.7 16.66 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -170.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -71.72 178.65 3.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.572 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.1 tt -98.47 93.33 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 122.125 0.964 . . . . 0.0 109.539 -170.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -102.01 94.1 5.6 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -170.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -130.14 90.97 40.49 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.551 170.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -55.77 149.66 49.14 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.806 1.671 . . . . 0.0 112.887 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.52 -34.74 77.5 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -31.45 67.88 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.81 -30.06 56.23 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.113 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.62 -35.45 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 119.769 1.168 . . . . 0.0 111.614 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.3 p -69.12 -36.83 77.94 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.21 1.368 . . . . 0.0 112.967 173.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.08 -37.42 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.815 -0.553 . . . . 0.0 111.902 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -59.96 -46.07 90.62 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.819 -0.551 . . . . 0.0 112.042 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.0 70.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -73.62 -9.99 59.24 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 m -106.87 30.22 6.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -134.07 162.52 31.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.044 0.926 . . . . 0.0 109.846 -169.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 174.97 2.31 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -58.52 -12.4 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 118.455 2.444 . . . . 0.0 118.455 -170.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -102.0 46.76 0.92 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.943 0.792 . . . . 0.0 110.676 170.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.31 140.58 24.75 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.5 t -146.3 106.27 4.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.184 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.259 3.1 tt -89.91 129.92 36.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -175.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 1.019 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 27.2 mm -104.42 91.11 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 122.337 1.065 . . . . 0.0 108.31 170.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.76 -95.13 0.2 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 120.745 3.058 . . . . 0.0 120.745 -162.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.5 169.62 9.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.017 -1.473 . . . . 0.0 109.464 -142.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -118.26 -118.07 0.32 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -158.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.09 -54.24 8.23 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -156.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -61.0 -29.33 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 124.548 2.118 . . . . 0.0 111.294 170.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.1 m-85 -76.78 -9.41 58.65 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.291 -1.777 . . . . 0.0 112.03 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -63.95 -56.05 17.99 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.295 -0.878 . . . . 0.0 111.468 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.84 -31.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 122.188 -0.32 . . . . 0.0 111.513 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.585 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.89 -46.5 87.56 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.539 -0.725 . . . . 0.0 112.451 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.9 -41.8 71.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.088 0.404 . . . . 0.0 111.777 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.6 tp -63.19 -45.14 93.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.6 mt -80.08 -34.95 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -71.75 -15.5 62.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 27.88 6.12 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.589 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 97.4 m-85 -106.52 159.6 16.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 172.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -118.71 154.13 33.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 161.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.646 HG12 ' CD1' ' A' ' 117' ' ' TRP . 22.5 mt -103.89 148.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 122.994 1.378 . . . . 0.0 109.282 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.82 123.11 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.891 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -115.48 100.18 7.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.942 1.829 . . . . 0.0 110.913 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -134.22 -178.54 0.88 Allowed Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 111.215 -2.72 . . . . 0.0 106.194 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.52 -7.14 1.2 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -135.07 115.27 13.28 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 161.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -86.77 115.02 23.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.296 -167.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.184 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 27.9 p -147.6 -158.62 0.93 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 122.674 1.226 . . . . 0.0 114.099 167.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.646 ' CD1' HG12 ' A' ' 109' ' ' ILE . 5.9 m0 -137.31 130.36 30.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.452 -1.703 . . . . 0.0 106.438 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.89 144.0 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 122.708 1.242 . . . . 0.0 108.276 167.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 76.4 tttt -87.16 110.39 20.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.797 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.499 0.666 . . . . 0.0 112.14 170.384 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.515 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 12.0 t80 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.1 141.94 28.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.218 1.008 . . . . 0.0 111.831 -165.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.44 141.77 28.21 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 166.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.53 -158.32 8.64 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 119.369 -1.396 . . . . 0.0 114.625 169.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.48 139.95 45.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.307 0.0 OUTLIER -124.38 129.35 50.54 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 174.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.44 120.23 40.95 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.614 HG23 ' HG1' ' A' ' 16' ' ' THR . 6.4 mt -124.81 139.98 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.636 -171.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -98.69 129.77 29.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 160.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -60.96 -11.99 20.59 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 N-CA-C 121.75 3.711 . . . . 0.0 121.75 -170.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.29 74.52 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -159.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.32 -29.83 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 119.29 0.95 . . . . 0.0 111.81 170.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.614 ' HG1' HG23 ' A' ' 11' ' ' ILE . 49.1 p -65.21 0.03 1.54 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 170.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -76.3 -10.32 59.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.118 1.781 . . . . 0.0 112.077 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.317 92.5 m -98.8 167.98 10.49 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 163.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.87 -3.17 13.27 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 N-CA-C 117.674 2.144 . . . . 0.0 117.674 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.96 -50.42 20.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.428 1.467 . . . . 0.0 114.521 -161.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.2 -32.46 71.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.429 -0.794 . . . . 0.0 112.585 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.49 -47.79 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.504 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.45 -47.3 70.57 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.778 ' HG1' HD12 ' A' ' 63' ' ' LEU . 98.3 m -58.89 -46.23 88.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.938 174.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.1 mmmt -60.92 -29.94 69.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.33 74.36 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.203 1.365 . . . . 0.0 113.488 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -60.0 -54.05 50.67 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.039 0.447 . . . . 0.0 111.401 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.06 45.77 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.94 -45.67 11.27 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.8 p -58.02 -34.19 69.78 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.92 -113.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -170.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 38.0 tptt -137.88 -13.1 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.532 -170.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.421 HG23 HG21 ' A' ' 59' ' ' THR . 3.3 p -117.26 110.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -170.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 81.6 tttt -98.65 139.58 34.15 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.218 1.009 . . . . 0.0 108.887 170.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.58 139.75 30.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.34 -30.05 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -160.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -121.61 169.88 10.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.782 1.277 . . . . 0.0 109.015 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -143.82 125.1 14.63 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.24 -1.346 . . . . 0.0 108.846 -169.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -125.87 113.84 17.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.873 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -86.8 149.93 24.5 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -40.03 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -79.93 -30.25 39.92 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -79.75 -32.54 41.06 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.356 -0.84 . . . . 0.0 113.009 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -73.61 -40.62 63.69 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.969 0.804 . . . . 0.0 112.844 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -70.55 -26.12 63.4 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.799 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.26 -42.28 16.03 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 119.106 -0.473 . . . . 0.0 112.149 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.76 15.44 2.63 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 169.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -76.21 -19.45 58.38 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.086 1.943 . . . . 0.0 115.103 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.62 121.85 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.0 t -98.96 159.38 15.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 125.249 2.452 . . . . 0.0 111.403 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.32 120.98 43.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.588 -3.46 . . . . 0.0 111.142 -158.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -98.16 169.17 9.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.552 162.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -120.55 52.67 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -159.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -86.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -100.04 57.45 0.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.017 0.913 . . . . 0.0 113.39 -158.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' THR . 4.4 m-85 -112.1 21.14 16.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.323 169.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.91 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -161.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.489 ' H ' ' C ' ' A' ' 57' ' ' TYR . 14.6 t -137.41 115.43 11.57 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 161.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 39.9 t -117.42 101.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 -164.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' HE2' HG22 ' A' ' 92' ' ' ILE . 4.7 m80 -97.83 134.4 41.03 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.66 110.31 18.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.377 1.084 . . . . 0.0 109.193 174.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.778 HD12 ' HG1' ' A' ' 25' ' ' THR . 84.7 mt -98.73 102.06 13.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.412 170.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.0 m -122.36 94.77 47.6 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.1 94.47 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.216 1.944 . . . . 0.0 112.853 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -120.07 -30.21 4.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.878 169.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.68 -89.61 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 170.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -112.22 -57.69 2.24 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.197 -0.314 . . . . 0.0 110.487 170.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.9 p -99.99 175.59 5.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.376 1.084 . . . . 0.0 111.684 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -82.1 100.48 9.8 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.4 pt -62.17 -151.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 170.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -79.64 139.75 37.32 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 123.255 1.502 . . . . 0.0 113.779 -160.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 -130.59 149.25 72.98 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 112.744 -2.026 . . . . 0.0 107.541 -170.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 32.3 Cg_exo -81.88 149.44 15.9 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 CA-C-N 120.894 1.355 . . . . 0.0 110.741 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -62.6 -40.35 96.67 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.5 -32.27 68.66 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -76.7 -30.26 56.62 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.742 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.42 -35.09 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 119.817 1.189 . . . . 0.0 111.554 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -70.25 -36.79 74.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.288 1.403 . . . . 0.0 112.884 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.56 -39.22 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 121.668 -0.645 . . . . 0.0 111.597 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -60.04 -46.2 90.29 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.814 -0.554 . . . . 0.0 112.073 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.92 70.35 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.85 -32.0 72.21 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -167.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.5 p -92.68 33.27 1.14 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.6 mt -134.16 175.49 9.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.619 1.199 . . . . 0.0 111.818 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -116.32 175.06 2.09 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.66 -25.98 21.73 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 N-CA-C 119.103 2.694 . . . . 0.0 119.103 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -102.27 51.15 0.82 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.68 1.582 . . . . 0.0 110.454 169.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.23 142.92 30.01 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.2 p -144.16 105.88 4.3 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.179 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.366 0.3 OUTLIER -89.68 129.65 36.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.084 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 1.075 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 39.9 mm -112.44 91.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.11 0.957 . . . . 0.0 109.699 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.09 -86.41 0.08 OUTLIER Glycine 0 C--N 1.315 -0.607 0 N-CA-C 120.902 3.121 . . . . 0.0 120.902 -171.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.453 HD13 HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -116.18 169.77 9.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 -137.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.498 ' HG ' ' H ' ' A' ' 96' ' ' ASP . 7.9 t -108.66 -131.79 0.31 Allowed 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.87 -1.144 . . . . 0.0 112.819 -156.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.498 ' H ' ' HG ' ' A' ' 95' ' ' SER . 25.7 m-20 -80.0 -49.42 11.85 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -158.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -58.69 -30.23 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 124.33 2.014 . . . . 0.0 112.984 168.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.4 m-85 -76.46 -14.99 60.02 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 113.167 -1.833 . . . . 0.0 110.453 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.5 -50.67 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.194 -0.941 . . . . 0.0 112.316 165.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.83 -36.82 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.786 -0.571 . . . . 0.0 111.202 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.505 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.97 -43.89 94.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.83 97.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.458 0.647 . . . . 0.0 111.796 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.73 -47.82 83.3 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.467 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.5 mt -76.35 -35.18 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.055 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -71.85 -19.97 61.89 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 33.31 4.09 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.884 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 98.0 m-85 -106.67 159.83 15.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.28 1.038 . . . . 0.0 108.28 168.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.56 106.39 10.55 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.637 HD13 ' HH ' ' A' ' 115' ' ' TYR . 16.8 tt -75.32 144.97 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 122.371 1.081 . . . . 0.0 112.05 -169.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.18 129.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.669 1.223 . . . . 0.0 108.635 -173.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -96.83 99.98 11.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.328 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.86 173.92 2.71 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.139 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -54.9 -14.28 7.76 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 118.966 2.641 . . . . 0.0 118.966 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -130.0 115.22 16.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 153.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.637 ' HH ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -84.46 139.01 32.49 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.604 -164.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.179 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 12.0 p -147.77 -155.02 0.59 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 123.209 1.481 . . . . 0.0 111.731 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.636 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.7 m0 -137.13 130.11 30.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.69 144.22 19.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.529 1.157 . . . . 0.0 108.299 171.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.31 134.63 36.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.169 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.469 0.521 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.594 170.362 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.746 ' HH ' ' HG3' ' A' ' 35' ' ' LYS . 1.5 t80 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -111.59 141.82 44.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.216 1.484 . . . . 0.0 112.155 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.06 120.87 42.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 112.466 -2.152 . . . . 0.0 105.79 165.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.91 -161.95 10.27 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 119.465 -1.35 . . . . 0.0 116.255 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.421 HD23 ' CE2' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -134.24 139.27 45.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.182 -1.009 . . . . 0.0 108.69 -165.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.99 134.65 52.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.341 1.067 . . . . 0.0 108.558 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -113.02 120.55 41.75 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.512 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.35 140.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -97.77 129.73 30.65 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 163.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -63.17 -10.59 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 N-CA-C 120.441 3.208 . . . . 0.0 120.441 -170.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.92 -50.26 62.95 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 -162.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.5 t -84.88 -30.14 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.553 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -81.91 0.21 40.79 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -170.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 93.6 m -76.32 -6.24 50.63 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 120.056 1.298 . . . . 0.0 111.537 164.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 m -113.19 71.48 1.46 Allowed Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.69 58.74 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.964 3.109 . . . . 0.0 115.971 -155.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.36 -50.15 23.5 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.59 -1.319 . . . . 0.0 111.751 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 -29.89 70.93 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.69 0.677 . . . . 0.0 112.348 176.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.95 -49.98 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.857 -0.527 . . . . 0.0 111.403 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.89 -36.58 77.25 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.294 -0.879 . . . . 0.0 113.298 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -63.1 -49.45 74.39 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.502 ' HA ' HE21 ' A' ' 28' ' ' GLN . 8.7 t -64.82 -38.01 89.56 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.198 0.908 . . . . 0.0 111.597 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HZ3' ' HB2' ' A' ' 36' ' ' PHE . 74.1 mmtt -62.39 -35.22 78.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 169.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.45 72.08 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.441 1.019 . . . . 0.0 113.489 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.502 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.5 mt-30 -59.49 -53.84 53.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.867 0.365 . . . . 0.0 111.6 174.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.87 76.09 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.83 -46.99 15.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -170.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 98.1 p -57.96 -20.55 38.68 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.74 -105.08 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.737 -0.602 . . . . 0.0 109.521 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -150.39 15.53 0.8 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -170.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.8 t -126.65 110.63 23.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.509 -168.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.746 ' HG3' ' HH ' ' A' ' 4' ' ' TYR . 68.6 mttm -99.33 134.94 41.46 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 165.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.508 ' HB2' ' HZ3' ' A' ' 26' ' ' LYS . 25.7 m-85 -89.06 139.72 30.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.26 -26.05 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -163.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.69 121.36 37.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -113.98 118.24 33.58 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.812 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.421 ' CE2' HD23 ' A' ' 8' ' ' LEU . 13.0 m-30 -121.97 106.14 10.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.812 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.73 149.76 25.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -63.25 -40.07 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -76.65 -30.24 56.74 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.96 -31.8 34.71 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.69 -40.39 69.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.551 1.069 . . . . 0.0 112.346 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.79 -18.55 61.47 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.14 -38.8 16.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.496 -0.752 . . . . 0.0 111.882 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.32 15.24 7.78 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.4 m -79.11 -3.3 44.75 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -171.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -114.72 169.55 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.588 -0.695 . . . . 0.0 109.369 -163.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -99.91 158.54 15.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.629 1.681 . . . . 0.0 109.515 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.4 150.08 52.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.312 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.3 169.52 16.35 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 160.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -120.59 46.33 2.02 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -82.25 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -100.2 63.46 1.15 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.888 0.851 . . . . 0.0 111.94 -161.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.469 ' C ' ' H ' ' A' ' 59' ' ' THR . 17.9 m-85 -112.25 21.59 15.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 117.138 -1.411 . . . . 0.0 112.666 167.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -61.74 31.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -158.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 57' ' ' TYR . 8.4 t -135.85 115.36 12.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 162.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.462 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 83.6 t -115.81 110.33 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -164.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.86 134.56 49.82 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 142.04 46.32 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 162.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.94 104.53 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 170.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.7 m -143.7 120.16 6.52 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.6 128.86 32.03 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.413 2.076 . . . . 0.0 113.507 170.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -103.39 30.12 5.16 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -170.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.99 -53.22 2.72 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.323 -0.861 . . . . 0.0 112.247 -170.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -79.83 -47.32 15.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -169.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.6 p -70.96 147.96 48.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.514 0.673 . . . . 0.0 111.704 170.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -82.59 -108.14 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 170.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.7 pp -88.63 149.71 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 119.742 1.155 . . . . 0.0 108.669 -170.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.25 34.3 tttp -125.57 -97.45 0.42 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -165.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.4 ' CE2' HG13 ' A' ' 78' ' ' ILE . 30.9 t80 -74.69 149.04 85.72 Favored Pre-proline 0 N--CA 1.48 1.07 0 O-C-N 120.715 -1.241 . . . . 0.0 112.002 -154.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -82.24 149.98 15.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 121.087 1.191 . . . . 0.0 111.581 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -62.33 -33.91 75.61 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.71 -30.37 71.04 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -76.62 -30.18 56.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.177 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.4 HG13 ' CE2' ' A' ' 73' ' ' PHE . 97.1 mt -61.39 -36.99 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 119.741 1.155 . . . . 0.0 111.242 166.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.4 m -64.17 -40.95 97.2 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.07 1.304 . . . . 0.0 112.448 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.08 -43.49 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.15 -37.81 88.69 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.363 -0.836 . . . . 0.0 112.914 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.86 -29.7 70.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.91 -10.4 59.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 77.3 p -104.27 11.35 34.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.21 101.49 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -165.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.517 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.257 54.1 mttp -74.19 -160.35 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.482 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.523 170.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 8.2 Cg_endo -54.21 -42.26 68.85 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 N-CA-C 120.611 3.273 . . . . 0.0 120.611 -155.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -102.11 43.31 1.08 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 121.348 1.886 . . . . 0.0 110.93 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.84 140.09 37.71 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 167.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 42.5 t -138.8 158.28 44.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 116.994 -1.882 . . . . 0.0 106.925 166.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 2.0 tt -129.01 105.26 8.08 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.038 -162.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -106.37 81.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.65 -82.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 120.627 3.011 . . . . 0.0 120.627 -155.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mt -116.22 170.6 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -147.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -110.12 -136.05 0.36 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -157.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.31 -47.82 19.0 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -161.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.62 -29.57 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 124.371 2.034 . . . . 0.0 111.236 171.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.429 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 13.7 m-85 -76.58 -16.41 59.6 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.359 -172.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.95 -52.4 65.36 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.282 -0.886 . . . . 0.0 112.871 168.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.63 -36.14 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.858 -0.526 . . . . 0.0 111.09 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.29 -44.11 97.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.06 81.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.211 0.529 . . . . 0.0 112.408 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.28 -44.76 95.79 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 99.0 mt -80.05 -33.71 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.256 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -71.94 -18.47 62.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.77 31.13 4.94 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.668 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.509 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 85.9 m-85 -106.9 159.97 15.86 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -131.01 111.46 12.04 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.604 HG13 ' CD1' ' A' ' 117' ' ' TRP . 14.1 tt -90.71 153.25 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 122.739 1.257 . . . . 0.0 112.578 -166.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.568 HG23 ' SG ' ' A' ' 116' ' ' CYS . 17.0 tt -154.04 130.38 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.193 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -93.45 98.86 11.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 123.243 1.497 . . . . 0.0 110.698 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -109.58 177.84 1.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.785 -2.007 . . . . 0.0 108.469 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -55.61 -14.28 9.8 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 119.041 2.67 . . . . 0.0 119.041 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -118.1 149.56 40.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 154.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.461 ' HE2' ' HE1' ' A' ' 117' ' ' TRP . 22.5 t80 -86.45 139.23 31.11 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 120.774 -1.204 . . . . 0.0 108.997 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.568 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.356 28.1 p -146.11 120.59 9.7 Favored 'General case' 0 CA--C 1.553 1.093 1 N-CA-C 129.216 6.747 . . . . 0.0 129.216 -173.684 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.604 ' CD1' HG13 ' A' ' 109' ' ' ILE . 8.2 m0 -109.75 117.51 34.07 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.422 1.464 . . . . 0.0 109.178 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -107.68 144.38 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.855 -1.153 . . . . 0.0 109.443 172.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -79.7 110.49 15.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.612 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.641 0.734 . . . . 0.0 109.173 -170.343 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.2 t80 . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.98 141.65 51.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.58 1.181 . . . . 0.0 110.945 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.673 ' HG1' ' CG2' ' A' ' 37' ' ' VAL . 7.8 t -94.34 120.78 35.09 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 163.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.09 -161.69 11.46 Favored Glycine 0 N--CA 1.466 0.666 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.586 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -134.04 139.77 46.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.672 -1.764 . . . . 0.0 107.4 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.6 tp -124.29 129.83 51.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.647 1.213 . . . . 0.0 108.805 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 8.6 mp -115.1 120.37 39.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.59 -1.641 . . . . 0.0 107.051 171.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 tt -128.72 140.0 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.28 0.562 . . . . 0.0 109.737 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -102.7 129.75 25.24 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.14 -13.46 31.98 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 N-CA-C 120.462 3.216 . . . . 0.0 120.462 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.13 -50.21 56.11 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -161.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.07 -30.12 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.273 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.4 p -80.77 0.14 36.06 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -76.35 3.72 10.42 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.034 1.288 . . . . 0.0 112.49 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 m -113.48 71.64 1.69 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 43.51 0.78 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.768 2.978 . . . . 0.0 116.255 -153.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.22 -40.34 90.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.418 -0.801 . . . . 0.0 112.226 163.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mp -62.26 -29.89 70.73 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.03 -50.06 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.115 -0.366 . . . . 0.0 110.779 173.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -47.43 56.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -61.75 -40.61 95.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.081 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -62.29 -38.59 89.95 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 169.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.31 78.08 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.942 1.246 . . . . 0.0 113.807 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -56.9 -56.38 22.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.71 91.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.84 -37.63 34.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -170.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -57.8 -27.7 63.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.806 1.185 . . . . 0.0 113.778 170.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.93 -119.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -153.28 40.5 0.53 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 124.317 2.008 . . . . 0.0 111.946 -170.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.04 110.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 111.183 -2.735 . . . . 0.0 108.7 170.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.09 141.87 35.88 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 167.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -88.7 139.64 30.26 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.673 ' CG2' ' HG1' ' A' ' 6' ' ' THR . 92.6 t -108.91 -36.64 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.468 -166.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -121.85 169.93 10.28 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.881 1.324 . . . . 0.0 111.309 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -135.8 125.16 24.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.635 -1.621 . . . . 0.0 108.248 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 15.6 m-30 -124.15 120.26 31.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.973 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.31 149.38 21.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 tp -63.5 -40.19 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -78.88 -30.33 44.89 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.5 -0.75 . . . . 0.0 112.92 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -80.3 -32.42 38.04 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.547 -0.721 . . . . 0.0 112.721 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.65 -40.43 80.23 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.457 -0.777 . . . . 0.0 111.89 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -78.06 -30.9 50.01 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.89 -36.75 36.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.848 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.89 15.31 2.9 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 170.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -78.06 -26.44 48.27 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.24 1.52 . . . . 0.0 114.456 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.61 120.24 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.8 m -126.87 120.12 28.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.633 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.08 -166.88 1.35 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.57 170.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -98.84 169.91 9.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.586 1.184 . . . . 0.0 110.056 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 76.9 m-20 -77.13 97.56 4.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.587 170.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.33 -151.18 0.43 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -166.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -100.08 31.73 3.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -162.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.542 ' C ' ' H ' ' A' ' 59' ' ' THR . 2.5 m-85 -81.86 21.51 0.85 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.373 -170.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HB2' ' HA2' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -61.38 35.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -166.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.542 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.62 115.45 8.25 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 163.706 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 68.4 t -118.62 134.48 62.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.237 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.508 ' HE2' HG22 ' A' ' 92' ' ' ILE . 3.6 m80 -122.61 134.77 54.5 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.72 110.89 19.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 169.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.35 102.02 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.63 1.205 . . . . 0.0 111.466 170.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -132.82 154.95 81.63 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.42 128.13 19.74 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.344 2.03 . . . . 0.0 115.816 170.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -100.77 30.18 4.14 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.116 -169.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.76 -61.95 1.3 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.032 -1.042 . . . . 0.0 109.307 -170.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -92.52 115.26 27.93 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -170.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -77.07 78.89 3.6 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.864 0.84 . . . . 0.0 111.17 170.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.14 -24.67 1.42 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.058 -170.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.8 pt -75.17 156.74 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.088 0.946 . . . . 0.0 112.513 -169.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -113.63 152.81 29.87 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.01 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 11.6 t80 -130.34 148.81 71.37 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 30.7 Cg_exo -82.02 149.54 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 CA-C-N 120.505 1.216 . . . . 0.0 110.456 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.68 -36.59 83.41 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.09 -32.9 72.55 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.61 -30.32 56.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.833 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.98 -34.9 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 119.954 1.252 . . . . 0.0 111.459 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.2 m -68.34 -39.16 82.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.893 1.224 . . . . 0.0 112.62 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.91 -37.54 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.947 -0.47 . . . . 0.0 111.774 174.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.04 -47.8 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.81 -0.556 . . . . 0.0 111.956 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.33 -30.06 70.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.21 -9.86 59.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 29.7 p -71.12 -35.25 71.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.05 167.05 14.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 123.16 1.457 . . . . 0.0 114.2 -150.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.73 101.89 0.57 Allowed Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.483 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -50.93 -6.98 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 N-CA-C 120.707 3.311 . . . . 0.0 120.707 -153.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -88.96 55.03 3.19 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.769 1.622 . . . . 0.0 108.809 160.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 58' ' ' GLU . . . -88.23 157.89 28.48 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.1 p -128.05 159.17 35.9 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.274 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -127.56 142.7 51.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.542 -2.117 . . . . 0.0 106.141 -173.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 1.057 HD13 ' SG ' ' A' ' 116' ' ' CYS . 46.7 mm -129.04 89.1 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 170.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.97 -88.43 0.09 OUTLIER Glycine 0 C--N 1.318 -0.472 0 N-CA-C 121.587 3.395 . . . . 0.0 121.587 -166.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mt -116.37 146.85 42.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.617 1.199 . . . . 0.0 109.513 -130.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.7 p -86.36 -136.68 0.08 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.526 -158.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.69 -50.5 13.51 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -156.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.22 -32.5 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 124.789 2.233 . . . . 0.0 113.015 170.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.0 m-85 -76.63 -14.89 59.95 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.737 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -59.08 -55.82 30.2 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.079 -1.013 . . . . 0.0 111.951 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.07 -34.85 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.897 -0.502 . . . . 0.0 111.49 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.01 -40.93 90.96 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 171.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.59 90.98 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.912 -0.492 . . . . 0.0 111.741 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.98 -49.45 71.39 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.702 0.763 . . . . 0.0 112.543 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.3 tt -80.24 -33.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.594 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -71.72 -19.71 62.01 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.96 33.28 4.09 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 119.607 -1.282 . . . . 0.0 112.597 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.476 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 95.8 m-85 -106.48 159.65 16.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 168.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -126.13 103.88 7.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.592 HG13 ' CD1' ' A' ' 117' ' ' TRP . 18.0 tt -76.15 140.69 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 122.882 1.325 . . . . 0.0 111.316 -168.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.45 119.02 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -106.56 94.55 5.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.598 1.666 . . . . 0.0 110.642 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -134.1 179.17 1.45 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 112.496 -2.138 . . . . 0.0 106.737 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.83 -11.53 3.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 118.654 2.521 . . . . 0.0 118.654 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -122.83 111.51 16.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 157.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.09 110.26 21.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.393 -0.813 . . . . 0.0 109.23 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.274 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 26.3 p -147.75 -157.03 0.77 Allowed 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 122.808 1.29 . . . . 0.0 113.65 170.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.592 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.5 m0 -137.33 130.42 30.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.618 -170.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -112.86 144.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.276 -1.515 . . . . 0.0 110.294 166.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.77 110.49 15.17 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.375 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.47 0.552 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.344 -170.321 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.725 ' HH ' ' HG3' ' A' ' 35' ' ' LYS . 4.3 t80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.37 141.96 27.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.65 0.738 . . . . 0.0 110.839 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -95.74 141.42 29.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 162.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.76 -160.12 9.22 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-O 124.132 1.962 . . . . 0.0 115.205 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.41 HD22 ' CE2' ' A' ' 40' ' ' PHE . 3.8 mt -134.2 139.67 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.4 -2.4 . . . . 0.0 107.751 -174.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.41 130.01 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.817 1.294 . . . . 0.0 107.839 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.409 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 8.7 mp -113.85 120.34 40.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.719 175.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.2 mt -121.3 139.9 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -171.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -94.11 129.77 36.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 165.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -60.68 -16.43 43.35 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 N-CA-C 121.056 3.444 . . . . 0.0 121.056 -170.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.78 72.49 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.317 1.417 . . . . 0.0 113.111 -162.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.02 -29.93 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.6 p -86.12 0.47 53.46 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -170.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -76.29 0.35 19.63 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 120.674 1.579 . . . . 0.0 112.601 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.322 90.8 m -98.87 168.09 10.29 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 162.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.74 -7.26 16.54 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 N-CA-C 117.837 2.206 . . . . 0.0 117.837 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.17 -50.48 19.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -159.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.29 -29.83 67.78 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.468 1.031 . . . . 0.0 112.579 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 t -66.26 -49.99 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.982 -0.449 . . . . 0.0 110.513 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.4 -39.73 88.4 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.982 -1.074 . . . . 0.0 113.29 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -59.87 -50.32 74.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 t -68.47 -34.51 76.07 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.615 -0.678 . . . . 0.0 111.698 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.27 -29.96 69.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 170.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.03 -47.09 66.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.482 1.037 . . . . 0.0 112.288 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.75 -48.72 77.19 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.97 60.64 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.549 169.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.29 70.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.2 -170.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -75.34 -19.53 59.56 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.1 -111.0 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.771 -0.581 . . . . 0.0 111.255 170.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -149.48 -10.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -166.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -98.98 149.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 121.592 -0.692 . . . . 0.0 112.402 170.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.725 ' HG3' ' HH ' ' A' ' 4' ' ' TYR . 89.9 mttt -128.29 143.9 51.07 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 164.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -92.54 139.84 30.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.754 0.788 . . . . 0.0 109.453 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.36 -32.69 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -121.62 169.98 10.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.292 1.52 . . . . 0.0 109.961 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -139.8 125.18 19.02 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.687 -172.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.41 ' CE2' HD22 ' A' ' 8' ' ' LEU . 21.4 m-30 -129.49 106.42 8.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -84.92 149.57 25.56 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.45 -0.781 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 tp -63.33 -40.11 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.12 -30.35 34.57 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.576 -0.702 . . . . 0.0 112.823 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -79.03 -31.59 44.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.122 -0.987 . . . . 0.0 112.789 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -72.6 -40.59 66.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.604 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.14 -15.29 58.98 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.978 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.34 -43.41 11.54 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.26 -0.9 . . . . 0.0 111.989 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.99 15.3 2.35 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -76.05 -25.58 55.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.638 1.719 . . . . 0.0 114.575 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.7 121.7 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -169.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -98.76 159.28 15.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 124.344 2.021 . . . . 0.0 109.349 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -130.91 120.74 24.03 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.028 -153.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.79 169.67 9.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.043 168.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 66.5 m-20 -111.13 88.55 2.81 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -170.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.5 -158.81 0.9 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -164.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -90.99 35.07 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.779 -1.555 . . . . 0.0 115.052 -163.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.542 ' C ' ' H ' ' A' ' 59' ' ' THR . 10.3 m-85 -82.03 21.84 0.85 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.374 -170.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.55 37.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -163.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.542 ' H ' ' C ' ' A' ' 57' ' ' TYR . 1.0 OUTLIER -141.22 115.4 9.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 163.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 18.7 t -118.61 134.51 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.633 -1.622 . . . . 0.0 106.743 -164.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.487 ' HE2' HG21 ' A' ' 92' ' ' ILE . 2.2 m80 -122.84 134.71 54.39 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.76 110.52 16.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.4 mt -98.05 100.7 12.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.451 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -126.2 92.45 45.66 Favored Pre-proline 0 N--CA 1.474 0.752 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 167.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.06 97.46 1.06 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.077 1.851 . . . . 0.0 111.994 170.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -120.11 -30.18 4.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.166 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.44 -108.21 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -112.08 -62.83 1.51 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 170.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.6 p -84.08 159.25 21.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.698 0.761 . . . . 0.0 111.164 170.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -75.85 178.81 5.91 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.117 -170.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.3 pt -105.05 -168.54 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.665 0.745 . . . . 0.0 112.119 170.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.69 143.44 34.59 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 123.088 1.423 . . . . 0.0 112.425 -163.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -130.29 149.11 72.4 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 113.055 -1.884 . . . . 0.0 107.254 -170.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -82.14 149.47 15.41 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 120.617 1.256 . . . . 0.0 110.242 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.54 -38.01 88.33 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.89 -35.15 70.6 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 mt -76.62 -30.26 56.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.51 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.05 -36.17 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 119.899 1.227 . . . . 0.0 111.429 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.8 m -68.62 -39.17 80.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.544 1.066 . . . . 0.0 112.814 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -36.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.992 -0.443 . . . . 0.0 111.855 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.7 -46.44 90.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.743 -0.598 . . . . 0.0 111.849 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.86 70.21 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.33 -10.15 59.55 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -169.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 67.0 m -76.17 -34.64 59.35 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 168.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.83 176.5 6.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 123.998 1.856 . . . . 0.0 114.885 -148.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -105.06 101.57 30.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 -170.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -51.34 16.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.384 1 N-CA-C 122.903 4.155 . . . . 0.0 122.903 -153.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -102.05 61.37 0.87 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 156.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.47 137.39 13.23 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.1 p -134.08 109.45 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.644 1.212 . . . . 0.0 107.884 -169.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.222 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.28 6.2 tt -93.38 132.25 37.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.813 -174.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 1.065 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 37.0 mm -115.68 84.94 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -170.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.88 -87.2 0.09 OUTLIER Glycine 0 C--N 1.315 -0.593 0 N-CA-C 121.168 3.227 . . . . 0.0 121.168 -163.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.88 169.85 8.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.169 -139.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.0 m -105.35 -155.32 0.54 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.282 -0.886 . . . . 0.0 112.37 -157.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.95 -42.98 84.32 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -163.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -59.8 -33.15 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 124.3 2.0 . . . . 0.0 112.545 169.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 32.0 m-85 -76.54 -12.85 60.09 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.785 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.81 -48.29 79.73 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.065 -1.022 . . . . 0.0 112.404 165.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.69 -38.33 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.489 -0.757 . . . . 0.0 110.714 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.34 -48.45 81.7 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 170.366 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.99 -41.58 71.4 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.56 -47.48 83.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.8 mt -77.16 -35.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.038 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -71.97 -16.74 62.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.84 29.93 5.36 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.947 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.3 m-85 -106.92 159.7 16.07 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.768 1.27 . . . . 0.0 108.809 173.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.59 109.52 11.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.36 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.608 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -85.63 111.15 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.905 1.336 . . . . 0.0 114.082 -164.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 19.0 tt -119.51 135.07 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.231 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -119.64 97.28 5.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.911 -168.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -117.31 -177.42 0.45 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 112.606 -2.088 . . . . 0.0 107.582 164.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.4 -11.11 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 N-CA-C 118.948 2.634 . . . . 0.0 118.948 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -103.95 113.31 26.75 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 154.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -80.12 115.16 19.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.612 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.222 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 24.4 p -147.35 -156.86 0.75 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.168 1.461 . . . . 0.0 112.343 166.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.608 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.4 m0 -132.58 149.66 52.28 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -174.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.58 144.18 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 122.983 1.373 . . . . 0.0 108.586 165.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.69 110.19 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.928 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.156 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.666 ' HH ' ' HG3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -88.89 141.8 28.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.016 0.912 . . . . 0.0 110.706 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.46 141.64 30.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 160.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.79 -168.25 11.78 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-O 123.964 1.869 . . . . 0.0 117.052 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.432 HD11 ' CE2' ' A' ' 40' ' ' PHE . 30.1 tp -134.39 115.14 13.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 111.215 -2.493 . . . . 0.0 106.213 -165.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 129.19 54.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.35 148.88 32.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.908 1.337 . . . . 0.0 108.646 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.77 HG22 ' HG1' ' A' ' 16' ' ' THR . 5.8 mt -133.7 111.63 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.651 -169.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -87.07 129.52 51.64 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -59.97 -19.74 56.89 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 N-CA-C 121.008 3.426 . . . . 0.0 121.008 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.44 74.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.685 1.13 . . . . 0.0 113.197 -162.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.59 -27.6 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -171.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.77 ' HG1' HG22 ' A' ' 11' ' ' ILE . 69.7 p -86.1 0.39 53.63 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -170.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.3 m -76.4 -0.26 22.13 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 120.681 1.582 . . . . 0.0 111.738 168.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 m -108.96 71.6 0.44 Allowed Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 43.86 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.088 3.192 . . . . 0.0 116.421 -153.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.39 -39.6 92.41 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.579 -0.701 . . . . 0.0 112.138 162.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.31 -30.72 68.56 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.11 -48.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 122.341 -0.224 . . . . 0.0 110.907 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.47 -33.07 74.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.9 -48.39 37.62 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -61.45 -42.58 98.98 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.523 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -65.52 -32.92 74.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.145 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.59 78.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.069 1.304 . . . . 0.0 113.177 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.0 -55.49 30.29 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.67 87.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.64 70.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -170.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.8 m -58.09 -28.67 64.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 170.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -85.84 -101.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.85 -0.531 . . . . 0.0 109.967 -170.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -147.26 27.72 1.02 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -131.05 110.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.978 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.666 ' HG3' ' HH ' ' A' ' 4' ' ' TYR . 99.7 mttt -101.4 139.46 37.03 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.072 -1.017 . . . . 0.0 108.989 168.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -88.99 139.84 30.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.83 -33.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.876 -166.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -121.82 169.58 10.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.684 1.23 . . . . 0.0 108.906 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -126.64 154.64 43.74 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.432 ' CE2' HD11 ' A' ' 8' ' ' LEU . 14.3 m-30 -136.12 112.93 10.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.7 149.24 25.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -63.47 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.79 -30.31 40.58 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.49 -29.68 30.39 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.099 -1.001 . . . . 0.0 113.113 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.89 -40.35 72.27 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.892 . . . . 0.0 111.874 174.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -73.37 -18.82 61.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.09 -46.41 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.291 -0.881 . . . . 0.0 112.1 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.74 15.15 1.41 Allowed Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -77.53 -10.55 59.55 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.024 1.912 . . . . 0.0 115.645 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.78 121.36 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.692 -0.63 . . . . 0.0 109.671 -169.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -98.97 120.29 39.17 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 123.814 1.769 . . . . 0.0 109.776 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -119.1 120.84 38.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.76 -158.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.5 169.57 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.472 1.129 . . . . 0.0 109.39 167.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -110.14 88.35 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.85 -119.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -100.09 56.89 0.95 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -156.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.5 ' C ' ' H ' ' A' ' 59' ' ' THR . 1.1 m-85 -112.05 10.73 20.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 170.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.253 19.3 mt-10 -78.75 46.55 0.67 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.944 2.611 . . . . 0.0 112.542 -170.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -112.99 108.85 17.92 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 150.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 59.5 t -118.61 110.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.54 -2.118 . . . . 0.0 107.894 -155.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.465 ' HE2' HG22 ' A' ' 92' ' ' ILE . 2.8 m80 -115.05 105.33 12.83 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 -174.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.83 141.97 28.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 119.819 -1.801 . . . . 0.0 109.498 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -124.06 80.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.481 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -134.06 81.9 49.94 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.94 1.7 . . . . 0.0 111.367 -170.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -80.22 104.93 1.7 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 121.993 1.795 . . . . 0.0 110.267 169.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -120.1 -30.2 4.72 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 170.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.1 -178.94 7.26 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.141 0.972 . . . . 0.0 111.194 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -74.86 -34.36 62.25 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.535 170.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.621 HG23 ' H ' ' A' ' 70' ' ' ASP . 6.0 t -78.31 -104.08 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -170.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.621 ' H ' HG23 ' A' ' 69' ' ' THR . 6.7 m-20 -135.07 178.46 7.01 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.669 1.122 . . . . 0.0 110.201 170.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.4 pt -108.48 -157.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.941 170.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -125.06 139.49 53.75 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 164.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -130.64 149.02 72.37 Favored Pre-proline 0 N--CA 1.476 0.851 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -82.27 149.63 15.19 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 120.046 1.052 . . . . 0.0 110.402 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.49 -34.59 77.17 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -59.29 -36.53 75.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.56 -30.15 56.95 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.985 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.89 -40.18 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 O-C-N 121.281 -0.887 . . . . 0.0 110.937 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.6 m -71.23 -30.92 66.94 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.996 -1.065 . . . . 0.0 113.853 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.96 -46.01 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.858 -0.526 . . . . 0.0 110.799 171.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -37.38 75.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.4 70.48 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.02 -9.79 58.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -68.41 -50.48 52.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.938 -0.476 . . . . 0.0 112.104 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.593 ' CD1' ' H ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -98.82 -141.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -174.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.594 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.262 74.9 mmtt -129.84 -139.51 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -170.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.594 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 49.6 Cg_endo -68.97 -50.25 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 CA-C-N 124.385 2.602 . . . . 0.0 114.129 170.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -79.33 53.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.217 1.371 . . . . 0.0 114.318 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.39 164.72 28.35 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 161.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.5 t -147.02 159.23 43.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.163 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.376 1.2 tm? -128.44 129.55 46.3 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 112.222 -2.263 . . . . 0.0 104.91 -162.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.799 HD12 ' CB ' ' A' ' 116' ' ' CYS . 40.3 mm -118.49 84.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.016 1.734 . . . . 0.0 108.256 170.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.82 -88.18 0.09 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 -161.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.61 169.77 8.94 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.798 -143.038 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.4 m -108.69 -148.47 0.42 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -158.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.54 -45.05 88.81 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -163.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.89 -31.19 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 124.762 2.22 . . . . 0.0 110.84 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 79.1 m-85 -76.75 -2.97 35.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.523 -174.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 87.3 tttt -67.2 -49.18 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.213 -0.929 . . . . 0.0 111.892 170.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.4 -34.41 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.02 169.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.593 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.19 -47.94 83.84 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 172.445 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.32 80.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 tp -58.94 -49.94 75.95 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.613 0.72 . . . . 0.0 112.55 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.19 -34.38 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.4 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -71.69 -16.68 62.25 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.67 29.04 5.74 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.496 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 82.7 m-85 -106.67 159.72 15.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -120.83 153.94 36.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.522 ' CG1' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -112.07 152.45 13.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.566 -167.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 tp -154.01 120.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.66 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -107.6 100.23 9.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 123.735 1.731 . . . . 0.0 110.196 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.73 -178.24 0.64 Allowed Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 111.72 -2.491 . . . . 0.0 106.698 169.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.06 -10.73 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 119.314 2.774 . . . . 0.0 119.314 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -119.71 111.53 18.14 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 158.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.44 115.33 27.49 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.941 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.163 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 11.7 p -147.12 -163.44 1.76 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 124.321 2.01 . . . . 0.0 114.334 172.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.522 ' CD1' ' CG1' ' A' ' 109' ' ' ILE . 13.2 m0 -137.65 130.35 29.91 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 110.559 -3.019 . . . . 0.0 106.412 -165.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 144.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.585 -1.322 . . . . 0.0 108.88 165.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -79.59 110.58 15.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.753 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.391 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.405 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 22.9 t80 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.63 141.81 28.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.97 0.89 . . . . 0.0 111.319 -165.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 m -96.96 141.17 30.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 172.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.2 -158.7 8.62 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 118.787 -1.673 . . . . 0.0 115.76 172.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.31 139.67 45.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 113.252 -1.474 . . . . 0.0 108.636 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.59 138.7 54.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.997 1.379 . . . . 0.0 107.815 165.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -125.91 120.46 30.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.264 -1.789 . . . . 0.0 108.983 178.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 tt -129.02 139.84 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.05 0.929 . . . . 0.0 111.316 -160.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -106.94 129.8 23.83 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 166.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -60.0 -15.82 35.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 N-CA-C 119.984 3.032 . . . . 0.0 119.984 -170.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -50.19 74.21 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.294 0.952 . . . . 0.0 112.206 -167.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -34.26 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -85.41 -0.01 53.56 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -76.48 -8.18 56.64 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 120.064 1.302 . . . . 0.0 111.59 164.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.5 m -111.62 71.46 0.93 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 164.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.84 53.3 0.77 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.3 3.334 . . . . 0.0 116.779 -154.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.12 -48.73 27.55 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.753 -1.217 . . . . 0.0 112.67 165.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.53 -30.34 71.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.27 -45.64 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.147 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.76 -34.94 78.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.57 -48.21 49.82 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 t -60.72 -40.96 94.26 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.81 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.91 -32.99 73.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.172 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.14 74.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.942 1.246 . . . . 0.0 113.823 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -55.05 -55.26 33.01 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.66 -46.31 84.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.037 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.24 -50.01 71.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -170.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -69.85 -20.55 63.41 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 112.574 -170.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.73 -103.13 0.06 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.314 0.578 . . . . 0.0 109.443 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -157.4 4.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.86 150.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.643 0.735 . . . . 0.0 111.451 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 88.4 tttt -128.42 135.03 48.95 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 161.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -88.93 139.56 30.33 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.83 -14.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -163.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.61 120.32 34.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -114.77 125.1 53.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -163.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 60.2 m-85 -130.17 102.35 6.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.689 -175.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.7 tt -85.24 149.34 25.56 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.061 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -63.42 -40.17 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.517 ' H ' HD23 ' A' ' 41' ' ' LEU . 22.1 t-20 -81.64 -30.34 32.83 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.197 -0.939 . . . . 0.0 112.762 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.91 -30.75 56.28 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.433 -0.792 . . . . 0.0 112.577 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -40.43 70.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.882 0.765 . . . . 0.0 112.306 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.17 -20.64 47.93 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.74 -30.55 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 111.623 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.53 15.14 11.57 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 t -78.4 -34.34 48.14 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 mt -114.98 120.3 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.753 0.787 . . . . 0.0 108.983 -167.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.0 m -133.05 158.71 42.07 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.5 mt -131.71 -138.5 0.2 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.93 178.77 4.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.013 0.911 . . . . 0.0 109.937 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -120.1 67.38 0.83 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.187 -169.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.19 -77.92 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 -170.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -82.9 7.74 14.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 -157.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.571 ' C ' ' H ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -90.13 21.25 3.83 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.16 -167.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.93 26.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -167.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.571 ' H ' ' C ' ' A' ' 57' ' ' TYR . 6.4 t -133.12 115.1 14.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 162.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 18.0 t -116.56 134.32 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -167.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.455 ' HE2' HG23 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -122.71 134.75 54.45 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.28 142.23 42.18 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.36 102.66 8.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.604 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.8 m -139.43 154.75 71.94 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 170.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.75 133.45 33.05 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.849 2.366 . . . . 0.0 116.366 170.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -95.08 8.77 41.92 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.266 -170.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.82 -179.26 4.12 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.409 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -82.73 94.16 7.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.623 0.725 . . . . 0.0 111.497 -170.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.4 m -88.0 -63.94 1.22 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 166.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -124.54 178.55 5.36 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 163.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.9 pt -108.26 8.33 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 170.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.17 139.82 53.3 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 122.346 1.07 . . . . 0.0 111.945 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -130.07 149.06 72.13 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 162.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -82.0 149.34 15.63 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 CA-C-N 121.233 1.476 . . . . 0.0 110.109 -175.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -37.9 88.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.11 -33.61 73.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -76.72 -30.15 56.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.34 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -36.72 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.75 1.159 . . . . 0.0 111.442 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -68.27 -36.24 79.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.84 1.2 . . . . 0.0 112.82 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.74 -41.14 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.941 -0.474 . . . . 0.0 111.533 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -60.06 -46.35 89.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.648 0.658 . . . . 0.0 112.364 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.88 70.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.7 -10.02 59.12 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -170.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -104.44 23.32 13.41 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.3 mt -134.12 -166.64 1.83 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.165 0.983 . . . . 0.0 110.829 -163.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.96 174.88 3.95 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -170.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.8 -22.72 14.25 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 170.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -102.51 45.83 0.95 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.741 1.61 . . . . 0.0 110.4 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.45 138.4 20.34 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -143.4 109.08 5.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.43 1.586 . . . . 0.0 107.041 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.151 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.368 0.2 OUTLIER -89.82 129.72 36.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -176.075 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 1.303 HD13 ' SG ' ' A' ' 116' ' ' CYS . 42.7 mm -111.44 95.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.243 1.021 . . . . 0.0 109.097 170.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.93 -83.68 0.06 OUTLIER Glycine 0 C--N 1.315 -0.625 0 N-CA-C 120.851 3.1 . . . . 0.0 120.851 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.435 HD12 HD12 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -116.09 169.94 8.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 118.764 -1.174 . . . . 0.0 108.476 -133.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -103.02 -140.94 0.36 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.07 -1.019 . . . . 0.0 112.63 -155.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.22 -44.79 24.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -162.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tp -56.63 -33.05 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 124.505 2.097 . . . . 0.0 112.569 167.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 71.8 m-85 -76.66 -10.88 59.7 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.203 -176.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.45 -51.52 69.51 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 112.256 167.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.44 -35.28 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.896 -0.503 . . . . 0.0 111.236 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -57.89 -42.96 85.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 170.126 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.35 94.57 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.164 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -54.92 -48.0 73.65 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.24 -35.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.076 -169.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.68 -18.74 62.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.95 4.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.004 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -106.71 159.69 16.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.5 154.27 35.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.539 1.162 . . . . 0.0 107.933 158.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.626 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.2 tt -107.48 149.26 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.745 -163.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.72 126.18 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 122.553 1.168 . . . . 0.0 107.953 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -106.05 100.21 9.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.593 1.663 . . . . 0.0 109.826 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -127.93 177.59 2.01 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 111.935 -2.393 . . . . 0.0 107.446 170.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.99 -11.82 4.16 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 N-CA-C 119.269 2.757 . . . . 0.0 119.269 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -115.94 108.12 15.86 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 157.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.48 ' HH ' HD12 ' A' ' 109' ' ' ILE . 9.9 t80 -86.8 113.06 22.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.668 -170.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.303 ' SG ' HD13 ' A' ' 92' ' ' ILE . 25.1 p -147.54 -153.95 0.52 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 123.072 1.415 . . . . 0.0 112.258 172.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.626 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.0 m0 -134.77 149.73 50.46 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.66 144.09 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 166.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -83.31 134.83 34.9 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.742 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 110.616 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 12.5 t80 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.764 0.316 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -105.06 160.58 14.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 123.367 1.556 . . . . 0.0 113.403 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.077 170.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.69 -156.39 9.5 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.849 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 tp -134.03 142.72 47.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -166.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.05 129.83 51.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 40' ' ' PHE . 1.3 mt -109.36 120.08 41.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 171.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.518 HG12 ' HG1' ' A' ' 16' ' ' THR . 21.3 tt -132.14 139.93 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.539 0.685 . . . . 0.0 109.324 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -101.08 129.75 26.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.39 -12.02 25.53 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.968 3.026 . . . . 0.0 119.968 -170.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.26 52.44 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -161.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -85.2 -29.81 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.175 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.518 ' HG1' HG12 ' A' ' 11' ' ' ILE . 66.2 p -81.08 0.24 36.91 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -76.33 -0.87 24.1 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.859 1.209 . . . . 0.0 112.247 165.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 m -112.47 71.5 1.18 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 163.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.17 46.1 1.08 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.986 3.124 . . . . 0.0 116.219 -152.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.24 -43.5 91.21 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.599 -0.688 . . . . 0.0 112.608 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.49 -29.94 70.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.25 -46.88 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.934 -0.479 . . . . 0.0 110.887 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.25 -33.92 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.89 -48.79 57.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.426 ' HA ' HE21 ' A' ' 28' ' ' GLN . 9.7 t -61.73 -39.21 90.74 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.477 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -66.3 -29.9 70.21 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.34 76.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.236 1.38 . . . . 0.0 113.428 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.426 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.7 mt-30 -59.69 -50.83 72.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.966 -0.459 . . . . 0.0 111.611 170.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.91 -42.66 59.58 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.69 -49.92 12.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -59.35 -37.39 77.74 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 170.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.9 -106.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.717 -0.615 . . . . 0.0 110.389 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.432 ' HB3' ' CD1' ' A' ' 4' ' ' TYR . 43.1 mmtm -129.76 -44.86 1.19 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -169.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.98 149.58 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.728 1.251 . . . . 0.0 111.335 -165.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -114.88 136.0 53.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.63 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -90.46 139.47 30.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.7 t -118.74 -32.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.63 -162.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -121.86 169.99 10.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.273 1.511 . . . . 0.0 110.859 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -134.49 125.4 27.31 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.757 -174.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.413 ' O ' HD23 ' A' ' 10' ' ' LEU . 18.4 m-30 -118.68 120.21 36.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 168.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.64 149.43 22.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.53 -40.09 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.97 -30.45 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -85.53 -31.5 22.68 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -0.918 . . . . 0.0 112.944 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -66.21 -40.56 90.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.26 0.937 . . . . 0.0 112.054 171.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -69.67 -24.98 63.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.992 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.13 -39.86 16.27 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.67 -0.644 . . . . 0.0 111.78 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.34 15.36 1.14 Allowed Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -79.74 -30.09 40.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -171.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.8 mt -114.75 120.28 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.867 0.841 . . . . 0.0 109.854 -164.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -128.26 120.45 27.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.239 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.5 -167.43 1.36 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.897 1.332 . . . . 0.0 110.537 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -98.58 120.5 39.12 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.203 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -81.17 46.67 0.94 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -161.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.03 4.42 0.63 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 119.594 3.183 . . . . 0.0 119.594 170.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -100.4 -34.59 9.89 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 122.089 2.222 . . . . 0.0 115.801 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 59' ' ' THR . 8.2 m-85 -81.87 22.04 0.8 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -157.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.3 37.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -167.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 57' ' ' TYR . 8.8 t -138.57 115.32 10.69 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 160.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 45.7 t -124.87 110.34 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.504 -160.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.488 ' HE2' HG23 ' A' ' 92' ' ' ILE . 3.6 m80 -105.88 134.6 48.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.408 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -118.06 110.42 17.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.25 -0.906 . . . . 0.0 109.017 176.357 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.51 89.5 3.23 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.468 -170.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -136.76 86.71 21.36 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -80.2 82.41 2.49 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.127 1.884 . . . . 0.0 112.84 170.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -120.18 -30.12 4.71 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.745 -0.597 . . . . 0.0 112.61 170.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.05 178.83 9.27 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.695 0.76 . . . . 0.0 109.771 -170.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -108.55 -67.39 0.98 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 170.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -103.6 -49.96 3.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.371 -170.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -92.68 69.85 4.82 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.731 0.777 . . . . 0.0 110.917 -170.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.456 HD11 ' H ' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -108.16 149.99 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 169.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.456 ' H ' HD11 ' A' ' 71' ' ' ILE . 99.4 mttt -112.64 139.39 48.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.382 1.087 . . . . 0.0 110.82 170.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -130.54 149.11 72.57 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 166.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -82.2 149.44 15.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 CA-C-N 120.962 1.379 . . . . 0.0 110.344 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -38.38 90.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.14 -31.76 70.39 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.68 -30.3 56.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.992 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.38 -35.28 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 120.203 1.365 . . . . 0.0 111.227 170.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.9 m -68.94 -39.93 79.26 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.597 1.09 . . . . 0.0 112.503 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.19 -38.09 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.942 -0.474 . . . . 0.0 111.84 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -40.48 91.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.709 -0.619 . . . . 0.0 112.571 176.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.0 70.72 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.86 -19.16 61.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.4 m -72.06 -17.02 62.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -111.15 159.93 17.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.123 0.963 . . . . 0.0 110.387 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -91.38 174.96 3.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.341 169.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -60.43 -10.61 13.93 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 117.508 2.08 . . . . 0.0 117.508 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -102.07 50.06 0.84 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 168.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.14 141.4 25.03 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.9 p -139.66 103.79 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.167 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.274 2.6 tt -89.96 129.78 36.25 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -178.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 1.145 HD11 ' SG ' ' A' ' 116' ' ' CYS . 32.3 mm -110.18 91.14 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -80.71 0.05 OUTLIER Glycine 0 C--N 1.315 -0.596 0 N-CA-C 121.22 3.248 . . . . 0.0 121.22 -163.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 mt -115.97 169.78 8.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.227 -141.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.839 ' HG ' ' H ' ' A' ' 96' ' ' ASP . 6.0 p -123.55 -117.31 0.29 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 119.636 -0.826 . . . . 0.0 113.009 -158.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.839 ' H ' ' HG ' ' A' ' 95' ' ' SER . 20.6 t70 -73.36 -59.39 2.73 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -155.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mt -59.7 -26.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 124.248 1.975 . . . . 0.0 111.593 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.583 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 62.4 m-85 -76.9 -18.73 58.12 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.283 -169.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -54.44 -53.96 47.22 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.988 -1.07 . . . . 0.0 112.436 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.06 -33.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.837 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.583 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.84 -43.34 94.65 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 172.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.61 97.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.86 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.03 -44.52 95.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -80.01 -35.63 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.038 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -71.78 -18.74 62.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 32.11 4.52 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.79 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.487 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.6 m-85 -106.77 159.96 15.84 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -128.51 109.09 11.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.621 HD11 ' HH ' ' A' ' 115' ' ' TYR . 20.2 tt -87.6 111.22 21.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 122.751 1.263 . . . . 0.0 114.393 -162.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.5 tt -105.12 125.25 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.756 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -115.41 81.53 1.6 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 124.285 1.993 . . . . 0.0 111.299 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -134.34 100.47 12.69 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 -170.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.63 29.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.971 1 N-CA-C 124.8 4.885 . . . . 0.0 124.8 -140.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -99.68 99.82 10.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 132.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.621 ' HH ' HD11 ' A' ' 109' ' ' ILE . 10.4 t80 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.572 -163.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 1.167 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 23.8 p -147.3 -156.49 0.72 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 123.104 1.43 . . . . 0.0 111.77 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.569 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.7 m0 -134.24 149.6 50.98 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 -174.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 143.91 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.351 1.072 . . . . 0.0 108.25 164.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 68.4 tttt -90.2 64.82 6.2 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.437 -178.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.379 170.13 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -117.47 141.63 48.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.772 1.273 . . . . 0.0 111.347 -170.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -105.26 120.89 42.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.359 174.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.27 -161.13 9.69 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 123.59 1.661 . . . . 0.0 117.086 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.5 tp -127.95 139.9 52.31 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 111.795 -2.203 . . . . 0.0 107.196 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -124.37 129.28 50.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 162.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -123.34 120.07 31.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -176.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.0 pt -131.21 139.99 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.492 -0.755 . . . . 0.0 111.218 -167.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.4 129.69 36.09 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 166.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.31 -13.9 18.08 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 N-CA-C 120.205 3.117 . . . . 0.0 120.205 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.52 -50.2 66.13 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -163.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.28 -34.02 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.166 170.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.5 p -83.49 0.4 46.53 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 t -76.58 -6.01 50.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.687 1.585 . . . . 0.0 114.573 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.312 62.8 m -98.94 168.11 10.24 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 169.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.59 -6.72 16.41 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 N-CA-C 116.915 1.852 . . . . 0.0 116.915 -170.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.12 -50.19 20.55 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.721 1.146 . . . . 0.0 113.833 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.99 -31.44 70.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.656 0.662 . . . . 0.0 112.123 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.77 -47.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 122.232 -0.292 . . . . 0.0 111.044 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.35 -32.69 72.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.49 -49.09 52.05 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.4 t -61.83 -40.08 94.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.176 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.33 -34.2 77.6 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.3 70.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.287 1.403 . . . . 0.0 113.246 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.297 0.5 OUTLIER -54.85 -53.7 51.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.11 82.93 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.58 -50.03 14.88 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -25.54 61.14 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -85.8 -114.83 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.628 -0.67 . . . . 0.0 109.659 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -154.1 11.79 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.1 149.88 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.817 0.818 . . . . 0.0 111.778 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.44 137.88 52.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 162.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -88.75 139.45 30.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.3 t -117.21 -35.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.542 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -122.05 120.15 33.5 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -157.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -114.88 114.17 25.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -162.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.512 ' O ' HD23 ' A' ' 10' ' ' LEU . 18.5 m-30 -119.05 120.57 37.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.6 tt -91.47 149.37 21.73 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.49 -40.05 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.543 ' H ' HD23 ' A' ' 41' ' ' LEU . 21.2 m120 -80.51 -30.35 37.28 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.55 -31.44 42.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.33 -0.856 . . . . 0.0 112.823 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.42 -40.36 70.51 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.866 0.757 . . . . 0.0 112.107 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -69.46 -24.56 63.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.26 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.09 -35.26 37.2 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.71 -0.619 . . . . 0.0 111.42 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.41 15.15 6.07 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.937 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.6 m -75.07 -36.1 61.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.68 1.24 . . . . 0.0 113.834 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.71 111.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 122.766 1.269 . . . . 0.0 108.815 -165.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.2 m -133.28 115.15 14.59 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.259 18.1 tp -124.63 -52.94 1.69 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.293 -0.963 . . . . 0.0 113.308 -159.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -149.36 169.47 20.75 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.6 49.05 1.5 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.14 -86.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 6' ' ' THR . 93.2 mttt -100.22 62.29 1.1 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -160.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.2 m-85 -112.15 22.06 15.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.827 166.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.48 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -161.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.03 115.53 6.7 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 168.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 14.0 t -119.59 134.51 62.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.601 -164.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -122.46 134.67 54.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.47 110.21 16.65 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.42 102.03 13.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.886 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -120.09 154.59 55.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 CA--C 1.537 0.639 0 C-N-CA 122.114 1.876 . . . . 0.0 115.148 170.45 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 7.7 t80 . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 21.4 Cg_exo -82.16 149.71 15.43 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.773 0.954 . . . . 0.0 111.171 175.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.58 -39.77 94.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.68 -31.43 69.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.5 mt -76.67 -30.29 56.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.445 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.01 -37.59 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.045 1.293 . . . . 0.0 111.226 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.4 p -68.47 -39.15 81.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.112 1.324 . . . . 0.0 112.672 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.19 -39.77 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.912 -0.493 . . . . 0.0 112.201 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -39.34 93.37 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.62 -0.675 . . . . 0.0 112.683 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.95 -29.8 70.76 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.11 -10.02 55.6 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -99.82 16.51 23.46 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.3 mt -131.18 -174.11 3.29 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.526 1.155 . . . . 0.0 110.289 -168.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 67.8 mttm -140.04 174.93 3.53 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -170.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 1.1 Cg_endo -61.4 -16.3 46.41 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 N-CA-C 118.341 2.401 . . . . 0.0 118.341 -170.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -102.27 45.06 0.98 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.467 1.03 . . . . 0.0 110.544 168.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.15 144.22 34.38 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 78.7 p -146.99 109.84 4.68 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.249 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.285 0.6 OUTLIER -93.29 129.96 39.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.805 -173.363 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' HB3' ' A' ' 116' ' ' CYS . 27.6 mm -113.34 84.56 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.471 1.032 . . . . 0.0 108.894 170.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -83.23 0.06 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 121.361 3.304 . . . . 0.0 121.361 -166.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.544 HD12 HD21 ' A' ' 91' ' ' LEU . 4.9 mt -116.36 146.89 42.12 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.636 1.208 . . . . 0.0 110.308 -135.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.2 p -94.61 -129.4 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.535 -156.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.5 -48.51 15.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -158.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.69 -29.52 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 124.555 2.122 . . . . 0.0 111.339 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.612 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 87.0 m-85 -76.73 -14.4 59.95 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.834 -172.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.31 -55.24 37.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.824 -1.173 . . . . 0.0 112.571 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.86 -34.35 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.812 -0.555 . . . . 0.0 111.295 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.35 -42.0 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 173.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.49 -48.66 80.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.882 0.849 . . . . 0.0 112.334 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.15 -35.45 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.212 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -71.57 -18.81 62.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 33.92 3.94 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.673 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.52 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 72.6 m-85 -106.7 159.64 16.06 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.29 104.39 9.1 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.013 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.61 HD11 ' OH ' ' A' ' 115' ' ' TYR . 19.8 tt -83.7 110.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.787 1.28 . . . . 0.0 114.377 -167.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.6 tt -111.64 131.41 63.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 113.183 -1.826 . . . . 0.0 108.928 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -109.42 86.93 2.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 124.059 1.885 . . . . 0.0 112.181 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 114' ' ' ASP . 55.1 mt-10 -134.41 100.49 12.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -54.77 28.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 1 N-CA-C 124.663 4.832 . . . . 0.0 124.663 -144.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.8 p-10 -99.58 100.29 11.28 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 131.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.61 ' OH ' HD11 ' A' ' 109' ' ' ILE . 19.3 t80 -80.05 115.28 19.53 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.907 -0.496 . . . . 0.0 110.763 -164.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.249 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.4 p -147.24 -161.16 1.27 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 124.621 2.153 . . . . 0.0 115.177 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.582 ' CD1' HG13 ' A' ' 109' ' ' ILE . 19.0 m0 -137.4 126.28 24.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 109.71 -3.405 . . . . 0.0 106.462 -167.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.303 0.1 OUTLIER -112.65 111.22 35.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 O-C-N 121.365 -0.834 . . . . 0.0 109.483 177.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -79.1 134.28 36.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.2 ttt . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.539 170.599 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -117.7 141.83 47.95 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -99.98 141.86 32.23 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 162.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.414 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -133.7 -159.47 9.0 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 122.98 1.322 . . . . 0.0 116.243 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.01 139.51 46.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 113.172 -1.514 . . . . 0.0 107.379 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.417 HD11 HG23 ' A' ' 11' ' ' ILE . 20.7 tp -124.6 131.4 53.48 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.292 1.044 . . . . 0.0 108.506 170.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 120.18 38.82 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.133 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 9' ' ' LEU . 6.0 pt -123.54 139.81 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.452 ' HB3' HG23 ' A' ' 64' ' ' THR . 6.0 t60 -90.32 130.01 43.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.13 -18.23 9.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 121.603 3.655 . . . . 0.0 121.603 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.19 71.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 -158.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.16 -27.28 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.26 168.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.6 p -71.52 -14.29 62.07 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.7 m -76.62 -4.03 40.86 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 120.795 1.634 . . . . 0.0 111.933 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.326 96.3 m -98.55 168.18 10.25 Favored Pre-proline 0 CA--C 1.558 1.264 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.42 -0.69 10.87 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 N-CA-C 117.768 2.18 . . . . 0.0 117.768 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.05 -50.54 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.351 1.432 . . . . 0.0 113.952 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.18 -31.51 70.18 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.741 0.7 . . . . 0.0 112.422 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.4 -48.41 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 122.121 -0.362 . . . . 0.0 110.768 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -61.84 -33.25 73.82 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -47.45 60.51 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -63.26 -39.99 96.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.432 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -62.72 -34.75 77.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.684 -0.674 . . . . 0.0 112.776 169.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -44.34 72.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.167 1.349 . . . . 0.0 113.674 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -59.9 -53.16 61.09 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.766 0.317 . . . . 0.0 111.704 173.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -58.6 -37.73 76.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.32 -42.94 19.82 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -170.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.9 p -57.8 -20.14 33.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 170.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.77 -100.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -158.14 19.21 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -170.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.463 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 38.9 t -129.93 110.73 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -167.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -99.09 134.94 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -88.97 139.68 30.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.113 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.83 -31.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.34 -168.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -121.74 120.36 34.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -161.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -114.64 124.59 52.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -165.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -127.47 120.2 27.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.17 149.73 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.427 HD13 ' OH ' ' A' ' 62' ' ' TYR . 4.1 tp -63.21 -39.53 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -77.65 -30.31 52.05 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -80.48 -32.82 37.01 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.392 -0.818 . . . . 0.0 113.043 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -73.89 -40.59 63.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.294 0.952 . . . . 0.0 112.393 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -74.24 -20.43 60.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.768 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.5 -37.37 25.37 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.61 -0.681 . . . . 0.0 111.593 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.75 15.21 6.4 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 120.613 -0.803 . . . . 0.0 114.966 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -76.27 -31.63 58.39 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.813 1.307 . . . . 0.0 114.199 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.73 120.26 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -167.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.5 m -122.59 120.05 32.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.046 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -122.35 -161.65 0.95 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.84 170.02 9.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.82 1.295 . . . . 0.0 111.202 -169.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -115.26 71.6 0.77 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.336 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.94 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 6' ' ' THR . 77.8 mttt -97.13 43.66 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -157.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.434 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.6 m-85 -112.21 21.68 15.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 117.545 -1.217 . . . . 0.0 110.685 -170.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.65 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -158.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' TYR . 7.0 t -134.37 115.31 13.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 164.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 65.9 t -119.43 110.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -163.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -107.63 134.29 50.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.427 ' OH ' HD13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -123.36 110.52 15.26 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.122 -0.986 . . . . 0.0 110.165 177.578 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.94 100.32 8.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 12' ' ' HIS . 63.1 m -119.96 88.63 40.89 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -170.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 CA--C 1.536 0.621 0 C-N-CA 122.185 1.923 . . . . 0.0 111.749 170.231 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 26.2 Cg_exo -82.33 149.91 15.16 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 120.659 0.906 . . . . 0.0 112.088 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -62.45 -35.42 79.23 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -60.34 -34.34 73.7 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.55 -30.4 57.07 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.655 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.9 -38.52 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 120.357 1.435 . . . . 0.0 111.298 171.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 95.2 p -69.18 -40.74 77.94 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.79 1.177 . . . . 0.0 113.11 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.1 -38.64 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.799 -0.563 . . . . 0.0 112.262 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -33.84 71.62 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.82 -29.77 69.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -69.16 -9.83 54.78 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.4 m -97.99 29.83 3.3 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.15 171.02 14.82 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.359 1.076 . . . . 0.0 112.989 -162.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 49.7 mttm -122.39 -158.02 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 170.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 10.7 Cg_endo -67.65 -43.72 5.2 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 119.834 2.974 . . . . 0.0 119.834 -163.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -90.51 63.29 5.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 122.386 2.357 . . . . 0.0 111.495 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.31 133.99 13.61 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 170.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.6 p -139.16 159.27 42.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.175 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.251 1.1 tt -127.94 129.62 47.12 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.862 HD13 ' CB ' ' A' ' 116' ' ' CYS . 24.8 mm -112.3 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.914 0.864 . . . . 0.0 109.41 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.552 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.72 -79.27 0.04 OUTLIER Glycine 0 C--N 1.318 -0.445 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 -161.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.552 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -115.65 171.15 7.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.962 1.363 . . . . 0.0 111.121 -139.175 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 m -92.97 -162.74 0.96 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.178 -1.373 . . . . 0.0 113.318 -164.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.17 -36.49 84.38 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.25 -32.63 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 124.817 2.246 . . . . 0.0 111.283 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.571 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 93.8 m-85 -76.81 -12.23 59.94 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.501 -172.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HG3' HD13 ' A' ' 109' ' ' ILE . 4.5 ttmp? -58.94 -53.63 56.24 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.815 -1.178 . . . . 0.0 112.367 169.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.04 -37.1 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.802 -0.561 . . . . 0.0 111.068 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.571 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.57 -45.57 93.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.92 172.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.02 74.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.871 -0.518 . . . . 0.0 111.72 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.58 -50.1 70.98 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.655 0.74 . . . . 0.0 112.748 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.35 -34.22 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -71.79 -17.8 62.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.69 29.94 5.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 92.2 m-85 -106.46 159.66 15.99 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -127.55 107.6 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.619 HG13 ' CD1' ' A' ' 117' ' ' TRP . 16.9 tt -76.18 149.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.484 1.135 . . . . 0.0 111.914 -167.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.08 125.13 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.47 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -106.48 100.0 9.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.483 1.611 . . . . 0.0 111.302 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -134.06 175.2 3.85 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 112.449 -2.16 . . . . 0.0 107.252 -170.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -54.97 -19.97 21.5 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.82 109.97 19.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 156.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -87.11 111.11 20.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.637 -0.664 . . . . 0.0 109.258 -170.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.175 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 17.6 p -147.26 -157.18 0.79 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 124.251 1.977 . . . . 0.0 112.694 174.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.619 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.4 m0 -137.25 149.93 47.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 110.305 -3.134 . . . . 0.0 104.421 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.74 144.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.363 161.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 10.0 tmtt? -91.64 134.47 34.66 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 108.765 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.665 0.745 . . . . 0.0 110.563 -170.016 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 122.22 1.009 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.3 147.23 24.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.813 1.292 . . . . 0.0 112.419 -165.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -105.21 120.88 42.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.653 170.013 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 59' ' ' THR . . . -129.32 -160.98 10.41 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 118.446 -1.835 . . . . 0.0 115.418 170.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 139.85 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -164.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.371 0.2 OUTLIER -124.8 129.29 50.15 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.143 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -116.04 120.36 38.84 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.29 139.48 51.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.902 0.858 . . . . 0.0 109.681 -167.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -103.19 129.67 25.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -9.32 17.5 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 N-CA-C 122.032 3.82 . . . . 0.0 122.032 -170.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.36 70.04 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.546 2.424 . . . . 0.0 117.546 -158.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.2 t -93.06 -30.69 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.23 0.923 . . . . 0.0 108.809 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.4 p -80.21 0.26 33.22 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -170.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -76.41 9.3 2.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.42 1.463 . . . . 0.0 113.134 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.332 64.2 m -99.03 168.34 9.85 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 164.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -77.45 -3.99 14.21 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 117.734 2.167 . . . . 0.0 117.734 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -50.4 19.23 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -164.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -29.89 67.9 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.886 0.766 . . . . 0.0 112.752 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.7 t -70.4 -44.29 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.498 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.63 -34.1 72.36 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.052 -1.03 . . . . 0.0 113.634 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.44 72.68 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -58.88 -47.85 83.48 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -29.82 70.18 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -47.54 64.6 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.386 0.994 . . . . 0.0 112.815 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.304 1.4 tm0? -54.98 -52.49 62.92 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -33.5 69.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.31 -50.16 19.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.1 m -60.72 -34.67 74.74 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 170.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.94 -131.02 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -145.1 5.71 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.482 HG21 HG21 ' A' ' 59' ' ' THR . 4.1 p -98.93 154.1 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.681 0.753 . . . . 0.0 111.742 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -128.03 142.43 51.23 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 166.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.73 100.65 12.83 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.637 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.18 -30.79 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.749 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.83 169.64 10.57 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.615 1.198 . . . . 0.0 109.769 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -142.68 116.46 9.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -118.73 115.34 24.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.74 149.51 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.452 HD13 ' OH ' ' A' ' 62' ' ' TYR . 2.8 tp -63.63 -40.26 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.08 -30.25 31.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.77 -29.09 18.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.087 0.858 . . . . 0.0 112.785 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -68.84 -40.45 79.42 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.015 1.279 . . . . 0.0 111.471 170.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.17 -27.91 66.83 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.97 19.54 19.89 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.54 11.22 45.11 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 117.459 1.743 . . . . 0.0 117.459 152.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -82.8 -23.6 33.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -167.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 51' ' ' THR . 8.8 mt -114.63 167.82 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.464 1.029 . . . . 0.0 110.364 -161.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.46 ' N ' HG22 ' A' ' 50' ' ' ILE . 7.4 m -99.73 117.42 34.05 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.718 1.247 . . . . 0.0 110.488 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -96.83 120.35 37.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.242 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -107.58 120.27 41.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 166.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -84.83 67.8 10.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.461 -170.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -74.32 0.07 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 6' ' ' THR . 49.8 mttp -100.27 45.78 0.97 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -160.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.27 21.48 15.74 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.701 165.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 86' ' ' LYS . 8.9 mm-40 -61.67 58.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 171.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.482 HG21 HG21 ' A' ' 34' ' ' VAL . 10.7 t -146.69 113.12 5.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 144.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.91 134.15 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 -170.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.58 134.56 54.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 167.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.452 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -120.79 110.74 16.72 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.965 0.888 . . . . 0.0 109.314 178.343 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.45 100.39 11.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.575 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -125.67 107.39 26.19 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.537 0.644 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 -162.226 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.1 t80 . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.92 149.7 50.39 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.714 1.609 . . . . 0.0 112.243 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.42 -31.91 72.68 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.69 -33.95 70.73 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.4 mt -76.79 -30.23 56.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.017 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -37.22 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 119.325 0.966 . . . . 0.0 111.382 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 97.1 p -70.52 -39.71 73.91 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.812 1.187 . . . . 0.0 112.717 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.03 -46.26 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.562 0.619 . . . . 0.0 111.448 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.05 -30.54 65.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.59 70.72 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -80.77 -9.94 59.77 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -171.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 p -97.74 50.95 1.05 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.1 159.93 28.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -156.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.513 ' H ' ' HG3' ' A' ' 58' ' ' GLU . 69.4 mmtt -100.5 174.9 2.65 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 110.67 -2.968 . . . . 0.0 106.417 163.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 14.2 Cg_endo -53.21 -28.53 42.53 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 118.629 2.511 . . . . 0.0 118.629 170.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -102.07 70.93 1.23 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.266 . . . . 0.0 110.968 170.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.43 131.74 24.64 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 163.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -147.44 120.21 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.607 1.194 . . . . 0.0 108.241 -170.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.199 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.254 0.5 OUTLIER -106.36 129.96 54.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.195 -166.908 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.718 HD13 ' CB ' ' A' ' 116' ' ' CYS . 26.3 mm -111.21 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.963 1.256 . . . . 0.0 108.269 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.92 -94.46 0.19 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 121.579 3.392 . . . . 0.0 121.579 -166.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.717 HD22 HD21 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.48 146.83 41.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.867 -137.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.3 m -107.21 -130.14 0.29 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.078 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.95 128.48 33.73 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.68 -13.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 2 O-C-N 114.952 -4.842 . . . . 0.0 117.848 11.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.764 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.3 m-85 -76.26 -0.79 23.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.591 -2.095 . . . . 0.0 113.155 -152.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.66 -55.74 10.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.74 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.58 -33.75 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.984 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.764 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.26 -41.42 96.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.311 -0.956 . . . . 0.0 113.123 172.513 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.694 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -59.71 -42.89 94.07 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.929 -0.482 . . . . 0.0 111.246 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 tp -55.86 -50.06 71.63 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.619 0.723 . . . . 0.0 112.419 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.1 tt -80.04 -34.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.567 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.63 -16.21 62.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.29 4.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.076 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 76.7 m-85 -106.47 159.7 15.96 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.11 154.17 32.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 102' ' ' ALA . 17.0 mt -104.32 153.25 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.98 1.371 . . . . 0.0 109.899 -171.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.7 tp -151.16 135.0 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.779 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -115.99 88.36 2.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.006 1.86 . . . . 0.0 112.295 -171.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 114' ' ' ASP . 46.1 mt-10 -134.34 100.38 12.74 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -54.95 29.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.102 1 N-CA-C 124.372 4.72 . . . . 0.0 124.372 -141.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 112' ' ' GLU . 12.4 m-20 -99.86 105.63 17.39 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 132.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -79.86 115.36 19.4 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.816 -0.552 . . . . 0.0 110.052 -166.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.199 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.79 -161.31 1.3 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 124.143 1.925 . . . . 0.0 115.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.673 ' CD1' HG12 ' A' ' 109' ' ' ILE . 24.5 m0 -137.05 149.71 47.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 110.384 -3.098 . . . . 0.0 103.905 -165.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.4 mm -110.97 144.72 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 162.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 9.2 tmtt? -93.72 110.01 21.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 18.6 mmt . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 122.017 0.913 . . . . 0.0 112.2 -168.451 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.76 141.84 48.25 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.122 -0.986 . . . . 0.0 111.134 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -96.95 141.42 30.15 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.15 -161.74 9.71 Favored Glycine 0 N--CA 1.466 0.696 0 CA-C-O 124.196 1.998 . . . . 0.0 116.319 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.22 143.77 48.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 110.922 -2.639 . . . . 0.0 107.437 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 136.11 54.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.394 1.092 . . . . 0.0 109.106 170.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mt -113.67 120.2 40.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.104 -1.407 . . . . 0.0 107.657 164.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.62 139.8 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -95.48 129.47 34.78 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 165.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.44 -9.53 18.26 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 N-CA-C 120.872 3.374 . . . . 0.0 120.872 -170.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 -50.31 64.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -161.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -87.33 -29.05 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.119 170.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.1 p -80.78 0.48 34.56 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -170.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.2 m -76.2 0.09 20.32 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 120.197 1.362 . . . . 0.0 111.599 166.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 m -114.26 71.36 2.17 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 161.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.72 52.85 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.038 3.158 . . . . 0.0 116.808 -154.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.96 -39.85 79.24 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.671 -1.268 . . . . 0.0 112.233 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.43 -29.96 68.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.77 -46.5 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 122.227 -0.296 . . . . 0.0 110.939 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.76 -38.48 78.57 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -66.89 -49.97 63.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.9 t -61.82 -38.63 88.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.376 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -63.71 -34.45 77.89 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.15 -40.54 78.13 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -64.25 -51.9 61.32 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.04 -0.412 . . . . 0.0 111.631 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.6 75.13 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.49 73.53 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -75.04 -22.6 58.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.092 0.86 . . . . 0.0 112.223 -170.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.87 -103.77 0.06 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.306 0.574 . . . . 0.0 109.809 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -161.81 10.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -166.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.67 149.71 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.877 0.846 . . . . 0.0 112.196 170.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -128.58 136.12 50.29 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -88.91 139.58 30.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.849 0.833 . . . . 0.0 108.758 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.05 -41.12 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.536 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -121.94 169.83 10.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.579 1.18 . . . . 0.0 111.176 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -137.28 125.12 22.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.282 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -121.59 149.12 43.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 117.301 -1.759 . . . . 0.0 109.189 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -123.47 111.27 16.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.6 tp -49.8 -35.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.23 -30.37 43.19 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.802 1.183 . . . . 0.0 113.737 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -81.76 -28.94 33.02 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.227 -0.92 . . . . 0.0 113.139 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.45 -40.6 85.42 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.3 0.955 . . . . 0.0 112.057 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -70.32 -23.34 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.97 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.02 -37.66 33.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.49 -0.756 . . . . 0.0 111.493 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.22 15.27 5.16 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -72.32 -28.27 62.96 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -114.81 120.46 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.737 0.78 . . . . 0.0 109.254 -165.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -108.02 120.37 42.12 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.505 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.679 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 15.2 tp -120.52 -165.95 1.26 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.933 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.679 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 48.1 mt-10 -98.62 -176.02 3.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.611 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -120.15 65.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.11 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 6' ' ' THR . 78.4 mttt -100.04 53.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -159.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.2 m-85 -112.63 21.74 15.29 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 116.903 -1.522 . . . . 0.0 112.079 166.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 1.2 pm0 -61.81 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -162.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.11 115.47 6.65 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 164.476 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.2 134.66 52.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -122.53 134.86 54.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 141.34 52.07 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.03 1.741 . . . . 0.0 109.286 164.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.0 tp -124.56 90.44 3.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.724 -170.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.5 m -138.01 114.46 9.21 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo . . . . . 0 CA--C 1.533 0.468 0 C-N-CA 122.509 2.14 . . . . 0.0 115.941 -170.095 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 5.5 t80 . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 111.571 0.211 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 17.4 Cg_exo -82.14 149.93 15.55 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.206 1.271 . . . . 0.0 111.207 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -62.35 -37.16 84.59 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.59 -30.88 70.1 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -76.81 -30.09 56.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.4 mt -64.4 -35.03 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 119.915 1.234 . . . . 0.0 111.63 168.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.5 p -69.56 -36.57 76.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.505 1.502 . . . . 0.0 112.688 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.34 -39.62 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.751 -0.593 . . . . 0.0 111.728 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -61.96 -40.87 97.05 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.698 -0.626 . . . . 0.0 112.655 174.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.85 70.76 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.12 -10.09 59.17 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.1 m -100.32 28.52 4.92 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mp -134.26 160.03 39.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 122.59 1.186 . . . . 0.0 111.238 -164.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -105.18 174.92 2.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.37 166.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.54 -25.33 32.21 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 118.581 2.493 . . . . 0.0 118.581 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.65 57.38 1.15 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.774 1.17 . . . . 0.0 110.208 168.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.9 145.98 36.01 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 167.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.6 p -141.62 159.27 42.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.234 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.343 1.7 tm? -128.19 129.48 46.54 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -170.554 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' HB3' ' A' ' 116' ' ' CYS . 44.2 mm -121.03 79.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.632 1.56 . . . . 0.0 110.019 170.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.25 -83.24 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 120.518 2.967 . . . . 0.0 120.518 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 91' ' ' LEU . 1.1 mt -116.54 146.93 42.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.486 -1.357 . . . . 0.0 111.024 -132.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -102.41 -109.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.068 -156.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.26 -60.19 2.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -157.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 mt -61.13 -26.63 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 124.253 1.978 . . . . 0.0 111.605 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 10.5 m-85 -76.56 -19.77 57.55 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.987 -171.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.37 -56.18 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.965 -1.085 . . . . 0.0 113.013 168.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.07 -35.23 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.824 -0.548 . . . . 0.0 111.324 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -58.63 -45.34 89.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 171.229 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.405 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . . . -57.52 -43.78 84.58 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.569 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -54.96 -49.88 70.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 112.72 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.3 tt -80.24 -34.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.72 30.51 5.19 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.076 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 47.7 m-85 -106.62 159.5 16.15 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 168.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.26 110.22 15.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 117' ' ' TRP . 15.2 tt -74.92 148.55 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 122.487 1.137 . . . . 0.0 111.873 -171.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -149.65 126.98 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.97 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -109.65 98.81 8.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 123.418 1.58 . . . . 0.0 111.582 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -134.31 178.45 1.76 Allowed Pre-proline 0 N--CA 1.472 0.652 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.148 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.55 -7.99 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 N-CA-C 118.732 2.551 . . . . 0.0 118.732 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -128.4 115.23 17.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 157.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -85.44 111.29 19.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.227 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.234 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 19.9 p -147.24 -158.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 124.424 2.059 . . . . 0.0 113.672 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.618 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.0 m0 -137.15 149.89 47.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 110.096 -3.229 . . . . 0.0 104.213 -169.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.43 144.59 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 164.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 16.1 ttpt -94.5 110.37 22.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.975 -1.078 . . . . 0.0 109.873 167.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 109.501 -170.341 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -96.61 141.95 29.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.744 1.259 . . . . 0.0 112.929 -160.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -98.38 120.45 38.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.525 169.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.0 -164.92 11.02 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.889 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.42 141.65 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -164.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -124.13 134.79 53.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.945 1.355 . . . . 0.0 107.855 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -122.7 120.07 32.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.761 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mt -118.14 139.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.21 129.71 24.65 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 165.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -59.85 -13.61 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 N-CA-C 121.48 3.608 . . . . 0.0 121.48 -170.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.54 60.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -161.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.1 m -88.92 -27.78 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.914 0.779 . . . . 0.0 110.715 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -76.36 -14.46 60.09 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -170.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.87 2.23 15.2 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.264 1.393 . . . . 0.0 112.067 -170.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.304 86.1 m -98.85 168.62 9.44 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 166.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -77.18 -9.24 17.76 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 118.298 2.384 . . . . 0.0 118.298 -170.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.43 -50.47 18.31 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -165.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.16 -29.81 67.91 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.744 0.702 . . . . 0.0 112.417 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.15 -50.01 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.852 -0.53 . . . . 0.0 110.453 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.45 -36.99 79.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -60.07 -50.03 75.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 t -66.4 -39.8 89.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.786 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -61.8 -33.3 73.88 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -36.33 77.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -60.17 -56.9 15.93 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.991 -0.443 . . . . 0.0 111.172 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.2 77.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.97 63.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 95.7 p -59.85 -28.6 67.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 170.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -85.92 -124.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.616 -0.678 . . . . 0.0 110.017 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -136.27 9.95 3.23 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -170.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.63 150.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.596 0.712 . . . . 0.0 109.884 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -128.24 136.55 51.2 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 163.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.91 100.87 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.211 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -81.47 -24.52 10.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.429 -1.714 . . . . 0.0 114.409 -164.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -121.71 169.75 10.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.279 1.038 . . . . 0.0 111.299 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -146.89 125.23 12.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.818 -169.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.444 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 31.0 m-85 -130.99 149.94 52.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.42 156.67 20.49 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.03 -40.08 87.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.147 -0.971 . . . . 0.0 113.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -82.02 -30.34 31.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -82.83 -30.48 28.69 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.403 1.001 . . . . 0.0 112.967 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.409 HD13 ' CD1' ' A' ' 40' ' ' PHE . 18.4 tp -71.92 -40.56 68.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.207 0.912 . . . . 0.0 112.364 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -74.99 -19.47 60.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.767 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.28 -37.33 21.82 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.798 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.54 15.09 8.37 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -79.6 -17.63 53.44 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.4 mt -114.93 120.38 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.0 m -110.82 107.94 17.6 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.29 1.043 . . . . 0.0 110.929 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -131.15 172.99 11.48 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.435 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.16 177.69 5.32 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.833 -1.167 . . . . 0.0 110.477 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -120.03 70.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.037 -158.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.02 -83.37 0.06 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 6' ' ' THR . 31.6 pttt -99.91 45.15 0.99 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -156.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 59' ' ' THR . 4.4 m-85 -112.24 21.77 15.45 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 116.325 -1.798 . . . . 0.0 112.041 -170.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.38 42.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -155.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 57' ' ' TYR . 10.3 t -141.64 115.11 8.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 159.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 100.679 -3.823 . . . . 0.0 100.679 -170.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.24 134.53 54.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 167.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.48 110.7 16.79 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.267 18.5 tp -97.61 114.05 25.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.186 0.993 . . . . 0.0 111.507 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.401 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 27.7 m -149.28 154.88 39.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 79.7 Cg_exo . . . . . 0 CA--C 1.536 0.575 0 C-N-CA 122.215 1.943 . . . . 0.0 114.013 170.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 34.9 Cg_exo -82.12 149.53 15.46 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 CA-C-N 121.071 1.418 . . . . 0.0 110.158 -173.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.65 -36.14 81.89 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -35.69 74.9 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.82 -30.19 56.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.099 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.08 -38.2 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 119.777 1.171 . . . . 0.0 111.133 168.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.7 m -68.02 -37.24 81.18 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.347 0.976 . . . . 0.0 112.634 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.28 -41.52 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.263 0.483 . . . . 0.0 111.808 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.84 -41.22 97.88 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.44 1.018 . . . . 0.0 112.362 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.93 -29.82 70.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.79 -9.94 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.7 m -84.96 -18.11 35.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.68 170.6 9.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 120.06 1.3 . . . . 0.0 111.914 -164.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 75.5 mttt -108.61 -164.9 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -170.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 12.9 Cg_endo -62.94 -29.73 76.22 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 123.159 2.164 . . . . 0.0 113.715 -170.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -102.07 41.27 1.23 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.46 145.68 29.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -147.13 117.52 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.363 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.278 0.6 OUTLIER -89.53 143.86 26.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.826 -1.988 . . . . 0.0 107.334 -173.279 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.966 HD13 ' CB ' ' A' ' 116' ' ' CYS . 46.4 mm -128.07 88.84 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.858 1.208 . . . . 0.0 108.868 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.46 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -144.15 -76.56 0.03 OUTLIER Glycine 0 C--N 1.316 -0.539 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.46 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.276 4.2 mp -115.56 169.89 8.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 122.688 1.233 . . . . 0.0 109.336 -129.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.81 -120.71 0.29 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.932 -157.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.1 -53.66 6.49 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 121.216 1.825 . . . . 0.0 115.792 -158.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.83 -29.9 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 124.86 2.267 . . . . 0.0 111.903 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.8 m-85 -76.97 -20.44 56.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.29 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -53.89 -55.36 27.58 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.797 -1.189 . . . . 0.0 112.427 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.12 -32.73 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.885 -0.51 . . . . 0.0 111.667 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.74 -43.79 97.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 173.157 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.4 88.94 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.05 -48.96 78.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.789 0.804 . . . . 0.0 112.526 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.17 -35.36 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.115 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -71.81 -17.59 62.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.7 31.6 4.78 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 119.285 -1.436 . . . . 0.0 112.523 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 50.6 m-85 -106.6 159.52 16.13 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -124.61 103.69 8.28 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.5 tt -78.67 142.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 122.707 1.242 . . . . 0.0 111.62 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.07 127.85 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.401 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -109.78 100.07 9.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.529 -1.668 . . . . 0.0 110.509 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.6 -174.86 0.29 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.353 170.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -56.37 -10.54 4.95 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 N-CA-C 118.935 2.629 . . . . 0.0 118.935 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -119.39 149.56 41.63 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 154.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.548 ' OH ' HD11 ' A' ' 109' ' ' ILE . 22.5 t80 -113.68 114.73 26.79 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 -170.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.363 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 28.1 p -147.73 -156.31 0.71 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.973 1.368 . . . . 0.0 114.651 170.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.618 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.9 m0 -137.21 127.7 26.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.919 -1.946 . . . . 0.0 108.28 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -108.78 110.83 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.56 -1.338 . . . . 0.0 110.183 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -79.58 110.07 14.55 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.104 0.954 . . . . 0.0 111.167 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.728 -170.296 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -106.53 142.03 36.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 122.375 1.083 . . . . 0.0 111.834 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.1 t -103.02 120.74 41.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 168.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.34 -159.6 10.07 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 118.405 -1.855 . . . . 0.0 113.32 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.25 144.46 48.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -170.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.26 0.1 OUTLIER -124.51 129.41 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 172.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -111.53 120.15 41.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.074 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.407 HG22 ' HB2' ' A' ' 63' ' ' LEU . 2.3 pt -124.52 139.63 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.405 ' CD2' HG23 ' A' ' 64' ' ' THR . 6.3 t60 -97.24 130.34 29.88 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -54.5 -20.73 21.67 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 N-CA-C 120.931 3.396 . . . . 0.0 120.931 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.73 72.68 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.977 1.717 . . . . 0.0 112.669 -164.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -96.07 -29.53 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -171.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.5 p -85.99 0.02 54.35 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -170.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.2 m -76.46 -5.06 45.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.431 1.469 . . . . 0.0 112.816 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.315 79.7 m -98.7 168.08 10.37 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 167.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.63 -9.45 17.19 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 N-CA-C 117.598 2.115 . . . . 0.0 117.598 -170.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.06 -50.19 20.74 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -163.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.08 -31.83 70.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.784 0.72 . . . . 0.0 112.057 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.45 -47.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.637 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.13 -33.89 74.12 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.93 -47.91 60.57 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -62.62 -39.71 94.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.54 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.01 -31.89 73.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.01 -45.97 69.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.11 1.323 . . . . 0.0 112.332 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.03 -51.25 66.87 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.93 82.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.19 -50.08 13.74 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 t -57.94 -28.18 64.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 170.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.99 -127.87 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.495 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -130.05 6.78 5.03 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -104.45 150.82 7.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.863 0.84 . . . . 0.0 109.98 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -127.99 141.11 51.62 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 164.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -100.32 100.51 11.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.006 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.78 -28.89 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.995 -163.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -121.91 169.63 10.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.329 1.062 . . . . 0.0 110.395 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -147.7 111.6 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -160.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.405 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 13.7 m-30 -119.01 120.47 37.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.5 mt -86.31 149.65 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.15 -39.73 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -78.03 -30.42 49.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.39 -25.48 29.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.492 1.042 . . . . 0.0 113.225 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -70.27 -40.19 74.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.842 1.201 . . . . 0.0 111.924 173.101 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -74.0 -21.07 60.13 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -88.3 -45.94 9.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.415 -0.803 . . . . 0.0 111.992 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.87 15.19 2.16 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 171.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -76.86 -13.55 59.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 120.213 2.006 . . . . 0.0 115.608 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.67 121.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.0 t -98.83 159.35 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 124.245 1.974 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.2 tp -130.44 120.54 24.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.217 -2.72 . . . . 0.0 111.309 -151.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.57 116.07 30.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.564 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -91.44 80.23 5.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.067 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.98 -78.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.16 14.2 20.81 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -155.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.6 m-85 -83.43 21.49 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.966 -170.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.65 27.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 57' ' ' TYR . 10.1 t -126.51 113.08 16.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.226 1.013 . . . . 0.0 108.938 160.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 91' ' ' LEU . 1.2 t -107.65 110.33 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -170.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -97.77 134.25 41.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.61 141.37 46.47 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 168.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 11' ' ' ILE . 30.7 mt -123.83 91.27 3.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.175 170.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 ' CD2' ' A' ' 12' ' ' HIS . 86.1 m -129.5 88.33 50.46 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.768 1.167 . . . . 0.0 110.015 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 CA--C 1.537 0.646 0 C-N-CA 121.911 1.741 . . . . 0.0 110.333 169.916 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -82.27 149.54 15.18 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 CA-C-N 120.626 1.259 . . . . 0.0 111.153 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ptmm? -62.48 -35.78 80.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.69 -28.36 69.01 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.69 -30.35 56.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.789 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.4 -38.17 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 120.391 1.451 . . . . 0.0 110.977 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.1 t -66.86 -43.28 83.98 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.504 1.047 . . . . 0.0 112.716 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.15 -39.9 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.42 -37.85 83.7 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.245 0.929 . . . . 0.0 112.42 174.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.47 -29.85 68.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.284 0.947 . . . . 0.0 113.456 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.77 -10.06 59.36 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.9 m -99.46 14.93 28.1 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.7 mt -134.14 -175.95 4.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.165 0.983 . . . . 0.0 111.556 -159.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -117.75 174.88 2.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.73 -28.62 30.67 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 119.525 2.856 . . . . 0.0 119.525 170.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.43 54.45 0.79 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.191 1.359 . . . . 0.0 108.356 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.17 138.58 21.47 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.3 p -142.91 104.36 4.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.419 ' HA ' HG12 ' A' ' 60' ' ' VAL 0.274 3.9 tt -89.86 129.46 36.23 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 4.6 mp -114.24 85.4 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 -170.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.39 -80.97 0.05 OUTLIER Glycine 0 N--CA 1.464 0.505 0 N-CA-C 121.769 3.468 . . . . 0.0 121.769 -155.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.441 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.259 0.8 OUTLIER -115.5 169.96 8.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.567 1.175 . . . . 0.0 110.058 -139.909 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.7 t -102.36 -148.84 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.113 -157.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.77 -42.59 24.19 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.08 -32.79 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 125.126 2.394 . . . . 0.0 112.96 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 75.7 m-85 -76.28 -10.27 59.28 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 112.941 -1.936 . . . . 0.0 110.093 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.8 tttt -59.32 -50.24 74.75 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.675 -1.266 . . . . 0.0 112.388 168.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -35.55 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.064 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.652 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.34 -47.83 84.36 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 171.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.98 -42.81 80.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.191 0.52 . . . . 0.0 111.949 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.4 tp -60.73 -44.83 96.17 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.0 mt -79.71 -35.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.922 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -71.7 -18.46 62.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 30.04 5.32 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.648 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.3 m-85 -106.66 159.78 15.95 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.122 0.963 . . . . 0.0 108.663 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.42 105.26 9.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.568 HG13 ' CD1' ' A' ' 117' ' ' TRP . 17.3 tt -75.49 146.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.058 -168.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.935 HG13 ' HB2' ' A' ' 116' ' ' CYS . 26.8 pt -143.16 134.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.582 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -112.2 100.13 8.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.04 1.4 . . . . 0.0 110.268 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.62 172.92 5.79 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 113.408 -1.724 . . . . 0.0 108.099 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.46 -8.86 2.06 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.12 115.38 22.34 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 158.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -79.87 142.42 35.24 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.816 -166.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.935 ' HB2' HG13 ' A' ' 110' ' ' ILE 1.064 0.5 OUTLIER -126.39 173.63 9.2 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 113.919 -2.943 . . . . 0.0 111.655 -175.114 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.568 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.0 m0 -137.4 130.23 30.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.993 2.117 . . . . 0.0 105.79 139.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.329 0.2 OUTLIER -110.14 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.207 -0.933 . . . . 0.0 111.265 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -78.19 134.86 37.56 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 123.37 1.557 . . . . 0.0 108.536 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 111.883 -2.417 . . . . 0.0 114.407 -157.792 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.144 0.973 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 34' ' ' VAL . 98.5 mttt -96.95 103.85 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.927 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.7 t -76.39 141.31 41.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 118.756 -1.177 . . . . 0.0 107.99 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.62 -161.92 9.89 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.49 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -134.23 141.21 46.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.283 -1.458 . . . . 0.0 107.53 -171.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.9 tp -124.17 130.56 52.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.615 1.198 . . . . 0.0 109.236 173.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.12 120.52 42.09 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.153 173.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.6 mt -125.13 111.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -167.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.24 129.46 51.55 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -62.98 -10.08 19.15 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 N-CA-C 121.69 3.688 . . . . 0.0 121.69 -169.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.16 -50.36 55.01 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -161.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -86.08 -31.78 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.963 170.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.9 p -81.79 0.39 39.46 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -170.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -76.53 20.05 0.24 Allowed 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 120.437 1.471 . . . . 0.0 112.296 166.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 m -133.2 71.48 76.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 170.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.08 50.56 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.194 3.263 . . . . 0.0 116.845 -155.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -72.97 -45.62 56.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.039 -1.038 . . . . 0.0 111.585 162.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.4 mt -57.98 -34.91 70.48 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.0 t -64.39 -49.25 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.24 175.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.74 -36.45 81.03 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -63.89 -49.45 72.62 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.7 t -63.84 -40.35 96.38 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.014 0.824 . . . . 0.0 111.316 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -65.03 -30.91 71.92 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -44.78 71.15 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.71 1.141 . . . . 0.0 113.653 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -58.36 -53.14 61.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.565 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.85 68.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.36 18.28 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.0 p -57.94 -27.38 63.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 170.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.87 -125.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -146.46 14.6 1.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.981 0.896 . . . . 0.0 113.223 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 5' ' ' LYS . 10.4 t -98.83 149.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.011 170.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -128.39 134.76 48.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 161.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -91.21 100.61 13.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.16 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.63 -17.09 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.589 -1.642 . . . . 0.0 113.928 -162.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.56 169.7 10.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.239 1.019 . . . . 0.0 109.644 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -143.39 125.22 15.11 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.372 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.416 ' CD1' HD21 ' A' ' 8' ' ' LEU . 2.9 m-85 -129.59 120.4 25.23 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.89 149.68 22.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp -63.3 -40.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -81.95 -30.47 31.72 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -82.12 -29.49 31.64 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.305 -0.872 . . . . 0.0 112.652 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.83 -40.66 68.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.367 0.985 . . . . 0.0 112.739 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -76.78 -16.9 59.33 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.668 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.05 -37.45 29.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.545 -0.722 . . . . 0.0 111.43 166.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.67 15.4 5.84 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -78.54 -24.92 45.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mt -114.81 120.3 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -120.08 120.2 35.55 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.786 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.469 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 11.8 tp -130.99 174.44 10.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.132 0.968 . . . . 0.0 109.575 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.469 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 46.5 mt-10 -98.94 175.05 6.07 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.692 1.234 . . . . 0.0 111.724 -170.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.1 m-20 -91.41 94.06 9.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.981 -170.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.69 -147.2 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -165.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -100.08 35.0 2.16 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.64 -163.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.8 m-85 -81.94 21.66 0.85 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.081 -170.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.52 27.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' TYR . 9.8 t -129.32 115.06 17.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 162.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.26 94.04 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -162.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -97.85 134.37 41.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.36 142.43 38.7 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 170.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.6 tp -122.99 108.98 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.872 0.844 . . . . 0.0 109.603 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.405 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 25.5 m -143.97 154.93 59.01 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -170.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 82.9 Cg_exo . . . . . 0 CA--C 1.536 0.577 0 C-N-CA 122.291 1.994 . . . . 0.0 114.702 170.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -82.34 149.71 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 CA-C-N 119.701 0.929 . . . . 0.0 110.587 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.48 -36.59 82.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.738 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.49 -30.1 71.02 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.6 mt -76.68 -30.14 56.61 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.268 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.26 -36.66 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 119.845 1.202 . . . . 0.0 111.061 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.8 m -66.93 -40.57 87.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.694 1.134 . . . . 0.0 112.717 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.81 -35.76 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 122.025 -0.422 . . . . 0.0 111.991 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -59.87 -47.73 84.57 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.698 -0.626 . . . . 0.0 111.498 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.3 -30.87 71.37 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.33 -10.55 59.84 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -166.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 72.1 p -74.53 -33.13 62.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 165.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 mt -88.66 -170.66 3.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 122.283 1.039 . . . . 0.0 112.079 -159.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -134.26 174.92 4.1 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -52.39 -22.39 15.98 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 N-CA-C 120.292 3.151 . . . . 0.0 120.292 -170.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -102.12 46.57 0.92 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.26 1.391 . . . . 0.0 111.096 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.44 140.67 28.64 Favored Glycine 0 N--CA 1.467 0.737 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -147.04 120.17 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.214 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.433 1.9 tm? -98.4 129.55 45.04 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 111.641 -2.527 . . . . 0.0 104.705 -167.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.089 HD13 ' HB3' ' A' ' 116' ' ' CYS . 44.2 mm -119.38 85.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.584 1.538 . . . . 0.0 109.804 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.04 -79.11 0.04 OUTLIER Glycine 0 N--CA 1.464 0.528 0 N-CA-C 120.878 3.111 . . . . 0.0 120.878 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.605 HD12 HD11 ' A' ' 91' ' ' LEU . 1.5 mp -115.88 169.99 8.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.669 -133.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.2 p -114.93 -123.4 0.29 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.355 -0.84 . . . . 0.0 113.185 -156.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.51 -51.02 11.4 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -157.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -60.35 -30.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.877 1.798 . . . . 0.0 111.266 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 77.7 m-85 -76.82 -16.63 59.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.581 -172.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.2 tttt -57.12 -55.13 38.76 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.373 -0.829 . . . . 0.0 112.277 169.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.93 -33.47 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.987 -0.446 . . . . 0.0 111.376 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.41 -45.28 95.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.02 84.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.34 -48.66 79.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.728 0.775 . . . . 0.0 112.554 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.6 tt -80.22 -35.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.309 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -71.63 -16.14 62.27 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.49 5.58 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 119.373 -1.394 . . . . 0.0 112.805 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 96.6 m-85 -106.63 159.58 16.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.79 108.79 11.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.669 HD11 ' OH ' ' A' ' 115' ' ' TYR . 18.1 tt -84.88 142.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.49 1.138 . . . . 0.0 112.569 -165.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.3 pt -147.13 135.07 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.579 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -126.61 100.14 6.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.002 1.858 . . . . 0.0 112.965 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.44 87.97 30.95 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.8 61.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 122.151 3.866 . . . . 0.0 122.151 -123.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -123.4 104.85 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.255 -2.869 . . . . 0.0 103.255 142.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.669 ' OH ' HD11 ' A' ' 109' ' ' ILE . 15.7 t80 -82.91 111.33 18.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -159.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.214 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.3 p -147.39 -156.75 0.74 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 125.061 2.362 . . . . 0.0 113.754 171.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.635 ' CD1' HG13 ' A' ' 109' ' ' ILE . 24.9 m0 -137.08 149.79 47.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 109.16 -3.654 . . . . 0.0 102.901 -167.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 144.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 6.2 ttpm? -88.44 134.92 33.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.532 0.682 . . . . 0.0 111.715 -171.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 -170.223 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 2.8 t80 . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.616 0.246 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.82 155.12 38.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.96 0.886 . . . . 0.0 110.582 -166.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -77.56 141.62 39.46 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.474 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -133.7 -162.97 10.24 Favored Glycine 0 N--CA 1.466 0.678 0 C-N-CA 119.421 -1.371 . . . . 0.0 114.759 173.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.28 139.85 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.117 -1.542 . . . . 0.0 107.925 -171.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -124.33 132.88 53.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.162 0.982 . . . . 0.0 108.843 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.65 149.65 27.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.253 165.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.48 143.2 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -111.22 129.59 23.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -60.16 -17.41 45.69 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 N-CA-C 120.261 3.139 . . . . 0.0 120.261 -170.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.25 67.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -161.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.97 -28.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.357 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.8 p -77.14 -11.92 59.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -170.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.6 m -76.63 -1.5 27.96 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.697 1.59 . . . . 0.0 111.718 -170.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 19' ' ' PRO 0.336 91.3 m -98.78 168.73 9.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 167.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' THR . 95.0 Cg_exo -75.82 -8.69 19.29 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 N-CA-C 118.019 2.277 . . . . 0.0 118.019 -170.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.15 -50.1 20.86 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -163.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.99 -32.94 72.87 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.74 0.7 . . . . 0.0 112.16 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.93 -46.6 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.686 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -62.61 -34.01 76.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.65 -49.07 57.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.5 t -61.52 -41.49 97.39 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.191 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.13 -33.76 76.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.735 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.75 73.18 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.196 1.362 . . . . 0.0 113.598 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -56.93 -54.91 41.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.75 0.309 . . . . 0.0 111.586 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.24 -43.35 78.56 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.35 47.25 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.9 p -57.89 -36.47 72.45 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.86 -94.64 0.1 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.958 0.885 . . . . 0.0 110.351 -170.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' CG ' ' A' ' 4' ' ' TYR . 44.4 mmtm -129.88 -42.09 1.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.285 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.251 59.5 t -97.64 149.96 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 123.256 1.503 . . . . 0.0 112.594 -160.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -121.35 134.96 55.14 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.222 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -95.38 139.75 31.23 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.72 -24.7 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -170.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -121.52 169.73 10.38 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.63 1.205 . . . . 0.0 110.286 -174.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -147.34 125.57 12.22 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 114.249 -1.342 . . . . 0.0 108.85 -168.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -133.04 120.28 21.13 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.657 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.8 tt -92.58 149.45 21.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.16 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.54 ' H ' HD23 ' A' ' 41' ' ' LEU . 22.0 t-20 -79.4 -30.2 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.315 -0.866 . . . . 0.0 113.021 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.19 -37.55 45.4 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.153 -0.967 . . . . 0.0 112.662 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.2 tp -68.57 -40.62 80.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.549 0.69 . . . . 0.0 112.8 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -73.5 -21.2 60.48 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.835 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -83.75 -36.1 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.541 -0.725 . . . . 0.0 112.047 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.56 15.33 6.44 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.329 0.892 . . . . 0.0 115.329 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -76.09 -35.66 59.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.849 1.324 . . . . 0.0 113.689 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.9 mt -114.69 120.35 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -168.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.7 m -129.8 120.21 24.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.596 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 38' ' ' ASP . 93.3 mt -119.6 179.9 4.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.849 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.79 175.32 6.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.608 1.194 . . . . 0.0 111.763 -168.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.8 m-20 -89.32 93.34 9.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.553 -170.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.82 -147.42 0.25 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -165.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -100.1 37.57 1.63 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.168 0.985 . . . . 0.0 113.243 -162.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.6 m-85 -82.28 21.74 0.9 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 117.191 -1.385 . . . . 0.0 112.259 -170.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.23 27.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -157.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.474 HG23 ' HA3' ' A' ' 7' ' ' GLY . 7.8 t -128.45 115.12 17.7 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 162.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 36.5 t -113.74 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -167.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -111.05 134.67 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.06 141.86 50.94 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.0 tp -123.78 94.28 4.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -170.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -140.47 154.72 69.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -170.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 CA--C 1.535 0.535 0 C-N-CA 122.824 2.35 . . . . 0.0 114.676 170.252 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.7 t80 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.935 -0.024 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 19.8 Cg_exo -82.7 151.86 14.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 121.757 1.638 . . . . 0.0 112.246 170.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -62.46 -34.26 76.45 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 166.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.13 -34.5 76.48 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.7 -30.07 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.683 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.409 HG13 ' CE2' ' A' ' 73' ' ' PHE . 96.8 mt -59.34 -41.05 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 119.608 1.095 . . . . 0.0 111.155 167.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -64.76 -40.34 95.12 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.963 -1.086 . . . . 0.0 112.823 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -64.17 -37.18 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.91 -42.56 94.14 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.446 -0.784 . . . . 0.0 112.384 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.47 -29.8 70.84 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -75.79 -9.98 59.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 71.9 m -74.8 -40.05 61.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 169.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.2 mt -91.17 164.33 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.923 1.344 . . . . 0.0 113.593 -154.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.72 101.69 0.54 Allowed Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 112.206 -2.27 . . . . 0.0 105.402 163.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -51.06 6.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 N-CA-C 122.183 3.878 . . . . 0.0 122.183 -154.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -94.7 57.77 2.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 123.039 1.4 . . . . 0.0 108.571 163.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.88 167.51 38.34 Favored Glycine 0 N--CA 1.466 0.691 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.159 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -146.14 120.07 9.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.225 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.307 0.6 OUTLIER -92.7 129.85 38.5 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 112.618 -2.083 . . . . 0.0 107.905 -173.727 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.711 HD13 ' CB ' ' A' ' 116' ' ' CYS . 23.3 mm -113.75 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.85 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.462 0.42 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.533 HD12 HD21 ' A' ' 91' ' ' LEU . 6.2 mt -115.93 146.56 41.98 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.859 1.314 . . . . 0.0 110.646 -131.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.3 t -90.79 179.45 5.79 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.348 -165.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.9 44.06 0.73 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 120.25 3.426 . . . . 0.0 120.25 -161.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mt -96.16 -26.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 126.716 3.15 . . . . 0.0 109.959 137.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.783 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 92.2 m-85 -76.68 2.95 12.74 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.347 -168.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -71.83 -52.17 18.83 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.583 -1.323 . . . . 0.0 111.509 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.85 -33.36 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.081 -0.387 . . . . 0.0 110.732 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.94 -46.61 89.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.197 171.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.538 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -57.99 -39.78 79.08 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.99 -0.444 . . . . 0.0 111.817 176.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -58.48 -50.01 75.29 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.706 0.765 . . . . 0.0 112.394 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.31 -34.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.438 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -71.79 -16.59 62.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 173.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.07 5.74 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.703 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 94.1 m-85 -106.54 159.56 16.08 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -117.46 154.09 32.0 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 161.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.63 HG12 ' CD1' ' A' ' 117' ' ' TRP . 19.1 mt -103.99 148.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.061 1.41 . . . . 0.0 109.812 -174.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 pt -140.29 125.57 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 113.246 -1.797 . . . . 0.0 106.628 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -121.99 87.41 2.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 124.072 1.892 . . . . 0.0 113.476 -168.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 114' ' ' ASP . 18.6 mp0 -134.21 100.29 12.96 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 -170.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -54.82 31.42 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.167 1 N-CA-C 124.342 4.709 . . . . 0.0 124.342 -139.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' GLU . 19.2 t70 -100.01 115.17 29.1 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 130.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -90.35 115.27 27.41 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.674 -164.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.225 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.86 -164.6 2.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.956 1.836 . . . . 0.0 115.452 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.63 ' CD1' HG12 ' A' ' 109' ' ' ILE . 22.7 m0 -137.55 130.04 29.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 110.804 -2.907 . . . . 0.0 105.625 -167.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.18 144.41 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -79.52 134.84 36.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.118 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 122.14 0.972 . . . . 0.0 111.138 170.334 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.79 141.74 35.96 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 123.086 1.422 . . . . 0.0 112.414 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -104.83 120.61 41.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.9 -1.954 . . . . 0.0 106.049 164.149 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -129.4 -163.62 11.23 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.906 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.37 145.02 48.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -167.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.34 135.72 53.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.583 1.182 . . . . 0.0 109.518 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -119.44 120.14 35.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.76 -1.563 . . . . 0.0 106.955 177.369 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -117.97 139.9 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 64' ' ' THR . 2.4 t60 -99.17 129.55 29.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -62.87 -11.46 24.45 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 N-CA-C 120.502 3.231 . . . . 0.0 120.502 -170.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.34 63.35 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -162.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.76 -30.16 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.574 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -81.04 0.32 36.38 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -76.23 -0.92 24.02 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 120.456 1.48 . . . . 0.0 112.018 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 m -114.82 71.48 2.58 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.99 55.88 3.5 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.717 2.945 . . . . 0.0 116.758 -154.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -71.91 -44.99 62.77 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.869 -1.144 . . . . 0.0 112.096 166.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.09 -29.93 68.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -65.2 -50.07 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.641 -0.662 . . . . 0.0 110.795 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.88 -38.18 81.49 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -60.81 -50.09 74.87 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -65.18 -38.49 90.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.534 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.61 -33.57 76.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.49 73.47 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -56.11 -56.17 24.07 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.99 96.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.3 -50.44 67.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -75.37 -11.49 60.06 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.544 -0.722 . . . . 0.0 112.704 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.85 -109.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.318 0.58 . . . . 0.0 111.467 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -139.68 20.27 2.52 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.88 110.55 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.245 -168.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.84 135.02 40.89 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -88.78 139.57 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.5 -32.63 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.014 -165.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.77 169.92 10.27 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.985 1.374 . . . . 0.0 110.904 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -142.41 125.32 16.12 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.018 -172.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.493 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 16.2 m-85 -119.61 149.64 41.62 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.009 166.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.37 149.72 26.71 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 164.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.419 HD13 ' OH ' ' A' ' 62' ' ' TYR . 4.5 tp -63.33 -39.41 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -78.85 -30.28 45.06 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.444 -0.785 . . . . 0.0 113.098 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.14 -30.46 38.99 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.283 -0.886 . . . . 0.0 112.933 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.63 -40.61 66.3 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 112.525 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.29 -27.64 66.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.632 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -83.16 -39.3 21.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.929 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.19 15.38 2.29 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.84 1.496 . . . . 0.0 116.84 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.4 m -78.88 -14.32 59.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 -168.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.73 161.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.542 1.064 . . . . 0.0 110.318 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -99.84 120.4 39.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.988 -172.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.69 120.0 36.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.475 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.51 120.1 39.09 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -92.46 65.6 4.49 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -167.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.17 -77.16 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 170.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 6' ' ' THR . 90.8 mttt -100.04 57.41 0.97 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.389 1.09 . . . . 0.0 113.629 -161.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 59' ' ' THR . 11.8 m-85 -112.34 21.52 15.66 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.984 163.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.73 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 -157.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 57' ' ' TYR . 8.7 t -131.14 116.39 17.65 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 162.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.53 HG11 HD22 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -98.64 134.79 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 171.035 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.52 134.55 54.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.419 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -123.22 110.45 15.25 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.255 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.04 89.74 3.09 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -170.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 12' ' ' HIS . 33.5 m -131.08 154.45 82.02 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -170.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 CA--C 1.532 0.407 0 C-N-CA 121.974 1.782 . . . . 0.0 112.984 170.202 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 15.8 t80 . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 32.2 Cg_exo -82.16 149.39 15.34 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 121.195 1.463 . . . . 0.0 110.25 -175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.73 -39.65 94.74 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -63.17 -27.64 69.51 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.83 -30.31 56.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.626 173.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.16 -35.08 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 119.729 1.15 . . . . 0.0 111.063 171.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.5 p -71.96 -36.79 69.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.789 1.177 . . . . 0.0 113.081 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.83 -38.43 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.696 -0.628 . . . . 0.0 111.816 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -40.53 95.57 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.457 -0.777 . . . . 0.0 112.168 174.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.95 -29.86 70.33 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -79.11 -29.42 43.23 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -76.52 -17.98 58.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 mp -124.32 100.82 6.87 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.553 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.266 80.4 mttt -74.77 -155.06 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.674 -166.145 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 6.1 Cg_endo -59.21 -31.38 95.17 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 N-CA-C 120.656 3.291 . . . . 0.0 120.656 -160.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -90.48 49.04 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.351 1.887 . . . . 0.0 110.659 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.43 144.07 26.55 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 173.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.7 p -146.71 117.07 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 123.445 1.593 . . . . 0.0 107.147 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.266 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.379 0.7 OUTLIER -97.42 133.95 41.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.39 -167.265 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.954 HD13 ' HB3' ' A' ' 116' ' ' CYS . 33.0 mm -121.53 87.39 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.576 1.535 . . . . 0.0 108.747 170.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.465 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -144.26 -78.58 0.04 OUTLIER Glycine 0 C--N 1.316 -0.546 0 N-CA-C 121.375 3.31 . . . . 0.0 121.375 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.465 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.271 5.5 mp -115.67 172.01 7.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.611 1.196 . . . . 0.0 109.868 -124.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -109.13 -141.71 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.486 -156.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.96 -45.79 39.88 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -163.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mt -57.21 -32.84 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 124.397 2.046 . . . . 0.0 111.31 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 90.7 m-85 -76.89 -16.0 59.52 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.347 -1.751 . . . . 0.0 112.296 -170.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.71 -55.08 39.53 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.94 -1.1 . . . . 0.0 111.979 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.16 -35.27 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.755 -0.59 . . . . 0.0 111.795 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.649 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.75 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 173.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.99 79.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.122 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.86 -46.67 74.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.607 0.718 . . . . 0.0 112.843 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.5 tt -80.2 -34.56 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.74 -17.89 62.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.78 21.52 9.63 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.618 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 119' ' ' LYS 0.271 94.7 m-85 -106.85 112.33 25.24 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -98.48 153.48 18.58 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.96 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.62 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -109.13 145.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 111.689 -2.505 . . . . 0.0 110.867 -155.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 pt -137.94 123.01 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -112.17 99.95 8.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.205 1.479 . . . . 0.0 110.723 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.0 -175.61 0.5 Allowed Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.085 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -55.52 -11.61 4.94 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 N-CA-C 118.733 2.551 . . . . 0.0 118.733 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -124.78 149.48 47.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 152.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.414 ' OH ' HD11 ' A' ' 109' ' ' ILE . 13.5 t80 -113.03 112.52 24.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -170.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.266 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 25.2 p -147.73 -153.36 0.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.148 1.451 . . . . 0.0 112.527 169.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.62 ' CD1' HG13 ' A' ' 109' ' ' ILE . 4.4 m0 -136.85 153.52 50.75 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.559 -2.11 . . . . 0.0 105.483 -172.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.27 144.4 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 162.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 61.7 tttm -79.88 134.99 36.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.894 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.645 0.735 . . . . 0.0 110.283 170.326 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.53 103.65 10.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.567 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -76.77 120.44 21.94 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.38 -154.82 7.54 Favored Glycine 0 N--CA 1.464 0.505 0 CA-C-O 123.187 1.437 . . . . 0.0 115.893 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.477 HD11 ' CE2' ' A' ' 40' ' ' PHE . 18.4 tp -134.1 149.84 51.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 112.245 -1.978 . . . . 0.0 109.233 -168.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 tp -124.61 133.75 53.16 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.629 1.204 . . . . 0.0 107.782 157.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -114.46 120.36 40.0 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.262 173.184 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.5 mt -118.04 139.76 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -172.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -103.02 129.6 25.29 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -59.08 -16.95 35.66 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 N-CA-C 121.261 3.524 . . . . 0.0 121.261 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -50.31 58.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -160.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.78 -35.2 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.843 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -71.19 -12.14 61.32 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 t -76.7 1.14 17.94 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.984 1.265 . . . . 0.0 112.147 -170.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.352 53.9 m -98.86 168.12 10.24 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.5 -2.83 13.0 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 N-CA-C 117.873 2.22 . . . . 0.0 117.873 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -74.15 -50.45 19.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.957 1.253 . . . . 0.0 114.21 -166.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.06 -30.15 68.42 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.778 0.717 . . . . 0.0 112.368 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.43 -46.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.102 -0.374 . . . . 0.0 111.146 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -62.2 -36.33 81.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.039 0.836 . . . . 0.0 113.223 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -46.75 75.23 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -58.93 -45.68 89.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.826 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -63.97 -29.82 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.98 74.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.893 1.224 . . . . 0.0 113.38 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -57.63 -52.98 63.19 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.154 -0.341 . . . . 0.0 111.858 171.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.86 -45.71 60.01 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.883 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.83 -50.53 28.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.49 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.5 t -75.54 -29.52 59.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -170.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.86 -127.84 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.006 -0.434 . . . . 0.0 111.94 170.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -139.39 1.48 1.97 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -165.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -99.47 149.81 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.817 0.818 . . . . 0.0 112.28 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -122.65 143.78 49.55 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -104.24 100.37 10.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.279 1.037 . . . . 0.0 109.425 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.74 -40.59 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.84 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.09 169.77 10.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.246 1.022 . . . . 0.0 110.538 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -144.86 113.02 6.48 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -164.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' A' ' 8' ' ' LEU . 17.4 m-30 -118.83 120.19 36.6 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.36 150.09 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.16 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -76.74 -30.05 56.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.8 -35.73 32.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 113.137 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.12 -40.52 78.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.814 0.733 . . . . 0.0 112.724 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -66.1 -27.91 68.42 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.076 173.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -79.9 -39.12 31.08 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.3 10.69 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -78.34 -11.18 59.92 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.1 mt -114.9 121.77 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -98.6 120.84 39.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 124.014 1.864 . . . . 0.0 110.227 -164.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.0 mt -96.52 149.81 21.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 111.199 -2.728 . . . . 0.0 111.565 -163.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.76 169.75 9.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.255 -1.793 . . . . 0.0 107.498 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -116.34 35.95 4.31 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.28 -74.66 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -168.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' THR . 50.9 pttt -78.24 32.92 0.19 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -162.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.443 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.6 m-85 -112.11 21.87 15.41 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 116.93 -1.51 . . . . 0.0 112.995 170.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.63 38.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -165.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.02 115.32 6.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 166.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.2 t -101.33 139.04 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -122.3 134.57 54.66 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -114.73 141.75 47.42 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.77 112.81 17.77 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 170.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.1 m -150.3 154.4 36.05 Favored Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 C-N-CA 122.902 2.401 . . . . 0.0 115.499 170.517 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.407 ' CE2' HG13 ' A' ' 78' ' ' ILE . 14.7 t80 . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 22.8 Cg_exo -82.09 149.8 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 CA-C-N 120.01 1.039 . . . . 0.0 111.365 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.52 -36.86 83.94 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -58.54 -34.22 70.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.67 -30.18 56.66 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.919 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.407 HG13 ' CE2' ' A' ' 73' ' ' PHE . 96.4 mt -59.84 -38.97 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 120.043 1.292 . . . . 0.0 111.236 167.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.6 m -65.68 -39.08 90.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.691 1.132 . . . . 0.0 112.908 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.55 -41.73 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.04 -41.5 92.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.652 -0.655 . . . . 0.0 112.58 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 85' ' ' LEU . . . -63.57 -29.76 70.97 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.88 -10.12 59.33 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -105.46 33.56 3.66 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 82' ' ' ALA . 92.5 mt -134.05 159.98 39.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.233 1.016 . . . . 0.0 111.053 -165.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.556 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 82.2 mttt -112.8 -156.4 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 165.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 14.8 Cg_endo -62.82 -33.81 74.63 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 CA-C-N 124.041 2.479 . . . . 0.0 113.855 -170.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -92.52 45.88 1.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 118.513 0.597 . . . . 0.0 109.912 -170.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 118' ' ' ILE . . . -79.74 116.71 4.34 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 172.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.4 t -139.32 107.04 5.62 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -166.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.23 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.279 1.3 tt -91.52 129.89 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -170.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.675 HD13 ' CB ' ' A' ' 116' ' ' CYS . 20.3 mm -105.89 86.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.977 0.894 . . . . 0.0 109.746 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.592 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.74 -83.49 0.06 OUTLIER Glycine 0 C--N 1.317 -0.488 0 N-CA-C 121.509 3.364 . . . . 0.0 121.509 -166.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.592 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -115.49 171.38 7.76 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.33 -1.348 . . . . 0.0 110.196 -138.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 85.0 p -110.28 -129.34 0.29 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.942 -163.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -79.3 -47.81 15.21 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -157.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.64 -29.78 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 124.607 2.146 . . . . 0.0 111.317 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 76.0 m-85 -76.66 -11.0 59.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.354 -1.748 . . . . 0.0 111.149 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -49.36 70.73 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.789 -1.194 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.09 -36.89 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.802 -0.561 . . . . 0.0 111.141 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -60.4 -43.0 97.1 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.929 171.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.538 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -57.28 -43.33 83.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 111.242 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.06 -48.26 76.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.4 tt -80.13 -35.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.811 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -71.96 0.47 9.24 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.38 41.79 97.96 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 119.807 1.185 . . . . 0.0 113.935 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.0 m-85 -106.91 111.76 24.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 165.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -98.88 117.93 34.49 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 123.474 1.607 . . . . 0.0 106.746 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.66 HG12 ' CD1' ' A' ' 117' ' ' TRP . 15.8 mt -74.74 152.52 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.811 -162.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.4 pt -139.58 128.93 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.159 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -106.86 78.82 1.27 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.302 2.001 . . . . 0.0 111.112 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.27 36.7 tt0 -93.13 162.49 28.25 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 111.341 -2.663 . . . . 0.0 107.14 166.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.56 -6.13 0.92 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 N-CA-C 118.934 2.628 . . . . 0.0 118.934 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -112.43 110.29 20.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 155.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -80.75 115.13 20.09 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.878 -0.514 . . . . 0.0 110.562 -168.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.23 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 15.0 p -147.04 -164.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 123.746 1.736 . . . . 0.0 114.102 172.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.66 ' CD1' HG12 ' A' ' 109' ' ' ILE . 3.1 m0 -137.79 130.19 29.38 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 111.459 -2.61 . . . . 0.0 106.073 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER -111.88 144.22 20.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 123.001 1.381 . . . . 0.0 107.478 169.389 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.87 134.84 36.33 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.467 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.47 0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.432 170.355 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 122.194 0.997 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -92.32 142.06 27.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.602 1.192 . . . . 0.0 111.148 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 56' ' ' LYS . 1.6 t -105.08 120.66 42.05 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.465 174.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.6 -161.12 10.05 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 118.814 -1.66 . . . . 0.0 113.811 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.458 HD13 ' OD2' ' A' ' 38' ' ' ASP . 42.5 tp -133.94 139.28 46.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.09 -1.055 . . . . 0.0 108.686 -167.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.7 tp -124.87 110.96 14.91 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 0.0 110.443 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.91 120.23 39.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.996 170.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -123.15 139.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.962 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.76 129.83 43.1 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.48 -11.02 10.05 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 N-CA-C 120.562 3.254 . . . . 0.0 120.562 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.71 -50.14 65.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -88.95 -30.29 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.873 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.5 p -78.74 -2.7 40.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -76.62 -9.8 58.93 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.933 1.242 . . . . 0.0 111.476 163.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.4 m -108.51 71.68 0.41 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 165.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.29 46.68 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.363 3.375 . . . . 0.0 116.235 -154.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.86 -49.98 66.18 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.396 -0.815 . . . . 0.0 112.772 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.97 -29.82 70.77 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 122.05 -0.406 . . . . 0.0 112.03 173.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -63.59 -50.0 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.735 -0.603 . . . . 0.0 111.322 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.63 -36.45 76.38 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.223 -0.923 . . . . 0.0 113.301 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.09 -49.88 72.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -64.9 -35.85 82.48 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.786 0.721 . . . . 0.0 111.562 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -64.99 -35.13 80.21 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.12 -45.28 70.56 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.536 1.062 . . . . 0.0 113.11 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.334 0.9 OUTLIER -54.99 -52.11 64.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.15 86.46 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.587 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.28 -50.46 65.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.419 -170.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 m -75.25 -13.95 60.48 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.835 -0.541 . . . . 0.0 112.021 -170.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.79 -113.94 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.838 -0.539 . . . . 0.0 110.393 170.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -150.72 35.22 0.61 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 t -112.65 149.85 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.443 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.23 134.91 49.07 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 162.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -98.78 100.73 11.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.21 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.84 -14.6 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -164.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.458 ' OD2' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -121.73 120.4 34.55 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -173.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -114.92 114.34 25.34 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.551 -167.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -123.68 120.21 32.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.839 0.828 . . . . 0.0 109.428 -174.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp -87.65 149.8 24.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.415 HD13 ' OH ' ' A' ' 62' ' ' TYR . 3.9 tp -63.29 -38.3 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -78.54 -30.29 46.86 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -77.69 -41.09 39.21 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.305 -0.872 . . . . 0.0 112.494 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -67.03 -40.38 87.21 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.644 0.735 . . . . 0.0 112.947 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -73.84 -21.37 60.14 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.761 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.92 -35.01 38.48 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.595 -0.69 . . . . 0.0 111.421 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.12 15.27 5.66 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.811 0.684 . . . . 0.0 114.811 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -78.46 -40.29 36.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.6 mt -114.93 118.74 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 122.481 1.134 . . . . 0.0 109.5 -167.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -133.31 159.23 40.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 157.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.294 1.8 pt? -131.34 -70.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.329 164.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -141.46 169.8 16.92 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.892 0.853 . . . . 0.0 109.81 172.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.54 63.14 0.85 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.55 -92.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 6' ' ' THR . 43.5 pttt -100.29 64.55 1.18 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -161.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.437 ' O ' ' N ' ' A' ' 59' ' ' THR . 5.7 m-85 -112.1 21.77 15.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 116.367 -1.778 . . . . 0.0 113.346 170.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.54 41.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -157.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -147.15 115.68 6.71 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 165.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 91' ' ' LEU 0.25 40.9 t -118.4 134.62 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.403 -164.489 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.59 134.74 54.51 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.415 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -117.79 110.41 17.77 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 168.13 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.23 104.97 17.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.031 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.8 m -119.84 120.08 30.7 Favored Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 167.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 121.875 1.717 . . . . 0.0 114.546 -164.487 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 14.7 t80 . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 27.4 Cg_exo -82.38 149.49 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 120.395 1.177 . . . . 0.0 110.161 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.6 -37.49 86.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.641 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.61 -29.55 70.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.2 mt -76.75 -30.16 56.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.322 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.31 -35.03 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-N 119.886 1.221 . . . . 0.0 111.033 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.2 t -68.5 -39.39 81.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.661 1.119 . . . . 0.0 112.657 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.916 -0.49 . . . . 0.0 111.755 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.98 -46.11 90.5 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.696 -0.628 . . . . 0.0 111.967 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.04 71.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.2 -13.01 56.29 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.3 m -71.26 -45.19 63.75 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 122.06 -0.4 . . . . 0.0 110.747 162.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.9 mt -97.67 161.47 13.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.926 1.346 . . . . 0.0 112.461 -163.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.424 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 63.9 mttp -108.43 -178.25 0.55 Allowed Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.287 -170.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 25.5 Cg_exo -56.15 -12.73 8.08 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 N-CA-C 119.96 3.023 . . . . 0.0 119.96 -170.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -102.37 33.32 3.17 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.14 1.336 . . . . 0.0 111.853 169.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.55 141.89 41.35 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 170.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 81.9 p -145.24 107.19 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.97 1.366 . . . . 0.0 108.325 -171.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -89.9 143.01 27.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.611 -1.632 . . . . 0.0 108.59 -172.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.38 88.41 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 167.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.22 -86.6 0.08 OUTLIER Glycine 0 CA--C 1.53 0.977 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 -159.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.54 169.82 8.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.052 1.926 . . . . 0.0 110.828 -147.297 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.4 m -104.89 -149.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -160.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.51 -43.06 86.31 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -163.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.01 -34.43 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 124.836 2.255 . . . . 0.0 110.526 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 65.7 m-85 -76.68 -10.49 59.42 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.142 -1.844 . . . . 0.0 111.073 -175.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.93 -52.83 58.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.829 -1.169 . . . . 0.0 112.188 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.76 -33.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.275 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.48 -46.01 91.85 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.531 -0.731 . . . . 0.0 112.847 172.342 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 109' ' ' ILE . . . -56.6 -42.57 78.98 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.886 -0.509 . . . . 0.0 111.827 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.05 -49.35 76.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.67 0.747 . . . . 0.0 112.502 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 tt -80.08 -34.62 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -170.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -71.61 -17.41 62.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.61 29.61 5.55 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 119.296 -1.43 . . . . 0.0 112.317 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.1 m-85 -106.71 159.84 15.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -126.88 108.1 10.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.548 1.166 . . . . 0.0 108.711 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.609 HG12 ' CD1' ' A' ' 117' ' ' TRP . 25.5 mt -84.5 111.24 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.962 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.676 HG13 ' SG ' ' A' ' 116' ' ' CYS . 44.9 pt -108.55 135.05 48.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.247 169.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -105.85 100.31 9.87 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.725 1.726 . . . . 0.0 110.668 -171.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -117.31 171.37 4.99 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 111.957 -2.383 . . . . 0.0 107.698 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -56.22 -8.5 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 N-CA-C 119.117 2.699 . . . . 0.0 119.117 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -119.47 115.26 23.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -79.57 139.09 37.63 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -165.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.676 ' SG ' HG13 ' A' ' 110' ' ' ILE 0.266 5.1 p -145.72 120.88 10.14 Favored 'General case' 0 CA--C 1.54 0.586 1 N-CA-C 123.375 4.583 . . . . 0.0 123.375 -164.141 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.609 ' CD1' HG12 ' A' ' 109' ' ' ILE . 4.0 m0 -109.64 111.06 22.32 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 143.98 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.682 1.23 . . . . 0.0 108.832 170.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 77.8 tttt -91.74 110.22 21.55 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.631 -174.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.832 0.825 . . . . 0.0 110.424 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -92.64 141.77 28.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.527 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 t -89.88 141.48 28.6 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 158.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.48 -167.09 11.55 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 123.762 1.757 . . . . 0.0 115.258 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 40' ' ' PHE . 30.5 tp -131.3 139.83 49.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 111.569 -2.315 . . . . 0.0 107.983 -173.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.285 0.2 OUTLIER -124.49 129.39 50.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 168.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -121.86 120.33 34.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -175.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.3 tt -129.1 139.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 -163.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -106.6 129.62 24.16 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -62.0 -11.67 22.58 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 N-CA-C 120.683 3.301 . . . . 0.0 120.683 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.21 -50.34 61.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -161.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.8 t -89.91 -30.35 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.689 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -84.17 0.24 49.42 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 5.72 7.01 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.364 1.438 . . . . 0.0 113.671 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.333 95.5 m -98.98 167.99 10.42 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 164.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.65 -13.23 16.4 Favored 'Trans proline' 0 N--CA 1.482 0.824 0 N-CA-C 117.133 1.936 . . . . 0.0 117.133 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.13 -50.34 19.86 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -161.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.32 -30.04 68.01 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.156 0.889 . . . . 0.0 112.189 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.59 -50.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.758 -0.589 . . . . 0.0 111.036 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.61 -36.78 76.99 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.304 -0.873 . . . . 0.0 113.335 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -61.86 -50.12 73.51 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.3 t -66.53 -37.57 85.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.691 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.89 -31.21 72.34 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 170.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.15 67.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.607 1.094 . . . . 0.0 113.195 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -56.39 -54.57 44.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.341 0.591 . . . . 0.0 111.185 171.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.48 -40.33 59.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.67 -50.02 9.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.2 p -60.77 -24.54 65.84 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -126.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.655 -0.653 . . . . 0.0 110.429 170.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -144.72 -9.15 0.63 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -168.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.61 110.46 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -98.78 146.7 25.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.632 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -88.7 100.36 13.06 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 123.374 1.559 . . . . 0.0 110.465 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -36.5 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 112.375 -2.193 . . . . 0.0 113.268 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -121.89 169.58 10.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.226 1.012 . . . . 0.0 111.377 -170.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -150.13 125.58 10.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.556 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.537 ' O ' HD23 ' A' ' 10' ' ' LEU . 30.4 m-85 -133.03 120.67 21.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.62 149.45 24.29 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 tp -63.63 -40.16 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -79.17 -30.28 43.43 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.746 . . . . 0.0 112.843 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -82.24 -24.92 34.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -40.41 71.4 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.434 1.015 . . . . 0.0 111.901 174.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -78.19 -27.66 47.98 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.96 -37.56 34.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.842 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.3 15.38 2.78 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 116.904 1.522 . . . . 0.0 116.904 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -75.62 -29.44 59.21 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.457 1.629 . . . . 0.0 114.612 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.58 120.16 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.8 m -124.45 120.2 31.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.762 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.5 mt -123.79 -163.44 1.14 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.87 171.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -98.79 169.84 9.18 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.923 1.344 . . . . 0.0 111.797 -166.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -90.21 94.62 9.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.426 170.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.65 -162.05 1.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -168.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -95.49 58.0 1.99 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.872 -170.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' THR . 3.9 m-85 -81.4 22.45 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 117.012 -1.47 . . . . 0.0 112.568 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.406 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 35.6 mt-10 -60.76 38.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -164.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.73 115.46 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 164.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.56 110.54 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.324 -157.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.37 106.55 16.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.982 -174.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.77 141.52 28.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 171.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.289 22.3 tp -123.53 115.11 20.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.867 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -149.27 154.35 38.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo . . . . . 0 CA--C 1.537 0.633 0 C-N-CA 122.559 2.172 . . . . 0.0 116.288 170.398 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 39.1 Cg_exo -82.12 149.67 15.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 CA-C-N 120.626 1.259 . . . . 0.0 110.332 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.62 -36.67 83.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -66.44 -26.08 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.87 -30.2 56.14 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.743 1.156 . . . . 0.0 111.106 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -39.14 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.935 1.243 . . . . 0.0 110.928 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.2 m -67.44 -40.99 85.47 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.321 -0.862 . . . . 0.0 112.586 176.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.91 -38.9 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.272 0.487 . . . . 0.0 112.266 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.86 -39.08 87.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.543 1.065 . . . . 0.0 112.381 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -29.65 70.67 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.23 -9.85 59.02 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.7 m -70.83 -36.43 72.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 165.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.83 159.77 18.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 123.02 1.391 . . . . 0.0 113.293 -153.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.02 101.76 0.68 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 112.02 -2.355 . . . . 0.0 105.329 162.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.17 11.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 N-CA-C 122.055 3.829 . . . . 0.0 122.055 -154.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -102.41 53.48 0.79 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.549 1.166 . . . . 0.0 108.165 162.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 58' ' ' GLU . . . -68.54 163.41 49.4 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 168.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 30.8 t -147.02 120.13 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.502 HD21 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -99.38 139.82 34.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.505 -168.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.63 90.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 167.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.55 -94.31 0.19 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 -160.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.502 HD12 HD21 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -116.44 169.9 8.96 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.919 -146.151 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -123.38 -115.74 0.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -156.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.26 -63.01 1.15 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -157.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -59.66 -27.95 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 124.373 2.035 . . . . 0.0 111.537 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.657 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 67.8 m-85 -76.82 -19.27 57.74 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.026 -170.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.23 -52.06 62.51 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.776 -1.202 . . . . 0.0 112.345 169.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.92 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.842 -0.536 . . . . 0.0 111.819 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.657 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.56 -43.22 97.52 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.133 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.34 -42.2 98.3 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.17 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.6 tp -55.88 -46.76 78.23 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 tt -79.95 -38.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.254 -171.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -71.98 1.93 6.45 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.66 43.63 96.11 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.774 -1.203 . . . . 0.0 114.048 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.562 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.5 m-85 -109.45 111.83 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 167.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -98.92 112.23 24.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 123.61 1.671 . . . . 0.0 108.107 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.581 HG13 ' CD1' ' A' ' 117' ' ' TRP 0.257 16.3 tt -83.59 156.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 112.057 -2.338 . . . . 0.0 112.619 -164.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.627 HG23 ' SG ' ' A' ' 116' ' ' CYS . 14.6 tt -147.21 128.32 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.843 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -102.66 98.32 8.38 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 123.282 1.515 . . . . 0.0 112.386 -167.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.16 171.61 8.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.056 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.47 -10.29 4.78 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 N-CA-C 119.295 2.767 . . . . 0.0 119.295 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -125.17 115.02 19.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 160.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.425 ' OH ' HD11 ' A' ' 109' ' ' ILE . 38.1 t80 -79.64 138.78 37.51 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.38 -163.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.627 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.289 5.4 p -146.26 120.89 9.79 Favored 'General case' 0 CA--C 1.55 0.955 1 N-CA-C 127.042 5.941 . . . . 0.0 127.042 -164.924 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.581 ' CD1' HG13 ' A' ' 109' ' ' ILE . 7.4 m0 -109.63 114.91 28.91 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.49 1.496 . . . . 0.0 109.229 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.3 OUTLIER -99.62 143.92 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -79.91 134.9 36.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.911 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 121.699 0.762 . . . . 0.0 109.846 170.455 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -84.34 141.79 30.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.687 0.756 . . . . 0.0 111.187 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.0 m -104.63 140.82 37.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.22 -156.69 7.95 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-O 123.86 1.811 . . . . 0.0 117.011 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.488 HD21 ' CD2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -134.54 142.37 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 111.472 -2.364 . . . . 0.0 109.704 -174.107 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 tp -124.21 133.23 53.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 162.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -120.14 120.29 35.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.442 174.007 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 16' ' ' THR . 16.1 tt -132.15 139.91 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -164.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -105.71 129.92 23.88 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -59.96 -12.37 18.62 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 N-CA-C 121.381 3.57 . . . . 0.0 121.381 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.33 -50.36 71.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -160.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.3 t -88.86 -28.92 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.491 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.411 ' HB ' HD11 ' A' ' 11' ' ' ILE . 47.7 p -79.05 0.3 28.39 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -170.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.1 m -76.62 0.74 19.09 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 119.575 1.079 . . . . 0.0 111.993 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 m -98.55 169.09 8.79 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 162.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -77.18 2.48 7.61 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 N-CA-C 120.676 3.299 . . . . 0.0 120.676 171.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.31 -50.93 16.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 121.212 1.824 . . . . 0.0 115.312 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.43 -31.6 70.03 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.558 -0.714 . . . . 0.0 112.56 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.88 -47.67 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.644 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.93 -33.27 75.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -64.74 -49.89 69.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -64.05 -41.75 97.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.321 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.7 -30.23 71.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.575 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -45.64 69.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.179 1.354 . . . . 0.0 113.511 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -56.52 -53.81 53.14 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.689 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.9 79.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.741 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.26 43.36 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.998 -0.439 . . . . 0.0 111.23 -170.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.2 p -73.32 -21.8 60.47 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.606 0.639 . . . . 0.0 111.568 -170.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.73 -113.44 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -157.41 17.36 0.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -168.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.87 152.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.3 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -128.39 135.02 48.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 165.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.75 100.56 13.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.816 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -21.22 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -167.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.98 121.47 37.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -167.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -114.2 124.28 51.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.089 0.947 . . . . 0.0 109.635 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CD2' HD21 ' A' ' 8' ' ' LEU . 22.2 m-30 -127.32 103.25 7.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.528 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 43' ' ' ASN . 8.0 tt -84.97 149.79 25.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.03 -39.94 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' H ' HD23 ' A' ' 41' ' ' LEU . 36.8 t30 -78.57 -30.13 46.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.64 -29.59 33.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.25 0.932 . . . . 0.0 113.19 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -40.51 54.71 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.38 0.991 . . . . 0.0 112.084 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -69.56 -28.23 65.81 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.34 -41.84 24.05 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.6 15.27 8.9 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.301 1.28 . . . . 0.0 116.301 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 m -73.38 -8.27 55.15 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 119.499 1.649 . . . . 0.0 115.45 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.9 mt -114.72 121.82 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.976 -0.452 . . . . 0.0 109.99 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.7 m -98.48 120.66 39.28 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.199 1.952 . . . . 0.0 108.978 -172.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.267 63.4 tp -96.73 149.54 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 110.752 -2.931 . . . . 0.0 111.591 -161.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.42 169.79 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.667 166.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -120.1 44.42 2.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -166.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -73.1 0.07 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 119.446 3.128 . . . . 0.0 119.446 -166.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -81.71 30.53 0.37 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -157.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 59' ' ' THR . 0.6 OUTLIER -112.22 21.27 15.99 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 117.659 -1.162 . . . . 0.0 112.621 -170.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.82 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 -166.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.09 115.5 6.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 169.313 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 24.4 t -119.33 134.34 63.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.706 -165.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -122.58 134.6 54.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.44 142.45 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.77 102.37 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -137.23 113.86 9.68 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 CA--C 1.534 0.516 0 C-N-CA 122.733 2.289 . . . . 0.0 114.974 170.335 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 8.2 t80 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.551 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -55.77 149.66 49.14 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.806 1.671 . . . . 0.0 112.887 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.52 -34.74 77.5 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -31.45 67.88 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.81 -30.06 56.23 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.113 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.62 -35.45 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 119.769 1.168 . . . . 0.0 111.614 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.3 p -69.12 -36.83 77.94 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.21 1.368 . . . . 0.0 112.967 173.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.08 -37.42 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.815 -0.553 . . . . 0.0 111.902 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -59.96 -46.07 90.62 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.819 -0.551 . . . . 0.0 112.042 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.0 70.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -73.62 -9.99 59.24 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 m -106.87 30.22 6.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -134.07 162.52 31.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.044 0.926 . . . . 0.0 109.846 -169.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 174.97 2.31 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -58.52 -12.4 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 118.455 2.444 . . . . 0.0 118.455 -170.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -102.0 46.76 0.92 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.943 0.792 . . . . 0.0 110.676 170.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.31 140.58 24.75 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.5 t -146.3 106.27 4.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.17 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.259 3.1 tt -89.91 129.92 36.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -175.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.001 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 27.2 mm -104.42 91.11 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 122.337 1.065 . . . . 0.0 108.31 170.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.76 -95.13 0.2 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 120.745 3.058 . . . . 0.0 120.745 -162.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.453 HD22 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.5 169.62 9.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.017 -1.473 . . . . 0.0 109.464 -142.387 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -118.26 -118.07 0.32 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -158.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.09 -54.24 8.23 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -156.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -61.0 -29.33 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 124.548 2.118 . . . . 0.0 111.294 170.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.72 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.1 m-85 -76.78 -9.41 58.65 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.291 -1.777 . . . . 0.0 112.03 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -63.95 -56.05 17.99 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.295 -0.878 . . . . 0.0 111.468 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.84 -31.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 122.188 -0.32 . . . . 0.0 111.513 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.72 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.89 -46.5 87.56 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.539 -0.725 . . . . 0.0 112.451 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -54.9 -41.8 71.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.088 0.404 . . . . 0.0 111.777 173.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.6 tp -63.19 -45.14 93.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.6 mt -80.08 -34.95 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -71.75 -15.5 62.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 27.88 6.12 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.589 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 97.4 m-85 -106.52 159.6 16.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 172.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -118.71 154.13 33.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 161.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.685 HG12 ' CD1' ' A' ' 117' ' ' TRP . 22.5 mt -103.89 148.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 122.994 1.378 . . . . 0.0 109.282 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.82 123.11 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.891 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -115.48 100.18 7.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.942 1.829 . . . . 0.0 110.913 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -134.22 -178.54 0.88 Allowed Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 111.215 -2.72 . . . . 0.0 106.194 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.52 -7.14 1.2 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -135.07 115.27 13.28 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 161.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -86.77 115.02 23.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.296 -167.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.17 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 27.9 p -147.6 -158.62 0.93 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 122.674 1.226 . . . . 0.0 114.099 167.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.685 ' CD1' HG12 ' A' ' 109' ' ' ILE . 5.9 m0 -137.31 130.36 30.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.452 -1.703 . . . . 0.0 106.438 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.89 144.0 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 122.708 1.242 . . . . 0.0 108.276 167.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 76.4 tttt -87.16 110.39 20.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.797 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.499 0.666 . . . . 0.0 112.14 170.384 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.0 t80 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.1 141.94 28.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.218 1.008 . . . . 0.0 111.831 -165.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -94.44 141.77 28.21 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 166.186 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.53 -158.32 8.64 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 119.369 -1.396 . . . . 0.0 114.625 169.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.48 139.95 45.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.307 0.0 OUTLIER -124.38 129.35 50.54 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 174.126 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.44 120.23 40.95 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.4 mt -124.81 139.98 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.636 -171.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -98.69 129.77 29.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 160.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -60.96 -11.99 20.59 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 N-CA-C 121.75 3.711 . . . . 0.0 121.75 -170.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.29 74.52 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -159.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 65' ' ' PRO . 44.8 t -96.32 -29.83 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 119.29 0.95 . . . . 0.0 111.81 170.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 p -65.21 0.03 1.54 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -76.3 -10.32 59.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.118 1.781 . . . . 0.0 112.077 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.317 92.5 m -98.8 167.98 10.49 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 163.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.87 -3.17 13.27 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 N-CA-C 117.674 2.144 . . . . 0.0 117.674 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.96 -50.42 20.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.428 1.467 . . . . 0.0 114.521 -161.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.2 -32.46 71.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.429 -0.794 . . . . 0.0 112.585 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.49 -47.79 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.504 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.45 -47.3 70.57 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.3 m -58.89 -46.23 88.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.938 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.1 mmmt -60.92 -29.94 69.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.33 74.36 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.203 1.365 . . . . 0.0 113.488 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -60.0 -54.05 50.67 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.039 0.447 . . . . 0.0 111.401 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.06 45.77 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.94 -45.67 11.27 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.8 p -58.02 -34.19 69.78 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.92 -113.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -170.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 38.0 tptt -137.88 -13.1 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.532 -170.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 59' ' ' THR . 3.3 p -117.26 110.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -170.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -98.65 139.58 34.15 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.218 1.009 . . . . 0.0 108.887 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.58 139.75 30.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.34 -30.05 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -160.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -121.61 169.88 10.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.782 1.277 . . . . 0.0 109.015 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -143.82 125.1 14.63 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.24 -1.346 . . . . 0.0 108.846 -169.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -125.87 113.84 17.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.873 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -86.8 149.93 24.5 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -40.03 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -79.93 -30.25 39.92 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -79.75 -32.54 41.06 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.356 -0.84 . . . . 0.0 113.009 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -73.61 -40.62 63.69 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.969 0.804 . . . . 0.0 112.844 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -70.55 -26.12 63.4 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.799 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.26 -42.28 16.03 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 119.106 -0.473 . . . . 0.0 112.149 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.76 15.44 2.63 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 169.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -76.21 -19.45 58.38 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.086 1.943 . . . . 0.0 115.103 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.62 121.85 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.0 t -98.96 159.38 15.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 125.249 2.452 . . . . 0.0 111.403 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.32 120.98 43.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.588 -3.46 . . . . 0.0 111.142 -158.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -98.16 169.17 9.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.552 162.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -120.55 52.67 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -159.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -86.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 6' ' ' THR . 95.4 mttt -100.04 57.45 0.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.017 0.913 . . . . 0.0 113.39 -158.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' THR . 4.4 m-85 -112.1 21.14 16.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.323 169.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.91 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -161.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.515 HG21 HG21 ' A' ' 34' ' ' VAL . 14.6 t -137.41 115.43 11.57 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 161.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -117.42 101.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 -164.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -97.83 134.4 41.03 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.66 110.31 18.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.377 1.084 . . . . 0.0 109.193 174.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.7 mt -98.73 102.06 13.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.412 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.0 m -122.36 94.77 47.6 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HG2' ' H ' ' A' ' 15' ' ' VAL . 60.7 Cg_endo . . . . . 0 CA--C 1.538 0.681 0 C-N-CA 122.216 1.944 . . . . 0.0 112.853 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 32.3 Cg_exo -81.88 149.44 15.9 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 CA-C-N 120.894 1.355 . . . . 0.0 110.741 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -62.6 -40.35 96.67 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.5 -32.27 68.66 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -76.7 -30.26 56.62 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.742 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.42 -35.09 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 119.817 1.189 . . . . 0.0 111.554 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -70.25 -36.79 74.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.288 1.403 . . . . 0.0 112.884 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.56 -39.22 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 121.668 -0.645 . . . . 0.0 111.597 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -60.04 -46.2 90.29 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.814 -0.554 . . . . 0.0 112.073 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.92 70.35 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.85 -32.0 72.21 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -167.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.5 p -92.68 33.27 1.14 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.6 mt -134.16 175.49 9.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.619 1.199 . . . . 0.0 111.818 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -116.32 175.06 2.09 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.66 -25.98 21.73 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 N-CA-C 119.103 2.694 . . . . 0.0 119.103 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -102.27 51.15 0.82 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.68 1.582 . . . . 0.0 110.454 169.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.23 142.92 30.01 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.2 p -144.16 105.88 4.3 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.211 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.366 0.3 OUTLIER -89.68 129.65 36.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.084 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.022 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 39.9 mm -112.44 91.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.11 0.957 . . . . 0.0 109.699 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.09 -86.41 0.08 OUTLIER Glycine 0 C--N 1.315 -0.607 0 N-CA-C 120.902 3.121 . . . . 0.0 120.902 -171.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.602 HD12 HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -116.18 169.77 9.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 -137.542 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 t -108.66 -131.79 0.31 Allowed 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.87 -1.144 . . . . 0.0 112.819 -156.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -80.0 -49.42 11.85 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -158.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -58.69 -30.23 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 124.33 2.014 . . . . 0.0 112.984 168.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.4 m-85 -76.46 -14.99 60.02 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 113.167 -1.833 . . . . 0.0 110.453 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.4 tttt -58.5 -50.67 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.194 -0.941 . . . . 0.0 112.316 165.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.83 -36.82 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.786 -0.571 . . . . 0.0 111.202 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.58 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.97 -43.89 94.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.83 97.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.458 0.647 . . . . 0.0 111.796 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.73 -47.82 83.3 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.467 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.5 mt -76.35 -35.18 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.055 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -71.85 -19.97 61.89 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 33.31 4.09 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.884 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 98.0 m-85 -106.67 159.83 15.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.28 1.038 . . . . 0.0 108.28 168.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.56 106.39 10.55 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.651 HG13 ' CD1' ' A' ' 117' ' ' TRP . 16.8 tt -75.32 144.97 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 122.371 1.081 . . . . 0.0 112.05 -169.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.18 129.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.669 1.223 . . . . 0.0 108.635 -173.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -96.83 99.98 11.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.328 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.86 173.92 2.71 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.139 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -54.9 -14.28 7.76 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 118.966 2.641 . . . . 0.0 118.966 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -130.0 115.22 16.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 153.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.46 139.01 32.49 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.604 -164.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.211 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 12.0 p -147.77 -155.02 0.59 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 123.209 1.481 . . . . 0.0 111.731 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.651 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.7 m0 -137.13 130.11 30.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.69 144.22 19.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.529 1.157 . . . . 0.0 108.299 171.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.31 134.63 36.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.169 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.469 0.521 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.594 170.362 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -111.59 141.82 44.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.216 1.484 . . . . 0.0 112.155 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -105.06 120.87 42.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 112.466 -2.152 . . . . 0.0 105.79 165.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.91 -161.95 10.27 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 119.465 -1.35 . . . . 0.0 116.255 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.532 HD21 ' CE2' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -134.24 139.27 45.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.182 -1.009 . . . . 0.0 108.69 -165.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.99 134.65 52.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.341 1.067 . . . . 0.0 108.558 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -113.02 120.55 41.75 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.512 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.35 140.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -97.77 129.73 30.65 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 163.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -63.17 -10.59 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 N-CA-C 120.441 3.208 . . . . 0.0 120.441 -170.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.92 -50.26 62.95 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 -162.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.5 t -84.88 -30.14 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.553 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -81.91 0.21 40.79 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -170.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 93.6 m -76.32 -6.24 50.63 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 120.056 1.298 . . . . 0.0 111.537 164.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 m -113.19 71.48 1.46 Allowed Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.69 58.74 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.964 3.109 . . . . 0.0 115.971 -155.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.36 -50.15 23.5 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.59 -1.319 . . . . 0.0 111.751 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 -29.89 70.93 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.69 0.677 . . . . 0.0 112.348 176.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.95 -49.98 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.857 -0.527 . . . . 0.0 111.403 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.89 -36.58 77.25 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.294 -0.879 . . . . 0.0 113.298 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -63.1 -49.45 74.39 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.7 t -64.82 -38.01 89.56 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.198 0.908 . . . . 0.0 111.597 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -62.39 -35.22 78.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 169.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.45 72.08 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.441 1.019 . . . . 0.0 113.489 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -59.49 -53.84 53.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.867 0.365 . . . . 0.0 111.6 174.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -57.15 -39.87 76.09 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.83 -46.99 15.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -170.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 98.1 p -57.96 -20.55 38.68 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.74 -105.08 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.737 -0.602 . . . . 0.0 109.521 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -150.39 15.53 0.8 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -170.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.438 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 22.8 t -126.65 110.63 23.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.509 -168.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.33 134.94 41.46 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 165.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -89.06 139.72 30.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.26 -26.05 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -163.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.69 121.36 37.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -113.98 118.24 33.58 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.812 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 8' ' ' LEU . 13.0 m-30 -121.97 106.14 10.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.812 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.73 149.76 25.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -63.25 -40.07 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -76.65 -30.24 56.74 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.96 -31.8 34.71 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.69 -40.39 69.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.551 1.069 . . . . 0.0 112.346 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.79 -18.55 61.47 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.14 -38.8 16.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.496 -0.752 . . . . 0.0 111.882 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.32 15.24 7.78 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.4 m -79.11 -3.3 44.75 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -171.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -114.72 169.55 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.588 -0.695 . . . . 0.0 109.369 -163.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -99.91 158.54 15.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.629 1.681 . . . . 0.0 109.515 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.4 150.08 52.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.312 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.3 169.52 16.35 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 160.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -120.59 46.33 2.02 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -82.25 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 6' ' ' THR . 65.9 mttm -100.2 63.46 1.15 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.888 0.851 . . . . 0.0 111.94 -161.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' THR . 17.9 m-85 -112.25 21.59 15.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 117.138 -1.411 . . . . 0.0 112.666 167.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -61.74 31.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -158.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 57' ' ' TYR . 8.4 t -135.85 115.36 12.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 162.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 83.6 t -115.81 110.33 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -164.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.86 134.56 49.82 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 142.04 46.32 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 162.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.94 104.53 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 170.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.7 m -143.7 120.16 6.52 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.536 0.61 0 C-N-CA 122.413 2.076 . . . . 0.0 113.507 170.095 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 30.9 t80 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 23.0 Cg_exo -82.24 149.98 15.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 121.087 1.191 . . . . 0.0 111.581 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -62.33 -33.91 75.61 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.71 -30.37 71.04 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -76.62 -30.18 56.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.177 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.413 HG13 ' CE2' ' A' ' 73' ' ' PHE . 97.1 mt -61.39 -36.99 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 119.741 1.155 . . . . 0.0 111.242 166.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.4 m -64.17 -40.95 97.2 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.07 1.304 . . . . 0.0 112.448 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.08 -43.49 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.15 -37.81 88.69 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.363 -0.836 . . . . 0.0 112.914 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.86 -29.7 70.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.91 -10.4 59.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 77.3 p -104.27 11.35 34.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.21 101.49 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -165.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HB3' ' HD2' ' A' ' 87' ' ' PRO 0.257 54.1 mttp -74.19 -160.35 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.482 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.523 170.599 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 8.2 Cg_endo -54.21 -42.26 68.85 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 N-CA-C 120.611 3.273 . . . . 0.0 120.611 -155.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -102.11 43.31 1.08 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 121.348 1.886 . . . . 0.0 110.93 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.84 140.09 37.71 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 167.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 42.5 t -138.8 158.28 44.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 116.994 -1.882 . . . . 0.0 106.925 166.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.594 HD21 HD12 ' A' ' 94' ' ' LEU . 2.0 tt -129.01 105.26 8.08 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.038 -162.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -106.37 81.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.65 -82.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 120.627 3.011 . . . . 0.0 120.627 -155.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.594 HD12 HD21 ' A' ' 91' ' ' LEU . 2.1 mt -116.22 170.6 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -147.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -110.12 -136.05 0.36 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -157.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.31 -47.82 19.0 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -161.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.62 -29.57 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 124.371 2.034 . . . . 0.0 111.236 171.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.484 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 13.7 m-85 -76.58 -16.41 59.6 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.359 -172.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.0 tttt -56.95 -52.4 65.36 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.282 -0.886 . . . . 0.0 112.871 168.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.63 -36.14 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.858 -0.526 . . . . 0.0 111.09 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.29 -44.11 97.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.259 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.06 81.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.211 0.529 . . . . 0.0 112.408 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.28 -44.76 95.79 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 99.0 mt -80.05 -33.71 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.256 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -71.94 -18.47 62.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.77 31.13 4.94 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.668 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 85.9 m-85 -106.9 159.97 15.86 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -131.01 111.46 12.04 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.589 HG13 ' CD1' ' A' ' 117' ' ' TRP . 14.1 tt -90.71 153.25 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 122.739 1.257 . . . . 0.0 112.578 -166.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.597 HG23 ' SG ' ' A' ' 116' ' ' CYS . 17.0 tt -154.04 130.38 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.193 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -93.45 98.86 11.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 123.243 1.497 . . . . 0.0 110.698 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -109.58 177.84 1.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.785 -2.007 . . . . 0.0 108.469 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -55.61 -14.28 9.8 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 119.041 2.67 . . . . 0.0 119.041 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -118.1 149.56 40.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 154.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.453 ' HE2' ' HE1' ' A' ' 117' ' ' TRP . 22.5 t80 -86.45 139.23 31.11 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 120.774 -1.204 . . . . 0.0 108.997 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.597 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.356 28.1 p -146.11 120.59 9.7 Favored 'General case' 0 CA--C 1.553 1.093 1 N-CA-C 129.216 6.747 . . . . 0.0 129.216 -173.684 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.589 ' CD1' HG13 ' A' ' 109' ' ' ILE . 8.2 m0 -109.75 117.51 34.07 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.422 1.464 . . . . 0.0 109.178 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -107.68 144.38 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.855 -1.153 . . . . 0.0 109.443 172.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -79.7 110.49 15.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.612 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.641 0.734 . . . . 0.0 109.173 -170.343 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.2 t80 . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.98 141.65 51.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.58 1.181 . . . . 0.0 110.945 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.8 t -94.34 120.78 35.09 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.09 -161.69 11.46 Favored Glycine 0 N--CA 1.466 0.666 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.586 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -134.04 139.77 46.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.672 -1.764 . . . . 0.0 107.4 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.6 tp -124.29 129.83 51.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.647 1.213 . . . . 0.0 108.805 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 mp -115.1 120.37 39.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.59 -1.641 . . . . 0.0 107.051 171.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 tt -128.72 140.0 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.28 0.562 . . . . 0.0 109.737 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -102.7 129.75 25.24 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.14 -13.46 31.98 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 N-CA-C 120.462 3.216 . . . . 0.0 120.462 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.13 -50.21 56.11 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -161.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.07 -30.12 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.273 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.4 p -80.77 0.14 36.06 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -76.35 3.72 10.42 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.034 1.288 . . . . 0.0 112.49 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 m -113.48 71.64 1.69 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 43.51 0.78 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.768 2.978 . . . . 0.0 116.255 -153.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.22 -40.34 90.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.418 -0.801 . . . . 0.0 112.226 163.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mp -62.26 -29.89 70.73 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.03 -50.06 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.115 -0.366 . . . . 0.0 110.779 173.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -47.43 56.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -61.75 -40.61 95.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.081 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -62.29 -38.59 89.95 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 169.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.31 78.08 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.942 1.246 . . . . 0.0 113.807 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -56.9 -56.38 22.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -64.63 -38.71 91.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.84 -37.63 34.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -170.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -57.8 -27.7 63.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.806 1.185 . . . . 0.0 113.778 170.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.93 -119.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -153.28 40.5 0.53 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 124.317 2.008 . . . . 0.0 111.946 -170.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.481 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 59.6 t -131.04 110.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 111.183 -2.735 . . . . 0.0 108.7 170.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.09 141.87 35.88 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 167.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -88.7 139.64 30.26 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.6 t -108.91 -36.64 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.468 -166.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -121.85 169.93 10.28 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.881 1.324 . . . . 0.0 111.309 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -135.8 125.16 24.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.635 -1.621 . . . . 0.0 108.248 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -124.15 120.26 31.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.973 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.31 149.38 21.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.403 HD13 ' OH ' ' A' ' 62' ' ' TYR . 2.9 tp -63.5 -40.19 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -78.88 -30.33 44.89 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.5 -0.75 . . . . 0.0 112.92 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -80.3 -32.42 38.04 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.547 -0.721 . . . . 0.0 112.721 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.65 -40.43 80.23 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.457 -0.777 . . . . 0.0 111.89 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -78.06 -30.9 50.01 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.89 -36.75 36.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.848 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.89 15.31 2.9 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 170.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -78.06 -26.44 48.27 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.24 1.52 . . . . 0.0 114.456 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.61 120.24 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.8 m -126.87 120.12 28.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.633 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.08 -166.88 1.35 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.57 170.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -98.84 169.91 9.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.586 1.184 . . . . 0.0 110.056 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 76.9 m-20 -77.13 97.56 4.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.587 170.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.33 -151.18 0.43 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -166.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -100.08 31.73 3.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -162.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.5 m-85 -81.86 21.51 0.85 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.373 -170.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.38 35.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -166.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.62 115.45 8.25 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 163.706 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 68.4 t -118.62 134.48 62.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.237 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -122.61 134.77 54.5 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.403 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -116.72 110.89 19.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 169.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.35 102.02 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.63 1.205 . . . . 0.0 111.466 170.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -132.82 154.95 81.63 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo . . . . . 0 CA--C 1.534 0.496 0 C-N-CA 122.344 2.03 . . . . 0.0 115.816 170.749 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 11.6 t80 . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 30.7 Cg_exo -82.02 149.54 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 CA-C-N 120.505 1.216 . . . . 0.0 110.456 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.68 -36.59 83.41 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.09 -32.9 72.55 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.61 -30.32 56.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.833 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.98 -34.9 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 119.954 1.252 . . . . 0.0 111.459 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.2 m -68.34 -39.16 82.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.893 1.224 . . . . 0.0 112.62 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.91 -37.54 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.947 -0.47 . . . . 0.0 111.774 174.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.04 -47.8 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.81 -0.556 . . . . 0.0 111.956 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.33 -30.06 70.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.21 -9.86 59.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 29.7 p -71.12 -35.25 71.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.05 167.05 14.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 123.16 1.457 . . . . 0.0 114.2 -150.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.73 101.89 0.57 Allowed Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.483 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -50.93 -6.98 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 N-CA-C 120.707 3.311 . . . . 0.0 120.707 -153.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -88.96 55.03 3.19 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.769 1.622 . . . . 0.0 108.809 160.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.23 157.89 28.48 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.1 p -128.05 159.17 35.9 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.274 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -127.56 142.7 51.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.542 -2.117 . . . . 0.0 106.141 -173.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.047 HD13 ' SG ' ' A' ' 116' ' ' CYS . 46.7 mm -129.04 89.1 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 170.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.97 -88.43 0.09 OUTLIER Glycine 0 C--N 1.318 -0.472 0 N-CA-C 121.587 3.395 . . . . 0.0 121.587 -166.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 91' ' ' LEU . 3.3 mt -116.37 146.85 42.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.617 1.199 . . . . 0.0 109.513 -130.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.7 p -86.36 -136.68 0.08 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.526 -158.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.69 -50.5 13.51 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -156.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.22 -32.5 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 124.789 2.233 . . . . 0.0 113.015 170.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.0 m-85 -76.63 -14.89 59.95 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.737 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -59.08 -55.82 30.2 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.079 -1.013 . . . . 0.0 111.951 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.07 -34.85 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.897 -0.502 . . . . 0.0 111.49 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.01 -40.93 90.96 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 171.768 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.406 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . . . -58.89 -43.59 90.98 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.912 -0.492 . . . . 0.0 111.741 173.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.98 -49.45 71.39 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.702 0.763 . . . . 0.0 112.543 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.3 tt -80.24 -33.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.594 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -71.72 -19.71 62.01 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.96 33.28 4.09 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 119.607 -1.282 . . . . 0.0 112.597 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.503 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 95.8 m-85 -106.48 159.65 16.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 168.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -126.13 103.88 7.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.593 HG13 ' CD1' ' A' ' 117' ' ' TRP . 18.0 tt -76.15 140.69 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 122.882 1.325 . . . . 0.0 111.316 -168.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.45 119.02 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -106.56 94.55 5.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.598 1.666 . . . . 0.0 110.642 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -134.1 179.17 1.45 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 112.496 -2.138 . . . . 0.0 106.737 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.83 -11.53 3.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 118.654 2.521 . . . . 0.0 118.654 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -122.83 111.51 16.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 157.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.09 110.26 21.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.393 -0.813 . . . . 0.0 109.23 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.274 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 26.3 p -147.75 -157.03 0.77 Allowed 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 122.808 1.29 . . . . 0.0 113.65 170.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.593 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.5 m0 -137.33 130.42 30.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.618 -170.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -112.86 144.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.276 -1.515 . . . . 0.0 110.294 166.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.77 110.49 15.17 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.375 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.47 0.552 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.344 -170.321 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.37 141.96 27.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.65 0.738 . . . . 0.0 110.839 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -95.74 141.42 29.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 162.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.76 -160.12 9.22 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-O 124.132 1.962 . . . . 0.0 115.205 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.452 HD21 ' CE2' ' A' ' 40' ' ' PHE . 3.8 mt -134.2 139.67 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.4 -2.4 . . . . 0.0 107.751 -174.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.41 130.01 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.817 1.294 . . . . 0.0 107.839 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.425 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 8.7 mp -113.85 120.34 40.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.719 175.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.2 mt -121.3 139.9 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -171.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -94.11 129.77 36.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 165.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -60.68 -16.43 43.35 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 N-CA-C 121.056 3.444 . . . . 0.0 121.056 -170.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.78 72.49 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.317 1.417 . . . . 0.0 113.111 -162.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.02 -29.93 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.6 p -86.12 0.47 53.46 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -170.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -76.29 0.35 19.63 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 120.674 1.579 . . . . 0.0 112.601 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.322 90.8 m -98.87 168.09 10.29 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 162.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.74 -7.26 16.54 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 N-CA-C 117.837 2.206 . . . . 0.0 117.837 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.17 -50.48 19.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -159.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.29 -29.83 67.78 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.468 1.031 . . . . 0.0 112.579 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 t -66.26 -49.99 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.982 -0.449 . . . . 0.0 110.513 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.4 -39.73 88.4 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.982 -1.074 . . . . 0.0 113.29 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -59.87 -50.32 74.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 t -68.47 -34.51 76.07 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.615 -0.678 . . . . 0.0 111.698 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.27 -29.96 69.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 170.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.03 -47.09 66.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.482 1.037 . . . . 0.0 112.288 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.75 -48.72 77.19 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.97 60.64 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.549 169.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.29 70.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.2 -170.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -75.34 -19.53 59.56 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.1 -111.0 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.771 -0.581 . . . . 0.0 111.255 170.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -149.48 -10.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -166.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -98.98 149.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 121.592 -0.692 . . . . 0.0 112.402 170.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -128.29 143.9 51.07 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 164.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -92.54 139.84 30.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.754 0.788 . . . . 0.0 109.453 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.36 -32.69 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -121.62 169.98 10.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.292 1.52 . . . . 0.0 109.961 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -139.8 125.18 19.02 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.687 -172.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.452 ' CE2' HD21 ' A' ' 8' ' ' LEU . 21.4 m-30 -129.49 106.42 8.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -84.92 149.57 25.56 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.45 -0.781 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 tp -63.33 -40.11 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.12 -30.35 34.57 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.576 -0.702 . . . . 0.0 112.823 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -79.03 -31.59 44.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.122 -0.987 . . . . 0.0 112.789 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -72.6 -40.59 66.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.604 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.14 -15.29 58.98 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.978 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.34 -43.41 11.54 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.26 -0.9 . . . . 0.0 111.989 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.99 15.3 2.35 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -76.05 -25.58 55.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.638 1.719 . . . . 0.0 114.575 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.7 121.7 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -169.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -98.76 159.28 15.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 124.344 2.021 . . . . 0.0 109.349 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -130.91 120.74 24.03 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.028 -153.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.79 169.67 9.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.043 168.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -111.13 88.55 2.81 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.5 -158.81 0.9 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -164.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -90.99 35.07 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.779 -1.555 . . . . 0.0 115.052 -163.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.3 m-85 -82.03 21.84 0.85 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.374 -170.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.55 37.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -163.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' TYR . 1.0 OUTLIER -141.22 115.4 9.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 163.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 18.7 t -118.61 134.51 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.633 -1.622 . . . . 0.0 106.743 -164.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -122.84 134.71 54.39 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.76 110.52 16.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.4 mt -98.05 100.7 12.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.451 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -126.2 92.45 45.66 Favored Pre-proline 0 N--CA 1.474 0.752 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 167.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.536 0.622 0 C-N-CA 122.077 1.851 . . . . 0.0 111.994 170.382 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 16.4 t80 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 30.3 Cg_exo -82.14 149.47 15.41 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 120.617 1.256 . . . . 0.0 110.242 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.54 -38.01 88.33 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.89 -35.15 70.6 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 mt -76.62 -30.26 56.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.51 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.05 -36.17 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 119.899 1.227 . . . . 0.0 111.429 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.8 m -68.62 -39.17 80.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.544 1.066 . . . . 0.0 112.814 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -36.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.992 -0.443 . . . . 0.0 111.855 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.7 -46.44 90.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.743 -0.598 . . . . 0.0 111.849 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.86 70.21 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.33 -10.15 59.55 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -169.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.0 m -76.17 -34.64 59.35 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 168.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.83 176.5 6.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 123.998 1.856 . . . . 0.0 114.885 -148.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 88' ' ' ASN . 29.3 tptp -105.06 101.57 30.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 -170.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -51.34 16.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.384 1 N-CA-C 122.903 4.155 . . . . 0.0 122.903 -153.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 86' ' ' LYS . 28.5 m120 -102.05 61.37 0.87 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 156.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.47 137.39 13.23 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.1 p -134.08 109.45 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.644 1.212 . . . . 0.0 107.884 -169.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.242 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.28 6.2 tt -93.38 132.25 37.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.813 -174.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.006 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 37.0 mm -115.68 84.94 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -170.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.88 -87.2 0.09 OUTLIER Glycine 0 C--N 1.315 -0.593 0 N-CA-C 121.168 3.227 . . . . 0.0 121.168 -163.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.88 169.85 8.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.169 -139.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.468 ' H ' ' HD2' ' A' ' 98' ' ' TYR . 43.0 m -105.35 -155.32 0.54 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.282 -0.886 . . . . 0.0 112.37 -157.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.95 -42.98 84.32 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -163.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -59.8 -33.15 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 124.3 2.0 . . . . 0.0 112.545 169.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.468 ' HD2' ' H ' ' A' ' 95' ' ' SER . 32.0 m-85 -76.54 -12.85 60.09 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.785 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.4 tttt -62.81 -48.29 79.73 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.065 -1.022 . . . . 0.0 112.404 165.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.69 -38.33 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.489 -0.757 . . . . 0.0 110.714 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.34 -48.45 81.7 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 170.366 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.99 -41.58 71.4 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.56 -47.48 83.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.8 mt -77.16 -35.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.038 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -71.97 -16.74 62.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.84 29.93 5.36 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.947 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.3 m-85 -106.92 159.7 16.07 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.768 1.27 . . . . 0.0 108.809 173.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.59 109.52 11.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.36 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.62 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -85.63 111.15 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.905 1.336 . . . . 0.0 114.082 -164.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 19.0 tt -119.51 135.07 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.231 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -119.64 97.28 5.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.911 -168.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -117.31 -177.42 0.45 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 112.606 -2.088 . . . . 0.0 107.582 164.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.4 -11.11 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 N-CA-C 118.948 2.634 . . . . 0.0 118.948 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -103.95 113.31 26.75 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 154.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.505 ' OH ' HD11 ' A' ' 109' ' ' ILE . 28.5 t80 -80.12 115.16 19.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.612 170.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.242 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 24.4 p -147.35 -156.86 0.75 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.168 1.461 . . . . 0.0 112.343 166.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.62 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.4 m0 -132.58 149.66 52.28 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -174.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.58 144.18 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 122.983 1.373 . . . . 0.0 108.586 165.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.69 110.19 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.928 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.156 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -88.89 141.8 28.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.016 0.912 . . . . 0.0 110.706 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.46 141.64 30.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 160.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.79 -168.25 11.78 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-O 123.964 1.869 . . . . 0.0 117.052 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.444 HD11 ' CE2' ' A' ' 40' ' ' PHE . 30.1 tp -134.39 115.14 13.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 111.215 -2.493 . . . . 0.0 106.213 -165.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 129.19 54.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.35 148.88 32.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.908 1.337 . . . . 0.0 108.646 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.8 mt -133.7 111.63 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.651 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -87.07 129.52 51.64 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -59.97 -19.74 56.89 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 N-CA-C 121.008 3.426 . . . . 0.0 121.008 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.44 74.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.685 1.13 . . . . 0.0 113.197 -162.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.59 -27.6 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -171.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.7 p -86.1 0.39 53.63 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -170.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.3 m -76.4 -0.26 22.13 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 120.681 1.582 . . . . 0.0 111.738 168.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 m -108.96 71.6 0.44 Allowed Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 43.86 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.088 3.192 . . . . 0.0 116.421 -153.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.39 -39.6 92.41 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.579 -0.701 . . . . 0.0 112.138 162.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.31 -30.72 68.56 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.11 -48.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 122.341 -0.224 . . . . 0.0 110.907 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.47 -33.07 74.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.9 -48.39 37.62 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -61.45 -42.58 98.98 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.523 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -65.52 -32.92 74.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.145 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.59 78.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.069 1.304 . . . . 0.0 113.177 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.0 -55.49 30.29 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.67 87.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.64 70.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -170.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.8 m -58.09 -28.67 64.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 170.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -85.84 -101.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.85 -0.531 . . . . 0.0 109.967 -170.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -147.26 27.72 1.02 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -131.05 110.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.978 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.4 139.46 37.03 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.072 -1.017 . . . . 0.0 108.989 168.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -88.99 139.84 30.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.83 -33.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.876 -166.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -121.82 169.58 10.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.684 1.23 . . . . 0.0 108.906 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -126.64 154.64 43.74 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.444 ' CE2' HD11 ' A' ' 8' ' ' LEU . 14.3 m-30 -136.12 112.93 10.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.7 149.24 25.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -63.47 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.79 -30.31 40.58 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.49 -29.68 30.39 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.099 -1.001 . . . . 0.0 113.113 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.89 -40.35 72.27 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.892 . . . . 0.0 111.874 174.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -73.37 -18.82 61.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.09 -46.41 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.291 -0.881 . . . . 0.0 112.1 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.74 15.15 1.41 Allowed Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -77.53 -10.55 59.55 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.024 1.912 . . . . 0.0 115.645 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.78 121.36 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.692 -0.63 . . . . 0.0 109.671 -169.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -98.97 120.29 39.17 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 123.814 1.769 . . . . 0.0 109.776 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -119.1 120.84 38.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.76 -158.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.5 169.57 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.472 1.129 . . . . 0.0 109.39 167.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -110.14 88.35 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.85 -119.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -100.09 56.89 0.95 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -156.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -112.05 10.73 20.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 85' ' ' LEU 0.253 19.3 mt-10 -78.75 46.55 0.67 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.944 2.611 . . . . 0.0 112.542 -170.122 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.99 108.85 17.92 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 150.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.61 110.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.54 -2.118 . . . . 0.0 107.894 -155.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -115.05 105.33 12.83 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 -174.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.83 141.97 28.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 119.819 -1.801 . . . . 0.0 109.498 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -124.06 80.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.481 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -134.06 81.9 49.94 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.94 1.7 . . . . 0.0 111.367 -170.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 CA--C 1.538 0.677 0 C-N-CA 121.993 1.795 . . . . 0.0 110.267 169.979 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 5.8 t80 . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 23.2 Cg_exo -82.27 149.63 15.19 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 120.046 1.052 . . . . 0.0 110.402 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.49 -34.59 77.17 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -59.29 -36.53 75.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.56 -30.15 56.95 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.985 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.89 -40.18 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 O-C-N 121.281 -0.887 . . . . 0.0 110.937 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.6 m -71.23 -30.92 66.94 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.996 -1.065 . . . . 0.0 113.853 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.96 -46.01 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.858 -0.526 . . . . 0.0 110.799 171.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -37.38 75.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.4 70.48 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.02 -9.79 58.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -68.41 -50.48 52.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.938 -0.476 . . . . 0.0 112.104 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.479 ' CD1' ' H ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -98.82 -141.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -174.004 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.581 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.262 74.9 mmtt -129.84 -139.51 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -170.268 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 49.6 Cg_endo -68.97 -50.25 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 CA-C-N 124.385 2.602 . . . . 0.0 114.129 170.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -79.33 53.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.217 1.371 . . . . 0.0 114.318 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.39 164.72 28.35 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 161.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.5 t -147.02 159.23 43.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.185 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.376 1.2 tm? -128.44 129.55 46.3 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 112.222 -2.263 . . . . 0.0 104.91 -162.124 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.804 HD13 ' CB ' ' A' ' 116' ' ' CYS . 40.3 mm -118.49 84.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.016 1.734 . . . . 0.0 108.256 170.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.82 -88.18 0.09 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 -161.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.61 169.77 8.94 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.798 -143.038 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.4 m -108.69 -148.47 0.42 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -158.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.54 -45.05 88.81 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -163.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.89 -31.19 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 124.762 2.22 . . . . 0.0 110.84 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.755 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 79.1 m-85 -76.75 -2.97 35.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.523 -174.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.408 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 87.3 tttt -67.2 -49.18 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.213 -0.929 . . . . 0.0 111.892 170.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.4 -34.41 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.02 169.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.755 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.19 -47.94 83.84 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 172.445 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.32 80.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 tp -58.94 -49.94 75.95 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.613 0.72 . . . . 0.0 112.55 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.19 -34.38 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.4 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -71.69 -16.68 62.25 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.67 29.04 5.74 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.496 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 82.7 m-85 -106.67 159.72 15.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -120.83 153.94 36.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.522 ' CG1' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -112.07 152.45 13.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.566 -167.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 tp -154.01 120.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.66 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -107.6 100.23 9.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 123.735 1.731 . . . . 0.0 110.196 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.73 -178.24 0.64 Allowed Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 111.72 -2.491 . . . . 0.0 106.698 169.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.06 -10.73 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 119.314 2.774 . . . . 0.0 119.314 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -119.71 111.53 18.14 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 158.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.44 115.33 27.49 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.941 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.185 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 11.7 p -147.12 -163.44 1.76 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 124.321 2.01 . . . . 0.0 114.334 172.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.522 ' CD2' HD12 ' A' ' 91' ' ' LEU . 13.2 m0 -137.65 130.35 29.91 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 110.559 -3.019 . . . . 0.0 106.412 -165.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 144.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.585 -1.322 . . . . 0.0 108.88 165.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -79.59 110.58 15.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.753 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.391 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.9 t80 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.63 141.81 28.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.97 0.89 . . . . 0.0 111.319 -165.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 m -96.96 141.17 30.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 172.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -134.2 -158.7 8.62 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 118.787 -1.673 . . . . 0.0 115.76 172.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.31 139.67 45.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 113.252 -1.474 . . . . 0.0 108.636 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.59 138.7 54.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.997 1.379 . . . . 0.0 107.815 165.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.91 120.46 30.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.264 -1.789 . . . . 0.0 108.983 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 tt -129.02 139.84 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.05 0.929 . . . . 0.0 111.316 -160.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -106.94 129.8 23.83 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 166.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -60.0 -15.82 35.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 N-CA-C 119.984 3.032 . . . . 0.0 119.984 -170.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -50.19 74.21 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.294 0.952 . . . . 0.0 112.206 -167.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -34.26 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -85.41 -0.01 53.56 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -76.48 -8.18 56.64 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 120.064 1.302 . . . . 0.0 111.59 164.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.5 m -111.62 71.46 0.93 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 164.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.84 53.3 0.77 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.3 3.334 . . . . 0.0 116.779 -154.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.12 -48.73 27.55 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.753 -1.217 . . . . 0.0 112.67 165.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.53 -30.34 71.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.27 -45.64 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.147 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.76 -34.94 78.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.57 -48.21 49.82 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 t -60.72 -40.96 94.26 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.81 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.91 -32.99 73.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.172 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.14 74.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.942 1.246 . . . . 0.0 113.823 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -55.05 -55.26 33.01 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.66 -46.31 84.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.037 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.24 -50.01 71.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -170.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -69.85 -20.55 63.41 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 112.574 -170.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.73 -103.13 0.06 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.314 0.578 . . . . 0.0 109.443 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -157.4 4.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.86 150.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.643 0.735 . . . . 0.0 111.451 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -128.42 135.03 48.95 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 161.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -88.93 139.56 30.33 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.83 -14.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -163.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.61 120.32 34.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -114.77 125.1 53.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -163.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -130.17 102.35 6.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.689 -175.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.7 tt -85.24 149.34 25.56 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.061 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -63.42 -40.17 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.512 ' H ' HD23 ' A' ' 41' ' ' LEU . 22.1 t-20 -81.64 -30.34 32.83 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.197 -0.939 . . . . 0.0 112.762 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.91 -30.75 56.28 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.433 -0.792 . . . . 0.0 112.577 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -40.43 70.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.882 0.765 . . . . 0.0 112.306 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.17 -20.64 47.93 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.74 -30.55 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 111.623 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.53 15.14 11.57 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 t -78.4 -34.34 48.14 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 mt -114.98 120.3 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.753 0.787 . . . . 0.0 108.983 -167.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.0 m -133.05 158.71 42.07 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.5 mt -131.71 -138.5 0.2 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.93 178.77 4.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.013 0.911 . . . . 0.0 109.937 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -120.1 67.38 0.83 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.187 -169.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.19 -77.92 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 -170.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -82.9 7.74 14.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 -157.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -90.13 21.25 3.83 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.16 -167.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.93 26.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -167.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 57' ' ' TYR . 6.4 t -133.12 115.1 14.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 162.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.56 134.32 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -167.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -122.71 134.75 54.45 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.28 142.23 42.18 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.36 102.66 8.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.604 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.423 HG22 ' HD2' ' A' ' 65' ' ' PRO . 29.8 m -139.43 154.75 71.94 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 170.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.423 ' HD2' HG22 ' A' ' 64' ' ' THR . 79.8 Cg_exo . . . . . 0 CA--C 1.532 0.388 0 C-N-CA 122.849 2.366 . . . . 0.0 116.366 170.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.2 t80 . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 31.2 Cg_exo -82.0 149.34 15.63 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 CA-C-N 121.233 1.476 . . . . 0.0 110.109 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -37.9 88.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.11 -33.61 73.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -76.72 -30.15 56.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.34 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -36.72 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.75 1.159 . . . . 0.0 111.442 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -68.27 -36.24 79.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.84 1.2 . . . . 0.0 112.82 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.74 -41.14 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.941 -0.474 . . . . 0.0 111.533 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -60.06 -46.35 89.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.648 0.658 . . . . 0.0 112.364 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.88 70.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.7 -10.02 59.12 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -170.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -104.44 23.32 13.41 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.3 mt -134.12 -166.64 1.83 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.165 0.983 . . . . 0.0 110.829 -163.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.96 174.88 3.95 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -170.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.8 -22.72 14.25 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 170.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -102.51 45.83 0.95 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.741 1.61 . . . . 0.0 110.4 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.45 138.4 20.34 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -143.4 109.08 5.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.43 1.586 . . . . 0.0 107.041 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.161 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.368 0.2 OUTLIER -89.82 129.72 36.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -176.075 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.255 HD13 ' SG ' ' A' ' 116' ' ' CYS . 42.7 mm -111.44 95.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.243 1.021 . . . . 0.0 109.097 170.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.93 -83.68 0.06 OUTLIER Glycine 0 C--N 1.315 -0.625 0 N-CA-C 120.851 3.1 . . . . 0.0 120.851 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.557 HD12 HD11 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -116.09 169.94 8.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 118.764 -1.174 . . . . 0.0 108.476 -133.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -103.02 -140.94 0.36 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.07 -1.019 . . . . 0.0 112.63 -155.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.22 -44.79 24.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -162.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tp -56.63 -33.05 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 124.505 2.097 . . . . 0.0 112.569 167.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.712 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 71.8 m-85 -76.66 -10.88 59.7 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.203 -176.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.6 tttt -58.45 -51.52 69.51 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 112.256 167.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.44 -35.28 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.896 -0.503 . . . . 0.0 111.236 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -57.89 -42.96 85.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 170.126 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.35 94.57 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.164 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -54.92 -48.0 73.65 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.24 -35.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.076 -169.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.68 -18.74 62.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.95 4.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.004 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -106.71 159.69 16.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.5 154.27 35.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.539 1.162 . . . . 0.0 107.933 158.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.626 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.2 tt -107.48 149.26 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.745 -163.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.72 126.18 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 122.553 1.168 . . . . 0.0 107.953 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -106.05 100.21 9.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.593 1.663 . . . . 0.0 109.826 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -127.93 177.59 2.01 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 111.935 -2.393 . . . . 0.0 107.446 170.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.99 -11.82 4.16 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 N-CA-C 119.269 2.757 . . . . 0.0 119.269 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -115.94 108.12 15.86 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 157.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -86.8 113.06 22.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.668 -170.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.255 ' SG ' HD13 ' A' ' 92' ' ' ILE . 25.1 p -147.54 -153.95 0.52 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 123.072 1.415 . . . . 0.0 112.258 172.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.626 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.0 m0 -134.77 149.73 50.46 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.66 144.09 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 166.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -83.31 134.83 34.9 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.742 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 110.616 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 12.5 t80 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.764 0.316 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -105.06 160.58 14.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 123.367 1.556 . . . . 0.0 113.403 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.077 170.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.414 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -123.69 -156.39 9.5 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.849 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 tp -134.03 142.72 47.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -166.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.05 129.83 51.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 40' ' ' PHE . 1.3 mt -109.36 120.08 41.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 171.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 tt -132.14 139.93 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.539 0.685 . . . . 0.0 109.324 -173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -101.08 129.75 26.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.39 -12.02 25.53 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.968 3.026 . . . . 0.0 119.968 -170.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.26 52.44 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -161.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -85.2 -29.81 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.175 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.2 p -81.08 0.24 36.91 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -76.33 -0.87 24.1 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.859 1.209 . . . . 0.0 112.247 165.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 m -112.47 71.5 1.18 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 163.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.17 46.1 1.08 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.986 3.124 . . . . 0.0 116.219 -152.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.24 -43.5 91.21 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.599 -0.688 . . . . 0.0 112.608 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.49 -29.94 70.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.25 -46.88 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.934 -0.479 . . . . 0.0 110.887 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.25 -33.92 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.89 -48.79 57.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 t -61.73 -39.21 90.74 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.477 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -66.3 -29.9 70.21 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.34 76.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.236 1.38 . . . . 0.0 113.428 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -59.69 -50.83 72.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.966 -0.459 . . . . 0.0 111.611 170.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.91 -42.66 59.58 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.69 -49.92 12.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -59.35 -37.39 77.74 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 170.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.9 -106.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.717 -0.615 . . . . 0.0 110.389 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 4' ' ' TYR . 43.1 mmtm -129.76 -44.86 1.19 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -169.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 59' ' ' THR . 2.3 p -97.98 149.58 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.728 1.251 . . . . 0.0 111.335 -165.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -114.88 136.0 53.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.63 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -90.46 139.47 30.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.7 t -118.74 -32.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.63 -162.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -121.86 169.99 10.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.273 1.511 . . . . 0.0 110.859 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -134.49 125.4 27.31 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.757 -174.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 10' ' ' LEU . 18.4 m-30 -118.68 120.21 36.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 168.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.64 149.43 22.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.53 -40.09 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.97 -30.45 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -85.53 -31.5 22.68 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -0.918 . . . . 0.0 112.944 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -66.21 -40.56 90.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.26 0.937 . . . . 0.0 112.054 171.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -69.67 -24.98 63.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.992 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.13 -39.86 16.27 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.67 -0.644 . . . . 0.0 111.78 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.34 15.36 1.14 Allowed Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -79.74 -30.09 40.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -171.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.8 mt -114.75 120.28 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.867 0.841 . . . . 0.0 109.854 -164.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -128.26 120.45 27.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.239 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.5 -167.43 1.36 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.897 1.332 . . . . 0.0 110.537 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -98.58 120.5 39.12 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.203 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -81.17 46.67 0.94 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -161.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.03 4.42 0.63 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 119.594 3.183 . . . . 0.0 119.594 170.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -100.4 -34.59 9.89 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 122.089 2.222 . . . . 0.0 115.801 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' THR . 8.2 m-85 -81.87 22.04 0.8 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -157.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.3 37.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -167.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.522 HG21 HG21 ' A' ' 34' ' ' VAL . 8.8 t -138.57 115.32 10.69 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 160.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.87 110.34 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.504 -160.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -105.88 134.6 48.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.408 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -118.06 110.42 17.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.25 -0.906 . . . . 0.0 109.017 176.357 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.51 89.5 3.23 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.468 -170.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -136.76 86.71 21.36 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 CA--C 1.54 0.786 0 C-N-CA 122.127 1.884 . . . . 0.0 112.84 170.343 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 28.6 Cg_exo -82.2 149.44 15.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 CA-C-N 120.962 1.379 . . . . 0.0 110.344 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -38.38 90.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.14 -31.76 70.39 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.68 -30.3 56.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.992 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.38 -35.28 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 120.203 1.365 . . . . 0.0 111.227 170.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.9 m -68.94 -39.93 79.26 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.597 1.09 . . . . 0.0 112.503 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.19 -38.09 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.942 -0.474 . . . . 0.0 111.84 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -65.85 -40.48 91.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.709 -0.619 . . . . 0.0 112.571 176.168 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.0 70.72 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.86 -19.16 61.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.4 m -72.06 -17.02 62.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -111.15 159.93 17.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.123 0.963 . . . . 0.0 110.387 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -91.38 174.96 3.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.341 169.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -60.43 -10.61 13.93 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 117.508 2.08 . . . . 0.0 117.508 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -102.07 50.06 0.84 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 168.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.14 141.4 25.03 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.9 p -139.66 103.79 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.194 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.274 2.6 tt -89.96 129.78 36.25 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -178.385 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.117 HD13 ' SG ' ' A' ' 116' ' ' CYS . 32.3 mm -110.18 91.14 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -80.71 0.05 OUTLIER Glycine 0 C--N 1.315 -0.596 0 N-CA-C 121.22 3.248 . . . . 0.0 121.22 -163.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.558 HD12 HD21 ' A' ' 91' ' ' LEU . 3.1 mt -115.97 169.78 8.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.227 -141.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 p -123.55 -117.31 0.29 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 119.636 -0.826 . . . . 0.0 113.009 -158.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.36 -59.39 2.73 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -155.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mt -59.7 -26.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 124.248 1.975 . . . . 0.0 111.593 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.712 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 62.4 m-85 -76.9 -18.73 58.12 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.283 -169.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -54.44 -53.96 47.22 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.988 -1.07 . . . . 0.0 112.436 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.06 -33.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.837 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.84 -43.34 94.65 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 172.102 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.61 97.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.86 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.03 -44.52 95.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -80.01 -35.63 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.038 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -71.78 -18.74 62.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 32.11 4.52 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.79 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.6 m-85 -106.77 159.96 15.84 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -128.51 109.09 11.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.593 HG13 ' CD1' ' A' ' 117' ' ' TRP . 20.2 tt -87.6 111.22 21.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 122.751 1.263 . . . . 0.0 114.393 -162.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.5 tt -105.12 125.25 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.756 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -115.41 81.53 1.6 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 124.285 1.993 . . . . 0.0 111.299 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 114' ' ' ASP . 90.1 mt-10 -134.34 100.47 12.69 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 -170.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.63 29.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.971 1 N-CA-C 124.8 4.885 . . . . 0.0 124.8 -140.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.2 m-20 -99.68 99.82 10.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 132.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.572 -163.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 1.194 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 23.8 p -147.3 -156.49 0.72 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 123.104 1.43 . . . . 0.0 111.77 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.593 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.7 m0 -134.24 149.6 50.98 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 -174.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 143.91 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.351 1.072 . . . . 0.0 108.25 164.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -90.2 64.82 6.2 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.437 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.379 170.13 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -117.47 141.63 48.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.772 1.273 . . . . 0.0 111.347 -170.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -105.26 120.89 42.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.359 174.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.27 -161.13 9.69 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 123.59 1.661 . . . . 0.0 117.086 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.5 tp -127.95 139.9 52.31 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 111.795 -2.203 . . . . 0.0 107.196 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -124.37 129.28 50.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 162.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -123.34 120.07 31.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -176.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.0 pt -131.21 139.99 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.492 -0.755 . . . . 0.0 111.218 -167.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.4 129.69 36.09 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 166.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.31 -13.9 18.08 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 N-CA-C 120.205 3.117 . . . . 0.0 120.205 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.52 -50.2 66.13 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -163.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.28 -34.02 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.166 170.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.5 p -83.49 0.4 46.53 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 t -76.58 -6.01 50.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.687 1.585 . . . . 0.0 114.573 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.312 62.8 m -98.94 168.11 10.24 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 169.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.59 -6.72 16.41 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 N-CA-C 116.915 1.852 . . . . 0.0 116.915 -170.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.12 -50.19 20.55 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.721 1.146 . . . . 0.0 113.833 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.99 -31.44 70.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.656 0.662 . . . . 0.0 112.123 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.77 -47.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 122.232 -0.292 . . . . 0.0 111.044 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.35 -32.69 72.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.49 -49.09 52.05 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.4 t -61.83 -40.08 94.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.176 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.33 -34.2 77.6 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.3 70.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.287 1.403 . . . . 0.0 113.246 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.297 0.5 OUTLIER -54.85 -53.7 51.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.11 82.93 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.58 -50.03 14.88 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -25.54 61.14 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -85.8 -114.83 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.628 -0.67 . . . . 0.0 109.659 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -154.1 11.79 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.1 149.88 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.817 0.818 . . . . 0.0 111.778 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.44 137.88 52.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 162.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -88.75 139.45 30.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.3 t -117.21 -35.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.542 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -122.05 120.15 33.5 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -157.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -114.88 114.17 25.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -162.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.512 ' O ' HD23 ' A' ' 10' ' ' LEU . 18.5 m-30 -119.05 120.57 37.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.6 tt -91.47 149.37 21.73 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.49 -40.05 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.543 ' H ' HD23 ' A' ' 41' ' ' LEU . 21.2 m120 -80.51 -30.35 37.28 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.55 -31.44 42.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.33 -0.856 . . . . 0.0 112.823 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.42 -40.36 70.51 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.866 0.757 . . . . 0.0 112.107 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -69.46 -24.56 63.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.26 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.09 -35.26 37.2 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.71 -0.619 . . . . 0.0 111.42 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.41 15.15 6.07 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.937 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.6 m -75.07 -36.1 61.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.68 1.24 . . . . 0.0 113.834 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.71 111.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 122.766 1.269 . . . . 0.0 108.815 -165.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.2 m -133.28 115.15 14.59 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.259 18.1 tp -124.63 -52.94 1.69 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.293 -0.963 . . . . 0.0 113.308 -159.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -149.36 169.47 20.75 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.6 49.05 1.5 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.14 -86.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 6' ' ' THR . 93.2 mttt -100.22 62.29 1.1 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -160.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.2 m-85 -112.15 22.06 15.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.827 166.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.48 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -161.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.03 115.53 6.7 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 168.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 14.0 t -119.59 134.51 62.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.601 -164.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -122.46 134.67 54.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.47 110.21 16.65 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.42 102.03 13.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.886 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -120.09 154.59 55.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.49 134.51 38.76 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.114 1.876 . . . . 0.0 115.148 170.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -120.08 30.04 7.2 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.195 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.83 -23.56 14.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 170.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -74.93 149.8 39.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.103 0.865 . . . . 0.0 110.595 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.5 m -106.45 74.22 1.01 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.997 0.903 . . . . 0.0 109.038 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -135.04 178.72 6.8 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 170.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 pt -90.74 149.26 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.571 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.43 -63.35 1.13 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 118.525 2.787 . . . . 0.0 118.525 -170.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 7.7 t80 -130.42 149.39 73.27 Favored Pre-proline 0 N--CA 1.474 0.749 0 O-C-N 120.861 -1.15 . . . . 0.0 110.331 -156.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 21.4 Cg_exo -82.16 149.71 15.43 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.773 0.954 . . . . 0.0 111.171 175.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.58 -39.77 94.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.68 -31.43 69.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.5 mt -76.67 -30.29 56.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.445 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.01 -37.59 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.045 1.293 . . . . 0.0 111.226 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.4 p -68.47 -39.15 81.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.112 1.324 . . . . 0.0 112.672 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.19 -39.77 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.912 -0.493 . . . . 0.0 112.201 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -39.34 93.37 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.62 -0.675 . . . . 0.0 112.683 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.95 -29.8 70.76 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.11 -10.02 55.6 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -99.82 16.51 23.46 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.3 mt -131.18 -174.11 3.29 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.526 1.155 . . . . 0.0 110.289 -168.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 67.8 mttm -140.04 174.93 3.53 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -170.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 1.1 Cg_endo -61.4 -16.3 46.41 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 N-CA-C 118.341 2.401 . . . . 0.0 118.341 -170.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -102.27 45.06 0.98 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.467 1.03 . . . . 0.0 110.544 168.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.15 144.22 34.38 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 78.7 p -146.99 109.84 4.68 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.249 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.285 0.6 OUTLIER -93.29 129.96 39.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.805 -173.363 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' HB3' ' A' ' 116' ' ' CYS . 27.6 mm -113.34 84.56 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.471 1.032 . . . . 0.0 108.894 170.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -83.23 0.06 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 121.361 3.304 . . . . 0.0 121.361 -166.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.544 HD12 HD21 ' A' ' 91' ' ' LEU . 4.9 mt -116.36 146.89 42.12 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.636 1.208 . . . . 0.0 110.308 -135.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.2 p -94.61 -129.4 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.535 -156.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.5 -48.51 15.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -158.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.69 -29.52 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 124.555 2.122 . . . . 0.0 111.339 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.612 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 87.0 m-85 -76.73 -14.4 59.95 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.834 -172.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.31 -55.24 37.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.824 -1.173 . . . . 0.0 112.571 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.86 -34.35 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.812 -0.555 . . . . 0.0 111.295 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.35 -42.0 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 173.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.49 -48.66 80.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.882 0.849 . . . . 0.0 112.334 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.15 -35.45 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.212 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -71.57 -18.81 62.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 33.92 3.94 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.673 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.52 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 72.6 m-85 -106.7 159.64 16.06 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.29 104.39 9.1 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.013 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.61 HD11 ' OH ' ' A' ' 115' ' ' TYR . 19.8 tt -83.7 110.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.787 1.28 . . . . 0.0 114.377 -167.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.6 tt -111.64 131.41 63.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 113.183 -1.826 . . . . 0.0 108.928 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -109.42 86.93 2.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 124.059 1.885 . . . . 0.0 112.181 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 114' ' ' ASP . 55.1 mt-10 -134.41 100.49 12.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -54.77 28.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 1 N-CA-C 124.663 4.832 . . . . 0.0 124.663 -144.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.8 p-10 -99.58 100.29 11.28 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 131.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.61 ' OH ' HD11 ' A' ' 109' ' ' ILE . 19.3 t80 -80.05 115.28 19.53 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.907 -0.496 . . . . 0.0 110.763 -164.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.249 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.4 p -147.24 -161.16 1.27 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 124.621 2.153 . . . . 0.0 115.177 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.582 ' CD1' HG13 ' A' ' 109' ' ' ILE . 19.0 m0 -137.4 126.28 24.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 109.71 -3.405 . . . . 0.0 106.462 -167.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.303 0.1 OUTLIER -112.65 111.22 35.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 O-C-N 121.365 -0.834 . . . . 0.0 109.483 177.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -79.1 134.28 36.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.2 ttt . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.539 170.599 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -117.7 141.83 47.95 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -99.98 141.86 32.23 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 162.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.414 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -133.7 -159.47 9.0 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 122.98 1.322 . . . . 0.0 116.243 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.01 139.51 46.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 113.172 -1.514 . . . . 0.0 107.379 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.417 HD11 HG23 ' A' ' 11' ' ' ILE . 20.7 tp -124.6 131.4 53.48 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.292 1.044 . . . . 0.0 108.506 170.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 120.18 38.82 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.133 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 9' ' ' LEU . 6.0 pt -123.54 139.81 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.452 ' HB3' HG23 ' A' ' 64' ' ' THR . 6.0 t60 -90.32 130.01 43.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.13 -18.23 9.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 121.603 3.655 . . . . 0.0 121.603 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.19 71.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 -158.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.16 -27.28 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.26 168.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.6 p -71.52 -14.29 62.07 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.7 m -76.62 -4.03 40.86 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 120.795 1.634 . . . . 0.0 111.933 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.326 96.3 m -98.55 168.18 10.25 Favored Pre-proline 0 CA--C 1.558 1.264 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.42 -0.69 10.87 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 N-CA-C 117.768 2.18 . . . . 0.0 117.768 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.05 -50.54 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.351 1.432 . . . . 0.0 113.952 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.18 -31.51 70.18 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.741 0.7 . . . . 0.0 112.422 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.4 -48.41 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 122.121 -0.362 . . . . 0.0 110.768 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -61.84 -33.25 73.82 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -47.45 60.51 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -63.26 -39.99 96.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.432 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -62.72 -34.75 77.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.684 -0.674 . . . . 0.0 112.776 169.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -44.34 72.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.167 1.349 . . . . 0.0 113.674 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -59.9 -53.16 61.09 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.766 0.317 . . . . 0.0 111.704 173.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -58.6 -37.73 76.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.32 -42.94 19.82 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -170.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.9 p -57.8 -20.14 33.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 170.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.77 -100.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -158.14 19.21 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -170.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.463 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 38.9 t -129.93 110.73 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -167.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -99.09 134.94 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -88.97 139.68 30.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.113 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.83 -31.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.34 -168.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -121.74 120.36 34.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -161.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -114.64 124.59 52.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -165.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -127.47 120.2 27.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.17 149.73 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.427 HD13 ' OH ' ' A' ' 62' ' ' TYR . 4.1 tp -63.21 -39.53 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -77.65 -30.31 52.05 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -80.48 -32.82 37.01 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.392 -0.818 . . . . 0.0 113.043 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -73.89 -40.59 63.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.294 0.952 . . . . 0.0 112.393 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -74.24 -20.43 60.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.768 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.5 -37.37 25.37 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.61 -0.681 . . . . 0.0 111.593 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.75 15.21 6.4 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 120.613 -0.803 . . . . 0.0 114.966 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -76.27 -31.63 58.39 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.813 1.307 . . . . 0.0 114.199 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.73 120.26 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -167.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.5 m -122.59 120.05 32.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.046 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -122.35 -161.65 0.95 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.84 170.02 9.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.82 1.295 . . . . 0.0 111.202 -169.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -115.26 71.6 0.77 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.336 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.94 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 6' ' ' THR . 77.8 mttt -97.13 43.66 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -157.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.434 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.6 m-85 -112.21 21.68 15.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 117.545 -1.217 . . . . 0.0 110.685 -170.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.65 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -158.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' TYR . 7.0 t -134.37 115.31 13.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 164.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 65.9 t -119.43 110.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -163.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -107.63 134.29 50.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.427 ' OH ' HD13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -123.36 110.52 15.26 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.122 -0.986 . . . . 0.0 110.165 177.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.94 100.32 8.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 12' ' ' HIS . 63.1 m -119.96 88.63 40.89 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -170.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.24 89.54 1.31 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.185 1.923 . . . . 0.0 111.749 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -120.12 -30.28 4.69 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 170.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.34 -174.12 2.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.713 0.768 . . . . 0.0 109.859 -170.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -75.43 -70.12 0.44 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.763 -0.586 . . . . 0.0 110.127 170.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.4 t -125.12 49.93 1.82 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -170.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -135.02 80.98 1.87 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -170.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.5 tt -108.13 100.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -170.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.63 100.33 11.73 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.305 170.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 -127.71 148.65 67.79 Favored Pre-proline 0 N--CA 1.473 0.723 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 168.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 26.2 Cg_exo -82.33 149.91 15.16 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 120.659 0.906 . . . . 0.0 112.088 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -62.45 -35.42 79.23 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -60.34 -34.34 73.7 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.55 -30.4 57.07 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.655 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.9 -38.52 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 120.357 1.435 . . . . 0.0 111.298 171.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 95.2 p -69.18 -40.74 77.94 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.79 1.177 . . . . 0.0 113.11 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.1 -38.64 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.799 -0.563 . . . . 0.0 112.262 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -33.84 71.62 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.82 -29.77 69.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -69.16 -9.83 54.78 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.4 m -97.99 29.83 3.3 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.15 171.02 14.82 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.359 1.076 . . . . 0.0 112.989 -162.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 49.7 mttm -122.39 -158.02 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 170.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 10.7 Cg_endo -67.65 -43.72 5.2 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 119.834 2.974 . . . . 0.0 119.834 -163.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -90.51 63.29 5.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 122.386 2.357 . . . . 0.0 111.495 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.31 133.99 13.61 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 170.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.6 p -139.16 159.27 42.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.175 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.251 1.1 tt -127.94 129.62 47.12 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.862 HD13 ' CB ' ' A' ' 116' ' ' CYS . 24.8 mm -112.3 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.914 0.864 . . . . 0.0 109.41 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.552 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.72 -79.27 0.04 OUTLIER Glycine 0 C--N 1.318 -0.445 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 -161.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.552 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -115.65 171.15 7.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.962 1.363 . . . . 0.0 111.121 -139.175 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 m -92.97 -162.74 0.96 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.178 -1.373 . . . . 0.0 113.318 -164.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.17 -36.49 84.38 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.25 -32.63 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 124.817 2.246 . . . . 0.0 111.283 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.571 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 93.8 m-85 -76.81 -12.23 59.94 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.501 -172.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HG3' HD13 ' A' ' 109' ' ' ILE . 4.5 ttmp? -58.94 -53.63 56.24 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.815 -1.178 . . . . 0.0 112.367 169.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.04 -37.1 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.802 -0.561 . . . . 0.0 111.068 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.571 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.57 -45.57 93.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.92 172.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.02 74.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.871 -0.518 . . . . 0.0 111.72 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.58 -50.1 70.98 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.655 0.74 . . . . 0.0 112.748 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.35 -34.22 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -71.79 -17.8 62.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.69 29.94 5.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 92.2 m-85 -106.46 159.66 15.99 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -127.55 107.6 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.619 HG13 ' CD1' ' A' ' 117' ' ' TRP . 16.9 tt -76.18 149.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.484 1.135 . . . . 0.0 111.914 -167.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.08 125.13 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.47 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -106.48 100.0 9.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.483 1.611 . . . . 0.0 111.302 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -134.06 175.2 3.85 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 112.449 -2.16 . . . . 0.0 107.252 -170.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -54.97 -19.97 21.5 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.82 109.97 19.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 156.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -87.11 111.11 20.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.637 -0.664 . . . . 0.0 109.258 -170.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.175 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 17.6 p -147.26 -157.18 0.79 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 124.251 1.977 . . . . 0.0 112.694 174.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.619 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.4 m0 -137.25 149.93 47.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 110.305 -3.134 . . . . 0.0 104.421 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.74 144.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.363 161.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 10.0 tmtt? -91.64 134.47 34.66 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 108.765 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.665 0.745 . . . . 0.0 110.563 -170.016 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 122.22 1.009 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.3 147.23 24.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.813 1.292 . . . . 0.0 112.419 -165.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -105.21 120.88 42.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.653 170.013 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 59' ' ' THR . . . -129.32 -160.98 10.41 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 118.446 -1.835 . . . . 0.0 115.418 170.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 139.85 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -164.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.371 0.2 OUTLIER -124.8 129.29 50.15 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.143 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -116.04 120.36 38.84 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.29 139.48 51.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.902 0.858 . . . . 0.0 109.681 -167.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -103.19 129.67 25.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -9.32 17.5 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 N-CA-C 122.032 3.82 . . . . 0.0 122.032 -170.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.36 70.04 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.546 2.424 . . . . 0.0 117.546 -158.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.2 t -93.06 -30.69 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.23 0.923 . . . . 0.0 108.809 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.4 p -80.21 0.26 33.22 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -170.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -76.41 9.3 2.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.42 1.463 . . . . 0.0 113.134 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.332 64.2 m -99.03 168.34 9.85 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 164.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -77.45 -3.99 14.21 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 117.734 2.167 . . . . 0.0 117.734 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -50.4 19.23 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -164.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -29.89 67.9 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.886 0.766 . . . . 0.0 112.752 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.7 t -70.4 -44.29 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.498 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.63 -34.1 72.36 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.052 -1.03 . . . . 0.0 113.634 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.44 72.68 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -58.88 -47.85 83.48 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -29.82 70.18 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -47.54 64.6 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.386 0.994 . . . . 0.0 112.815 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.304 1.4 tm0? -54.98 -52.49 62.92 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -33.5 69.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.31 -50.16 19.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.1 m -60.72 -34.67 74.74 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 170.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.94 -131.02 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -145.1 5.71 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.482 HG21 HG21 ' A' ' 59' ' ' THR . 4.1 p -98.93 154.1 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.681 0.753 . . . . 0.0 111.742 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -128.03 142.43 51.23 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 166.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.73 100.65 12.83 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.637 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.18 -30.79 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.749 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.83 169.64 10.57 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.615 1.198 . . . . 0.0 109.769 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -142.68 116.46 9.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -118.73 115.34 24.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.74 149.51 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.452 HD13 ' OH ' ' A' ' 62' ' ' TYR . 2.8 tp -63.63 -40.26 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.08 -30.25 31.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.77 -29.09 18.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.087 0.858 . . . . 0.0 112.785 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -68.84 -40.45 79.42 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.015 1.279 . . . . 0.0 111.471 170.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.17 -27.91 66.83 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.97 19.54 19.89 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.54 11.22 45.11 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 117.459 1.743 . . . . 0.0 117.459 152.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -82.8 -23.6 33.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -167.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 51' ' ' THR . 8.8 mt -114.63 167.82 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.464 1.029 . . . . 0.0 110.364 -161.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.46 ' N ' HG22 ' A' ' 50' ' ' ILE . 7.4 m -99.73 117.42 34.05 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.718 1.247 . . . . 0.0 110.488 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -96.83 120.35 37.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.242 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -107.58 120.27 41.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 166.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -84.83 67.8 10.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.461 -170.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -74.32 0.07 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 6' ' ' THR . 49.8 mttp -100.27 45.78 0.97 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -160.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.27 21.48 15.74 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.701 165.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 86' ' ' LYS . 8.9 mm-40 -61.67 58.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 171.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.482 HG21 HG21 ' A' ' 34' ' ' VAL . 10.7 t -146.69 113.12 5.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 144.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.91 134.15 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 -170.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.58 134.56 54.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 167.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.452 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -120.79 110.74 16.72 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.965 0.888 . . . . 0.0 109.314 178.343 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.45 100.39 11.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.575 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -125.67 107.39 26.19 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.25 -53.07 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.644 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 -162.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.93 30.04 1.12 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -161.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.46 178.49 4.72 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.675 -1.266 . . . . 0.0 110.668 -170.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -112.3 -78.64 0.58 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -125.11 -56.4 1.55 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -170.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -109.47 100.07 9.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -170.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.86 167.66 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.808 0.813 . . . . 0.0 110.189 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -85.98 94.79 9.3 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 168.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -124.05 90.96 50.2 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.64 170.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.92 149.7 50.39 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.714 1.609 . . . . 0.0 112.243 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.42 -31.91 72.68 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.69 -33.95 70.73 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.4 mt -76.79 -30.23 56.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.017 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -37.22 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 119.325 0.966 . . . . 0.0 111.382 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 97.1 p -70.52 -39.71 73.91 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.812 1.187 . . . . 0.0 112.717 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.03 -46.26 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.562 0.619 . . . . 0.0 111.448 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.05 -30.54 65.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.59 70.72 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -80.77 -9.94 59.77 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -171.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 p -97.74 50.95 1.05 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.1 159.93 28.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -156.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.513 ' H ' ' HG3' ' A' ' 58' ' ' GLU . 69.4 mmtt -100.5 174.9 2.65 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 110.67 -2.968 . . . . 0.0 106.417 163.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 14.2 Cg_endo -53.21 -28.53 42.53 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 118.629 2.511 . . . . 0.0 118.629 170.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -102.07 70.93 1.23 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.266 . . . . 0.0 110.968 170.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.43 131.74 24.64 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 163.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -147.44 120.21 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.607 1.194 . . . . 0.0 108.241 -170.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.199 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.254 0.5 OUTLIER -106.36 129.96 54.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.195 -166.908 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.718 HD13 ' CB ' ' A' ' 116' ' ' CYS . 26.3 mm -111.21 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.963 1.256 . . . . 0.0 108.269 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.92 -94.46 0.19 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 121.579 3.392 . . . . 0.0 121.579 -166.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.717 HD22 HD21 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.48 146.83 41.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.867 -137.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.3 m -107.21 -130.14 0.29 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.078 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.95 128.48 33.73 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.68 -13.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 2 O-C-N 114.952 -4.842 . . . . 0.0 117.848 11.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.764 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.3 m-85 -76.26 -0.79 23.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.591 -2.095 . . . . 0.0 113.155 -152.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.66 -55.74 10.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.74 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.58 -33.75 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.984 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.764 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.26 -41.42 96.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.311 -0.956 . . . . 0.0 113.123 172.513 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.694 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -59.71 -42.89 94.07 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.929 -0.482 . . . . 0.0 111.246 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 tp -55.86 -50.06 71.63 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.619 0.723 . . . . 0.0 112.419 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.1 tt -80.04 -34.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.567 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.63 -16.21 62.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.29 4.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.076 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 76.7 m-85 -106.47 159.7 15.96 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.11 154.17 32.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 102' ' ' ALA . 17.0 mt -104.32 153.25 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.98 1.371 . . . . 0.0 109.899 -171.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.7 tp -151.16 135.0 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.779 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -115.99 88.36 2.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.006 1.86 . . . . 0.0 112.295 -171.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 114' ' ' ASP . 46.1 mt-10 -134.34 100.38 12.74 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -54.95 29.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.102 1 N-CA-C 124.372 4.72 . . . . 0.0 124.372 -141.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 112' ' ' GLU . 12.4 m-20 -99.86 105.63 17.39 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 132.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -79.86 115.36 19.4 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.816 -0.552 . . . . 0.0 110.052 -166.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.199 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.79 -161.31 1.3 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 124.143 1.925 . . . . 0.0 115.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.673 ' CD1' HG12 ' A' ' 109' ' ' ILE . 24.5 m0 -137.05 149.71 47.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 110.384 -3.098 . . . . 0.0 103.905 -165.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.4 mm -110.97 144.72 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 162.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 9.2 tmtt? -93.72 110.01 21.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 18.6 mmt . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 122.017 0.913 . . . . 0.0 112.2 -168.451 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.76 141.84 48.25 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.122 -0.986 . . . . 0.0 111.134 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -96.95 141.42 30.15 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.15 -161.74 9.71 Favored Glycine 0 N--CA 1.466 0.696 0 CA-C-O 124.196 1.998 . . . . 0.0 116.319 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.22 143.77 48.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 110.922 -2.639 . . . . 0.0 107.437 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 136.11 54.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.394 1.092 . . . . 0.0 109.106 170.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mt -113.67 120.2 40.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.104 -1.407 . . . . 0.0 107.657 164.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.62 139.8 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -95.48 129.47 34.78 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 165.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.44 -9.53 18.26 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 N-CA-C 120.872 3.374 . . . . 0.0 120.872 -170.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 -50.31 64.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -161.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -87.33 -29.05 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.119 170.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.1 p -80.78 0.48 34.56 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -170.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.2 m -76.2 0.09 20.32 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 120.197 1.362 . . . . 0.0 111.599 166.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 m -114.26 71.36 2.17 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 161.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.72 52.85 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.038 3.158 . . . . 0.0 116.808 -154.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.96 -39.85 79.24 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.671 -1.268 . . . . 0.0 112.233 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.43 -29.96 68.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.77 -46.5 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 122.227 -0.296 . . . . 0.0 110.939 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.76 -38.48 78.57 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -66.89 -49.97 63.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.9 t -61.82 -38.63 88.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.376 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -63.71 -34.45 77.89 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.15 -40.54 78.13 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -64.25 -51.9 61.32 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.04 -0.412 . . . . 0.0 111.631 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.6 75.13 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.49 73.53 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -75.04 -22.6 58.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.092 0.86 . . . . 0.0 112.223 -170.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.87 -103.77 0.06 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.306 0.574 . . . . 0.0 109.809 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -161.81 10.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -166.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.67 149.71 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.877 0.846 . . . . 0.0 112.196 170.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -128.58 136.12 50.29 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -88.91 139.58 30.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.849 0.833 . . . . 0.0 108.758 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.05 -41.12 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.536 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -121.94 169.83 10.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.579 1.18 . . . . 0.0 111.176 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -137.28 125.12 22.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.282 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -121.59 149.12 43.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 117.301 -1.759 . . . . 0.0 109.189 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -123.47 111.27 16.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.6 tp -49.8 -35.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.23 -30.37 43.19 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.802 1.183 . . . . 0.0 113.737 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -81.76 -28.94 33.02 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.227 -0.92 . . . . 0.0 113.139 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.45 -40.6 85.42 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.3 0.955 . . . . 0.0 112.057 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -70.32 -23.34 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.97 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.02 -37.66 33.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.49 -0.756 . . . . 0.0 111.493 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.22 15.27 5.16 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -72.32 -28.27 62.96 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -114.81 120.46 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.737 0.78 . . . . 0.0 109.254 -165.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -108.02 120.37 42.12 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.505 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.679 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 15.2 tp -120.52 -165.95 1.26 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.933 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.679 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 48.1 mt-10 -98.62 -176.02 3.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.611 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -120.15 65.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.11 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 6' ' ' THR . 78.4 mttt -100.04 53.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -159.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.2 m-85 -112.63 21.74 15.29 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 116.903 -1.522 . . . . 0.0 112.079 166.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 1.2 pm0 -61.81 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -162.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.11 115.47 6.65 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 164.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.2 134.66 52.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -122.53 134.86 54.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 141.34 52.07 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.03 1.741 . . . . 0.0 109.286 164.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.0 tp -124.56 90.44 3.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.724 -170.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.5 m -138.01 114.46 9.21 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.21 151.87 33.66 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.509 2.14 . . . . 0.0 115.941 -170.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -106.19 30.22 6.1 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.442 -170.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.8 -58.33 1.94 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.046 -1.034 . . . . 0.0 109.748 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -82.31 115.31 21.31 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -170.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -78.88 76.34 5.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -165.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -135.17 178.86 6.7 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -170.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -90.46 149.41 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 120.847 -1.158 . . . . 0.0 109.331 -170.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mtpt -94.08 -71.0 0.68 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 5.5 t80 -130.34 149.24 72.81 Favored Pre-proline 0 N--CA 1.475 0.791 0 O-C-N 120.796 -1.19 . . . . 0.0 111.571 -155.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 17.4 Cg_exo -82.14 149.93 15.55 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.206 1.271 . . . . 0.0 111.207 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -62.35 -37.16 84.59 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.59 -30.88 70.1 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -76.81 -30.09 56.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.4 mt -64.4 -35.03 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 119.915 1.234 . . . . 0.0 111.63 168.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.5 p -69.56 -36.57 76.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.505 1.502 . . . . 0.0 112.688 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.34 -39.62 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.751 -0.593 . . . . 0.0 111.728 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -61.96 -40.87 97.05 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.698 -0.626 . . . . 0.0 112.655 174.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.85 70.76 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.12 -10.09 59.17 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.1 m -100.32 28.52 4.92 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mp -134.26 160.03 39.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 122.59 1.186 . . . . 0.0 111.238 -164.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -105.18 174.92 2.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.37 166.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.54 -25.33 32.21 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 118.581 2.493 . . . . 0.0 118.581 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.65 57.38 1.15 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.774 1.17 . . . . 0.0 110.208 168.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.9 145.98 36.01 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 167.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.6 p -141.62 159.27 42.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.234 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.343 1.7 tm? -128.19 129.48 46.54 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -170.554 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' HB3' ' A' ' 116' ' ' CYS . 44.2 mm -121.03 79.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.632 1.56 . . . . 0.0 110.019 170.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.25 -83.24 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 120.518 2.967 . . . . 0.0 120.518 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 91' ' ' LEU . 1.1 mt -116.54 146.93 42.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.486 -1.357 . . . . 0.0 111.024 -132.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -102.41 -109.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.068 -156.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.26 -60.19 2.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -157.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 mt -61.13 -26.63 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 124.253 1.978 . . . . 0.0 111.605 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 10.5 m-85 -76.56 -19.77 57.55 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.987 -171.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.37 -56.18 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.965 -1.085 . . . . 0.0 113.013 168.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.07 -35.23 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.824 -0.548 . . . . 0.0 111.324 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -58.63 -45.34 89.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 171.229 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.405 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . . . -57.52 -43.78 84.58 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.569 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -54.96 -49.88 70.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 112.72 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.3 tt -80.24 -34.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.72 30.51 5.19 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.076 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 47.7 m-85 -106.62 159.5 16.15 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 168.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.26 110.22 15.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 117' ' ' TRP . 15.2 tt -74.92 148.55 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 122.487 1.137 . . . . 0.0 111.873 -171.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -149.65 126.98 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.97 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -109.65 98.81 8.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 123.418 1.58 . . . . 0.0 111.582 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -134.31 178.45 1.76 Allowed Pre-proline 0 N--CA 1.472 0.652 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.148 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.55 -7.99 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 N-CA-C 118.732 2.551 . . . . 0.0 118.732 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -128.4 115.23 17.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 157.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -85.44 111.29 19.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.227 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.234 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 19.9 p -147.24 -158.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 124.424 2.059 . . . . 0.0 113.672 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.618 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.0 m0 -137.15 149.89 47.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 110.096 -3.229 . . . . 0.0 104.213 -169.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.43 144.59 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 164.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 16.1 ttpt -94.5 110.37 22.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.975 -1.078 . . . . 0.0 109.873 167.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 109.501 -170.341 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -96.61 141.95 29.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.744 1.259 . . . . 0.0 112.929 -160.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -98.38 120.45 38.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.525 169.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.0 -164.92 11.02 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.889 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.42 141.65 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -164.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -124.13 134.79 53.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.945 1.355 . . . . 0.0 107.855 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -122.7 120.07 32.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.761 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mt -118.14 139.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.21 129.71 24.65 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 165.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -59.85 -13.61 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 N-CA-C 121.48 3.608 . . . . 0.0 121.48 -170.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.54 60.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -161.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.1 m -88.92 -27.78 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.914 0.779 . . . . 0.0 110.715 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -76.36 -14.46 60.09 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -170.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.87 2.23 15.2 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.264 1.393 . . . . 0.0 112.067 -170.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.304 86.1 m -98.85 168.62 9.44 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 166.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -77.18 -9.24 17.76 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 118.298 2.384 . . . . 0.0 118.298 -170.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.43 -50.47 18.31 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -165.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.16 -29.81 67.91 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.744 0.702 . . . . 0.0 112.417 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.15 -50.01 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.852 -0.53 . . . . 0.0 110.453 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.45 -36.99 79.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -60.07 -50.03 75.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 t -66.4 -39.8 89.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.786 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -61.8 -33.3 73.88 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -36.33 77.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -60.17 -56.9 15.93 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.991 -0.443 . . . . 0.0 111.172 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.2 77.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.97 63.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 95.7 p -59.85 -28.6 67.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 170.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -85.92 -124.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.616 -0.678 . . . . 0.0 110.017 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -136.27 9.95 3.23 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -170.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.63 150.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.596 0.712 . . . . 0.0 109.884 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -128.24 136.55 51.2 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 163.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.91 100.87 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.211 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -81.47 -24.52 10.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.429 -1.714 . . . . 0.0 114.409 -164.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -121.71 169.75 10.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.279 1.038 . . . . 0.0 111.299 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -146.89 125.23 12.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.818 -169.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.444 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 31.0 m-85 -130.99 149.94 52.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.42 156.67 20.49 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.03 -40.08 87.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.147 -0.971 . . . . 0.0 113.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -82.02 -30.34 31.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -82.83 -30.48 28.69 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.403 1.001 . . . . 0.0 112.967 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.409 HD13 ' CD1' ' A' ' 40' ' ' PHE . 18.4 tp -71.92 -40.56 68.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.207 0.912 . . . . 0.0 112.364 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -74.99 -19.47 60.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.767 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.28 -37.33 21.82 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.798 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.54 15.09 8.37 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -79.6 -17.63 53.44 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.4 mt -114.93 120.38 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.0 m -110.82 107.94 17.6 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.29 1.043 . . . . 0.0 110.929 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -131.15 172.99 11.48 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.435 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.16 177.69 5.32 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.833 -1.167 . . . . 0.0 110.477 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -120.03 70.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.037 -158.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.02 -83.37 0.06 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 6' ' ' THR . 31.6 pttt -99.91 45.15 0.99 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -156.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 59' ' ' THR . 4.4 m-85 -112.24 21.77 15.45 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 116.325 -1.798 . . . . 0.0 112.041 -170.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.38 42.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -155.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 57' ' ' TYR . 10.3 t -141.64 115.11 8.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 159.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 100.679 -3.823 . . . . 0.0 100.679 -170.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.24 134.53 54.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 167.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.48 110.7 16.79 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.267 18.5 tp -97.61 114.05 25.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.186 0.993 . . . . 0.0 111.507 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.401 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 27.7 m -149.28 154.88 39.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 79.7 Cg_exo -49.75 128.59 21.75 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.215 1.943 . . . . 0.0 114.013 170.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.85 -19.67 24.36 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.64 71.92 1.74 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.04 0.924 . . . . 0.0 109.751 170.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -112.05 115.25 28.6 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.739 -170.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -78.71 9.87 3.76 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -135.21 90.72 2.65 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.6 tt -99.94 71.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -170.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -125.11 139.88 53.38 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.928 0.87 . . . . 0.0 111.047 170.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 -130.08 148.94 71.72 Favored Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 163.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 34.9 Cg_exo -82.12 149.53 15.46 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 CA-C-N 121.071 1.418 . . . . 0.0 110.158 -173.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.65 -36.14 81.89 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -35.69 74.9 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.82 -30.19 56.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.099 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.08 -38.2 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 119.777 1.171 . . . . 0.0 111.133 168.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.7 m -68.02 -37.24 81.18 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.347 0.976 . . . . 0.0 112.634 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.28 -41.52 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.263 0.483 . . . . 0.0 111.808 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.84 -41.22 97.88 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.44 1.018 . . . . 0.0 112.362 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.93 -29.82 70.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.79 -9.94 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.7 m -84.96 -18.11 35.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.68 170.6 9.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 120.06 1.3 . . . . 0.0 111.914 -164.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 75.5 mttt -108.61 -164.9 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -170.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 12.9 Cg_endo -62.94 -29.73 76.22 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 123.159 2.164 . . . . 0.0 113.715 -170.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -102.07 41.27 1.23 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.46 145.68 29.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -147.13 117.52 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.363 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.278 0.6 OUTLIER -89.53 143.86 26.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.826 -1.988 . . . . 0.0 107.334 -173.279 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.966 HD13 ' CB ' ' A' ' 116' ' ' CYS . 46.4 mm -128.07 88.84 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.858 1.208 . . . . 0.0 108.868 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.46 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -144.15 -76.56 0.03 OUTLIER Glycine 0 C--N 1.316 -0.539 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.46 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.276 4.2 mp -115.56 169.89 8.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 122.688 1.233 . . . . 0.0 109.336 -129.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.81 -120.71 0.29 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.932 -157.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.1 -53.66 6.49 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 121.216 1.825 . . . . 0.0 115.792 -158.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.83 -29.9 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 124.86 2.267 . . . . 0.0 111.903 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.8 m-85 -76.97 -20.44 56.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.29 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -53.89 -55.36 27.58 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.797 -1.189 . . . . 0.0 112.427 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.12 -32.73 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.885 -0.51 . . . . 0.0 111.667 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.74 -43.79 97.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 173.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.4 88.94 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.05 -48.96 78.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.789 0.804 . . . . 0.0 112.526 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.17 -35.36 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.115 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -71.81 -17.59 62.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.7 31.6 4.78 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 119.285 -1.436 . . . . 0.0 112.523 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 50.6 m-85 -106.6 159.52 16.13 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -124.61 103.69 8.28 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.5 tt -78.67 142.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 122.707 1.242 . . . . 0.0 111.62 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.07 127.85 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.401 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -109.78 100.07 9.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.529 -1.668 . . . . 0.0 110.509 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.6 -174.86 0.29 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.353 170.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -56.37 -10.54 4.95 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 N-CA-C 118.935 2.629 . . . . 0.0 118.935 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -119.39 149.56 41.63 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 154.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.548 ' OH ' HD11 ' A' ' 109' ' ' ILE . 22.5 t80 -113.68 114.73 26.79 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 -170.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.363 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 28.1 p -147.73 -156.31 0.71 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.973 1.368 . . . . 0.0 114.651 170.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.618 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.9 m0 -137.21 127.7 26.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.919 -1.946 . . . . 0.0 108.28 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -108.78 110.83 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.56 -1.338 . . . . 0.0 110.183 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -79.58 110.07 14.55 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.104 0.954 . . . . 0.0 111.167 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.728 -170.296 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -106.53 142.03 36.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 122.375 1.083 . . . . 0.0 111.834 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.1 t -103.02 120.74 41.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 168.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.34 -159.6 10.07 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 118.405 -1.855 . . . . 0.0 113.32 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.25 144.46 48.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -170.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.26 0.1 OUTLIER -124.51 129.41 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 172.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -111.53 120.15 41.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.074 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.407 HG22 ' HB2' ' A' ' 63' ' ' LEU . 2.3 pt -124.52 139.63 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.405 ' CD2' HG23 ' A' ' 64' ' ' THR . 6.3 t60 -97.24 130.34 29.88 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -54.5 -20.73 21.67 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 N-CA-C 120.931 3.396 . . . . 0.0 120.931 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.73 72.68 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.977 1.717 . . . . 0.0 112.669 -164.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -96.07 -29.53 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -171.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.5 p -85.99 0.02 54.35 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -170.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.2 m -76.46 -5.06 45.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.431 1.469 . . . . 0.0 112.816 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.315 79.7 m -98.7 168.08 10.37 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 167.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.63 -9.45 17.19 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 N-CA-C 117.598 2.115 . . . . 0.0 117.598 -170.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.06 -50.19 20.74 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -163.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.08 -31.83 70.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.784 0.72 . . . . 0.0 112.057 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.45 -47.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.637 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.13 -33.89 74.12 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.93 -47.91 60.57 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -62.62 -39.71 94.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.54 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.01 -31.89 73.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.01 -45.97 69.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.11 1.323 . . . . 0.0 112.332 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.03 -51.25 66.87 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.93 82.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.19 -50.08 13.74 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 t -57.94 -28.18 64.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 170.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.99 -127.87 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.495 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -130.05 6.78 5.03 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -104.45 150.82 7.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.863 0.84 . . . . 0.0 109.98 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -127.99 141.11 51.62 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 164.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -100.32 100.51 11.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.006 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.78 -28.89 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.995 -163.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -121.91 169.63 10.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.329 1.062 . . . . 0.0 110.395 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -147.7 111.6 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -160.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.405 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 13.7 m-30 -119.01 120.47 37.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.5 mt -86.31 149.65 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.15 -39.73 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -78.03 -30.42 49.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.39 -25.48 29.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.492 1.042 . . . . 0.0 113.225 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -70.27 -40.19 74.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.842 1.201 . . . . 0.0 111.924 173.101 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -74.0 -21.07 60.13 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -88.3 -45.94 9.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.415 -0.803 . . . . 0.0 111.992 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.87 15.19 2.16 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 171.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -76.86 -13.55 59.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 120.213 2.006 . . . . 0.0 115.608 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.67 121.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.0 t -98.83 159.35 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 124.245 1.974 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.2 tp -130.44 120.54 24.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.217 -2.72 . . . . 0.0 111.309 -151.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.57 116.07 30.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.564 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -91.44 80.23 5.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.067 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.98 -78.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.16 14.2 20.81 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -155.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.6 m-85 -83.43 21.49 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.966 -170.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.65 27.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 57' ' ' TYR . 10.1 t -126.51 113.08 16.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.226 1.013 . . . . 0.0 108.938 160.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 91' ' ' LEU . 1.2 t -107.65 110.33 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -170.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -97.77 134.25 41.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.61 141.37 46.47 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 168.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 11' ' ' ILE . 30.7 mt -123.83 91.27 3.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.175 170.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 ' CD2' ' A' ' 12' ' ' HIS . 86.1 m -129.5 88.33 50.46 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.768 1.167 . . . . 0.0 110.015 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.22 76.45 4.52 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.911 1.741 . . . . 0.0 110.333 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -120.09 -30.32 4.7 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.67 178.45 5.96 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.157 0.98 . . . . 0.0 110.787 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -112.33 -56.64 2.37 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.991 -170.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 m -83.17 -49.7 9.2 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -170.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.88 178.78 0.43 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.728 0.775 . . . . 0.0 112.706 -169.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 pt -103.87 73.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.068 0.461 . . . . 0.0 111.204 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.05 26.71 0.34 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 118.351 -1.339 . . . . 0.0 114.506 170.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -130.49 148.86 71.65 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -82.27 149.54 15.18 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 CA-C-N 120.626 1.259 . . . . 0.0 111.153 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ptmm? -62.48 -35.78 80.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.69 -28.36 69.01 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.69 -30.35 56.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.789 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.4 -38.17 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 120.391 1.451 . . . . 0.0 110.977 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.1 t -66.86 -43.28 83.98 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.504 1.047 . . . . 0.0 112.716 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.15 -39.9 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.42 -37.85 83.7 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.245 0.929 . . . . 0.0 112.42 174.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.47 -29.85 68.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.284 0.947 . . . . 0.0 113.456 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.77 -10.06 59.36 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.9 m -99.46 14.93 28.1 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.7 mt -134.14 -175.95 4.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.165 0.983 . . . . 0.0 111.556 -159.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -117.75 174.88 2.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.73 -28.62 30.67 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 119.525 2.856 . . . . 0.0 119.525 170.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.43 54.45 0.79 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.191 1.359 . . . . 0.0 108.356 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.17 138.58 21.47 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.3 p -142.91 104.36 4.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.419 ' HA ' HG12 ' A' ' 60' ' ' VAL 0.274 3.9 tt -89.86 129.46 36.23 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 4.6 mp -114.24 85.4 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 -170.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.39 -80.97 0.05 OUTLIER Glycine 0 N--CA 1.464 0.505 0 N-CA-C 121.769 3.468 . . . . 0.0 121.769 -155.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.441 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.259 0.8 OUTLIER -115.5 169.96 8.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.567 1.175 . . . . 0.0 110.058 -139.909 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.7 t -102.36 -148.84 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.113 -157.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.77 -42.59 24.19 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.08 -32.79 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 125.126 2.394 . . . . 0.0 112.96 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 75.7 m-85 -76.28 -10.27 59.28 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 112.941 -1.936 . . . . 0.0 110.093 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.8 tttt -59.32 -50.24 74.75 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.675 -1.266 . . . . 0.0 112.388 168.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -35.55 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.064 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.652 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.34 -47.83 84.36 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 171.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.98 -42.81 80.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.191 0.52 . . . . 0.0 111.949 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.4 tp -60.73 -44.83 96.17 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.0 mt -79.71 -35.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.922 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -71.7 -18.46 62.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 30.04 5.32 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.648 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.3 m-85 -106.66 159.78 15.95 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.122 0.963 . . . . 0.0 108.663 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.42 105.26 9.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.568 HG13 ' CD1' ' A' ' 117' ' ' TRP . 17.3 tt -75.49 146.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.058 -168.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.935 HG13 ' HB2' ' A' ' 116' ' ' CYS . 26.8 pt -143.16 134.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.582 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -112.2 100.13 8.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.04 1.4 . . . . 0.0 110.268 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.62 172.92 5.79 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 113.408 -1.724 . . . . 0.0 108.099 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.46 -8.86 2.06 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.12 115.38 22.34 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 158.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -79.87 142.42 35.24 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.816 -166.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.935 ' HB2' HG13 ' A' ' 110' ' ' ILE 1.064 0.5 OUTLIER -126.39 173.63 9.2 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 113.919 -2.943 . . . . 0.0 111.655 -175.114 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.568 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.0 m0 -137.4 130.23 30.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.993 2.117 . . . . 0.0 105.79 139.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.329 0.2 OUTLIER -110.14 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.207 -0.933 . . . . 0.0 111.265 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -78.19 134.86 37.56 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 123.37 1.557 . . . . 0.0 108.536 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 111.883 -2.417 . . . . 0.0 114.407 -157.792 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.144 0.973 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 34' ' ' VAL . 98.5 mttt -96.95 103.85 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.927 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.7 t -76.39 141.31 41.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 118.756 -1.177 . . . . 0.0 107.99 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.62 -161.92 9.89 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.49 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -134.23 141.21 46.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.283 -1.458 . . . . 0.0 107.53 -171.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.9 tp -124.17 130.56 52.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.615 1.198 . . . . 0.0 109.236 173.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.12 120.52 42.09 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.153 173.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.6 mt -125.13 111.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -167.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.24 129.46 51.55 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -62.98 -10.08 19.15 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 N-CA-C 121.69 3.688 . . . . 0.0 121.69 -169.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.16 -50.36 55.01 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -161.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -86.08 -31.78 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.963 170.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.9 p -81.79 0.39 39.46 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -170.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -76.53 20.05 0.24 Allowed 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 120.437 1.471 . . . . 0.0 112.296 166.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 m -133.2 71.48 76.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 170.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.08 50.56 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.194 3.263 . . . . 0.0 116.845 -155.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -72.97 -45.62 56.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.039 -1.038 . . . . 0.0 111.585 162.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.4 mt -57.98 -34.91 70.48 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.0 t -64.39 -49.25 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.24 175.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.74 -36.45 81.03 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -63.89 -49.45 72.62 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.7 t -63.84 -40.35 96.38 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.014 0.824 . . . . 0.0 111.316 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -65.03 -30.91 71.92 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -44.78 71.15 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.71 1.141 . . . . 0.0 113.653 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -58.36 -53.14 61.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.565 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.85 68.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.36 18.28 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.0 p -57.94 -27.38 63.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 170.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.87 -125.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -146.46 14.6 1.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.981 0.896 . . . . 0.0 113.223 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 5' ' ' LYS . 10.4 t -98.83 149.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.011 170.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -128.39 134.76 48.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 161.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -91.21 100.61 13.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.16 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.63 -17.09 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.589 -1.642 . . . . 0.0 113.928 -162.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.56 169.7 10.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.239 1.019 . . . . 0.0 109.644 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -143.39 125.22 15.11 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.372 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.416 ' CD1' HD21 ' A' ' 8' ' ' LEU . 2.9 m-85 -129.59 120.4 25.23 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.89 149.68 22.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp -63.3 -40.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -81.95 -30.47 31.72 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -82.12 -29.49 31.64 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.305 -0.872 . . . . 0.0 112.652 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.83 -40.66 68.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.367 0.985 . . . . 0.0 112.739 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -76.78 -16.9 59.33 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.668 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.05 -37.45 29.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.545 -0.722 . . . . 0.0 111.43 166.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.67 15.4 5.84 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -78.54 -24.92 45.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mt -114.81 120.3 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -120.08 120.2 35.55 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.786 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.469 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 11.8 tp -130.99 174.44 10.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.132 0.968 . . . . 0.0 109.575 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.469 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 46.5 mt-10 -98.94 175.05 6.07 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.692 1.234 . . . . 0.0 111.724 -170.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.1 m-20 -91.41 94.06 9.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.981 -170.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.69 -147.2 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -165.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -100.08 35.0 2.16 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.64 -163.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.8 m-85 -81.94 21.66 0.85 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.081 -170.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.52 27.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' TYR . 9.8 t -129.32 115.06 17.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 162.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.26 94.04 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -162.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -97.85 134.37 41.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.36 142.43 38.7 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 170.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.6 tp -122.99 108.98 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.872 0.844 . . . . 0.0 109.603 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.405 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 25.5 m -143.97 154.93 59.01 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -170.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 82.9 Cg_exo -49.78 129.54 24.35 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.291 1.994 . . . . 0.0 114.702 170.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -89.89 -8.93 50.73 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -170.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.89 178.9 4.68 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.133 170.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -85.07 97.88 10.11 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.666 0.746 . . . . 0.0 110.103 -170.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.2 p -115.83 -63.05 1.51 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -135.27 88.36 2.41 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -170.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.9 pt -97.6 45.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.399 0.618 . . . . 0.0 111.292 -170.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.13 99.99 6.35 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -170.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -115.08 148.92 41.65 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 170.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -82.34 149.71 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 CA-C-N 119.701 0.929 . . . . 0.0 110.587 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.48 -36.59 82.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.738 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.49 -30.1 71.02 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.6 mt -76.68 -30.14 56.61 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.268 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.26 -36.66 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 119.845 1.202 . . . . 0.0 111.061 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.8 m -66.93 -40.57 87.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.694 1.134 . . . . 0.0 112.717 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.81 -35.76 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 122.025 -0.422 . . . . 0.0 111.991 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -59.87 -47.73 84.57 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.698 -0.626 . . . . 0.0 111.498 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.3 -30.87 71.37 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.33 -10.55 59.84 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -166.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 72.1 p -74.53 -33.13 62.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 165.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 mt -88.66 -170.66 3.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 122.283 1.039 . . . . 0.0 112.079 -159.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -134.26 174.92 4.1 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -52.39 -22.39 15.98 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 N-CA-C 120.292 3.151 . . . . 0.0 120.292 -170.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -102.12 46.57 0.92 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.26 1.391 . . . . 0.0 111.096 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.44 140.67 28.64 Favored Glycine 0 N--CA 1.467 0.737 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -147.04 120.17 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.214 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.433 1.9 tm? -98.4 129.55 45.04 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 111.641 -2.527 . . . . 0.0 104.705 -167.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.089 HD13 ' HB3' ' A' ' 116' ' ' CYS . 44.2 mm -119.38 85.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.584 1.538 . . . . 0.0 109.804 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.04 -79.11 0.04 OUTLIER Glycine 0 N--CA 1.464 0.528 0 N-CA-C 120.878 3.111 . . . . 0.0 120.878 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.605 HD12 HD11 ' A' ' 91' ' ' LEU . 1.5 mp -115.88 169.99 8.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.669 -133.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.2 p -114.93 -123.4 0.29 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.355 -0.84 . . . . 0.0 113.185 -156.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.51 -51.02 11.4 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -157.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -60.35 -30.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.877 1.798 . . . . 0.0 111.266 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 77.7 m-85 -76.82 -16.63 59.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.581 -172.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.2 tttt -57.12 -55.13 38.76 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.373 -0.829 . . . . 0.0 112.277 169.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.93 -33.47 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.987 -0.446 . . . . 0.0 111.376 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.41 -45.28 95.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.02 84.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.34 -48.66 79.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.728 0.775 . . . . 0.0 112.554 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.6 tt -80.22 -35.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.309 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -71.63 -16.14 62.27 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.49 5.58 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 119.373 -1.394 . . . . 0.0 112.805 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 96.6 m-85 -106.63 159.58 16.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.79 108.79 11.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.669 HD11 ' OH ' ' A' ' 115' ' ' TYR . 18.1 tt -84.88 142.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.49 1.138 . . . . 0.0 112.569 -165.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.3 pt -147.13 135.07 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.579 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -126.61 100.14 6.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.002 1.858 . . . . 0.0 112.965 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.44 87.97 30.95 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.8 61.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 122.151 3.866 . . . . 0.0 122.151 -123.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -123.4 104.85 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.255 -2.869 . . . . 0.0 103.255 142.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.669 ' OH ' HD11 ' A' ' 109' ' ' ILE . 15.7 t80 -82.91 111.33 18.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -159.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.214 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.3 p -147.39 -156.75 0.74 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 125.061 2.362 . . . . 0.0 113.754 171.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.635 ' CD1' HG13 ' A' ' 109' ' ' ILE . 24.9 m0 -137.08 149.79 47.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 109.16 -3.654 . . . . 0.0 102.901 -167.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 144.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 6.2 ttpm? -88.44 134.92 33.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.532 0.682 . . . . 0.0 111.715 -171.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 -170.223 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 2.8 t80 . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.616 0.246 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.82 155.12 38.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.96 0.886 . . . . 0.0 110.582 -166.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -77.56 141.62 39.46 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.474 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -133.7 -162.97 10.24 Favored Glycine 0 N--CA 1.466 0.678 0 C-N-CA 119.421 -1.371 . . . . 0.0 114.759 173.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.28 139.85 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.117 -1.542 . . . . 0.0 107.925 -171.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -124.33 132.88 53.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.162 0.982 . . . . 0.0 108.843 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.65 149.65 27.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.253 165.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.48 143.2 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -111.22 129.59 23.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -60.16 -17.41 45.69 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 N-CA-C 120.261 3.139 . . . . 0.0 120.261 -170.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.25 67.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -161.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.97 -28.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.357 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.8 p -77.14 -11.92 59.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -170.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.6 m -76.63 -1.5 27.96 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.697 1.59 . . . . 0.0 111.718 -170.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 19' ' ' PRO 0.336 91.3 m -98.78 168.73 9.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 167.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' THR . 95.0 Cg_exo -75.82 -8.69 19.29 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 N-CA-C 118.019 2.277 . . . . 0.0 118.019 -170.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.15 -50.1 20.86 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -163.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.99 -32.94 72.87 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.74 0.7 . . . . 0.0 112.16 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.93 -46.6 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.686 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -62.61 -34.01 76.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.65 -49.07 57.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.5 t -61.52 -41.49 97.39 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.191 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.13 -33.76 76.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.735 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.75 73.18 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.196 1.362 . . . . 0.0 113.598 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -56.93 -54.91 41.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.75 0.309 . . . . 0.0 111.586 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.24 -43.35 78.56 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.35 47.25 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.9 p -57.89 -36.47 72.45 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.86 -94.64 0.1 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.958 0.885 . . . . 0.0 110.351 -170.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' CG ' ' A' ' 4' ' ' TYR . 44.4 mmtm -129.88 -42.09 1.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.285 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.251 59.5 t -97.64 149.96 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 123.256 1.503 . . . . 0.0 112.594 -160.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -121.35 134.96 55.14 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.222 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -95.38 139.75 31.23 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.72 -24.7 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -170.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -121.52 169.73 10.38 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.63 1.205 . . . . 0.0 110.286 -174.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -147.34 125.57 12.22 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 114.249 -1.342 . . . . 0.0 108.85 -168.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -133.04 120.28 21.13 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.657 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.8 tt -92.58 149.45 21.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.16 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.54 ' H ' HD23 ' A' ' 41' ' ' LEU . 22.0 t-20 -79.4 -30.2 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.315 -0.866 . . . . 0.0 113.021 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.19 -37.55 45.4 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.153 -0.967 . . . . 0.0 112.662 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.2 tp -68.57 -40.62 80.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.549 0.69 . . . . 0.0 112.8 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -73.5 -21.2 60.48 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.835 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -83.75 -36.1 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.541 -0.725 . . . . 0.0 112.047 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.56 15.33 6.44 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.329 0.892 . . . . 0.0 115.329 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -76.09 -35.66 59.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.849 1.324 . . . . 0.0 113.689 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.9 mt -114.69 120.35 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -168.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.7 m -129.8 120.21 24.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.596 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 38' ' ' ASP . 93.3 mt -119.6 179.9 4.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.849 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.79 175.32 6.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.608 1.194 . . . . 0.0 111.763 -168.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.8 m-20 -89.32 93.34 9.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.553 -170.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.82 -147.42 0.25 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -165.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -100.1 37.57 1.63 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.168 0.985 . . . . 0.0 113.243 -162.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.6 m-85 -82.28 21.74 0.9 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 117.191 -1.385 . . . . 0.0 112.259 -170.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.23 27.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -157.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.474 HG23 ' HA3' ' A' ' 7' ' ' GLY . 7.8 t -128.45 115.12 17.7 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 162.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 36.5 t -113.74 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -167.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -111.05 134.67 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.06 141.86 50.94 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.0 tp -123.78 94.28 4.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -170.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -140.47 154.72 69.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -170.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.97 145.37 19.3 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.824 2.35 . . . . 0.0 114.676 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.95 -16.94 28.87 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -166.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.85 178.52 4.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.806 1.184 . . . . 0.0 111.514 170.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -112.37 149.91 31.82 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.877 0.846 . . . . 0.0 111.227 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.6 p -125.03 -64.89 1.06 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 164.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -135.14 178.92 6.66 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.4 pt -88.95 90.64 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 122.439 1.114 . . . . 0.0 108.201 -170.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -79.8 -66.47 0.87 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 117.437 -1.268 . . . . 0.0 114.266 -167.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.7 t80 -77.05 148.47 78.52 Favored Pre-proline 0 N--CA 1.482 1.132 0 CA-C-N 122.837 2.562 . . . . 0.0 110.935 -170.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 19.8 Cg_exo -82.7 151.86 14.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 121.757 1.638 . . . . 0.0 112.246 170.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -62.46 -34.26 76.45 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 166.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.13 -34.5 76.48 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.7 -30.07 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.683 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.409 HG13 ' CE2' ' A' ' 73' ' ' PHE . 96.8 mt -59.34 -41.05 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 119.608 1.095 . . . . 0.0 111.155 167.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -64.76 -40.34 95.12 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.963 -1.086 . . . . 0.0 112.823 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -64.17 -37.18 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.91 -42.56 94.14 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.446 -0.784 . . . . 0.0 112.384 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.47 -29.8 70.84 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -75.79 -9.98 59.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 71.9 m -74.8 -40.05 61.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 169.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.2 mt -91.17 164.33 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.923 1.344 . . . . 0.0 113.593 -154.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.72 101.69 0.54 Allowed Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 112.206 -2.27 . . . . 0.0 105.402 163.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -51.06 6.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 N-CA-C 122.183 3.878 . . . . 0.0 122.183 -154.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -94.7 57.77 2.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 123.039 1.4 . . . . 0.0 108.571 163.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.88 167.51 38.34 Favored Glycine 0 N--CA 1.466 0.691 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.159 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -146.14 120.07 9.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.225 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.307 0.6 OUTLIER -92.7 129.85 38.5 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 112.618 -2.083 . . . . 0.0 107.905 -173.727 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.711 HD13 ' CB ' ' A' ' 116' ' ' CYS . 23.3 mm -113.75 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.85 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.462 0.42 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.533 HD12 HD21 ' A' ' 91' ' ' LEU . 6.2 mt -115.93 146.56 41.98 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.859 1.314 . . . . 0.0 110.646 -131.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.3 t -90.79 179.45 5.79 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.348 -165.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.9 44.06 0.73 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 120.25 3.426 . . . . 0.0 120.25 -161.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mt -96.16 -26.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 126.716 3.15 . . . . 0.0 109.959 137.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.783 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 92.2 m-85 -76.68 2.95 12.74 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.347 -168.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -71.83 -52.17 18.83 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.583 -1.323 . . . . 0.0 111.509 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.85 -33.36 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.081 -0.387 . . . . 0.0 110.732 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.94 -46.61 89.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.197 171.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.538 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -57.99 -39.78 79.08 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.99 -0.444 . . . . 0.0 111.817 176.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -58.48 -50.01 75.29 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.706 0.765 . . . . 0.0 112.394 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.31 -34.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.438 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -71.79 -16.59 62.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 173.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.07 5.74 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.703 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 94.1 m-85 -106.54 159.56 16.08 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -117.46 154.09 32.0 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 161.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.63 HG12 ' CD1' ' A' ' 117' ' ' TRP . 19.1 mt -103.99 148.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.061 1.41 . . . . 0.0 109.812 -174.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 pt -140.29 125.57 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 113.246 -1.797 . . . . 0.0 106.628 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -121.99 87.41 2.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 124.072 1.892 . . . . 0.0 113.476 -168.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 114' ' ' ASP . 18.6 mp0 -134.21 100.29 12.96 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 -170.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -54.82 31.42 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.167 1 N-CA-C 124.342 4.709 . . . . 0.0 124.342 -139.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' GLU . 19.2 t70 -100.01 115.17 29.1 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 130.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -90.35 115.27 27.41 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.674 -164.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.225 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.86 -164.6 2.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.956 1.836 . . . . 0.0 115.452 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.63 ' CD1' HG12 ' A' ' 109' ' ' ILE . 22.7 m0 -137.55 130.04 29.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 110.804 -2.907 . . . . 0.0 105.625 -167.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.18 144.41 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -79.52 134.84 36.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.118 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 122.14 0.972 . . . . 0.0 111.138 170.334 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.79 141.74 35.96 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 123.086 1.422 . . . . 0.0 112.414 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -104.83 120.61 41.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.9 -1.954 . . . . 0.0 106.049 164.149 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -129.4 -163.62 11.23 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.906 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.37 145.02 48.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -167.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.34 135.72 53.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.583 1.182 . . . . 0.0 109.518 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -119.44 120.14 35.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.76 -1.563 . . . . 0.0 106.955 177.369 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -117.97 139.9 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 64' ' ' THR . 2.4 t60 -99.17 129.55 29.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -62.87 -11.46 24.45 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 N-CA-C 120.502 3.231 . . . . 0.0 120.502 -170.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.34 63.35 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -162.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.76 -30.16 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.574 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -81.04 0.32 36.38 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -76.23 -0.92 24.02 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 120.456 1.48 . . . . 0.0 112.018 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 m -114.82 71.48 2.58 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.99 55.88 3.5 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.717 2.945 . . . . 0.0 116.758 -154.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -71.91 -44.99 62.77 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.869 -1.144 . . . . 0.0 112.096 166.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.09 -29.93 68.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -65.2 -50.07 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.641 -0.662 . . . . 0.0 110.795 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.88 -38.18 81.49 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -60.81 -50.09 74.87 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -65.18 -38.49 90.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.534 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.61 -33.57 76.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.49 73.47 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -56.11 -56.17 24.07 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.99 96.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.3 -50.44 67.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -75.37 -11.49 60.06 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.544 -0.722 . . . . 0.0 112.704 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.85 -109.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.318 0.58 . . . . 0.0 111.467 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -139.68 20.27 2.52 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.88 110.55 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.245 -168.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.84 135.02 40.89 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -88.78 139.57 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.5 -32.63 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.014 -165.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.77 169.92 10.27 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.985 1.374 . . . . 0.0 110.904 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -142.41 125.32 16.12 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.018 -172.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.493 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 16.2 m-85 -119.61 149.64 41.62 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.009 166.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.37 149.72 26.71 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 164.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.419 HD13 ' OH ' ' A' ' 62' ' ' TYR . 4.5 tp -63.33 -39.41 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -78.85 -30.28 45.06 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.444 -0.785 . . . . 0.0 113.098 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.14 -30.46 38.99 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.283 -0.886 . . . . 0.0 112.933 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.63 -40.61 66.3 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 112.525 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.29 -27.64 66.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.632 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -83.16 -39.3 21.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.929 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.19 15.38 2.29 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.84 1.496 . . . . 0.0 116.84 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.4 m -78.88 -14.32 59.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 -168.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.73 161.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.542 1.064 . . . . 0.0 110.318 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -99.84 120.4 39.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.988 -172.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.69 120.0 36.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.475 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.51 120.1 39.09 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -92.46 65.6 4.49 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -167.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.17 -77.16 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 170.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 6' ' ' THR . 90.8 mttt -100.04 57.41 0.97 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.389 1.09 . . . . 0.0 113.629 -161.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 59' ' ' THR . 11.8 m-85 -112.34 21.52 15.66 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.984 163.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.73 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 -157.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 57' ' ' TYR . 8.7 t -131.14 116.39 17.65 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 162.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.53 HG11 HD22 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -98.64 134.79 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 171.035 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.52 134.55 54.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.419 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -123.22 110.45 15.25 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.255 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.04 89.74 3.09 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -170.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 12' ' ' HIS . 33.5 m -131.08 154.45 82.02 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -170.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -73.93 141.19 29.71 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 121.974 1.782 . . . . 0.0 112.984 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -89.91 -30.14 18.06 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.262 -170.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.44 73.33 1.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.873 0.844 . . . . 0.0 109.452 -170.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -112.18 160.22 17.8 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.163 170.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.4 p -89.77 9.7 26.32 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.693 -0.803 . . . . 0.0 112.968 170.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -135.34 90.8 2.66 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.9 pt -98.72 69.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.687 0.756 . . . . 0.0 109.53 -170.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.01 139.75 53.53 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.197 0.999 . . . . 0.0 110.532 -170.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 15.8 t80 -130.24 149.02 72.13 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 166.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 32.2 Cg_exo -82.16 149.39 15.34 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 121.195 1.463 . . . . 0.0 110.25 -175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.73 -39.65 94.74 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -63.17 -27.64 69.51 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.83 -30.31 56.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.626 173.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.16 -35.08 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 119.729 1.15 . . . . 0.0 111.063 171.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.5 p -71.96 -36.79 69.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.789 1.177 . . . . 0.0 113.081 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.83 -38.43 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.696 -0.628 . . . . 0.0 111.816 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -40.53 95.57 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.457 -0.777 . . . . 0.0 112.168 174.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.95 -29.86 70.33 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -79.11 -29.42 43.23 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -76.52 -17.98 58.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 mp -124.32 100.82 6.87 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.553 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.266 80.4 mttt -74.77 -155.06 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.674 -166.145 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 6.1 Cg_endo -59.21 -31.38 95.17 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 N-CA-C 120.656 3.291 . . . . 0.0 120.656 -160.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -90.48 49.04 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.351 1.887 . . . . 0.0 110.659 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.43 144.07 26.55 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 173.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.7 p -146.71 117.07 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 123.445 1.593 . . . . 0.0 107.147 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.266 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.379 0.7 OUTLIER -97.42 133.95 41.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.39 -167.265 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.954 HD13 ' HB3' ' A' ' 116' ' ' CYS . 33.0 mm -121.53 87.39 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.576 1.535 . . . . 0.0 108.747 170.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.465 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -144.26 -78.58 0.04 OUTLIER Glycine 0 C--N 1.316 -0.546 0 N-CA-C 121.375 3.31 . . . . 0.0 121.375 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.465 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.271 5.5 mp -115.67 172.01 7.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.611 1.196 . . . . 0.0 109.868 -124.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -109.13 -141.71 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.486 -156.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.96 -45.79 39.88 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -163.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mt -57.21 -32.84 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 124.397 2.046 . . . . 0.0 111.31 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 90.7 m-85 -76.89 -16.0 59.52 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.347 -1.751 . . . . 0.0 112.296 -170.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.71 -55.08 39.53 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.94 -1.1 . . . . 0.0 111.979 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.16 -35.27 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.755 -0.59 . . . . 0.0 111.795 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.649 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.75 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 173.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.99 79.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.122 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.86 -46.67 74.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.607 0.718 . . . . 0.0 112.843 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.5 tt -80.2 -34.56 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.74 -17.89 62.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.78 21.52 9.63 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.618 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 119' ' ' LYS 0.271 94.7 m-85 -106.85 112.33 25.24 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -98.48 153.48 18.58 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.96 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.62 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -109.13 145.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 111.689 -2.505 . . . . 0.0 110.867 -155.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 pt -137.94 123.01 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -112.17 99.95 8.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.205 1.479 . . . . 0.0 110.723 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.0 -175.61 0.5 Allowed Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.085 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -55.52 -11.61 4.94 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 N-CA-C 118.733 2.551 . . . . 0.0 118.733 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -124.78 149.48 47.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 152.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.414 ' OH ' HD11 ' A' ' 109' ' ' ILE . 13.5 t80 -113.03 112.52 24.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -170.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.266 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 25.2 p -147.73 -153.36 0.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.148 1.451 . . . . 0.0 112.527 169.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.62 ' CD1' HG13 ' A' ' 109' ' ' ILE . 4.4 m0 -136.85 153.52 50.75 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.559 -2.11 . . . . 0.0 105.483 -172.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.27 144.4 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 162.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 61.7 tttm -79.88 134.99 36.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.894 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.645 0.735 . . . . 0.0 110.283 170.326 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.53 103.65 10.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.567 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -76.77 120.44 21.94 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.38 -154.82 7.54 Favored Glycine 0 N--CA 1.464 0.505 0 CA-C-O 123.187 1.437 . . . . 0.0 115.893 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.477 HD11 ' CE2' ' A' ' 40' ' ' PHE . 18.4 tp -134.1 149.84 51.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 112.245 -1.978 . . . . 0.0 109.233 -168.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 tp -124.61 133.75 53.16 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.629 1.204 . . . . 0.0 107.782 157.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -114.46 120.36 40.0 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.262 173.184 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.5 mt -118.04 139.76 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -172.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -103.02 129.6 25.29 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -59.08 -16.95 35.66 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 N-CA-C 121.261 3.524 . . . . 0.0 121.261 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -50.31 58.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -160.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.78 -35.2 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.843 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -71.19 -12.14 61.32 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 t -76.7 1.14 17.94 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.984 1.265 . . . . 0.0 112.147 -170.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.352 53.9 m -98.86 168.12 10.24 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.5 -2.83 13.0 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 N-CA-C 117.873 2.22 . . . . 0.0 117.873 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -74.15 -50.45 19.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.957 1.253 . . . . 0.0 114.21 -166.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.06 -30.15 68.42 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.778 0.717 . . . . 0.0 112.368 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.43 -46.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.102 -0.374 . . . . 0.0 111.146 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -62.2 -36.33 81.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.039 0.836 . . . . 0.0 113.223 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -46.75 75.23 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -58.93 -45.68 89.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.826 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -63.97 -29.82 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.98 74.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.893 1.224 . . . . 0.0 113.38 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -57.63 -52.98 63.19 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.154 -0.341 . . . . 0.0 111.858 171.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.86 -45.71 60.01 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.883 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.83 -50.53 28.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.49 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.5 t -75.54 -29.52 59.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -170.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.86 -127.84 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.006 -0.434 . . . . 0.0 111.94 170.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -139.39 1.48 1.97 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -165.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -99.47 149.81 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.817 0.818 . . . . 0.0 112.28 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -122.65 143.78 49.55 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -104.24 100.37 10.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.279 1.037 . . . . 0.0 109.425 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.74 -40.59 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.84 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.09 169.77 10.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.246 1.022 . . . . 0.0 110.538 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -144.86 113.02 6.48 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -164.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' A' ' 8' ' ' LEU . 17.4 m-30 -118.83 120.19 36.6 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.36 150.09 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.16 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -76.74 -30.05 56.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.8 -35.73 32.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 113.137 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.12 -40.52 78.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.814 0.733 . . . . 0.0 112.724 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -66.1 -27.91 68.42 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.076 173.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -79.9 -39.12 31.08 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.3 10.69 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -78.34 -11.18 59.92 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.1 mt -114.9 121.77 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -98.6 120.84 39.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 124.014 1.864 . . . . 0.0 110.227 -164.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.0 mt -96.52 149.81 21.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 111.199 -2.728 . . . . 0.0 111.565 -163.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.76 169.75 9.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.255 -1.793 . . . . 0.0 107.498 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -116.34 35.95 4.31 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.28 -74.66 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -168.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' THR . 50.9 pttt -78.24 32.92 0.19 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -162.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.443 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.6 m-85 -112.11 21.87 15.41 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 116.93 -1.51 . . . . 0.0 112.995 170.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.63 38.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -165.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.02 115.32 6.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 166.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.2 t -101.33 139.04 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -122.3 134.57 54.66 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -114.73 141.75 47.42 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.77 112.81 17.77 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 170.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.1 m -150.3 154.4 36.05 Favored Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -57.67 147.43 79.86 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.902 2.401 . . . . 0.0 115.499 170.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -120.09 30.01 7.22 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.654 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.37 -59.59 1.8 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.205 -0.934 . . . . 0.0 110.428 -170.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -81.64 115.31 20.85 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -170.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.2 p -73.71 89.75 1.8 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.335 1.064 . . . . 0.0 112.165 -170.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.05 178.89 6.67 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 170.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.13 149.31 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.577 170.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -106.07 -52.06 2.87 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 118.592 2.812 . . . . 0.0 118.592 -169.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.407 ' CE2' HG13 ' A' ' 78' ' ' ILE . 14.7 t80 -130.54 149.14 72.65 Favored Pre-proline 0 N--CA 1.473 0.704 0 O-C-N 120.837 -1.164 . . . . 0.0 108.76 -158.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 22.8 Cg_exo -82.09 149.8 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 CA-C-N 120.01 1.039 . . . . 0.0 111.365 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.52 -36.86 83.94 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -58.54 -34.22 70.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.67 -30.18 56.66 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.919 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.407 HG13 ' CE2' ' A' ' 73' ' ' PHE . 96.4 mt -59.84 -38.97 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 120.043 1.292 . . . . 0.0 111.236 167.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.6 m -65.68 -39.08 90.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.691 1.132 . . . . 0.0 112.908 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.55 -41.73 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.04 -41.5 92.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.652 -0.655 . . . . 0.0 112.58 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 85' ' ' LEU . . . -63.57 -29.76 70.97 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.88 -10.12 59.33 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -105.46 33.56 3.66 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 82' ' ' ALA . 92.5 mt -134.05 159.98 39.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.233 1.016 . . . . 0.0 111.053 -165.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.556 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 82.2 mttt -112.8 -156.4 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 165.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 14.8 Cg_endo -62.82 -33.81 74.63 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 CA-C-N 124.041 2.479 . . . . 0.0 113.855 -170.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -92.52 45.88 1.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 118.513 0.597 . . . . 0.0 109.912 -170.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 118' ' ' ILE . . . -79.74 116.71 4.34 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 172.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.4 t -139.32 107.04 5.62 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -166.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.23 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.279 1.3 tt -91.52 129.89 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -170.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.675 HD13 ' CB ' ' A' ' 116' ' ' CYS . 20.3 mm -105.89 86.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.977 0.894 . . . . 0.0 109.746 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.592 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.74 -83.49 0.06 OUTLIER Glycine 0 C--N 1.317 -0.488 0 N-CA-C 121.509 3.364 . . . . 0.0 121.509 -166.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.592 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -115.49 171.38 7.76 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.33 -1.348 . . . . 0.0 110.196 -138.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 85.0 p -110.28 -129.34 0.29 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.942 -163.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -79.3 -47.81 15.21 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -157.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.64 -29.78 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 124.607 2.146 . . . . 0.0 111.317 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 76.0 m-85 -76.66 -11.0 59.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.354 -1.748 . . . . 0.0 111.149 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -49.36 70.73 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.789 -1.194 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.09 -36.89 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.802 -0.561 . . . . 0.0 111.141 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -60.4 -43.0 97.1 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.929 171.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.538 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -57.28 -43.33 83.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 111.242 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.06 -48.26 76.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.4 tt -80.13 -35.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.811 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -71.96 0.47 9.24 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.38 41.79 97.96 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 119.807 1.185 . . . . 0.0 113.935 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.0 m-85 -106.91 111.76 24.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 165.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -98.88 117.93 34.49 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 123.474 1.607 . . . . 0.0 106.746 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.66 HG12 ' CD1' ' A' ' 117' ' ' TRP . 15.8 mt -74.74 152.52 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.811 -162.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.4 pt -139.58 128.93 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.159 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -106.86 78.82 1.27 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.302 2.001 . . . . 0.0 111.112 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.27 36.7 tt0 -93.13 162.49 28.25 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 111.341 -2.663 . . . . 0.0 107.14 166.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.56 -6.13 0.92 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 N-CA-C 118.934 2.628 . . . . 0.0 118.934 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -112.43 110.29 20.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 155.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -80.75 115.13 20.09 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.878 -0.514 . . . . 0.0 110.562 -168.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.23 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 15.0 p -147.04 -164.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 123.746 1.736 . . . . 0.0 114.102 172.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.66 ' CD1' HG12 ' A' ' 109' ' ' ILE . 3.1 m0 -137.79 130.19 29.38 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 111.459 -2.61 . . . . 0.0 106.073 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER -111.88 144.22 20.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 123.001 1.381 . . . . 0.0 107.478 169.389 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.87 134.84 36.33 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.467 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.47 0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.432 170.355 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 122.194 0.997 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -92.32 142.06 27.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.602 1.192 . . . . 0.0 111.148 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 56' ' ' LYS . 1.6 t -105.08 120.66 42.05 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.465 174.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.6 -161.12 10.05 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 118.814 -1.66 . . . . 0.0 113.811 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.458 HD13 ' OD2' ' A' ' 38' ' ' ASP . 42.5 tp -133.94 139.28 46.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.09 -1.055 . . . . 0.0 108.686 -167.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.7 tp -124.87 110.96 14.91 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 0.0 110.443 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.91 120.23 39.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.996 170.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -123.15 139.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.962 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.76 129.83 43.1 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.48 -11.02 10.05 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 N-CA-C 120.562 3.254 . . . . 0.0 120.562 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.71 -50.14 65.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -88.95 -30.29 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.873 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.5 p -78.74 -2.7 40.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -76.62 -9.8 58.93 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.933 1.242 . . . . 0.0 111.476 163.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.4 m -108.51 71.68 0.41 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 165.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.29 46.68 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.363 3.375 . . . . 0.0 116.235 -154.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.86 -49.98 66.18 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.396 -0.815 . . . . 0.0 112.772 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.97 -29.82 70.77 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 122.05 -0.406 . . . . 0.0 112.03 173.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -63.59 -50.0 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.735 -0.603 . . . . 0.0 111.322 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.63 -36.45 76.38 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.223 -0.923 . . . . 0.0 113.301 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.09 -49.88 72.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -64.9 -35.85 82.48 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.786 0.721 . . . . 0.0 111.562 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -64.99 -35.13 80.21 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.12 -45.28 70.56 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.536 1.062 . . . . 0.0 113.11 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.334 0.9 OUTLIER -54.99 -52.11 64.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.15 86.46 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.587 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.28 -50.46 65.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.419 -170.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 m -75.25 -13.95 60.48 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.835 -0.541 . . . . 0.0 112.021 -170.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.79 -113.94 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.838 -0.539 . . . . 0.0 110.393 170.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -150.72 35.22 0.61 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 t -112.65 149.85 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.443 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.23 134.91 49.07 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 162.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -98.78 100.73 11.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.21 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.84 -14.6 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -164.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.458 ' OD2' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -121.73 120.4 34.55 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -173.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -114.92 114.34 25.34 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.551 -167.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -123.68 120.21 32.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.839 0.828 . . . . 0.0 109.428 -174.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp -87.65 149.8 24.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.415 HD13 ' OH ' ' A' ' 62' ' ' TYR . 3.9 tp -63.29 -38.3 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -78.54 -30.29 46.86 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -77.69 -41.09 39.21 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.305 -0.872 . . . . 0.0 112.494 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -67.03 -40.38 87.21 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.644 0.735 . . . . 0.0 112.947 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -73.84 -21.37 60.14 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.761 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.92 -35.01 38.48 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.595 -0.69 . . . . 0.0 111.421 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.12 15.27 5.66 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.811 0.684 . . . . 0.0 114.811 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -78.46 -40.29 36.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.6 mt -114.93 118.74 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 122.481 1.134 . . . . 0.0 109.5 -167.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -133.31 159.23 40.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 157.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.294 1.8 pt? -131.34 -70.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.329 164.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -141.46 169.8 16.92 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.892 0.853 . . . . 0.0 109.81 172.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.54 63.14 0.85 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.55 -92.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 6' ' ' THR . 43.5 pttt -100.29 64.55 1.18 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -161.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.437 ' O ' ' N ' ' A' ' 59' ' ' THR . 5.7 m-85 -112.1 21.77 15.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 116.367 -1.778 . . . . 0.0 113.346 170.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.54 41.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -157.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -147.15 115.68 6.71 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 165.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 91' ' ' LEU 0.25 40.9 t -118.4 134.62 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.403 -164.489 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.59 134.74 54.51 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.415 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -117.79 110.41 17.77 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 168.13 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.23 104.97 17.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.031 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.8 m -119.84 120.08 30.7 Favored Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 167.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.01 -91.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 121.875 1.717 . . . . 0.0 114.546 -164.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -96.84 -24.09 16.06 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -165.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.87 62.73 1.17 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.321 0.964 . . . . 0.0 111.829 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -112.1 97.21 6.5 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.9 p -125.02 -58.53 1.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -91.09 -167.53 1.83 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.488 0.661 . . . . 0.0 109.629 -170.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tp -82.66 71.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -88.75 35.01 0.77 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 14.7 t80 -130.5 148.81 71.45 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 164.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 27.4 Cg_exo -82.38 149.49 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 120.395 1.177 . . . . 0.0 110.161 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.6 -37.49 86.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.641 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.61 -29.55 70.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.2 mt -76.75 -30.16 56.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.322 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.31 -35.03 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-N 119.886 1.221 . . . . 0.0 111.033 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.2 t -68.5 -39.39 81.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.661 1.119 . . . . 0.0 112.657 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.916 -0.49 . . . . 0.0 111.755 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.98 -46.11 90.5 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.696 -0.628 . . . . 0.0 111.967 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.04 71.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.2 -13.01 56.29 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.3 m -71.26 -45.19 63.75 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 122.06 -0.4 . . . . 0.0 110.747 162.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.9 mt -97.67 161.47 13.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.926 1.346 . . . . 0.0 112.461 -163.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.424 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 63.9 mttp -108.43 -178.25 0.55 Allowed Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.287 -170.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 25.5 Cg_exo -56.15 -12.73 8.08 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 N-CA-C 119.96 3.023 . . . . 0.0 119.96 -170.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -102.37 33.32 3.17 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.14 1.336 . . . . 0.0 111.853 169.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.55 141.89 41.35 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 170.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 81.9 p -145.24 107.19 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.97 1.366 . . . . 0.0 108.325 -171.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -89.9 143.01 27.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.611 -1.632 . . . . 0.0 108.59 -172.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.38 88.41 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 167.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.22 -86.6 0.08 OUTLIER Glycine 0 CA--C 1.53 0.977 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 -159.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.54 169.82 8.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.052 1.926 . . . . 0.0 110.828 -147.297 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.4 m -104.89 -149.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -160.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.51 -43.06 86.31 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -163.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.01 -34.43 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 124.836 2.255 . . . . 0.0 110.526 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 65.7 m-85 -76.68 -10.49 59.42 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.142 -1.844 . . . . 0.0 111.073 -175.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.93 -52.83 58.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.829 -1.169 . . . . 0.0 112.188 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.76 -33.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.275 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.48 -46.01 91.85 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.531 -0.731 . . . . 0.0 112.847 172.342 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 109' ' ' ILE . . . -56.6 -42.57 78.98 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.886 -0.509 . . . . 0.0 111.827 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.05 -49.35 76.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.67 0.747 . . . . 0.0 112.502 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 tt -80.08 -34.62 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -170.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -71.61 -17.41 62.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.61 29.61 5.55 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 119.296 -1.43 . . . . 0.0 112.317 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.1 m-85 -106.71 159.84 15.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -126.88 108.1 10.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.548 1.166 . . . . 0.0 108.711 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.609 HG12 ' CD1' ' A' ' 117' ' ' TRP . 25.5 mt -84.5 111.24 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.962 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.676 HG13 ' SG ' ' A' ' 116' ' ' CYS . 44.9 pt -108.55 135.05 48.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.247 169.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -105.85 100.31 9.87 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.725 1.726 . . . . 0.0 110.668 -171.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -117.31 171.37 4.99 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 111.957 -2.383 . . . . 0.0 107.698 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -56.22 -8.5 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 N-CA-C 119.117 2.699 . . . . 0.0 119.117 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -119.47 115.26 23.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -79.57 139.09 37.63 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -165.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.676 ' SG ' HG13 ' A' ' 110' ' ' ILE 0.266 5.1 p -145.72 120.88 10.14 Favored 'General case' 0 CA--C 1.54 0.586 1 N-CA-C 123.375 4.583 . . . . 0.0 123.375 -164.141 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.609 ' CD1' HG12 ' A' ' 109' ' ' ILE . 4.0 m0 -109.64 111.06 22.32 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 143.98 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.682 1.23 . . . . 0.0 108.832 170.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 77.8 tttt -91.74 110.22 21.55 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.631 -174.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.832 0.825 . . . . 0.0 110.424 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -92.64 141.77 28.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.527 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 t -89.88 141.48 28.6 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 158.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.48 -167.09 11.55 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 123.762 1.757 . . . . 0.0 115.258 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 40' ' ' PHE . 30.5 tp -131.3 139.83 49.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 111.569 -2.315 . . . . 0.0 107.983 -173.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.285 0.2 OUTLIER -124.49 129.39 50.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 168.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -121.86 120.33 34.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -175.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.3 tt -129.1 139.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 -163.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -106.6 129.62 24.16 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -62.0 -11.67 22.58 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 N-CA-C 120.683 3.301 . . . . 0.0 120.683 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.21 -50.34 61.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -161.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.8 t -89.91 -30.35 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.689 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -84.17 0.24 49.42 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 5.72 7.01 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.364 1.438 . . . . 0.0 113.671 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.333 95.5 m -98.98 167.99 10.42 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 164.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.65 -13.23 16.4 Favored 'Trans proline' 0 N--CA 1.482 0.824 0 N-CA-C 117.133 1.936 . . . . 0.0 117.133 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.13 -50.34 19.86 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -161.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.32 -30.04 68.01 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.156 0.889 . . . . 0.0 112.189 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.59 -50.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.758 -0.589 . . . . 0.0 111.036 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.61 -36.78 76.99 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.304 -0.873 . . . . 0.0 113.335 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -61.86 -50.12 73.51 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.3 t -66.53 -37.57 85.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.691 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.89 -31.21 72.34 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 170.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.15 67.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.607 1.094 . . . . 0.0 113.195 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -56.39 -54.57 44.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.341 0.591 . . . . 0.0 111.185 171.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.48 -40.33 59.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.67 -50.02 9.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.2 p -60.77 -24.54 65.84 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -126.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.655 -0.653 . . . . 0.0 110.429 170.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -144.72 -9.15 0.63 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -168.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.61 110.46 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -98.78 146.7 25.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.632 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -88.7 100.36 13.06 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 123.374 1.559 . . . . 0.0 110.465 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -36.5 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 112.375 -2.193 . . . . 0.0 113.268 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -121.89 169.58 10.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.226 1.012 . . . . 0.0 111.377 -170.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -150.13 125.58 10.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.556 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.537 ' O ' HD23 ' A' ' 10' ' ' LEU . 30.4 m-85 -133.03 120.67 21.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.62 149.45 24.29 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 tp -63.63 -40.16 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -79.17 -30.28 43.43 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.746 . . . . 0.0 112.843 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -82.24 -24.92 34.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -40.41 71.4 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.434 1.015 . . . . 0.0 111.901 174.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -78.19 -27.66 47.98 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.96 -37.56 34.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.842 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.3 15.38 2.78 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 116.904 1.522 . . . . 0.0 116.904 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -75.62 -29.44 59.21 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.457 1.629 . . . . 0.0 114.612 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.58 120.16 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.8 m -124.45 120.2 31.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.762 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.5 mt -123.79 -163.44 1.14 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.87 171.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -98.79 169.84 9.18 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.923 1.344 . . . . 0.0 111.797 -166.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -90.21 94.62 9.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.426 170.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.65 -162.05 1.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -168.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -95.49 58.0 1.99 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.872 -170.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' THR . 3.9 m-85 -81.4 22.45 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 117.012 -1.47 . . . . 0.0 112.568 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.406 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 35.6 mt-10 -60.76 38.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -164.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.73 115.46 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 164.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.56 110.54 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.324 -157.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.37 106.55 16.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.982 -174.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.77 141.52 28.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 171.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.289 22.3 tp -123.53 115.11 20.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.867 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -149.27 154.35 38.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.34 128.86 31.78 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.559 2.172 . . . . 0.0 116.288 170.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.01 28.68 7.94 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.592 -170.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.93 -68.42 0.81 Allowed 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.13 -0.981 . . . . 0.0 109.029 -170.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.28 115.15 21.85 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -82.01 78.74 8.67 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.879 0.847 . . . . 0.0 110.265 170.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -135.14 47.7 2.32 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.027 168.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.6 pt -108.11 149.86 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -170.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -124.98 140.1 53.22 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.051 0.929 . . . . 0.0 110.757 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 -127.03 149.03 68.21 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 167.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 39.1 Cg_exo -82.12 149.67 15.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 CA-C-N 120.626 1.259 . . . . 0.0 110.332 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.62 -36.67 83.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -66.44 -26.08 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.87 -30.2 56.14 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.743 1.156 . . . . 0.0 111.106 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -39.14 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.935 1.243 . . . . 0.0 110.928 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.2 m -67.44 -40.99 85.47 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.321 -0.862 . . . . 0.0 112.586 176.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.91 -38.9 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.272 0.487 . . . . 0.0 112.266 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.86 -39.08 87.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.543 1.065 . . . . 0.0 112.381 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -29.65 70.67 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.23 -9.85 59.02 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.7 m -70.83 -36.43 72.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 165.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.83 159.77 18.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 123.02 1.391 . . . . 0.0 113.293 -153.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.02 101.76 0.68 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 112.02 -2.355 . . . . 0.0 105.329 162.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.17 11.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 N-CA-C 122.055 3.829 . . . . 0.0 122.055 -154.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -102.41 53.48 0.79 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.549 1.166 . . . . 0.0 108.165 162.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 58' ' ' GLU . . . -68.54 163.41 49.4 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 168.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 30.8 t -147.02 120.13 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.502 HD21 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -99.38 139.82 34.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.505 -168.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.63 90.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 167.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.55 -94.31 0.19 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 -160.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.502 HD12 HD21 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -116.44 169.9 8.96 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.919 -146.151 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -123.38 -115.74 0.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -156.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.26 -63.01 1.15 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -157.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -59.66 -27.95 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 124.373 2.035 . . . . 0.0 111.537 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.657 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 67.8 m-85 -76.82 -19.27 57.74 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.026 -170.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.23 -52.06 62.51 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.776 -1.202 . . . . 0.0 112.345 169.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.92 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.842 -0.536 . . . . 0.0 111.819 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.657 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.56 -43.22 97.52 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.34 -42.2 98.3 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.17 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.6 tp -55.88 -46.76 78.23 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 tt -79.95 -38.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.254 -171.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -71.98 1.93 6.45 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.66 43.63 96.11 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.774 -1.203 . . . . 0.0 114.048 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.562 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.5 m-85 -109.45 111.83 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 167.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -98.92 112.23 24.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 123.61 1.671 . . . . 0.0 108.107 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.581 HG13 ' CD1' ' A' ' 117' ' ' TRP 0.257 16.3 tt -83.59 156.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 112.057 -2.338 . . . . 0.0 112.619 -164.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.627 HG23 ' SG ' ' A' ' 116' ' ' CYS . 14.6 tt -147.21 128.32 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.843 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -102.66 98.32 8.38 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 123.282 1.515 . . . . 0.0 112.386 -167.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.16 171.61 8.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.056 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.47 -10.29 4.78 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 N-CA-C 119.295 2.767 . . . . 0.0 119.295 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -125.17 115.02 19.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 160.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.425 ' OH ' HD11 ' A' ' 109' ' ' ILE . 38.1 t80 -79.64 138.78 37.51 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.38 -163.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.627 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.289 5.4 p -146.26 120.89 9.79 Favored 'General case' 0 CA--C 1.55 0.955 1 N-CA-C 127.042 5.941 . . . . 0.0 127.042 -164.924 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.581 ' CD1' HG13 ' A' ' 109' ' ' ILE . 7.4 m0 -109.63 114.91 28.91 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.49 1.496 . . . . 0.0 109.229 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.3 OUTLIER -99.62 143.92 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -79.91 134.9 36.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.911 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 121.699 0.762 . . . . 0.0 109.846 170.455 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -84.34 141.79 30.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.687 0.756 . . . . 0.0 111.187 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.0 m -104.63 140.82 37.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.22 -156.69 7.95 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-O 123.86 1.811 . . . . 0.0 117.011 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.488 HD21 ' CD2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -134.54 142.37 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 111.472 -2.364 . . . . 0.0 109.704 -174.107 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 tp -124.21 133.23 53.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 162.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -120.14 120.29 35.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.442 174.007 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 16' ' ' THR . 16.1 tt -132.15 139.91 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -164.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -105.71 129.92 23.88 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -59.96 -12.37 18.62 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 N-CA-C 121.381 3.57 . . . . 0.0 121.381 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.33 -50.36 71.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -160.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.3 t -88.86 -28.92 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.491 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.411 ' HB ' HD11 ' A' ' 11' ' ' ILE . 47.7 p -79.05 0.3 28.39 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -170.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.1 m -76.62 0.74 19.09 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 119.575 1.079 . . . . 0.0 111.993 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 m -98.55 169.09 8.79 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 162.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -77.18 2.48 7.61 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 N-CA-C 120.676 3.299 . . . . 0.0 120.676 171.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.31 -50.93 16.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 121.212 1.824 . . . . 0.0 115.312 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.43 -31.6 70.03 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.558 -0.714 . . . . 0.0 112.56 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.88 -47.67 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.644 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.93 -33.27 75.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -64.74 -49.89 69.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -64.05 -41.75 97.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.321 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.7 -30.23 71.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.575 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -45.64 69.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.179 1.354 . . . . 0.0 113.511 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -56.52 -53.81 53.14 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.689 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.9 79.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.741 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.26 43.36 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.998 -0.439 . . . . 0.0 111.23 -170.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.2 p -73.32 -21.8 60.47 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.606 0.639 . . . . 0.0 111.568 -170.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.73 -113.44 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -157.41 17.36 0.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -168.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.87 152.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.3 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -128.39 135.02 48.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 165.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.75 100.56 13.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.816 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -21.22 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -167.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.98 121.47 37.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -167.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -114.2 124.28 51.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.089 0.947 . . . . 0.0 109.635 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CD2' HD21 ' A' ' 8' ' ' LEU . 22.2 m-30 -127.32 103.25 7.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.528 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 43' ' ' ASN . 8.0 tt -84.97 149.79 25.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.03 -39.94 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' H ' HD23 ' A' ' 41' ' ' LEU . 36.8 t30 -78.57 -30.13 46.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.64 -29.59 33.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.25 0.932 . . . . 0.0 113.19 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -40.51 54.71 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.38 0.991 . . . . 0.0 112.084 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -69.56 -28.23 65.81 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.34 -41.84 24.05 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.6 15.27 8.9 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.301 1.28 . . . . 0.0 116.301 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 m -73.38 -8.27 55.15 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 119.499 1.649 . . . . 0.0 115.45 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.9 mt -114.72 121.82 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.976 -0.452 . . . . 0.0 109.99 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.7 m -98.48 120.66 39.28 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.199 1.952 . . . . 0.0 108.978 -172.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.267 63.4 tp -96.73 149.54 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 110.752 -2.931 . . . . 0.0 111.591 -161.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.42 169.79 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.667 166.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -120.1 44.42 2.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -166.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -73.1 0.07 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 119.446 3.128 . . . . 0.0 119.446 -166.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -81.71 30.53 0.37 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -157.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 59' ' ' THR . 0.6 OUTLIER -112.22 21.27 15.99 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 117.659 -1.162 . . . . 0.0 112.621 -170.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.82 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 -166.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.09 115.5 6.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 169.313 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 24.4 t -119.33 134.34 63.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.706 -165.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -122.58 134.6 54.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.44 142.45 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.77 102.37 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -137.23 113.86 9.68 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.3 133.76 36.91 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.733 2.289 . . . . 0.0 114.974 170.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -120.04 30.18 7.14 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.884 -170.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.84 -66.0 0.93 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.516 -0.74 . . . . 0.0 110.256 -170.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -80.65 -63.59 1.38 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -170.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.1 p -90.84 158.7 16.66 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -170.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -71.72 178.65 3.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.572 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.1 tt -98.47 93.33 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 122.125 0.964 . . . . 0.0 109.539 -170.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -102.01 94.1 5.6 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -170.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -130.14 90.97 40.49 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.551 170.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -55.77 149.66 49.14 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.806 1.671 . . . . 0.0 112.887 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.52 -34.74 77.5 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -31.45 67.88 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.81 -30.06 56.23 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.113 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.62 -35.45 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 119.769 1.168 . . . . 0.0 111.614 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.3 p -69.12 -36.83 77.94 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.21 1.368 . . . . 0.0 112.967 173.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.08 -37.42 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.815 -0.553 . . . . 0.0 111.902 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -59.96 -46.07 90.62 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.819 -0.551 . . . . 0.0 112.042 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.0 70.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -73.62 -9.99 59.24 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 m -106.87 30.22 6.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -134.07 162.52 31.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.044 0.926 . . . . 0.0 109.846 -169.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 174.97 2.31 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -58.52 -12.4 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 118.455 2.444 . . . . 0.0 118.455 -170.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -102.0 46.76 0.92 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.943 0.792 . . . . 0.0 110.676 170.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.31 140.58 24.75 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.5 t -146.3 106.27 4.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.17 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.259 3.1 tt -89.91 129.92 36.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -175.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.001 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 27.2 mm -104.42 91.11 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 122.337 1.065 . . . . 0.0 108.31 170.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.76 -95.13 0.2 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 120.745 3.058 . . . . 0.0 120.745 -162.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.453 HD22 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.5 169.62 9.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.017 -1.473 . . . . 0.0 109.464 -142.387 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -118.26 -118.07 0.32 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -158.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.09 -54.24 8.23 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -156.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -61.0 -29.33 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 124.548 2.118 . . . . 0.0 111.294 170.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.72 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.1 m-85 -76.78 -9.41 58.65 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.291 -1.777 . . . . 0.0 112.03 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -63.95 -56.05 17.99 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.295 -0.878 . . . . 0.0 111.468 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.84 -31.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 122.188 -0.32 . . . . 0.0 111.513 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.72 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.89 -46.5 87.56 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.539 -0.725 . . . . 0.0 112.451 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -54.9 -41.8 71.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.088 0.404 . . . . 0.0 111.777 173.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.6 tp -63.19 -45.14 93.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.6 mt -80.08 -34.95 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -71.75 -15.5 62.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 27.88 6.12 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.589 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 97.4 m-85 -106.52 159.6 16.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 172.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -118.71 154.13 33.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 161.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.685 HG12 ' CD1' ' A' ' 117' ' ' TRP . 22.5 mt -103.89 148.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 122.994 1.378 . . . . 0.0 109.282 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.82 123.11 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.891 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -115.48 100.18 7.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.942 1.829 . . . . 0.0 110.913 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -134.22 -178.54 0.88 Allowed Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 111.215 -2.72 . . . . 0.0 106.194 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.52 -7.14 1.2 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -135.07 115.27 13.28 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 161.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -86.77 115.02 23.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.296 -167.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.17 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 27.9 p -147.6 -158.62 0.93 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 122.674 1.226 . . . . 0.0 114.099 167.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.685 ' CD1' HG12 ' A' ' 109' ' ' ILE . 5.9 m0 -137.31 130.36 30.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.452 -1.703 . . . . 0.0 106.438 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.89 144.0 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 122.708 1.242 . . . . 0.0 108.276 167.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 76.4 tttt -87.16 110.39 20.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.797 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.499 0.666 . . . . 0.0 112.14 170.384 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.0 t80 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.1 141.94 28.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.218 1.008 . . . . 0.0 111.831 -165.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -94.44 141.77 28.21 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 166.186 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.53 -158.32 8.64 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 119.369 -1.396 . . . . 0.0 114.625 169.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.48 139.95 45.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.307 0.0 OUTLIER -124.38 129.35 50.54 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 174.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.44 120.23 40.95 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.4 mt -124.81 139.98 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.636 -171.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -98.69 129.77 29.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 160.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -60.96 -11.99 20.59 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 N-CA-C 121.75 3.711 . . . . 0.0 121.75 -170.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.29 74.52 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -159.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 65' ' ' PRO . 44.8 t -96.32 -29.83 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 119.29 0.95 . . . . 0.0 111.81 170.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 p -65.21 0.03 1.54 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -76.3 -10.32 59.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.118 1.781 . . . . 0.0 112.077 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.317 92.5 m -98.8 167.98 10.49 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 163.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.87 -3.17 13.27 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 N-CA-C 117.674 2.144 . . . . 0.0 117.674 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.96 -50.42 20.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.428 1.467 . . . . 0.0 114.521 -161.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.2 -32.46 71.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.429 -0.794 . . . . 0.0 112.585 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.49 -47.79 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.504 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.45 -47.3 70.57 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.3 m -58.89 -46.23 88.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.938 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.1 mmmt -60.92 -29.94 69.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.33 74.36 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.203 1.365 . . . . 0.0 113.488 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -60.0 -54.05 50.67 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.039 0.447 . . . . 0.0 111.401 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.06 45.77 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.94 -45.67 11.27 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.8 p -58.02 -34.19 69.78 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.92 -113.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -170.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 38.0 tptt -137.88 -13.1 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.532 -170.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 59' ' ' THR . 3.3 p -117.26 110.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -170.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -98.65 139.58 34.15 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.218 1.009 . . . . 0.0 108.887 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.58 139.75 30.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.34 -30.05 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -160.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -121.61 169.88 10.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.782 1.277 . . . . 0.0 109.015 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -143.82 125.1 14.63 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.24 -1.346 . . . . 0.0 108.846 -169.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -125.87 113.84 17.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.873 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -86.8 149.93 24.5 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -40.03 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -79.93 -30.25 39.92 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -79.75 -32.54 41.06 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.356 -0.84 . . . . 0.0 113.009 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -73.61 -40.62 63.69 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.969 0.804 . . . . 0.0 112.844 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -70.55 -26.12 63.4 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.799 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.26 -42.28 16.03 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 119.106 -0.473 . . . . 0.0 112.149 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.76 15.44 2.63 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 169.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -76.21 -19.45 58.38 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.086 1.943 . . . . 0.0 115.103 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.62 121.85 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.0 t -98.96 159.38 15.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 125.249 2.452 . . . . 0.0 111.403 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.32 120.98 43.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.588 -3.46 . . . . 0.0 111.142 -158.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -98.16 169.17 9.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.552 162.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -120.55 52.67 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -159.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -86.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 6' ' ' THR . 95.4 mttt -100.04 57.45 0.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.017 0.913 . . . . 0.0 113.39 -158.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' THR . 4.4 m-85 -112.1 21.14 16.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.323 169.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.91 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -161.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.515 HG21 HG21 ' A' ' 34' ' ' VAL . 14.6 t -137.41 115.43 11.57 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 161.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -117.42 101.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 -164.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -97.83 134.4 41.03 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.66 110.31 18.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.377 1.084 . . . . 0.0 109.193 174.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.7 mt -98.73 102.06 13.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.412 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.0 m -122.36 94.77 47.6 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HG2' ' H ' ' A' ' 15' ' ' VAL . 60.7 Cg_endo -80.1 94.47 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.216 1.944 . . . . 0.0 112.853 170.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -120.07 -30.21 4.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.878 169.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.68 -89.61 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 170.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -112.22 -57.69 2.24 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.197 -0.314 . . . . 0.0 110.487 170.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.9 p -99.99 175.59 5.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.376 1.084 . . . . 0.0 111.684 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -82.1 100.48 9.8 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.4 pt -62.17 -151.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 170.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -79.64 139.75 37.32 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 123.255 1.502 . . . . 0.0 113.779 -160.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 -130.59 149.25 72.98 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 112.744 -2.026 . . . . 0.0 107.541 -170.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 32.3 Cg_exo -81.88 149.44 15.9 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 CA-C-N 120.894 1.355 . . . . 0.0 110.741 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -62.6 -40.35 96.67 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.5 -32.27 68.66 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -76.7 -30.26 56.62 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.742 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.42 -35.09 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 119.817 1.189 . . . . 0.0 111.554 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -70.25 -36.79 74.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.288 1.403 . . . . 0.0 112.884 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.56 -39.22 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 121.668 -0.645 . . . . 0.0 111.597 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -60.04 -46.2 90.29 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.814 -0.554 . . . . 0.0 112.073 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.92 70.35 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.85 -32.0 72.21 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -167.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.5 p -92.68 33.27 1.14 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.6 mt -134.16 175.49 9.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.619 1.199 . . . . 0.0 111.818 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -116.32 175.06 2.09 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.66 -25.98 21.73 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 N-CA-C 119.103 2.694 . . . . 0.0 119.103 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -102.27 51.15 0.82 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.68 1.582 . . . . 0.0 110.454 169.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.23 142.92 30.01 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.2 p -144.16 105.88 4.3 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.211 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.366 0.3 OUTLIER -89.68 129.65 36.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.084 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.022 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 39.9 mm -112.44 91.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.11 0.957 . . . . 0.0 109.699 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.09 -86.41 0.08 OUTLIER Glycine 0 C--N 1.315 -0.607 0 N-CA-C 120.902 3.121 . . . . 0.0 120.902 -171.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.602 HD12 HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -116.18 169.77 9.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 -137.542 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 t -108.66 -131.79 0.31 Allowed 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.87 -1.144 . . . . 0.0 112.819 -156.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -80.0 -49.42 11.85 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -158.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -58.69 -30.23 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 124.33 2.014 . . . . 0.0 112.984 168.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.4 m-85 -76.46 -14.99 60.02 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 113.167 -1.833 . . . . 0.0 110.453 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.4 tttt -58.5 -50.67 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.194 -0.941 . . . . 0.0 112.316 165.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.83 -36.82 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.786 -0.571 . . . . 0.0 111.202 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.58 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.97 -43.89 94.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.83 97.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.458 0.647 . . . . 0.0 111.796 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.73 -47.82 83.3 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.467 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.5 mt -76.35 -35.18 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.055 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -71.85 -19.97 61.89 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 33.31 4.09 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.884 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 98.0 m-85 -106.67 159.83 15.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.28 1.038 . . . . 0.0 108.28 168.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.56 106.39 10.55 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.651 HG13 ' CD1' ' A' ' 117' ' ' TRP . 16.8 tt -75.32 144.97 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 122.371 1.081 . . . . 0.0 112.05 -169.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.18 129.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.669 1.223 . . . . 0.0 108.635 -173.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -96.83 99.98 11.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.328 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.86 173.92 2.71 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.139 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -54.9 -14.28 7.76 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 118.966 2.641 . . . . 0.0 118.966 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -130.0 115.22 16.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 153.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.46 139.01 32.49 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.604 -164.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.211 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 12.0 p -147.77 -155.02 0.59 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 123.209 1.481 . . . . 0.0 111.731 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.651 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.7 m0 -137.13 130.11 30.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.69 144.22 19.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.529 1.157 . . . . 0.0 108.299 171.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.31 134.63 36.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.169 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.469 0.521 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.594 170.362 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -111.59 141.82 44.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.216 1.484 . . . . 0.0 112.155 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -105.06 120.87 42.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 112.466 -2.152 . . . . 0.0 105.79 165.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.91 -161.95 10.27 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 119.465 -1.35 . . . . 0.0 116.255 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.532 HD21 ' CE2' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -134.24 139.27 45.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.182 -1.009 . . . . 0.0 108.69 -165.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.99 134.65 52.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.341 1.067 . . . . 0.0 108.558 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -113.02 120.55 41.75 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.512 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.35 140.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -97.77 129.73 30.65 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 163.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -63.17 -10.59 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 N-CA-C 120.441 3.208 . . . . 0.0 120.441 -170.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.92 -50.26 62.95 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 -162.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.5 t -84.88 -30.14 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.553 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -81.91 0.21 40.79 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -170.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 93.6 m -76.32 -6.24 50.63 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 120.056 1.298 . . . . 0.0 111.537 164.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 m -113.19 71.48 1.46 Allowed Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.69 58.74 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.964 3.109 . . . . 0.0 115.971 -155.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.36 -50.15 23.5 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.59 -1.319 . . . . 0.0 111.751 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 -29.89 70.93 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.69 0.677 . . . . 0.0 112.348 176.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.95 -49.98 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.857 -0.527 . . . . 0.0 111.403 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.89 -36.58 77.25 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.294 -0.879 . . . . 0.0 113.298 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -63.1 -49.45 74.39 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.7 t -64.82 -38.01 89.56 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.198 0.908 . . . . 0.0 111.597 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -62.39 -35.22 78.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 169.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.45 72.08 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.441 1.019 . . . . 0.0 113.489 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -59.49 -53.84 53.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.867 0.365 . . . . 0.0 111.6 174.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -57.15 -39.87 76.09 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.83 -46.99 15.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -170.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 98.1 p -57.96 -20.55 38.68 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.74 -105.08 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.737 -0.602 . . . . 0.0 109.521 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -150.39 15.53 0.8 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -170.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.438 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 22.8 t -126.65 110.63 23.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.509 -168.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.33 134.94 41.46 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 165.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -89.06 139.72 30.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.26 -26.05 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -163.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.69 121.36 37.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -113.98 118.24 33.58 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.812 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 8' ' ' LEU . 13.0 m-30 -121.97 106.14 10.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.812 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.73 149.76 25.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -63.25 -40.07 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -76.65 -30.24 56.74 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.96 -31.8 34.71 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.69 -40.39 69.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.551 1.069 . . . . 0.0 112.346 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.79 -18.55 61.47 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.14 -38.8 16.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.496 -0.752 . . . . 0.0 111.882 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.32 15.24 7.78 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.4 m -79.11 -3.3 44.75 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -171.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -114.72 169.55 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.588 -0.695 . . . . 0.0 109.369 -163.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -99.91 158.54 15.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.629 1.681 . . . . 0.0 109.515 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.4 150.08 52.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.312 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.3 169.52 16.35 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 160.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -120.59 46.33 2.02 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -82.25 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 6' ' ' THR . 65.9 mttm -100.2 63.46 1.15 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.888 0.851 . . . . 0.0 111.94 -161.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' THR . 17.9 m-85 -112.25 21.59 15.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 117.138 -1.411 . . . . 0.0 112.666 167.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -61.74 31.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -158.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 57' ' ' TYR . 8.4 t -135.85 115.36 12.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 162.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 83.6 t -115.81 110.33 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -164.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.86 134.56 49.82 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 142.04 46.32 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 162.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.94 104.53 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 170.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.7 m -143.7 120.16 6.52 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.6 128.86 32.03 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.413 2.076 . . . . 0.0 113.507 170.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -103.39 30.12 5.16 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -170.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.99 -53.22 2.72 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.323 -0.861 . . . . 0.0 112.247 -170.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -79.83 -47.32 15.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -169.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.6 p -70.96 147.96 48.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.514 0.673 . . . . 0.0 111.704 170.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -82.59 -108.14 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 170.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.7 pp -88.63 149.71 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 119.742 1.155 . . . . 0.0 108.669 -170.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.25 34.3 tttp -125.57 -97.45 0.42 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -165.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 30.9 t80 -74.69 149.04 85.72 Favored Pre-proline 0 N--CA 1.48 1.07 0 O-C-N 120.715 -1.241 . . . . 0.0 112.002 -154.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 23.0 Cg_exo -82.24 149.98 15.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 121.087 1.191 . . . . 0.0 111.581 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -62.33 -33.91 75.61 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.71 -30.37 71.04 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -76.62 -30.18 56.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.177 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.413 HG13 ' CE2' ' A' ' 73' ' ' PHE . 97.1 mt -61.39 -36.99 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 119.741 1.155 . . . . 0.0 111.242 166.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.4 m -64.17 -40.95 97.2 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.07 1.304 . . . . 0.0 112.448 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.08 -43.49 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.15 -37.81 88.69 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.363 -0.836 . . . . 0.0 112.914 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.86 -29.7 70.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.91 -10.4 59.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 77.3 p -104.27 11.35 34.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.21 101.49 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -165.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HB3' ' HD2' ' A' ' 87' ' ' PRO 0.257 54.1 mttp -74.19 -160.35 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.482 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.523 170.599 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 8.2 Cg_endo -54.21 -42.26 68.85 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 N-CA-C 120.611 3.273 . . . . 0.0 120.611 -155.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -102.11 43.31 1.08 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 121.348 1.886 . . . . 0.0 110.93 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.84 140.09 37.71 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 167.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 42.5 t -138.8 158.28 44.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 116.994 -1.882 . . . . 0.0 106.925 166.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.594 HD21 HD12 ' A' ' 94' ' ' LEU . 2.0 tt -129.01 105.26 8.08 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.038 -162.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -106.37 81.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.65 -82.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 120.627 3.011 . . . . 0.0 120.627 -155.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.594 HD12 HD21 ' A' ' 91' ' ' LEU . 2.1 mt -116.22 170.6 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -147.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -110.12 -136.05 0.36 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -157.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.31 -47.82 19.0 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -161.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.62 -29.57 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 124.371 2.034 . . . . 0.0 111.236 171.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.484 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 13.7 m-85 -76.58 -16.41 59.6 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.359 -172.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.0 tttt -56.95 -52.4 65.36 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.282 -0.886 . . . . 0.0 112.871 168.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.63 -36.14 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.858 -0.526 . . . . 0.0 111.09 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.29 -44.11 97.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.259 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.06 81.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.211 0.529 . . . . 0.0 112.408 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.28 -44.76 95.79 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 99.0 mt -80.05 -33.71 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.256 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -71.94 -18.47 62.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.77 31.13 4.94 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.668 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 85.9 m-85 -106.9 159.97 15.86 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -131.01 111.46 12.04 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.589 HG13 ' CD1' ' A' ' 117' ' ' TRP . 14.1 tt -90.71 153.25 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 122.739 1.257 . . . . 0.0 112.578 -166.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.597 HG23 ' SG ' ' A' ' 116' ' ' CYS . 17.0 tt -154.04 130.38 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.193 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -93.45 98.86 11.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 123.243 1.497 . . . . 0.0 110.698 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -109.58 177.84 1.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.785 -2.007 . . . . 0.0 108.469 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -55.61 -14.28 9.8 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 119.041 2.67 . . . . 0.0 119.041 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -118.1 149.56 40.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 154.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.453 ' HE2' ' HE1' ' A' ' 117' ' ' TRP . 22.5 t80 -86.45 139.23 31.11 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 120.774 -1.204 . . . . 0.0 108.997 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.597 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.356 28.1 p -146.11 120.59 9.7 Favored 'General case' 0 CA--C 1.553 1.093 1 N-CA-C 129.216 6.747 . . . . 0.0 129.216 -173.684 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.589 ' CD1' HG13 ' A' ' 109' ' ' ILE . 8.2 m0 -109.75 117.51 34.07 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.422 1.464 . . . . 0.0 109.178 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -107.68 144.38 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.855 -1.153 . . . . 0.0 109.443 172.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -79.7 110.49 15.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.612 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.641 0.734 . . . . 0.0 109.173 -170.343 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.2 t80 . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.98 141.65 51.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.58 1.181 . . . . 0.0 110.945 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.8 t -94.34 120.78 35.09 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.09 -161.69 11.46 Favored Glycine 0 N--CA 1.466 0.666 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.586 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -134.04 139.77 46.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.672 -1.764 . . . . 0.0 107.4 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.6 tp -124.29 129.83 51.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.647 1.213 . . . . 0.0 108.805 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 mp -115.1 120.37 39.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.59 -1.641 . . . . 0.0 107.051 171.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 tt -128.72 140.0 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.28 0.562 . . . . 0.0 109.737 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -102.7 129.75 25.24 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.14 -13.46 31.98 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 N-CA-C 120.462 3.216 . . . . 0.0 120.462 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.13 -50.21 56.11 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -161.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.07 -30.12 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.273 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.4 p -80.77 0.14 36.06 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -76.35 3.72 10.42 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.034 1.288 . . . . 0.0 112.49 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 m -113.48 71.64 1.69 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 43.51 0.78 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.768 2.978 . . . . 0.0 116.255 -153.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.22 -40.34 90.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.418 -0.801 . . . . 0.0 112.226 163.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mp -62.26 -29.89 70.73 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.03 -50.06 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.115 -0.366 . . . . 0.0 110.779 173.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -47.43 56.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -61.75 -40.61 95.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.081 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -62.29 -38.59 89.95 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 169.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.31 78.08 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.942 1.246 . . . . 0.0 113.807 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -56.9 -56.38 22.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -64.63 -38.71 91.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.84 -37.63 34.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -170.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -57.8 -27.7 63.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.806 1.185 . . . . 0.0 113.778 170.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.93 -119.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -153.28 40.5 0.53 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 124.317 2.008 . . . . 0.0 111.946 -170.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.481 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 59.6 t -131.04 110.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 111.183 -2.735 . . . . 0.0 108.7 170.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.09 141.87 35.88 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 167.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -88.7 139.64 30.26 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.6 t -108.91 -36.64 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.468 -166.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -121.85 169.93 10.28 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.881 1.324 . . . . 0.0 111.309 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -135.8 125.16 24.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.635 -1.621 . . . . 0.0 108.248 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -124.15 120.26 31.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.973 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.31 149.38 21.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.403 HD13 ' OH ' ' A' ' 62' ' ' TYR . 2.9 tp -63.5 -40.19 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -78.88 -30.33 44.89 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.5 -0.75 . . . . 0.0 112.92 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -80.3 -32.42 38.04 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.547 -0.721 . . . . 0.0 112.721 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.65 -40.43 80.23 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.457 -0.777 . . . . 0.0 111.89 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -78.06 -30.9 50.01 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.89 -36.75 36.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.848 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.89 15.31 2.9 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 170.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -78.06 -26.44 48.27 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.24 1.52 . . . . 0.0 114.456 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.61 120.24 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.8 m -126.87 120.12 28.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.633 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.08 -166.88 1.35 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.57 170.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -98.84 169.91 9.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.586 1.184 . . . . 0.0 110.056 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 76.9 m-20 -77.13 97.56 4.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.587 170.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.33 -151.18 0.43 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -166.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -100.08 31.73 3.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -162.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.5 m-85 -81.86 21.51 0.85 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.373 -170.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.38 35.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -166.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.62 115.45 8.25 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 163.706 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 68.4 t -118.62 134.48 62.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.237 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -122.61 134.77 54.5 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.403 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -116.72 110.89 19.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 169.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.35 102.02 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.63 1.205 . . . . 0.0 111.466 170.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -132.82 154.95 81.63 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.42 128.13 19.74 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.344 2.03 . . . . 0.0 115.816 170.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -100.77 30.18 4.14 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.116 -169.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.76 -61.95 1.3 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.032 -1.042 . . . . 0.0 109.307 -170.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -92.52 115.26 27.93 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -170.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -77.07 78.89 3.6 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.864 0.84 . . . . 0.0 111.17 170.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.14 -24.67 1.42 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.058 -170.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.8 pt -75.17 156.74 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.088 0.946 . . . . 0.0 112.513 -169.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -113.63 152.81 29.87 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.01 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 11.6 t80 -130.34 148.81 71.37 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 30.7 Cg_exo -82.02 149.54 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 CA-C-N 120.505 1.216 . . . . 0.0 110.456 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.68 -36.59 83.41 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.09 -32.9 72.55 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.61 -30.32 56.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.833 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.98 -34.9 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 119.954 1.252 . . . . 0.0 111.459 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.2 m -68.34 -39.16 82.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.893 1.224 . . . . 0.0 112.62 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.91 -37.54 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.947 -0.47 . . . . 0.0 111.774 174.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.04 -47.8 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.81 -0.556 . . . . 0.0 111.956 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.33 -30.06 70.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.21 -9.86 59.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 29.7 p -71.12 -35.25 71.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.05 167.05 14.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 123.16 1.457 . . . . 0.0 114.2 -150.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.73 101.89 0.57 Allowed Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.483 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -50.93 -6.98 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 N-CA-C 120.707 3.311 . . . . 0.0 120.707 -153.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -88.96 55.03 3.19 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.769 1.622 . . . . 0.0 108.809 160.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.23 157.89 28.48 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.1 p -128.05 159.17 35.9 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.274 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -127.56 142.7 51.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.542 -2.117 . . . . 0.0 106.141 -173.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.047 HD13 ' SG ' ' A' ' 116' ' ' CYS . 46.7 mm -129.04 89.1 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 170.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.97 -88.43 0.09 OUTLIER Glycine 0 C--N 1.318 -0.472 0 N-CA-C 121.587 3.395 . . . . 0.0 121.587 -166.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 91' ' ' LEU . 3.3 mt -116.37 146.85 42.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.617 1.199 . . . . 0.0 109.513 -130.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.7 p -86.36 -136.68 0.08 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.526 -158.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.69 -50.5 13.51 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -156.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.22 -32.5 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 124.789 2.233 . . . . 0.0 113.015 170.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.0 m-85 -76.63 -14.89 59.95 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.737 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -59.08 -55.82 30.2 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.079 -1.013 . . . . 0.0 111.951 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.07 -34.85 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.897 -0.502 . . . . 0.0 111.49 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.01 -40.93 90.96 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 171.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.406 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . . . -58.89 -43.59 90.98 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.912 -0.492 . . . . 0.0 111.741 173.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.98 -49.45 71.39 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.702 0.763 . . . . 0.0 112.543 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.3 tt -80.24 -33.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.594 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -71.72 -19.71 62.01 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.96 33.28 4.09 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 119.607 -1.282 . . . . 0.0 112.597 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.503 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 95.8 m-85 -106.48 159.65 16.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 168.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -126.13 103.88 7.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.593 HG13 ' CD1' ' A' ' 117' ' ' TRP . 18.0 tt -76.15 140.69 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 122.882 1.325 . . . . 0.0 111.316 -168.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.45 119.02 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -106.56 94.55 5.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.598 1.666 . . . . 0.0 110.642 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -134.1 179.17 1.45 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 112.496 -2.138 . . . . 0.0 106.737 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.83 -11.53 3.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 118.654 2.521 . . . . 0.0 118.654 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -122.83 111.51 16.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 157.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.09 110.26 21.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.393 -0.813 . . . . 0.0 109.23 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.274 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 26.3 p -147.75 -157.03 0.77 Allowed 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 122.808 1.29 . . . . 0.0 113.65 170.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.593 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.5 m0 -137.33 130.42 30.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.618 -170.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -112.86 144.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.276 -1.515 . . . . 0.0 110.294 166.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.77 110.49 15.17 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.375 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.47 0.552 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.344 -170.321 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.37 141.96 27.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.65 0.738 . . . . 0.0 110.839 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -95.74 141.42 29.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 162.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.76 -160.12 9.22 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-O 124.132 1.962 . . . . 0.0 115.205 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.452 HD21 ' CE2' ' A' ' 40' ' ' PHE . 3.8 mt -134.2 139.67 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.4 -2.4 . . . . 0.0 107.751 -174.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.41 130.01 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.817 1.294 . . . . 0.0 107.839 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.425 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 8.7 mp -113.85 120.34 40.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.719 175.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.2 mt -121.3 139.9 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -171.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -94.11 129.77 36.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 165.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -60.68 -16.43 43.35 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 N-CA-C 121.056 3.444 . . . . 0.0 121.056 -170.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.78 72.49 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.317 1.417 . . . . 0.0 113.111 -162.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.02 -29.93 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.6 p -86.12 0.47 53.46 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -170.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -76.29 0.35 19.63 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 120.674 1.579 . . . . 0.0 112.601 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.322 90.8 m -98.87 168.09 10.29 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 162.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.74 -7.26 16.54 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 N-CA-C 117.837 2.206 . . . . 0.0 117.837 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.17 -50.48 19.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -159.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.29 -29.83 67.78 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.468 1.031 . . . . 0.0 112.579 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 t -66.26 -49.99 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.982 -0.449 . . . . 0.0 110.513 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.4 -39.73 88.4 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.982 -1.074 . . . . 0.0 113.29 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -59.87 -50.32 74.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 t -68.47 -34.51 76.07 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.615 -0.678 . . . . 0.0 111.698 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.27 -29.96 69.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 170.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.03 -47.09 66.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.482 1.037 . . . . 0.0 112.288 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.75 -48.72 77.19 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.97 60.64 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.549 169.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.29 70.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.2 -170.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -75.34 -19.53 59.56 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.1 -111.0 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.771 -0.581 . . . . 0.0 111.255 170.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -149.48 -10.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -166.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -98.98 149.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 121.592 -0.692 . . . . 0.0 112.402 170.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -128.29 143.9 51.07 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 164.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -92.54 139.84 30.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.754 0.788 . . . . 0.0 109.453 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.36 -32.69 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -121.62 169.98 10.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.292 1.52 . . . . 0.0 109.961 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -139.8 125.18 19.02 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.687 -172.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.452 ' CE2' HD21 ' A' ' 8' ' ' LEU . 21.4 m-30 -129.49 106.42 8.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -84.92 149.57 25.56 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.45 -0.781 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 tp -63.33 -40.11 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.12 -30.35 34.57 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.576 -0.702 . . . . 0.0 112.823 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -79.03 -31.59 44.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.122 -0.987 . . . . 0.0 112.789 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -72.6 -40.59 66.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.604 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.14 -15.29 58.98 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.978 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.34 -43.41 11.54 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.26 -0.9 . . . . 0.0 111.989 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.99 15.3 2.35 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -76.05 -25.58 55.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.638 1.719 . . . . 0.0 114.575 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.7 121.7 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -169.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -98.76 159.28 15.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 124.344 2.021 . . . . 0.0 109.349 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -130.91 120.74 24.03 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.028 -153.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.79 169.67 9.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.043 168.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -111.13 88.55 2.81 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.5 -158.81 0.9 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -164.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -90.99 35.07 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.779 -1.555 . . . . 0.0 115.052 -163.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.3 m-85 -82.03 21.84 0.85 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.374 -170.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.55 37.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -163.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' TYR . 1.0 OUTLIER -141.22 115.4 9.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 163.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 18.7 t -118.61 134.51 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.633 -1.622 . . . . 0.0 106.743 -164.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -122.84 134.71 54.39 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.76 110.52 16.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.4 mt -98.05 100.7 12.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.451 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -126.2 92.45 45.66 Favored Pre-proline 0 N--CA 1.474 0.752 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 167.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.06 97.46 1.06 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.077 1.851 . . . . 0.0 111.994 170.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -120.11 -30.18 4.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.166 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.44 -108.21 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -112.08 -62.83 1.51 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 170.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.6 p -84.08 159.25 21.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.698 0.761 . . . . 0.0 111.164 170.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -75.85 178.81 5.91 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.117 -170.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.3 pt -105.05 -168.54 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.665 0.745 . . . . 0.0 112.119 170.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.69 143.44 34.59 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 123.088 1.423 . . . . 0.0 112.425 -163.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 16.4 t80 -130.29 149.11 72.4 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 113.055 -1.884 . . . . 0.0 107.254 -170.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 30.3 Cg_exo -82.14 149.47 15.41 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 120.617 1.256 . . . . 0.0 110.242 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.54 -38.01 88.33 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.89 -35.15 70.6 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 mt -76.62 -30.26 56.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.51 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.05 -36.17 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 119.899 1.227 . . . . 0.0 111.429 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.8 m -68.62 -39.17 80.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.544 1.066 . . . . 0.0 112.814 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -36.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.992 -0.443 . . . . 0.0 111.855 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.7 -46.44 90.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.743 -0.598 . . . . 0.0 111.849 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.86 70.21 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.33 -10.15 59.55 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -169.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.0 m -76.17 -34.64 59.35 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 168.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.83 176.5 6.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 123.998 1.856 . . . . 0.0 114.885 -148.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 88' ' ' ASN . 29.3 tptp -105.06 101.57 30.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 -170.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -51.34 16.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.384 1 N-CA-C 122.903 4.155 . . . . 0.0 122.903 -153.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 86' ' ' LYS . 28.5 m120 -102.05 61.37 0.87 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 156.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.47 137.39 13.23 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.1 p -134.08 109.45 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.644 1.212 . . . . 0.0 107.884 -169.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.242 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.28 6.2 tt -93.38 132.25 37.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.813 -174.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.006 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 37.0 mm -115.68 84.94 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -170.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.88 -87.2 0.09 OUTLIER Glycine 0 C--N 1.315 -0.593 0 N-CA-C 121.168 3.227 . . . . 0.0 121.168 -163.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.88 169.85 8.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.169 -139.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.468 ' H ' ' HD2' ' A' ' 98' ' ' TYR . 43.0 m -105.35 -155.32 0.54 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.282 -0.886 . . . . 0.0 112.37 -157.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.95 -42.98 84.32 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -163.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -59.8 -33.15 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 124.3 2.0 . . . . 0.0 112.545 169.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.468 ' HD2' ' H ' ' A' ' 95' ' ' SER . 32.0 m-85 -76.54 -12.85 60.09 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.785 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.4 tttt -62.81 -48.29 79.73 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.065 -1.022 . . . . 0.0 112.404 165.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.69 -38.33 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.489 -0.757 . . . . 0.0 110.714 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.34 -48.45 81.7 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 170.366 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.99 -41.58 71.4 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.56 -47.48 83.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.8 mt -77.16 -35.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.038 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -71.97 -16.74 62.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.84 29.93 5.36 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.947 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.3 m-85 -106.92 159.7 16.07 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.768 1.27 . . . . 0.0 108.809 173.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.59 109.52 11.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.36 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.62 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -85.63 111.15 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.905 1.336 . . . . 0.0 114.082 -164.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 19.0 tt -119.51 135.07 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.231 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -119.64 97.28 5.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.911 -168.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -117.31 -177.42 0.45 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 112.606 -2.088 . . . . 0.0 107.582 164.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.4 -11.11 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 N-CA-C 118.948 2.634 . . . . 0.0 118.948 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -103.95 113.31 26.75 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 154.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.505 ' OH ' HD11 ' A' ' 109' ' ' ILE . 28.5 t80 -80.12 115.16 19.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.612 170.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.242 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 24.4 p -147.35 -156.86 0.75 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.168 1.461 . . . . 0.0 112.343 166.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.62 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.4 m0 -132.58 149.66 52.28 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -174.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.58 144.18 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 122.983 1.373 . . . . 0.0 108.586 165.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.69 110.19 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.928 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.156 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -88.89 141.8 28.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.016 0.912 . . . . 0.0 110.706 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.46 141.64 30.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 160.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.79 -168.25 11.78 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-O 123.964 1.869 . . . . 0.0 117.052 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.444 HD11 ' CE2' ' A' ' 40' ' ' PHE . 30.1 tp -134.39 115.14 13.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 111.215 -2.493 . . . . 0.0 106.213 -165.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 129.19 54.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.35 148.88 32.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.908 1.337 . . . . 0.0 108.646 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.8 mt -133.7 111.63 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.651 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -87.07 129.52 51.64 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -59.97 -19.74 56.89 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 N-CA-C 121.008 3.426 . . . . 0.0 121.008 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.44 74.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.685 1.13 . . . . 0.0 113.197 -162.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.59 -27.6 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -171.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.7 p -86.1 0.39 53.63 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -170.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.3 m -76.4 -0.26 22.13 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 120.681 1.582 . . . . 0.0 111.738 168.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 m -108.96 71.6 0.44 Allowed Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 43.86 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.088 3.192 . . . . 0.0 116.421 -153.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.39 -39.6 92.41 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.579 -0.701 . . . . 0.0 112.138 162.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.31 -30.72 68.56 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.11 -48.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 122.341 -0.224 . . . . 0.0 110.907 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.47 -33.07 74.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.9 -48.39 37.62 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -61.45 -42.58 98.98 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.523 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -65.52 -32.92 74.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.145 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.59 78.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.069 1.304 . . . . 0.0 113.177 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.0 -55.49 30.29 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.67 87.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.64 70.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -170.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.8 m -58.09 -28.67 64.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 170.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -85.84 -101.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.85 -0.531 . . . . 0.0 109.967 -170.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -147.26 27.72 1.02 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -131.05 110.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.978 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.4 139.46 37.03 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.072 -1.017 . . . . 0.0 108.989 168.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -88.99 139.84 30.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.83 -33.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.876 -166.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -121.82 169.58 10.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.684 1.23 . . . . 0.0 108.906 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -126.64 154.64 43.74 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.444 ' CE2' HD11 ' A' ' 8' ' ' LEU . 14.3 m-30 -136.12 112.93 10.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.7 149.24 25.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -63.47 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.79 -30.31 40.58 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.49 -29.68 30.39 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.099 -1.001 . . . . 0.0 113.113 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.89 -40.35 72.27 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.892 . . . . 0.0 111.874 174.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -73.37 -18.82 61.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.09 -46.41 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.291 -0.881 . . . . 0.0 112.1 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.74 15.15 1.41 Allowed Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -77.53 -10.55 59.55 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.024 1.912 . . . . 0.0 115.645 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.78 121.36 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.692 -0.63 . . . . 0.0 109.671 -169.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -98.97 120.29 39.17 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 123.814 1.769 . . . . 0.0 109.776 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -119.1 120.84 38.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.76 -158.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.5 169.57 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.472 1.129 . . . . 0.0 109.39 167.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -110.14 88.35 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.85 -119.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -100.09 56.89 0.95 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -156.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -112.05 10.73 20.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 85' ' ' LEU 0.253 19.3 mt-10 -78.75 46.55 0.67 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.944 2.611 . . . . 0.0 112.542 -170.122 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.99 108.85 17.92 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 150.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.61 110.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.54 -2.118 . . . . 0.0 107.894 -155.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -115.05 105.33 12.83 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 -174.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.83 141.97 28.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 119.819 -1.801 . . . . 0.0 109.498 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -124.06 80.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.481 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -134.06 81.9 49.94 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.94 1.7 . . . . 0.0 111.367 -170.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -80.22 104.93 1.7 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 121.993 1.795 . . . . 0.0 110.267 169.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -120.1 -30.2 4.72 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 170.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.1 -178.94 7.26 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.141 0.972 . . . . 0.0 111.194 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -74.86 -34.36 62.25 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.535 170.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 70' ' ' ASP . 6.0 t -78.31 -104.08 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -170.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.506 ' H ' HG23 ' A' ' 69' ' ' THR . 6.7 m-20 -135.07 178.46 7.01 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.669 1.122 . . . . 0.0 110.201 170.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.4 pt -108.48 -157.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.941 170.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -125.06 139.49 53.75 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 164.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 5.8 t80 -130.64 149.02 72.37 Favored Pre-proline 0 N--CA 1.476 0.851 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 170.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 23.2 Cg_exo -82.27 149.63 15.19 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 120.046 1.052 . . . . 0.0 110.402 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.49 -34.59 77.17 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -59.29 -36.53 75.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.56 -30.15 56.95 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.985 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.89 -40.18 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 O-C-N 121.281 -0.887 . . . . 0.0 110.937 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.6 m -71.23 -30.92 66.94 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.996 -1.065 . . . . 0.0 113.853 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.96 -46.01 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.858 -0.526 . . . . 0.0 110.799 171.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -37.38 75.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.4 70.48 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.02 -9.79 58.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -68.41 -50.48 52.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.938 -0.476 . . . . 0.0 112.104 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.479 ' CD1' ' H ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -98.82 -141.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -174.004 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.581 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.262 74.9 mmtt -129.84 -139.51 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -170.268 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 49.6 Cg_endo -68.97 -50.25 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 CA-C-N 124.385 2.602 . . . . 0.0 114.129 170.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -79.33 53.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.217 1.371 . . . . 0.0 114.318 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.39 164.72 28.35 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 161.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.5 t -147.02 159.23 43.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.185 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.376 1.2 tm? -128.44 129.55 46.3 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 112.222 -2.263 . . . . 0.0 104.91 -162.124 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.804 HD13 ' CB ' ' A' ' 116' ' ' CYS . 40.3 mm -118.49 84.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.016 1.734 . . . . 0.0 108.256 170.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.82 -88.18 0.09 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 -161.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.61 169.77 8.94 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.798 -143.038 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.4 m -108.69 -148.47 0.42 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -158.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.54 -45.05 88.81 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -163.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.89 -31.19 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 124.762 2.22 . . . . 0.0 110.84 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.755 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 79.1 m-85 -76.75 -2.97 35.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.523 -174.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.408 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 87.3 tttt -67.2 -49.18 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.213 -0.929 . . . . 0.0 111.892 170.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.4 -34.41 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.02 169.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.755 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.19 -47.94 83.84 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 172.445 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.32 80.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 tp -58.94 -49.94 75.95 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.613 0.72 . . . . 0.0 112.55 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.19 -34.38 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.4 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -71.69 -16.68 62.25 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.67 29.04 5.74 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.496 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 82.7 m-85 -106.67 159.72 15.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -120.83 153.94 36.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.522 ' CG1' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -112.07 152.45 13.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.566 -167.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 tp -154.01 120.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.66 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -107.6 100.23 9.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 123.735 1.731 . . . . 0.0 110.196 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.73 -178.24 0.64 Allowed Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 111.72 -2.491 . . . . 0.0 106.698 169.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.06 -10.73 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 119.314 2.774 . . . . 0.0 119.314 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -119.71 111.53 18.14 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 158.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.44 115.33 27.49 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.941 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.185 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 11.7 p -147.12 -163.44 1.76 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 124.321 2.01 . . . . 0.0 114.334 172.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.522 ' CD2' HD12 ' A' ' 91' ' ' LEU . 13.2 m0 -137.65 130.35 29.91 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 110.559 -3.019 . . . . 0.0 106.412 -165.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 144.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.585 -1.322 . . . . 0.0 108.88 165.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -79.59 110.58 15.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.753 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.391 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.9 t80 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.63 141.81 28.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.97 0.89 . . . . 0.0 111.319 -165.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 m -96.96 141.17 30.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 172.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -134.2 -158.7 8.62 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 118.787 -1.673 . . . . 0.0 115.76 172.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.31 139.67 45.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 113.252 -1.474 . . . . 0.0 108.636 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.59 138.7 54.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.997 1.379 . . . . 0.0 107.815 165.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.91 120.46 30.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.264 -1.789 . . . . 0.0 108.983 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 tt -129.02 139.84 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.05 0.929 . . . . 0.0 111.316 -160.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -106.94 129.8 23.83 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 166.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -60.0 -15.82 35.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 N-CA-C 119.984 3.032 . . . . 0.0 119.984 -170.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -50.19 74.21 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.294 0.952 . . . . 0.0 112.206 -167.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -34.26 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -85.41 -0.01 53.56 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -76.48 -8.18 56.64 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 120.064 1.302 . . . . 0.0 111.59 164.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.5 m -111.62 71.46 0.93 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 164.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.84 53.3 0.77 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.3 3.334 . . . . 0.0 116.779 -154.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.12 -48.73 27.55 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.753 -1.217 . . . . 0.0 112.67 165.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.53 -30.34 71.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.27 -45.64 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.147 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.76 -34.94 78.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.57 -48.21 49.82 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 t -60.72 -40.96 94.26 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.81 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.91 -32.99 73.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.172 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.14 74.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.942 1.246 . . . . 0.0 113.823 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -55.05 -55.26 33.01 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.66 -46.31 84.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.037 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.24 -50.01 71.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -170.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -69.85 -20.55 63.41 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 112.574 -170.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.73 -103.13 0.06 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.314 0.578 . . . . 0.0 109.443 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -157.4 4.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.86 150.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.643 0.735 . . . . 0.0 111.451 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -128.42 135.03 48.95 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 161.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -88.93 139.56 30.33 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.83 -14.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -163.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.61 120.32 34.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -114.77 125.1 53.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -163.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -130.17 102.35 6.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.689 -175.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.7 tt -85.24 149.34 25.56 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.061 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -63.42 -40.17 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' H ' HD23 ' A' ' 41' ' ' LEU . 22.1 t-20 -81.64 -30.34 32.83 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.197 -0.939 . . . . 0.0 112.762 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.91 -30.75 56.28 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.433 -0.792 . . . . 0.0 112.577 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -40.43 70.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.882 0.765 . . . . 0.0 112.306 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.17 -20.64 47.93 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.74 -30.55 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 111.623 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.53 15.14 11.57 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 t -78.4 -34.34 48.14 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 mt -114.98 120.3 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.753 0.787 . . . . 0.0 108.983 -167.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.0 m -133.05 158.71 42.07 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.5 mt -131.71 -138.5 0.2 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.93 178.77 4.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.013 0.911 . . . . 0.0 109.937 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -120.1 67.38 0.83 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.187 -169.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.19 -77.92 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 -170.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -82.9 7.74 14.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 -157.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -90.13 21.25 3.83 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.16 -167.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.93 26.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -167.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 57' ' ' TYR . 6.4 t -133.12 115.1 14.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 162.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.56 134.32 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -167.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -122.71 134.75 54.45 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.28 142.23 42.18 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.36 102.66 8.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.604 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.423 HG22 ' HD2' ' A' ' 65' ' ' PRO . 29.8 m -139.43 154.75 71.94 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 170.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.423 ' HD2' HG22 ' A' ' 64' ' ' THR . 79.8 Cg_exo -49.75 133.45 33.05 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.849 2.366 . . . . 0.0 116.366 170.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -95.08 8.77 41.92 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.266 -170.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.82 -179.26 4.12 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.409 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -82.73 94.16 7.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.623 0.725 . . . . 0.0 111.497 -170.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.4 m -88.0 -63.94 1.22 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 166.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -124.54 178.55 5.36 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 163.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.9 pt -108.26 8.33 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 170.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.17 139.82 53.3 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 122.346 1.07 . . . . 0.0 111.945 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.2 t80 -130.07 149.06 72.13 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 162.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 31.2 Cg_exo -82.0 149.34 15.63 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 CA-C-N 121.233 1.476 . . . . 0.0 110.109 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -37.9 88.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.11 -33.61 73.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -76.72 -30.15 56.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.34 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -36.72 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.75 1.159 . . . . 0.0 111.442 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -68.27 -36.24 79.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.84 1.2 . . . . 0.0 112.82 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.74 -41.14 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.941 -0.474 . . . . 0.0 111.533 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -60.06 -46.35 89.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.648 0.658 . . . . 0.0 112.364 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.88 70.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.7 -10.02 59.12 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -170.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -104.44 23.32 13.41 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.3 mt -134.12 -166.64 1.83 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.165 0.983 . . . . 0.0 110.829 -163.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.96 174.88 3.95 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -170.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.8 -22.72 14.25 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 170.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -102.51 45.83 0.95 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.741 1.61 . . . . 0.0 110.4 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.45 138.4 20.34 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -143.4 109.08 5.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.43 1.586 . . . . 0.0 107.041 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.161 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.368 0.2 OUTLIER -89.82 129.72 36.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -176.075 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.255 HD13 ' SG ' ' A' ' 116' ' ' CYS . 42.7 mm -111.44 95.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.243 1.021 . . . . 0.0 109.097 170.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.93 -83.68 0.06 OUTLIER Glycine 0 C--N 1.315 -0.625 0 N-CA-C 120.851 3.1 . . . . 0.0 120.851 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.557 HD12 HD11 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -116.09 169.94 8.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 118.764 -1.174 . . . . 0.0 108.476 -133.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -103.02 -140.94 0.36 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.07 -1.019 . . . . 0.0 112.63 -155.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.22 -44.79 24.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -162.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tp -56.63 -33.05 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 124.505 2.097 . . . . 0.0 112.569 167.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.712 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 71.8 m-85 -76.66 -10.88 59.7 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.203 -176.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.6 tttt -58.45 -51.52 69.51 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 112.256 167.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.44 -35.28 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.896 -0.503 . . . . 0.0 111.236 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -57.89 -42.96 85.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 170.126 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.35 94.57 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.164 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -54.92 -48.0 73.65 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.24 -35.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.076 -169.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.68 -18.74 62.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.95 4.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.004 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -106.71 159.69 16.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.5 154.27 35.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.539 1.162 . . . . 0.0 107.933 158.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.626 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.2 tt -107.48 149.26 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.745 -163.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.72 126.18 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 122.553 1.168 . . . . 0.0 107.953 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -106.05 100.21 9.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.593 1.663 . . . . 0.0 109.826 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -127.93 177.59 2.01 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 111.935 -2.393 . . . . 0.0 107.446 170.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.99 -11.82 4.16 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 N-CA-C 119.269 2.757 . . . . 0.0 119.269 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -115.94 108.12 15.86 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 157.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -86.8 113.06 22.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.668 -170.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.255 ' SG ' HD13 ' A' ' 92' ' ' ILE . 25.1 p -147.54 -153.95 0.52 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 123.072 1.415 . . . . 0.0 112.258 172.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.626 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.0 m0 -134.77 149.73 50.46 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.66 144.09 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 166.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -83.31 134.83 34.9 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.742 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 110.616 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 12.5 t80 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.764 0.316 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -105.06 160.58 14.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 123.367 1.556 . . . . 0.0 113.403 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.077 170.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.414 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -123.69 -156.39 9.5 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.849 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 tp -134.03 142.72 47.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -166.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.05 129.83 51.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 40' ' ' PHE . 1.3 mt -109.36 120.08 41.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 171.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 tt -132.14 139.93 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.539 0.685 . . . . 0.0 109.324 -173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -101.08 129.75 26.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.39 -12.02 25.53 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.968 3.026 . . . . 0.0 119.968 -170.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.26 52.44 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -161.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -85.2 -29.81 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.175 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.2 p -81.08 0.24 36.91 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -76.33 -0.87 24.1 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.859 1.209 . . . . 0.0 112.247 165.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 m -112.47 71.5 1.18 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 163.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.17 46.1 1.08 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.986 3.124 . . . . 0.0 116.219 -152.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.24 -43.5 91.21 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.599 -0.688 . . . . 0.0 112.608 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.49 -29.94 70.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.25 -46.88 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.934 -0.479 . . . . 0.0 110.887 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.25 -33.92 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.89 -48.79 57.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 t -61.73 -39.21 90.74 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.477 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -66.3 -29.9 70.21 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.34 76.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.236 1.38 . . . . 0.0 113.428 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -59.69 -50.83 72.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.966 -0.459 . . . . 0.0 111.611 170.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.91 -42.66 59.58 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.69 -49.92 12.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -59.35 -37.39 77.74 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 170.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.9 -106.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.717 -0.615 . . . . 0.0 110.389 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 4' ' ' TYR . 43.1 mmtm -129.76 -44.86 1.19 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -169.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 59' ' ' THR . 2.3 p -97.98 149.58 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.728 1.251 . . . . 0.0 111.335 -165.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -114.88 136.0 53.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.63 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -90.46 139.47 30.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.7 t -118.74 -32.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.63 -162.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -121.86 169.99 10.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.273 1.511 . . . . 0.0 110.859 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -134.49 125.4 27.31 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.757 -174.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 10' ' ' LEU . 18.4 m-30 -118.68 120.21 36.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 168.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.64 149.43 22.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.53 -40.09 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.97 -30.45 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -85.53 -31.5 22.68 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -0.918 . . . . 0.0 112.944 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -66.21 -40.56 90.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.26 0.937 . . . . 0.0 112.054 171.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -69.67 -24.98 63.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.992 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.13 -39.86 16.27 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.67 -0.644 . . . . 0.0 111.78 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.34 15.36 1.14 Allowed Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -79.74 -30.09 40.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -171.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.8 mt -114.75 120.28 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.867 0.841 . . . . 0.0 109.854 -164.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -128.26 120.45 27.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.239 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.5 -167.43 1.36 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.897 1.332 . . . . 0.0 110.537 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -98.58 120.5 39.12 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.203 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -81.17 46.67 0.94 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -161.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.03 4.42 0.63 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 119.594 3.183 . . . . 0.0 119.594 170.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -100.4 -34.59 9.89 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 122.089 2.222 . . . . 0.0 115.801 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' THR . 8.2 m-85 -81.87 22.04 0.8 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -157.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.3 37.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -167.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.522 HG21 HG21 ' A' ' 34' ' ' VAL . 8.8 t -138.57 115.32 10.69 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 160.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.87 110.34 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.504 -160.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -105.88 134.6 48.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.408 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -118.06 110.42 17.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.25 -0.906 . . . . 0.0 109.017 176.357 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.51 89.5 3.23 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.468 -170.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -136.76 86.71 21.36 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -80.2 82.41 2.49 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.127 1.884 . . . . 0.0 112.84 170.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -120.18 -30.12 4.71 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.745 -0.597 . . . . 0.0 112.61 170.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.05 178.83 9.27 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.695 0.76 . . . . 0.0 109.771 -170.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -108.55 -67.39 0.98 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 170.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -103.6 -49.96 3.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.371 -170.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -92.68 69.85 4.82 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.731 0.777 . . . . 0.0 110.917 -170.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.16 149.99 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 169.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -112.64 139.39 48.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.382 1.087 . . . . 0.0 110.82 170.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 -130.54 149.11 72.57 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 166.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 28.6 Cg_exo -82.2 149.44 15.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 CA-C-N 120.962 1.379 . . . . 0.0 110.344 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -38.38 90.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.14 -31.76 70.39 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.68 -30.3 56.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.992 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.38 -35.28 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 120.203 1.365 . . . . 0.0 111.227 170.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.9 m -68.94 -39.93 79.26 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.597 1.09 . . . . 0.0 112.503 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.19 -38.09 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.942 -0.474 . . . . 0.0 111.84 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -65.85 -40.48 91.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.709 -0.619 . . . . 0.0 112.571 176.168 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.0 70.72 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.86 -19.16 61.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.4 m -72.06 -17.02 62.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -111.15 159.93 17.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.123 0.963 . . . . 0.0 110.387 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -91.38 174.96 3.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.341 169.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -60.43 -10.61 13.93 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 117.508 2.08 . . . . 0.0 117.508 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -102.07 50.06 0.84 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 168.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.14 141.4 25.03 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.9 p -139.66 103.79 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.194 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.274 2.6 tt -89.96 129.78 36.25 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -178.385 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.117 HD13 ' SG ' ' A' ' 116' ' ' CYS . 32.3 mm -110.18 91.14 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -80.71 0.05 OUTLIER Glycine 0 C--N 1.315 -0.596 0 N-CA-C 121.22 3.248 . . . . 0.0 121.22 -163.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.558 HD12 HD21 ' A' ' 91' ' ' LEU . 3.1 mt -115.97 169.78 8.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.227 -141.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 p -123.55 -117.31 0.29 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 119.636 -0.826 . . . . 0.0 113.009 -158.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.36 -59.39 2.73 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -155.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mt -59.7 -26.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 124.248 1.975 . . . . 0.0 111.593 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.712 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 62.4 m-85 -76.9 -18.73 58.12 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.283 -169.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -54.44 -53.96 47.22 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.988 -1.07 . . . . 0.0 112.436 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.06 -33.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.837 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.84 -43.34 94.65 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 172.102 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.61 97.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.86 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.03 -44.52 95.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -80.01 -35.63 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.038 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -71.78 -18.74 62.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 32.11 4.52 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.79 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.6 m-85 -106.77 159.96 15.84 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -128.51 109.09 11.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.593 HG13 ' CD1' ' A' ' 117' ' ' TRP . 20.2 tt -87.6 111.22 21.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 122.751 1.263 . . . . 0.0 114.393 -162.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.5 tt -105.12 125.25 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.756 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -115.41 81.53 1.6 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 124.285 1.993 . . . . 0.0 111.299 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 114' ' ' ASP . 90.1 mt-10 -134.34 100.47 12.69 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 -170.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.63 29.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.971 1 N-CA-C 124.8 4.885 . . . . 0.0 124.8 -140.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.2 m-20 -99.68 99.82 10.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 132.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.572 -163.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 1.194 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 23.8 p -147.3 -156.49 0.72 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 123.104 1.43 . . . . 0.0 111.77 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.593 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.7 m0 -134.24 149.6 50.98 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 -174.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 143.91 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.351 1.072 . . . . 0.0 108.25 164.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -90.2 64.82 6.2 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.437 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.379 170.13 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -117.47 141.63 48.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.772 1.273 . . . . 0.0 111.347 -170.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -105.26 120.89 42.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.359 174.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.27 -161.13 9.69 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 123.59 1.661 . . . . 0.0 117.086 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.5 tp -127.95 139.9 52.31 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 111.795 -2.203 . . . . 0.0 107.196 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -124.37 129.28 50.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 162.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -123.34 120.07 31.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -176.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.0 pt -131.21 139.99 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.492 -0.755 . . . . 0.0 111.218 -167.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.4 129.69 36.09 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 166.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.31 -13.9 18.08 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 N-CA-C 120.205 3.117 . . . . 0.0 120.205 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.52 -50.2 66.13 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -163.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.28 -34.02 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.166 170.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.5 p -83.49 0.4 46.53 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 t -76.58 -6.01 50.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.687 1.585 . . . . 0.0 114.573 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.312 62.8 m -98.94 168.11 10.24 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 169.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.59 -6.72 16.41 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 N-CA-C 116.915 1.852 . . . . 0.0 116.915 -170.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.12 -50.19 20.55 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.721 1.146 . . . . 0.0 113.833 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.99 -31.44 70.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.656 0.662 . . . . 0.0 112.123 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.77 -47.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 122.232 -0.292 . . . . 0.0 111.044 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.35 -32.69 72.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.49 -49.09 52.05 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.4 t -61.83 -40.08 94.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.176 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.33 -34.2 77.6 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.3 70.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.287 1.403 . . . . 0.0 113.246 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.297 1.5 tm0? -54.85 -53.7 51.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.11 82.93 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.58 -50.03 14.88 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -25.54 61.14 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -85.8 -114.83 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.628 -0.67 . . . . 0.0 109.659 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -154.1 11.79 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.1 149.88 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.817 0.818 . . . . 0.0 111.778 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.44 137.88 52.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 162.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -88.75 139.45 30.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.3 t -117.21 -35.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.542 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -122.05 120.15 33.5 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -157.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -114.88 114.17 25.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -162.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.512 ' O ' HD23 ' A' ' 10' ' ' LEU . 18.5 m-30 -119.05 120.57 37.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.6 tt -91.47 149.37 21.73 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.49 -40.05 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.543 ' H ' HD23 ' A' ' 41' ' ' LEU . 21.2 m120 -80.51 -30.35 37.28 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.55 -31.44 42.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.33 -0.856 . . . . 0.0 112.823 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.42 -40.36 70.51 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.866 0.757 . . . . 0.0 112.107 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.46 -24.56 63.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.26 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.09 -35.26 37.2 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.71 -0.619 . . . . 0.0 111.42 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.41 15.15 6.07 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.937 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.6 m -75.07 -36.1 61.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.68 1.24 . . . . 0.0 113.834 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.71 111.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 122.766 1.269 . . . . 0.0 108.815 -165.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.2 m -133.28 115.15 14.59 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.259 18.1 tp -124.63 -52.94 1.69 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.293 -0.963 . . . . 0.0 113.308 -159.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -149.36 169.47 20.75 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -120.6 49.05 1.5 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 170.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.14 -86.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 6' ' ' THR . 93.2 mttt -100.22 62.29 1.1 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -160.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.2 m-85 -112.15 22.06 15.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.827 166.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.48 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -161.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.03 115.53 6.7 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 168.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 14.0 t -119.59 134.51 62.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.601 -164.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -122.46 134.67 54.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.47 110.21 16.65 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.42 102.03 13.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.886 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -120.09 154.59 55.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 CA--C 1.537 0.639 0 C-N-CA 122.114 1.876 . . . . 0.0 115.148 170.45 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 7.7 t80 . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 21.4 Cg_exo -82.16 149.71 15.43 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.773 0.954 . . . . 0.0 111.171 175.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.58 -39.77 94.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.68 -31.43 69.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.5 mt -76.67 -30.29 56.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.445 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.01 -37.59 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.045 1.293 . . . . 0.0 111.226 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.4 p -68.47 -39.15 81.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.112 1.324 . . . . 0.0 112.672 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.19 -39.77 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.912 -0.493 . . . . 0.0 112.201 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -39.34 93.37 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.62 -0.675 . . . . 0.0 112.683 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.95 -29.8 70.76 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.11 -10.02 55.6 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -99.82 16.51 23.46 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.3 mt -131.18 -174.11 3.29 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.526 1.155 . . . . 0.0 110.289 -168.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 67.8 mttm -140.04 174.93 3.53 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -170.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 1.1 Cg_endo -61.4 -16.3 46.41 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 N-CA-C 118.341 2.401 . . . . 0.0 118.341 -170.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -102.27 45.06 0.98 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.467 1.03 . . . . 0.0 110.544 168.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.15 144.22 34.38 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 78.7 p -146.99 109.84 4.68 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.249 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.285 0.6 OUTLIER -93.29 129.96 39.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.805 -173.363 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' HB3' ' A' ' 116' ' ' CYS . 27.6 mm -113.34 84.56 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.471 1.032 . . . . 0.0 108.894 170.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -83.23 0.06 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 121.361 3.304 . . . . 0.0 121.361 -166.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.544 HD12 HD21 ' A' ' 91' ' ' LEU . 4.9 mt -116.36 146.89 42.12 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.636 1.208 . . . . 0.0 110.308 -135.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.2 p -94.61 -129.4 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.535 -156.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.5 -48.51 15.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -158.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.69 -29.52 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 124.555 2.122 . . . . 0.0 111.339 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.612 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 87.0 m-85 -76.73 -14.4 59.95 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.834 -172.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.31 -55.24 37.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.824 -1.173 . . . . 0.0 112.571 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.86 -34.35 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.812 -0.555 . . . . 0.0 111.295 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.35 -42.0 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 173.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.49 -48.66 80.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.882 0.849 . . . . 0.0 112.334 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.15 -35.45 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.212 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -71.57 -18.81 62.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 33.92 3.94 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.673 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.52 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 72.6 m-85 -106.7 159.64 16.06 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.29 104.39 9.1 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.013 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.61 HD11 ' OH ' ' A' ' 115' ' ' TYR . 19.8 tt -83.7 110.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.787 1.28 . . . . 0.0 114.377 -167.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.6 tt -111.64 131.41 63.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 113.183 -1.826 . . . . 0.0 108.928 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -109.42 86.93 2.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 124.059 1.885 . . . . 0.0 112.181 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 114' ' ' ASP . 55.1 mt-10 -134.41 100.49 12.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -54.77 28.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 1 N-CA-C 124.663 4.832 . . . . 0.0 124.663 -144.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.8 p-10 -99.58 100.29 11.28 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 131.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.61 ' OH ' HD11 ' A' ' 109' ' ' ILE . 19.3 t80 -80.05 115.28 19.53 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.907 -0.496 . . . . 0.0 110.763 -164.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.249 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.4 p -147.24 -161.16 1.27 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 124.621 2.153 . . . . 0.0 115.177 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.582 ' CD1' HG13 ' A' ' 109' ' ' ILE . 19.0 m0 -137.4 126.28 24.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 109.71 -3.405 . . . . 0.0 106.462 -167.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.303 0.1 OUTLIER -112.65 111.22 35.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 O-C-N 121.365 -0.834 . . . . 0.0 109.483 177.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -79.1 134.28 36.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.2 ttt . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.539 170.599 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -117.7 141.83 47.95 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -99.98 141.86 32.23 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 162.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.414 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -133.7 -159.47 9.0 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 122.98 1.322 . . . . 0.0 116.243 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.01 139.51 46.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 113.172 -1.514 . . . . 0.0 107.379 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.417 HD11 HG23 ' A' ' 11' ' ' ILE . 20.7 tp -124.6 131.4 53.48 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.292 1.044 . . . . 0.0 108.506 170.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 120.18 38.82 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.133 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 9' ' ' LEU . 6.0 pt -123.54 139.81 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.452 ' HB3' HG23 ' A' ' 64' ' ' THR . 6.0 t60 -90.32 130.01 43.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.13 -18.23 9.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 121.603 3.655 . . . . 0.0 121.603 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.19 71.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 -158.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.16 -27.28 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.26 168.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.6 p -71.52 -14.29 62.07 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.7 m -76.62 -4.03 40.86 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 120.795 1.634 . . . . 0.0 111.933 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.326 96.3 m -98.55 168.18 10.25 Favored Pre-proline 0 CA--C 1.558 1.264 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.42 -0.69 10.87 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 N-CA-C 117.768 2.18 . . . . 0.0 117.768 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.05 -50.54 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.351 1.432 . . . . 0.0 113.952 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.18 -31.51 70.18 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.741 0.7 . . . . 0.0 112.422 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.4 -48.41 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 122.121 -0.362 . . . . 0.0 110.768 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -61.84 -33.25 73.82 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -47.45 60.51 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.431 ' HA ' HE21 ' A' ' 28' ' ' GLN . 6.8 t -63.26 -39.99 96.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.432 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -62.72 -34.75 77.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.684 -0.674 . . . . 0.0 112.776 169.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -44.34 72.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.167 1.349 . . . . 0.0 113.674 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.3 mt-30 -59.9 -53.16 61.09 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.766 0.317 . . . . 0.0 111.704 173.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -58.6 -37.73 76.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.32 -42.94 19.82 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -170.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.9 p -57.8 -20.14 33.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 170.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.77 -100.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -158.14 19.21 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -170.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.463 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 38.9 t -129.93 110.73 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -167.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -99.09 134.94 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -88.97 139.68 30.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.113 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.83 -31.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.34 -168.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -121.74 120.36 34.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -161.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -114.64 124.59 52.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -165.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -127.47 120.2 27.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.17 149.73 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.427 HD13 ' OH ' ' A' ' 62' ' ' TYR . 4.1 tp -63.21 -39.53 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -77.65 -30.31 52.05 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -80.48 -32.82 37.01 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.392 -0.818 . . . . 0.0 113.043 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -73.89 -40.59 63.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.294 0.952 . . . . 0.0 112.393 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -74.24 -20.43 60.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.768 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.5 -37.37 25.37 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.61 -0.681 . . . . 0.0 111.593 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.75 15.21 6.4 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 120.613 -0.803 . . . . 0.0 114.966 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -76.27 -31.63 58.39 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.813 1.307 . . . . 0.0 114.199 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.73 120.26 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -167.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.5 m -122.59 120.05 32.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.046 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -122.35 -161.65 0.95 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.84 170.02 9.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.82 1.295 . . . . 0.0 111.202 -169.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -115.26 71.6 0.77 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.336 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.94 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 6' ' ' THR . 77.8 mttt -97.13 43.66 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -157.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.434 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.6 m-85 -112.21 21.68 15.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 117.545 -1.217 . . . . 0.0 110.685 -170.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.65 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -158.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' TYR . 7.0 t -134.37 115.31 13.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 164.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 65.9 t -119.43 110.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -163.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -107.63 134.29 50.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.427 ' OH ' HD13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -123.36 110.52 15.26 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.122 -0.986 . . . . 0.0 110.165 177.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.94 100.32 8.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 12' ' ' HIS . 63.1 m -119.96 88.63 40.89 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -170.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 CA--C 1.536 0.621 0 C-N-CA 122.185 1.923 . . . . 0.0 111.749 170.231 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 26.2 Cg_exo -82.33 149.91 15.16 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 120.659 0.906 . . . . 0.0 112.088 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -62.45 -35.42 79.23 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -60.34 -34.34 73.7 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.55 -30.4 57.07 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.655 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.9 -38.52 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 120.357 1.435 . . . . 0.0 111.298 171.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 95.2 p -69.18 -40.74 77.94 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.79 1.177 . . . . 0.0 113.11 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.1 -38.64 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.799 -0.563 . . . . 0.0 112.262 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -33.84 71.62 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.82 -29.77 69.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -69.16 -9.83 54.78 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.4 m -97.99 29.83 3.3 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.15 171.02 14.82 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.359 1.076 . . . . 0.0 112.989 -162.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 49.7 mttm -122.39 -158.02 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 170.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 10.7 Cg_endo -67.65 -43.72 5.2 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 119.834 2.974 . . . . 0.0 119.834 -163.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -90.51 63.29 5.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 122.386 2.357 . . . . 0.0 111.495 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.31 133.99 13.61 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 170.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.6 p -139.16 159.27 42.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.175 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.251 1.1 tt -127.94 129.62 47.12 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.862 HD13 ' CB ' ' A' ' 116' ' ' CYS . 24.8 mm -112.3 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.914 0.864 . . . . 0.0 109.41 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.552 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.72 -79.27 0.04 OUTLIER Glycine 0 C--N 1.318 -0.445 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 -161.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.552 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -115.65 171.15 7.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.962 1.363 . . . . 0.0 111.121 -139.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 m -92.97 -162.74 0.96 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.178 -1.373 . . . . 0.0 113.318 -164.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.17 -36.49 84.38 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.25 -32.63 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 124.817 2.246 . . . . 0.0 111.283 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.571 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 93.8 m-85 -76.81 -12.23 59.94 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.501 -172.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HG3' HD13 ' A' ' 109' ' ' ILE . 4.5 ttmp? -58.94 -53.63 56.24 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.815 -1.178 . . . . 0.0 112.367 169.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.04 -37.1 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.802 -0.561 . . . . 0.0 111.068 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.571 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.57 -45.57 93.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.92 172.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.02 74.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.871 -0.518 . . . . 0.0 111.72 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.58 -50.1 70.98 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.655 0.74 . . . . 0.0 112.748 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.35 -34.22 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -71.79 -17.8 62.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.69 29.94 5.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 92.2 m-85 -106.46 159.66 15.99 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -127.55 107.6 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.619 HG13 ' CD1' ' A' ' 117' ' ' TRP . 16.9 tt -76.18 149.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.484 1.135 . . . . 0.0 111.914 -167.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.08 125.13 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.47 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -106.48 100.0 9.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.483 1.611 . . . . 0.0 111.302 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -134.06 175.2 3.85 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 112.449 -2.16 . . . . 0.0 107.252 -170.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -54.97 -19.97 21.5 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.82 109.97 19.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 156.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -87.11 111.11 20.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.637 -0.664 . . . . 0.0 109.258 -170.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.175 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 17.6 p -147.26 -157.18 0.79 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 124.251 1.977 . . . . 0.0 112.694 174.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.619 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.4 m0 -137.25 149.93 47.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 110.305 -3.134 . . . . 0.0 104.421 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.74 144.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.363 161.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 10.0 tmtt? -91.64 134.47 34.66 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 108.765 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.665 0.745 . . . . 0.0 110.563 -170.016 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 122.22 1.009 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.3 147.23 24.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.813 1.292 . . . . 0.0 112.419 -165.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -105.21 120.88 42.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.653 170.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 59' ' ' THR . . . -129.32 -160.98 10.41 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 118.446 -1.835 . . . . 0.0 115.418 170.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 139.85 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -164.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.371 0.2 OUTLIER -124.8 129.29 50.15 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -116.04 120.36 38.84 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.29 139.48 51.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.902 0.858 . . . . 0.0 109.681 -167.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -103.19 129.67 25.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -9.32 17.5 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 N-CA-C 122.032 3.82 . . . . 0.0 122.032 -170.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.36 70.04 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.546 2.424 . . . . 0.0 117.546 -158.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.2 t -93.06 -30.69 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.23 0.923 . . . . 0.0 108.809 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.4 p -80.21 0.26 33.22 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -170.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -76.41 9.3 2.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.42 1.463 . . . . 0.0 113.134 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.332 64.2 m -99.03 168.34 9.85 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 164.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -77.45 -3.99 14.21 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 117.734 2.167 . . . . 0.0 117.734 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -50.4 19.23 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -164.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -29.89 67.9 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.886 0.766 . . . . 0.0 112.752 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.7 t -70.4 -44.29 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.498 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.63 -34.1 72.36 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.052 -1.03 . . . . 0.0 113.634 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.44 72.68 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -58.88 -47.85 83.48 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -29.82 70.18 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -47.54 64.6 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.386 0.994 . . . . 0.0 112.815 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.304 1.4 tm0? -54.98 -52.49 62.92 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -33.5 69.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.31 -50.16 19.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.1 m -60.72 -34.67 74.74 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 170.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.94 -131.02 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -145.1 5.71 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.482 HG21 HG21 ' A' ' 59' ' ' THR . 4.1 p -98.93 154.1 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.681 0.753 . . . . 0.0 111.742 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -128.03 142.43 51.23 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 166.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.73 100.65 12.83 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.637 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.18 -30.79 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.749 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.83 169.64 10.57 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.615 1.198 . . . . 0.0 109.769 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -142.68 116.46 9.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -118.73 115.34 24.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.74 149.51 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.452 HD13 ' OH ' ' A' ' 62' ' ' TYR . 2.8 tp -63.63 -40.26 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.08 -30.25 31.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.77 -29.09 18.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.087 0.858 . . . . 0.0 112.785 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -68.84 -40.45 79.42 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.015 1.279 . . . . 0.0 111.471 170.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.17 -27.91 66.83 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.97 19.54 19.89 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.54 11.22 45.11 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 117.459 1.743 . . . . 0.0 117.459 152.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -82.8 -23.6 33.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -167.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 51' ' ' THR . 8.8 mt -114.63 167.82 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.464 1.029 . . . . 0.0 110.364 -161.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.46 ' N ' HG22 ' A' ' 50' ' ' ILE . 7.4 m -99.73 117.42 34.05 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.718 1.247 . . . . 0.0 110.488 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -96.83 120.35 37.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.242 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -107.58 120.27 41.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 166.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -84.83 67.8 10.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.461 -170.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -74.32 0.07 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 6' ' ' THR . 49.8 mttp -100.27 45.78 0.97 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -160.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.27 21.48 15.74 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.701 165.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 86' ' ' LYS . 8.9 mm-40 -61.67 58.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 171.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.482 HG21 HG21 ' A' ' 34' ' ' VAL . 10.7 t -146.69 113.12 5.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 144.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.91 134.15 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 -170.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.58 134.56 54.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 167.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.452 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -120.79 110.74 16.72 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.965 0.888 . . . . 0.0 109.314 178.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.45 100.39 11.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.575 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -125.67 107.39 26.19 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.537 0.644 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 -162.226 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.1 t80 . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.92 149.7 50.39 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.714 1.609 . . . . 0.0 112.243 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.42 -31.91 72.68 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.69 -33.95 70.73 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.4 mt -76.79 -30.23 56.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.017 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -37.22 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 119.325 0.966 . . . . 0.0 111.382 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 97.1 p -70.52 -39.71 73.91 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.812 1.187 . . . . 0.0 112.717 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.03 -46.26 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.562 0.619 . . . . 0.0 111.448 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.05 -30.54 65.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.59 70.72 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -80.77 -9.94 59.77 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -171.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 p -97.74 50.95 1.05 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.1 159.93 28.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -156.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.513 ' H ' ' HG3' ' A' ' 58' ' ' GLU . 69.4 mmtt -100.5 174.9 2.65 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 110.67 -2.968 . . . . 0.0 106.417 163.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 14.2 Cg_endo -53.21 -28.53 42.53 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 118.629 2.511 . . . . 0.0 118.629 170.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -102.07 70.93 1.23 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.266 . . . . 0.0 110.968 170.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.43 131.74 24.64 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 163.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -147.44 120.21 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.607 1.194 . . . . 0.0 108.241 -170.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.199 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.254 0.5 OUTLIER -106.36 129.96 54.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.195 -166.908 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.718 HD13 ' CB ' ' A' ' 116' ' ' CYS . 26.3 mm -111.21 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.963 1.256 . . . . 0.0 108.269 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.92 -94.46 0.19 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 121.579 3.392 . . . . 0.0 121.579 -166.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.717 HD22 HD21 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.48 146.83 41.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.867 -137.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.3 m -107.21 -130.14 0.29 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.078 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.95 128.48 33.73 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.68 -13.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 2 O-C-N 114.952 -4.842 . . . . 0.0 117.848 11.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.764 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.3 m-85 -76.26 -0.79 23.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.591 -2.095 . . . . 0.0 113.155 -152.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.66 -55.74 10.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.74 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.58 -33.75 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.984 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.764 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.26 -41.42 96.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.311 -0.956 . . . . 0.0 113.123 172.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.694 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -59.71 -42.89 94.07 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.929 -0.482 . . . . 0.0 111.246 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 tp -55.86 -50.06 71.63 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.619 0.723 . . . . 0.0 112.419 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.1 tt -80.04 -34.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.567 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.63 -16.21 62.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.29 4.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.076 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 76.7 m-85 -106.47 159.7 15.96 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.11 154.17 32.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 102' ' ' ALA . 17.0 mt -104.32 153.25 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.98 1.371 . . . . 0.0 109.899 -171.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.7 tp -151.16 135.0 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.779 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -115.99 88.36 2.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.006 1.86 . . . . 0.0 112.295 -171.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 114' ' ' ASP . 46.1 mt-10 -134.34 100.38 12.74 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -54.95 29.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.102 1 N-CA-C 124.372 4.72 . . . . 0.0 124.372 -141.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 112' ' ' GLU . 12.4 m-20 -99.86 105.63 17.39 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 132.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -79.86 115.36 19.4 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.816 -0.552 . . . . 0.0 110.052 -166.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.199 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.79 -161.31 1.3 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 124.143 1.925 . . . . 0.0 115.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.673 ' CD1' HG12 ' A' ' 109' ' ' ILE . 24.5 m0 -137.05 149.71 47.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 110.384 -3.098 . . . . 0.0 103.905 -165.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.4 mm -110.97 144.72 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 162.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 9.2 tmtt? -93.72 110.01 21.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 18.6 mmt . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 122.017 0.913 . . . . 0.0 112.2 -168.451 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.76 141.84 48.25 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.122 -0.986 . . . . 0.0 111.134 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -96.95 141.42 30.15 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.15 -161.74 9.71 Favored Glycine 0 N--CA 1.466 0.696 0 CA-C-O 124.196 1.998 . . . . 0.0 116.319 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.22 143.77 48.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 110.922 -2.639 . . . . 0.0 107.437 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 136.11 54.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.394 1.092 . . . . 0.0 109.106 170.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mt -113.67 120.2 40.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.104 -1.407 . . . . 0.0 107.657 164.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.62 139.8 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -95.48 129.47 34.78 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 165.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.44 -9.53 18.26 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 N-CA-C 120.872 3.374 . . . . 0.0 120.872 -170.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 -50.31 64.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -161.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -87.33 -29.05 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.119 170.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.1 p -80.78 0.48 34.56 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -170.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.2 m -76.2 0.09 20.32 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 120.197 1.362 . . . . 0.0 111.599 166.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 m -114.26 71.36 2.17 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 161.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.72 52.85 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.038 3.158 . . . . 0.0 116.808 -154.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.96 -39.85 79.24 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.671 -1.268 . . . . 0.0 112.233 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.43 -29.96 68.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.77 -46.5 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 122.227 -0.296 . . . . 0.0 110.939 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.76 -38.48 78.57 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -66.89 -49.97 63.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.513 ' HA ' HE21 ' A' ' 28' ' ' GLN . 7.9 t -61.82 -38.63 88.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.376 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -63.71 -34.45 77.89 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.15 -40.54 78.13 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.513 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.1 mt-30 -64.25 -51.9 61.32 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.04 -0.412 . . . . 0.0 111.631 173.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.6 75.13 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.49 73.53 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -75.04 -22.6 58.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.092 0.86 . . . . 0.0 112.223 -170.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.87 -103.77 0.06 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.306 0.574 . . . . 0.0 109.809 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -161.81 10.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -166.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.67 149.71 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.877 0.846 . . . . 0.0 112.196 170.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -128.58 136.12 50.29 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -88.91 139.58 30.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.849 0.833 . . . . 0.0 108.758 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.05 -41.12 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.536 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -121.94 169.83 10.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.579 1.18 . . . . 0.0 111.176 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -137.28 125.12 22.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.282 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -121.59 149.12 43.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 117.301 -1.759 . . . . 0.0 109.189 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -123.47 111.27 16.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.6 tp -49.8 -35.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.23 -30.37 43.19 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.802 1.183 . . . . 0.0 113.737 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -81.76 -28.94 33.02 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.227 -0.92 . . . . 0.0 113.139 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.45 -40.6 85.42 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.3 0.955 . . . . 0.0 112.057 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -70.32 -23.34 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.97 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.02 -37.66 33.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.49 -0.756 . . . . 0.0 111.493 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.22 15.27 5.16 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -72.32 -28.27 62.96 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -114.81 120.46 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.737 0.78 . . . . 0.0 109.254 -165.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -108.02 120.37 42.12 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.505 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.679 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 15.2 tp -120.52 -165.95 1.26 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.933 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.679 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 48.1 mt-10 -98.62 -176.02 3.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.611 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -120.15 65.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.11 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 6' ' ' THR . 78.4 mttt -100.04 53.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -159.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.2 m-85 -112.63 21.74 15.29 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 116.903 -1.522 . . . . 0.0 112.079 166.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 1.2 pm0 -61.81 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -162.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.11 115.47 6.65 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 164.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.2 134.66 52.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -122.53 134.86 54.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 141.34 52.07 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.03 1.741 . . . . 0.0 109.286 164.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.0 tp -124.56 90.44 3.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.724 -170.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.5 m -138.01 114.46 9.21 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo . . . . . 0 CA--C 1.533 0.468 0 C-N-CA 122.509 2.14 . . . . 0.0 115.941 -170.095 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 5.5 t80 . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 111.571 0.211 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 17.4 Cg_exo -82.14 149.93 15.55 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.206 1.271 . . . . 0.0 111.207 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -62.35 -37.16 84.59 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.59 -30.88 70.1 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -76.81 -30.09 56.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.4 mt -64.4 -35.03 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 119.915 1.234 . . . . 0.0 111.63 168.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.5 p -69.56 -36.57 76.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.505 1.502 . . . . 0.0 112.688 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.34 -39.62 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.751 -0.593 . . . . 0.0 111.728 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -61.96 -40.87 97.05 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.698 -0.626 . . . . 0.0 112.655 174.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.85 70.76 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.12 -10.09 59.17 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.1 m -100.32 28.52 4.92 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mp -134.26 160.03 39.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 122.59 1.186 . . . . 0.0 111.238 -164.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -105.18 174.92 2.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.37 166.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.54 -25.33 32.21 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 118.581 2.493 . . . . 0.0 118.581 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.65 57.38 1.15 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.774 1.17 . . . . 0.0 110.208 168.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.9 145.98 36.01 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 167.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.6 p -141.62 159.27 42.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.234 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.343 1.7 tm? -128.19 129.48 46.54 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -170.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' HB3' ' A' ' 116' ' ' CYS . 44.2 mm -121.03 79.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.632 1.56 . . . . 0.0 110.019 170.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.25 -83.24 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 120.518 2.967 . . . . 0.0 120.518 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 91' ' ' LEU . 1.1 mt -116.54 146.93 42.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.486 -1.357 . . . . 0.0 111.024 -132.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -102.41 -109.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.068 -156.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.26 -60.19 2.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -157.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 mt -61.13 -26.63 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 124.253 1.978 . . . . 0.0 111.605 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 10.5 m-85 -76.56 -19.77 57.55 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.987 -171.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.37 -56.18 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.965 -1.085 . . . . 0.0 113.013 168.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.07 -35.23 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.824 -0.548 . . . . 0.0 111.324 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -58.63 -45.34 89.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 171.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.405 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . . . -57.52 -43.78 84.58 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.569 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -54.96 -49.88 70.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 112.72 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.3 tt -80.24 -34.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.72 30.51 5.19 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.076 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 47.7 m-85 -106.62 159.5 16.15 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 168.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.26 110.22 15.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 117' ' ' TRP . 15.2 tt -74.92 148.55 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 122.487 1.137 . . . . 0.0 111.873 -171.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -149.65 126.98 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.97 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -109.65 98.81 8.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 123.418 1.58 . . . . 0.0 111.582 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -134.31 178.45 1.76 Allowed Pre-proline 0 N--CA 1.472 0.652 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.148 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.55 -7.99 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 N-CA-C 118.732 2.551 . . . . 0.0 118.732 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -128.4 115.23 17.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 157.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -85.44 111.29 19.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.227 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.234 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 19.9 p -147.24 -158.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 124.424 2.059 . . . . 0.0 113.672 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.618 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.0 m0 -137.15 149.89 47.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 110.096 -3.229 . . . . 0.0 104.213 -169.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.43 144.59 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 164.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 16.1 ttpt -94.5 110.37 22.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.975 -1.078 . . . . 0.0 109.873 167.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 109.501 -170.341 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -96.61 141.95 29.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.744 1.259 . . . . 0.0 112.929 -160.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -98.38 120.45 38.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.525 169.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.0 -164.92 11.02 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.889 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.42 141.65 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -164.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -124.13 134.79 53.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.945 1.355 . . . . 0.0 107.855 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -122.7 120.07 32.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.761 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mt -118.14 139.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.21 129.71 24.65 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 165.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -59.85 -13.61 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 N-CA-C 121.48 3.608 . . . . 0.0 121.48 -170.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.54 60.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -161.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.1 m -88.92 -27.78 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.914 0.779 . . . . 0.0 110.715 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -76.36 -14.46 60.09 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -170.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.87 2.23 15.2 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.264 1.393 . . . . 0.0 112.067 -170.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.304 86.1 m -98.85 168.62 9.44 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 166.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -77.18 -9.24 17.76 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 118.298 2.384 . . . . 0.0 118.298 -170.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.43 -50.47 18.31 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -165.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.16 -29.81 67.91 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.744 0.702 . . . . 0.0 112.417 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.15 -50.01 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.852 -0.53 . . . . 0.0 110.453 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.45 -36.99 79.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -60.07 -50.03 75.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.449 ' HA ' HE21 ' A' ' 28' ' ' GLN . 13.8 t -66.4 -39.8 89.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.786 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -61.8 -33.3 73.88 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -36.33 77.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.5 mt-30 -60.17 -56.9 15.93 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.991 -0.443 . . . . 0.0 111.172 172.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.2 77.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.97 63.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 95.7 p -59.85 -28.6 67.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 170.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -85.92 -124.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.616 -0.678 . . . . 0.0 110.017 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -136.27 9.95 3.23 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -170.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.63 150.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.596 0.712 . . . . 0.0 109.884 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -128.24 136.55 51.2 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 163.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.91 100.87 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.211 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -81.47 -24.52 10.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.429 -1.714 . . . . 0.0 114.409 -164.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -121.71 169.75 10.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.279 1.038 . . . . 0.0 111.299 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -146.89 125.23 12.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.818 -169.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.444 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 31.0 m-85 -130.99 149.94 52.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.42 156.67 20.49 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.03 -40.08 87.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.147 -0.971 . . . . 0.0 113.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -82.02 -30.34 31.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -82.83 -30.48 28.69 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.403 1.001 . . . . 0.0 112.967 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.409 HD13 ' CD1' ' A' ' 40' ' ' PHE . 18.4 tp -71.92 -40.56 68.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.207 0.912 . . . . 0.0 112.364 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -74.99 -19.47 60.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.767 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.28 -37.33 21.82 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.798 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.54 15.09 8.37 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -79.6 -17.63 53.44 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.4 mt -114.93 120.38 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.0 m -110.82 107.94 17.6 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.29 1.043 . . . . 0.0 110.929 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -131.15 172.99 11.48 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.435 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.16 177.69 5.32 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.833 -1.167 . . . . 0.0 110.477 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -120.03 70.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.037 -158.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.02 -83.37 0.06 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 6' ' ' THR . 31.6 pttt -99.91 45.15 0.99 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -156.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 59' ' ' THR . 4.4 m-85 -112.24 21.77 15.45 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 116.325 -1.798 . . . . 0.0 112.041 -170.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.38 42.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -155.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 57' ' ' TYR . 10.3 t -141.64 115.11 8.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 159.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 100.679 -3.823 . . . . 0.0 100.679 -170.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.24 134.53 54.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 167.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.48 110.7 16.79 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.267 18.5 tp -97.61 114.05 25.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.186 0.993 . . . . 0.0 111.507 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.401 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 27.7 m -149.28 154.88 39.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 79.7 Cg_exo . . . . . 0 CA--C 1.536 0.575 0 C-N-CA 122.215 1.943 . . . . 0.0 114.013 170.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 34.9 Cg_exo -82.12 149.53 15.46 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 CA-C-N 121.071 1.418 . . . . 0.0 110.158 -173.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.65 -36.14 81.89 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -35.69 74.9 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.82 -30.19 56.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.099 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.08 -38.2 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 119.777 1.171 . . . . 0.0 111.133 168.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.7 m -68.02 -37.24 81.18 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.347 0.976 . . . . 0.0 112.634 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.28 -41.52 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.263 0.483 . . . . 0.0 111.808 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.84 -41.22 97.88 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.44 1.018 . . . . 0.0 112.362 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.93 -29.82 70.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.79 -9.94 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.7 m -84.96 -18.11 35.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.68 170.6 9.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 120.06 1.3 . . . . 0.0 111.914 -164.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 75.5 mttt -108.61 -164.9 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -170.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 12.9 Cg_endo -62.94 -29.73 76.22 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 123.159 2.164 . . . . 0.0 113.715 -170.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -102.07 41.27 1.23 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.46 145.68 29.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -147.13 117.52 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.363 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.278 0.6 OUTLIER -89.53 143.86 26.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.826 -1.988 . . . . 0.0 107.334 -173.279 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.966 HD13 ' CB ' ' A' ' 116' ' ' CYS . 46.4 mm -128.07 88.84 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.858 1.208 . . . . 0.0 108.868 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.46 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -144.15 -76.56 0.03 OUTLIER Glycine 0 C--N 1.316 -0.539 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.46 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.276 4.2 mp -115.56 169.89 8.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 122.688 1.233 . . . . 0.0 109.336 -129.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.81 -120.71 0.29 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.932 -157.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.1 -53.66 6.49 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 121.216 1.825 . . . . 0.0 115.792 -158.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.83 -29.9 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 124.86 2.267 . . . . 0.0 111.903 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.8 m-85 -76.97 -20.44 56.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.29 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -53.89 -55.36 27.58 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.797 -1.189 . . . . 0.0 112.427 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.12 -32.73 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.885 -0.51 . . . . 0.0 111.667 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.74 -43.79 97.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 173.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.4 88.94 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.05 -48.96 78.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.789 0.804 . . . . 0.0 112.526 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.17 -35.36 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.115 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -71.81 -17.59 62.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.7 31.6 4.78 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 119.285 -1.436 . . . . 0.0 112.523 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 50.6 m-85 -106.6 159.52 16.13 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -124.61 103.69 8.28 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.5 tt -78.67 142.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 122.707 1.242 . . . . 0.0 111.62 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.07 127.85 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.401 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -109.78 100.07 9.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.529 -1.668 . . . . 0.0 110.509 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.6 -174.86 0.29 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.353 170.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -56.37 -10.54 4.95 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 N-CA-C 118.935 2.629 . . . . 0.0 118.935 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -119.39 149.56 41.63 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 154.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.548 ' OH ' HD11 ' A' ' 109' ' ' ILE . 22.5 t80 -113.68 114.73 26.79 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 -170.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.363 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 28.1 p -147.73 -156.31 0.71 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.973 1.368 . . . . 0.0 114.651 170.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.618 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.9 m0 -137.21 127.7 26.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.919 -1.946 . . . . 0.0 108.28 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -108.78 110.83 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.56 -1.338 . . . . 0.0 110.183 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -79.58 110.07 14.55 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.104 0.954 . . . . 0.0 111.167 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.728 -170.296 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -106.53 142.03 36.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 122.375 1.083 . . . . 0.0 111.834 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.1 t -103.02 120.74 41.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 168.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.34 -159.6 10.07 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 118.405 -1.855 . . . . 0.0 113.32 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.25 144.46 48.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -170.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.26 0.1 OUTLIER -124.51 129.41 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 172.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -111.53 120.15 41.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.407 HG22 ' HB2' ' A' ' 63' ' ' LEU . 2.3 pt -124.52 139.63 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.405 ' CD2' HG23 ' A' ' 64' ' ' THR . 6.3 t60 -97.24 130.34 29.88 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -54.5 -20.73 21.67 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 N-CA-C 120.931 3.396 . . . . 0.0 120.931 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.73 72.68 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.977 1.717 . . . . 0.0 112.669 -164.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -96.07 -29.53 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -171.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.5 p -85.99 0.02 54.35 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -170.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.2 m -76.46 -5.06 45.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.431 1.469 . . . . 0.0 112.816 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.315 79.7 m -98.7 168.08 10.37 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 167.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.63 -9.45 17.19 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 N-CA-C 117.598 2.115 . . . . 0.0 117.598 -170.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.06 -50.19 20.74 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -163.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.08 -31.83 70.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.784 0.72 . . . . 0.0 112.057 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.45 -47.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.637 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.13 -33.89 74.12 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.93 -47.91 60.57 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -62.62 -39.71 94.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.54 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.01 -31.89 73.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.01 -45.97 69.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.11 1.323 . . . . 0.0 112.332 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.03 -51.25 66.87 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.93 82.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.19 -50.08 13.74 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 t -57.94 -28.18 64.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 170.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.99 -127.87 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.495 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -130.05 6.78 5.03 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -104.45 150.82 7.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.863 0.84 . . . . 0.0 109.98 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -127.99 141.11 51.62 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 164.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -100.32 100.51 11.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.006 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.78 -28.89 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.995 -163.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -121.91 169.63 10.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.329 1.062 . . . . 0.0 110.395 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -147.7 111.6 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -160.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.405 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 13.7 m-30 -119.01 120.47 37.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.5 mt -86.31 149.65 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.15 -39.73 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -78.03 -30.42 49.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.39 -25.48 29.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.492 1.042 . . . . 0.0 113.225 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -70.27 -40.19 74.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.842 1.201 . . . . 0.0 111.924 173.101 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -74.0 -21.07 60.13 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -88.3 -45.94 9.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.415 -0.803 . . . . 0.0 111.992 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.87 15.19 2.16 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 171.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -76.86 -13.55 59.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 120.213 2.006 . . . . 0.0 115.608 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.67 121.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.0 t -98.83 159.35 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 124.245 1.974 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.2 tp -130.44 120.54 24.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.217 -2.72 . . . . 0.0 111.309 -151.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.57 116.07 30.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.564 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -91.44 80.23 5.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.067 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.98 -78.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.16 14.2 20.81 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -155.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.6 m-85 -83.43 21.49 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.966 -170.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.65 27.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 57' ' ' TYR . 10.1 t -126.51 113.08 16.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.226 1.013 . . . . 0.0 108.938 160.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 91' ' ' LEU . 1.2 t -107.65 110.33 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -170.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -97.77 134.25 41.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.61 141.37 46.47 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 168.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 11' ' ' ILE . 30.7 mt -123.83 91.27 3.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.175 170.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 ' CD2' ' A' ' 12' ' ' HIS . 86.1 m -129.5 88.33 50.46 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.768 1.167 . . . . 0.0 110.015 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 CA--C 1.537 0.646 0 C-N-CA 121.911 1.741 . . . . 0.0 110.333 169.916 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -82.27 149.54 15.18 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 CA-C-N 120.626 1.259 . . . . 0.0 111.153 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ptmm? -62.48 -35.78 80.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.69 -28.36 69.01 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.69 -30.35 56.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.789 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.4 -38.17 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 120.391 1.451 . . . . 0.0 110.977 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.1 t -66.86 -43.28 83.98 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.504 1.047 . . . . 0.0 112.716 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.15 -39.9 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.42 -37.85 83.7 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.245 0.929 . . . . 0.0 112.42 174.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.47 -29.85 68.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.284 0.947 . . . . 0.0 113.456 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.77 -10.06 59.36 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.9 m -99.46 14.93 28.1 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.7 mt -134.14 -175.95 4.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.165 0.983 . . . . 0.0 111.556 -159.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -117.75 174.88 2.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.73 -28.62 30.67 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 119.525 2.856 . . . . 0.0 119.525 170.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.43 54.45 0.79 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.191 1.359 . . . . 0.0 108.356 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.17 138.58 21.47 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.3 p -142.91 104.36 4.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.419 ' HA ' HG12 ' A' ' 60' ' ' VAL 0.274 3.9 tt -89.86 129.46 36.23 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 4.6 mp -114.24 85.4 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 -170.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.39 -80.97 0.05 OUTLIER Glycine 0 N--CA 1.464 0.505 0 N-CA-C 121.769 3.468 . . . . 0.0 121.769 -155.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.441 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.259 0.8 OUTLIER -115.5 169.96 8.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.567 1.175 . . . . 0.0 110.058 -139.909 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.7 t -102.36 -148.84 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.113 -157.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.77 -42.59 24.19 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.08 -32.79 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 125.126 2.394 . . . . 0.0 112.96 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 75.7 m-85 -76.28 -10.27 59.28 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 112.941 -1.936 . . . . 0.0 110.093 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.8 tttt -59.32 -50.24 74.75 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.675 -1.266 . . . . 0.0 112.388 168.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -35.55 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.064 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.652 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.34 -47.83 84.36 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 171.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.98 -42.81 80.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.191 0.52 . . . . 0.0 111.949 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.4 tp -60.73 -44.83 96.17 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.0 mt -79.71 -35.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.922 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -71.7 -18.46 62.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 30.04 5.32 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.648 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.3 m-85 -106.66 159.78 15.95 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.122 0.963 . . . . 0.0 108.663 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.42 105.26 9.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.568 HG13 ' CD1' ' A' ' 117' ' ' TRP . 17.3 tt -75.49 146.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.058 -168.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.935 HG13 ' HB2' ' A' ' 116' ' ' CYS . 26.8 pt -143.16 134.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.582 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -112.2 100.13 8.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.04 1.4 . . . . 0.0 110.268 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.62 172.92 5.79 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 113.408 -1.724 . . . . 0.0 108.099 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.46 -8.86 2.06 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.12 115.38 22.34 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 158.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -79.87 142.42 35.24 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.816 -166.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.935 ' HB2' HG13 ' A' ' 110' ' ' ILE 1.064 0.5 OUTLIER -126.39 173.63 9.2 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 113.919 -2.943 . . . . 0.0 111.655 -175.114 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.568 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.0 m0 -137.4 130.23 30.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.993 2.117 . . . . 0.0 105.79 139.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.329 0.2 OUTLIER -110.14 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.207 -0.933 . . . . 0.0 111.265 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -78.19 134.86 37.56 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 123.37 1.557 . . . . 0.0 108.536 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 111.883 -2.417 . . . . 0.0 114.407 -157.792 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.144 0.973 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 34' ' ' VAL . 98.5 mttt -96.95 103.85 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.927 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.7 t -76.39 141.31 41.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 118.756 -1.177 . . . . 0.0 107.99 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.62 -161.92 9.89 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.49 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -134.23 141.21 46.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.283 -1.458 . . . . 0.0 107.53 -171.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.9 tp -124.17 130.56 52.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.615 1.198 . . . . 0.0 109.236 173.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.12 120.52 42.09 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.153 173.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.6 mt -125.13 111.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -167.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.24 129.46 51.55 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -62.98 -10.08 19.15 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 N-CA-C 121.69 3.688 . . . . 0.0 121.69 -169.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.16 -50.36 55.01 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -161.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -86.08 -31.78 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.963 170.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.9 p -81.79 0.39 39.46 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -170.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -76.53 20.05 0.24 Allowed 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 120.437 1.471 . . . . 0.0 112.296 166.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 m -133.2 71.48 76.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 170.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.08 50.56 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.194 3.263 . . . . 0.0 116.845 -155.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -72.97 -45.62 56.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.039 -1.038 . . . . 0.0 111.585 162.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.4 mt -57.98 -34.91 70.48 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.0 t -64.39 -49.25 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.24 175.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.74 -36.45 81.03 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -63.89 -49.45 72.62 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.47 ' HA ' HE21 ' A' ' 28' ' ' GLN . 12.7 t -63.84 -40.35 96.38 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.014 0.824 . . . . 0.0 111.316 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -65.03 -30.91 71.92 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -44.78 71.15 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.71 1.141 . . . . 0.0 113.653 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.47 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.8 mt-30 -58.36 -53.14 61.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.565 173.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.85 68.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.36 18.28 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.0 p -57.94 -27.38 63.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 170.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.87 -125.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -146.46 14.6 1.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.981 0.896 . . . . 0.0 113.223 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 5' ' ' LYS . 10.4 t -98.83 149.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.011 170.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -128.39 134.76 48.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 161.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -91.21 100.61 13.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.16 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.63 -17.09 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.589 -1.642 . . . . 0.0 113.928 -162.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.56 169.7 10.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.239 1.019 . . . . 0.0 109.644 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -143.39 125.22 15.11 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.372 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.416 ' CD1' HD21 ' A' ' 8' ' ' LEU . 2.9 m-85 -129.59 120.4 25.23 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.89 149.68 22.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp -63.3 -40.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -81.95 -30.47 31.72 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -82.12 -29.49 31.64 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.305 -0.872 . . . . 0.0 112.652 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.83 -40.66 68.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.367 0.985 . . . . 0.0 112.739 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -76.78 -16.9 59.33 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.668 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.05 -37.45 29.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.545 -0.722 . . . . 0.0 111.43 166.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.67 15.4 5.84 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -78.54 -24.92 45.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mt -114.81 120.3 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -120.08 120.2 35.55 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.786 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.469 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 11.8 tp -130.99 174.44 10.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.132 0.968 . . . . 0.0 109.575 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.469 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 46.5 mt-10 -98.94 175.05 6.07 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.692 1.234 . . . . 0.0 111.724 -170.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.1 m-20 -91.41 94.06 9.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.981 -170.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.69 -147.2 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -165.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -100.08 35.0 2.16 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.64 -163.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.8 m-85 -81.94 21.66 0.85 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.081 -170.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.52 27.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' TYR . 9.8 t -129.32 115.06 17.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 162.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.26 94.04 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -162.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -97.85 134.37 41.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.36 142.43 38.7 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 170.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.6 tp -122.99 108.98 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.872 0.844 . . . . 0.0 109.603 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.405 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 25.5 m -143.97 154.93 59.01 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -170.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 82.9 Cg_exo . . . . . 0 CA--C 1.536 0.577 0 C-N-CA 122.291 1.994 . . . . 0.0 114.702 170.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -82.34 149.71 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 CA-C-N 119.701 0.929 . . . . 0.0 110.587 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.48 -36.59 82.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.738 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.49 -30.1 71.02 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.6 mt -76.68 -30.14 56.61 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.268 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.26 -36.66 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 119.845 1.202 . . . . 0.0 111.061 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.8 m -66.93 -40.57 87.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.694 1.134 . . . . 0.0 112.717 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.81 -35.76 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 122.025 -0.422 . . . . 0.0 111.991 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -59.87 -47.73 84.57 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.698 -0.626 . . . . 0.0 111.498 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.3 -30.87 71.37 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.33 -10.55 59.84 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -166.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 72.1 p -74.53 -33.13 62.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 165.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 mt -88.66 -170.66 3.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 122.283 1.039 . . . . 0.0 112.079 -159.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -134.26 174.92 4.1 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -52.39 -22.39 15.98 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 N-CA-C 120.292 3.151 . . . . 0.0 120.292 -170.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -102.12 46.57 0.92 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.26 1.391 . . . . 0.0 111.096 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.44 140.67 28.64 Favored Glycine 0 N--CA 1.467 0.737 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -147.04 120.17 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.214 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.433 1.9 tm? -98.4 129.55 45.04 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 111.641 -2.527 . . . . 0.0 104.705 -167.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.089 HD13 ' HB3' ' A' ' 116' ' ' CYS . 44.2 mm -119.38 85.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.584 1.538 . . . . 0.0 109.804 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.04 -79.11 0.04 OUTLIER Glycine 0 N--CA 1.464 0.528 0 N-CA-C 120.878 3.111 . . . . 0.0 120.878 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.605 HD12 HD11 ' A' ' 91' ' ' LEU . 1.5 mp -115.88 169.99 8.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.669 -133.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.2 p -114.93 -123.4 0.29 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.355 -0.84 . . . . 0.0 113.185 -156.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.51 -51.02 11.4 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -157.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -60.35 -30.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.877 1.798 . . . . 0.0 111.266 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 77.7 m-85 -76.82 -16.63 59.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.581 -172.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.2 tttt -57.12 -55.13 38.76 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.373 -0.829 . . . . 0.0 112.277 169.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.93 -33.47 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.987 -0.446 . . . . 0.0 111.376 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.41 -45.28 95.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.02 84.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.34 -48.66 79.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.728 0.775 . . . . 0.0 112.554 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.6 tt -80.22 -35.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.309 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.63 -16.14 62.27 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.49 5.58 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 119.373 -1.394 . . . . 0.0 112.805 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 96.6 m-85 -106.63 159.58 16.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.79 108.79 11.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.669 HD11 ' OH ' ' A' ' 115' ' ' TYR . 18.1 tt -84.88 142.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.49 1.138 . . . . 0.0 112.569 -165.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.3 pt -147.13 135.07 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.579 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -126.61 100.14 6.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.002 1.858 . . . . 0.0 112.965 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.44 87.97 30.95 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.8 61.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 122.151 3.866 . . . . 0.0 122.151 -123.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -123.4 104.85 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.255 -2.869 . . . . 0.0 103.255 142.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.669 ' OH ' HD11 ' A' ' 109' ' ' ILE . 15.7 t80 -82.91 111.33 18.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -159.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.214 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.3 p -147.39 -156.75 0.74 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 125.061 2.362 . . . . 0.0 113.754 171.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.635 ' CD1' HG13 ' A' ' 109' ' ' ILE . 24.9 m0 -137.08 149.79 47.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 109.16 -3.654 . . . . 0.0 102.901 -167.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 144.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 6.2 ttpm? -88.44 134.92 33.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.532 0.682 . . . . 0.0 111.715 -171.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 -170.223 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 2.8 t80 . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.616 0.246 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.82 155.12 38.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.96 0.886 . . . . 0.0 110.582 -166.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -77.56 141.62 39.46 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.474 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -133.7 -162.97 10.24 Favored Glycine 0 N--CA 1.466 0.678 0 C-N-CA 119.421 -1.371 . . . . 0.0 114.759 173.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.28 139.85 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.117 -1.542 . . . . 0.0 107.925 -171.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -124.33 132.88 53.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.162 0.982 . . . . 0.0 108.843 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.65 149.65 27.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.253 165.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.48 143.2 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -111.22 129.59 23.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -60.16 -17.41 45.69 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 N-CA-C 120.261 3.139 . . . . 0.0 120.261 -170.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.25 67.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -161.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.97 -28.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.357 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.8 p -77.14 -11.92 59.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -170.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.6 m -76.63 -1.5 27.96 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.697 1.59 . . . . 0.0 111.718 -170.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 19' ' ' PRO 0.336 91.3 m -98.78 168.73 9.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 167.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' THR . 95.0 Cg_exo -75.82 -8.69 19.29 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 N-CA-C 118.019 2.277 . . . . 0.0 118.019 -170.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.15 -50.1 20.86 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -163.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.99 -32.94 72.87 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.74 0.7 . . . . 0.0 112.16 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.93 -46.6 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.686 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -62.61 -34.01 76.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.65 -49.07 57.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.512 ' HA ' HE21 ' A' ' 28' ' ' GLN . 8.5 t -61.52 -41.49 97.39 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.191 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.13 -33.76 76.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.735 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.75 73.18 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.196 1.362 . . . . 0.0 113.598 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.512 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.5 mt-30 -56.93 -54.91 41.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.75 0.309 . . . . 0.0 111.586 173.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.24 -43.35 78.56 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.35 47.25 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.9 p -57.89 -36.47 72.45 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.86 -94.64 0.1 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.958 0.885 . . . . 0.0 110.351 -170.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' CG ' ' A' ' 4' ' ' TYR . 44.4 mmtm -129.88 -42.09 1.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.285 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.251 59.5 t -97.64 149.96 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 123.256 1.503 . . . . 0.0 112.594 -160.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -121.35 134.96 55.14 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.222 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -95.38 139.75 31.23 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.72 -24.7 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -170.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -121.52 169.73 10.38 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.63 1.205 . . . . 0.0 110.286 -174.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -147.34 125.57 12.22 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 114.249 -1.342 . . . . 0.0 108.85 -168.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -133.04 120.28 21.13 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.657 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.8 tt -92.58 149.45 21.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.16 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.54 ' H ' HD23 ' A' ' 41' ' ' LEU . 22.0 t-20 -79.4 -30.2 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.315 -0.866 . . . . 0.0 113.021 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.19 -37.55 45.4 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.153 -0.967 . . . . 0.0 112.662 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.2 tp -68.57 -40.62 80.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.549 0.69 . . . . 0.0 112.8 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -73.5 -21.2 60.48 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.835 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -83.75 -36.1 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.541 -0.725 . . . . 0.0 112.047 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.56 15.33 6.44 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.329 0.892 . . . . 0.0 115.329 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -76.09 -35.66 59.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.849 1.324 . . . . 0.0 113.689 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.9 mt -114.69 120.35 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -168.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.7 m -129.8 120.21 24.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.596 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 38' ' ' ASP . 93.3 mt -119.6 179.9 4.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.849 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.79 175.32 6.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.608 1.194 . . . . 0.0 111.763 -168.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.8 m-20 -89.32 93.34 9.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.553 -170.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.82 -147.42 0.25 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -165.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -100.1 37.57 1.63 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.168 0.985 . . . . 0.0 113.243 -162.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.6 m-85 -82.28 21.74 0.9 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 117.191 -1.385 . . . . 0.0 112.259 -170.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.23 27.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -157.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.474 HG23 ' HA3' ' A' ' 7' ' ' GLY . 7.8 t -128.45 115.12 17.7 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 162.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 36.5 t -113.74 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -167.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -111.05 134.67 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.06 141.86 50.94 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.0 tp -123.78 94.28 4.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -170.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -140.47 154.72 69.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -170.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 CA--C 1.535 0.535 0 C-N-CA 122.824 2.35 . . . . 0.0 114.676 170.252 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.7 t80 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.935 -0.024 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 19.8 Cg_exo -82.7 151.86 14.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 121.757 1.638 . . . . 0.0 112.246 170.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -62.46 -34.26 76.45 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 166.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.13 -34.5 76.48 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.7 -30.07 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.683 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.409 HG13 ' CE2' ' A' ' 73' ' ' PHE . 96.8 mt -59.34 -41.05 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 119.608 1.095 . . . . 0.0 111.155 167.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -64.76 -40.34 95.12 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.963 -1.086 . . . . 0.0 112.823 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -64.17 -37.18 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.91 -42.56 94.14 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.446 -0.784 . . . . 0.0 112.384 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.47 -29.8 70.84 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -75.79 -9.98 59.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 71.9 m -74.8 -40.05 61.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 169.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.2 mt -91.17 164.33 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.923 1.344 . . . . 0.0 113.593 -154.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.72 101.69 0.54 Allowed Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 112.206 -2.27 . . . . 0.0 105.402 163.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -51.06 6.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 N-CA-C 122.183 3.878 . . . . 0.0 122.183 -154.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -94.7 57.77 2.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 123.039 1.4 . . . . 0.0 108.571 163.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.88 167.51 38.34 Favored Glycine 0 N--CA 1.466 0.691 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.159 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -146.14 120.07 9.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.225 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.307 0.6 OUTLIER -92.7 129.85 38.5 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 112.618 -2.083 . . . . 0.0 107.905 -173.727 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.711 HD13 ' CB ' ' A' ' 116' ' ' CYS . 23.3 mm -113.75 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.85 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.462 0.42 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.533 HD12 HD21 ' A' ' 91' ' ' LEU . 6.2 mt -115.93 146.56 41.98 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.859 1.314 . . . . 0.0 110.646 -131.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.3 t -90.79 179.45 5.79 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.348 -165.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.9 44.06 0.73 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 120.25 3.426 . . . . 0.0 120.25 -161.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mt -96.16 -26.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 126.716 3.15 . . . . 0.0 109.959 137.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.783 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 92.2 m-85 -76.68 2.95 12.74 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.347 -168.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -71.83 -52.17 18.83 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.583 -1.323 . . . . 0.0 111.509 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.85 -33.36 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.081 -0.387 . . . . 0.0 110.732 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.94 -46.61 89.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.197 171.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.538 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -57.99 -39.78 79.08 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.99 -0.444 . . . . 0.0 111.817 176.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -58.48 -50.01 75.29 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.706 0.765 . . . . 0.0 112.394 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.31 -34.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.438 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -71.79 -16.59 62.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 173.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.07 5.74 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.703 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 94.1 m-85 -106.54 159.56 16.08 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -117.46 154.09 32.0 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 161.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.63 HG12 ' CD1' ' A' ' 117' ' ' TRP . 19.1 mt -103.99 148.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.061 1.41 . . . . 0.0 109.812 -174.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 pt -140.29 125.57 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 113.246 -1.797 . . . . 0.0 106.628 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -121.99 87.41 2.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 124.072 1.892 . . . . 0.0 113.476 -168.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 114' ' ' ASP . 18.6 mp0 -134.21 100.29 12.96 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 -170.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -54.82 31.42 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.167 1 N-CA-C 124.342 4.709 . . . . 0.0 124.342 -139.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' GLU . 19.2 t70 -100.01 115.17 29.1 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 130.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -90.35 115.27 27.41 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.674 -164.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.225 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.86 -164.6 2.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.956 1.836 . . . . 0.0 115.452 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.63 ' CD1' HG12 ' A' ' 109' ' ' ILE . 22.7 m0 -137.55 130.04 29.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 110.804 -2.907 . . . . 0.0 105.625 -167.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.18 144.41 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -79.52 134.84 36.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.118 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 122.14 0.972 . . . . 0.0 111.138 170.334 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.79 141.74 35.96 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 123.086 1.422 . . . . 0.0 112.414 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -104.83 120.61 41.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.9 -1.954 . . . . 0.0 106.049 164.149 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -129.4 -163.62 11.23 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.906 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.37 145.02 48.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -167.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.34 135.72 53.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.583 1.182 . . . . 0.0 109.518 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -119.44 120.14 35.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.76 -1.563 . . . . 0.0 106.955 177.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -117.97 139.9 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 64' ' ' THR . 2.4 t60 -99.17 129.55 29.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -62.87 -11.46 24.45 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 N-CA-C 120.502 3.231 . . . . 0.0 120.502 -170.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.34 63.35 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -162.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.76 -30.16 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.574 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -81.04 0.32 36.38 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -76.23 -0.92 24.02 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 120.456 1.48 . . . . 0.0 112.018 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 m -114.82 71.48 2.58 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.99 55.88 3.5 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.717 2.945 . . . . 0.0 116.758 -154.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -71.91 -44.99 62.77 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.869 -1.144 . . . . 0.0 112.096 166.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.09 -29.93 68.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -65.2 -50.07 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.641 -0.662 . . . . 0.0 110.795 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.88 -38.18 81.49 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -60.81 -50.09 74.87 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -65.18 -38.49 90.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.534 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.61 -33.57 76.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.49 73.47 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -56.11 -56.17 24.07 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.99 96.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.3 -50.44 67.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -75.37 -11.49 60.06 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.544 -0.722 . . . . 0.0 112.704 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.85 -109.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.318 0.58 . . . . 0.0 111.467 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -139.68 20.27 2.52 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.88 110.55 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.245 -168.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.84 135.02 40.89 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -88.78 139.57 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.5 -32.63 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.014 -165.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.77 169.92 10.27 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.985 1.374 . . . . 0.0 110.904 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -142.41 125.32 16.12 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.018 -172.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.493 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 16.2 m-85 -119.61 149.64 41.62 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.009 166.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.37 149.72 26.71 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 164.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.419 HD13 ' OH ' ' A' ' 62' ' ' TYR . 4.5 tp -63.33 -39.41 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -78.85 -30.28 45.06 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.444 -0.785 . . . . 0.0 113.098 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.14 -30.46 38.99 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.283 -0.886 . . . . 0.0 112.933 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.63 -40.61 66.3 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 112.525 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.29 -27.64 66.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.632 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -83.16 -39.3 21.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.929 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.19 15.38 2.29 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.84 1.496 . . . . 0.0 116.84 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.4 m -78.88 -14.32 59.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 -168.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.73 161.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.542 1.064 . . . . 0.0 110.318 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -99.84 120.4 39.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.988 -172.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.69 120.0 36.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.475 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.51 120.1 39.09 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -92.46 65.6 4.49 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -167.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.17 -77.16 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 170.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 6' ' ' THR . 90.8 mttt -100.04 57.41 0.97 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.389 1.09 . . . . 0.0 113.629 -161.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 59' ' ' THR . 11.8 m-85 -112.34 21.52 15.66 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.984 163.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.73 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 -157.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 57' ' ' TYR . 8.7 t -131.14 116.39 17.65 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 162.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.53 HG11 HD22 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -98.64 134.79 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 171.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.52 134.55 54.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.419 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -123.22 110.45 15.25 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.255 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.04 89.74 3.09 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -170.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 12' ' ' HIS . 33.5 m -131.08 154.45 82.02 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -170.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 CA--C 1.532 0.407 0 C-N-CA 121.974 1.782 . . . . 0.0 112.984 170.202 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 15.8 t80 . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 32.2 Cg_exo -82.16 149.39 15.34 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 121.195 1.463 . . . . 0.0 110.25 -175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.73 -39.65 94.74 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -63.17 -27.64 69.51 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.83 -30.31 56.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.626 173.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.16 -35.08 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 119.729 1.15 . . . . 0.0 111.063 171.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.5 p -71.96 -36.79 69.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.789 1.177 . . . . 0.0 113.081 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.83 -38.43 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.696 -0.628 . . . . 0.0 111.816 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -40.53 95.57 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.457 -0.777 . . . . 0.0 112.168 174.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.95 -29.86 70.33 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -79.11 -29.42 43.23 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -76.52 -17.98 58.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 mp -124.32 100.82 6.87 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.553 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.266 80.4 mttt -74.77 -155.06 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.674 -166.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 6.1 Cg_endo -59.21 -31.38 95.17 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 N-CA-C 120.656 3.291 . . . . 0.0 120.656 -160.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -90.48 49.04 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.351 1.887 . . . . 0.0 110.659 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.43 144.07 26.55 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 173.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.7 p -146.71 117.07 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 123.445 1.593 . . . . 0.0 107.147 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.266 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.379 0.7 OUTLIER -97.42 133.95 41.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.39 -167.265 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.954 HD13 ' HB3' ' A' ' 116' ' ' CYS . 33.0 mm -121.53 87.39 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.576 1.535 . . . . 0.0 108.747 170.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.465 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -144.26 -78.58 0.04 OUTLIER Glycine 0 C--N 1.316 -0.546 0 N-CA-C 121.375 3.31 . . . . 0.0 121.375 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.465 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.271 5.5 mp -115.67 172.01 7.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.611 1.196 . . . . 0.0 109.868 -124.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -109.13 -141.71 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.486 -156.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.96 -45.79 39.88 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -163.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mt -57.21 -32.84 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 124.397 2.046 . . . . 0.0 111.31 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 90.7 m-85 -76.89 -16.0 59.52 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.347 -1.751 . . . . 0.0 112.296 -170.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.71 -55.08 39.53 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.94 -1.1 . . . . 0.0 111.979 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.16 -35.27 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.755 -0.59 . . . . 0.0 111.795 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.649 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.75 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 173.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.99 79.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.122 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.86 -46.67 74.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.607 0.718 . . . . 0.0 112.843 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.5 tt -80.2 -34.56 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.74 -17.89 62.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.78 21.52 9.63 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.618 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 119' ' ' LYS 0.271 94.7 m-85 -106.85 112.33 25.24 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -98.48 153.48 18.58 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.96 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.62 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -109.13 145.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 111.689 -2.505 . . . . 0.0 110.867 -155.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 pt -137.94 123.01 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -112.17 99.95 8.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.205 1.479 . . . . 0.0 110.723 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.0 -175.61 0.5 Allowed Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.085 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -55.52 -11.61 4.94 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 N-CA-C 118.733 2.551 . . . . 0.0 118.733 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -124.78 149.48 47.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 152.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.414 ' OH ' HD11 ' A' ' 109' ' ' ILE . 13.5 t80 -113.03 112.52 24.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -170.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.266 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 25.2 p -147.73 -153.36 0.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.148 1.451 . . . . 0.0 112.527 169.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.62 ' CD1' HG13 ' A' ' 109' ' ' ILE . 4.4 m0 -136.85 153.52 50.75 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.559 -2.11 . . . . 0.0 105.483 -172.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.27 144.4 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 162.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 61.7 tttm -79.88 134.99 36.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.894 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.645 0.735 . . . . 0.0 110.283 170.326 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.53 103.65 10.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.567 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -76.77 120.44 21.94 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.38 -154.82 7.54 Favored Glycine 0 N--CA 1.464 0.505 0 CA-C-O 123.187 1.437 . . . . 0.0 115.893 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.477 HD11 ' CE2' ' A' ' 40' ' ' PHE . 18.4 tp -134.1 149.84 51.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 112.245 -1.978 . . . . 0.0 109.233 -168.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 tp -124.61 133.75 53.16 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.629 1.204 . . . . 0.0 107.782 157.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -114.46 120.36 40.0 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.262 173.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.5 mt -118.04 139.76 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -172.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -103.02 129.6 25.29 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -59.08 -16.95 35.66 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 N-CA-C 121.261 3.524 . . . . 0.0 121.261 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -50.31 58.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -160.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.78 -35.2 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.843 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -71.19 -12.14 61.32 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 t -76.7 1.14 17.94 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.984 1.265 . . . . 0.0 112.147 -170.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.352 53.9 m -98.86 168.12 10.24 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.5 -2.83 13.0 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 N-CA-C 117.873 2.22 . . . . 0.0 117.873 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -74.15 -50.45 19.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.957 1.253 . . . . 0.0 114.21 -166.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.06 -30.15 68.42 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.778 0.717 . . . . 0.0 112.368 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.43 -46.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.102 -0.374 . . . . 0.0 111.146 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -62.2 -36.33 81.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.039 0.836 . . . . 0.0 113.223 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -46.75 75.23 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.532 ' HA ' HE21 ' A' ' 28' ' ' GLN . 90.0 m -58.93 -45.68 89.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.826 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -63.97 -29.82 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.98 74.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.893 1.224 . . . . 0.0 113.38 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.532 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.1 mt-30 -57.63 -52.98 63.19 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.154 -0.341 . . . . 0.0 111.858 171.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.86 -45.71 60.01 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.883 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.83 -50.53 28.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.49 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.5 t -75.54 -29.52 59.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -170.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.86 -127.84 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.006 -0.434 . . . . 0.0 111.94 170.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -139.39 1.48 1.97 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -165.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -99.47 149.81 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.817 0.818 . . . . 0.0 112.28 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -122.65 143.78 49.55 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -104.24 100.37 10.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.279 1.037 . . . . 0.0 109.425 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.74 -40.59 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.84 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.09 169.77 10.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.246 1.022 . . . . 0.0 110.538 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -144.86 113.02 6.48 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -164.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' A' ' 8' ' ' LEU . 17.4 m-30 -118.83 120.19 36.6 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.36 150.09 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.16 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -76.74 -30.05 56.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.8 -35.73 32.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 113.137 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.12 -40.52 78.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.814 0.733 . . . . 0.0 112.724 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -66.1 -27.91 68.42 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.076 173.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -79.9 -39.12 31.08 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.3 10.69 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -78.34 -11.18 59.92 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.1 mt -114.9 121.77 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -98.6 120.84 39.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 124.014 1.864 . . . . 0.0 110.227 -164.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.0 mt -96.52 149.81 21.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 111.199 -2.728 . . . . 0.0 111.565 -163.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.76 169.75 9.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.255 -1.793 . . . . 0.0 107.498 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -116.34 35.95 4.31 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.28 -74.66 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -168.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' THR . 50.9 pttt -78.24 32.92 0.19 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -162.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.443 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.6 m-85 -112.11 21.87 15.41 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 116.93 -1.51 . . . . 0.0 112.995 170.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.63 38.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -165.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.02 115.32 6.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 166.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.2 t -101.33 139.04 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -122.3 134.57 54.66 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -114.73 141.75 47.42 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.77 112.81 17.77 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 170.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.1 m -150.3 154.4 36.05 Favored Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 C-N-CA 122.902 2.401 . . . . 0.0 115.499 170.517 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.407 ' CE2' HG13 ' A' ' 78' ' ' ILE . 14.7 t80 . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 22.8 Cg_exo -82.09 149.8 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 CA-C-N 120.01 1.039 . . . . 0.0 111.365 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.52 -36.86 83.94 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -58.54 -34.22 70.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.67 -30.18 56.66 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.919 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.407 HG13 ' CE2' ' A' ' 73' ' ' PHE . 96.4 mt -59.84 -38.97 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 120.043 1.292 . . . . 0.0 111.236 167.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.6 m -65.68 -39.08 90.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.691 1.132 . . . . 0.0 112.908 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.55 -41.73 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.04 -41.5 92.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.652 -0.655 . . . . 0.0 112.58 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 85' ' ' LEU . . . -63.57 -29.76 70.97 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.88 -10.12 59.33 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -105.46 33.56 3.66 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 82' ' ' ALA . 92.5 mt -134.05 159.98 39.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.233 1.016 . . . . 0.0 111.053 -165.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.556 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 82.2 mttt -112.8 -156.4 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 165.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 14.8 Cg_endo -62.82 -33.81 74.63 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 CA-C-N 124.041 2.479 . . . . 0.0 113.855 -170.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -92.52 45.88 1.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 118.513 0.597 . . . . 0.0 109.912 -170.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 118' ' ' ILE . . . -79.74 116.71 4.34 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 172.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.4 t -139.32 107.04 5.62 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -166.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.23 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.279 1.3 tt -91.52 129.89 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -170.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.675 HD13 ' CB ' ' A' ' 116' ' ' CYS . 20.3 mm -105.89 86.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.977 0.894 . . . . 0.0 109.746 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.592 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.74 -83.49 0.06 OUTLIER Glycine 0 C--N 1.317 -0.488 0 N-CA-C 121.509 3.364 . . . . 0.0 121.509 -166.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.592 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -115.49 171.38 7.76 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.33 -1.348 . . . . 0.0 110.196 -138.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 85.0 p -110.28 -129.34 0.29 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.942 -163.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -79.3 -47.81 15.21 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -157.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.64 -29.78 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 124.607 2.146 . . . . 0.0 111.317 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 76.0 m-85 -76.66 -11.0 59.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.354 -1.748 . . . . 0.0 111.149 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -49.36 70.73 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.789 -1.194 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.09 -36.89 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.802 -0.561 . . . . 0.0 111.141 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -60.4 -43.0 97.1 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.929 171.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.538 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -57.28 -43.33 83.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 111.242 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.06 -48.26 76.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.4 tt -80.13 -35.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.811 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -71.96 0.47 9.24 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.38 41.79 97.96 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 119.807 1.185 . . . . 0.0 113.935 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.0 m-85 -106.91 111.76 24.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 165.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -98.88 117.93 34.49 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 123.474 1.607 . . . . 0.0 106.746 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.66 HG12 ' CD1' ' A' ' 117' ' ' TRP . 15.8 mt -74.74 152.52 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.811 -162.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.4 pt -139.58 128.93 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.159 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -106.86 78.82 1.27 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.302 2.001 . . . . 0.0 111.112 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.27 36.7 tt0 -93.13 162.49 28.25 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 111.341 -2.663 . . . . 0.0 107.14 166.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.56 -6.13 0.92 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 N-CA-C 118.934 2.628 . . . . 0.0 118.934 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -112.43 110.29 20.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 155.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -80.75 115.13 20.09 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.878 -0.514 . . . . 0.0 110.562 -168.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.23 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 15.0 p -147.04 -164.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 123.746 1.736 . . . . 0.0 114.102 172.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.66 ' CD1' HG12 ' A' ' 109' ' ' ILE . 3.1 m0 -137.79 130.19 29.38 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 111.459 -2.61 . . . . 0.0 106.073 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER -111.88 144.22 20.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 123.001 1.381 . . . . 0.0 107.478 169.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.87 134.84 36.33 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.467 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.47 0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.432 170.355 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 122.194 0.997 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -92.32 142.06 27.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.602 1.192 . . . . 0.0 111.148 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 56' ' ' LYS . 1.6 t -105.08 120.66 42.05 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.465 174.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.6 -161.12 10.05 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 118.814 -1.66 . . . . 0.0 113.811 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.458 HD13 ' OD2' ' A' ' 38' ' ' ASP . 42.5 tp -133.94 139.28 46.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.09 -1.055 . . . . 0.0 108.686 -167.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.7 tp -124.87 110.96 14.91 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 0.0 110.443 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.91 120.23 39.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.996 170.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -123.15 139.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.962 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.76 129.83 43.1 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.48 -11.02 10.05 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 N-CA-C 120.562 3.254 . . . . 0.0 120.562 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.71 -50.14 65.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -88.95 -30.29 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.873 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.5 p -78.74 -2.7 40.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -76.62 -9.8 58.93 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.933 1.242 . . . . 0.0 111.476 163.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.4 m -108.51 71.68 0.41 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 165.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.29 46.68 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.363 3.375 . . . . 0.0 116.235 -154.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.86 -49.98 66.18 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.396 -0.815 . . . . 0.0 112.772 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.97 -29.82 70.77 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 122.05 -0.406 . . . . 0.0 112.03 173.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -63.59 -50.0 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.735 -0.603 . . . . 0.0 111.322 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.63 -36.45 76.38 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.223 -0.923 . . . . 0.0 113.301 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.09 -49.88 72.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -64.9 -35.85 82.48 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.786 0.721 . . . . 0.0 111.562 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -64.99 -35.13 80.21 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.12 -45.28 70.56 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.536 1.062 . . . . 0.0 113.11 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.334 2.3 tm0? -54.99 -52.11 64.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.15 86.46 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.587 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.28 -50.46 65.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.419 -170.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 m -75.25 -13.95 60.48 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.835 -0.541 . . . . 0.0 112.021 -170.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.79 -113.94 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.838 -0.539 . . . . 0.0 110.393 170.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -150.72 35.22 0.61 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 t -112.65 149.85 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.443 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.23 134.91 49.07 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 162.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -98.78 100.73 11.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.21 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.84 -14.6 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -164.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.458 ' OD2' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -121.73 120.4 34.55 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -173.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -114.92 114.34 25.34 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.551 -167.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -123.68 120.21 32.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.839 0.828 . . . . 0.0 109.428 -174.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp -87.65 149.8 24.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.415 HD13 ' OH ' ' A' ' 62' ' ' TYR . 3.9 tp -63.29 -38.3 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -78.54 -30.29 46.86 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -77.69 -41.09 39.21 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.305 -0.872 . . . . 0.0 112.494 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -67.03 -40.38 87.21 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.644 0.735 . . . . 0.0 112.947 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -73.84 -21.37 60.14 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.761 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.92 -35.01 38.48 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.595 -0.69 . . . . 0.0 111.421 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.12 15.27 5.66 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.811 0.684 . . . . 0.0 114.811 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -78.46 -40.29 36.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.6 mt -114.93 118.74 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 122.481 1.134 . . . . 0.0 109.5 -167.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -133.31 159.23 40.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 157.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.294 1.8 pt? -131.34 -70.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.329 164.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -141.46 169.8 16.92 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.892 0.853 . . . . 0.0 109.81 172.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.54 63.14 0.85 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.55 -92.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 6' ' ' THR . 43.5 pttt -100.29 64.55 1.18 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -161.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.437 ' O ' ' N ' ' A' ' 59' ' ' THR . 5.7 m-85 -112.1 21.77 15.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 116.367 -1.778 . . . . 0.0 113.346 170.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.54 41.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -157.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -147.15 115.68 6.71 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 165.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 91' ' ' LEU 0.25 40.9 t -118.4 134.62 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.403 -164.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.59 134.74 54.51 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.415 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -117.79 110.41 17.77 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 168.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.23 104.97 17.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.031 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.8 m -119.84 120.08 30.7 Favored Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 167.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 121.875 1.717 . . . . 0.0 114.546 -164.487 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 14.7 t80 . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 27.4 Cg_exo -82.38 149.49 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 120.395 1.177 . . . . 0.0 110.161 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.6 -37.49 86.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.641 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.61 -29.55 70.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.2 mt -76.75 -30.16 56.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.322 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.31 -35.03 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-N 119.886 1.221 . . . . 0.0 111.033 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.2 t -68.5 -39.39 81.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.661 1.119 . . . . 0.0 112.657 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.916 -0.49 . . . . 0.0 111.755 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.98 -46.11 90.5 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.696 -0.628 . . . . 0.0 111.967 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.04 71.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.2 -13.01 56.29 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.3 m -71.26 -45.19 63.75 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 122.06 -0.4 . . . . 0.0 110.747 162.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.9 mt -97.67 161.47 13.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.926 1.346 . . . . 0.0 112.461 -163.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.424 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 63.9 mttp -108.43 -178.25 0.55 Allowed Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.287 -170.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 25.5 Cg_exo -56.15 -12.73 8.08 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 N-CA-C 119.96 3.023 . . . . 0.0 119.96 -170.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -102.37 33.32 3.17 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.14 1.336 . . . . 0.0 111.853 169.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.55 141.89 41.35 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 170.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 81.9 p -145.24 107.19 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.97 1.366 . . . . 0.0 108.325 -171.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -89.9 143.01 27.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.611 -1.632 . . . . 0.0 108.59 -172.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.38 88.41 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 167.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.22 -86.6 0.08 OUTLIER Glycine 0 CA--C 1.53 0.977 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 -159.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.54 169.82 8.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.052 1.926 . . . . 0.0 110.828 -147.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.4 m -104.89 -149.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -160.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.51 -43.06 86.31 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -163.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.01 -34.43 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 124.836 2.255 . . . . 0.0 110.526 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 65.7 m-85 -76.68 -10.49 59.42 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.142 -1.844 . . . . 0.0 111.073 -175.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.93 -52.83 58.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.829 -1.169 . . . . 0.0 112.188 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.76 -33.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.275 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.48 -46.01 91.85 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.531 -0.731 . . . . 0.0 112.847 172.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 109' ' ' ILE . . . -56.6 -42.57 78.98 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.886 -0.509 . . . . 0.0 111.827 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.05 -49.35 76.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.67 0.747 . . . . 0.0 112.502 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 tt -80.08 -34.62 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -170.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -71.61 -17.41 62.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.61 29.61 5.55 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 119.296 -1.43 . . . . 0.0 112.317 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.1 m-85 -106.71 159.84 15.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -126.88 108.1 10.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.548 1.166 . . . . 0.0 108.711 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.609 HG12 ' CD1' ' A' ' 117' ' ' TRP . 25.5 mt -84.5 111.24 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.962 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.676 HG13 ' SG ' ' A' ' 116' ' ' CYS . 44.9 pt -108.55 135.05 48.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.247 169.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -105.85 100.31 9.87 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.725 1.726 . . . . 0.0 110.668 -171.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -117.31 171.37 4.99 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 111.957 -2.383 . . . . 0.0 107.698 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -56.22 -8.5 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 N-CA-C 119.117 2.699 . . . . 0.0 119.117 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -119.47 115.26 23.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -79.57 139.09 37.63 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -165.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.676 ' SG ' HG13 ' A' ' 110' ' ' ILE 0.266 5.1 p -145.72 120.88 10.14 Favored 'General case' 0 CA--C 1.54 0.586 1 N-CA-C 123.375 4.583 . . . . 0.0 123.375 -164.141 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.609 ' CD1' HG12 ' A' ' 109' ' ' ILE . 4.0 m0 -109.64 111.06 22.32 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 143.98 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.682 1.23 . . . . 0.0 108.832 170.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 77.8 tttt -91.74 110.22 21.55 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.631 -174.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.832 0.825 . . . . 0.0 110.424 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -92.64 141.77 28.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.527 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 t -89.88 141.48 28.6 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 158.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.48 -167.09 11.55 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 123.762 1.757 . . . . 0.0 115.258 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 40' ' ' PHE . 30.5 tp -131.3 139.83 49.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 111.569 -2.315 . . . . 0.0 107.983 -173.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.285 0.2 OUTLIER -124.49 129.39 50.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 168.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -121.86 120.33 34.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -175.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.3 tt -129.1 139.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 -163.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -106.6 129.62 24.16 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -62.0 -11.67 22.58 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 N-CA-C 120.683 3.301 . . . . 0.0 120.683 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.21 -50.34 61.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -161.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.8 t -89.91 -30.35 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.689 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -84.17 0.24 49.42 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 5.72 7.01 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.364 1.438 . . . . 0.0 113.671 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.333 95.5 m -98.98 167.99 10.42 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 164.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.65 -13.23 16.4 Favored 'Trans proline' 0 N--CA 1.482 0.824 0 N-CA-C 117.133 1.936 . . . . 0.0 117.133 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.13 -50.34 19.86 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -161.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.32 -30.04 68.01 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.156 0.889 . . . . 0.0 112.189 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.59 -50.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.758 -0.589 . . . . 0.0 111.036 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.61 -36.78 76.99 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.304 -0.873 . . . . 0.0 113.335 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -61.86 -50.12 73.51 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.496 ' HA ' HE21 ' A' ' 28' ' ' GLN . 12.3 t -66.53 -37.57 85.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.691 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.89 -31.21 72.34 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 170.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.15 67.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.607 1.094 . . . . 0.0 113.195 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.496 HE21 ' HA ' ' A' ' 25' ' ' THR . 35.0 mt-30 -56.39 -54.57 44.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.341 0.591 . . . . 0.0 111.185 171.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.48 -40.33 59.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.67 -50.02 9.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.2 p -60.77 -24.54 65.84 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -126.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.655 -0.653 . . . . 0.0 110.429 170.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -144.72 -9.15 0.63 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -168.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.61 110.46 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -98.78 146.7 25.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.632 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -88.7 100.36 13.06 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 123.374 1.559 . . . . 0.0 110.465 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -36.5 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 112.375 -2.193 . . . . 0.0 113.268 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -121.89 169.58 10.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.226 1.012 . . . . 0.0 111.377 -170.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -150.13 125.58 10.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.556 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.537 ' O ' HD23 ' A' ' 10' ' ' LEU . 30.4 m-85 -133.03 120.67 21.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.62 149.45 24.29 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 tp -63.63 -40.16 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -79.17 -30.28 43.43 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.746 . . . . 0.0 112.843 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -82.24 -24.92 34.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -40.41 71.4 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.434 1.015 . . . . 0.0 111.901 174.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -78.19 -27.66 47.98 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.96 -37.56 34.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.842 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.3 15.38 2.78 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 116.904 1.522 . . . . 0.0 116.904 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -75.62 -29.44 59.21 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.457 1.629 . . . . 0.0 114.612 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.58 120.16 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.8 m -124.45 120.2 31.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.762 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.5 mt -123.79 -163.44 1.14 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.87 171.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -98.79 169.84 9.18 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.923 1.344 . . . . 0.0 111.797 -166.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -90.21 94.62 9.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.426 170.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.65 -162.05 1.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -168.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -95.49 58.0 1.99 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.872 -170.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' THR . 3.9 m-85 -81.4 22.45 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 117.012 -1.47 . . . . 0.0 112.568 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.406 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 35.6 mt-10 -60.76 38.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -164.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.73 115.46 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 164.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.56 110.54 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.324 -157.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.37 106.55 16.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.982 -174.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.77 141.52 28.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 171.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.289 22.3 tp -123.53 115.11 20.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.867 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -149.27 154.35 38.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo . . . . . 0 CA--C 1.537 0.633 0 C-N-CA 122.559 2.172 . . . . 0.0 116.288 170.398 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 39.1 Cg_exo -82.12 149.67 15.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 CA-C-N 120.626 1.259 . . . . 0.0 110.332 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.62 -36.67 83.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -66.44 -26.08 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.87 -30.2 56.14 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.743 1.156 . . . . 0.0 111.106 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -39.14 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.935 1.243 . . . . 0.0 110.928 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.2 m -67.44 -40.99 85.47 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.321 -0.862 . . . . 0.0 112.586 176.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.91 -38.9 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.272 0.487 . . . . 0.0 112.266 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.86 -39.08 87.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.543 1.065 . . . . 0.0 112.381 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -29.65 70.67 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.23 -9.85 59.02 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.7 m -70.83 -36.43 72.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 165.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.83 159.77 18.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 123.02 1.391 . . . . 0.0 113.293 -153.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.02 101.76 0.68 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 112.02 -2.355 . . . . 0.0 105.329 162.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.17 11.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 N-CA-C 122.055 3.829 . . . . 0.0 122.055 -154.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -102.41 53.48 0.79 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.549 1.166 . . . . 0.0 108.165 162.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 58' ' ' GLU . . . -68.54 163.41 49.4 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 168.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 30.8 t -147.02 120.13 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.502 HD21 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -99.38 139.82 34.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.505 -168.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.63 90.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 167.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.55 -94.31 0.19 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 -160.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.502 HD12 HD21 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -116.44 169.9 8.96 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.919 -146.151 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -123.38 -115.74 0.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -156.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.26 -63.01 1.15 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -157.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -59.66 -27.95 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 124.373 2.035 . . . . 0.0 111.537 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.657 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 67.8 m-85 -76.82 -19.27 57.74 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.026 -170.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.23 -52.06 62.51 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.776 -1.202 . . . . 0.0 112.345 169.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.92 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.842 -0.536 . . . . 0.0 111.819 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.657 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.56 -43.22 97.52 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.34 -42.2 98.3 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.17 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.6 tp -55.88 -46.76 78.23 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 tt -79.95 -38.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.254 -171.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -71.98 1.93 6.45 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.66 43.63 96.11 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.774 -1.203 . . . . 0.0 114.048 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.562 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.5 m-85 -109.45 111.83 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 167.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -98.92 112.23 24.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 123.61 1.671 . . . . 0.0 108.107 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.581 HG13 ' CD1' ' A' ' 117' ' ' TRP 0.257 16.3 tt -83.59 156.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 112.057 -2.338 . . . . 0.0 112.619 -164.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.627 HG23 ' SG ' ' A' ' 116' ' ' CYS . 14.6 tt -147.21 128.32 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.843 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -102.66 98.32 8.38 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 123.282 1.515 . . . . 0.0 112.386 -167.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.16 171.61 8.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.056 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.47 -10.29 4.78 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 N-CA-C 119.295 2.767 . . . . 0.0 119.295 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -125.17 115.02 19.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 160.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.425 ' OH ' HD11 ' A' ' 109' ' ' ILE . 38.1 t80 -79.64 138.78 37.51 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.38 -163.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.627 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.289 5.4 p -146.26 120.89 9.79 Favored 'General case' 0 CA--C 1.55 0.955 1 N-CA-C 127.042 5.941 . . . . 0.0 127.042 -164.924 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.581 ' CD1' HG13 ' A' ' 109' ' ' ILE . 7.4 m0 -109.63 114.91 28.91 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.49 1.496 . . . . 0.0 109.229 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.3 OUTLIER -99.62 143.92 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -79.91 134.9 36.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.911 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 121.699 0.762 . . . . 0.0 109.846 170.455 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -84.34 141.79 30.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.687 0.756 . . . . 0.0 111.187 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.0 m -104.63 140.82 37.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.22 -156.69 7.95 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-O 123.86 1.811 . . . . 0.0 117.011 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.488 HD21 ' CD2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -134.54 142.37 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 111.472 -2.364 . . . . 0.0 109.704 -174.107 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 tp -124.21 133.23 53.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 162.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -120.14 120.29 35.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.442 174.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 16' ' ' THR . 16.1 tt -132.15 139.91 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -164.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -105.71 129.92 23.88 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -59.96 -12.37 18.62 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 N-CA-C 121.381 3.57 . . . . 0.0 121.381 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.33 -50.36 71.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -160.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.3 t -88.86 -28.92 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.491 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.411 ' HB ' HD11 ' A' ' 11' ' ' ILE . 47.7 p -79.05 0.3 28.39 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -170.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.1 m -76.62 0.74 19.09 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 119.575 1.079 . . . . 0.0 111.993 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 m -98.55 169.09 8.79 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 162.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -77.18 2.48 7.61 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 N-CA-C 120.676 3.299 . . . . 0.0 120.676 171.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.31 -50.93 16.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 121.212 1.824 . . . . 0.0 115.312 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.43 -31.6 70.03 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.558 -0.714 . . . . 0.0 112.56 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.88 -47.67 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.644 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.93 -33.27 75.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -64.74 -49.89 69.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.474 ' HA ' HE21 ' A' ' 28' ' ' GLN . 10.1 t -64.05 -41.75 97.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.321 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.7 -30.23 71.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.575 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -45.64 69.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.179 1.354 . . . . 0.0 113.511 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.4 mt-30 -56.52 -53.81 53.14 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.689 173.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.9 79.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.741 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.26 43.36 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.998 -0.439 . . . . 0.0 111.23 -170.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.2 p -73.32 -21.8 60.47 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.606 0.639 . . . . 0.0 111.568 -170.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.73 -113.44 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -157.41 17.36 0.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -168.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.87 152.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.3 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -128.39 135.02 48.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 165.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.75 100.56 13.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.816 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -21.22 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -167.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.98 121.47 37.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -167.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -114.2 124.28 51.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.089 0.947 . . . . 0.0 109.635 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CD2' HD21 ' A' ' 8' ' ' LEU . 22.2 m-30 -127.32 103.25 7.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.528 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 43' ' ' ASN . 8.0 tt -84.97 149.79 25.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.03 -39.94 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' H ' HD23 ' A' ' 41' ' ' LEU . 36.8 t30 -78.57 -30.13 46.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.64 -29.59 33.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.25 0.932 . . . . 0.0 113.19 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -40.51 54.71 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.38 0.991 . . . . 0.0 112.084 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -69.56 -28.23 65.81 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.34 -41.84 24.05 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.6 15.27 8.9 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.301 1.28 . . . . 0.0 116.301 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 m -73.38 -8.27 55.15 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 119.499 1.649 . . . . 0.0 115.45 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.9 mt -114.72 121.82 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.976 -0.452 . . . . 0.0 109.99 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.7 m -98.48 120.66 39.28 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.199 1.952 . . . . 0.0 108.978 -172.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.267 63.4 tp -96.73 149.54 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 110.752 -2.931 . . . . 0.0 111.591 -161.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.42 169.79 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.667 166.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -120.1 44.42 2.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -166.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -73.1 0.07 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 119.446 3.128 . . . . 0.0 119.446 -166.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -81.71 30.53 0.37 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -157.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 59' ' ' THR . 0.6 OUTLIER -112.22 21.27 15.99 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 117.659 -1.162 . . . . 0.0 112.621 -170.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.82 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 -166.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.09 115.5 6.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 169.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 24.4 t -119.33 134.34 63.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.706 -165.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -122.58 134.6 54.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.44 142.45 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.77 102.37 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -137.23 113.86 9.68 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 CA--C 1.534 0.516 0 C-N-CA 122.733 2.289 . . . . 0.0 114.974 170.335 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 8.2 t80 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.551 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -55.77 149.66 49.14 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.806 1.671 . . . . 0.0 112.887 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.52 -34.74 77.5 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -31.45 67.88 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.81 -30.06 56.23 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.113 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.62 -35.45 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 119.769 1.168 . . . . 0.0 111.614 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.3 p -69.12 -36.83 77.94 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.21 1.368 . . . . 0.0 112.967 173.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.08 -37.42 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.815 -0.553 . . . . 0.0 111.902 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -59.96 -46.07 90.62 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.819 -0.551 . . . . 0.0 112.042 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.0 70.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -73.62 -9.99 59.24 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 m -106.87 30.22 6.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -134.07 162.52 31.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.044 0.926 . . . . 0.0 109.846 -169.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 174.97 2.31 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -58.52 -12.4 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 118.455 2.444 . . . . 0.0 118.455 -170.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -102.0 46.76 0.92 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.943 0.792 . . . . 0.0 110.676 170.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.31 140.58 24.75 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.5 t -146.3 106.27 4.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.17 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.259 3.1 tt -89.91 129.92 36.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -175.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.001 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 27.2 mm -104.42 91.11 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 122.337 1.065 . . . . 0.0 108.31 170.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.76 -95.13 0.2 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 120.745 3.058 . . . . 0.0 120.745 -162.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.453 HD22 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.5 169.62 9.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.017 -1.473 . . . . 0.0 109.464 -142.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -118.26 -118.07 0.32 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -158.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.09 -54.24 8.23 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -156.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -61.0 -29.33 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 124.548 2.118 . . . . 0.0 111.294 170.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.72 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.1 m-85 -76.78 -9.41 58.65 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.291 -1.777 . . . . 0.0 112.03 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -63.95 -56.05 17.99 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.295 -0.878 . . . . 0.0 111.468 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.84 -31.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 122.188 -0.32 . . . . 0.0 111.513 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.72 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.89 -46.5 87.56 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.539 -0.725 . . . . 0.0 112.451 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -54.9 -41.8 71.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.088 0.404 . . . . 0.0 111.777 173.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.6 tp -63.19 -45.14 93.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.6 mt -80.08 -34.95 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -71.75 -15.5 62.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 27.88 6.12 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.589 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 97.4 m-85 -106.52 159.6 16.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 172.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -118.71 154.13 33.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 161.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.685 HG12 ' CD1' ' A' ' 117' ' ' TRP . 22.5 mt -103.89 148.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 122.994 1.378 . . . . 0.0 109.282 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.82 123.11 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.891 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -115.48 100.18 7.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.942 1.829 . . . . 0.0 110.913 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -134.22 -178.54 0.88 Allowed Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 111.215 -2.72 . . . . 0.0 106.194 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.52 -7.14 1.2 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -135.07 115.27 13.28 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 161.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -86.77 115.02 23.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.296 -167.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.17 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 27.9 p -147.6 -158.62 0.93 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 122.674 1.226 . . . . 0.0 114.099 167.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.685 ' CD1' HG12 ' A' ' 109' ' ' ILE . 5.9 m0 -137.31 130.36 30.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.452 -1.703 . . . . 0.0 106.438 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.89 144.0 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 122.708 1.242 . . . . 0.0 108.276 167.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 76.4 tttt -87.16 110.39 20.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.797 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.499 0.666 . . . . 0.0 112.14 170.384 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.0 t80 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.1 141.94 28.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.218 1.008 . . . . 0.0 111.831 -165.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -94.44 141.77 28.21 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 166.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.53 -158.32 8.64 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 119.369 -1.396 . . . . 0.0 114.625 169.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.48 139.95 45.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.307 0.0 OUTLIER -124.38 129.35 50.54 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 174.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.44 120.23 40.95 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.4 mt -124.81 139.98 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.636 -171.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -98.69 129.77 29.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 160.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -60.96 -11.99 20.59 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 N-CA-C 121.75 3.711 . . . . 0.0 121.75 -170.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.29 74.52 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -159.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 65' ' ' PRO . 44.8 t -96.32 -29.83 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 119.29 0.95 . . . . 0.0 111.81 170.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 p -65.21 0.03 1.54 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -76.3 -10.32 59.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.118 1.781 . . . . 0.0 112.077 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.317 92.5 m -98.8 167.98 10.49 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 163.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.87 -3.17 13.27 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 N-CA-C 117.674 2.144 . . . . 0.0 117.674 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.96 -50.42 20.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.428 1.467 . . . . 0.0 114.521 -161.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.2 -32.46 71.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.429 -0.794 . . . . 0.0 112.585 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.49 -47.79 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.504 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.45 -47.3 70.57 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.3 m -58.89 -46.23 88.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.938 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.1 mmmt -60.92 -29.94 69.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.33 74.36 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.203 1.365 . . . . 0.0 113.488 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -60.0 -54.05 50.67 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.039 0.447 . . . . 0.0 111.401 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.06 45.77 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.94 -45.67 11.27 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.8 p -58.02 -34.19 69.78 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.92 -113.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -170.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 38.0 tptt -137.88 -13.1 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.532 -170.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 59' ' ' THR . 3.3 p -117.26 110.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -170.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -98.65 139.58 34.15 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.218 1.009 . . . . 0.0 108.887 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.58 139.75 30.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.34 -30.05 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -160.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -121.61 169.88 10.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.782 1.277 . . . . 0.0 109.015 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -143.82 125.1 14.63 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.24 -1.346 . . . . 0.0 108.846 -169.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -125.87 113.84 17.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.873 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -86.8 149.93 24.5 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -40.03 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -79.93 -30.25 39.92 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -79.75 -32.54 41.06 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.356 -0.84 . . . . 0.0 113.009 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -73.61 -40.62 63.69 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.969 0.804 . . . . 0.0 112.844 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -70.55 -26.12 63.4 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.799 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.26 -42.28 16.03 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 119.106 -0.473 . . . . 0.0 112.149 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.76 15.44 2.63 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 169.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -76.21 -19.45 58.38 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.086 1.943 . . . . 0.0 115.103 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.62 121.85 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.0 t -98.96 159.38 15.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 125.249 2.452 . . . . 0.0 111.403 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.32 120.98 43.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.588 -3.46 . . . . 0.0 111.142 -158.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -98.16 169.17 9.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.552 162.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -120.55 52.67 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -159.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -86.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 6' ' ' THR . 95.4 mttt -100.04 57.45 0.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.017 0.913 . . . . 0.0 113.39 -158.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' THR . 4.4 m-85 -112.1 21.14 16.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.323 169.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.91 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -161.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.515 HG21 HG21 ' A' ' 34' ' ' VAL . 14.6 t -137.41 115.43 11.57 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 161.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -117.42 101.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 -164.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -97.83 134.4 41.03 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.66 110.31 18.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.377 1.084 . . . . 0.0 109.193 174.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.7 mt -98.73 102.06 13.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.412 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.0 m -122.36 94.77 47.6 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HG2' ' H ' ' A' ' 15' ' ' VAL . 60.7 Cg_endo . . . . . 0 CA--C 1.538 0.681 0 C-N-CA 122.216 1.944 . . . . 0.0 112.853 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 32.3 Cg_exo -81.88 149.44 15.9 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 CA-C-N 120.894 1.355 . . . . 0.0 110.741 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -62.6 -40.35 96.67 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.5 -32.27 68.66 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -76.7 -30.26 56.62 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.742 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.42 -35.09 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 119.817 1.189 . . . . 0.0 111.554 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -70.25 -36.79 74.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.288 1.403 . . . . 0.0 112.884 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.56 -39.22 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 121.668 -0.645 . . . . 0.0 111.597 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -60.04 -46.2 90.29 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.814 -0.554 . . . . 0.0 112.073 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.92 70.35 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.85 -32.0 72.21 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -167.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.5 p -92.68 33.27 1.14 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.6 mt -134.16 175.49 9.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.619 1.199 . . . . 0.0 111.818 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -116.32 175.06 2.09 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.66 -25.98 21.73 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 N-CA-C 119.103 2.694 . . . . 0.0 119.103 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -102.27 51.15 0.82 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.68 1.582 . . . . 0.0 110.454 169.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.23 142.92 30.01 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.2 p -144.16 105.88 4.3 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.211 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.366 0.3 OUTLIER -89.68 129.65 36.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.084 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.022 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 39.9 mm -112.44 91.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.11 0.957 . . . . 0.0 109.699 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.09 -86.41 0.08 OUTLIER Glycine 0 C--N 1.315 -0.607 0 N-CA-C 120.902 3.121 . . . . 0.0 120.902 -171.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.602 HD12 HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -116.18 169.77 9.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 -137.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 t -108.66 -131.79 0.31 Allowed 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.87 -1.144 . . . . 0.0 112.819 -156.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -80.0 -49.42 11.85 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -158.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -58.69 -30.23 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 124.33 2.014 . . . . 0.0 112.984 168.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.4 m-85 -76.46 -14.99 60.02 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 113.167 -1.833 . . . . 0.0 110.453 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.4 tttt -58.5 -50.67 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.194 -0.941 . . . . 0.0 112.316 165.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.83 -36.82 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.786 -0.571 . . . . 0.0 111.202 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.58 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.97 -43.89 94.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.83 97.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.458 0.647 . . . . 0.0 111.796 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.73 -47.82 83.3 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.467 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.5 mt -76.35 -35.18 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.055 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -71.85 -19.97 61.89 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 33.31 4.09 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.884 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 98.0 m-85 -106.67 159.83 15.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.28 1.038 . . . . 0.0 108.28 168.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.56 106.39 10.55 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.651 HG13 ' CD1' ' A' ' 117' ' ' TRP . 16.8 tt -75.32 144.97 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 122.371 1.081 . . . . 0.0 112.05 -169.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.18 129.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.669 1.223 . . . . 0.0 108.635 -173.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -96.83 99.98 11.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.328 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.86 173.92 2.71 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.139 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -54.9 -14.28 7.76 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 118.966 2.641 . . . . 0.0 118.966 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -130.0 115.22 16.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 153.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.46 139.01 32.49 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.604 -164.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.211 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 12.0 p -147.77 -155.02 0.59 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 123.209 1.481 . . . . 0.0 111.731 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.651 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.7 m0 -137.13 130.11 30.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.69 144.22 19.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.529 1.157 . . . . 0.0 108.299 171.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.31 134.63 36.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.169 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.469 0.521 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.594 170.362 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -111.59 141.82 44.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.216 1.484 . . . . 0.0 112.155 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -105.06 120.87 42.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 112.466 -2.152 . . . . 0.0 105.79 165.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.91 -161.95 10.27 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 119.465 -1.35 . . . . 0.0 116.255 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.532 HD21 ' CE2' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -134.24 139.27 45.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.182 -1.009 . . . . 0.0 108.69 -165.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.99 134.65 52.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.341 1.067 . . . . 0.0 108.558 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -113.02 120.55 41.75 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.512 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.35 140.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -97.77 129.73 30.65 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 163.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -63.17 -10.59 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 N-CA-C 120.441 3.208 . . . . 0.0 120.441 -170.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.92 -50.26 62.95 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 -162.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.5 t -84.88 -30.14 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.553 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -81.91 0.21 40.79 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -170.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 93.6 m -76.32 -6.24 50.63 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 120.056 1.298 . . . . 0.0 111.537 164.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 m -113.19 71.48 1.46 Allowed Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.69 58.74 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.964 3.109 . . . . 0.0 115.971 -155.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.36 -50.15 23.5 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.59 -1.319 . . . . 0.0 111.751 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 -29.89 70.93 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.69 0.677 . . . . 0.0 112.348 176.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.95 -49.98 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.857 -0.527 . . . . 0.0 111.403 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.89 -36.58 77.25 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.294 -0.879 . . . . 0.0 113.298 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -63.1 -49.45 74.39 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.539 ' HA ' HE21 ' A' ' 28' ' ' GLN . 8.7 t -64.82 -38.01 89.56 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.198 0.908 . . . . 0.0 111.597 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -62.39 -35.22 78.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 169.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.45 72.08 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.441 1.019 . . . . 0.0 113.489 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.539 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.5 mt-30 -59.49 -53.84 53.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.867 0.365 . . . . 0.0 111.6 174.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -57.15 -39.87 76.09 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.83 -46.99 15.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -170.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 98.1 p -57.96 -20.55 38.68 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.74 -105.08 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.737 -0.602 . . . . 0.0 109.521 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -150.39 15.53 0.8 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -170.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.438 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 22.8 t -126.65 110.63 23.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.509 -168.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.33 134.94 41.46 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 165.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -89.06 139.72 30.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.26 -26.05 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -163.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.69 121.36 37.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -113.98 118.24 33.58 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.812 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 8' ' ' LEU . 13.0 m-30 -121.97 106.14 10.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.812 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.73 149.76 25.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -63.25 -40.07 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -76.65 -30.24 56.74 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.96 -31.8 34.71 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.69 -40.39 69.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.551 1.069 . . . . 0.0 112.346 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.79 -18.55 61.47 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.14 -38.8 16.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.496 -0.752 . . . . 0.0 111.882 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.32 15.24 7.78 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.4 m -79.11 -3.3 44.75 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -171.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -114.72 169.55 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.588 -0.695 . . . . 0.0 109.369 -163.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -99.91 158.54 15.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.629 1.681 . . . . 0.0 109.515 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.4 150.08 52.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.312 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.3 169.52 16.35 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 160.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -120.59 46.33 2.02 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -82.25 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 6' ' ' THR . 65.9 mttm -100.2 63.46 1.15 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.888 0.851 . . . . 0.0 111.94 -161.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' THR . 17.9 m-85 -112.25 21.59 15.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 117.138 -1.411 . . . . 0.0 112.666 167.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -61.74 31.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -158.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 57' ' ' TYR . 8.4 t -135.85 115.36 12.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 162.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 83.6 t -115.81 110.33 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -164.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.86 134.56 49.82 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 142.04 46.32 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 162.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.94 104.53 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 170.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.7 m -143.7 120.16 6.52 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.536 0.61 0 C-N-CA 122.413 2.076 . . . . 0.0 113.507 170.095 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 30.9 t80 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 23.0 Cg_exo -82.24 149.98 15.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 121.087 1.191 . . . . 0.0 111.581 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -62.33 -33.91 75.61 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.71 -30.37 71.04 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -76.62 -30.18 56.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.177 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.413 HG13 ' CE2' ' A' ' 73' ' ' PHE . 97.1 mt -61.39 -36.99 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 119.741 1.155 . . . . 0.0 111.242 166.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.4 m -64.17 -40.95 97.2 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.07 1.304 . . . . 0.0 112.448 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.08 -43.49 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.15 -37.81 88.69 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.363 -0.836 . . . . 0.0 112.914 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.86 -29.7 70.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.91 -10.4 59.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 77.3 p -104.27 11.35 34.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.21 101.49 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -165.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HB3' ' HD2' ' A' ' 87' ' ' PRO 0.257 54.1 mttp -74.19 -160.35 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.482 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.523 170.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 8.2 Cg_endo -54.21 -42.26 68.85 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 N-CA-C 120.611 3.273 . . . . 0.0 120.611 -155.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -102.11 43.31 1.08 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 121.348 1.886 . . . . 0.0 110.93 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.84 140.09 37.71 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 167.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 42.5 t -138.8 158.28 44.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 116.994 -1.882 . . . . 0.0 106.925 166.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.594 HD21 HD12 ' A' ' 94' ' ' LEU . 2.0 tt -129.01 105.26 8.08 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.038 -162.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -106.37 81.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.65 -82.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 120.627 3.011 . . . . 0.0 120.627 -155.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.594 HD12 HD21 ' A' ' 91' ' ' LEU . 2.1 mt -116.22 170.6 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -147.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -110.12 -136.05 0.36 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -157.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.31 -47.82 19.0 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -161.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.62 -29.57 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 124.371 2.034 . . . . 0.0 111.236 171.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.484 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 13.7 m-85 -76.58 -16.41 59.6 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.359 -172.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.0 tttt -56.95 -52.4 65.36 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.282 -0.886 . . . . 0.0 112.871 168.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.63 -36.14 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.858 -0.526 . . . . 0.0 111.09 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.29 -44.11 97.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.06 81.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.211 0.529 . . . . 0.0 112.408 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.28 -44.76 95.79 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 99.0 mt -80.05 -33.71 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.256 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -71.94 -18.47 62.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.77 31.13 4.94 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.668 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 85.9 m-85 -106.9 159.97 15.86 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -131.01 111.46 12.04 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.589 HG13 ' CD1' ' A' ' 117' ' ' TRP . 14.1 tt -90.71 153.25 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 122.739 1.257 . . . . 0.0 112.578 -166.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.597 HG23 ' SG ' ' A' ' 116' ' ' CYS . 17.0 tt -154.04 130.38 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.193 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -93.45 98.86 11.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 123.243 1.497 . . . . 0.0 110.698 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -109.58 177.84 1.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.785 -2.007 . . . . 0.0 108.469 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -55.61 -14.28 9.8 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 119.041 2.67 . . . . 0.0 119.041 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -118.1 149.56 40.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 154.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.453 ' HE2' ' HE1' ' A' ' 117' ' ' TRP . 22.5 t80 -86.45 139.23 31.11 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 120.774 -1.204 . . . . 0.0 108.997 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.597 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.356 28.1 p -146.11 120.59 9.7 Favored 'General case' 0 CA--C 1.553 1.093 1 N-CA-C 129.216 6.747 . . . . 0.0 129.216 -173.684 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.589 ' CD1' HG13 ' A' ' 109' ' ' ILE . 8.2 m0 -109.75 117.51 34.07 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.422 1.464 . . . . 0.0 109.178 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -107.68 144.38 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.855 -1.153 . . . . 0.0 109.443 172.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -79.7 110.49 15.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.612 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.641 0.734 . . . . 0.0 109.173 -170.343 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.2 t80 . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.98 141.65 51.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.58 1.181 . . . . 0.0 110.945 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.8 t -94.34 120.78 35.09 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.09 -161.69 11.46 Favored Glycine 0 N--CA 1.466 0.666 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.586 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -134.04 139.77 46.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.672 -1.764 . . . . 0.0 107.4 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.6 tp -124.29 129.83 51.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.647 1.213 . . . . 0.0 108.805 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 mp -115.1 120.37 39.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.59 -1.641 . . . . 0.0 107.051 171.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 tt -128.72 140.0 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.28 0.562 . . . . 0.0 109.737 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -102.7 129.75 25.24 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.14 -13.46 31.98 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 N-CA-C 120.462 3.216 . . . . 0.0 120.462 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.13 -50.21 56.11 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -161.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.07 -30.12 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.273 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.4 p -80.77 0.14 36.06 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -76.35 3.72 10.42 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.034 1.288 . . . . 0.0 112.49 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 m -113.48 71.64 1.69 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 43.51 0.78 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.768 2.978 . . . . 0.0 116.255 -153.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.22 -40.34 90.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.418 -0.801 . . . . 0.0 112.226 163.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mp -62.26 -29.89 70.73 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.03 -50.06 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.115 -0.366 . . . . 0.0 110.779 173.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -47.43 56.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -61.75 -40.61 95.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.081 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -62.29 -38.59 89.95 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 169.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.31 78.08 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.942 1.246 . . . . 0.0 113.807 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -56.9 -56.38 22.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -64.63 -38.71 91.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.84 -37.63 34.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -170.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -57.8 -27.7 63.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.806 1.185 . . . . 0.0 113.778 170.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.93 -119.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -153.28 40.5 0.53 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 124.317 2.008 . . . . 0.0 111.946 -170.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.481 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 59.6 t -131.04 110.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 111.183 -2.735 . . . . 0.0 108.7 170.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.09 141.87 35.88 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 167.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -88.7 139.64 30.26 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.6 t -108.91 -36.64 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.468 -166.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -121.85 169.93 10.28 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.881 1.324 . . . . 0.0 111.309 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -135.8 125.16 24.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.635 -1.621 . . . . 0.0 108.248 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -124.15 120.26 31.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.973 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.31 149.38 21.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.403 HD13 ' OH ' ' A' ' 62' ' ' TYR . 2.9 tp -63.5 -40.19 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -78.88 -30.33 44.89 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.5 -0.75 . . . . 0.0 112.92 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -80.3 -32.42 38.04 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.547 -0.721 . . . . 0.0 112.721 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.65 -40.43 80.23 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.457 -0.777 . . . . 0.0 111.89 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -78.06 -30.9 50.01 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.89 -36.75 36.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.848 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.89 15.31 2.9 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 170.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -78.06 -26.44 48.27 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.24 1.52 . . . . 0.0 114.456 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.61 120.24 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.8 m -126.87 120.12 28.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.633 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.08 -166.88 1.35 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.57 170.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -98.84 169.91 9.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.586 1.184 . . . . 0.0 110.056 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 76.9 m-20 -77.13 97.56 4.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.587 170.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.33 -151.18 0.43 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -166.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -100.08 31.73 3.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -162.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.5 m-85 -81.86 21.51 0.85 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.373 -170.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.38 35.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -166.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.62 115.45 8.25 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 163.706 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 68.4 t -118.62 134.48 62.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.237 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -122.61 134.77 54.5 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.403 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -116.72 110.89 19.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 169.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.35 102.02 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.63 1.205 . . . . 0.0 111.466 170.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -132.82 154.95 81.63 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo . . . . . 0 CA--C 1.534 0.496 0 C-N-CA 122.344 2.03 . . . . 0.0 115.816 170.749 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 11.6 t80 . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 30.7 Cg_exo -82.02 149.54 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 CA-C-N 120.505 1.216 . . . . 0.0 110.456 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.68 -36.59 83.41 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.09 -32.9 72.55 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.61 -30.32 56.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.833 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.98 -34.9 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 119.954 1.252 . . . . 0.0 111.459 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.2 m -68.34 -39.16 82.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.893 1.224 . . . . 0.0 112.62 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.91 -37.54 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.947 -0.47 . . . . 0.0 111.774 174.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.04 -47.8 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.81 -0.556 . . . . 0.0 111.956 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.33 -30.06 70.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.21 -9.86 59.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 29.7 p -71.12 -35.25 71.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.05 167.05 14.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 123.16 1.457 . . . . 0.0 114.2 -150.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.73 101.89 0.57 Allowed Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.483 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -50.93 -6.98 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 N-CA-C 120.707 3.311 . . . . 0.0 120.707 -153.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -88.96 55.03 3.19 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.769 1.622 . . . . 0.0 108.809 160.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.23 157.89 28.48 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.1 p -128.05 159.17 35.9 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.274 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -127.56 142.7 51.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.542 -2.117 . . . . 0.0 106.141 -173.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.047 HD13 ' SG ' ' A' ' 116' ' ' CYS . 46.7 mm -129.04 89.1 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 170.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.97 -88.43 0.09 OUTLIER Glycine 0 C--N 1.318 -0.472 0 N-CA-C 121.587 3.395 . . . . 0.0 121.587 -166.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 91' ' ' LEU . 3.3 mt -116.37 146.85 42.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.617 1.199 . . . . 0.0 109.513 -130.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.7 p -86.36 -136.68 0.08 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.526 -158.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.69 -50.5 13.51 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -156.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.22 -32.5 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 124.789 2.233 . . . . 0.0 113.015 170.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.0 m-85 -76.63 -14.89 59.95 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.737 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -59.08 -55.82 30.2 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.079 -1.013 . . . . 0.0 111.951 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.07 -34.85 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.897 -0.502 . . . . 0.0 111.49 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.01 -40.93 90.96 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 171.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.406 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . . . -58.89 -43.59 90.98 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.912 -0.492 . . . . 0.0 111.741 173.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.98 -49.45 71.39 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.702 0.763 . . . . 0.0 112.543 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.3 tt -80.24 -33.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.594 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -71.72 -19.71 62.01 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.96 33.28 4.09 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 119.607 -1.282 . . . . 0.0 112.597 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.503 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 95.8 m-85 -106.48 159.65 16.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 168.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -126.13 103.88 7.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.593 HG13 ' CD1' ' A' ' 117' ' ' TRP . 18.0 tt -76.15 140.69 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 122.882 1.325 . . . . 0.0 111.316 -168.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.45 119.02 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -106.56 94.55 5.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.598 1.666 . . . . 0.0 110.642 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -134.1 179.17 1.45 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 112.496 -2.138 . . . . 0.0 106.737 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.83 -11.53 3.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 118.654 2.521 . . . . 0.0 118.654 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -122.83 111.51 16.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 157.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.09 110.26 21.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.393 -0.813 . . . . 0.0 109.23 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.274 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 26.3 p -147.75 -157.03 0.77 Allowed 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 122.808 1.29 . . . . 0.0 113.65 170.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.593 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.5 m0 -137.33 130.42 30.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.618 -170.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -112.86 144.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.276 -1.515 . . . . 0.0 110.294 166.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.77 110.49 15.17 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.375 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.47 0.552 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.344 -170.321 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.37 141.96 27.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.65 0.738 . . . . 0.0 110.839 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -95.74 141.42 29.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 162.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.76 -160.12 9.22 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-O 124.132 1.962 . . . . 0.0 115.205 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.452 HD21 ' CE2' ' A' ' 40' ' ' PHE . 3.8 mt -134.2 139.67 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.4 -2.4 . . . . 0.0 107.751 -174.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.41 130.01 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.817 1.294 . . . . 0.0 107.839 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.425 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 8.7 mp -113.85 120.34 40.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.719 175.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.2 mt -121.3 139.9 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -171.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -94.11 129.77 36.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 165.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -60.68 -16.43 43.35 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 N-CA-C 121.056 3.444 . . . . 0.0 121.056 -170.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.78 72.49 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.317 1.417 . . . . 0.0 113.111 -162.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.02 -29.93 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.6 p -86.12 0.47 53.46 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -170.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -76.29 0.35 19.63 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 120.674 1.579 . . . . 0.0 112.601 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.322 90.8 m -98.87 168.09 10.29 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 162.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.74 -7.26 16.54 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 N-CA-C 117.837 2.206 . . . . 0.0 117.837 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.17 -50.48 19.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -159.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.29 -29.83 67.78 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.468 1.031 . . . . 0.0 112.579 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 t -66.26 -49.99 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.982 -0.449 . . . . 0.0 110.513 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.4 -39.73 88.4 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.982 -1.074 . . . . 0.0 113.29 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -59.87 -50.32 74.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 t -68.47 -34.51 76.07 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.615 -0.678 . . . . 0.0 111.698 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.27 -29.96 69.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 170.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.03 -47.09 66.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.482 1.037 . . . . 0.0 112.288 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.75 -48.72 77.19 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.97 60.64 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.549 169.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.29 70.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.2 -170.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -75.34 -19.53 59.56 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.1 -111.0 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.771 -0.581 . . . . 0.0 111.255 170.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -149.48 -10.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -166.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -98.98 149.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 121.592 -0.692 . . . . 0.0 112.402 170.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -128.29 143.9 51.07 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 164.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -92.54 139.84 30.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.754 0.788 . . . . 0.0 109.453 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.36 -32.69 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -121.62 169.98 10.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.292 1.52 . . . . 0.0 109.961 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -139.8 125.18 19.02 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.687 -172.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.452 ' CE2' HD21 ' A' ' 8' ' ' LEU . 21.4 m-30 -129.49 106.42 8.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -84.92 149.57 25.56 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.45 -0.781 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 tp -63.33 -40.11 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.12 -30.35 34.57 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.576 -0.702 . . . . 0.0 112.823 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -79.03 -31.59 44.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.122 -0.987 . . . . 0.0 112.789 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -72.6 -40.59 66.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.604 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.14 -15.29 58.98 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.978 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.34 -43.41 11.54 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.26 -0.9 . . . . 0.0 111.989 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.99 15.3 2.35 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -76.05 -25.58 55.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.638 1.719 . . . . 0.0 114.575 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.7 121.7 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -169.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -98.76 159.28 15.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 124.344 2.021 . . . . 0.0 109.349 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -130.91 120.74 24.03 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.028 -153.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.79 169.67 9.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.043 168.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -111.13 88.55 2.81 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.5 -158.81 0.9 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -164.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -90.99 35.07 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.779 -1.555 . . . . 0.0 115.052 -163.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.3 m-85 -82.03 21.84 0.85 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.374 -170.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.55 37.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -163.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' TYR . 1.0 OUTLIER -141.22 115.4 9.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 163.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 18.7 t -118.61 134.51 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.633 -1.622 . . . . 0.0 106.743 -164.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -122.84 134.71 54.39 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.76 110.52 16.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.4 mt -98.05 100.7 12.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.451 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -126.2 92.45 45.66 Favored Pre-proline 0 N--CA 1.474 0.752 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 167.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.536 0.622 0 C-N-CA 122.077 1.851 . . . . 0.0 111.994 170.382 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 16.4 t80 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 30.3 Cg_exo -82.14 149.47 15.41 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 120.617 1.256 . . . . 0.0 110.242 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.54 -38.01 88.33 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.89 -35.15 70.6 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 mt -76.62 -30.26 56.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.51 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.05 -36.17 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 119.899 1.227 . . . . 0.0 111.429 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.8 m -68.62 -39.17 80.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.544 1.066 . . . . 0.0 112.814 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -36.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.992 -0.443 . . . . 0.0 111.855 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.7 -46.44 90.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.743 -0.598 . . . . 0.0 111.849 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.86 70.21 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.33 -10.15 59.55 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -169.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.0 m -76.17 -34.64 59.35 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 168.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.83 176.5 6.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 123.998 1.856 . . . . 0.0 114.885 -148.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 88' ' ' ASN . 29.3 tptp -105.06 101.57 30.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 -170.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -51.34 16.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.384 1 N-CA-C 122.903 4.155 . . . . 0.0 122.903 -153.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 86' ' ' LYS . 28.5 m120 -102.05 61.37 0.87 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 156.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.47 137.39 13.23 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.1 p -134.08 109.45 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.644 1.212 . . . . 0.0 107.884 -169.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.242 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.28 6.2 tt -93.38 132.25 37.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.813 -174.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.006 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 37.0 mm -115.68 84.94 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -170.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.88 -87.2 0.09 OUTLIER Glycine 0 C--N 1.315 -0.593 0 N-CA-C 121.168 3.227 . . . . 0.0 121.168 -163.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.88 169.85 8.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.169 -139.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.468 ' H ' ' HD2' ' A' ' 98' ' ' TYR . 43.0 m -105.35 -155.32 0.54 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.282 -0.886 . . . . 0.0 112.37 -157.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.95 -42.98 84.32 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -163.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -59.8 -33.15 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 124.3 2.0 . . . . 0.0 112.545 169.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.468 ' HD2' ' H ' ' A' ' 95' ' ' SER . 32.0 m-85 -76.54 -12.85 60.09 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.785 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.4 tttt -62.81 -48.29 79.73 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.065 -1.022 . . . . 0.0 112.404 165.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.69 -38.33 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.489 -0.757 . . . . 0.0 110.714 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.34 -48.45 81.7 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 170.366 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.99 -41.58 71.4 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.56 -47.48 83.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.8 mt -77.16 -35.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.038 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -71.97 -16.74 62.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.84 29.93 5.36 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.947 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.3 m-85 -106.92 159.7 16.07 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.768 1.27 . . . . 0.0 108.809 173.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.59 109.52 11.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.36 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.62 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -85.63 111.15 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.905 1.336 . . . . 0.0 114.082 -164.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 19.0 tt -119.51 135.07 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.231 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -119.64 97.28 5.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.911 -168.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -117.31 -177.42 0.45 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 112.606 -2.088 . . . . 0.0 107.582 164.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.4 -11.11 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 N-CA-C 118.948 2.634 . . . . 0.0 118.948 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -103.95 113.31 26.75 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 154.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.505 ' OH ' HD11 ' A' ' 109' ' ' ILE . 28.5 t80 -80.12 115.16 19.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.612 170.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.242 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 24.4 p -147.35 -156.86 0.75 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.168 1.461 . . . . 0.0 112.343 166.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.62 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.4 m0 -132.58 149.66 52.28 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -174.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.58 144.18 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 122.983 1.373 . . . . 0.0 108.586 165.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.69 110.19 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.928 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.156 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -88.89 141.8 28.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.016 0.912 . . . . 0.0 110.706 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.46 141.64 30.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 160.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.79 -168.25 11.78 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-O 123.964 1.869 . . . . 0.0 117.052 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.444 HD11 ' CE2' ' A' ' 40' ' ' PHE . 30.1 tp -134.39 115.14 13.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 111.215 -2.493 . . . . 0.0 106.213 -165.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 129.19 54.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.35 148.88 32.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.908 1.337 . . . . 0.0 108.646 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.8 mt -133.7 111.63 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.651 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -87.07 129.52 51.64 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -59.97 -19.74 56.89 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 N-CA-C 121.008 3.426 . . . . 0.0 121.008 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.44 74.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.685 1.13 . . . . 0.0 113.197 -162.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.59 -27.6 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -171.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.7 p -86.1 0.39 53.63 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -170.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.3 m -76.4 -0.26 22.13 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 120.681 1.582 . . . . 0.0 111.738 168.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 m -108.96 71.6 0.44 Allowed Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 43.86 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.088 3.192 . . . . 0.0 116.421 -153.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.39 -39.6 92.41 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.579 -0.701 . . . . 0.0 112.138 162.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.31 -30.72 68.56 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.11 -48.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 122.341 -0.224 . . . . 0.0 110.907 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.47 -33.07 74.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.9 -48.39 37.62 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -61.45 -42.58 98.98 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.523 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -65.52 -32.92 74.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.145 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.59 78.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.069 1.304 . . . . 0.0 113.177 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.0 -55.49 30.29 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.67 87.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.64 70.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -170.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.8 m -58.09 -28.67 64.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 170.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -85.84 -101.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.85 -0.531 . . . . 0.0 109.967 -170.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -147.26 27.72 1.02 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -131.05 110.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.978 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.4 139.46 37.03 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.072 -1.017 . . . . 0.0 108.989 168.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -88.99 139.84 30.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.83 -33.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.876 -166.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -121.82 169.58 10.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.684 1.23 . . . . 0.0 108.906 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -126.64 154.64 43.74 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.444 ' CE2' HD11 ' A' ' 8' ' ' LEU . 14.3 m-30 -136.12 112.93 10.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.7 149.24 25.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -63.47 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.79 -30.31 40.58 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.49 -29.68 30.39 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.099 -1.001 . . . . 0.0 113.113 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.89 -40.35 72.27 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.892 . . . . 0.0 111.874 174.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -73.37 -18.82 61.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.09 -46.41 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.291 -0.881 . . . . 0.0 112.1 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.74 15.15 1.41 Allowed Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -77.53 -10.55 59.55 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.024 1.912 . . . . 0.0 115.645 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.78 121.36 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.692 -0.63 . . . . 0.0 109.671 -169.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -98.97 120.29 39.17 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 123.814 1.769 . . . . 0.0 109.776 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -119.1 120.84 38.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.76 -158.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.5 169.57 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.472 1.129 . . . . 0.0 109.39 167.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -110.14 88.35 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.85 -119.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -100.09 56.89 0.95 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -156.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -112.05 10.73 20.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 85' ' ' LEU 0.253 19.3 mt-10 -78.75 46.55 0.67 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.944 2.611 . . . . 0.0 112.542 -170.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.99 108.85 17.92 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 150.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.61 110.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.54 -2.118 . . . . 0.0 107.894 -155.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -115.05 105.33 12.83 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 -174.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.83 141.97 28.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 119.819 -1.801 . . . . 0.0 109.498 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -124.06 80.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.481 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -134.06 81.9 49.94 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.94 1.7 . . . . 0.0 111.367 -170.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 CA--C 1.538 0.677 0 C-N-CA 121.993 1.795 . . . . 0.0 110.267 169.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 5.8 t80 . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 23.2 Cg_exo -82.27 149.63 15.19 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 120.046 1.052 . . . . 0.0 110.402 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.49 -34.59 77.17 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -59.29 -36.53 75.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.56 -30.15 56.95 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.985 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.89 -40.18 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 O-C-N 121.281 -0.887 . . . . 0.0 110.937 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.6 m -71.23 -30.92 66.94 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.996 -1.065 . . . . 0.0 113.853 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.96 -46.01 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.858 -0.526 . . . . 0.0 110.799 171.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -37.38 75.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.4 70.48 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.02 -9.79 58.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -68.41 -50.48 52.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.938 -0.476 . . . . 0.0 112.104 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.479 ' CD1' ' H ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -98.82 -141.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -174.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.581 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.262 74.9 mmtt -129.84 -139.51 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -170.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 49.6 Cg_endo -68.97 -50.25 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 CA-C-N 124.385 2.602 . . . . 0.0 114.129 170.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -79.33 53.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.217 1.371 . . . . 0.0 114.318 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.39 164.72 28.35 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 161.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.5 t -147.02 159.23 43.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.185 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.376 1.2 tm? -128.44 129.55 46.3 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 112.222 -2.263 . . . . 0.0 104.91 -162.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.804 HD13 ' CB ' ' A' ' 116' ' ' CYS . 40.3 mm -118.49 84.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.016 1.734 . . . . 0.0 108.256 170.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.82 -88.18 0.09 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 -161.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.61 169.77 8.94 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.798 -143.038 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.4 m -108.69 -148.47 0.42 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -158.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.54 -45.05 88.81 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -163.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.89 -31.19 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 124.762 2.22 . . . . 0.0 110.84 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.755 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 79.1 m-85 -76.75 -2.97 35.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.523 -174.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.408 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 87.3 tttt -67.2 -49.18 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.213 -0.929 . . . . 0.0 111.892 170.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.4 -34.41 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.02 169.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.755 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.19 -47.94 83.84 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 172.445 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.32 80.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 tp -58.94 -49.94 75.95 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.613 0.72 . . . . 0.0 112.55 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.19 -34.38 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.4 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -71.69 -16.68 62.25 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.67 29.04 5.74 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.496 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 82.7 m-85 -106.67 159.72 15.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -120.83 153.94 36.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.522 ' CG1' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -112.07 152.45 13.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.566 -167.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 tp -154.01 120.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.66 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -107.6 100.23 9.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 123.735 1.731 . . . . 0.0 110.196 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.73 -178.24 0.64 Allowed Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 111.72 -2.491 . . . . 0.0 106.698 169.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.06 -10.73 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 119.314 2.774 . . . . 0.0 119.314 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -119.71 111.53 18.14 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 158.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.44 115.33 27.49 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.941 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.185 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 11.7 p -147.12 -163.44 1.76 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 124.321 2.01 . . . . 0.0 114.334 172.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.522 ' CD2' HD12 ' A' ' 91' ' ' LEU . 13.2 m0 -137.65 130.35 29.91 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 110.559 -3.019 . . . . 0.0 106.412 -165.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 144.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.585 -1.322 . . . . 0.0 108.88 165.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -79.59 110.58 15.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.753 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.391 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.9 t80 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.63 141.81 28.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.97 0.89 . . . . 0.0 111.319 -165.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 m -96.96 141.17 30.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 172.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -134.2 -158.7 8.62 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 118.787 -1.673 . . . . 0.0 115.76 172.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.31 139.67 45.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 113.252 -1.474 . . . . 0.0 108.636 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.59 138.7 54.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.997 1.379 . . . . 0.0 107.815 165.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.91 120.46 30.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.264 -1.789 . . . . 0.0 108.983 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 tt -129.02 139.84 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.05 0.929 . . . . 0.0 111.316 -160.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -106.94 129.8 23.83 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 166.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -60.0 -15.82 35.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 N-CA-C 119.984 3.032 . . . . 0.0 119.984 -170.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -50.19 74.21 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.294 0.952 . . . . 0.0 112.206 -167.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -34.26 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -85.41 -0.01 53.56 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -76.48 -8.18 56.64 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 120.064 1.302 . . . . 0.0 111.59 164.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.5 m -111.62 71.46 0.93 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 164.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.84 53.3 0.77 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.3 3.334 . . . . 0.0 116.779 -154.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.12 -48.73 27.55 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.753 -1.217 . . . . 0.0 112.67 165.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.53 -30.34 71.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.27 -45.64 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.147 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.76 -34.94 78.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.57 -48.21 49.82 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 t -60.72 -40.96 94.26 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.81 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.91 -32.99 73.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.172 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.14 74.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.942 1.246 . . . . 0.0 113.823 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -55.05 -55.26 33.01 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.66 -46.31 84.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.037 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.24 -50.01 71.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -170.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -69.85 -20.55 63.41 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 112.574 -170.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.73 -103.13 0.06 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.314 0.578 . . . . 0.0 109.443 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -157.4 4.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.86 150.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.643 0.735 . . . . 0.0 111.451 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -128.42 135.03 48.95 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 161.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -88.93 139.56 30.33 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.83 -14.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -163.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.61 120.32 34.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -114.77 125.1 53.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -163.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -130.17 102.35 6.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.689 -175.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.7 tt -85.24 149.34 25.56 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.061 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -63.42 -40.17 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.512 ' H ' HD23 ' A' ' 41' ' ' LEU . 22.1 t-20 -81.64 -30.34 32.83 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.197 -0.939 . . . . 0.0 112.762 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.91 -30.75 56.28 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.433 -0.792 . . . . 0.0 112.577 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -40.43 70.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.882 0.765 . . . . 0.0 112.306 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.17 -20.64 47.93 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.74 -30.55 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 111.623 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.53 15.14 11.57 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 t -78.4 -34.34 48.14 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 mt -114.98 120.3 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.753 0.787 . . . . 0.0 108.983 -167.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.0 m -133.05 158.71 42.07 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.5 mt -131.71 -138.5 0.2 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.93 178.77 4.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.013 0.911 . . . . 0.0 109.937 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -120.1 67.38 0.83 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.187 -169.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.19 -77.92 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 -170.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -82.9 7.74 14.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 -157.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -90.13 21.25 3.83 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.16 -167.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.93 26.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -167.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 57' ' ' TYR . 6.4 t -133.12 115.1 14.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 162.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.56 134.32 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -167.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -122.71 134.75 54.45 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.28 142.23 42.18 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.36 102.66 8.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.604 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.423 HG22 ' HD2' ' A' ' 65' ' ' PRO . 29.8 m -139.43 154.75 71.94 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 170.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.423 ' HD2' HG22 ' A' ' 64' ' ' THR . 79.8 Cg_exo . . . . . 0 CA--C 1.532 0.388 0 C-N-CA 122.849 2.366 . . . . 0.0 116.366 170.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.2 t80 . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 31.2 Cg_exo -82.0 149.34 15.63 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 CA-C-N 121.233 1.476 . . . . 0.0 110.109 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -37.9 88.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.11 -33.61 73.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -76.72 -30.15 56.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.34 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -36.72 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.75 1.159 . . . . 0.0 111.442 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -68.27 -36.24 79.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.84 1.2 . . . . 0.0 112.82 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.74 -41.14 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.941 -0.474 . . . . 0.0 111.533 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -60.06 -46.35 89.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.648 0.658 . . . . 0.0 112.364 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.88 70.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.7 -10.02 59.12 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -170.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -104.44 23.32 13.41 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.3 mt -134.12 -166.64 1.83 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.165 0.983 . . . . 0.0 110.829 -163.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.96 174.88 3.95 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -170.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.8 -22.72 14.25 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 170.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -102.51 45.83 0.95 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.741 1.61 . . . . 0.0 110.4 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.45 138.4 20.34 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -143.4 109.08 5.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.43 1.586 . . . . 0.0 107.041 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.161 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.368 0.2 OUTLIER -89.82 129.72 36.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -176.075 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.255 HD13 ' SG ' ' A' ' 116' ' ' CYS . 42.7 mm -111.44 95.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.243 1.021 . . . . 0.0 109.097 170.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.93 -83.68 0.06 OUTLIER Glycine 0 C--N 1.315 -0.625 0 N-CA-C 120.851 3.1 . . . . 0.0 120.851 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.557 HD12 HD11 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -116.09 169.94 8.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 118.764 -1.174 . . . . 0.0 108.476 -133.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -103.02 -140.94 0.36 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.07 -1.019 . . . . 0.0 112.63 -155.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.22 -44.79 24.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -162.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tp -56.63 -33.05 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 124.505 2.097 . . . . 0.0 112.569 167.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.712 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 71.8 m-85 -76.66 -10.88 59.7 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.203 -176.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.6 tttt -58.45 -51.52 69.51 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 112.256 167.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.44 -35.28 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.896 -0.503 . . . . 0.0 111.236 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -57.89 -42.96 85.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 170.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.35 94.57 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.164 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -54.92 -48.0 73.65 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.24 -35.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.076 -169.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.68 -18.74 62.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.95 4.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.004 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -106.71 159.69 16.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.5 154.27 35.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.539 1.162 . . . . 0.0 107.933 158.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.626 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.2 tt -107.48 149.26 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.745 -163.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.72 126.18 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 122.553 1.168 . . . . 0.0 107.953 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -106.05 100.21 9.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.593 1.663 . . . . 0.0 109.826 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -127.93 177.59 2.01 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 111.935 -2.393 . . . . 0.0 107.446 170.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.99 -11.82 4.16 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 N-CA-C 119.269 2.757 . . . . 0.0 119.269 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -115.94 108.12 15.86 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 157.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -86.8 113.06 22.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.668 -170.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.255 ' SG ' HD13 ' A' ' 92' ' ' ILE . 25.1 p -147.54 -153.95 0.52 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 123.072 1.415 . . . . 0.0 112.258 172.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.626 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.0 m0 -134.77 149.73 50.46 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.66 144.09 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 166.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -83.31 134.83 34.9 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.742 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 110.616 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 12.5 t80 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.764 0.316 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -105.06 160.58 14.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 123.367 1.556 . . . . 0.0 113.403 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.077 170.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.414 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -123.69 -156.39 9.5 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.849 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 tp -134.03 142.72 47.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -166.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.05 129.83 51.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 40' ' ' PHE . 1.3 mt -109.36 120.08 41.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 171.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 tt -132.14 139.93 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.539 0.685 . . . . 0.0 109.324 -173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -101.08 129.75 26.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.39 -12.02 25.53 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.968 3.026 . . . . 0.0 119.968 -170.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.26 52.44 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -161.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -85.2 -29.81 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.175 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.2 p -81.08 0.24 36.91 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -76.33 -0.87 24.1 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.859 1.209 . . . . 0.0 112.247 165.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 m -112.47 71.5 1.18 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 163.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.17 46.1 1.08 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.986 3.124 . . . . 0.0 116.219 -152.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.24 -43.5 91.21 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.599 -0.688 . . . . 0.0 112.608 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.49 -29.94 70.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.25 -46.88 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.934 -0.479 . . . . 0.0 110.887 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.25 -33.92 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.89 -48.79 57.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.463 ' HA ' HE21 ' A' ' 28' ' ' GLN . 9.7 t -61.73 -39.21 90.74 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.477 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -66.3 -29.9 70.21 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.34 76.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.236 1.38 . . . . 0.0 113.428 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.463 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.7 mt-30 -59.69 -50.83 72.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.966 -0.459 . . . . 0.0 111.611 170.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.91 -42.66 59.58 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.69 -49.92 12.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -59.35 -37.39 77.74 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 170.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.9 -106.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.717 -0.615 . . . . 0.0 110.389 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 4' ' ' TYR . 43.1 mmtm -129.76 -44.86 1.19 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -169.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 59' ' ' THR . 2.3 p -97.98 149.58 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.728 1.251 . . . . 0.0 111.335 -165.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -114.88 136.0 53.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.63 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -90.46 139.47 30.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.7 t -118.74 -32.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.63 -162.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -121.86 169.99 10.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.273 1.511 . . . . 0.0 110.859 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -134.49 125.4 27.31 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.757 -174.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 10' ' ' LEU . 18.4 m-30 -118.68 120.21 36.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 168.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.64 149.43 22.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.53 -40.09 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.97 -30.45 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -85.53 -31.5 22.68 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -0.918 . . . . 0.0 112.944 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -66.21 -40.56 90.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.26 0.937 . . . . 0.0 112.054 171.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -69.67 -24.98 63.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.992 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.13 -39.86 16.27 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.67 -0.644 . . . . 0.0 111.78 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.34 15.36 1.14 Allowed Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -79.74 -30.09 40.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -171.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.8 mt -114.75 120.28 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.867 0.841 . . . . 0.0 109.854 -164.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -128.26 120.45 27.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.239 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.5 -167.43 1.36 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.897 1.332 . . . . 0.0 110.537 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -98.58 120.5 39.12 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.203 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -81.17 46.67 0.94 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -161.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.03 4.42 0.63 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 119.594 3.183 . . . . 0.0 119.594 170.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -100.4 -34.59 9.89 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 122.089 2.222 . . . . 0.0 115.801 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' THR . 8.2 m-85 -81.87 22.04 0.8 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -157.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.3 37.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -167.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.522 HG21 HG21 ' A' ' 34' ' ' VAL . 8.8 t -138.57 115.32 10.69 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 160.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.87 110.34 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.504 -160.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -105.88 134.6 48.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.408 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -118.06 110.42 17.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.25 -0.906 . . . . 0.0 109.017 176.357 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.51 89.5 3.23 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.468 -170.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -136.76 86.71 21.36 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 CA--C 1.54 0.786 0 C-N-CA 122.127 1.884 . . . . 0.0 112.84 170.343 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 28.6 Cg_exo -82.2 149.44 15.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 CA-C-N 120.962 1.379 . . . . 0.0 110.344 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -38.38 90.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.14 -31.76 70.39 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.68 -30.3 56.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.992 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.38 -35.28 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 120.203 1.365 . . . . 0.0 111.227 170.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.9 m -68.94 -39.93 79.26 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.597 1.09 . . . . 0.0 112.503 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.19 -38.09 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.942 -0.474 . . . . 0.0 111.84 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -65.85 -40.48 91.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.709 -0.619 . . . . 0.0 112.571 176.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.0 70.72 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.86 -19.16 61.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.4 m -72.06 -17.02 62.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -111.15 159.93 17.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.123 0.963 . . . . 0.0 110.387 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -91.38 174.96 3.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.341 169.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -60.43 -10.61 13.93 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 117.508 2.08 . . . . 0.0 117.508 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -102.07 50.06 0.84 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 168.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.14 141.4 25.03 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.9 p -139.66 103.79 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.194 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.274 2.6 tt -89.96 129.78 36.25 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -178.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.117 HD13 ' SG ' ' A' ' 116' ' ' CYS . 32.3 mm -110.18 91.14 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -80.71 0.05 OUTLIER Glycine 0 C--N 1.315 -0.596 0 N-CA-C 121.22 3.248 . . . . 0.0 121.22 -163.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.558 HD12 HD21 ' A' ' 91' ' ' LEU . 3.1 mt -115.97 169.78 8.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.227 -141.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 p -123.55 -117.31 0.29 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 119.636 -0.826 . . . . 0.0 113.009 -158.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.36 -59.39 2.73 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -155.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mt -59.7 -26.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 124.248 1.975 . . . . 0.0 111.593 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.712 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 62.4 m-85 -76.9 -18.73 58.12 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.283 -169.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -54.44 -53.96 47.22 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.988 -1.07 . . . . 0.0 112.436 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.06 -33.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.837 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.84 -43.34 94.65 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 172.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.61 97.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.86 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.03 -44.52 95.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -80.01 -35.63 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.038 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -71.78 -18.74 62.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 32.11 4.52 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.79 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.6 m-85 -106.77 159.96 15.84 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -128.51 109.09 11.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.593 HG13 ' CD1' ' A' ' 117' ' ' TRP . 20.2 tt -87.6 111.22 21.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 122.751 1.263 . . . . 0.0 114.393 -162.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.5 tt -105.12 125.25 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.756 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -115.41 81.53 1.6 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 124.285 1.993 . . . . 0.0 111.299 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 114' ' ' ASP . 90.1 mt-10 -134.34 100.47 12.69 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 -170.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.63 29.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.971 1 N-CA-C 124.8 4.885 . . . . 0.0 124.8 -140.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.2 m-20 -99.68 99.82 10.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 132.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.572 -163.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 1.194 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 23.8 p -147.3 -156.49 0.72 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 123.104 1.43 . . . . 0.0 111.77 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.593 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.7 m0 -134.24 149.6 50.98 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 -174.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 143.91 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.351 1.072 . . . . 0.0 108.25 164.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -90.2 64.82 6.2 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.437 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.379 170.13 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -117.47 141.63 48.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 122.772 1.273 . . . . 0.0 111.347 -170.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -105.26 120.89 42.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.359 174.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.27 -161.13 9.69 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 123.59 1.661 . . . . 0.0 117.086 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.5 tp -127.95 139.9 52.31 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 111.795 -2.203 . . . . 0.0 107.196 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -124.37 129.28 50.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 162.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -123.34 120.07 31.97 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -176.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.0 pt -131.21 139.99 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.492 -0.755 . . . . 0.0 111.218 -167.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.4 129.69 36.09 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 166.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.31 -13.9 18.08 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 N-CA-C 120.205 3.117 . . . . 0.0 120.205 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.52 -50.2 66.13 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -163.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.28 -34.02 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.166 170.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.5 p -83.49 0.4 46.53 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -170.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 t -76.58 -6.01 50.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.687 1.585 . . . . 0.0 114.573 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.312 62.8 m -98.94 168.11 10.24 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 169.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.59 -6.72 16.41 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 N-CA-C 116.915 1.852 . . . . 0.0 116.915 -170.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.12 -50.19 20.55 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.721 1.146 . . . . 0.0 113.833 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.99 -31.44 70.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.656 0.662 . . . . 0.0 112.123 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.77 -47.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 122.232 -0.292 . . . . 0.0 111.044 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.35 -32.69 72.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.49 -49.09 52.05 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.4 t -61.83 -40.08 94.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.176 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.33 -34.2 77.6 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.3 70.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.287 1.403 . . . . 0.0 113.246 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.297 1.5 tm0? -54.85 -53.7 51.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.11 82.93 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.58 -50.03 14.88 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -25.54 61.14 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -85.8 -114.83 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.628 -0.67 . . . . 0.0 109.659 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -154.1 11.79 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.1 149.88 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.817 0.818 . . . . 0.0 111.778 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.44 137.88 52.05 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 162.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -88.75 139.45 30.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.3 t -117.21 -35.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.542 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -122.05 120.15 33.5 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -157.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -114.88 114.17 25.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -162.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.512 ' O ' HD23 ' A' ' 10' ' ' LEU . 18.5 m-30 -119.05 120.57 37.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.6 tt -91.47 149.37 21.73 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.49 -40.05 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.543 ' H ' HD23 ' A' ' 41' ' ' LEU . 21.2 m120 -80.51 -30.35 37.28 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.55 -31.44 42.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.33 -0.856 . . . . 0.0 112.823 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.42 -40.36 70.51 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.866 0.757 . . . . 0.0 112.107 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.46 -24.56 63.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.26 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.09 -35.26 37.2 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.71 -0.619 . . . . 0.0 111.42 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.41 15.15 6.07 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.937 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.6 m -75.07 -36.1 61.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.68 1.24 . . . . 0.0 113.834 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.71 111.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 122.766 1.269 . . . . 0.0 108.815 -165.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.2 m -133.28 115.15 14.59 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.259 18.1 tp -124.63 -52.94 1.69 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.293 -0.963 . . . . 0.0 113.308 -159.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -149.36 169.47 20.75 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -120.6 49.05 1.5 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 170.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.14 -86.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -170.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 6' ' ' THR . 93.2 mttt -100.22 62.29 1.1 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -160.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.2 m-85 -112.15 22.06 15.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.827 166.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.48 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -161.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.03 115.53 6.7 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 168.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 14.0 t -119.59 134.51 62.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.601 -164.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -122.46 134.67 54.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.47 110.21 16.65 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.42 102.03 13.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.886 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -120.09 154.59 55.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.49 134.51 38.76 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.114 1.876 . . . . 0.0 115.148 170.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -120.08 30.04 7.2 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.195 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.83 -23.56 14.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 170.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -74.93 149.8 39.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.103 0.865 . . . . 0.0 110.595 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.5 m -106.45 74.22 1.01 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.997 0.903 . . . . 0.0 109.038 170.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -135.04 178.72 6.8 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 170.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 pt -90.74 149.26 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.571 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -99.43 -63.35 1.13 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 118.525 2.787 . . . . 0.0 118.525 -170.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 7.7 t80 -130.42 149.39 73.27 Favored Pre-proline 0 N--CA 1.474 0.749 0 O-C-N 120.861 -1.15 . . . . 0.0 110.331 -156.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 21.4 Cg_exo -82.16 149.71 15.43 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.773 0.954 . . . . 0.0 111.171 175.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.58 -39.77 94.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.68 -31.43 69.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.5 mt -76.67 -30.29 56.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.445 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.01 -37.59 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.045 1.293 . . . . 0.0 111.226 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.4 p -68.47 -39.15 81.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.112 1.324 . . . . 0.0 112.672 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.19 -39.77 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.912 -0.493 . . . . 0.0 112.201 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -39.34 93.37 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.62 -0.675 . . . . 0.0 112.683 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.95 -29.8 70.76 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.11 -10.02 55.6 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -99.82 16.51 23.46 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.3 mt -131.18 -174.11 3.29 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.526 1.155 . . . . 0.0 110.289 -168.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 67.8 mttm -140.04 174.93 3.53 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -170.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 1.1 Cg_endo -61.4 -16.3 46.41 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 N-CA-C 118.341 2.401 . . . . 0.0 118.341 -170.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -102.27 45.06 0.98 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.467 1.03 . . . . 0.0 110.544 168.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.15 144.22 34.38 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 78.7 p -146.99 109.84 4.68 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.249 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.285 0.6 OUTLIER -93.29 129.96 39.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.805 -173.363 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' HB3' ' A' ' 116' ' ' CYS . 27.6 mm -113.34 84.56 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.471 1.032 . . . . 0.0 108.894 170.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -83.23 0.06 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 121.361 3.304 . . . . 0.0 121.361 -166.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.544 HD12 HD21 ' A' ' 91' ' ' LEU . 4.9 mt -116.36 146.89 42.12 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.636 1.208 . . . . 0.0 110.308 -135.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.2 p -94.61 -129.4 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.535 -156.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.5 -48.51 15.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -158.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.69 -29.52 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 124.555 2.122 . . . . 0.0 111.339 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.612 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 87.0 m-85 -76.73 -14.4 59.95 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.834 -172.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.31 -55.24 37.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.824 -1.173 . . . . 0.0 112.571 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.86 -34.35 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.812 -0.555 . . . . 0.0 111.295 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.35 -42.0 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 173.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.85 92.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.49 -48.66 80.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.882 0.849 . . . . 0.0 112.334 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.15 -35.45 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.212 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -71.57 -18.81 62.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 33.92 3.94 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.673 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.52 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 72.6 m-85 -106.7 159.64 16.06 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.29 104.39 9.1 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.013 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.61 HD11 ' OH ' ' A' ' 115' ' ' TYR . 19.8 tt -83.7 110.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.787 1.28 . . . . 0.0 114.377 -167.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.6 tt -111.64 131.41 63.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 113.183 -1.826 . . . . 0.0 108.928 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -109.42 86.93 2.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 124.059 1.885 . . . . 0.0 112.181 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 114' ' ' ASP . 55.1 mt-10 -134.41 100.49 12.59 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -54.77 28.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 1 N-CA-C 124.663 4.832 . . . . 0.0 124.663 -144.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.8 p-10 -99.58 100.29 11.28 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 131.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.61 ' OH ' HD11 ' A' ' 109' ' ' ILE . 19.3 t80 -80.05 115.28 19.53 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.907 -0.496 . . . . 0.0 110.763 -164.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.249 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.4 p -147.24 -161.16 1.27 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 124.621 2.153 . . . . 0.0 115.177 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.582 ' CD1' HG13 ' A' ' 109' ' ' ILE . 19.0 m0 -137.4 126.28 24.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 109.71 -3.405 . . . . 0.0 106.462 -167.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.303 0.1 OUTLIER -112.65 111.22 35.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 O-C-N 121.365 -0.834 . . . . 0.0 109.483 177.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -79.1 134.28 36.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.2 ttt . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.539 170.599 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -117.7 141.83 47.95 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -99.98 141.86 32.23 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 162.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.414 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -133.7 -159.47 9.0 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 122.98 1.322 . . . . 0.0 116.243 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.01 139.51 46.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 113.172 -1.514 . . . . 0.0 107.379 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.417 HD11 HG23 ' A' ' 11' ' ' ILE . 20.7 tp -124.6 131.4 53.48 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 122.292 1.044 . . . . 0.0 108.506 170.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 120.18 38.82 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.133 169.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 9' ' ' LEU . 6.0 pt -123.54 139.81 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.452 ' HB3' HG23 ' A' ' 64' ' ' THR . 6.0 t60 -90.32 130.01 43.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.13 -18.23 9.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 121.603 3.655 . . . . 0.0 121.603 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.19 71.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 -158.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.16 -27.28 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.26 168.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.6 p -71.52 -14.29 62.07 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.7 m -76.62 -4.03 40.86 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 120.795 1.634 . . . . 0.0 111.933 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.326 96.3 m -98.55 168.18 10.25 Favored Pre-proline 0 CA--C 1.558 1.264 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.42 -0.69 10.87 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 N-CA-C 117.768 2.18 . . . . 0.0 117.768 -170.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.05 -50.54 19.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.351 1.432 . . . . 0.0 113.952 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.18 -31.51 70.18 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.741 0.7 . . . . 0.0 112.422 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.4 -48.41 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 122.121 -0.362 . . . . 0.0 110.768 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -61.84 -33.25 73.82 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -47.45 60.51 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.431 ' HA ' HE21 ' A' ' 28' ' ' GLN . 6.8 t -63.26 -39.99 96.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.432 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -62.72 -34.75 77.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.684 -0.674 . . . . 0.0 112.776 169.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -44.34 72.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.167 1.349 . . . . 0.0 113.674 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.3 mt-30 -59.9 -53.16 61.09 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.766 0.317 . . . . 0.0 111.704 173.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -58.6 -37.73 76.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.32 -42.94 19.82 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -170.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.9 p -57.8 -20.14 33.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 170.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.77 -100.37 0.07 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -158.14 19.21 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -170.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.463 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 38.9 t -129.93 110.73 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -167.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -99.09 134.94 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -88.97 139.68 30.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.113 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.83 -31.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.34 -168.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -121.74 120.36 34.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -161.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -114.64 124.59 52.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -165.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -127.47 120.2 27.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.17 149.73 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.427 HD13 ' OH ' ' A' ' 62' ' ' TYR . 4.1 tp -63.21 -39.53 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -77.65 -30.31 52.05 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -80.48 -32.82 37.01 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.392 -0.818 . . . . 0.0 113.043 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -73.89 -40.59 63.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.294 0.952 . . . . 0.0 112.393 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -74.24 -20.43 60.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.768 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.5 -37.37 25.37 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.61 -0.681 . . . . 0.0 111.593 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.75 15.21 6.4 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 120.613 -0.803 . . . . 0.0 114.966 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -76.27 -31.63 58.39 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 118.813 1.307 . . . . 0.0 114.199 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.73 120.26 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -167.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.5 m -122.59 120.05 32.64 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.046 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -122.35 -161.65 0.95 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.84 170.02 9.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.82 1.295 . . . . 0.0 111.202 -169.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -115.26 71.6 0.77 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.336 -170.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.94 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 6' ' ' THR . 77.8 mttt -97.13 43.66 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -157.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.434 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.6 m-85 -112.21 21.68 15.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 117.545 -1.217 . . . . 0.0 110.685 -170.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.65 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -158.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' TYR . 7.0 t -134.37 115.31 13.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 164.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 65.9 t -119.43 110.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -163.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -107.63 134.29 50.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.427 ' OH ' HD13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -123.36 110.52 15.26 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.122 -0.986 . . . . 0.0 110.165 177.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.94 100.32 8.33 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 12' ' ' HIS . 63.1 m -119.96 88.63 40.89 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -170.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.24 89.54 1.31 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.185 1.923 . . . . 0.0 111.749 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -120.12 -30.28 4.69 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 170.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.34 -174.12 2.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.713 0.768 . . . . 0.0 109.859 -170.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -75.43 -70.12 0.44 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.763 -0.586 . . . . 0.0 110.127 170.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.4 t -125.12 49.93 1.82 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -170.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -135.02 80.98 1.87 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -170.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.5 tt -108.13 100.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -170.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.63 100.33 11.73 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.305 170.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 -127.71 148.65 67.79 Favored Pre-proline 0 N--CA 1.473 0.723 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 168.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 26.2 Cg_exo -82.33 149.91 15.16 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 120.659 0.906 . . . . 0.0 112.088 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -62.45 -35.42 79.23 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -60.34 -34.34 73.7 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.55 -30.4 57.07 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.655 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.9 -38.52 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 120.357 1.435 . . . . 0.0 111.298 171.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 95.2 p -69.18 -40.74 77.94 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.79 1.177 . . . . 0.0 113.11 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.1 -38.64 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.799 -0.563 . . . . 0.0 112.262 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -33.84 71.62 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.82 -29.77 69.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -69.16 -9.83 54.78 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.4 m -97.99 29.83 3.3 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.15 171.02 14.82 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.359 1.076 . . . . 0.0 112.989 -162.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 49.7 mttm -122.39 -158.02 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 170.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 10.7 Cg_endo -67.65 -43.72 5.2 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 119.834 2.974 . . . . 0.0 119.834 -163.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -90.51 63.29 5.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 122.386 2.357 . . . . 0.0 111.495 170.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.31 133.99 13.61 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 170.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.6 p -139.16 159.27 42.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.175 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.251 1.1 tt -127.94 129.62 47.12 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.862 HD13 ' CB ' ' A' ' 116' ' ' CYS . 24.8 mm -112.3 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.914 0.864 . . . . 0.0 109.41 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.552 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.72 -79.27 0.04 OUTLIER Glycine 0 C--N 1.318 -0.445 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 -161.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.552 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -115.65 171.15 7.92 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.962 1.363 . . . . 0.0 111.121 -139.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 m -92.97 -162.74 0.96 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.178 -1.373 . . . . 0.0 113.318 -164.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.17 -36.49 84.38 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.25 -32.63 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 124.817 2.246 . . . . 0.0 111.283 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.571 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 93.8 m-85 -76.81 -12.23 59.94 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.501 -172.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HG3' HD13 ' A' ' 109' ' ' ILE . 4.5 ttmp? -58.94 -53.63 56.24 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.815 -1.178 . . . . 0.0 112.367 169.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.04 -37.1 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.802 -0.561 . . . . 0.0 111.068 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.571 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.57 -45.57 93.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.92 172.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.02 74.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.871 -0.518 . . . . 0.0 111.72 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.58 -50.1 70.98 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.655 0.74 . . . . 0.0 112.748 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 tt -80.35 -34.22 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -71.79 -17.8 62.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.69 29.94 5.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 92.2 m-85 -106.46 159.66 15.99 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -127.55 107.6 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.619 HG13 ' CD1' ' A' ' 117' ' ' TRP . 16.9 tt -76.18 149.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.484 1.135 . . . . 0.0 111.914 -167.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.08 125.13 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.47 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -106.48 100.0 9.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.483 1.611 . . . . 0.0 111.302 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -134.06 175.2 3.85 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 112.449 -2.16 . . . . 0.0 107.252 -170.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -54.97 -19.97 21.5 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.82 109.97 19.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 156.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -87.11 111.11 20.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.637 -0.664 . . . . 0.0 109.258 -170.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.175 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 17.6 p -147.26 -157.18 0.79 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 124.251 1.977 . . . . 0.0 112.694 174.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.619 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.4 m0 -137.25 149.93 47.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 110.305 -3.134 . . . . 0.0 104.421 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.74 144.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.363 161.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 10.0 tmtt? -91.64 134.47 34.66 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 108.765 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.665 0.745 . . . . 0.0 110.563 -170.016 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 122.22 1.009 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.3 147.23 24.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.813 1.292 . . . . 0.0 112.419 -165.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -105.21 120.88 42.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.653 170.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 59' ' ' THR . . . -129.32 -160.98 10.41 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 118.446 -1.835 . . . . 0.0 115.418 170.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 139.85 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -164.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.371 0.2 OUTLIER -124.8 129.29 50.15 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -116.04 120.36 38.84 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.29 139.48 51.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.902 0.858 . . . . 0.0 109.681 -167.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -103.19 129.67 25.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -9.32 17.5 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 N-CA-C 122.032 3.82 . . . . 0.0 122.032 -170.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.36 70.04 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.546 2.424 . . . . 0.0 117.546 -158.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.2 t -93.06 -30.69 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.23 0.923 . . . . 0.0 108.809 167.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.4 p -80.21 0.26 33.22 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -170.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -76.41 9.3 2.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.42 1.463 . . . . 0.0 113.134 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.332 64.2 m -99.03 168.34 9.85 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 164.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -77.45 -3.99 14.21 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 117.734 2.167 . . . . 0.0 117.734 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -50.4 19.23 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -164.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -29.89 67.9 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.886 0.766 . . . . 0.0 112.752 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.7 t -70.4 -44.29 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.498 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.63 -34.1 72.36 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.052 -1.03 . . . . 0.0 113.634 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.44 72.68 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -58.88 -47.85 83.48 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -29.82 70.18 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -47.54 64.6 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.386 0.994 . . . . 0.0 112.815 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.304 1.4 tm0? -54.98 -52.49 62.92 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.17 -33.5 69.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.31 -50.16 19.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.1 m -60.72 -34.67 74.74 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 170.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.94 -131.02 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -145.1 5.71 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.482 HG21 HG21 ' A' ' 59' ' ' THR . 4.1 p -98.93 154.1 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.681 0.753 . . . . 0.0 111.742 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -128.03 142.43 51.23 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 166.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.73 100.65 12.83 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.637 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.18 -30.79 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.749 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.83 169.64 10.57 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.615 1.198 . . . . 0.0 109.769 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -142.68 116.46 9.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -118.73 115.34 24.27 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.74 149.51 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.452 HD13 ' OH ' ' A' ' 62' ' ' TYR . 2.8 tp -63.63 -40.26 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.08 -30.25 31.4 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.77 -29.09 18.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.087 0.858 . . . . 0.0 112.785 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -68.84 -40.45 79.42 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.015 1.279 . . . . 0.0 111.471 170.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.17 -27.91 66.83 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.97 19.54 19.89 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.54 11.22 45.11 Favored Glycine 0 CA--C 1.54 1.655 0 N-CA-C 117.459 1.743 . . . . 0.0 117.459 152.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -82.8 -23.6 33.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -167.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 51' ' ' THR . 8.8 mt -114.63 167.82 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.464 1.029 . . . . 0.0 110.364 -161.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.46 ' N ' HG22 ' A' ' 50' ' ' ILE . 7.4 m -99.73 117.42 34.05 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.718 1.247 . . . . 0.0 110.488 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.1 mt -96.83 120.35 37.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.242 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -107.58 120.27 41.73 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 166.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -84.83 67.8 10.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.461 -170.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -74.32 0.07 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 170.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 6' ' ' THR . 49.8 mttp -100.27 45.78 0.97 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -160.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.27 21.48 15.74 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.701 165.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 86' ' ' LYS . 8.9 mm-40 -61.67 58.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 171.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.482 HG21 HG21 ' A' ' 34' ' ' VAL . 10.7 t -146.69 113.12 5.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 144.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.91 134.15 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 -170.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.58 134.56 54.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 167.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.452 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -120.79 110.74 16.72 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.965 0.888 . . . . 0.0 109.314 178.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.45 100.39 11.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.575 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -125.67 107.39 26.19 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.25 -53.07 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.644 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 -162.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.93 30.04 1.12 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -161.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.46 178.49 4.72 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.675 -1.266 . . . . 0.0 110.668 -170.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -112.3 -78.64 0.58 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -125.11 -56.4 1.55 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -170.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -109.47 100.07 9.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -170.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.86 167.66 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.808 0.813 . . . . 0.0 110.189 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -85.98 94.79 9.3 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 168.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -124.05 90.96 50.2 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.64 170.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.92 149.7 50.39 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.714 1.609 . . . . 0.0 112.243 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.42 -31.91 72.68 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -58.69 -33.95 70.73 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.4 mt -76.79 -30.23 56.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.017 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -37.22 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 119.325 0.966 . . . . 0.0 111.382 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 97.1 p -70.52 -39.71 73.91 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.812 1.187 . . . . 0.0 112.717 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.03 -46.26 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.562 0.619 . . . . 0.0 111.448 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.05 -30.54 65.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.59 70.72 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -80.77 -9.94 59.77 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -171.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 p -97.74 50.95 1.05 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.1 159.93 28.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -156.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.513 ' H ' ' HG3' ' A' ' 58' ' ' GLU . 69.4 mmtt -100.5 174.9 2.65 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 110.67 -2.968 . . . . 0.0 106.417 163.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 14.2 Cg_endo -53.21 -28.53 42.53 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 118.629 2.511 . . . . 0.0 118.629 170.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -102.07 70.93 1.23 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.266 . . . . 0.0 110.968 170.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.43 131.74 24.64 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 163.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -147.44 120.21 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.607 1.194 . . . . 0.0 108.241 -170.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.199 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.254 0.5 OUTLIER -106.36 129.96 54.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.195 -166.908 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.718 HD13 ' CB ' ' A' ' 116' ' ' CYS . 26.3 mm -111.21 82.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.963 1.256 . . . . 0.0 108.269 170.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.92 -94.46 0.19 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 121.579 3.392 . . . . 0.0 121.579 -166.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.717 HD22 HD21 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.48 146.83 41.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.867 -137.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.3 m -107.21 -130.14 0.29 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.078 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.95 128.48 33.73 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.68 -13.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 2 O-C-N 114.952 -4.842 . . . . 0.0 117.848 11.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.764 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.3 m-85 -76.26 -0.79 23.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 112.591 -2.095 . . . . 0.0 113.155 -152.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.66 -55.74 10.48 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.74 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.58 -33.75 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.984 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.764 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.26 -41.42 96.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.311 -0.956 . . . . 0.0 113.123 172.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.694 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -59.71 -42.89 94.07 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.929 -0.482 . . . . 0.0 111.246 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 tp -55.86 -50.06 71.63 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.619 0.723 . . . . 0.0 112.419 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.1 tt -80.04 -34.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.567 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.63 -16.21 62.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.29 4.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.076 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 76.7 m-85 -106.47 159.7 15.96 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.11 154.17 32.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 102' ' ' ALA . 17.0 mt -104.32 153.25 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.98 1.371 . . . . 0.0 109.899 -171.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.7 tp -151.16 135.0 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.779 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -115.99 88.36 2.87 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.006 1.86 . . . . 0.0 112.295 -171.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 114' ' ' ASP . 46.1 mt-10 -134.34 100.38 12.74 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -54.95 29.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.102 1 N-CA-C 124.372 4.72 . . . . 0.0 124.372 -141.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 112' ' ' GLU . 12.4 m-20 -99.86 105.63 17.39 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 132.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -79.86 115.36 19.4 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.816 -0.552 . . . . 0.0 110.052 -166.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.199 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.79 -161.31 1.3 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 124.143 1.925 . . . . 0.0 115.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.673 ' CD1' HG12 ' A' ' 109' ' ' ILE . 24.5 m0 -137.05 149.71 47.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 110.384 -3.098 . . . . 0.0 103.905 -165.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.4 mm -110.97 144.72 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 162.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 9.2 tmtt? -93.72 110.01 21.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 18.6 mmt . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 122.017 0.913 . . . . 0.0 112.2 -168.451 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.76 141.84 48.25 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.122 -0.986 . . . . 0.0 111.134 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -96.95 141.42 30.15 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.15 -161.74 9.71 Favored Glycine 0 N--CA 1.466 0.696 0 CA-C-O 124.196 1.998 . . . . 0.0 116.319 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.22 143.77 48.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 110.922 -2.639 . . . . 0.0 107.437 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.03 136.11 54.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.394 1.092 . . . . 0.0 109.106 170.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mt -113.67 120.2 40.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.104 -1.407 . . . . 0.0 107.657 164.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.62 139.8 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -95.48 129.47 34.78 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 165.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.44 -9.53 18.26 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 N-CA-C 120.872 3.374 . . . . 0.0 120.872 -170.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 -50.31 64.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -161.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -87.33 -29.05 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.119 170.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.1 p -80.78 0.48 34.56 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -170.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.2 m -76.2 0.09 20.32 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 120.197 1.362 . . . . 0.0 111.599 166.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 m -114.26 71.36 2.17 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 161.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.72 52.85 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.038 3.158 . . . . 0.0 116.808 -154.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.96 -39.85 79.24 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.671 -1.268 . . . . 0.0 112.233 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.43 -29.96 68.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.77 -46.5 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 122.227 -0.296 . . . . 0.0 110.939 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.76 -38.48 78.57 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -66.89 -49.97 63.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.513 ' HA ' HE21 ' A' ' 28' ' ' GLN . 7.9 t -61.82 -38.63 88.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.376 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -63.71 -34.45 77.89 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.15 -40.54 78.13 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.513 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.1 mt-30 -64.25 -51.9 61.32 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.04 -0.412 . . . . 0.0 111.631 173.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.6 75.13 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.49 73.53 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 170.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -75.04 -22.6 58.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.092 0.86 . . . . 0.0 112.223 -170.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.87 -103.77 0.06 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.306 0.574 . . . . 0.0 109.809 170.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -161.81 10.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -166.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.67 149.71 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.877 0.846 . . . . 0.0 112.196 170.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -128.58 136.12 50.29 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -88.91 139.58 30.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.849 0.833 . . . . 0.0 108.758 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.05 -41.12 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.536 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -121.94 169.83 10.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.579 1.18 . . . . 0.0 111.176 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -137.28 125.12 22.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.282 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -121.59 149.12 43.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 117.301 -1.759 . . . . 0.0 109.189 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -123.47 111.27 16.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.6 tp -49.8 -35.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.23 -30.37 43.19 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.802 1.183 . . . . 0.0 113.737 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -81.76 -28.94 33.02 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.227 -0.92 . . . . 0.0 113.139 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.45 -40.6 85.42 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.3 0.955 . . . . 0.0 112.057 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -70.32 -23.34 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.97 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.02 -37.66 33.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.49 -0.756 . . . . 0.0 111.493 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.22 15.27 5.16 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -72.32 -28.27 62.96 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -114.81 120.46 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.737 0.78 . . . . 0.0 109.254 -165.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -108.02 120.37 42.12 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.505 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.679 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 15.2 tp -120.52 -165.95 1.26 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.933 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.679 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 48.1 mt-10 -98.62 -176.02 3.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.611 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -120.15 65.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.11 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 6' ' ' THR . 78.4 mttt -100.04 53.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -159.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.2 m-85 -112.63 21.74 15.29 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 116.903 -1.522 . . . . 0.0 112.079 166.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 1.2 pm0 -61.81 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -162.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.11 115.47 6.65 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 164.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.2 134.66 52.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -122.53 134.86 54.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 141.34 52.07 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.03 1.741 . . . . 0.0 109.286 164.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.0 tp -124.56 90.44 3.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.724 -170.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.5 m -138.01 114.46 9.21 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.21 151.87 33.66 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.509 2.14 . . . . 0.0 115.941 -170.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -106.19 30.22 6.1 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.442 -170.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.8 -58.33 1.94 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.046 -1.034 . . . . 0.0 109.748 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -82.31 115.31 21.31 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -170.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -78.88 76.34 5.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -165.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -135.17 178.86 6.7 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -170.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -90.46 149.41 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 120.847 -1.158 . . . . 0.0 109.331 -170.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mtpt -94.08 -71.0 0.68 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 5.5 t80 -130.34 149.24 72.81 Favored Pre-proline 0 N--CA 1.475 0.791 0 O-C-N 120.796 -1.19 . . . . 0.0 111.571 -155.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 17.4 Cg_exo -82.14 149.93 15.55 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.206 1.271 . . . . 0.0 111.207 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -62.35 -37.16 84.59 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.59 -30.88 70.1 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -76.81 -30.09 56.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.4 mt -64.4 -35.03 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 119.915 1.234 . . . . 0.0 111.63 168.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.5 p -69.56 -36.57 76.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.505 1.502 . . . . 0.0 112.688 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.34 -39.62 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.751 -0.593 . . . . 0.0 111.728 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -61.96 -40.87 97.05 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.698 -0.626 . . . . 0.0 112.655 174.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.85 70.76 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.12 -10.09 59.17 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.1 m -100.32 28.52 4.92 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mp -134.26 160.03 39.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 122.59 1.186 . . . . 0.0 111.238 -164.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -105.18 174.92 2.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.37 166.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.54 -25.33 32.21 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 118.581 2.493 . . . . 0.0 118.581 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.65 57.38 1.15 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.774 1.17 . . . . 0.0 110.208 168.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.9 145.98 36.01 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 167.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.6 p -141.62 159.27 42.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.234 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.343 1.7 tm? -128.19 129.48 46.54 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 -170.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.822 HD13 ' HB3' ' A' ' 116' ' ' CYS . 44.2 mm -121.03 79.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.632 1.56 . . . . 0.0 110.019 170.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.25 -83.24 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 120.518 2.967 . . . . 0.0 120.518 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 91' ' ' LEU . 1.1 mt -116.54 146.93 42.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.486 -1.357 . . . . 0.0 111.024 -132.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -102.41 -109.62 0.24 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.068 -156.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.26 -60.19 2.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -157.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 mt -61.13 -26.63 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 124.253 1.978 . . . . 0.0 111.605 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 10.5 m-85 -76.56 -19.77 57.55 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.987 -171.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.37 -56.18 21.16 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.965 -1.085 . . . . 0.0 113.013 168.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.07 -35.23 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.824 -0.548 . . . . 0.0 111.324 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -58.63 -45.34 89.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 171.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.405 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . . . -57.52 -43.78 84.58 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.569 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -54.96 -49.88 70.29 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.53 0.681 . . . . 0.0 112.72 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.3 tt -80.24 -34.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.72 30.51 5.19 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 119.385 -1.388 . . . . 0.0 113.076 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 47.7 m-85 -106.62 159.5 16.15 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 168.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.26 110.22 15.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 117' ' ' TRP . 15.2 tt -74.92 148.55 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 122.487 1.137 . . . . 0.0 111.873 -171.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -149.65 126.98 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.97 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -109.65 98.81 8.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 123.418 1.58 . . . . 0.0 111.582 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -134.31 178.45 1.76 Allowed Pre-proline 0 N--CA 1.472 0.652 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.148 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.55 -7.99 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 N-CA-C 118.732 2.551 . . . . 0.0 118.732 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -128.4 115.23 17.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 157.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -85.44 111.29 19.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.227 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.234 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 19.9 p -147.24 -158.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 124.424 2.059 . . . . 0.0 113.672 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.618 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.0 m0 -137.15 149.89 47.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 110.096 -3.229 . . . . 0.0 104.213 -169.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.43 144.59 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 164.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 16.1 ttpt -94.5 110.37 22.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.975 -1.078 . . . . 0.0 109.873 167.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.533 0.682 . . . . 0.0 109.501 -170.341 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -96.61 141.95 29.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.744 1.259 . . . . 0.0 112.929 -160.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -98.38 120.45 38.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.525 169.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.0 -164.92 11.02 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.889 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.42 141.65 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -164.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -124.13 134.79 53.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.945 1.355 . . . . 0.0 107.855 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -122.7 120.07 32.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.761 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mt -118.14 139.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.21 129.71 24.65 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 165.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -59.85 -13.61 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 N-CA-C 121.48 3.608 . . . . 0.0 121.48 -170.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.19 -50.54 60.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -161.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.1 m -88.92 -27.78 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.914 0.779 . . . . 0.0 110.715 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -76.36 -14.46 60.09 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -170.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.87 2.23 15.2 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.264 1.393 . . . . 0.0 112.067 -170.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.304 86.1 m -98.85 168.62 9.44 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 166.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -77.18 -9.24 17.76 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 N-CA-C 118.298 2.384 . . . . 0.0 118.298 -170.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.43 -50.47 18.31 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -165.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.16 -29.81 67.91 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.744 0.702 . . . . 0.0 112.417 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.15 -50.01 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.852 -0.53 . . . . 0.0 110.453 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.45 -36.99 79.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -60.07 -50.03 75.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.449 ' HA ' HE21 ' A' ' 28' ' ' GLN . 13.8 t -66.4 -39.8 89.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.786 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -61.8 -33.3 73.88 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -36.33 77.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.5 mt-30 -60.17 -56.9 15.93 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.991 -0.443 . . . . 0.0 111.172 172.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.2 77.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.97 63.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 95.7 p -59.85 -28.6 67.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 170.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -85.92 -124.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.616 -0.678 . . . . 0.0 110.017 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -136.27 9.95 3.23 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -170.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.63 150.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.596 0.712 . . . . 0.0 109.884 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -128.24 136.55 51.2 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 163.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.91 100.87 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.211 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -81.47 -24.52 10.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.429 -1.714 . . . . 0.0 114.409 -164.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -121.71 169.75 10.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.279 1.038 . . . . 0.0 111.299 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -146.89 125.23 12.29 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.818 -169.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.444 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 31.0 m-85 -130.99 149.94 52.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -110.42 156.67 20.49 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.03 -40.08 87.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.147 -0.971 . . . . 0.0 113.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -82.02 -30.34 31.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -82.83 -30.48 28.69 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.403 1.001 . . . . 0.0 112.967 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.409 HD13 ' CD1' ' A' ' 40' ' ' PHE . 18.4 tp -71.92 -40.56 68.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.207 0.912 . . . . 0.0 112.364 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -74.99 -19.47 60.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.767 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.28 -37.33 21.82 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.798 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.54 15.09 8.37 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -79.6 -17.63 53.44 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.4 mt -114.93 120.38 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.0 m -110.82 107.94 17.6 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.29 1.043 . . . . 0.0 110.929 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -131.15 172.99 11.48 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.435 172.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.16 177.69 5.32 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.833 -1.167 . . . . 0.0 110.477 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -120.03 70.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.037 -158.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.02 -83.37 0.06 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 6' ' ' THR . 31.6 pttt -99.91 45.15 0.99 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 -156.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 59' ' ' THR . 4.4 m-85 -112.24 21.77 15.45 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 116.325 -1.798 . . . . 0.0 112.041 -170.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.38 42.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -155.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 57' ' ' TYR . 10.3 t -141.64 115.11 8.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 159.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 100.679 -3.823 . . . . 0.0 100.679 -170.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.24 134.53 54.69 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 167.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.48 110.7 16.79 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.267 18.5 tp -97.61 114.05 25.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.186 0.993 . . . . 0.0 111.507 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.401 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 27.7 m -149.28 154.88 39.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 79.7 Cg_exo -49.75 128.59 21.75 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.215 1.943 . . . . 0.0 114.013 170.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.85 -19.67 24.36 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.64 71.92 1.74 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.04 0.924 . . . . 0.0 109.751 170.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -112.05 115.25 28.6 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.739 -170.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -78.71 9.87 3.76 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -135.21 90.72 2.65 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.6 tt -99.94 71.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -170.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -125.11 139.88 53.38 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.928 0.87 . . . . 0.0 111.047 170.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 -130.08 148.94 71.72 Favored Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 163.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 34.9 Cg_exo -82.12 149.53 15.46 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 CA-C-N 121.071 1.418 . . . . 0.0 110.158 -173.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.65 -36.14 81.89 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -35.69 74.9 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.82 -30.19 56.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.099 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.08 -38.2 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 119.777 1.171 . . . . 0.0 111.133 168.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.7 m -68.02 -37.24 81.18 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.347 0.976 . . . . 0.0 112.634 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.28 -41.52 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.263 0.483 . . . . 0.0 111.808 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.84 -41.22 97.88 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.44 1.018 . . . . 0.0 112.362 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.93 -29.82 70.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.79 -9.94 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.7 m -84.96 -18.11 35.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.68 170.6 9.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 120.06 1.3 . . . . 0.0 111.914 -164.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 75.5 mttt -108.61 -164.9 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -170.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 12.9 Cg_endo -62.94 -29.73 76.22 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 123.159 2.164 . . . . 0.0 113.715 -170.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -102.07 41.27 1.23 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.46 145.68 29.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -147.13 117.52 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.363 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.278 0.6 OUTLIER -89.53 143.86 26.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 112.826 -1.988 . . . . 0.0 107.334 -173.279 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.966 HD13 ' CB ' ' A' ' 116' ' ' CYS . 46.4 mm -128.07 88.84 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.858 1.208 . . . . 0.0 108.868 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.46 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -144.15 -76.56 0.03 OUTLIER Glycine 0 C--N 1.316 -0.539 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.46 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.276 4.2 mp -115.56 169.89 8.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 122.688 1.233 . . . . 0.0 109.336 -129.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.81 -120.71 0.29 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.932 -157.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -80.1 -53.66 6.49 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 121.216 1.825 . . . . 0.0 115.792 -158.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.83 -29.9 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 124.86 2.267 . . . . 0.0 111.903 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.8 m-85 -76.97 -20.44 56.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 112.895 -1.957 . . . . 0.0 111.29 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -53.89 -55.36 27.58 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.797 -1.189 . . . . 0.0 112.427 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.12 -32.73 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.885 -0.51 . . . . 0.0 111.667 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.74 -43.79 97.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 173.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.4 88.94 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.05 -48.96 78.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.789 0.804 . . . . 0.0 112.526 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.17 -35.36 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.115 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -71.81 -17.59 62.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.7 31.6 4.78 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 119.285 -1.436 . . . . 0.0 112.523 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 50.6 m-85 -106.6 159.52 16.13 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -124.61 103.69 8.28 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.618 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.5 tt -78.67 142.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 122.707 1.242 . . . . 0.0 111.62 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.07 127.85 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.401 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -109.78 100.07 9.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.529 -1.668 . . . . 0.0 110.509 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.6 -174.86 0.29 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.353 170.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -56.37 -10.54 4.95 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 N-CA-C 118.935 2.629 . . . . 0.0 118.935 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -119.39 149.56 41.63 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 154.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.548 ' OH ' HD11 ' A' ' 109' ' ' ILE . 22.5 t80 -113.68 114.73 26.79 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 -170.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.363 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 28.1 p -147.73 -156.31 0.71 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.973 1.368 . . . . 0.0 114.651 170.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.618 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.9 m0 -137.21 127.7 26.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.919 -1.946 . . . . 0.0 108.28 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -108.78 110.83 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.56 -1.338 . . . . 0.0 110.183 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -79.58 110.07 14.55 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.104 0.954 . . . . 0.0 111.167 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.728 -170.296 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -106.53 142.03 36.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 122.375 1.083 . . . . 0.0 111.834 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.1 t -103.02 120.74 41.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 168.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.34 -159.6 10.07 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 118.405 -1.855 . . . . 0.0 113.32 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.25 144.46 48.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -170.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.26 0.1 OUTLIER -124.51 129.41 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 172.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -111.53 120.15 41.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.407 HG22 ' HB2' ' A' ' 63' ' ' LEU . 2.3 pt -124.52 139.63 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.405 ' CD2' HG23 ' A' ' 64' ' ' THR . 6.3 t60 -97.24 130.34 29.88 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -54.5 -20.73 21.67 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 N-CA-C 120.931 3.396 . . . . 0.0 120.931 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.73 72.68 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.977 1.717 . . . . 0.0 112.669 -164.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -96.07 -29.53 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -171.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.5 p -85.99 0.02 54.35 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -170.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.2 m -76.46 -5.06 45.8 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.431 1.469 . . . . 0.0 112.816 170.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.315 79.7 m -98.7 168.08 10.37 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 167.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.63 -9.45 17.19 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 N-CA-C 117.598 2.115 . . . . 0.0 117.598 -170.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.06 -50.19 20.74 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -163.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.08 -31.83 70.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.784 0.72 . . . . 0.0 112.057 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.45 -47.71 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.637 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.13 -33.89 74.12 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.93 -47.91 60.57 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -62.62 -39.71 94.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.54 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.01 -31.89 73.24 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.01 -45.97 69.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.11 1.323 . . . . 0.0 112.332 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.03 -51.25 66.87 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.93 82.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.19 -50.08 13.74 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 t -57.94 -28.18 64.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 170.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.99 -127.87 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.495 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -130.05 6.78 5.03 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -104.45 150.82 7.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.863 0.84 . . . . 0.0 109.98 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -127.99 141.11 51.62 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 164.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -100.32 100.51 11.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.006 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.78 -28.89 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.995 -163.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -121.91 169.63 10.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.329 1.062 . . . . 0.0 110.395 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -147.7 111.6 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -160.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.405 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 13.7 m-30 -119.01 120.47 37.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.5 mt -86.31 149.65 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.15 -39.73 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -78.03 -30.42 49.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.39 -25.48 29.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.492 1.042 . . . . 0.0 113.225 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -70.27 -40.19 74.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.842 1.201 . . . . 0.0 111.924 173.101 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -74.0 -21.07 60.13 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -88.3 -45.94 9.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.415 -0.803 . . . . 0.0 111.992 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.87 15.19 2.16 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 171.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -76.86 -13.55 59.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 120.213 2.006 . . . . 0.0 115.608 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.67 121.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.0 t -98.83 159.35 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 124.245 1.974 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.2 tp -130.44 120.54 24.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.217 -2.72 . . . . 0.0 111.309 -151.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -98.57 116.07 30.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.564 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -91.44 80.23 5.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.067 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.98 -78.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.16 14.2 20.81 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -155.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.6 m-85 -83.43 21.49 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.966 -170.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.65 27.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 57' ' ' TYR . 10.1 t -126.51 113.08 16.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.226 1.013 . . . . 0.0 108.938 160.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 91' ' ' LEU . 1.2 t -107.65 110.33 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -170.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -97.77 134.25 41.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.61 141.37 46.47 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 168.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 11' ' ' ILE . 30.7 mt -123.83 91.27 3.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.175 170.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 ' CD2' ' A' ' 12' ' ' HIS . 86.1 m -129.5 88.33 50.46 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.768 1.167 . . . . 0.0 110.015 170.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.22 76.45 4.52 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.911 1.741 . . . . 0.0 110.333 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -120.09 -30.32 4.7 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.67 178.45 5.96 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.157 0.98 . . . . 0.0 110.787 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -112.33 -56.64 2.37 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.991 -170.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 m -83.17 -49.7 9.2 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -170.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.88 178.78 0.43 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.728 0.775 . . . . 0.0 112.706 -169.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 pt -103.87 73.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.068 0.461 . . . . 0.0 111.204 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.05 26.71 0.34 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 118.351 -1.339 . . . . 0.0 114.506 170.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -130.49 148.86 71.65 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -82.27 149.54 15.18 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 CA-C-N 120.626 1.259 . . . . 0.0 111.153 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ptmm? -62.48 -35.78 80.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.69 -28.36 69.01 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.69 -30.35 56.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.789 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.4 -38.17 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 120.391 1.451 . . . . 0.0 110.977 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.1 t -66.86 -43.28 83.98 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.504 1.047 . . . . 0.0 112.716 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.15 -39.9 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.42 -37.85 83.7 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.245 0.929 . . . . 0.0 112.42 174.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.47 -29.85 68.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.284 0.947 . . . . 0.0 113.456 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.77 -10.06 59.36 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.9 m -99.46 14.93 28.1 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.7 mt -134.14 -175.95 4.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.165 0.983 . . . . 0.0 111.556 -159.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -117.75 174.88 2.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.73 -28.62 30.67 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 119.525 2.856 . . . . 0.0 119.525 170.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -102.43 54.45 0.79 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.191 1.359 . . . . 0.0 108.356 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.17 138.58 21.47 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.3 p -142.91 104.36 4.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.419 ' HA ' HG12 ' A' ' 60' ' ' VAL 0.274 3.9 tt -89.86 129.46 36.23 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 4.6 mp -114.24 85.4 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 -170.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.39 -80.97 0.05 OUTLIER Glycine 0 N--CA 1.464 0.505 0 N-CA-C 121.769 3.468 . . . . 0.0 121.769 -155.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.441 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.259 0.8 OUTLIER -115.5 169.96 8.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.567 1.175 . . . . 0.0 110.058 -139.909 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.7 t -102.36 -148.84 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.113 -157.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.77 -42.59 24.19 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.08 -32.79 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 125.126 2.394 . . . . 0.0 112.96 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 75.7 m-85 -76.28 -10.27 59.28 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 112.941 -1.936 . . . . 0.0 110.093 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.8 tttt -59.32 -50.24 74.75 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.675 -1.266 . . . . 0.0 112.388 168.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -35.55 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.064 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.652 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.34 -47.83 84.36 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 171.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.98 -42.81 80.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.191 0.52 . . . . 0.0 111.949 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.4 tp -60.73 -44.83 96.17 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.0 mt -79.71 -35.31 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.922 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -71.7 -18.46 62.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 30.04 5.32 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.648 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.3 m-85 -106.66 159.78 15.95 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.122 0.963 . . . . 0.0 108.663 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.42 105.26 9.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.568 HG13 ' CD1' ' A' ' 117' ' ' TRP . 17.3 tt -75.49 146.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.058 -168.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.935 HG13 ' HB2' ' A' ' 116' ' ' CYS . 26.8 pt -143.16 134.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.582 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -112.2 100.13 8.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 123.04 1.4 . . . . 0.0 110.268 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.62 172.92 5.79 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 113.408 -1.724 . . . . 0.0 108.099 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.46 -8.86 2.06 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.12 115.38 22.34 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 158.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -79.87 142.42 35.24 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.816 -166.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.935 ' HB2' HG13 ' A' ' 110' ' ' ILE 1.064 0.5 OUTLIER -126.39 173.63 9.2 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 113.919 -2.943 . . . . 0.0 111.655 -175.114 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.568 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.0 m0 -137.4 130.23 30.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.993 2.117 . . . . 0.0 105.79 139.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.329 0.2 OUTLIER -110.14 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.207 -0.933 . . . . 0.0 111.265 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -78.19 134.86 37.56 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 123.37 1.557 . . . . 0.0 108.536 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 111.883 -2.417 . . . . 0.0 114.407 -157.792 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 122.144 0.973 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 34' ' ' VAL . 98.5 mttt -96.95 103.85 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.927 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.7 t -76.39 141.31 41.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 118.756 -1.177 . . . . 0.0 107.99 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.62 -161.92 9.89 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.49 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -134.23 141.21 46.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.283 -1.458 . . . . 0.0 107.53 -171.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.9 tp -124.17 130.56 52.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.615 1.198 . . . . 0.0 109.236 173.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.12 120.52 42.09 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.153 173.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.6 mt -125.13 111.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -167.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.24 129.46 51.55 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -62.98 -10.08 19.15 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 N-CA-C 121.69 3.688 . . . . 0.0 121.69 -169.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.16 -50.36 55.01 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -161.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -86.08 -31.78 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.963 170.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.9 p -81.79 0.39 39.46 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -170.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -76.53 20.05 0.24 Allowed 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 120.437 1.471 . . . . 0.0 112.296 166.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 m -133.2 71.48 76.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 170.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.08 50.56 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.194 3.263 . . . . 0.0 116.845 -155.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -72.97 -45.62 56.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.039 -1.038 . . . . 0.0 111.585 162.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.4 mt -57.98 -34.91 70.48 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.0 t -64.39 -49.25 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.24 175.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.74 -36.45 81.03 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -63.89 -49.45 72.62 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.47 ' HA ' HE21 ' A' ' 28' ' ' GLN . 12.7 t -63.84 -40.35 96.38 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.014 0.824 . . . . 0.0 111.316 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -65.03 -30.91 71.92 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -44.78 71.15 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.71 1.141 . . . . 0.0 113.653 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.47 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.8 mt-30 -58.36 -53.14 61.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.565 173.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.85 68.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.36 18.28 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.0 p -57.94 -27.38 63.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 170.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.87 -125.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -146.46 14.6 1.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.981 0.896 . . . . 0.0 113.223 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 5' ' ' LYS . 10.4 t -98.83 149.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.011 170.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -128.39 134.76 48.88 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 161.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -91.21 100.61 13.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.16 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.63 -17.09 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 113.589 -1.642 . . . . 0.0 113.928 -162.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.56 169.7 10.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.239 1.019 . . . . 0.0 109.644 -174.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -143.39 125.22 15.11 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.372 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.416 ' CD1' HD21 ' A' ' 8' ' ' LEU . 2.9 m-85 -129.59 120.4 25.23 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.89 149.68 22.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp -63.3 -40.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -81.95 -30.47 31.72 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -82.12 -29.49 31.64 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.305 -0.872 . . . . 0.0 112.652 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.83 -40.66 68.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.367 0.985 . . . . 0.0 112.739 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -76.78 -16.9 59.33 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.668 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.05 -37.45 29.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.545 -0.722 . . . . 0.0 111.43 166.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.67 15.4 5.84 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -78.54 -24.92 45.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mt -114.81 120.3 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -120.08 120.2 35.55 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.786 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.469 ' HG ' ' H ' ' A' ' 53' ' ' GLU . 11.8 tp -130.99 174.44 10.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.132 0.968 . . . . 0.0 109.575 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.469 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 46.5 mt-10 -98.94 175.05 6.07 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.692 1.234 . . . . 0.0 111.724 -170.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.1 m-20 -91.41 94.06 9.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.981 -170.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.69 -147.2 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -165.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -100.08 35.0 2.16 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.64 -163.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.8 m-85 -81.94 21.66 0.85 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.081 -170.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.52 27.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -158.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' TYR . 9.8 t -129.32 115.06 17.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 162.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.26 94.04 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -162.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -97.85 134.37 41.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.36 142.43 38.7 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 170.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.6 tp -122.99 108.98 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.872 0.844 . . . . 0.0 109.603 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.405 ' CG2' ' HD2' ' A' ' 65' ' ' PRO . 25.5 m -143.97 154.93 59.01 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -170.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 82.9 Cg_exo -49.78 129.54 24.35 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.291 1.994 . . . . 0.0 114.702 170.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -89.89 -8.93 50.73 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -170.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.89 178.9 4.68 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.133 170.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -85.07 97.88 10.11 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.666 0.746 . . . . 0.0 110.103 -170.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.2 p -115.83 -63.05 1.51 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -135.27 88.36 2.41 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -170.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.9 pt -97.6 45.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.399 0.618 . . . . 0.0 111.292 -170.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.13 99.99 6.35 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -170.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -115.08 148.92 41.65 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 170.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -82.34 149.71 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 CA-C-N 119.701 0.929 . . . . 0.0 110.587 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.48 -36.59 82.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.738 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.49 -30.1 71.02 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.6 mt -76.68 -30.14 56.61 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.268 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.26 -36.66 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 119.845 1.202 . . . . 0.0 111.061 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.8 m -66.93 -40.57 87.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.694 1.134 . . . . 0.0 112.717 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.81 -35.76 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 122.025 -0.422 . . . . 0.0 111.991 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -59.87 -47.73 84.57 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.698 -0.626 . . . . 0.0 111.498 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.3 -30.87 71.37 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.33 -10.55 59.84 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -166.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 72.1 p -74.53 -33.13 62.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 165.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 mt -88.66 -170.66 3.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 122.283 1.039 . . . . 0.0 112.079 -159.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -134.26 174.92 4.1 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -52.39 -22.39 15.98 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 N-CA-C 120.292 3.151 . . . . 0.0 120.292 -170.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -102.12 46.57 0.92 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.26 1.391 . . . . 0.0 111.096 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -73.44 140.67 28.64 Favored Glycine 0 N--CA 1.467 0.737 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -147.04 120.17 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.214 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.433 1.9 tm? -98.4 129.55 45.04 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 111.641 -2.527 . . . . 0.0 104.705 -167.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.089 HD13 ' HB3' ' A' ' 116' ' ' CYS . 44.2 mm -119.38 85.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.584 1.538 . . . . 0.0 109.804 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.04 -79.11 0.04 OUTLIER Glycine 0 N--CA 1.464 0.528 0 N-CA-C 120.878 3.111 . . . . 0.0 120.878 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.605 HD12 HD11 ' A' ' 91' ' ' LEU . 1.5 mp -115.88 169.99 8.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.669 -133.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.2 p -114.93 -123.4 0.29 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.355 -0.84 . . . . 0.0 113.185 -156.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.51 -51.02 11.4 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -157.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 mt -60.35 -30.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.877 1.798 . . . . 0.0 111.266 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 77.7 m-85 -76.82 -16.63 59.38 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.581 -172.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.2 tttt -57.12 -55.13 38.76 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.373 -0.829 . . . . 0.0 112.277 169.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.93 -33.47 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.987 -0.446 . . . . 0.0 111.376 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.41 -45.28 95.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.02 84.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.34 -48.66 79.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.728 0.775 . . . . 0.0 112.554 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.6 tt -80.22 -35.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.309 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.63 -16.14 62.27 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.49 5.58 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 119.373 -1.394 . . . . 0.0 112.805 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 96.6 m-85 -106.63 159.58 16.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.79 108.79 11.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.669 HD11 ' OH ' ' A' ' 115' ' ' TYR . 18.1 tt -84.88 142.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.49 1.138 . . . . 0.0 112.569 -165.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.3 pt -147.13 135.07 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.579 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -126.61 100.14 6.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.002 1.858 . . . . 0.0 112.965 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.44 87.97 30.95 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.8 61.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 122.151 3.866 . . . . 0.0 122.151 -123.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -123.4 104.85 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.255 -2.869 . . . . 0.0 103.255 142.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.669 ' OH ' HD11 ' A' ' 109' ' ' ILE . 15.7 t80 -82.91 111.33 18.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -159.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.214 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 14.3 p -147.39 -156.75 0.74 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 125.061 2.362 . . . . 0.0 113.754 171.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.635 ' CD1' HG13 ' A' ' 109' ' ' ILE . 24.9 m0 -137.08 149.79 47.61 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 109.16 -3.654 . . . . 0.0 102.901 -167.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 144.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 6.2 ttpm? -88.44 134.92 33.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.532 0.682 . . . . 0.0 111.715 -171.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 -170.223 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 33' ' ' LYS . 2.8 t80 . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.616 0.246 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.82 155.12 38.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.96 0.886 . . . . 0.0 110.582 -166.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -77.56 141.62 39.46 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.474 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -133.7 -162.97 10.24 Favored Glycine 0 N--CA 1.466 0.678 0 C-N-CA 119.421 -1.371 . . . . 0.0 114.759 173.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.28 139.85 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.117 -1.542 . . . . 0.0 107.925 -171.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -124.33 132.88 53.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.162 0.982 . . . . 0.0 108.843 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.65 149.65 27.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.253 165.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.48 143.2 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -111.22 129.59 23.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -60.16 -17.41 45.69 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 N-CA-C 120.261 3.139 . . . . 0.0 120.261 -170.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.25 67.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -161.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.97 -28.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.357 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.8 p -77.14 -11.92 59.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -170.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.6 m -76.63 -1.5 27.96 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.697 1.59 . . . . 0.0 111.718 -170.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 19' ' ' PRO 0.336 91.3 m -98.78 168.73 9.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 167.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' THR . 95.0 Cg_exo -75.82 -8.69 19.29 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 N-CA-C 118.019 2.277 . . . . 0.0 118.019 -170.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.15 -50.1 20.86 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -163.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.99 -32.94 72.87 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.74 0.7 . . . . 0.0 112.16 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.93 -46.6 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.686 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -62.61 -34.01 76.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.65 -49.07 57.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.512 ' HA ' HE21 ' A' ' 28' ' ' GLN . 8.5 t -61.52 -41.49 97.39 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.191 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -65.13 -33.76 76.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.735 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -43.75 73.18 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.196 1.362 . . . . 0.0 113.598 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.512 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.5 mt-30 -56.93 -54.91 41.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.75 0.309 . . . . 0.0 111.586 173.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.24 -43.35 78.56 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.35 47.25 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.9 p -57.89 -36.47 72.45 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.86 -94.64 0.1 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.958 0.885 . . . . 0.0 110.351 -170.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' CG ' ' A' ' 4' ' ' TYR . 44.4 mmtm -129.88 -42.09 1.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.285 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.251 59.5 t -97.64 149.96 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 123.256 1.503 . . . . 0.0 112.594 -160.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -121.35 134.96 55.14 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.222 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -95.38 139.75 31.23 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.72 -24.7 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -170.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -121.52 169.73 10.38 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.63 1.205 . . . . 0.0 110.286 -174.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -147.34 125.57 12.22 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 114.249 -1.342 . . . . 0.0 108.85 -168.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -133.04 120.28 21.13 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.657 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.8 tt -92.58 149.45 21.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.16 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.54 ' H ' HD23 ' A' ' 41' ' ' LEU . 22.0 t-20 -79.4 -30.2 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.315 -0.866 . . . . 0.0 113.021 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.19 -37.55 45.4 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.153 -0.967 . . . . 0.0 112.662 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.2 tp -68.57 -40.62 80.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.549 0.69 . . . . 0.0 112.8 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -73.5 -21.2 60.48 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.835 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -83.75 -36.1 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.541 -0.725 . . . . 0.0 112.047 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.56 15.33 6.44 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.329 0.892 . . . . 0.0 115.329 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -76.09 -35.66 59.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.849 1.324 . . . . 0.0 113.689 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.9 mt -114.69 120.35 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -168.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.7 m -129.8 120.21 24.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.596 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 38' ' ' ASP . 93.3 mt -119.6 179.9 4.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.849 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.79 175.32 6.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.608 1.194 . . . . 0.0 111.763 -168.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 78.8 m-20 -89.32 93.34 9.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.553 -170.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.82 -147.42 0.25 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 -165.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -100.1 37.57 1.63 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.168 0.985 . . . . 0.0 113.243 -162.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.6 m-85 -82.28 21.74 0.9 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 117.191 -1.385 . . . . 0.0 112.259 -170.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.23 27.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -157.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.474 HG23 ' HA3' ' A' ' 7' ' ' GLY . 7.8 t -128.45 115.12 17.7 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 162.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 36.5 t -113.74 110.27 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -167.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -111.05 134.67 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.06 141.86 50.94 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.0 tp -123.78 94.28 4.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -170.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -140.47 154.72 69.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -170.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.97 145.37 19.3 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.824 2.35 . . . . 0.0 114.676 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.95 -16.94 28.87 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -166.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.85 178.52 4.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.806 1.184 . . . . 0.0 111.514 170.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -112.37 149.91 31.82 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.877 0.846 . . . . 0.0 111.227 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.6 p -125.03 -64.89 1.06 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 164.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -135.14 178.92 6.66 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.4 pt -88.95 90.64 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 122.439 1.114 . . . . 0.0 108.201 -170.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -79.8 -66.47 0.87 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 117.437 -1.268 . . . . 0.0 114.266 -167.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.7 t80 -77.05 148.47 78.52 Favored Pre-proline 0 N--CA 1.482 1.132 0 CA-C-N 122.837 2.562 . . . . 0.0 110.935 -170.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 19.8 Cg_exo -82.7 151.86 14.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 121.757 1.638 . . . . 0.0 112.246 170.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -62.46 -34.26 76.45 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 166.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.13 -34.5 76.48 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.7 -30.07 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.683 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.409 HG13 ' CE2' ' A' ' 73' ' ' PHE . 96.8 mt -59.34 -41.05 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 119.608 1.095 . . . . 0.0 111.155 167.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -64.76 -40.34 95.12 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.963 -1.086 . . . . 0.0 112.823 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -64.17 -37.18 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.91 -42.56 94.14 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.446 -0.784 . . . . 0.0 112.384 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.47 -29.8 70.84 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -75.79 -9.98 59.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 71.9 m -74.8 -40.05 61.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 169.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.2 mt -91.17 164.33 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.923 1.344 . . . . 0.0 113.593 -154.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.72 101.69 0.54 Allowed Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 112.206 -2.27 . . . . 0.0 105.402 163.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -51.06 6.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 N-CA-C 122.183 3.878 . . . . 0.0 122.183 -154.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -94.7 57.77 2.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 123.039 1.4 . . . . 0.0 108.571 163.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.88 167.51 38.34 Favored Glycine 0 N--CA 1.466 0.691 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.159 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -146.14 120.07 9.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.225 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.307 0.6 OUTLIER -92.7 129.85 38.5 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 112.618 -2.083 . . . . 0.0 107.905 -173.727 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.711 HD13 ' CB ' ' A' ' 116' ' ' CYS . 23.3 mm -113.75 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.85 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.462 0.42 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.533 HD12 HD21 ' A' ' 91' ' ' LEU . 6.2 mt -115.93 146.56 41.98 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.859 1.314 . . . . 0.0 110.646 -131.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.3 t -90.79 179.45 5.79 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.348 -165.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.9 44.06 0.73 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 120.25 3.426 . . . . 0.0 120.25 -161.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mt -96.16 -26.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 126.716 3.15 . . . . 0.0 109.959 137.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.783 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 92.2 m-85 -76.68 2.95 12.74 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 112.363 -2.199 . . . . 0.0 110.347 -168.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -71.83 -52.17 18.83 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.583 -1.323 . . . . 0.0 111.509 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.85 -33.36 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 122.081 -0.387 . . . . 0.0 110.732 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.94 -46.61 89.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 119.032 -1.067 . . . . 0.0 113.197 171.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.538 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -57.99 -39.78 79.08 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.99 -0.444 . . . . 0.0 111.817 176.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -58.48 -50.01 75.29 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.706 0.765 . . . . 0.0 112.394 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.8 tt -80.31 -34.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.438 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -71.79 -16.59 62.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 173.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.66 29.07 5.74 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.703 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 94.1 m-85 -106.54 159.56 16.08 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -117.46 154.09 32.0 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 161.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.63 HG12 ' CD1' ' A' ' 117' ' ' TRP . 19.1 mt -103.99 148.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.061 1.41 . . . . 0.0 109.812 -174.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 pt -140.29 125.57 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 113.246 -1.797 . . . . 0.0 106.628 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -121.99 87.41 2.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 124.072 1.892 . . . . 0.0 113.476 -168.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 114' ' ' ASP . 18.6 mp0 -134.21 100.29 12.96 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 -170.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -54.82 31.42 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.167 1 N-CA-C 124.342 4.709 . . . . 0.0 124.342 -139.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' GLU . 19.2 t70 -100.01 115.17 29.1 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 130.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -90.35 115.27 27.41 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.674 -164.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.225 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 14.5 p -146.86 -164.6 2.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.956 1.836 . . . . 0.0 115.452 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.63 ' CD1' HG12 ' A' ' 109' ' ' ILE . 22.7 m0 -137.55 130.04 29.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 110.804 -2.907 . . . . 0.0 105.625 -167.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.18 144.41 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -79.52 134.84 36.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.118 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 122.14 0.972 . . . . 0.0 111.138 170.334 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.79 141.74 35.96 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 123.086 1.422 . . . . 0.0 112.414 170.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -104.83 120.61 41.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.9 -1.954 . . . . 0.0 106.049 164.149 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -129.4 -163.62 11.23 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 119.728 -1.225 . . . . 0.0 114.906 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.37 145.02 48.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -167.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.34 135.72 53.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.583 1.182 . . . . 0.0 109.518 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -119.44 120.14 35.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.76 -1.563 . . . . 0.0 106.955 177.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -117.97 139.9 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 64' ' ' THR . 2.4 t60 -99.17 129.55 29.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -62.87 -11.46 24.45 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 N-CA-C 120.502 3.231 . . . . 0.0 120.502 -170.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.34 63.35 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -162.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.76 -30.16 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.574 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -81.04 0.32 36.38 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -76.23 -0.92 24.02 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 120.456 1.48 . . . . 0.0 112.018 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 m -114.82 71.48 2.58 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.99 55.88 3.5 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.717 2.945 . . . . 0.0 116.758 -154.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -71.91 -44.99 62.77 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.869 -1.144 . . . . 0.0 112.096 166.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.09 -29.93 68.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -65.2 -50.07 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.641 -0.662 . . . . 0.0 110.795 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.88 -38.18 81.49 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -60.81 -50.09 74.87 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -65.18 -38.49 90.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.534 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.61 -33.57 76.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.49 73.47 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -56.11 -56.17 24.07 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.99 96.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.3 -50.44 67.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 170.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -75.37 -11.49 60.06 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.544 -0.722 . . . . 0.0 112.704 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.85 -109.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.318 0.58 . . . . 0.0 111.467 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -139.68 20.27 2.52 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -121.88 110.55 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.245 -168.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.84 135.02 40.89 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -88.78 139.57 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.5 -32.63 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.014 -165.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.77 169.92 10.27 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.985 1.374 . . . . 0.0 110.904 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -142.41 125.32 16.12 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.018 -172.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.493 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 16.2 m-85 -119.61 149.64 41.62 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.009 166.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.37 149.72 26.71 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 164.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.419 HD13 ' OH ' ' A' ' 62' ' ' TYR . 4.5 tp -63.33 -39.41 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -78.85 -30.28 45.06 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.444 -0.785 . . . . 0.0 113.098 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.14 -30.46 38.99 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.283 -0.886 . . . . 0.0 112.933 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.63 -40.61 66.3 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.893 0.854 . . . . 0.0 112.525 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.29 -27.64 66.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.632 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -83.16 -39.3 21.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.929 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.19 15.38 2.29 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.84 1.496 . . . . 0.0 116.84 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.4 m -78.88 -14.32 59.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 -168.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.73 161.1 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.542 1.064 . . . . 0.0 110.318 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -99.84 120.4 39.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.988 -172.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.69 120.0 36.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.475 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.51 120.1 39.09 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -92.46 65.6 4.49 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -167.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.17 -77.16 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 170.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 6' ' ' THR . 90.8 mttt -100.04 57.41 0.97 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.389 1.09 . . . . 0.0 113.629 -161.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 59' ' ' THR . 11.8 m-85 -112.34 21.52 15.66 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.984 163.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.73 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 -157.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 57' ' ' TYR . 8.7 t -131.14 116.39 17.65 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 162.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.53 HG11 HD22 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -98.64 134.79 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 171.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.52 134.55 54.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.419 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -123.22 110.45 15.25 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.255 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.04 89.74 3.09 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -170.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 12' ' ' HIS . 33.5 m -131.08 154.45 82.02 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -170.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -73.93 141.19 29.71 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 121.974 1.782 . . . . 0.0 112.984 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -89.91 -30.14 18.06 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.262 -170.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.44 73.33 1.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.873 0.844 . . . . 0.0 109.452 -170.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -112.18 160.22 17.8 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.163 170.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.4 p -89.77 9.7 26.32 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.693 -0.803 . . . . 0.0 112.968 170.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -135.34 90.8 2.66 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.9 pt -98.72 69.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.687 0.756 . . . . 0.0 109.53 -170.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.01 139.75 53.53 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.197 0.999 . . . . 0.0 110.532 -170.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 15.8 t80 -130.24 149.02 72.13 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 166.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 32.2 Cg_exo -82.16 149.39 15.34 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 121.195 1.463 . . . . 0.0 110.25 -175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.73 -39.65 94.74 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -63.17 -27.64 69.51 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.83 -30.31 56.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.626 173.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.16 -35.08 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 119.729 1.15 . . . . 0.0 111.063 171.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.5 p -71.96 -36.79 69.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.789 1.177 . . . . 0.0 113.081 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.83 -38.43 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.696 -0.628 . . . . 0.0 111.816 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -40.53 95.57 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.457 -0.777 . . . . 0.0 112.168 174.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.95 -29.86 70.33 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -79.11 -29.42 43.23 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -76.52 -17.98 58.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 mp -124.32 100.82 6.87 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.553 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.266 80.4 mttt -74.77 -155.06 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.674 -166.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 6.1 Cg_endo -59.21 -31.38 95.17 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 N-CA-C 120.656 3.291 . . . . 0.0 120.656 -160.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -90.48 49.04 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.351 1.887 . . . . 0.0 110.659 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.43 144.07 26.55 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 173.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.7 p -146.71 117.07 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 123.445 1.593 . . . . 0.0 107.147 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.266 ' O ' ' CB ' ' A' ' 116' ' ' CYS 0.379 0.7 OUTLIER -97.42 133.95 41.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.39 -167.265 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.954 HD13 ' HB3' ' A' ' 116' ' ' CYS . 33.0 mm -121.53 87.39 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.576 1.535 . . . . 0.0 108.747 170.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.465 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -144.26 -78.58 0.04 OUTLIER Glycine 0 C--N 1.316 -0.546 0 N-CA-C 121.375 3.31 . . . . 0.0 121.375 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.465 HD13 ' HA3' ' A' ' 93' ' ' GLY 0.271 5.5 mp -115.67 172.01 7.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.611 1.196 . . . . 0.0 109.868 -124.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -109.13 -141.71 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.375 -1.284 . . . . 0.0 113.486 -156.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.96 -45.79 39.88 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -163.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mt -57.21 -32.84 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 124.397 2.046 . . . . 0.0 111.31 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 90.7 m-85 -76.89 -16.0 59.52 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.347 -1.751 . . . . 0.0 112.296 -170.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -57.71 -55.08 39.53 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.94 -1.1 . . . . 0.0 111.979 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.16 -35.27 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.755 -0.59 . . . . 0.0 111.795 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.649 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.75 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 173.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.99 79.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.196 0.522 . . . . 0.0 111.122 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.86 -46.67 74.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.607 0.718 . . . . 0.0 112.843 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.5 tt -80.2 -34.56 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.74 -17.89 62.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.78 21.52 9.63 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.618 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 119' ' ' LYS 0.271 94.7 m-85 -106.85 112.33 25.24 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -98.48 153.48 18.58 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.96 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.62 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -109.13 145.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 111.689 -2.505 . . . . 0.0 110.867 -155.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 pt -137.94 123.01 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -112.17 99.95 8.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.205 1.479 . . . . 0.0 110.723 -175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.0 -175.61 0.5 Allowed Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.085 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -55.52 -11.61 4.94 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 N-CA-C 118.733 2.551 . . . . 0.0 118.733 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -124.78 149.48 47.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 152.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.414 ' OH ' HD11 ' A' ' 109' ' ' ILE . 13.5 t80 -113.03 112.52 24.0 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 -170.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.266 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 25.2 p -147.73 -153.36 0.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.148 1.451 . . . . 0.0 112.527 169.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.62 ' CD1' HG13 ' A' ' 109' ' ' ILE . 4.4 m0 -136.85 153.52 50.75 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.559 -2.11 . . . . 0.0 105.483 -172.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.27 144.4 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 162.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 61.7 tttm -79.88 134.99 36.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.894 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.645 0.735 . . . . 0.0 110.283 170.326 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.53 103.65 10.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.567 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -76.77 120.44 21.94 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.38 -154.82 7.54 Favored Glycine 0 N--CA 1.464 0.505 0 CA-C-O 123.187 1.437 . . . . 0.0 115.893 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.477 HD11 ' CE2' ' A' ' 40' ' ' PHE . 18.4 tp -134.1 149.84 51.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 112.245 -1.978 . . . . 0.0 109.233 -168.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 tp -124.61 133.75 53.16 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.629 1.204 . . . . 0.0 107.782 157.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -114.46 120.36 40.0 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.262 173.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.5 mt -118.04 139.76 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -172.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -103.02 129.6 25.29 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -59.08 -16.95 35.66 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 N-CA-C 121.261 3.524 . . . . 0.0 121.261 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -50.31 58.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -160.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.78 -35.2 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.843 170.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -71.19 -12.14 61.32 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 t -76.7 1.14 17.94 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.984 1.265 . . . . 0.0 112.147 -170.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.352 53.9 m -98.86 168.12 10.24 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.5 -2.83 13.0 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 N-CA-C 117.873 2.22 . . . . 0.0 117.873 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -74.15 -50.45 19.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.957 1.253 . . . . 0.0 114.21 -166.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.06 -30.15 68.42 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.778 0.717 . . . . 0.0 112.368 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.43 -46.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.102 -0.374 . . . . 0.0 111.146 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -62.2 -36.33 81.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.039 0.836 . . . . 0.0 113.223 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -46.75 75.23 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.532 ' HA ' HE21 ' A' ' 28' ' ' GLN . 90.0 m -58.93 -45.68 89.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.826 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -63.97 -29.82 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.98 74.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.893 1.224 . . . . 0.0 113.38 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.532 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.1 mt-30 -57.63 -52.98 63.19 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.154 -0.341 . . . . 0.0 111.858 171.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.86 -45.71 60.01 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.883 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.83 -50.53 28.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.49 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.5 t -75.54 -29.52 59.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -170.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -85.86 -127.84 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.006 -0.434 . . . . 0.0 111.94 170.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -139.39 1.48 1.97 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -165.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -99.47 149.81 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.817 0.818 . . . . 0.0 112.28 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -122.65 143.78 49.55 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -104.24 100.37 10.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.279 1.037 . . . . 0.0 109.425 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.74 -40.59 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.84 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.09 169.77 10.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.246 1.022 . . . . 0.0 110.538 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -144.86 113.02 6.48 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -164.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' A' ' 8' ' ' LEU . 17.4 m-30 -118.83 120.19 36.6 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.36 150.09 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.16 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -76.74 -30.05 56.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.8 -35.73 32.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 113.137 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.12 -40.52 78.25 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.814 0.733 . . . . 0.0 112.724 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -66.1 -27.91 68.42 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.076 173.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -79.9 -39.12 31.08 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.3 10.69 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -78.34 -11.18 59.92 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.1 mt -114.9 121.77 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -169.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -98.6 120.84 39.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 124.014 1.864 . . . . 0.0 110.227 -164.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.0 mt -96.52 149.81 21.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 111.199 -2.728 . . . . 0.0 111.565 -163.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.76 169.75 9.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.255 -1.793 . . . . 0.0 107.498 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -116.34 35.95 4.31 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.28 -74.66 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -168.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' THR . 50.9 pttt -78.24 32.92 0.19 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -162.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.443 ' O ' ' N ' ' A' ' 59' ' ' THR . 7.6 m-85 -112.11 21.87 15.41 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 116.93 -1.51 . . . . 0.0 112.995 170.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.63 38.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -165.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.02 115.32 6.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 166.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.2 t -101.33 139.04 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -122.3 134.57 54.66 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -114.73 141.75 47.42 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.77 112.81 17.77 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 170.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.1 m -150.3 154.4 36.05 Favored Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -57.67 147.43 79.86 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.902 2.401 . . . . 0.0 115.499 170.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -120.09 30.01 7.22 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.654 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.37 -59.59 1.8 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.205 -0.934 . . . . 0.0 110.428 -170.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -81.64 115.31 20.85 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -170.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.2 p -73.71 89.75 1.8 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.335 1.064 . . . . 0.0 112.165 -170.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.05 178.89 6.67 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 170.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.13 149.31 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.577 170.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -106.07 -52.06 2.87 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 118.592 2.812 . . . . 0.0 118.592 -169.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.407 ' CE2' HG13 ' A' ' 78' ' ' ILE . 14.7 t80 -130.54 149.14 72.65 Favored Pre-proline 0 N--CA 1.473 0.704 0 O-C-N 120.837 -1.164 . . . . 0.0 108.76 -158.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 22.8 Cg_exo -82.09 149.8 15.61 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 CA-C-N 120.01 1.039 . . . . 0.0 111.365 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.52 -36.86 83.94 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -58.54 -34.22 70.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.67 -30.18 56.66 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.919 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.407 HG13 ' CE2' ' A' ' 73' ' ' PHE . 96.4 mt -59.84 -38.97 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 120.043 1.292 . . . . 0.0 111.236 167.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.6 m -65.68 -39.08 90.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.691 1.132 . . . . 0.0 112.908 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.55 -41.73 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.04 -41.5 92.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.652 -0.655 . . . . 0.0 112.58 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 85' ' ' LEU . . . -63.57 -29.76 70.97 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.88 -10.12 59.33 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -105.46 33.56 3.66 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 82' ' ' ALA . 92.5 mt -134.05 159.98 39.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.233 1.016 . . . . 0.0 111.053 -165.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.556 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 82.2 mttt -112.8 -156.4 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 165.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 14.8 Cg_endo -62.82 -33.81 74.63 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 CA-C-N 124.041 2.479 . . . . 0.0 113.855 -170.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -92.52 45.88 1.22 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 118.513 0.597 . . . . 0.0 109.912 -170.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 118' ' ' ILE . . . -79.74 116.71 4.34 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 172.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.4 t -139.32 107.04 5.62 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -166.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.23 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.279 1.3 tt -91.52 129.89 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -170.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.675 HD13 ' CB ' ' A' ' 116' ' ' CYS . 20.3 mm -105.89 86.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.977 0.894 . . . . 0.0 109.746 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.592 ' HA3' HD13 ' A' ' 94' ' ' LEU . . . -143.74 -83.49 0.06 OUTLIER Glycine 0 C--N 1.317 -0.488 0 N-CA-C 121.509 3.364 . . . . 0.0 121.509 -166.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.592 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -115.49 171.38 7.76 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.33 -1.348 . . . . 0.0 110.196 -138.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 85.0 p -110.28 -129.34 0.29 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.942 -163.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -79.3 -47.81 15.21 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -157.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 mm -59.64 -29.78 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 124.607 2.146 . . . . 0.0 111.317 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 76.0 m-85 -76.66 -11.0 59.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.354 -1.748 . . . . 0.0 111.149 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -64.92 -49.36 70.73 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.789 -1.194 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.09 -36.89 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.802 -0.561 . . . . 0.0 111.141 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -60.4 -43.0 97.1 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.929 171.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.538 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -57.28 -43.33 83.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 111.242 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.06 -48.26 76.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.4 tt -80.13 -35.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.811 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -71.96 0.47 9.24 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.38 41.79 97.96 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 119.807 1.185 . . . . 0.0 113.935 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.0 m-85 -106.91 111.76 24.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 165.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -98.88 117.93 34.49 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 123.474 1.607 . . . . 0.0 106.746 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.66 HG12 ' CD1' ' A' ' 117' ' ' TRP . 15.8 mt -74.74 152.52 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.811 -162.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.4 pt -139.58 128.93 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.159 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -106.86 78.82 1.27 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 124.302 2.001 . . . . 0.0 111.112 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.27 36.7 tt0 -93.13 162.49 28.25 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 111.341 -2.663 . . . . 0.0 107.14 166.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.56 -6.13 0.92 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 N-CA-C 118.934 2.628 . . . . 0.0 118.934 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -112.43 110.29 20.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 155.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -80.75 115.13 20.09 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.878 -0.514 . . . . 0.0 110.562 -168.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.23 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 15.0 p -147.04 -164.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 123.746 1.736 . . . . 0.0 114.102 172.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.66 ' CD1' HG12 ' A' ' 109' ' ' ILE . 3.1 m0 -137.79 130.19 29.38 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 111.459 -2.61 . . . . 0.0 106.073 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER -111.88 144.22 20.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 123.001 1.381 . . . . 0.0 107.478 169.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.87 134.84 36.33 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 113.682 -1.599 . . . . 0.0 109.467 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.47 0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.432 170.355 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 122.194 0.997 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -92.32 142.06 27.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.602 1.192 . . . . 0.0 111.148 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 56' ' ' LYS . 1.6 t -105.08 120.66 42.05 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.465 174.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.6 -161.12 10.05 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 118.814 -1.66 . . . . 0.0 113.811 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.458 HD13 ' OD2' ' A' ' 38' ' ' ASP . 42.5 tp -133.94 139.28 46.03 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.09 -1.055 . . . . 0.0 108.686 -167.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.7 tp -124.87 110.96 14.91 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 0.0 110.443 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.91 120.23 39.0 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.996 170.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -123.15 139.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.962 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.76 129.83 43.1 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.48 -11.02 10.05 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 N-CA-C 120.562 3.254 . . . . 0.0 120.562 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.71 -50.14 65.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -88.95 -30.29 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.873 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.5 p -78.74 -2.7 40.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -76.62 -9.8 58.93 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.933 1.242 . . . . 0.0 111.476 163.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.4 m -108.51 71.68 0.41 Allowed Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 165.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.29 46.68 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.363 3.375 . . . . 0.0 116.235 -154.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.86 -49.98 66.18 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.396 -0.815 . . . . 0.0 112.772 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.97 -29.82 70.77 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 122.05 -0.406 . . . . 0.0 112.03 173.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -63.59 -50.0 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.735 -0.603 . . . . 0.0 111.322 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.63 -36.45 76.38 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.223 -0.923 . . . . 0.0 113.301 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.09 -49.88 72.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -64.9 -35.85 82.48 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.786 0.721 . . . . 0.0 111.562 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -64.99 -35.13 80.21 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.12 -45.28 70.56 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.536 1.062 . . . . 0.0 113.11 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.334 2.3 tm0? -54.99 -52.11 64.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.15 86.46 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.587 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.28 -50.46 65.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.419 -170.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 m -75.25 -13.95 60.48 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.835 -0.541 . . . . 0.0 112.021 -170.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -85.79 -113.94 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.838 -0.539 . . . . 0.0 110.393 170.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -150.72 35.22 0.61 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 t -112.65 149.85 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.443 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.23 134.91 49.07 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 162.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -98.78 100.73 11.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.21 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.84 -14.6 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -164.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.458 ' OD2' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -121.73 120.4 34.55 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -173.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -114.92 114.34 25.34 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.551 -167.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -123.68 120.21 32.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.839 0.828 . . . . 0.0 109.428 -174.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp -87.65 149.8 24.05 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.415 HD13 ' OH ' ' A' ' 62' ' ' TYR . 3.9 tp -63.29 -38.3 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -78.54 -30.29 46.86 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -77.69 -41.09 39.21 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.305 -0.872 . . . . 0.0 112.494 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -67.03 -40.38 87.21 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.644 0.735 . . . . 0.0 112.947 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -73.84 -21.37 60.14 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.761 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.92 -35.01 38.48 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.595 -0.69 . . . . 0.0 111.421 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.12 15.27 5.66 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.811 0.684 . . . . 0.0 114.811 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -78.46 -40.29 36.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.6 mt -114.93 118.74 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 122.481 1.134 . . . . 0.0 109.5 -167.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.4 m -133.31 159.23 40.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 157.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.294 1.8 pt? -131.34 -70.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.329 164.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -141.46 169.8 16.92 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.892 0.853 . . . . 0.0 109.81 172.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -120.54 63.14 0.85 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.55 -92.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 6' ' ' THR . 43.5 pttt -100.29 64.55 1.18 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -161.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.437 ' O ' ' N ' ' A' ' 59' ' ' THR . 5.7 m-85 -112.1 21.77 15.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 116.367 -1.778 . . . . 0.0 113.346 170.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.54 41.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -157.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -147.15 115.68 6.71 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 165.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 91' ' ' LEU 0.25 40.9 t -118.4 134.62 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.403 -164.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.59 134.74 54.51 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.415 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -117.79 110.41 17.77 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 168.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.23 104.97 17.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.031 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.8 m -119.84 120.08 30.7 Favored Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 167.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.01 -91.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 121.875 1.717 . . . . 0.0 114.546 -164.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -96.84 -24.09 16.06 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -165.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.87 62.73 1.17 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.321 0.964 . . . . 0.0 111.829 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -112.1 97.21 6.5 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.9 p -125.02 -58.53 1.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -91.09 -167.53 1.83 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.488 0.661 . . . . 0.0 109.629 -170.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tp -82.66 71.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -88.75 35.01 0.77 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 14.7 t80 -130.5 148.81 71.45 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 164.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 27.4 Cg_exo -82.38 149.49 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 120.395 1.177 . . . . 0.0 110.161 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.6 -37.49 86.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.641 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.61 -29.55 70.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.2 mt -76.75 -30.16 56.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.322 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.31 -35.03 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-N 119.886 1.221 . . . . 0.0 111.033 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.2 t -68.5 -39.39 81.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.661 1.119 . . . . 0.0 112.657 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 121.916 -0.49 . . . . 0.0 111.755 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.98 -46.11 90.5 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.696 -0.628 . . . . 0.0 111.967 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.04 71.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.2 -13.01 56.29 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.3 m -71.26 -45.19 63.75 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 122.06 -0.4 . . . . 0.0 110.747 162.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.9 mt -97.67 161.47 13.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.926 1.346 . . . . 0.0 112.461 -163.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.424 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 63.9 mttp -108.43 -178.25 0.55 Allowed Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.287 -170.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 25.5 Cg_exo -56.15 -12.73 8.08 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 N-CA-C 119.96 3.023 . . . . 0.0 119.96 -170.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -102.37 33.32 3.17 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.14 1.336 . . . . 0.0 111.853 169.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.55 141.89 41.35 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 170.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 81.9 p -145.24 107.19 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.97 1.366 . . . . 0.0 108.325 -171.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -89.9 143.01 27.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.611 -1.632 . . . . 0.0 108.59 -172.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.38 88.41 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 167.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.22 -86.6 0.08 OUTLIER Glycine 0 CA--C 1.53 0.977 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 -159.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.54 169.82 8.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 120.052 1.926 . . . . 0.0 110.828 -147.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.4 m -104.89 -149.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -160.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.51 -43.06 86.31 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -163.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.01 -34.43 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 124.836 2.255 . . . . 0.0 110.526 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 65.7 m-85 -76.68 -10.49 59.42 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.142 -1.844 . . . . 0.0 111.073 -175.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.93 -52.83 58.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.829 -1.169 . . . . 0.0 112.188 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.76 -33.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.275 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.48 -46.01 91.85 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.531 -0.731 . . . . 0.0 112.847 172.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 109' ' ' ILE . . . -56.6 -42.57 78.98 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.886 -0.509 . . . . 0.0 111.827 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.05 -49.35 76.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.67 0.747 . . . . 0.0 112.502 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 tt -80.08 -34.62 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -170.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -71.61 -17.41 62.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.61 29.61 5.55 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 119.296 -1.43 . . . . 0.0 112.317 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.1 m-85 -106.71 159.84 15.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -126.88 108.1 10.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.548 1.166 . . . . 0.0 108.711 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.609 HG12 ' CD1' ' A' ' 117' ' ' TRP . 25.5 mt -84.5 111.24 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.962 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.676 HG13 ' SG ' ' A' ' 116' ' ' CYS . 44.9 pt -108.55 135.05 48.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.247 169.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -105.85 100.31 9.87 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.725 1.726 . . . . 0.0 110.668 -171.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -117.31 171.37 4.99 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 111.957 -2.383 . . . . 0.0 107.698 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -56.22 -8.5 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 N-CA-C 119.117 2.699 . . . . 0.0 119.117 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -119.47 115.26 23.69 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -79.57 139.09 37.63 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -165.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.676 ' SG ' HG13 ' A' ' 110' ' ' ILE 0.266 5.1 p -145.72 120.88 10.14 Favored 'General case' 0 CA--C 1.54 0.586 1 N-CA-C 123.375 4.583 . . . . 0.0 123.375 -164.141 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.609 ' CD1' HG12 ' A' ' 109' ' ' ILE . 4.0 m0 -109.64 111.06 22.32 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 143.98 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.682 1.23 . . . . 0.0 108.832 170.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 77.8 tttt -91.74 110.22 21.55 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.631 -174.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.832 0.825 . . . . 0.0 110.424 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -92.64 141.77 28.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.527 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 t -89.88 141.48 28.6 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 158.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.48 -167.09 11.55 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 123.762 1.757 . . . . 0.0 115.258 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 40' ' ' PHE . 30.5 tp -131.3 139.83 49.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 111.569 -2.315 . . . . 0.0 107.983 -173.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.285 0.2 OUTLIER -124.49 129.39 50.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 168.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -121.86 120.33 34.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -175.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.3 tt -129.1 139.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 -163.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -106.6 129.62 24.16 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -62.0 -11.67 22.58 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 N-CA-C 120.683 3.301 . . . . 0.0 120.683 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.21 -50.34 61.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -161.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.8 t -89.91 -30.35 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.689 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -84.17 0.24 49.42 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 5.72 7.01 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.364 1.438 . . . . 0.0 113.671 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.333 95.5 m -98.98 167.99 10.42 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 164.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.65 -13.23 16.4 Favored 'Trans proline' 0 N--CA 1.482 0.824 0 N-CA-C 117.133 1.936 . . . . 0.0 117.133 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.13 -50.34 19.86 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -161.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.32 -30.04 68.01 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.156 0.889 . . . . 0.0 112.189 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.59 -50.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.758 -0.589 . . . . 0.0 111.036 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.61 -36.78 76.99 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.304 -0.873 . . . . 0.0 113.335 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -61.86 -50.12 73.51 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.496 ' HA ' HE21 ' A' ' 28' ' ' GLN . 12.3 t -66.53 -37.57 85.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.691 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.89 -31.21 72.34 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 170.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.15 67.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.607 1.094 . . . . 0.0 113.195 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.496 HE21 ' HA ' ' A' ' 25' ' ' THR . 35.0 mt-30 -56.39 -54.57 44.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.341 0.591 . . . . 0.0 111.185 171.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.48 -40.33 59.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.67 -50.02 9.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.2 p -60.77 -24.54 65.84 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -126.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.655 -0.653 . . . . 0.0 110.429 170.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -144.72 -9.15 0.63 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -168.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.61 110.46 26.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -98.78 146.7 25.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.632 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -88.7 100.36 13.06 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 123.374 1.559 . . . . 0.0 110.465 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -36.5 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 112.375 -2.193 . . . . 0.0 113.268 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -121.89 169.58 10.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.226 1.012 . . . . 0.0 111.377 -170.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -150.13 125.58 10.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.556 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.537 ' O ' HD23 ' A' ' 10' ' ' LEU . 30.4 m-85 -133.03 120.67 21.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.62 149.45 24.29 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 tp -63.63 -40.16 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -79.17 -30.28 43.43 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.746 . . . . 0.0 112.843 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -82.24 -24.92 34.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -40.41 71.4 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.434 1.015 . . . . 0.0 111.901 174.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -78.19 -27.66 47.98 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.96 -37.56 34.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.842 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.3 15.38 2.78 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 116.904 1.522 . . . . 0.0 116.904 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -75.62 -29.44 59.21 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.457 1.629 . . . . 0.0 114.612 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.1 mt -114.58 120.16 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.8 m -124.45 120.2 31.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.762 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.5 mt -123.79 -163.44 1.14 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.87 171.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -98.79 169.84 9.18 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.923 1.344 . . . . 0.0 111.797 -166.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -90.21 94.62 9.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.426 170.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.65 -162.05 1.41 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -168.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -95.49 58.0 1.99 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.901 -1.499 . . . . 0.0 110.872 -170.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' THR . 3.9 m-85 -81.4 22.45 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 117.012 -1.47 . . . . 0.0 112.568 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.406 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 35.6 mt-10 -60.76 38.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -164.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.73 115.46 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 164.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.56 110.54 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.324 -157.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.37 106.55 16.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.982 -174.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.77 141.52 28.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 171.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.289 22.3 tp -123.53 115.11 20.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.867 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -149.27 154.35 38.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.34 128.86 31.78 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.559 2.172 . . . . 0.0 116.288 170.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.01 28.68 7.94 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.592 -170.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.93 -68.42 0.81 Allowed 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.13 -0.981 . . . . 0.0 109.029 -170.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.28 115.15 21.85 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -82.01 78.74 8.67 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.879 0.847 . . . . 0.0 110.265 170.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -135.14 47.7 2.32 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.027 168.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.6 pt -108.11 149.86 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -170.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -124.98 140.1 53.22 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.051 0.929 . . . . 0.0 110.757 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 -127.03 149.03 68.21 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 167.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 39.1 Cg_exo -82.12 149.67 15.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 CA-C-N 120.626 1.259 . . . . 0.0 110.332 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.62 -36.67 83.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -66.44 -26.08 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.87 -30.2 56.14 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.743 1.156 . . . . 0.0 111.106 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -39.14 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.935 1.243 . . . . 0.0 110.928 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.2 m -67.44 -40.99 85.47 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.321 -0.862 . . . . 0.0 112.586 176.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.91 -38.9 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.272 0.487 . . . . 0.0 112.266 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.86 -39.08 87.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.543 1.065 . . . . 0.0 112.381 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -29.65 70.67 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.23 -9.85 59.02 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.7 m -70.83 -36.43 72.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 165.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.83 159.77 18.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 123.02 1.391 . . . . 0.0 113.293 -153.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.02 101.76 0.68 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 112.02 -2.355 . . . . 0.0 105.329 162.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.17 11.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.532 0 N-CA-C 122.055 3.829 . . . . 0.0 122.055 -154.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -102.41 53.48 0.79 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.549 1.166 . . . . 0.0 108.165 162.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 58' ' ' GLU . . . -68.54 163.41 49.4 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 168.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 30.8 t -147.02 120.13 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.502 HD21 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -99.38 139.82 34.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.505 -168.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.63 90.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 167.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.55 -94.31 0.19 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 -160.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.502 HD12 HD21 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -116.44 169.9 8.96 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.919 -146.151 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -123.38 -115.74 0.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -156.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.26 -63.01 1.15 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -157.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.5 mt -59.66 -27.95 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 124.373 2.035 . . . . 0.0 111.537 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.657 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 67.8 m-85 -76.82 -19.27 57.74 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.026 -170.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.23 -52.06 62.51 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.776 -1.202 . . . . 0.0 112.345 169.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.92 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.842 -0.536 . . . . 0.0 111.819 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.657 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.56 -43.22 97.52 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.34 -42.2 98.3 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.17 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.6 tp -55.88 -46.76 78.23 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 tt -79.95 -38.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.254 -171.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -71.98 1.93 6.45 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.66 43.63 96.11 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 120.774 -1.203 . . . . 0.0 114.048 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.562 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 86.5 m-85 -109.45 111.83 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 167.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -98.92 112.23 24.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 123.61 1.671 . . . . 0.0 108.107 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.581 HG13 ' CD1' ' A' ' 117' ' ' TRP 0.257 16.3 tt -83.59 156.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 112.057 -2.338 . . . . 0.0 112.619 -164.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.627 HG23 ' SG ' ' A' ' 116' ' ' CYS . 14.6 tt -147.21 128.32 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.843 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -102.66 98.32 8.38 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 123.282 1.515 . . . . 0.0 112.386 -167.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.16 171.61 8.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.056 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.47 -10.29 4.78 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 N-CA-C 119.295 2.767 . . . . 0.0 119.295 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -125.17 115.02 19.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 160.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.425 ' OH ' HD11 ' A' ' 109' ' ' ILE . 38.1 t80 -79.64 138.78 37.51 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.38 -163.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.627 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.289 5.4 p -146.26 120.89 9.79 Favored 'General case' 0 CA--C 1.55 0.955 1 N-CA-C 127.042 5.941 . . . . 0.0 127.042 -164.924 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.581 ' CD1' HG13 ' A' ' 109' ' ' ILE . 7.4 m0 -109.63 114.91 28.91 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.49 1.496 . . . . 0.0 109.229 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.3 OUTLIER -99.62 143.92 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -79.91 134.9 36.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.911 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 121.699 0.762 . . . . 0.0 109.846 170.455 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -84.34 141.79 30.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.687 0.756 . . . . 0.0 111.187 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.0 m -104.63 140.82 37.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.22 -156.69 7.95 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-O 123.86 1.811 . . . . 0.0 117.011 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.488 HD21 ' CD2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -134.54 142.37 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 111.472 -2.364 . . . . 0.0 109.704 -174.107 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 tp -124.21 133.23 53.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 162.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -120.14 120.29 35.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.442 174.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 16' ' ' THR . 16.1 tt -132.15 139.91 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -164.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -105.71 129.92 23.88 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -59.96 -12.37 18.62 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 N-CA-C 121.381 3.57 . . . . 0.0 121.381 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.33 -50.36 71.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -160.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.3 t -88.86 -28.92 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.491 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.411 ' HB ' HD11 ' A' ' 11' ' ' ILE . 47.7 p -79.05 0.3 28.39 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -170.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.1 m -76.62 0.74 19.09 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 119.575 1.079 . . . . 0.0 111.993 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 m -98.55 169.09 8.79 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 162.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -77.18 2.48 7.61 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 N-CA-C 120.676 3.299 . . . . 0.0 120.676 171.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.31 -50.93 16.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 121.212 1.824 . . . . 0.0 115.312 -165.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.43 -31.6 70.03 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.558 -0.714 . . . . 0.0 112.56 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.88 -47.67 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.644 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.93 -33.27 75.63 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -64.74 -49.89 69.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.474 ' HA ' HE21 ' A' ' 28' ' ' GLN . 10.1 t -64.05 -41.75 97.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.321 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.7 -30.23 71.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.575 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.28 -45.64 69.15 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.179 1.354 . . . . 0.0 113.511 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.4 mt-30 -56.52 -53.81 53.14 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.689 173.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.9 79.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.741 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.26 43.36 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.998 -0.439 . . . . 0.0 111.23 -170.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.2 p -73.32 -21.8 60.47 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.606 0.639 . . . . 0.0 111.568 -170.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.73 -113.44 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -157.41 17.36 0.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -168.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.87 152.67 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.3 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -128.39 135.02 48.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 165.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.75 100.56 13.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.816 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.57 -21.22 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -167.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.98 121.47 37.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -167.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -114.2 124.28 51.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.089 0.947 . . . . 0.0 109.635 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CD2' HD21 ' A' ' 8' ' ' LEU . 22.2 m-30 -127.32 103.25 7.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.528 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 43' ' ' ASN . 8.0 tt -84.97 149.79 25.37 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.03 -39.94 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' H ' HD23 ' A' ' 41' ' ' LEU . 36.8 t30 -78.57 -30.13 46.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.64 -29.59 33.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.25 0.932 . . . . 0.0 113.19 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -40.51 54.71 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.38 0.991 . . . . 0.0 112.084 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -69.56 -28.23 65.81 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.34 -41.84 24.05 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.6 15.27 8.9 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.301 1.28 . . . . 0.0 116.301 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 m -73.38 -8.27 55.15 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 119.499 1.649 . . . . 0.0 115.45 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.9 mt -114.72 121.82 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.976 -0.452 . . . . 0.0 109.99 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.7 m -98.48 120.66 39.28 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.199 1.952 . . . . 0.0 108.978 -172.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.267 63.4 tp -96.73 149.54 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 110.752 -2.931 . . . . 0.0 111.591 -161.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -110.42 169.79 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.667 166.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -120.1 44.42 2.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -166.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.12 -73.1 0.07 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 119.446 3.128 . . . . 0.0 119.446 -166.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -81.71 30.53 0.37 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -157.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 59' ' ' THR . 0.6 OUTLIER -112.22 21.27 15.99 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 117.659 -1.162 . . . . 0.0 112.621 -170.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.82 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 -166.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -147.09 115.5 6.67 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 169.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 24.4 t -119.33 134.34 63.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.11 -1.405 . . . . 0.0 107.706 -165.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -122.58 134.6 54.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.44 142.45 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.77 102.37 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -137.23 113.86 9.68 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.3 133.76 36.91 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.733 2.289 . . . . 0.0 114.974 170.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -120.04 30.18 7.14 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.884 -170.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.84 -66.0 0.93 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.516 -0.74 . . . . 0.0 110.256 -170.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -80.65 -63.59 1.38 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -170.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.1 p -90.84 158.7 16.66 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -170.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -71.72 178.65 3.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.572 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.1 tt -98.47 93.33 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 122.125 0.964 . . . . 0.0 109.539 -170.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -102.01 94.1 5.6 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -170.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -130.14 90.97 40.49 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.551 170.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -55.77 149.66 49.14 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.806 1.671 . . . . 0.0 112.887 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.52 -34.74 77.5 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.5 -31.45 67.88 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.81 -30.06 56.23 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.113 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.62 -35.45 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 119.769 1.168 . . . . 0.0 111.614 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 98.3 p -69.12 -36.83 77.94 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.21 1.368 . . . . 0.0 112.967 173.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.08 -37.42 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.815 -0.553 . . . . 0.0 111.902 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -59.96 -46.07 90.62 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.819 -0.551 . . . . 0.0 112.042 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.11 -30.0 70.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -73.62 -9.99 59.24 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 m -106.87 30.22 6.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -134.07 162.52 31.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.044 0.926 . . . . 0.0 109.846 -169.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 174.97 2.31 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -58.52 -12.4 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 118.455 2.444 . . . . 0.0 118.455 -170.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -102.0 46.76 0.92 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.943 0.792 . . . . 0.0 110.676 170.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.31 140.58 24.75 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.5 t -146.3 106.27 4.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.17 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.259 3.1 tt -89.91 129.92 36.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -175.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.001 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 27.2 mm -104.42 91.11 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 122.337 1.065 . . . . 0.0 108.31 170.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.76 -95.13 0.2 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 120.745 3.058 . . . . 0.0 120.745 -162.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.453 HD22 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.5 169.62 9.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 118.017 -1.473 . . . . 0.0 109.464 -142.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -118.26 -118.07 0.32 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -158.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.09 -54.24 8.23 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -156.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -61.0 -29.33 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 124.548 2.118 . . . . 0.0 111.294 170.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.72 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 91.1 m-85 -76.78 -9.41 58.65 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.291 -1.777 . . . . 0.0 112.03 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -63.95 -56.05 17.99 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.295 -0.878 . . . . 0.0 111.468 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.84 -31.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 122.188 -0.32 . . . . 0.0 111.513 172.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.72 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -62.89 -46.5 87.56 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.539 -0.725 . . . . 0.0 112.451 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' HD11 ' A' ' 109' ' ' ILE . . . -54.9 -41.8 71.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.088 0.404 . . . . 0.0 111.777 173.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.6 tp -63.19 -45.14 93.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.6 mt -80.08 -34.95 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -71.75 -15.5 62.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 27.88 6.12 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.589 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 97.4 m-85 -106.52 159.6 16.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 172.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -118.71 154.13 33.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 161.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.685 HG12 ' CD1' ' A' ' 117' ' ' TRP . 22.5 mt -103.89 148.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 122.994 1.378 . . . . 0.0 109.282 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.82 123.11 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.891 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -115.48 100.18 7.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.942 1.829 . . . . 0.0 110.913 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -134.22 -178.54 0.88 Allowed Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 111.215 -2.72 . . . . 0.0 106.194 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.52 -7.14 1.2 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -135.07 115.27 13.28 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 161.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -86.77 115.02 23.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.296 -167.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.17 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 27.9 p -147.6 -158.62 0.93 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 122.674 1.226 . . . . 0.0 114.099 167.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.685 ' CD1' HG12 ' A' ' 109' ' ' ILE . 5.9 m0 -137.31 130.36 30.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.452 -1.703 . . . . 0.0 106.438 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.89 144.0 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 122.708 1.242 . . . . 0.0 108.276 167.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 76.4 tttt -87.16 110.39 20.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.797 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.499 0.666 . . . . 0.0 112.14 170.384 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.0 t80 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.1 141.94 28.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.218 1.008 . . . . 0.0 111.831 -165.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -94.44 141.77 28.21 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 166.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.53 -158.32 8.64 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 119.369 -1.396 . . . . 0.0 114.625 169.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.48 139.95 45.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -174.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.307 0.0 OUTLIER -124.38 129.35 50.54 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 174.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.44 120.23 40.95 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.4 mt -124.81 139.98 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.636 -171.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -98.69 129.77 29.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 160.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -60.96 -11.99 20.59 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 N-CA-C 121.75 3.711 . . . . 0.0 121.75 -170.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.29 74.52 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -159.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 65' ' ' PRO . 44.8 t -96.32 -29.83 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 119.29 0.95 . . . . 0.0 111.81 170.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 p -65.21 0.03 1.54 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -76.3 -10.32 59.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.118 1.781 . . . . 0.0 112.077 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.317 92.5 m -98.8 167.98 10.49 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 163.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.87 -3.17 13.27 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 N-CA-C 117.674 2.144 . . . . 0.0 117.674 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.96 -50.42 20.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.428 1.467 . . . . 0.0 114.521 -161.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.2 -32.46 71.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.429 -0.794 . . . . 0.0 112.585 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.49 -47.79 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.504 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.45 -47.3 70.57 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.3 m -58.89 -46.23 88.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.938 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.1 mmmt -60.92 -29.94 69.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.33 74.36 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.203 1.365 . . . . 0.0 113.488 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -60.0 -54.05 50.67 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.039 0.447 . . . . 0.0 111.401 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.06 45.77 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.94 -45.67 11.27 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.8 p -58.02 -34.19 69.78 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.92 -113.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -170.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 38.0 tptt -137.88 -13.1 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.532 -170.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 59' ' ' THR . 3.3 p -117.26 110.41 31.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -170.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -98.65 139.58 34.15 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.218 1.009 . . . . 0.0 108.887 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.58 139.75 30.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.34 -30.05 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -160.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -121.61 169.88 10.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.782 1.277 . . . . 0.0 109.015 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -143.82 125.1 14.63 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.24 -1.346 . . . . 0.0 108.846 -169.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -125.87 113.84 17.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.873 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -86.8 149.93 24.5 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -40.03 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -79.93 -30.25 39.92 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -79.75 -32.54 41.06 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.356 -0.84 . . . . 0.0 113.009 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -73.61 -40.62 63.69 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.969 0.804 . . . . 0.0 112.844 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -70.55 -26.12 63.4 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.799 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.26 -42.28 16.03 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 119.106 -0.473 . . . . 0.0 112.149 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.76 15.44 2.63 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 169.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -76.21 -19.45 58.38 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.086 1.943 . . . . 0.0 115.103 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.62 121.85 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.0 t -98.96 159.38 15.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 125.249 2.452 . . . . 0.0 111.403 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.32 120.98 43.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 109.588 -3.46 . . . . 0.0 111.142 -158.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -98.16 169.17 9.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.475 -1.29 . . . . 0.0 107.552 162.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -120.55 52.67 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -159.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -86.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 6' ' ' THR . 95.4 mttt -100.04 57.45 0.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.017 0.913 . . . . 0.0 113.39 -158.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' THR . 4.4 m-85 -112.1 21.14 16.18 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.323 169.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.91 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -161.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.515 HG21 HG21 ' A' ' 34' ' ' VAL . 14.6 t -137.41 115.43 11.57 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 161.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -117.42 101.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 -164.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -97.83 134.4 41.03 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.66 110.31 18.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.377 1.084 . . . . 0.0 109.193 174.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.7 mt -98.73 102.06 13.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.412 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.0 m -122.36 94.77 47.6 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HG2' ' H ' ' A' ' 15' ' ' VAL . 60.7 Cg_endo -80.1 94.47 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.216 1.944 . . . . 0.0 112.853 170.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -120.07 -30.21 4.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.878 169.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.68 -89.61 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 170.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -112.22 -57.69 2.24 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.197 -0.314 . . . . 0.0 110.487 170.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.9 p -99.99 175.59 5.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.376 1.084 . . . . 0.0 111.684 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -82.1 100.48 9.8 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.4 pt -62.17 -151.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 170.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -79.64 139.75 37.32 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 123.255 1.502 . . . . 0.0 113.779 -160.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.9 t80 -130.59 149.25 72.98 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 112.744 -2.026 . . . . 0.0 107.541 -170.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 32.3 Cg_exo -81.88 149.44 15.9 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 CA-C-N 120.894 1.355 . . . . 0.0 110.741 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -62.6 -40.35 96.67 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.5 -32.27 68.66 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -76.7 -30.26 56.62 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.742 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.42 -35.09 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 119.817 1.189 . . . . 0.0 111.554 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -70.25 -36.79 74.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.288 1.403 . . . . 0.0 112.884 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.56 -39.22 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 121.668 -0.645 . . . . 0.0 111.597 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -60.04 -46.2 90.29 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.814 -0.554 . . . . 0.0 112.073 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 -29.92 70.35 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.85 -32.0 72.21 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -167.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.5 p -92.68 33.27 1.14 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.6 mt -134.16 175.49 9.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.619 1.199 . . . . 0.0 111.818 -166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -116.32 175.06 2.09 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.66 -25.98 21.73 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 N-CA-C 119.103 2.694 . . . . 0.0 119.103 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -102.27 51.15 0.82 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.68 1.582 . . . . 0.0 110.454 169.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.23 142.92 30.01 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.2 p -144.16 105.88 4.3 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.211 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.366 0.3 OUTLIER -89.68 129.65 36.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.084 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.022 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 39.9 mm -112.44 91.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 122.11 0.957 . . . . 0.0 109.699 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.09 -86.41 0.08 OUTLIER Glycine 0 C--N 1.315 -0.607 0 N-CA-C 120.902 3.121 . . . . 0.0 120.902 -171.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.602 HD12 HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -116.18 169.77 9.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 -137.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 t -108.66 -131.79 0.31 Allowed 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.87 -1.144 . . . . 0.0 112.819 -156.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -80.0 -49.42 11.85 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -158.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -58.69 -30.23 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 124.33 2.014 . . . . 0.0 112.984 168.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.4 m-85 -76.46 -14.99 60.02 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 113.167 -1.833 . . . . 0.0 110.453 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.4 tttt -58.5 -50.67 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.194 -0.941 . . . . 0.0 112.316 165.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.83 -36.82 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.786 -0.571 . . . . 0.0 111.202 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.58 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.97 -43.89 94.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 170.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.83 97.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.458 0.647 . . . . 0.0 111.796 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.73 -47.82 83.3 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.467 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.5 mt -76.35 -35.18 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.055 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -71.85 -19.97 61.89 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 33.31 4.09 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.884 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 98.0 m-85 -106.67 159.83 15.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.28 1.038 . . . . 0.0 108.28 168.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.56 106.39 10.55 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.651 HG13 ' CD1' ' A' ' 117' ' ' TRP . 16.8 tt -75.32 144.97 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 122.371 1.081 . . . . 0.0 112.05 -169.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.7 tt -154.18 129.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 122.669 1.223 . . . . 0.0 108.635 -173.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -96.83 99.98 11.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.328 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.86 173.92 2.71 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 113.168 -1.833 . . . . 0.0 108.139 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -54.9 -14.28 7.76 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 118.966 2.641 . . . . 0.0 118.966 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -130.0 115.22 16.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 153.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.46 139.01 32.49 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.604 -164.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.211 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 12.0 p -147.77 -155.02 0.59 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 123.209 1.481 . . . . 0.0 111.731 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.651 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.7 m0 -137.13 130.11 30.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.69 144.22 19.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.529 1.157 . . . . 0.0 108.299 171.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.31 134.63 36.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.169 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.469 0.521 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.594 170.362 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -111.59 141.82 44.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.216 1.484 . . . . 0.0 112.155 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -105.06 120.87 42.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 112.466 -2.152 . . . . 0.0 105.79 165.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.91 -161.95 10.27 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 119.465 -1.35 . . . . 0.0 116.255 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.532 HD21 ' CE2' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -134.24 139.27 45.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.182 -1.009 . . . . 0.0 108.69 -165.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.99 134.65 52.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.341 1.067 . . . . 0.0 108.558 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -113.02 120.55 41.75 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.512 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.35 140.65 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -97.77 129.73 30.65 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 163.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -63.17 -10.59 21.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 N-CA-C 120.441 3.208 . . . . 0.0 120.441 -170.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.92 -50.26 62.95 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 -162.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.5 t -84.88 -30.14 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.553 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -81.91 0.21 40.79 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -170.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 93.6 m -76.32 -6.24 50.63 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 120.056 1.298 . . . . 0.0 111.537 164.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 m -113.19 71.48 1.46 Allowed Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.69 58.74 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.964 3.109 . . . . 0.0 115.971 -155.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.36 -50.15 23.5 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.59 -1.319 . . . . 0.0 111.751 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 -29.89 70.93 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.69 0.677 . . . . 0.0 112.348 176.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.95 -49.98 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 121.857 -0.527 . . . . 0.0 111.403 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.89 -36.58 77.25 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.294 -0.879 . . . . 0.0 113.298 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -63.1 -49.45 74.39 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.539 ' HA ' HE21 ' A' ' 28' ' ' GLN . 8.7 t -64.82 -38.01 89.56 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.198 0.908 . . . . 0.0 111.597 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -62.39 -35.22 78.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 169.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.45 72.08 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.441 1.019 . . . . 0.0 113.489 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.539 HE21 ' HA ' ' A' ' 25' ' ' THR . 34.5 mt-30 -59.49 -53.84 53.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.867 0.365 . . . . 0.0 111.6 174.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -57.15 -39.87 76.09 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.83 -46.99 15.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -170.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 98.1 p -57.96 -20.55 38.68 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.74 -105.08 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.737 -0.602 . . . . 0.0 109.521 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -150.39 15.53 0.8 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -170.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.438 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 22.8 t -126.65 110.63 23.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.509 -168.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.33 134.94 41.46 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 165.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -89.06 139.72 30.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.26 -26.05 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -163.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.69 121.36 37.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -113.98 118.24 33.58 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.812 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 8' ' ' LEU . 13.0 m-30 -121.97 106.14 10.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.812 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.73 149.76 25.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -63.25 -40.07 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -76.65 -30.24 56.74 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.96 -31.8 34.71 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.69 -40.39 69.59 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.551 1.069 . . . . 0.0 112.346 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -72.79 -18.55 61.47 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.14 -38.8 16.11 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.496 -0.752 . . . . 0.0 111.882 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.32 15.24 7.78 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.4 m -79.11 -3.3 44.75 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 -171.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -114.72 169.55 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.588 -0.695 . . . . 0.0 109.369 -163.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -99.91 158.54 15.74 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 123.629 1.681 . . . . 0.0 109.515 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.4 150.08 52.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.312 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.3 169.52 16.35 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 160.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -120.59 46.33 2.02 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.06 -82.25 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 6' ' ' THR . 65.9 mttm -100.2 63.46 1.15 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.888 0.851 . . . . 0.0 111.94 -161.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' THR . 17.9 m-85 -112.25 21.59 15.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 117.138 -1.411 . . . . 0.0 112.666 167.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -61.74 31.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -158.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 57' ' ' TYR . 8.4 t -135.85 115.36 12.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 162.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 83.6 t -115.81 110.33 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -164.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.86 134.56 49.82 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 142.04 46.32 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 162.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.94 104.53 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 170.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.7 m -143.7 120.16 6.52 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.6 128.86 32.03 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.413 2.076 . . . . 0.0 113.507 170.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -103.39 30.12 5.16 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -170.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.99 -53.22 2.72 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.323 -0.861 . . . . 0.0 112.247 -170.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -79.83 -47.32 15.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -169.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.6 p -70.96 147.96 48.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.514 0.673 . . . . 0.0 111.704 170.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -82.59 -108.14 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 170.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.7 pp -88.63 149.71 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 119.742 1.155 . . . . 0.0 108.669 -170.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.25 34.3 tttp -125.57 -97.45 0.42 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -165.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 30.9 t80 -74.69 149.04 85.72 Favored Pre-proline 0 N--CA 1.48 1.07 0 O-C-N 120.715 -1.241 . . . . 0.0 112.002 -154.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 23.0 Cg_exo -82.24 149.98 15.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 121.087 1.191 . . . . 0.0 111.581 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -62.33 -33.91 75.61 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.71 -30.37 71.04 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -76.62 -30.18 56.8 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.177 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.413 HG13 ' CE2' ' A' ' 73' ' ' PHE . 97.1 mt -61.39 -36.99 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 119.741 1.155 . . . . 0.0 111.242 166.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.4 m -64.17 -40.95 97.2 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.07 1.304 . . . . 0.0 112.448 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.08 -43.49 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.15 -37.81 88.69 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.363 -0.836 . . . . 0.0 112.914 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.86 -29.7 70.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 174.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.91 -10.4 59.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 77.3 p -104.27 11.35 34.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.21 101.49 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -165.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HB3' ' HD2' ' A' ' 87' ' ' PRO 0.257 54.1 mttp -74.19 -160.35 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.482 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.523 170.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 8.2 Cg_endo -54.21 -42.26 68.85 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 N-CA-C 120.611 3.273 . . . . 0.0 120.611 -155.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -102.11 43.31 1.08 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 121.348 1.886 . . . . 0.0 110.93 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.84 140.09 37.71 Favored Glycine 0 N--CA 1.468 0.821 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 167.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 42.5 t -138.8 158.28 44.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 116.994 -1.882 . . . . 0.0 106.925 166.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.594 HD21 HD12 ' A' ' 94' ' ' LEU . 2.0 tt -129.01 105.26 8.08 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.038 -162.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -106.37 81.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 -170.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.65 -82.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 120.627 3.011 . . . . 0.0 120.627 -155.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.594 HD12 HD21 ' A' ' 91' ' ' LEU . 2.1 mt -116.22 170.6 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -147.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -110.12 -136.05 0.36 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -157.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.31 -47.82 19.0 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -161.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.62 -29.57 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 124.371 2.034 . . . . 0.0 111.236 171.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.484 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 13.7 m-85 -76.58 -16.41 59.6 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.359 -172.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.0 tttt -56.95 -52.4 65.36 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.282 -0.886 . . . . 0.0 112.871 168.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.63 -36.14 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.858 -0.526 . . . . 0.0 111.09 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -61.29 -44.11 97.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.06 81.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.211 0.529 . . . . 0.0 112.408 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.28 -44.76 95.79 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 99.0 mt -80.05 -33.71 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.256 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -71.94 -18.47 62.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.77 31.13 4.94 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.668 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 85.9 m-85 -106.9 159.97 15.86 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -131.01 111.46 12.04 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.589 HG13 ' CD1' ' A' ' 117' ' ' TRP . 14.1 tt -90.71 153.25 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 122.739 1.257 . . . . 0.0 112.578 -166.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.597 HG23 ' SG ' ' A' ' 116' ' ' CYS . 17.0 tt -154.04 130.38 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.193 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -93.45 98.86 11.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 123.243 1.497 . . . . 0.0 110.698 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -109.58 177.84 1.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 112.785 -2.007 . . . . 0.0 108.469 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -55.61 -14.28 9.8 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 119.041 2.67 . . . . 0.0 119.041 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -118.1 149.56 40.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 154.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.453 ' HE2' ' HE1' ' A' ' 117' ' ' TRP . 22.5 t80 -86.45 139.23 31.11 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 120.774 -1.204 . . . . 0.0 108.997 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.597 ' SG ' HG23 ' A' ' 110' ' ' ILE 0.356 28.1 p -146.11 120.59 9.7 Favored 'General case' 0 CA--C 1.553 1.093 1 N-CA-C 129.216 6.747 . . . . 0.0 129.216 -173.684 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.589 ' CD1' HG13 ' A' ' 109' ' ' ILE . 8.2 m0 -109.75 117.51 34.07 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.422 1.464 . . . . 0.0 109.178 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -107.68 144.38 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.855 -1.153 . . . . 0.0 109.443 172.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -79.7 110.49 15.09 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.612 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.641 0.734 . . . . 0.0 109.173 -170.343 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.2 t80 . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.98 141.65 51.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.58 1.181 . . . . 0.0 110.945 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.8 t -94.34 120.78 35.09 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.09 -161.69 11.46 Favored Glycine 0 N--CA 1.466 0.666 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.586 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -134.04 139.77 46.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.672 -1.764 . . . . 0.0 107.4 -165.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.6 tp -124.29 129.83 51.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.647 1.213 . . . . 0.0 108.805 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 mp -115.1 120.37 39.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.59 -1.641 . . . . 0.0 107.051 171.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.2 tt -128.72 140.0 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.28 0.562 . . . . 0.0 109.737 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -102.7 129.75 25.24 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.14 -13.46 31.98 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 N-CA-C 120.462 3.216 . . . . 0.0 120.462 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.13 -50.21 56.11 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -161.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.07 -30.12 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.273 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.4 p -80.77 0.14 36.06 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -76.35 3.72 10.42 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.034 1.288 . . . . 0.0 112.49 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 m -113.48 71.64 1.69 Allowed Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 43.51 0.78 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.768 2.978 . . . . 0.0 116.255 -153.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.22 -40.34 90.22 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.418 -0.801 . . . . 0.0 112.226 163.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mp -62.26 -29.89 70.73 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.03 -50.06 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.115 -0.366 . . . . 0.0 110.779 173.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -47.43 56.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 t -61.75 -40.61 95.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.081 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -62.29 -38.59 89.95 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 169.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.31 78.08 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.942 1.246 . . . . 0.0 113.807 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -56.9 -56.38 22.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . -64.63 -38.71 91.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.84 -37.63 34.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -170.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -57.8 -27.7 63.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.806 1.185 . . . . 0.0 113.778 170.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.93 -119.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -153.28 40.5 0.53 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 124.317 2.008 . . . . 0.0 111.946 -170.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.481 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 59.6 t -131.04 110.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 111.183 -2.735 . . . . 0.0 108.7 170.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.09 141.87 35.88 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 167.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -88.7 139.64 30.26 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.6 t -108.91 -36.64 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.468 -166.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -121.85 169.93 10.28 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.881 1.324 . . . . 0.0 111.309 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -135.8 125.16 24.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.635 -1.621 . . . . 0.0 108.248 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -124.15 120.26 31.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.973 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.31 149.38 21.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.403 HD13 ' OH ' ' A' ' 62' ' ' TYR . 2.9 tp -63.5 -40.19 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -78.88 -30.33 44.89 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.5 -0.75 . . . . 0.0 112.92 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -80.3 -32.42 38.04 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.547 -0.721 . . . . 0.0 112.721 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.65 -40.43 80.23 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.457 -0.777 . . . . 0.0 111.89 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -78.06 -30.9 50.01 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.89 -36.75 36.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.848 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.89 15.31 2.9 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 170.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 t -78.06 -26.44 48.27 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.24 1.52 . . . . 0.0 114.456 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.61 120.24 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.8 m -126.87 120.12 28.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.633 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.08 -166.88 1.35 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.57 170.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -98.84 169.91 9.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.586 1.184 . . . . 0.0 110.056 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 76.9 m-20 -77.13 97.56 4.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.587 170.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.33 -151.18 0.43 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -166.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -100.08 31.73 3.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -162.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 59' ' ' THR . 2.5 m-85 -81.86 21.51 0.85 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.373 -170.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.38 35.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -166.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -143.62 115.45 8.25 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 163.706 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 68.4 t -118.62 134.48 62.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.237 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -122.61 134.77 54.5 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.403 ' OH ' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -116.72 110.89 19.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 169.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.35 102.02 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.63 1.205 . . . . 0.0 111.466 170.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -132.82 154.95 81.63 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.42 128.13 19.74 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.344 2.03 . . . . 0.0 115.816 170.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -100.77 30.18 4.14 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.116 -169.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.76 -61.95 1.3 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.032 -1.042 . . . . 0.0 109.307 -170.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -92.52 115.26 27.93 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -170.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 m -77.07 78.89 3.6 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.864 0.84 . . . . 0.0 111.17 170.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.14 -24.67 1.42 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.058 -170.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.8 pt -75.17 156.74 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.088 0.946 . . . . 0.0 112.513 -169.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -113.63 152.81 29.87 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.01 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 11.6 t80 -130.34 148.81 71.37 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 30.7 Cg_exo -82.02 149.54 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 CA-C-N 120.505 1.216 . . . . 0.0 110.456 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.68 -36.59 83.41 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.09 -32.9 72.55 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.61 -30.32 56.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.833 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.98 -34.9 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 119.954 1.252 . . . . 0.0 111.459 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.2 m -68.34 -39.16 82.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.893 1.224 . . . . 0.0 112.62 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.91 -37.54 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.947 -0.47 . . . . 0.0 111.774 174.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.04 -47.8 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.81 -0.556 . . . . 0.0 111.956 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.33 -30.06 70.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.402 1.631 . . . . 0.0 115.402 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.21 -9.86 59.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 54' ' ' ASN . 29.7 p -71.12 -35.25 71.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.05 167.05 14.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 123.16 1.457 . . . . 0.0 114.2 -150.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.73 101.89 0.57 Allowed Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 111.893 -2.412 . . . . 0.0 106.483 166.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -50.93 -6.98 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.269 0 N-CA-C 120.707 3.311 . . . . 0.0 120.707 -153.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -88.96 55.03 3.19 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.769 1.622 . . . . 0.0 108.809 160.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.23 157.89 28.48 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.1 p -128.05 159.17 35.9 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.274 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -127.56 142.7 51.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.542 -2.117 . . . . 0.0 106.141 -173.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.047 HD13 ' SG ' ' A' ' 116' ' ' CYS . 46.7 mm -129.04 89.1 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 170.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.97 -88.43 0.09 OUTLIER Glycine 0 C--N 1.318 -0.472 0 N-CA-C 121.587 3.395 . . . . 0.0 121.587 -166.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 91' ' ' LEU . 3.3 mt -116.37 146.85 42.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.617 1.199 . . . . 0.0 109.513 -130.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.7 p -86.36 -136.68 0.08 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.526 -158.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.69 -50.5 13.51 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -156.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.22 -32.5 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 124.789 2.233 . . . . 0.0 113.015 170.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 51.0 m-85 -76.63 -14.89 59.95 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.737 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -59.08 -55.82 30.2 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.079 -1.013 . . . . 0.0 111.951 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.07 -34.85 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.897 -0.502 . . . . 0.0 111.49 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -60.01 -40.93 90.96 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 171.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.406 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . . . -58.89 -43.59 90.98 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.912 -0.492 . . . . 0.0 111.741 173.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.98 -49.45 71.39 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.702 0.763 . . . . 0.0 112.543 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.3 tt -80.24 -33.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.594 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -71.72 -19.71 62.01 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.96 33.28 4.09 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 119.607 -1.282 . . . . 0.0 112.597 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.503 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 95.8 m-85 -106.48 159.65 16.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 168.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -126.13 103.88 7.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.593 HG13 ' CD1' ' A' ' 117' ' ' TRP . 18.0 tt -76.15 140.69 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 122.882 1.325 . . . . 0.0 111.316 -168.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.45 119.02 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -106.56 94.55 5.2 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 123.598 1.666 . . . . 0.0 110.642 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -134.1 179.17 1.45 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 112.496 -2.138 . . . . 0.0 106.737 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.83 -11.53 3.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 118.654 2.521 . . . . 0.0 118.654 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -122.83 111.51 16.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 157.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.09 110.26 21.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.393 -0.813 . . . . 0.0 109.23 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.274 ' CB ' ' O ' ' A' ' 91' ' ' LEU . 26.3 p -147.75 -157.03 0.77 Allowed 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 122.808 1.29 . . . . 0.0 113.65 170.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.593 ' CD1' HG13 ' A' ' 109' ' ' ILE . 22.5 m0 -137.33 130.42 30.71 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.618 -170.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -112.86 144.58 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.276 -1.515 . . . . 0.0 110.294 166.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.77 110.49 15.17 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.375 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.47 0.552 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.344 -170.321 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.37 141.96 27.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.65 0.738 . . . . 0.0 110.839 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -95.74 141.42 29.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 162.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.76 -160.12 9.22 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-O 124.132 1.962 . . . . 0.0 115.205 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.452 HD21 ' CE2' ' A' ' 40' ' ' PHE . 3.8 mt -134.2 139.67 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 111.4 -2.4 . . . . 0.0 107.751 -174.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.41 130.01 51.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.817 1.294 . . . . 0.0 107.839 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.425 ' HG ' ' HB2' ' A' ' 40' ' ' PHE . 8.7 mp -113.85 120.34 40.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.719 175.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.2 mt -121.3 139.9 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -171.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -94.11 129.77 36.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 165.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -60.68 -16.43 43.35 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 N-CA-C 121.056 3.444 . . . . 0.0 121.056 -170.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.78 72.49 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.317 1.417 . . . . 0.0 113.111 -162.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.02 -29.93 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.6 p -86.12 0.47 53.46 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -170.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -76.29 0.35 19.63 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 120.674 1.579 . . . . 0.0 112.601 170.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.322 90.8 m -98.87 168.09 10.29 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 162.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.74 -7.26 16.54 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 N-CA-C 117.837 2.206 . . . . 0.0 117.837 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.17 -50.48 19.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -159.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.29 -29.83 67.78 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.468 1.031 . . . . 0.0 112.579 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 t -66.26 -49.99 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.982 -0.449 . . . . 0.0 110.513 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.4 -39.73 88.4 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.982 -1.074 . . . . 0.0 113.29 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -59.87 -50.32 74.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 t -68.47 -34.51 76.07 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.615 -0.678 . . . . 0.0 111.698 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.27 -29.96 69.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 170.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.03 -47.09 66.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.482 1.037 . . . . 0.0 112.288 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.75 -48.72 77.19 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 173.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.97 60.64 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.549 169.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.29 70.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.2 -170.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -75.34 -19.53 59.56 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.1 -111.0 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.771 -0.581 . . . . 0.0 111.255 170.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -149.48 -10.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -166.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -98.98 149.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 121.592 -0.692 . . . . 0.0 112.402 170.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -128.29 143.9 51.07 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 164.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -92.54 139.84 30.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.754 0.788 . . . . 0.0 109.453 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.36 -32.69 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -121.62 169.98 10.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.292 1.52 . . . . 0.0 109.961 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -139.8 125.18 19.02 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.687 -172.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.452 ' CE2' HD21 ' A' ' 8' ' ' LEU . 21.4 m-30 -129.49 106.42 8.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mp -84.92 149.57 25.56 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.45 -0.781 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 tp -63.33 -40.11 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.12 -30.35 34.57 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.576 -0.702 . . . . 0.0 112.823 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -79.03 -31.59 44.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.122 -0.987 . . . . 0.0 112.789 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -72.6 -40.59 66.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.604 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.14 -15.29 58.98 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.978 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.34 -43.41 11.54 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.26 -0.9 . . . . 0.0 111.989 171.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.99 15.3 2.35 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -76.05 -25.58 55.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.638 1.719 . . . . 0.0 114.575 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.7 121.7 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -169.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -98.76 159.28 15.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 124.344 2.021 . . . . 0.0 109.349 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -130.91 120.74 24.03 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.028 -153.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.79 169.67 9.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.043 168.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -111.13 88.55 2.81 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.5 -158.81 0.9 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -164.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -90.99 35.07 0.9 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.779 -1.555 . . . . 0.0 115.052 -163.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 59' ' ' THR . 10.3 m-85 -82.03 21.84 0.85 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.374 -170.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.55 37.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -163.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' TYR . 1.0 OUTLIER -141.22 115.4 9.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 163.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 91' ' ' LEU . 18.7 t -118.61 134.51 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.633 -1.622 . . . . 0.0 106.743 -164.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -122.84 134.71 54.39 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.76 110.52 16.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.4 mt -98.05 100.7 12.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.451 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.5 m -126.2 92.45 45.66 Favored Pre-proline 0 N--CA 1.474 0.752 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 167.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.06 97.46 1.06 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.077 1.851 . . . . 0.0 111.994 170.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -120.11 -30.18 4.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.166 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.44 -108.21 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -112.08 -62.83 1.51 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 170.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.6 p -84.08 159.25 21.18 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.698 0.761 . . . . 0.0 111.164 170.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -75.85 178.81 5.91 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.117 -170.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.3 pt -105.05 -168.54 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.665 0.745 . . . . 0.0 112.119 170.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.69 143.44 34.59 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 123.088 1.423 . . . . 0.0 112.425 -163.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 16.4 t80 -130.29 149.11 72.4 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 113.055 -1.884 . . . . 0.0 107.254 -170.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 30.3 Cg_exo -82.14 149.47 15.41 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 CA-C-N 120.617 1.256 . . . . 0.0 110.242 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.54 -38.01 88.33 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.89 -35.15 70.6 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 mt -76.62 -30.26 56.82 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.51 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.05 -36.17 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 119.899 1.227 . . . . 0.0 111.429 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.8 m -68.62 -39.17 80.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.544 1.066 . . . . 0.0 112.814 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -36.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.992 -0.443 . . . . 0.0 111.855 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.7 -46.44 90.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.743 -0.598 . . . . 0.0 111.849 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.86 70.21 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.33 -10.15 59.55 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -169.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.0 m -76.17 -34.64 59.35 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 168.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.83 176.5 6.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 123.998 1.856 . . . . 0.0 114.885 -148.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 88' ' ' ASN . 29.3 tptp -105.06 101.57 30.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 -170.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -51.34 16.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.384 1 N-CA-C 122.903 4.155 . . . . 0.0 122.903 -153.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 86' ' ' LYS . 28.5 m120 -102.05 61.37 0.87 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 156.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.47 137.39 13.23 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.1 p -134.08 109.45 8.95 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.644 1.212 . . . . 0.0 107.884 -169.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.242 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.28 6.2 tt -93.38 132.25 37.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.813 -174.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.006 ' HA ' ' HB3' ' A' ' 116' ' ' CYS . 37.0 mm -115.68 84.94 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -170.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.88 -87.2 0.09 OUTLIER Glycine 0 C--N 1.315 -0.593 0 N-CA-C 121.168 3.227 . . . . 0.0 121.168 -163.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.88 169.85 8.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.169 -139.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.468 ' H ' ' HD2' ' A' ' 98' ' ' TYR . 43.0 m -105.35 -155.32 0.54 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.282 -0.886 . . . . 0.0 112.37 -157.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.95 -42.98 84.32 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -163.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.5 tp -59.8 -33.15 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 124.3 2.0 . . . . 0.0 112.545 169.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.468 ' HD2' ' H ' ' A' ' 95' ' ' SER . 32.0 m-85 -76.54 -12.85 60.09 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.785 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.4 tttt -62.81 -48.29 79.73 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.065 -1.022 . . . . 0.0 112.404 165.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.69 -38.33 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.489 -0.757 . . . . 0.0 110.714 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -60.34 -48.45 81.7 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 170.366 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.99 -41.58 71.4 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.56 -47.48 83.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.8 mt -77.16 -35.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.038 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -71.97 -16.74 62.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.84 29.93 5.36 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.947 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 87.3 m-85 -106.92 159.7 16.07 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.768 1.27 . . . . 0.0 108.809 173.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.59 109.52 11.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.36 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.62 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.1 tt -85.63 111.15 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.905 1.336 . . . . 0.0 114.082 -164.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 19.0 tt -119.51 135.07 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.231 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -119.64 97.28 5.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.911 -168.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -117.31 -177.42 0.45 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 112.606 -2.088 . . . . 0.0 107.582 164.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.4 -11.11 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 N-CA-C 118.948 2.634 . . . . 0.0 118.948 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -103.95 113.31 26.75 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 154.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.505 ' OH ' HD11 ' A' ' 109' ' ' ILE . 28.5 t80 -80.12 115.16 19.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.612 170.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.242 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 24.4 p -147.35 -156.86 0.75 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.168 1.461 . . . . 0.0 112.343 166.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.62 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.4 m0 -132.58 149.66 52.28 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -174.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.58 144.18 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 122.983 1.373 . . . . 0.0 108.586 165.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -79.69 110.19 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.928 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.156 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -88.89 141.8 28.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.016 0.912 . . . . 0.0 110.706 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.46 141.64 30.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 160.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.79 -168.25 11.78 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-O 123.964 1.869 . . . . 0.0 117.052 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.444 HD11 ' CE2' ' A' ' 40' ' ' PHE . 30.1 tp -134.39 115.14 13.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 111.215 -2.493 . . . . 0.0 106.213 -165.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 129.19 54.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.35 148.88 32.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.908 1.337 . . . . 0.0 108.646 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.8 mt -133.7 111.63 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.651 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -87.07 129.52 51.64 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -59.97 -19.74 56.89 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 N-CA-C 121.008 3.426 . . . . 0.0 121.008 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.44 74.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.685 1.13 . . . . 0.0 113.197 -162.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.59 -27.6 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -171.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.7 p -86.1 0.39 53.63 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -170.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.3 m -76.4 -0.26 22.13 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 120.681 1.582 . . . . 0.0 111.738 168.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.3 m -108.96 71.6 0.44 Allowed Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 43.86 0.74 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.088 3.192 . . . . 0.0 116.421 -153.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.39 -39.6 92.41 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.579 -0.701 . . . . 0.0 112.138 162.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.31 -30.72 68.56 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.11 -48.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 122.341 -0.224 . . . . 0.0 110.907 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.47 -33.07 74.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.9 -48.39 37.62 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -61.45 -42.58 98.98 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.523 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -65.52 -32.92 74.78 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.145 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.59 78.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.069 1.304 . . . . 0.0 113.177 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.0 -55.49 30.29 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.67 87.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.64 70.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -170.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.8 m -58.09 -28.67 64.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 170.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -85.84 -101.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.85 -0.531 . . . . 0.0 109.967 -170.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -147.26 27.72 1.02 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -131.05 110.55 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.978 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.4 139.46 37.03 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.072 -1.017 . . . . 0.0 108.989 168.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -88.99 139.84 30.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.83 -33.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.876 -166.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -121.82 169.58 10.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.684 1.23 . . . . 0.0 108.906 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -126.64 154.64 43.74 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.444 ' CE2' HD11 ' A' ' 8' ' ' LEU . 14.3 m-30 -136.12 112.93 10.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.7 149.24 25.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -63.47 -40.16 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.79 -30.31 40.58 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.49 -29.68 30.39 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.099 -1.001 . . . . 0.0 113.113 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.89 -40.35 72.27 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.892 . . . . 0.0 111.874 174.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -73.37 -18.82 61.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.09 -46.41 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.291 -0.881 . . . . 0.0 112.1 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.74 15.15 1.41 Allowed Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -77.53 -10.55 59.55 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.024 1.912 . . . . 0.0 115.645 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.78 121.36 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.692 -0.63 . . . . 0.0 109.671 -169.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -98.97 120.29 39.17 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 123.814 1.769 . . . . 0.0 109.776 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -119.1 120.84 38.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.76 -158.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.5 169.57 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.472 1.129 . . . . 0.0 109.39 167.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -110.14 88.35 2.74 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.85 -119.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -100.09 56.89 0.95 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -156.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -112.05 10.73 20.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 85' ' ' LEU 0.253 19.3 mt-10 -78.75 46.55 0.67 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.944 2.611 . . . . 0.0 112.542 -170.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.99 108.85 17.92 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 150.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.61 110.58 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 112.54 -2.118 . . . . 0.0 107.894 -155.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -115.05 105.33 12.83 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 -174.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.83 141.97 28.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 119.819 -1.801 . . . . 0.0 109.498 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.1 tp -124.06 80.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.481 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -134.06 81.9 49.94 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.94 1.7 . . . . 0.0 111.367 -170.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -80.22 104.93 1.7 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 121.993 1.795 . . . . 0.0 110.267 169.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -120.1 -30.2 4.72 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 170.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.1 -178.94 7.26 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.141 0.972 . . . . 0.0 111.194 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -74.86 -34.36 62.25 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.535 170.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 70' ' ' ASP . 6.0 t -78.31 -104.08 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -170.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.506 ' H ' HG23 ' A' ' 69' ' ' THR . 6.7 m-20 -135.07 178.46 7.01 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.669 1.122 . . . . 0.0 110.201 170.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.4 pt -108.48 -157.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.941 170.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -125.06 139.49 53.75 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 164.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 5.8 t80 -130.64 149.02 72.37 Favored Pre-proline 0 N--CA 1.476 0.851 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 170.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 23.2 Cg_exo -82.27 149.63 15.19 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 120.046 1.052 . . . . 0.0 110.402 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.49 -34.59 77.17 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -59.29 -36.53 75.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.56 -30.15 56.95 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.985 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.89 -40.18 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 O-C-N 121.281 -0.887 . . . . 0.0 110.937 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.6 m -71.23 -30.92 66.94 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.996 -1.065 . . . . 0.0 113.853 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -59.96 -46.01 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.858 -0.526 . . . . 0.0 110.799 171.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -37.38 75.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.32 -29.4 70.48 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.02 -9.79 58.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -68.41 -50.48 52.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.938 -0.476 . . . . 0.0 112.104 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.479 ' CD1' ' H ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -98.82 -141.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -174.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.581 ' CB ' ' HD2' ' A' ' 87' ' ' PRO 0.262 74.9 mmtt -129.84 -139.51 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -170.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 86' ' ' LYS . 49.6 Cg_endo -68.97 -50.25 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 CA-C-N 124.385 2.602 . . . . 0.0 114.129 170.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -79.33 53.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.217 1.371 . . . . 0.0 114.318 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.39 164.72 28.35 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 161.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.5 t -147.02 159.23 43.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.185 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.376 1.2 tm? -128.44 129.55 46.3 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 112.222 -2.263 . . . . 0.0 104.91 -162.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.804 HD13 ' CB ' ' A' ' 116' ' ' CYS . 40.3 mm -118.49 84.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.016 1.734 . . . . 0.0 108.256 170.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.82 -88.18 0.09 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 -161.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -115.61 169.77 8.94 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.798 -143.038 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.4 m -108.69 -148.47 0.42 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -158.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.54 -45.05 88.81 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -163.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -58.89 -31.19 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 124.762 2.22 . . . . 0.0 110.84 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.755 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 79.1 m-85 -76.75 -2.97 35.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.523 -174.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.408 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 87.3 tttt -67.2 -49.18 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.213 -0.929 . . . . 0.0 111.892 170.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.4 -34.41 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.02 169.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.755 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -61.19 -47.94 83.84 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 172.445 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.32 80.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 tp -58.94 -49.94 75.95 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.613 0.72 . . . . 0.0 112.55 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.19 -34.38 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.4 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -71.69 -16.68 62.25 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.67 29.04 5.74 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.496 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 82.7 m-85 -106.67 159.72 15.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -120.83 153.94 36.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.522 ' CG1' ' CD1' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -112.07 152.45 13.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.566 -167.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 tp -154.01 120.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.66 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -107.6 100.23 9.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 123.735 1.731 . . . . 0.0 110.196 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.73 -178.24 0.64 Allowed Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 111.72 -2.491 . . . . 0.0 106.698 169.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.06 -10.73 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 N-CA-C 119.314 2.774 . . . . 0.0 119.314 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -119.71 111.53 18.14 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 158.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.44 115.33 27.49 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.941 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.185 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 11.7 p -147.12 -163.44 1.76 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 124.321 2.01 . . . . 0.0 114.334 172.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.522 ' CD2' HD12 ' A' ' 91' ' ' LEU . 13.2 m0 -137.65 130.35 29.91 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 110.559 -3.019 . . . . 0.0 106.412 -165.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.45 144.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 120.585 -1.322 . . . . 0.0 108.88 165.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -79.59 110.58 15.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.753 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.391 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.9 t80 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.63 141.81 28.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.97 0.89 . . . . 0.0 111.319 -165.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 m -96.96 141.17 30.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 172.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -134.2 -158.7 8.62 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 118.787 -1.673 . . . . 0.0 115.76 172.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.31 139.67 45.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 113.252 -1.474 . . . . 0.0 108.636 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.59 138.7 54.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.997 1.379 . . . . 0.0 107.815 165.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.91 120.46 30.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.264 -1.789 . . . . 0.0 108.983 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 tt -129.02 139.84 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 122.05 0.929 . . . . 0.0 111.316 -160.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -106.94 129.8 23.83 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 166.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -60.0 -15.82 35.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 N-CA-C 119.984 3.032 . . . . 0.0 119.984 -170.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -50.19 74.21 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.294 0.952 . . . . 0.0 112.206 -167.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -34.26 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -85.41 -0.01 53.56 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -76.48 -8.18 56.64 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 120.064 1.302 . . . . 0.0 111.59 164.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.5 m -111.62 71.46 0.93 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 164.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.84 53.3 0.77 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.3 3.334 . . . . 0.0 116.779 -154.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.12 -48.73 27.55 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.753 -1.217 . . . . 0.0 112.67 165.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.53 -30.34 71.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.27 -45.64 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.147 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.76 -34.94 78.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.57 -48.21 49.82 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 t -60.72 -40.96 94.26 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.81 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.91 -32.99 73.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.172 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.14 74.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.942 1.246 . . . . 0.0 113.823 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -55.05 -55.26 33.01 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.66 -46.31 84.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.037 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.24 -50.01 71.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -170.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -69.85 -20.55 63.41 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 112.574 -170.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.73 -103.13 0.06 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.314 0.578 . . . . 0.0 109.443 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -157.4 4.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.86 150.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.643 0.735 . . . . 0.0 111.451 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -128.42 135.03 48.95 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 161.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -88.93 139.56 30.33 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.83 -14.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -163.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.61 120.32 34.45 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -114.77 125.1 53.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -163.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -130.17 102.35 6.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.689 -175.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 43' ' ' ASN . 7.7 tt -85.24 149.34 25.56 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.061 -174.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -63.42 -40.17 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' H ' HD23 ' A' ' 41' ' ' LEU . 22.1 t-20 -81.64 -30.34 32.83 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.197 -0.939 . . . . 0.0 112.762 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.91 -30.75 56.28 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.433 -0.792 . . . . 0.0 112.577 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -40.43 70.66 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.882 0.765 . . . . 0.0 112.306 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -79.17 -20.64 47.93 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.74 -30.55 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 111.623 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.53 15.14 11.57 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 t -78.4 -34.34 48.14 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 mt -114.98 120.3 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.753 0.787 . . . . 0.0 108.983 -167.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.0 m -133.05 158.71 42.07 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.5 mt -131.71 -138.5 0.2 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.93 178.77 4.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.013 0.911 . . . . 0.0 109.937 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -120.1 67.38 0.83 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.187 -169.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.19 -77.92 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 -170.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -82.9 7.74 14.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 -157.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -90.13 21.25 3.83 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.16 -167.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.93 26.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -167.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 57' ' ' TYR . 6.4 t -133.12 115.1 14.66 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 162.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.56 134.32 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -167.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -122.71 134.75 54.45 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.28 142.23 42.18 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -123.36 102.66 8.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.604 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.423 HG22 ' HD2' ' A' ' 65' ' ' PRO . 29.8 m -139.43 154.75 71.94 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 170.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.423 ' HD2' HG22 ' A' ' 64' ' ' THR . 79.8 Cg_exo -49.75 133.45 33.05 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.849 2.366 . . . . 0.0 116.366 170.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -95.08 8.77 41.92 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.266 -170.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.82 -179.26 4.12 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.409 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -82.73 94.16 7.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.623 0.725 . . . . 0.0 111.497 -170.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.4 m -88.0 -63.94 1.22 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 166.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -124.54 178.55 5.36 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 163.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.9 pt -108.26 8.33 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 170.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.17 139.82 53.3 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 122.346 1.07 . . . . 0.0 111.945 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.2 t80 -130.07 149.06 72.13 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 162.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 31.2 Cg_exo -82.0 149.34 15.63 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 CA-C-N 121.233 1.476 . . . . 0.0 110.109 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -37.9 88.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.11 -33.61 73.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -76.72 -30.15 56.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.34 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -36.72 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.75 1.159 . . . . 0.0 111.442 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.0 t -68.27 -36.24 79.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.84 1.2 . . . . 0.0 112.82 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.74 -41.14 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.941 -0.474 . . . . 0.0 111.533 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -60.06 -46.35 89.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.648 0.658 . . . . 0.0 112.364 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.88 70.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.7 -10.02 59.12 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -170.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -104.44 23.32 13.41 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.3 mt -134.12 -166.64 1.83 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.165 0.983 . . . . 0.0 110.829 -163.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -136.96 174.88 3.95 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -170.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.8 -22.72 14.25 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 170.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -102.51 45.83 0.95 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.741 1.61 . . . . 0.0 110.4 170.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.45 138.4 20.34 Favored Glycine 0 N--CA 1.465 0.633 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -143.4 109.08 5.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.43 1.586 . . . . 0.0 107.041 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.161 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.368 0.2 OUTLIER -89.82 129.72 36.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -176.075 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.255 HD13 ' SG ' ' A' ' 116' ' ' CYS . 42.7 mm -111.44 95.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.243 1.021 . . . . 0.0 109.097 170.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.93 -83.68 0.06 OUTLIER Glycine 0 C--N 1.315 -0.625 0 N-CA-C 120.851 3.1 . . . . 0.0 120.851 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.557 HD12 HD11 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -116.09 169.94 8.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 118.764 -1.174 . . . . 0.0 108.476 -133.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -103.02 -140.94 0.36 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.07 -1.019 . . . . 0.0 112.63 -155.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.22 -44.79 24.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -162.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tp -56.63 -33.05 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 124.505 2.097 . . . . 0.0 112.569 167.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.712 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 71.8 m-85 -76.66 -10.88 59.7 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.203 -176.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HG3' HD13 ' A' ' 109' ' ' ILE . 87.6 tttt -58.45 -51.52 69.51 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 112.256 167.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.44 -35.28 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.896 -0.503 . . . . 0.0 111.236 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -57.89 -42.96 85.77 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 170.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.35 94.57 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.122 0.487 . . . . 0.0 111.164 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -54.92 -48.0 73.65 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.4 tt -80.24 -35.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.076 -169.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.68 -18.74 62.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.94 31.95 4.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.004 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -106.71 159.69 16.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.5 154.27 35.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.539 1.162 . . . . 0.0 107.933 158.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.626 HG13 ' CD1' ' A' ' 117' ' ' TRP . 19.2 tt -107.48 149.26 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.745 -163.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.72 126.18 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 122.553 1.168 . . . . 0.0 107.953 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -106.05 100.21 9.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.593 1.663 . . . . 0.0 109.826 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -127.93 177.59 2.01 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 111.935 -2.393 . . . . 0.0 107.446 170.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -54.99 -11.82 4.16 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 N-CA-C 119.269 2.757 . . . . 0.0 119.269 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -115.94 108.12 15.86 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 157.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -86.8 113.06 22.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.668 -170.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.255 ' SG ' HD13 ' A' ' 92' ' ' ILE . 25.1 p -147.54 -153.95 0.52 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 123.072 1.415 . . . . 0.0 112.258 172.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.626 ' CD1' HG13 ' A' ' 109' ' ' ILE . 11.0 m0 -134.77 149.73 50.46 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.66 144.09 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 166.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -83.31 134.83 34.9 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.742 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.798 0.809 . . . . 0.0 110.616 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 12.5 t80 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.764 0.316 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -105.06 160.58 14.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 123.367 1.556 . . . . 0.0 113.403 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.077 170.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.414 ' HA3' HG23 ' A' ' 59' ' ' THR . . . -123.69 -156.39 9.5 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.849 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 tp -134.03 142.72 47.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -166.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.05 129.83 51.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 40' ' ' PHE . 1.3 mt -109.36 120.08 41.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 171.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 tt -132.14 139.93 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.539 0.685 . . . . 0.0 109.324 -173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -101.08 129.75 26.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.39 -12.02 25.53 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.968 3.026 . . . . 0.0 119.968 -170.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.26 52.44 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -161.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -85.2 -29.81 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.175 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.2 p -81.08 0.24 36.91 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -76.33 -0.87 24.1 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.859 1.209 . . . . 0.0 112.247 165.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 m -112.47 71.5 1.18 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 163.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.17 46.1 1.08 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.986 3.124 . . . . 0.0 116.219 -152.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.24 -43.5 91.21 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.599 -0.688 . . . . 0.0 112.608 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.49 -29.94 70.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.25 -46.88 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.934 -0.479 . . . . 0.0 110.887 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.25 -33.92 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -69.89 -48.79 57.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.463 ' HA ' HE21 ' A' ' 28' ' ' GLN . 9.7 t -61.73 -39.21 90.74 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.477 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -66.3 -29.9 70.21 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.99 -42.34 76.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.236 1.38 . . . . 0.0 113.428 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.463 HE21 ' HA ' ' A' ' 25' ' ' THR . 33.7 mt-30 -59.69 -50.83 72.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.966 -0.459 . . . . 0.0 111.611 170.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.91 -42.66 59.58 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.69 -49.92 12.31 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -59.35 -37.39 77.74 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 170.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.9 -106.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.717 -0.615 . . . . 0.0 110.389 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 4' ' ' TYR . 43.1 mmtm -129.76 -44.86 1.19 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -169.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 59' ' ' THR . 2.3 p -97.98 149.58 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.728 1.251 . . . . 0.0 111.335 -165.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -114.88 136.0 53.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.653 -1.612 . . . . 0.0 107.63 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -90.46 139.47 30.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.7 t -118.74 -32.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.63 -162.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -121.86 169.99 10.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 123.273 1.511 . . . . 0.0 110.859 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -134.49 125.4 27.31 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.757 -174.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 10' ' ' LEU . 18.4 m-30 -118.68 120.21 36.73 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 168.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.64 149.43 22.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.53 -40.09 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -81.97 -30.45 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -85.53 -31.5 22.68 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -0.918 . . . . 0.0 112.944 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 tp -66.21 -40.56 90.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.26 0.937 . . . . 0.0 112.054 171.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -69.67 -24.98 63.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.992 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.13 -39.86 16.27 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.67 -0.644 . . . . 0.0 111.78 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.34 15.36 1.14 Allowed Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -79.74 -30.09 40.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -171.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.8 mt -114.75 120.28 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.867 0.841 . . . . 0.0 109.854 -164.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -128.26 120.45 27.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.239 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.5 -167.43 1.36 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.897 1.332 . . . . 0.0 110.537 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -98.58 120.5 39.12 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.203 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -81.17 46.67 0.94 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -161.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.03 4.42 0.63 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 119.594 3.183 . . . . 0.0 119.594 170.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -100.4 -34.59 9.89 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 122.089 2.222 . . . . 0.0 115.801 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' THR . 8.2 m-85 -81.87 22.04 0.8 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -157.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.3 37.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -167.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.522 HG21 HG21 ' A' ' 34' ' ' VAL . 8.8 t -138.57 115.32 10.69 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 160.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.87 110.34 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.504 -160.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -105.88 134.6 48.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.408 ' CD1' ' HB3' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -118.06 110.42 17.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.25 -0.906 . . . . 0.0 109.017 176.357 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.51 89.5 3.23 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.468 -170.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -136.76 86.71 21.36 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -80.2 82.41 2.49 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.127 1.884 . . . . 0.0 112.84 170.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -120.18 -30.12 4.71 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.745 -0.597 . . . . 0.0 112.61 170.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.05 178.83 9.27 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.695 0.76 . . . . 0.0 109.771 -170.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -108.55 -67.39 0.98 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 170.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -103.6 -49.96 3.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.371 -170.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -92.68 69.85 4.82 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.731 0.777 . . . . 0.0 110.917 -170.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.16 149.99 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 169.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -112.64 139.39 48.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.382 1.087 . . . . 0.0 110.82 170.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 13.1 t80 -130.54 149.11 72.57 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 166.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' PHE . 28.6 Cg_exo -82.2 149.44 15.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 CA-C-N 120.962 1.379 . . . . 0.0 110.344 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.68 -38.38 90.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.14 -31.76 70.39 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.68 -30.3 56.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.992 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.38 -35.28 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 120.203 1.365 . . . . 0.0 111.227 170.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.9 m -68.94 -39.93 79.26 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.597 1.09 . . . . 0.0 112.503 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.19 -38.09 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.942 -0.474 . . . . 0.0 111.84 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -65.85 -40.48 91.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.709 -0.619 . . . . 0.0 112.571 176.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.0 70.72 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.86 -19.16 61.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.4 m -72.06 -17.02 62.04 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -111.15 159.93 17.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.123 0.963 . . . . 0.0 110.387 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -91.38 174.96 3.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.341 169.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -60.43 -10.61 13.93 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 N-CA-C 117.508 2.08 . . . . 0.0 117.508 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -102.07 50.06 0.84 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 168.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.14 141.4 25.03 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.9 p -139.66 103.79 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.194 ' O ' ' HB2' ' A' ' 116' ' ' CYS 0.274 2.6 tt -89.96 129.78 36.25 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -178.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.117 HD13 ' SG ' ' A' ' 116' ' ' CYS . 32.3 mm -110.18 91.14 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.96 -80.71 0.05 OUTLIER Glycine 0 C--N 1.315 -0.596 0 N-CA-C 121.22 3.248 . . . . 0.0 121.22 -163.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.558 HD12 HD21 ' A' ' 91' ' ' LEU . 3.1 mt -115.97 169.78 8.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.227 -141.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 p -123.55 -117.31 0.29 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 119.636 -0.826 . . . . 0.0 113.009 -158.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.36 -59.39 2.73 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -155.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mt -59.7 -26.76 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 124.248 1.975 . . . . 0.0 111.593 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.712 ' HA ' ' HB2' ' A' ' 101' ' ' ASP . 62.4 m-85 -76.9 -18.73 58.12 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.283 -169.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -54.44 -53.96 47.22 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.988 -1.07 . . . . 0.0 112.436 170.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.06 -33.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.837 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -59.84 -43.34 94.65 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 172.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.61 97.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.86 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.03 -44.52 95.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -80.01 -35.63 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.038 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -71.78 -18.74 62.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.92 32.11 4.52 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.79 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 117' ' ' TRP . 91.6 m-85 -106.77 159.96 15.84 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -128.51 109.09 11.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.593 HG13 ' CD1' ' A' ' 117' ' ' TRP . 20.2 tt -87.6 111.22 21.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 122.751 1.263 . . . . 0.0 114.393 -162.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.5 tt -105.12 125.25 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.756 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -115.41 81.53 1.6 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 124.285 1.993 . . . . 0.0 111.299 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 114' ' ' ASP . 90.1 mt-10 -134.34 100.47 12.69 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 -170.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.63 29.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.971 1 N-CA-C 124.8 4.885 . . . . 0.0 124.8 -140.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.2 m-20 -99.68 99.82 10.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 132.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -90.31 115.13 27.28 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.572 -163.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 1.194 ' HB2' ' O ' ' A' ' 91' ' ' LEU . 23.8 p -147.3 -156.49 0.72 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 123.104 1.43 . . . . 0.0 111.77 170.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.593 ' CD1' HG13 ' A' ' 109' ' ' ILE . 10.7 m0 -134.24 149.6 50.98 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 -174.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 143.91 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.351 1.072 . . . . 0.0 108.25 164.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -90.2 64.82 6.2 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.437 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.379 170.13 . . . . . . . . 0 0 . 1 stop_ save_